Citrus Sinensis ID: 006714
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 634 | 2.2.26 [Sep-21-2011] | |||||||
| F4I114 | 714 | Probable serine/threonine | no | no | 0.503 | 0.446 | 0.483 | 3e-97 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.362 | 0.402 | 0.640 | 5e-90 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.414 | 0.512 | 0.478 | 1e-67 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.414 | 0.520 | 0.48 | 3e-65 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.417 | 0.510 | 0.460 | 1e-64 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.411 | 0.508 | 0.476 | 8e-64 | |
| Q14004 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.362 | 0.152 | 0.434 | 6e-52 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | no | no | 0.410 | 0.171 | 0.405 | 7e-52 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.362 | 0.152 | 0.434 | 1e-51 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | no | no | 0.392 | 0.167 | 0.398 | 3e-51 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 356 bits (914), Expect = 3e-97, Method: Compositional matrix adjust.
Identities = 189/391 (48%), Positives = 242/391 (61%), Gaps = 72/391 (18%)
Query: 102 GEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
G QV AGWP+WL++VAGEAI GW+P +AD+FEKLEKIGQGTYSSV++ARDL+T ++VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 162 KIKC----------------------------------------------YMNQLLHGLE 175
K++ YM L GL
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 176 ------------HCHSRGVLH------------RDIKGSNLLVNNEGVLKLADFGLANFS 211
C+ + +LH RDIKGSNLL+++ LK+ DFGLANF
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 271
+QPLTSRVVTLWYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
LHKIFKLCGSP ++YWK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 332 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRK 391
R T ++AL SE+F+T P A D SSLP Y P KEID K +E+ ++K + ++++
Sbjct: 433 DARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQ 492
Query: 392 TTRKSHGMSKLAPVEDVAVRTQFAKKINGHS 422
+R+S + AP + T K+ H+
Sbjct: 493 VSRESKAVP--APDSNAESLTSIQKRQGQHN 521
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (851), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 148/231 (64%), Positives = 186/231 (80%), Gaps = 1/231 (0%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
++KC M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA + H++P+TS
Sbjct: 218 EVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTS 277
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYR PELLLGATDYG +DLWS GC+ AELL G+PI+ GRTEVEQLHKI+KLCGS
Sbjct: 278 RVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGS 337
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P +DYWKK K H ++KP++PY S+RETFKD P +++ LI+ LLS+EP R TASAAL
Sbjct: 338 PSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAAL 397
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHR-EDARRKKVGGRVRGAETRK 391
SE+F+++PYAC+ + LP YPPSKEIDAK R E+ RR++ + +G RK
Sbjct: 398 KSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARK 448
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 132/276 (47%), Positives = 176/276 (63%), Gaps = 13/276 (4%)
Query: 140 QGTYSSVFRARDLD-------TGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 192
+G+ VF D D G + +IKCYM QLL GL +CH VLHRDIKGSNL
Sbjct: 111 KGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNL 170
Query: 193 LVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 252
L++NEG LKLADFGLA ++ H LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+
Sbjct: 171 LIDNEGNLKLADFGLARSFSSDHNGNLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCI 230
Query: 253 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRET 311
FAELL GKPIL G+ E EQL KIF+LCG+P + W +K+P FKPQ+P ++E+
Sbjct: 231 FAELLNGKPILTGKNEPEQLSKIFELCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKES 290
Query: 312 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 371
FK A++L+E +L+++P +R +A AL +EYF T P CD SLP Y S E K
Sbjct: 291 FKHFDQHALDLLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKK 350
Query: 372 REDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVED 407
+ +R+ A R+ + S+L P+++
Sbjct: 351 KRQQQRQ-----AEEAAKRQKLQHPPPHSRLPPIQN 381
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 132/275 (48%), Positives = 169/275 (61%), Gaps = 12/275 (4%)
Query: 140 QGTYSSVFRARDLD-------TGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 192
+G VF D D G + +IKCYM QLL GL +CH VLHRDIKGSNL
Sbjct: 111 KGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 170
Query: 193 LVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 252
L++NEG LKLADFGLA + H LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+
Sbjct: 171 LIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCI 230
Query: 253 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRET 311
FAELL KPIL G+ E EQL+KIF+LCGSP + W SK+P FKP +P +RE
Sbjct: 231 FAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREF 290
Query: 312 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 371
F+ A+ L+E +L ++P +R +A AL +EYF T P CD SLP Y S E K
Sbjct: 291 FRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKK 350
Query: 372 REDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 406
+ +R+ A+ +K S+L P++
Sbjct: 351 KRQQQRQN----EEAAKRQKLQHPPLQHSRLPPLQ 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 128/278 (46%), Positives = 169/278 (60%), Gaps = 13/278 (4%)
Query: 140 QGTYSSVFRARDLD-------TGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 192
+G+ VF D D G + +IKCYM QLL GL +CH VLHRDIKGSNL
Sbjct: 111 KGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNL 170
Query: 193 LVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 252
L++NEG LKLADFGLA + H LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+
Sbjct: 171 LIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCI 230
Query: 253 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRET 311
FAELL GKPIL G+ E EQL KIF +CG+P + W +K+P FKP + ++E
Sbjct: 231 FAELLNGKPILPGKNEPEQLSKIFDVCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEY 290
Query: 312 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 371
FK A++L+E +L+++P +R +A AL +EYF + P CD SLP Y S E K
Sbjct: 291 FKHFDRLALDLLEKMLTLDPAQRISAQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKK 350
Query: 372 REDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVA 409
+ R+ A R+ T+ +L P++
Sbjct: 351 KRQQMRQ-----ADEAAKRQKTQHPQPHGRLPPIQQTG 383
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 130/273 (47%), Positives = 167/273 (61%), Gaps = 12/273 (4%)
Query: 140 QGTYSSVFRARDLD-------TGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 192
+G VF D D G + +IKCYM QLL GL +CH VLHRDIKGSNL
Sbjct: 111 KGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 170
Query: 193 LVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 252
L++NEG LKLADFGLA + H LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+
Sbjct: 171 LIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCI 230
Query: 253 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRET 311
FAELL GKPIL G+TE EQL+KI++LCGSP + W SK+P K +P +RE
Sbjct: 231 FAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREI 290
Query: 312 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 371
++ A+ L+E +L ++P +R A AL +EYF T P CD SLP Y S E K
Sbjct: 291 YRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTK- 349
Query: 372 REDARRKKVGGRVRGAETRKTTRKSHGMSKLAP 404
+R+++ A+ +K S+L P
Sbjct: 350 ---KKRQQMRHNEEAAKKQKLQHPQQQHSRLPP 379
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 102/235 (43%), Positives = 141/235 (60%), Gaps = 5/235 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IK +M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++
Sbjct: 814 IKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNK 873
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 874 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSP 933
Query: 283 PDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL
Sbjct: 934 CPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQAL 993
Query: 342 ASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 395
E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 994 QCEFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 7e-52, Method: Compositional matrix adjust.
Identities = 109/269 (40%), Positives = 156/269 (57%), Gaps = 9/269 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IK +M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++
Sbjct: 815 IKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNK 874
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 875 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSP 934
Query: 283 PDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL
Sbjct: 935 CPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQAL 994
Query: 342 ASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK--SHG 398
E+ +P LP++ E+ +K R RR+K G T K RK S G
Sbjct: 995 QCEFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTVKAPRKDLSLG 1051
Query: 399 M--SKLAPVEDVAVRTQFAKKINGHSLHI 425
M S+ + + V +Q + N ++ +
Sbjct: 1052 MDDSRTSTPQSVLPSSQLKPQGNSNAAPV 1080
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 205 bits (521), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 102/235 (43%), Positives = 141/235 (60%), Gaps = 5/235 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IK +M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++
Sbjct: 814 IKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNK 873
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V+TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 874 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSP 933
Query: 283 PDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL
Sbjct: 934 CPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQAL 993
Query: 342 ASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 395
E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 994 QCEFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDLSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 110/276 (39%), Positives = 156/276 (56%), Gaps = 27/276 (9%)
Query: 137 KIGQGTYSSVFRARD------LDTGKI-VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKG 189
K +G + VF D L++G + + IK +M QL+ GLE+CH + LHRDIK
Sbjct: 803 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLEYCHKKNFLHRDIKC 862
Query: 190 SNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 249
SN+L+NN G +KLADFGLA N+ +P T++V+TLWYRPPELLLG Y P++D+WS
Sbjct: 863 SNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAIDVWSC 922
Query: 250 GCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSL 308
GC+ EL KPI Q E+ QL I +LCGSP W KLP+ KP++ Y L
Sbjct: 923 GCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRL 982
Query: 309 RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID 368
RE F +P+ A++L++ +L+++P KR TA L S++ D+ + PP D
Sbjct: 983 REEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLK------DVELSKMAPP----D 1032
Query: 369 AKHREDA---------RRKKVGGRVRGAETRKTTRK 395
H +D R+++ G V KT+RK
Sbjct: 1033 LPHWQDCHELWSKKRRRQRQSGVVVEEPPPSKTSRK 1068
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 634 | ||||||
| 255547313 | 661 | ATP binding protein, putative [Ricinus c | 0.925 | 0.888 | 0.656 | 0.0 | |
| 224119046 | 685 | predicted protein [Populus trichocarpa] | 0.962 | 0.890 | 0.657 | 0.0 | |
| 359491675 | 663 | PREDICTED: probable serine/threonine-pro | 0.925 | 0.885 | 0.649 | 0.0 | |
| 297733936 | 686 | unnamed protein product [Vitis vinifera] | 0.962 | 0.889 | 0.656 | 0.0 | |
| 356508521 | 674 | PREDICTED: probable serine/threonine-pro | 0.951 | 0.894 | 0.622 | 0.0 | |
| 356516828 | 677 | PREDICTED: probable serine/threonine-pro | 0.955 | 0.895 | 0.619 | 0.0 | |
| 449439293 | 697 | PREDICTED: probable serine/threonine-pro | 0.979 | 0.890 | 0.604 | 0.0 | |
| 79346260 | 709 | protein kinase domain-containing protein | 0.984 | 0.880 | 0.583 | 0.0 | |
| 238479065 | 690 | protein kinase domain-containing protein | 0.958 | 0.881 | 0.573 | 0.0 | |
| 79379990 | 699 | protein kinase domain-containing protein | 0.954 | 0.865 | 0.572 | 0.0 |
| >gi|255547313|ref|XP_002514714.1| ATP binding protein, putative [Ricinus communis] gi|223546318|gb|EEF47820.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2228), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/702 (65%), Positives = 512/702 (72%), Gaps = 115/702 (16%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA D SGGF NSGRIR G
Sbjct: 1 MGCVSSKQAVSVTPAFDHSGGF-------------NSGRIRAG----------------- 30
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
ELGESGRASSN ES+SFRL NL KYIEGE VAAGWPAWLSAVAGEA
Sbjct: 31 --------------ELGESGRASSNGESVSFRLRNLQKYIEGEHVAAGWPAWLSAVAGEA 76
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---------------- 164
IQGWVPL+ADAFEKLEKIGQGTYSSVFRAR+++TG+IVALKK++
Sbjct: 77 IQGWVPLKADAFEKLEKIGQGTYSSVFRAREIETGRIVALKKVRFDNFEPESVRFMAREI 136
Query: 165 -----------------------CYMNQLLHGLEH-------------------CHSRGV 182
C + + +EH C+ R +
Sbjct: 137 LILRRLDHPNVMKLDGLITSRLSCSIYLVFEYMEHDITGLLSCPDVRFSESQIKCYMRQL 196
Query: 183 L------------HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
L HRDIKGSNLLVNNEG+LK+ DFGLANF +TGHRQPLTSRVVTLWYRP
Sbjct: 197 LFGLEHCHSKGVMHRDIKGSNLLVNNEGMLKVGDFGLANFCHTGHRQPLTSRVVTLWYRP 256
Query: 231 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290
PELLLG+T+YG SVDLWSVGCVFAELL+GKP+LQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 257 PELLLGSTEYGASVDLWSVGCVFAELLLGKPVLQGRTEVEQLHKIFKLCGSPPDEYWKKS 316
Query: 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350
+LPHATLFKPQQPYDSSLRE FKDLPTTAVNLIETLLSVEPYKR TAS+ALASEYF TKP
Sbjct: 317 RLPHATLFKPQQPYDSSLREIFKDLPTTAVNLIETLLSVEPYKRGTASSALASEYFMTKP 376
Query: 351 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAV 410
YACD SSLP YPPSKEIDAK+RE+ARRKK GR RGAETRK RK G++KLAP ED
Sbjct: 377 YACDPSSLPKYPPSKEIDAKNREEARRKKTSGRSRGAETRKPARKPGGINKLAPAEDATA 436
Query: 411 RTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTS 469
R Q ++ ++ + K D SG E +K +D EE HVKNAS GDIPFSGPLQVS+S
Sbjct: 437 RIQGSQNSITTNVCLPKGVDAKSGGEARKASLDKLEEIFHVKNASQGDIPFSGPLQVSSS 496
Query: 470 SGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSRTD 529
SGFAWA+RRKDDAS+RSH+RSTSR + N LE S AL ++N+DSR+ ENGD I G RT+
Sbjct: 497 SGFAWARRRKDDASVRSHSRSTSRSLINNGLENSTALQEKSNFDSRRRENGDAIYGIRTN 556
Query: 530 SRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQ 589
SRGHDS E K A+ QWSQLERPDSFDAS+GYHSQELSLALYQREEM +RNNLGFQDQ
Sbjct: 557 SRGHDSNEISKRALQKQWSQLERPDSFDASEGYHSQELSLALYQREEMEARRNNLGFQDQ 616
Query: 590 GEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 631
G+KV+FSGPLLSQSHR+DELLERHERQIRQAVRKSWFQRGKK
Sbjct: 617 GDKVDFSGPLLSQSHRVDELLERHERQIRQAVRKSWFQRGKK 658
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119046|ref|XP_002317972.1| predicted protein [Populus trichocarpa] gi|222858645|gb|EEE96192.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2216), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/709 (65%), Positives = 520/709 (73%), Gaps = 99/709 (13%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVG---NGSGSRNGRGSSNR 57
MGCV++KQAVSVTPALD SG F N+GRIRVG + S +NG +R
Sbjct: 1 MGCVSAKQAVSVTPALDHSGAF-------------NTGRIRVGVDQHPSFKKNG----DR 43
Query: 58 KKGSKGEFGVAVSCGGSELGESGRA-SSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAV 116
+ + + VSCGGSELGESGRA SSN ESLSFRL NLHKYIEGEQVAAGWPAWLSAV
Sbjct: 44 RHHHE----MVVSCGGSELGESGRAPSSNGESLSFRLRNLHKYIEGEQVAAGWPAWLSAV 99
Query: 117 AGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK------------ 164
AGEAI GWVPL AD FEKL+KIGQGTYSSVFRAR+ +TG+IVALKK++
Sbjct: 100 AGEAIHGWVPLNADGFEKLDKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVRFM 159
Query: 165 ---------------------------CYMNQLLHGLEH-------------------CH 178
C + + +EH C+
Sbjct: 160 AREILILRRLDHPNIMKLDGLITSRLSCSLYLVFEYMEHDITGLLSCPDVRFSESQIKCY 219
Query: 179 SRGVL------------HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226
R +L HRDIKGSNLLVNNEG+LK+ DFGLANF +GHRQPLTSRVVTL
Sbjct: 220 MRQLLSGLDHCHSKGVMHRDIKGSNLLVNNEGILKVGDFGLANFCTSGHRQPLTSRVVTL 279
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286
WYRPPELLLG+TDYG SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 280 WYRPPELLLGSTDYGASVDLWSVGCVFAELLLGKPILQGRTEVEQLHKIFKLCGSPPDEY 339
Query: 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
WKKSKLPHATLFKPQQPYDS LRETFKDLPTTAVNLIETLLSVEPY R TA +ALASEYF
Sbjct: 340 WKKSKLPHATLFKPQQPYDSCLRETFKDLPTTAVNLIETLLSVEPYNRGTAFSALASEYF 399
Query: 347 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 406
STKPYACD SSLP YPPSKEIDAK E+A RKK+ GR RG ETRK TRK +G+SKLAP E
Sbjct: 400 STKPYACDPSSLPKYPPSKEIDAKKHEEAGRKKISGRGRGTETRKCTRKPYGISKLAPAE 459
Query: 407 DVAVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 465
D+A R Q +IN ++ I K D SG E +KP +D EE H+KNAS GDIPFSGPLQ
Sbjct: 460 DLAARIQ-CGQINTSNMRIPKVRDGKSGGEARKPSLDKLEEIFHIKNASQGDIPFSGPLQ 518
Query: 466 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 525
VS+SSGFAWAKRR DASIRSH+RS SRG N LEPS+ +NN DS++H NGD+I G
Sbjct: 519 VSSSSGFAWAKRRNGDASIRSHSRSISRGHSNNGLEPSS--EEKNNSDSKQHNNGDLIYG 576
Query: 526 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 585
RT+SRGH+S E K A+ QWSQ ERPDSFDAS+ YHSQELSLALYQRE M +KR+NL
Sbjct: 577 VRTNSRGHNSYEISKFALQKQWSQFERPDSFDASEEYHSQELSLALYQREGMESKRSNLV 636
Query: 586 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 634
FQDQ +KV+FSGPLLSQSHR+DELLERHER IRQAVRKSWF RGKK K
Sbjct: 637 FQDQMDKVDFSGPLLSQSHRVDELLERHERHIRQAVRKSWFHRGKKHGK 685
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491675|ref|XP_003634302.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 854 bits (2207), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/704 (64%), Positives = 515/704 (73%), Gaps = 117/704 (16%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA DVS FR DN+G R SR GR
Sbjct: 1 MGCVSSKQAVSVTPAFDVSVAFR-----------DNAGSGR------SRGGR-------- 35
Query: 61 SKGEFGVAVSCGGSELGESGRASSNS--ESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
LGESGR SSN +SLSFRLGNLHKY+EGEQVAAGWPAWLSAVAG
Sbjct: 36 ---------------LGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAG 80
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK-------------- 164
EAIQGWVPLRAD+++ LEKIGQGTYS+VFRAR+L+TG++VALKK++
Sbjct: 81 EAIQGWVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAR 140
Query: 165 -------------------------C-------YMNQLLHGLEHC--------------- 177
C YM L GL C
Sbjct: 141 EITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTK 200
Query: 178 ---------HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
HSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 201 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 260
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 261 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 320
Query: 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 321 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 380
Query: 349 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 408
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E+
Sbjct: 381 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAENF 438
Query: 409 AVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVS 467
+TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPLQVS
Sbjct: 439 TAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPLQVS 498
Query: 468 TSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSR 527
TSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ NG R
Sbjct: 499 TSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSNGGR 556
Query: 528 TDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQ 587
TDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L +Q
Sbjct: 557 TDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHLSYQ 616
Query: 588 DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 631
DQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 617 DQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733936|emb|CBI15183.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2192), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/704 (65%), Positives = 522/704 (74%), Gaps = 94/704 (13%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA DVS FR DN+G R SR GR + +
Sbjct: 1 MGCVSSKQAVSVTPAFDVSVAFR-----------DNAGSGR------SRGGRVVAAEFEK 43
Query: 61 SKGEFGVAVSCGGSELGESGRASSNS--ESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
K G GSELGESGR SSN +SLSFRLGNLHKY+EGEQVAAGWPAWLSAVAG
Sbjct: 44 KKKSGGGESGLSGSELGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAG 103
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK-------------- 164
EAIQGWVPLRAD+++ LEKIGQGTYS+VFRAR+L+TG++VALKK++
Sbjct: 104 EAIQGWVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAR 163
Query: 165 -------------------------C-------YMNQLLHGLEHC--------------- 177
C YM L GL C
Sbjct: 164 EITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTK 223
Query: 178 ---------HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
HSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 224 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 283
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 284 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 343
Query: 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 344 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 403
Query: 349 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 408
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E+
Sbjct: 404 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAENF 461
Query: 409 AVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVS 467
+TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPLQVS
Sbjct: 462 TAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPLQVS 521
Query: 468 TSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSR 527
TSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ NG R
Sbjct: 522 TSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSNGGR 579
Query: 528 TDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQ 587
TDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L +Q
Sbjct: 580 TDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHLSYQ 639
Query: 588 DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 631
DQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 640 DQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 683
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508521|ref|XP_003523004.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2189), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/705 (62%), Positives = 507/705 (71%), Gaps = 102/705 (14%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA+D G FR + AGG + + R +G G
Sbjct: 1 MGCVSSKQAVSVTPAIDHYGAFR----SNAGGPCEPEKK-RTESGGGPSQ---------- 45
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
SE+GESGR SSN ESLSFRLGNL KY++GE VAAGWPAWLSAVAGEA
Sbjct: 46 -------------SEVGESGRTSSNCESLSFRLGNLQKYVQGEHVAAGWPAWLSAVAGEA 92
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---------------- 164
IQGWVPLRADAFEKLEKIGQGTYSSVFRAR+L+T KIVALKK++
Sbjct: 93 IQGWVPLRADAFEKLEKIGQGTYSSVFRARELETRKIVALKKVRFDNFEPESVRFMAREI 152
Query: 165 -----------------------CYMNQLLHGLEH-------------------CHSRGV 182
C + + +EH C+ + +
Sbjct: 153 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQL 212
Query: 183 L------------HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
L HRDIKGSNLLVNNEGVLK+ADFGLAN+ N+GHRQPLTSRVVTLWYRP
Sbjct: 213 LAGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANYVNSGHRQPLTSRVVTLWYRP 272
Query: 231 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290
PELLLG+TDY PSVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 273 PELLLGSTDYDPSVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKS 332
Query: 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350
KLPHATLFKP+QPYDS LR++FKDLPTT+V+L++TLLSVEPYKR TA++AL+SEYF TKP
Sbjct: 333 KLPHATLFKPEQPYDSCLRQSFKDLPTTSVHLLQTLLSVEPYKRGTATSALSSEYFKTKP 392
Query: 351 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAV 410
YACD SSLP+YPPSKEIDAKHR D RKK+ GRVRG TRK +RK G +KLAP E +A
Sbjct: 393 YACDPSSLPVYPPSKEIDAKHR-DESRKKISGRVRGTATRKPSRKPLGFNKLAPAEGLAS 451
Query: 411 RTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTS 469
+TQ ++K+NG S HIL+++++ G + QK E+A H+KNAS GDIP SGPLQVSTS
Sbjct: 452 QTQTSQKVNGRSFHILEEEKIKIGDKAQKSSSGKPEDAFHMKNASQGDIPLSGPLQVSTS 511
Query: 470 SGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSRTD 529
SGFAWAK RKDD S RSH R+ SRG + NALEPS L+TRNN D+ EN + G +
Sbjct: 512 SGFAWAKSRKDDTSFRSHCRTISRGHIFNALEPS-TLNTRNNLDTTNQENKEFC-GRYPN 569
Query: 530 SRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQ 589
SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS ALY RE+ +KR+NL FQDQ
Sbjct: 570 SRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSTALYHREDSVSKRSNLTFQDQ 629
Query: 590 GEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 634
GEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 630 GEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 674
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516828|ref|XP_003527095.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/705 (61%), Positives = 509/705 (72%), Gaps = 99/705 (14%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA+D SG FR + AGG + ++
Sbjct: 1 MGCVSSKQAVSVTPAIDHSGAFR----SNAGGLAE------------------PEKKRSK 38
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
+ E G A SE+GESGR SSN +SLSFRLGNLHKY++GE VAAGWPAWLSAVAGEA
Sbjct: 39 KRTESGGA---SQSEVGESGRTSSNCDSLSFRLGNLHKYVQGEHVAAGWPAWLSAVAGEA 95
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---------------- 164
I GWVPLRADAFEKLEKIGQGTYSSVFRAR+L+TGKIVALKK++
Sbjct: 96 IHGWVPLRADAFEKLEKIGQGTYSSVFRARELETGKIVALKKVRFDNFEPESVRFMAREI 155
Query: 165 -----------------------CYMNQLLHGLEH-------------------CHSRGV 182
C + + +EH C+ + +
Sbjct: 156 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQL 215
Query: 183 L----HRDIKG--------SNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
L H ++G SNLLVNNEGVLK+ADFGLANF N GHRQPLTSRVVTLWYRP
Sbjct: 216 LVGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANFVNPGHRQPLTSRVVTLWYRP 275
Query: 231 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290
PELLLG+TDYGP+VDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 276 PELLLGSTDYGPAVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKS 335
Query: 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350
+LPHATLFKPQQPYDS LR++FKDLP T+V+L++TLLS+EPYKR TA++AL+SEYF TKP
Sbjct: 336 RLPHATLFKPQQPYDSCLRQSFKDLPVTSVHLLQTLLSIEPYKRGTATSALSSEYFKTKP 395
Query: 351 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAV 410
YACD SSLP+YPPSKEIDAKHRE++ RKK+ GRVRG ETRK +RK G +KLAP ED+A
Sbjct: 396 YACDPSSLPVYPPSKEIDAKHREES-RKKISGRVRGTETRKPSRKPLGFNKLAPAEDLAS 454
Query: 411 RTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTS 469
+TQ + K+N S +L+++ G + QKP E+ASHVKNAS GDIP SGPLQVSTS
Sbjct: 455 QTQTSHKVNARSFRVLEEERTKIGDKAQKPSSGKPEDASHVKNASQGDIPLSGPLQVSTS 514
Query: 470 SGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSRTD 529
SGFAWAK RKDD S RSH R+ SRG N LEP L++RNN D+R EN + G T+
Sbjct: 515 SGFAWAKSRKDDTSFRSHCRTISRGHTFNPLEP-CTLNSRNNLDTRNQENKEFSGGC-TN 572
Query: 530 SRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQ 589
SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS+ALY RE+ A+KR+NL FQDQ
Sbjct: 573 SRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSIALYHREDSASKRSNLSFQDQ 632
Query: 590 GEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 634
GEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 633 GEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439293|ref|XP_004137420.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449486990|ref|XP_004157463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/705 (60%), Positives = 495/705 (70%), Gaps = 84/705 (11%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVG-NGSGSRNGRGSSNRKK 59
MGCV +KQAVSVTPA D SG FR + G NSGR R+G G + + + KK
Sbjct: 1 MGCVNTKQAVSVTPAFDHSGVFRDNESTAVG----NSGRSRLGLVGEIEKVSKPKAKVKK 56
Query: 60 GSKGEF-GVAVSCGGSELGESGRASSN---SESLSFRLGNLHKYIEGEQVAAGWPAWLSA 115
S EF GV GSE GESGRASS +E+LSFRLGNL+KYIEGEQVAAGWPAWLSA
Sbjct: 57 KSSSEFNGV-----GSEFGESGRASSKGGGNETLSFRLGNLNKYIEGEQVAAGWPAWLSA 111
Query: 116 VAGEAIQGWVP------------------------------------LRADAFE------ 133
VAGEAIQGWVP +R D FE
Sbjct: 112 VAGEAIQGWVPLRSDAYEKLEKIGQGTYSSVFRARELETGRIVALKKVRFDNFEPESVRF 171
Query: 134 -----------------KLEKIGQGTYSS----VFRARDLDTGKIVAL-------KKIKC 165
KLE + S VF D D +++ +IKC
Sbjct: 172 MAREIMILRGLDHPNIIKLEGLITSRLSCSIYLVFEYMDHDITGLLSCPDITFSESQIKC 231
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
YM QLL GLEHCHSRGV+HRDIKGSNLLVNNEGVLK+ADFGLANF NTGHRQPLTSRVVT
Sbjct: 232 YMKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGVLKVADFGLANFCNTGHRQPLTSRVVT 291
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
LWYRPPELLLG+TDY SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 292 LWYRPPELLLGSTDYNASVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDE 351
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345
YWKKSKLPHATLFKPQ PY++ LR+TFKD P+T VNL+ETLLSVEPYKR AS+AL SEY
Sbjct: 352 YWKKSKLPHATLFKPQHPYNNCLRQTFKDHPSTTVNLLETLLSVEPYKRGVASSALISEY 411
Query: 346 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 405
FSTKPYACD SS+PIYPP+KEIDAK RE+ RRKK GR RG + R+ TRK G+SKLAP
Sbjct: 412 FSTKPYACDPSSMPIYPPNKEIDAKQREETRRKKGSGRSRGLDNRRLTRKHLGISKLAPA 471
Query: 406 EDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 465
ED++V + KI+ ++ ++ ++ + G E +K +D EE HVKN+S GDIPFSGPLQ
Sbjct: 472 EDLSVSARDLHKISINAQNLKEEKVIKGVEAEKMSMDKLEETIHVKNSSQGDIPFSGPLQ 531
Query: 466 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 525
VSTSSGFAWA+RR+DDASIR ++RS SRG +IN LE S LH+ +N DS+ HE D+ +
Sbjct: 532 VSTSSGFAWARRRRDDASIRCYSRSISRGHLINGLEDSTTLHSISNLDSKIHEKSDMSSI 591
Query: 526 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 585
SR+ S+GH+S E K+ M N W + ERPDSFD SD YHSQE + ALY R+E KR L
Sbjct: 592 SRSSSKGHESNERSKVVMRNPWGKFERPDSFDTSDEYHSQEFAAALYLRDEKEAKRKQLS 651
Query: 586 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGK 630
+QDQ +KVE+SGPLLSQS R+DELL+RHER IRQ VR+SWFQRGK
Sbjct: 652 YQDQVDKVEYSGPLLSQSSRVDELLDRHERHIRQTVRRSWFQRGK 696
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79346260|ref|NP_173302.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332191623|gb|AEE29744.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/713 (58%), Positives = 488/713 (68%), Gaps = 89/713 (12%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGR----GSSN 56
MGCV SKQ VSVTPA+D SG FR + SGRI V + + S +
Sbjct: 1 MGCVNSKQTVSVTPAIDHSGVFRDNVCS-------GSGRIVVEDLPPVTETKLLSWWSKS 53
Query: 57 RKKGSKGEFGVAVSCGGSELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLS 114
KK S + G + EL ESGRASSN SES+SFRLGNL KY+E EQVAAGWPAWLS
Sbjct: 54 GKKSSSKKSGSELGSDFGELSESGRASSNCRSESVSFRLGNLSKYLEAEQVAAGWPAWLS 113
Query: 115 AVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---------- 164
VAGEAI GWVP R+DAFEKLEKIGQGTYSSVFRAR+ +TG+IVALKK++
Sbjct: 114 NVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVR 173
Query: 165 -----------------------------CYMNQLLHGLEH------------------- 176
C ++ + +EH
Sbjct: 174 FMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIK 233
Query: 177 CHSRGVL------------HRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRV 223
C+ + +L HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRV
Sbjct: 234 CYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRV 293
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
VTLWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP
Sbjct: 294 VTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPP 353
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRET--FKDLPTTAVNLIETLLSVEPYKRATASAAL 341
+DYWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS AL
Sbjct: 354 EDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTAL 413
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGR-VRGAETRKTTRKSHGMS 400
S+YF++KP+ACD SSLP+Y PSKEIDAKHRED RKK+ G RG E+RK TRK +
Sbjct: 414 VSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFA 473
Query: 401 KLAPVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIP 459
KLAP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS GD+P
Sbjct: 474 KLAPAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVP 533
Query: 460 FSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDS-RKHE 518
FSGPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS +
Sbjct: 534 FSGPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEK 593
Query: 519 NGDIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMA 578
+ +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A
Sbjct: 594 EKEEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKA 653
Query: 579 TKRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 631
K +LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 654 AKLGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|238479065|ref|NP_001154470.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332197458|gb|AEE35579.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/710 (57%), Positives = 490/710 (69%), Gaps = 102/710 (14%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQ VSVTPA+D SG F+ + +G SGRI V + + S R +
Sbjct: 1 MGCVSSKQTVSVTPAIDHSGVFKDNENECSG-----SGRIVVEDPPRPTLKKLVSWRSRS 55
Query: 61 SKGEFGVAVSCGGSELG-ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGE 119
K + GSELG ESGRAS +SLSFRLGN+ +Y+E EQVAAGWPAWLS VAGE
Sbjct: 56 GKRRSQKS----GSELGSESGRAS---DSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGE 108
Query: 120 AIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK--------------- 164
AI GWVPLR+DAFEKLEKIGQGTYS+VFRA + +TG+IVALKK++
Sbjct: 109 AIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMARE 168
Query: 165 ------------------------CYMNQLLHGLEH-------------------CHSRG 181
C + + +EH C+ +
Sbjct: 169 ILILRRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQ 228
Query: 182 VL------------HRDIKGSNLLVNNEGVLKLADFGLANFSN-TGH-RQPLTSRVVTLW 227
+L HRDIKGSNLL++NEG+LK+ADFGLANFSN +GH ++PLTSRVVTLW
Sbjct: 229 LLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLW 288
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287
YRPPELLLGATDYG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+DYW
Sbjct: 289 YRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYW 348
Query: 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347
KKSKLPHA LFKPQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S+YF+
Sbjct: 349 KKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFT 408
Query: 348 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGR-VRGAETRKTTRKSHGMSKLAPVE 406
TKP+ACD SSLPIYPPSKEID KHR++A RKK+ G RG + RK +RK+H ++LAP
Sbjct: 409 TKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLAP-- 466
Query: 407 DVAVRTQFAKKINGHSLH--ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPL 464
DV +T+ +K GH +H I D L G+ +Q PL ++EASHVK+AS GD+PFSGPL
Sbjct: 467 DVRHQTETFQKRIGHLVHSSIESDARLCGK-LQNPLDHKKDEASHVKHASQGDVPFSGPL 525
Query: 465 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSR--KHENGDI 522
QVS S+ FAWAKR KDD +R H RS SRG + + S A + +++ +S+ K E D
Sbjct: 526 QVSKSNSFAWAKREKDDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESKINKDEKED- 584
Query: 523 INGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKR- 581
+TDSRG +S E VK +ML QW QLERPDSF ASD YHSQELSL LYQR+EMA K
Sbjct: 585 ----KTDSRGEESYEMVKRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEMAKKMG 640
Query: 582 NNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 631
NNLG G+K+EFSGPLLSQS+ +DELLERHER IR+ +RK WFQ+ KK
Sbjct: 641 NNLG---DGDKIEFSGPLLSQSYGVDELLERHERNIRKLIRKPWFQKDKK 687
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79379990|ref|NP_177573.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332197457|gb|AEE35578.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1887), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/707 (57%), Positives = 488/707 (69%), Gaps = 102/707 (14%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQ VSVTPA+D SG F+ + +G SGRI V + + S R +
Sbjct: 1 MGCVSSKQTVSVTPAIDHSGVFKDNENECSG-----SGRIVVEDPPRPTLKKLVSWRSRS 55
Query: 61 SKGEFGVAVSCGGSELG-ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGE 119
K + GSELG ESGRAS +SLSFRLGN+ +Y+E EQVAAGWPAWLS VAGE
Sbjct: 56 GKRRSQKS----GSELGSESGRAS---DSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGE 108
Query: 120 AIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK--------------- 164
AI GWVPLR+DAFEKLEKIGQGTYS+VFRA + +TG+IVALKK++
Sbjct: 109 AIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMARE 168
Query: 165 ------------------------CYMNQLLHGLEH-------------------CHSRG 181
C + + +EH C+ +
Sbjct: 169 ILILRRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQ 228
Query: 182 VL------------HRDIKGSNLLVNNEGVLKLADFGLANFSN-TGH-RQPLTSRVVTLW 227
+L HRDIKGSNLL++NEG+LK+ADFGLANFSN +GH ++PLTSRVVTLW
Sbjct: 229 LLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLW 288
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287
YRPPELLLGATDYG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+DYW
Sbjct: 289 YRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYW 348
Query: 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347
KKSKLPHA LFKPQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S+YF+
Sbjct: 349 KKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFT 408
Query: 348 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGR-VRGAETRKTTRKSHGMSKLAPVE 406
TKP+ACD SSLPIYPPSKEID KHR++A RKK+ G RG + RK +RK+H ++LAP
Sbjct: 409 TKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLAP-- 466
Query: 407 DVAVRTQFAKKINGHSLH--ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPL 464
DV +T+ +K GH +H I D L G+ +Q PL ++EASHVK+AS GD+PFSGPL
Sbjct: 467 DVRHQTETFQKRIGHLVHSSIESDARLCGK-LQNPLDHKKDEASHVKHASQGDVPFSGPL 525
Query: 465 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSR--KHENGDI 522
QVS S+ FAWAKR KDD +R H RS SRG + + S A + +++ +S+ K E D
Sbjct: 526 QVSKSNSFAWAKREKDDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESKINKDEKED- 584
Query: 523 INGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKR- 581
+TDSRG +S E VK +ML QW QLERPDSF ASD YHSQELSL LYQR+EMA K
Sbjct: 585 ----KTDSRGEESYEMVKRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEMAKKMG 640
Query: 582 NNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQR 628
NNLG G+K+EFSGPLLSQS+ +DELLERHER IR+ +RK WFQ+
Sbjct: 641 NNLG---DGDKIEFSGPLLSQSYGVDELLERHERNIRKLIRKPWFQK 684
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 634 | ||||||
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.741 | 0.662 | 0.670 | 9.3e-216 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.717 | 0.650 | 0.661 | 2.1e-205 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.335 | 0.330 | 0.723 | 1.3e-129 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.427 | 0.379 | 0.576 | 1.9e-116 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.335 | 0.346 | 0.661 | 1.9e-114 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.553 | 0.545 | 0.475 | 1.5e-112 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.495 | 0.452 | 0.535 | 2.7e-111 | |
| TAIR|locus:504955609 | 629 | AT3G01085 [Arabidopsis thalian | 0.501 | 0.505 | 0.491 | 5e-110 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.397 | 0.439 | 0.575 | 6.4e-110 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.474 | 0.406 | 0.527 | 6.4e-110 |
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1652 (586.6 bits), Expect = 9.3e-216, Sum P(3) = 9.3e-216
Identities = 319/476 (67%), Positives = 373/476 (78%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLT 220
+IKCYM QLL GL+HCH+RGV+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLT
Sbjct: 231 QIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLT 290
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
SRVVTLWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCG
Sbjct: 291 SRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCG 350
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATAS 338
SPP+DYWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS
Sbjct: 351 SPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTAS 410
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSH 397
AL S+YF++KP+ACD SSLP+Y PSKEIDAKHRED E+RK TRK
Sbjct: 411 TALVSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPP 470
Query: 398 GMSKLAPVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHG 456
+KLAP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS G
Sbjct: 471 AFAKLAPAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQG 530
Query: 457 DIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRK 516
D+PFSGPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS+
Sbjct: 531 DVPFSGPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKN 590
Query: 517 HENG-DIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQRE 575
+E + +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQRE
Sbjct: 591 NEKEKEEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQRE 650
Query: 576 EMATKRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 631
E A K +LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 651 EKAAKLGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 2.1e-205, Sum P(3) = 2.1e-205
Identities = 315/476 (66%), Positives = 374/476 (78%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQ-PL 219
+IKCYM QLL GL+HCHSRGV+HRDIKGSNLL++NEG+LK+ADFGLANFSN+ GH++ PL
Sbjct: 221 QIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPL 280
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
TSRVVTLWYRPPELLLGATDYG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLC
Sbjct: 281 TSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLC 340
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
GSPP+DYWKKSKLPHA LFKPQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+
Sbjct: 341 GSPPEDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASS 400
Query: 340 ALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHG 398
AL S+YF+TKP+ACD SSLPIYPPSKEID KHR++A + RK +RK+H
Sbjct: 401 ALVSQYFTTKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHS 460
Query: 399 MSKLAPVEDVAVRTQ-FAKKINGHSLH--ILKDDELSGREVQKPLVDNREEASHVKNASH 455
++LAP DV +T+ F K+I GH +H I D L G+ +Q PL ++EASHVK+AS
Sbjct: 461 FNRLAP--DVRHQTETFQKRI-GHLVHSSIESDARLCGK-LQNPLDHKKDEASHVKHASQ 516
Query: 456 GDIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSR 515
GD+PFSGPLQVS S+ FAWAKR KDD +R H RS SRG + + S A + +++ +S+
Sbjct: 517 GDVPFSGPLQVSKSNSFAWAKREKDDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESK 576
Query: 516 --KHENGDIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQ 573
K E D +TDSRG +S E VK +ML QW QLERPDSF ASD YHSQELSL LYQ
Sbjct: 577 INKDEKED-----KTDSRGEESYEMVKRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQ 631
Query: 574 REEMATKR-NNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQR 628
R+EMA K NNLG G+K+EFSGPLLSQS+ +DELLERHER IR+ +RK WFQ+
Sbjct: 632 RDEMAKKMGNNLG---DGDKIEFSGPLLSQSYGVDELLERHERNIRKLIRKPWFQK 684
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 1.3e-129, Sum P(3) = 1.3e-129
Identities = 154/213 (72%), Positives = 181/213 (84%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+IKCYM QLL GLEHCH RGV+HRDIK SN+LVNN+GVLKL DFGLAN ++ LTS
Sbjct: 205 QIKCYMKQLLWGLEHCHMRGVIHRDIKASNILVNNKGVLKLGDFGLANVVTPSNKNQLTS 264
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYR PELL+G+T YG SVDLWSVGCVFAE+L+GKPIL+GRTE+EQLHKI+KLCGS
Sbjct: 265 RVVTLWYRAPELLMGSTSYGVSVDLWSVGCVFAEILMGKPILKGRTEIEQLHKIYKLCGS 324
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P D +WK++KLPHAT FKPQ Y+++LRE KDL T V L+ETLLS+EP KR TAS+AL
Sbjct: 325 PQDSFWKRTKLPHATSFKPQHTYEATLRERCKDLSATGVYLLETLLSMEPDKRGTASSAL 384
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 374
SEYF T+PYACD SSLP YPP+KE+DAK+R+D
Sbjct: 385 NSEYFLTRPYACDPSSLPKYPPNKEMDAKYRDD 417
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 822 (294.4 bits), Expect = 1.9e-116, Sum P(3) = 1.9e-116
Identities = 158/274 (57%), Positives = 196/274 (71%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+IKCYM QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF +QPLTS
Sbjct: 263 QIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTS 322
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGS
Sbjct: 323 RVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGS 382
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P ++YWK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP R T ++AL
Sbjct: 383 PSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASAL 442
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSK 401
SE+F+T P A D SSLP Y P KEID K +E+ ++++ +R+S +
Sbjct: 443 ESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRESKAVP- 501
Query: 402 LAPVEDVAVRTQFAKKINGHSLHILKDDELSGRE 435
AP + T K+ H+ + D+ + E
Sbjct: 502 -APDSNAESLTSIQKRQGQHN-QVSNSDKFNPGE 533
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 788 (282.4 bits), Expect = 1.9e-114, Sum P(3) = 1.9e-114
Identities = 141/213 (66%), Positives = 177/213 (83%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+IKC+M QLL GLEHCHSRG+LHRDIKGSNLLVNN+GVLK+ DFGLA+F QPLTS
Sbjct: 241 QIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTS 300
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYR PELLLG+T+YGP++DLWSVGC+ AEL + KPI+ GRTEVEQ+HKIFKLCGS
Sbjct: 301 RVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGS 360
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P +++W +K P AT +KPQ PY L ETFK+L +++++L++ LLSVEP KR +AS+ L
Sbjct: 361 PSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTL 420
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 374
SE+F+T+P C +SSLP YPPSKE+DAK R++
Sbjct: 421 LSEFFTTEPLPCHISSLPKYPPSKELDAKVRDE 453
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 1.5e-112, Sum P(3) = 1.5e-112
Identities = 175/368 (47%), Positives = 230/368 (62%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
++KCYM QLL GL HCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA F + + PLTS
Sbjct: 237 QVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTS 296
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYRPPELLLGA YG VDLWS GC+ EL GKPIL G+TEVEQLHKIFKLCGS
Sbjct: 297 RVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGS 356
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P +DYW+K KLP + F+P PY + E FKDLPT ++L+E LLS++P +R +A+ AL
Sbjct: 357 PTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARAL 416
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSK 401
SEYF T+P+ACD SSLP YPPSKEIDAK R+DA + +T R+SH
Sbjct: 417 ESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQT-RRSHERKL 475
Query: 402 LAPVE------DVAVRTQFAKK-INGHSLHILKD----DELSGREVQK-PLVDNRE--EA 447
+ PV+ AV + + + G+S ++D + SGR P++ NR
Sbjct: 476 IPPVKANNPSLSTAVENPYLRSCVPGNSQRQMQDMTCNNPTSGRVSHSGPMMKNRNLSRL 535
Query: 448 SHVKNASHGDIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVI-NALEPSAAL 506
++VK+ + IP G+ + ++ D R R+ +R + N+ +
Sbjct: 536 TYVKDNAAPRIPSYRANSAGQGGGYVGSDQQMMDQQ-RKELRTFNRADTMDNSKRQTKIP 594
Query: 507 HTRNNYDS 514
+ + YDS
Sbjct: 595 NDPSWYDS 602
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 2.7e-111, Sum P(2) = 2.7e-111
Identities = 180/336 (53%), Positives = 223/336 (66%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
++KCY+ QLLHGL+HCHSRGVLHRDIKGSNLL++N GVLK+ADFGLA+F + QPLTS
Sbjct: 234 QVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTS 293
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYRPPELLLGAT YG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGS
Sbjct: 294 RVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 353
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P +DYW KS+LPHAT+FKP QPY + ETFK+ P A+ L+ETLLSV P R TA+AAL
Sbjct: 354 PTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAAL 413
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHR-EDAXXXXXXXXXXXAETRKTTRKSHGM- 399
SE+FST+P CD SSLP YPPSKE+DA+ R E++ + R+ T++S +
Sbjct: 414 KSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQRHQERRGTKESRAIP 473
Query: 400 SKLAPVEDVAV----RTQFAKKINGHSLHILKDDELSGREVQKP------LVDNREEASH 449
+ A E VA ++Q + + ++ SG + P NRE +
Sbjct: 474 APDANAELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRPSSQAFEPNRESQGN 533
Query: 450 V---KNASHGDIPFSGPLQVSTSSGFAWAKRRKDDA 482
+ K ASH SGPL S S A +R D+
Sbjct: 534 IIPHKRASH-----SGPL--SRRSASAKGRRNYQDS 562
|
|
| TAIR|locus:504955609 AT3G01085 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 5.0e-110, Sum P(3) = 5.0e-110
Identities = 168/342 (49%), Positives = 228/342 (66%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+IKCYM QLL G+EHCH RG++HRDIK +N+LVNN+GVLKLADFGLAN ++ LTS
Sbjct: 215 QIKCYMKQLLWGVEHCHLRGIMHRDIKAANILVNNKGVLKLADFGLANIVTPRNKNQLTS 274
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYR PELL+G+T Y SVDLWSVGCVFAE+L G+P+L+GRTE+EQLHKI+KL GS
Sbjct: 275 RVVTLWYRAPELLMGSTSYSVSVDLWSVGCVFAEILTGRPLLKGRTEIEQLHKIYKLSGS 334
Query: 282 PPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
P +++W+K+KL P +F+PQ Y+ LRE F + P TA+NL+E LLS++P KR TAS+A
Sbjct: 335 PDEEFWEKNKLHPQTKMFRPQHQYEGCLRERFDEFPKTAINLLENLLSIDPEKRGTASSA 394
Query: 341 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMS 400
L SEYF+T+PYACD S+LP YPP+KE+DAK+RE+ T+K G S
Sbjct: 395 LMSEYFNTQPYACDPSTLPKYPPNKEMDAKYREELQRRRRVSIKK--RDNLATKKL-GKS 451
Query: 401 KLAPVEDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLV-DNREEASHVKNASHGDIP 459
+ A V++ +L+ L + + +E + +V E S S + P
Sbjct: 452 RRATVKEPT------------NLNRLPTHQETKKEAETEIVVQTPSETSQATTRS--EFP 497
Query: 460 FSGPLQVST-SSGFAWA--KRRKDD--ASIRSHTRSTSRGQV 496
++ Q + +SGFAWA K+RK++ AS ++ + S V
Sbjct: 498 YNSLSQTTAPASGFAWAGTKKRKENDVASTLTYIQPGSASHV 539
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.4e-110, Sum P(3) = 6.4e-110
Identities = 145/252 (57%), Positives = 185/252 (73%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
++KC M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA + H++P+TS
Sbjct: 218 EVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTS 277
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
RVVTLWYR PELLLGATDYG +DLWS GC+ AELL G+PI+ GRTEVEQLHKI+KLCGS
Sbjct: 278 RVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGS 337
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P +DYWKK K H ++KP++PY S+RETFKD P +++ LI+ LLS+EP R TASAAL
Sbjct: 338 PSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAAL 397
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSK 401
SE+F+++PYAC+ + LP YPPSKEIDAK R++ + + R ++
Sbjct: 398 KSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRSNR 457
Query: 402 LAPVEDVAVRTQ 413
P + Q
Sbjct: 458 ALPAPEANAELQ 469
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 6.4e-110, Sum P(3) = 6.4e-110
Identities = 162/307 (52%), Positives = 201/307 (65%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
++KCYM QLL GLEHCHSRGVLHRDIKGSNLL++++GVLK+ADFGLA F + LTS
Sbjct: 313 QVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGLATFFDPAKSVSLTS 372
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
VVTLWYRPPELLLGA+ YG VDLWS GC+ EL GKPIL G+TEVEQLHKIFKLCGS
Sbjct: 373 HVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKTEVEQLHKIFKLCGS 432
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P ++YW+K KLP + FK PY + E FKD P + ++L+ETLLS++P R++A AL
Sbjct: 433 PTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLLSIDPDHRSSADRAL 492
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSK 401
SEYF TKP+ACD S+LP YPPSKEIDAK R++A TR SH
Sbjct: 493 ESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMRAEKQERQDSMTRISHERKF 552
Query: 402 LAPVE-DVAVRTQFAKKINGHSLHILKDDELSGREVQKPL--VDNREEASHVKNASHG-D 457
+ PV+ + ++ K+ L D S +E + P V + + H +N G
Sbjct: 553 VPPVKANNSLSMTMEKQYK--DLRSRNDSFKSFKEERTPHGPVPDYQNMQHNRNNQTGVR 610
Query: 458 IPFSGPL 464
I SGPL
Sbjct: 611 ISHSGPL 617
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 634 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-101 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-82 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-80 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-72 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-71 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-71 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-70 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-64 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-61 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-60 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-57 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-55 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-55 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-54 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-52 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-52 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-51 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-51 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-50 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-50 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-50 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-49 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-48 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-48 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-48 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-46 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-46 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-46 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-45 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-45 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-45 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-44 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-43 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-43 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-42 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-42 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-41 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-40 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-39 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-39 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-39 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-39 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-38 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-38 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-37 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-36 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-36 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-35 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-33 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-32 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-31 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-29 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-28 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-28 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-08 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-08 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-07 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.001 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 0.002 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.004 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.004 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = e-101
Identities = 114/186 (61%), Positives = 140/186 (75%), Gaps = 2/186 (1%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IKCYM QLL GL++ HS G+LHRDIKGSN+L+NN+GVLKLADFGLA + T+R
Sbjct: 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V+TLWYRPPELLLGAT YGP VD+WSVGC+ AEL +GKPI QG TE+EQL KIF+LCGSP
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 283 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPT-TAVNLIETLLSVEPYKRATASAA 340
D+ W SKLP KP++PY LRE FK L +A++L++ LL+++P KR +A A
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281
Query: 341 LASEYF 346
L EYF
Sbjct: 282 LQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 2e-82
Identities = 94/198 (47%), Positives = 125/198 (63%), Gaps = 4/198 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IK YM L GLE+ HS +LHRD+K +NLL+ ++GVLKLADFGLA + +R +T +
Sbjct: 104 IKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQ 162
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT WYR PELL GA YG VD+WSVGC+FAELL+ P L G ++++QL KIF+ G+P
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222
Query: 283 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
++ W + LP FKP P L++ F A++L++ LL++ P KR TA AL
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280
Query: 342 ASEYFSTKPYACDLSSLP 359
YFS P S LP
Sbjct: 281 EHPYFSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 4e-80
Identities = 85/189 (44%), Positives = 115/189 (60%), Gaps = 5/189 (2%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQP 218
IK M QLL GL +CHS +LHRD+K N+L+N +GVLKLADFGLA F
Sbjct: 97 PNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-- 154
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
T VVTLWYR PE+LLG+ Y +VD+WSVGC+FAE++ GKP+ G +E++QL KIF++
Sbjct: 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214
Query: 279 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
G+P ++ W +KLP P+ P L + L ++L+ +L P KR +A
Sbjct: 215 LGTPTEESWPGVTKLPDYKPTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273
Query: 338 SAALASEYF 346
AL YF
Sbjct: 274 KEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 2e-72
Identities = 90/193 (46%), Positives = 120/193 (62%), Gaps = 16/193 (8%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----- 217
+KC M QLL G+ H H +LHRD+K SNLL+NN G+LK+ DFGLA R+
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA-------REYGSPL 160
Query: 218 -PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
P T VVTLWYR PELLLGA +Y ++D+WSVGC+FAELL KP+ G++E++QL+KIF
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
Query: 277 KLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYK 333
KL G+P + W S+LP A + + LR+ F L +L+ LL+ +P K
Sbjct: 221 KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAK 280
Query: 334 RATASAALASEYF 346
R +A AL YF
Sbjct: 281 RISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 2e-71
Identities = 96/203 (47%), Positives = 131/203 (64%), Gaps = 6/203 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTS 221
+KC M QLL GL++ H ++HRD+K SNLL+ ++G LK+ADFGLA G +P+T
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGLPAKPMTP 167
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+VVTLWYR PELLLG T Y ++D+W+VGC+ AELL KP+L G++E+EQL I +L G+
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227
Query: 282 PPDDYWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
P + W S LP F P+QPY ++L+ F L + L+ LL +P KRATA
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286
Query: 340 ALASEYFSTKPYACDLSSLPIYP 362
AL S YF KP C+ +P +P
Sbjct: 287 ALESSYFKEKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 4e-71
Identities = 91/195 (46%), Positives = 122/195 (62%), Gaps = 11/195 (5%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSN 212
IKCYM QLL G+ + H +LHRDIK +N+L++N+G+LK+ADFGLA
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
G + T+ VVT WYRPPELLLG Y +VD+W +GCVFAE+ +PILQG+++++QL
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 273 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
H IFKLCG+P ++ W LP Y +L E F L ++L+ LLS++P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296
Query: 332 YKRATASAALASEYF 346
YKR TAS AL YF
Sbjct: 297 YKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 6e-70
Identities = 93/184 (50%), Positives = 124/184 (67%), Gaps = 1/184 (0%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IK +M QLL GL +CH + LHRDIK SN+L+NN+G +KLADFGLA N+ +P T++
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V+TLWYRPPELLLG YGP++D+WS GC+ EL KPI Q E+ QL I +LCGSP
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 283 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA AL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297
Query: 342 ASEY 345
S +
Sbjct: 298 NSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 3e-64
Identities = 91/211 (43%), Positives = 132/211 (62%), Gaps = 16/211 (7%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------N 209
+KC + Q+L+GL H +HRD+ +N+ +N++G+ K+ADFGLA
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
R+ +TS+VVTLWYR PELL+GA Y +VD+WSVGC+FAELL GKP+ G E+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 270 EQLHKIFKLCGSPPDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
+QL +IF+L G+P +D W + KLP T F P++P D L+ F + A++L+++LL
Sbjct: 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKD--LKTIFPNASDDAIDLLQSLLK 298
Query: 329 VEPYKRATASAALASEYFSTKPYACDLSSLP 359
+ P +R +A AL EYF + P CD S LP
Sbjct: 299 LNPLERISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 1e-61
Identities = 91/195 (46%), Positives = 119/195 (61%), Gaps = 2/195 (1%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
D + + IK Y+ QLL GL CHS G+LHRD+K NLL+N EGVLKLADFGLA
Sbjct: 90 DRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG 149
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
+ R P T VVT WYR PELLLG Y VD+WSVGC+FAELL +P+ G++E++QL
Sbjct: 150 SPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208
Query: 273 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
KIF+ G+P + W K + L F + L + F + A++L+ +L +P
Sbjct: 209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDP 268
Query: 332 YKRATASAALASEYF 346
+KR TA ALA YF
Sbjct: 269 HKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 80/187 (42%), Positives = 115/187 (61%), Gaps = 5/187 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+K YM LL G+ + H+ G++HRD+K +NLL++ +GVLK+ADFGLA + + + +
Sbjct: 101 VKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V T WYR PELL GA Y P VDLW+VGC+FAELL G P+ G ++EQL +F+ G+P
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 283 PDDYWKK-SKLPHAT--LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
++ W + LP F +P L E F D A++L++ LL +P KR +A+
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKP--IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278
Query: 340 ALASEYF 346
AL YF
Sbjct: 279 ALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 8e-57
Identities = 91/218 (41%), Positives = 123/218 (56%), Gaps = 27/218 (12%)
Query: 146 VFRARDLDTGKIVALKK--------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSN 191
VF DLD LKK IK Y+ QLL G+ +CHS VLHRD+K N
Sbjct: 76 VFEFLDLD------LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN 129
Query: 192 LLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 251
LL++ EG LKLADFGLA R T VVTLWYR PE+LLG+ Y VD+WS+GC
Sbjct: 130 LLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGC 188
Query: 252 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQP--YDSSL 308
+FAE++ +P+ G +E++QL +IF+ G+P +D W + LP +KP P L
Sbjct: 189 IFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---YKPTFPKWARQDL 245
Query: 309 RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
+ +L ++L+ +L +P KR +A AAL YF
Sbjct: 246 SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-55
Identities = 77/188 (40%), Positives = 116/188 (61%), Gaps = 9/188 (4%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPL 219
+ IK M QLL G++ HS ++HRD+K N+LV ++G +K+ADFGLA +S L
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MAL 163
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
TS VVTLWYR PE+LL ++ Y VD+WSVGC+FAEL +P+ +G +E +QL KIF +
Sbjct: 164 TSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222
Query: 280 GSPPDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
G P ++ W + LP ++ F P S + ++ ++L++ +L+ P+KR +A
Sbjct: 223 GLPSEEEWPRNVSLPRSS-FPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 339 AALASEYF 346
AL YF
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 89/198 (44%), Positives = 116/198 (58%), Gaps = 16/198 (8%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHR 216
L +IK M LL+GL + H +LHRD+K +N+L+ +G+LKLADFGLA + S
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T+RVVTLWYRPPELLLG DYGP +D+W GC+ AE+ PI+QG TE QL I
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237
Query: 277 KLCGSPPDDYWKK-SKLPHATLFK----PQQPYD---SSLRETFKDLPTTAVNLIETLLS 328
+LCGS + W KL LFK PQ L+ KD A++LI+ LL
Sbjct: 238 QLCGSITPEVWPGVDKLE---LFKKMELPQGQKRKVKERLKPYVKDP--HALDLIDKLLV 292
Query: 329 VEPYKRATASAALASEYF 346
++P KR A AL ++F
Sbjct: 293 LDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 6e-55
Identities = 80/213 (37%), Positives = 118/213 (55%), Gaps = 15/213 (7%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LT 220
I+ ++ Q+L GL++ HS V+HRD+K SN+LVN+ LK+ DFGLA + + LT
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
VVT WYR PELLL ++ Y ++D+WSVGC+FAELL KP+ GR ++QL+ I ++ G
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+P ++ K A + P L + F A++L+E +L +P KR TA
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 371
ALA Y + ++ P E AK
Sbjct: 285 EALAHPYLA-----------QLHDPEDEPVAKP 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 9e-54
Identities = 84/284 (29%), Positives = 118/284 (41%), Gaps = 93/284 (32%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK----------------CYMNQLLHG-- 173
+E L K+G G++ +V++A+ TGKIVA+K +K + +L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 174 ----------------LEHC----------------------------------HSRGVL 183
+E+C HS G++
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 184 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 243
HRD+K N+L++ GV+K+ADFGLA LT+ V T WY PE+LLG YGP
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 244 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPDDYWKKSKLPHATLFKPQQ 302
VD+WS+G + ELL GKP G ++QL I + L D K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW------------- 226
Query: 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
SS E KD LI+ L+ +P KR TA L +F
Sbjct: 227 ---SSGSEEAKD-------LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 102/285 (35%), Positives = 141/285 (49%), Gaps = 72/285 (25%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK----------------CYMNQL----- 170
+EKLEKIG+GTY +VF+A++ +T +IVALK+++ C + +L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 171 ------LHG-------LEHC----------------------------------HSRGVL 183
LH E+C HS VL
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 184 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 243
HRD+K NLL+N G LKLADFGLA R ++ VVTLWYRPP++L GA Y S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 244 VDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQ 301
+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++ W SKLP + P
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY-PM 239
Query: 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
P +SL L +T +L++ LL P +R +A AL YF
Sbjct: 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 4e-52
Identities = 81/202 (40%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-- 210
D G +++ ++ ++ QLL GL +CH R VLHRD+K NLL++ G LKLADFGLA
Sbjct: 95 DCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154
Query: 211 --SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
S T ++ VVTLWYRPP++LLG+T+Y S+D+W VGC+F E+ G+P+ G T+
Sbjct: 155 VPSKT-----YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 269 V-EQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIE 324
V +QLHKIF++ G+P ++ W S P + L D L
Sbjct: 210 VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELAL 269
Query: 325 TLLSVEPYKRATASAALASEYF 346
L EP KR +A+ A+ YF
Sbjct: 270 KFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 28/195 (14%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
L ++ + + Y+ Q+L LE+ HS+G++HRD+K N+L++ +G +KLADFGLA
Sbjct: 88 LKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQL 147
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 271
+ G + LT+ V T Y PE+LLG YG +VD+WS+G + ELL GKP G +Q
Sbjct: 148 DPGEK--LTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQ 201
Query: 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
L ++FK G P + D+ A +LI LL +P
Sbjct: 202 LLELFKKIGKPKPPFPPP----------------------EWDISPEAKDLIRKLLVKDP 239
Query: 332 YKRATASAALASEYF 346
KR TA AL +F
Sbjct: 240 EKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 87/203 (42%), Positives = 125/203 (61%), Gaps = 10/203 (4%)
Query: 150 RDLDT---GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206
+ LD+ G+ + + +K Y+ Q+L G+ CHSR VLHRD+K NLL++N+GV+KLADFG
Sbjct: 87 KYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFG 146
Query: 207 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 266
LA R T VVTLWYR PE+LLG+ Y VD+WS+G +FAE+ KP+ G
Sbjct: 147 LARAFGIPVRV-YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
Query: 267 TEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLI 323
+E++QL +IF++ G+P +D W + LP +K P SLR K+L ++L+
Sbjct: 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPD---YKNTFPKWKKGSLRSAVKNLDEDGLDLL 262
Query: 324 ETLLSVEPYKRATASAALASEYF 346
E +L +P KR +A AL YF
Sbjct: 263 EKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 5e-51
Identities = 72/189 (38%), Positives = 108/189 (57%), Gaps = 5/189 (2%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
++ Y+ QLL + +CHS ++HRDIK N+LV+ GVLKL DFG A PLT
Sbjct: 101 AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
V T WYR PELL+G T+YG VD+W++GC+ AELL G+P+ G ++++QL+ I K G
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220
Query: 282 -PP---DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
PP + + + +P QP +S R + + A++ ++ L ++P +R T
Sbjct: 221 LPPSHQELFSSNPRFAGVAFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTC 279
Query: 338 SAALASEYF 346
L YF
Sbjct: 280 DELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 3e-50
Identities = 87/192 (45%), Positives = 117/192 (60%), Gaps = 13/192 (6%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA-NFSNTGHRQP 218
K IK +M QLL G+ HCH GV+HRD+K NLLV+ + G+LK+AD GL FS P
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IP 164
Query: 219 L---TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
+ T +VTLWYR PE+LLG+T Y VD+WSVGC+FAE+ +P+ G +E++QL I
Sbjct: 165 VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224
Query: 276 FKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
FKL G+P + W SKL F +P D L DL ++L++ +L +P KR
Sbjct: 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKR 282
Query: 335 ATASAALASEYF 346
+A AAL YF
Sbjct: 283 ISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 78/193 (40%), Positives = 108/193 (55%), Gaps = 19/193 (9%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTG 214
+K + QLL G+ CH VLHRD+K NLL+N G LKLADFGLA FSN
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-- 159
Query: 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
VVTLWYR P++LLG+ Y S+D+WSVGC+ AE++ G+P+ G +QL K
Sbjct: 160 -------EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
Query: 275 IFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 333
IF++ G+P + W S+LP P+ P L++ F ++L+ LL + P
Sbjct: 213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPEL 271
Query: 334 RATASAALASEYF 346
R +A AL +F
Sbjct: 272 RISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 7e-50
Identities = 78/194 (40%), Positives = 110/194 (56%), Gaps = 3/194 (1%)
Query: 154 TGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213
GK + I+ + Q+L GL H H G HRD+K NLLV+ V+K+ADFGLA
Sbjct: 92 KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EI 149
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
R P T V T WYR PE+LL +T Y VD+W++GC+ AEL +P+ G +E++QL+
Sbjct: 150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209
Query: 274 KIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 332
KI + G+P W + KL F+ Q +SL + + A++LI+ +L +P
Sbjct: 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK 269
Query: 333 KRATASAALASEYF 346
KR TAS AL YF
Sbjct: 270 KRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 80/200 (40%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
QLL GL++ HS VLHRD+K SNLL+N LK+ DFGLA ++ +T VVT WY
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWY 174
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
R PELLL ++Y ++D+WSVGC+FAELL KP+ G+ V QL I +L GSP ++
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 289 KSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
+ A + PY S F A++L+E +L +P KR T ALA Y
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
Query: 347 STKPYACDLSSLPIYPPSKE 366
+ ++ PS E
Sbjct: 295 A-----------SLHDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 90/212 (42%), Positives = 123/212 (58%), Gaps = 14/212 (6%)
Query: 146 VFRARDLDTGKIV--------ALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 197
VF DLD K + + IK Y+ Q+L G+ +CHS VLHRD+K NLL++
Sbjct: 79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138
Query: 198 -GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
LKLADFGLA R T VVTLWYR PE+LLG+ Y VD+WSVGC+FAE+
Sbjct: 139 TNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197
Query: 257 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLP-HATLFKPQQPYDSSLRETFKD 314
+ KP+ G +E+++L KIF++ G+P ++ W + LP + + F P D L
Sbjct: 198 VNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD--LATVVPT 255
Query: 315 LPTTAVNLIETLLSVEPYKRATASAALASEYF 346
L V+L+ +L ++P KR TA AAL EYF
Sbjct: 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 82/192 (42%), Positives = 112/192 (58%), Gaps = 7/192 (3%)
Query: 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217
+ L IK Y+ QLL GL CHS VLHRD+K NLL+N EG +KLADFGLA R
Sbjct: 97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T VVTLWYR PE+LLG Y +VD+WS+GC+FAE++ + + G +E++QL +IF+
Sbjct: 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215
Query: 278 LCGSPPDDYWKK-SKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
G+P + W + LP +KP P + L +L+ +L +P KR
Sbjct: 216 TLGTPDEVVWPGVTSLPD---YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272
Query: 335 ATASAALASEYF 346
+A AALA +F
Sbjct: 273 ISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 80/220 (36%), Positives = 111/220 (50%), Gaps = 19/220 (8%)
Query: 160 LKKI-KCY-MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNT 213
L+ + K Y M QLL L++ HS V+HRD+K SN+L+N++ +KLADFGLA
Sbjct: 104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
LT V T WYR PE+LLG+T Y VD+WSVGC+ E+L+GKP+ G + + QL
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223
Query: 274 KIFKLCGSPPDDYWK--KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
KI ++ G P + + KS L L E A++L++ LL P
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283
Query: 332 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 371
KR TA AL Y + + PS E +
Sbjct: 284 NKRLTAEEALEHPYVA-----------QFHNPSDEPVLPY 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 78/207 (37%), Positives = 112/207 (54%), Gaps = 23/207 (11%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQP 218
+K + Q+L+G+ + HS VLHRD+K +N+LV E GV+K+ D GLA N +
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 219 LTSR--VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-------- 268
VVT+WYR PELLLGA Y ++D+W++GC+FAELL +PI +GR
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229
Query: 269 -VEQLHKIFKLCGSPPDDYWKK-SKLPH----ATLFKPQQPYDSSLR---ETFKDLPTTA 319
+QL +IF++ G+P + W K+P FK + +SL E K +
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289
Query: 320 VNLIETLLSVEPYKRATASAALASEYF 346
+L+ LL +P KR TA AL YF
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 7e-46
Identities = 80/196 (40%), Positives = 114/196 (58%), Gaps = 4/196 (2%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
D G + + +K ++ QLL GL +CH R VLHRD+K NLL+N G LKLADFGLA +
Sbjct: 96 DCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AK 154
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
+ + ++ VVTLWYRPP++LLG+TDY +D+W VGC+F E+ G+P+ G T EQL
Sbjct: 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
Query: 273 HKIFKLCGSPPDDYWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
H IF++ G+P ++ W S + P+ D + L + L+ LL E
Sbjct: 215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPR-LDSDGAELLSKLLQFE 273
Query: 331 PYKRATASAALASEYF 346
KR +A A+ YF
Sbjct: 274 GRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 7e-46
Identities = 80/198 (40%), Positives = 118/198 (59%), Gaps = 12/198 (6%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214
G ++++ +K +M QLL GL +CH R +LHRD+K NLL+N +G LKLADFGLA + +
Sbjct: 97 GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSV 155
Query: 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
+ ++ VVTLWYRPP++LLG+T+Y +D+W VGC+ E+ G+P+ G T E+LH
Sbjct: 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYD------SSLRETFKDLPTTAVNLIETLLS 328
IF+L G+P ++ W P T + + Y L L T ++L+ +LL
Sbjct: 216 IFRLLGTPTEETW-----PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLL 270
Query: 329 VEPYKRATASAALASEYF 346
E R +A AAL YF
Sbjct: 271 YETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 70/186 (37%), Positives = 105/186 (56%), Gaps = 3/186 (1%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
K++K YM QLL L+H H G+ HRDIK N+L+ ++ +LKLADFG + + P T
Sbjct: 100 KRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYT 156
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
+ T WYR PE LL YGP +D+W+VGCVF E+L P+ G E++Q+ KI + G
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG 216
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
+P + KK + + + LR+ + ++L++ LL+ +P +R TA A
Sbjct: 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276
Query: 341 LASEYF 346
L YF
Sbjct: 277 LRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 5e-45
Identities = 83/216 (38%), Positives = 124/216 (57%), Gaps = 20/216 (9%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
D G I+++ +K ++ Q+L GL +CH R VLHRD+K NLL+N G LKLADFGLA +
Sbjct: 96 DCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AK 154
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
+ + ++ VVTLWYRPP++LLG+++Y +D+W VGC+F E+ G+P+ G T ++L
Sbjct: 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214
Query: 273 HKIFKLCGSPPDDYW---------KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323
H IF+L G+P ++ W K P +KPQ + + R L T + L+
Sbjct: 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPK---YKPQPLINHAPR-----LDTEGIELL 266
Query: 324 ETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 359
L E KR +A A+ YF + + SLP
Sbjct: 267 TKFLQYESKKRISAEEAMKHAYF--RSLGTRIHSLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 9e-45
Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209
R + I KKI + Q L + CH +HRD+K N+L+ +G +KL DFG A
Sbjct: 95 RGVPEHLI---KKI-IW--QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR 148
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
T V T WYR PELL+G T YGP VD+W++GCVFAELL G+P+ G+++V
Sbjct: 149 ILTGPGDD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207
Query: 270 EQLHKIFKLCGS---------PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 320
+QL+ I K G + ++K +P +P L F ++ + A+
Sbjct: 208 DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREP-------LESKFPNISSPAL 260
Query: 321 NLIETLLSVEPYKRATASAALASEYF 346
+ ++ L ++P +R + L YF
Sbjct: 261 SFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 80/222 (36%), Positives = 122/222 (54%), Gaps = 18/222 (8%)
Query: 151 DLDTGKIVALKK-----IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 205
D IV +K I+ + Q+L GL++ HS G++HRD+K SN+ VN + LK+ DF
Sbjct: 103 GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 162
Query: 206 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 265
GLA ++ +T V T WYR PE++L Y +VD+WSVGC+ AELL GK + G
Sbjct: 163 GLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
Query: 266 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT----AVN 321
++QL +I L G+P ++ +K A + P ++ FK++ + A++
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMP--KKDFKEVFSGANPLAID 276
Query: 322 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 363
L+E +L ++P KR TA+ ALA Y Y D P+ PP
Sbjct: 277 LLEKMLVLDPDKRITAAEALAHPYL--AEYH-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 73/197 (37%), Positives = 114/197 (57%), Gaps = 19/197 (9%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHR 216
+ ++ Q+L GL++ HS VLHRD+K NLLVN + LK+ DFGLA N G
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF- 165
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
+T V T WYR PE++L Y ++D+WSVGC+ AELL KP+ +G+ V+QL++I
Sbjct: 166 --MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223
Query: 277 KLCGSPPDDYWKKSKLPHA-----TL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
++ G+P ++ + P A +L P++P++S F + A++L+E LL+ +
Sbjct: 224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI----FPNANPLALDLLEKLLAFD 279
Query: 331 PYKRATASAALASEYFS 347
P KR + AL Y +
Sbjct: 280 PTKRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 85/190 (44%), Positives = 117/190 (61%), Gaps = 9/190 (4%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
++ +M QLL GL + H + +LHRD+K NLL++ G LKLADFGLA + + Q +S
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSE 163
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGS 281
VVTLWYRPP++LLGATDY ++D+W GC+F E+L G+P G ++V EQL KI+ + G
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV 223
Query: 282 PPDDYWKK-SKLPH--ATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRAT 336
P +D W SKLP+ F P +P LR +K L P A +L +L + P R +
Sbjct: 224 PTEDTWPGVSKLPNYKPEWFLPCKP--QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
Query: 337 ASAALASEYF 346
A AL YF
Sbjct: 282 AQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 78/188 (41%), Positives = 111/188 (59%), Gaps = 7/188 (3%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
+ IK M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + + L
Sbjct: 107 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMAL 164
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T VVTLWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L
Sbjct: 165 TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223
Query: 280 GSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
G PP+D W + LP F P+ P ++ ++ + L+ +L+ P+KR +A
Sbjct: 224 GLPPEDDWPRDVTLPRGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF 280
Query: 339 AALASEYF 346
AL +F
Sbjct: 281 RALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 68/193 (35%), Positives = 104/193 (53%), Gaps = 9/193 (4%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPL 219
I+ ++ QLL GL++ HS V+HRD+K SNLLVN + L++ DFG+A S T H+ +
Sbjct: 109 IRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T V T WYR PELLL +Y ++D+WSVGC+FAE+L + + G+ V QL I +
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 280 GSPPDDYWKKSKLPHA----TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
GSP ++ + +QP + F A++L+ +L +P +R
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVP--WSKIFPKASPEALDLLSQMLQFDPEERI 286
Query: 336 TASAALASEYFST 348
T AL + +
Sbjct: 287 TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 72/186 (38%), Positives = 107/186 (57%), Gaps = 3/186 (1%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+K ++ Q+L GL++ HS G+LHRDIK NLLVN+ VLK+ DFGLA + +T
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT +YR PE+L+G+ Y +VD+WSVGC+FAELL + + Q ++ ++QL I L G+P
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 283 PDDYWKKS---KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+ + + H + P L AV+L+ +L +P KR +A+
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284
Query: 340 ALASEY 345
ALA Y
Sbjct: 285 ALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 76/199 (38%), Positives = 109/199 (54%), Gaps = 24/199 (12%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ ++ Q+L GL++ HS GV+HRD+K SN+L+N LK+ DFGLA + + +T
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQ--MTGY 165
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V T +YR PE++L Y VD+WS GC+FAE+L GKP+ G+ V Q I L G+P
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225
Query: 283 PDDYWKK----------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 332
PDD LP + P E FK+ +A++L+E +L +P
Sbjct: 226 PDDVINTICSENTLRFVQSLPK----REPVP----FSEKFKNADPSAIDLLEKMLVFDPQ 277
Query: 333 KRATASAALASEYFSTKPY 351
KR +A+ ALA Y PY
Sbjct: 278 KRISAAEALAHPYL--APY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 82/195 (42%), Positives = 119/195 (61%), Gaps = 11/195 (5%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+K ++ QLL GL + H R +LHRD+K NLL+++ G LKLADFGLA + + ++
Sbjct: 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNE 163
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGS 281
VVTLWYRPP++LLG+T+Y +D+W VGC+F E++ G G +++ QL +IF + G+
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223
Query: 282 PPDDYWKK-SKLPHATLFKPQQ--PYDS-SLRETFKDLPTT--AVNLIETLLSVEPYKRA 335
P +D W LPH FKP++ Y +LR+ + L A +L LL P R
Sbjct: 224 PNEDTWPGVHSLPH---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL 280
Query: 336 TASAALASEYFSTKP 350
+A AAL+ EYFS P
Sbjct: 281 SAQAALSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 72/203 (35%), Positives = 103/203 (50%), Gaps = 33/203 (16%)
Query: 165 CY-MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTS 221
Y + Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA H LT
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
V T WYR PE++L + Y ++D+WSVGC+ AE+L +P+ G+ + QL+ I + G+
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 282 PPDD------------YWK----KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 325
P + Y K K K+P LF P A++L++
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLF----PNADPK----------ALDLLDK 274
Query: 326 LLSVEPYKRATASAALASEYFST 348
+L+ P+KR T ALA Y
Sbjct: 275 MLTFNPHKRITVEEALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 74/202 (36%), Positives = 111/202 (54%), Gaps = 20/202 (9%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA-----NFSNTGHR 216
+ +M QLL GL++ HS VLHRD+K +N+ +N E VLK+ DFGLA ++S+ G+
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY- 174
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
L+ +VT WYR P LLL +Y ++D+W+ GC+FAE+L GKP+ G E+EQ+ I
Sbjct: 175 --LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
Query: 277 KLCGSPP-----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
+ S P D + +P +P LR+ + A++ +E +L+ P
Sbjct: 233 E---SVPVVREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPGVNPEALDFLEQILTFNP 288
Query: 332 YKRATASAALASEYFSTKPYAC 353
R TA AL Y S Y+C
Sbjct: 289 MDRLTAEEALMHPYMS--CYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 74/202 (36%), Positives = 118/202 (58%), Gaps = 11/202 (5%)
Query: 153 DTGKIVALKK-----IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
D GK++ +K I+ + Q+L GL++ H+ G++HRD+K NL VN + LK+ DFGL
Sbjct: 105 DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
A +++ +T VVT WYR PE++L Y +VD+WSVGC+ AE+L GKP+ +G
Sbjct: 165 ARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
Query: 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIET 325
++QL +I K+ G+P ++ +K + A + + P R + AVN++E
Sbjct: 221 HLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEK 280
Query: 326 LLSVEPYKRATASAALASEYFS 347
+L ++ R TA+ ALA YF
Sbjct: 281 MLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 2e-39
Identities = 69/190 (36%), Positives = 110/190 (57%), Gaps = 5/190 (2%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
+++ Y+ Q+L G+E CHS ++HRDIK N+LV+ GV+KL DFG A +
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T V T WYR PELL+G T YG +VD+W+VGC+ E+L G+P+ G ++++QL+ I K
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL 217
Query: 280 GSPPDDY---WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
G+ + ++K+ L A + P+ L + F L ++L + L ++P R +
Sbjct: 218 GNLIPRHQEIFQKNPL-FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
Query: 337 ASAALASEYF 346
+S L E+F
Sbjct: 277 SSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 81/191 (42%), Positives = 113/191 (59%), Gaps = 9/191 (4%)
Query: 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217
V + IK M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + +
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQM 164
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
LTS VVTLWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223
Query: 278 LCGSP-PDDYWKKSKLPHATLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ G P +D+ + LP K QP + + D+ +L+ L+ P KR
Sbjct: 224 VIGLPGEEDWPRDVALPRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRI 279
Query: 336 TASAALASEYF 346
+A +AL+ YF
Sbjct: 280 SAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 7e-38
Identities = 80/221 (36%), Positives = 121/221 (54%), Gaps = 11/221 (4%)
Query: 153 DTGKIVALKK-----IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
D IV +K ++ + QLL GL++ HS G++HRD+K SN+ VN + L++ DFGL
Sbjct: 105 DLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
A ++ +T V T WYR PE++L Y +VD+WSVGC+ AELL GK + G
Sbjct: 165 ARQAD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
Query: 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIET 325
++QL +I ++ G+P + KK HA + P+ L++ F+ A++L+E
Sbjct: 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEK 280
Query: 326 LLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKE 366
+L ++ KR +AS ALA YFS D Y S E
Sbjct: 281 MLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 80/228 (35%), Positives = 119/228 (52%), Gaps = 17/228 (7%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRV 223
++ QLL L++ H+ V HRD+K N+L N + LK+ DFGLA F++T T V
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 224 VTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
T WYR PEL G+ + Y P++D+WS+GC+FAE+L GKP+ G+ V QL I L G+
Sbjct: 168 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226
Query: 282 PPDDYWKKSKLPHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
P + + + A + + +QP + F + A+ L+E LL+ +P R TA
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTA 284
Query: 338 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR 385
ALA YF L+ + P ++ I E RR+ VR
Sbjct: 285 EEALADPYFK------GLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 73/202 (36%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 153 DTGKIVALKK-----IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
D IV +K ++ + Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGL
Sbjct: 107 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
A ++ +T V T WYR PE++L Y +VD+WSVGC+ AELL G+ + G
Sbjct: 167 ARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
Query: 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIET 325
++QL I +L G+P + KK A + + F AV+L+E
Sbjct: 223 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282
Query: 326 LLSVEPYKRATASAALASEYFS 347
+L ++ KR TA+ ALA YF+
Sbjct: 283 MLVLDSDKRITAAQALAHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 74/201 (36%), Positives = 114/201 (56%), Gaps = 12/201 (5%)
Query: 153 DTGKIVALK----KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
D KI+ K++ + Q+L GL++ HS G++HRD+K NL VN + LK+ DFGLA
Sbjct: 105 DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
++ +T VVT WYR PE++L Y +VD+WSVGC+ AE+L GK + +G+
Sbjct: 165 RHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIET 325
++QL +I K+ G P ++ +K + A + P+ P F AV+L+E
Sbjct: 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEK 279
Query: 326 LLSVEPYKRATASAALASEYF 346
+L ++ KR TA+ AL YF
Sbjct: 280 MLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 8e-35
Identities = 75/187 (40%), Positives = 109/187 (58%), Gaps = 7/187 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTS 221
+K Y QL L + HS+ + HRD+K NLL++ N LKL DFG A G R S
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VS 229
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+ + +YR PEL+LGAT+Y +DLWS+GC+ AE+++G PI G++ V+QL +I ++ G+
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289
Query: 282 PPDDYWKKSKLPHATL-FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASA 339
P +D K+ +A + F +P D L++ F K P A+N I L EP KR
Sbjct: 290 PTEDQLKEMNPNYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347
Query: 340 ALASEYF 346
ALA +F
Sbjct: 348 ALADPFF 354
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 29/197 (14%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 183
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
R PE++LG Y +VD+WSVGC+ E++ G + G ++Q +KI + G+P D++
Sbjct: 184 RAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242
Query: 289 K--------------------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
+ +L LF P + L+ + A +L+ +L
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK------ASQARDLLSKMLV 296
Query: 329 VEPYKRATASAALASEY 345
++P KR + AL Y
Sbjct: 297 IDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 80/208 (38%), Positives = 117/208 (56%), Gaps = 24/208 (11%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR-- 216
+K + Q+L G+ + H+ VLHRD+K +N+LV EG +K+AD G A N+ +
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-------- 268
L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 229
Query: 269 -VEQLHKIFKLCGSPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLP-TT 318
+QL +IF + G P D W+ K+P H+TL F+ + SL E K P +
Sbjct: 230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 289
Query: 319 AVNLIETLLSVEPYKRATASAALASEYF 346
A +L++ LL+++P KR T+ A+ YF
Sbjct: 290 AFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-32
Identities = 71/188 (37%), Positives = 99/188 (52%), Gaps = 4/188 (2%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
K++ Y+ QL+ + CH ++HRDIK NLL+++ VLKL DFG A + G T
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
V T WYR PELLLGA YG +VD+WSVGC+ EL G+P+ G +E++QL I K+ G
Sbjct: 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219
Query: 282 PPDDYWK--KSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATAS 338
P + K S L P + SL + L ++L++ LL + P R
Sbjct: 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE 279
Query: 339 AALASEYF 346
L F
Sbjct: 280 QCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 81/208 (38%), Positives = 116/208 (55%), Gaps = 24/208 (11%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR-- 216
+K + Q+L G+ + H+ VLHRD+K +N+LV EG +K+AD G A N+ +
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-------- 268
L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229
Query: 269 -VEQLHKIFKLCGSPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLPTTA 319
+QL +IF + G P D W+ K+P + TL F+ +SSL E K P +
Sbjct: 230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 289
Query: 320 VN-LIETLLSVEPYKRATASAALASEYF 346
V L++ LL+++P KR T+ AL YF
Sbjct: 290 VFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 6e-31
Identities = 59/257 (22%), Positives = 102/257 (39%), Gaps = 32/257 (12%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E + G+ + + ++ + + Q+L LE+ HS+G++HRDIK N+L+
Sbjct: 77 MEYVDGGSLEDLLKKIG--RKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL 134
Query: 195 N-NEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDL 246
+ + V+KL DFGLA S + ++ V T Y PE+LLG + S D+
Sbjct: 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI 194
Query: 247 WSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303
WS+G ELL G P +G Q KI +P P
Sbjct: 195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPE--------- 245
Query: 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 363
+ A +L++ LL+ +P R ++S+ L+ + + S + P
Sbjct: 246 ----------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 364 SKEIDAKHREDARRKKV 380
+ +
Sbjct: 296 DSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 40/98 (40%), Positives = 59/98 (60%), Gaps = 2/98 (2%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQP 218
+I + Q+L GLE+ HS G++HRD+K N+L+++ G +KLADFGL+ T +
Sbjct: 91 EDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL-TSDKSL 149
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
L + V T Y PE+LLG Y D+WS+G + EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 58/184 (31%), Positives = 87/184 (47%), Gaps = 42/184 (22%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 221
I+ Y Q+L GL + HS G++HRDIKG+N+LV+++GV+KLADFG A + + S
Sbjct: 103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
T ++ PE++ G +YG + D+WS+GC E+ GKP
Sbjct: 163 VRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPP------------------- 202
Query: 282 PPDDYWKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
W + P A L+K P+ P + L A + + L +P KR
Sbjct: 203 -----WSELGNPMAALYKIGSSGEPPEIP---------EHLSEEAKDFLRKCLRRDPKKR 248
Query: 335 ATAS 338
TA
Sbjct: 249 PTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 16/215 (7%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 191
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
R PE++LG Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ K
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 289 KSKLPHATLFKPQQPYDS-SLRETFKDL------------PTTAVNLIETLLSVEPYKRA 335
K + T + + Y S + F D+ + A +L+ +L ++ KR
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 336 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 370
+ AL Y + + + P P K++D +
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 73/221 (33%), Positives = 116/221 (52%), Gaps = 26/221 (11%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYY 188
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
R PE++LG Y +VD+WSVGC+ EL+ G I QG ++Q +K+ + G+P ++
Sbjct: 189 RAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 289 K--SKLPHATLFKPQQPYDSSLRETFKD--LP----------TTAVNLIETLLSVEPYKR 334
+ + + +PQ P S E F D P + A +L+ +L ++P KR
Sbjct: 248 RLQPTVRNYVENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306
Query: 335 ATASAALASEYFST--KPYACDLSSLPIYPPSKEIDAKHRE 373
+ AL Y + P + PP + DA+ E
Sbjct: 307 ISVDEALRHPYITVWYDPAEAEA------PPPQIYDAQLEE 341
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 69/223 (30%), Positives = 121/223 (54%), Gaps = 16/223 (7%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+++ + Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MT 176
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
VVT +YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G
Sbjct: 177 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 281 SPPDDYWKK----------SKLPHATLFKPQQPYDSSL---RETFKDLPTTAVNLIETLL 327
+P ++ KK ++ +A L P+ DS E K + A +L+ +L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 328 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 370
++P KR + AL Y + ++ + P K++D +
Sbjct: 296 VIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 35/179 (19%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF------SNTGHR 216
+ Y+ +++ LE+ HS G++HRD+K N+L+++ G LKL DFGL+ N
Sbjct: 95 ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154
Query: 217 QPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
+ R+V T Y PE++LG + +VD WS+GC+ E L+G P G T E I
Sbjct: 155 EKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI 213
Query: 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
P+D ++ A++LI LL +P KR
Sbjct: 214 LNGKIEWPED---------------------------VEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 41/100 (41%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTS 221
I +LL GLE+ HS G++HRDIK +N+L+ ++G +KL DFGL+ S+T R +
Sbjct: 100 IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---T 156
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
V T ++ PE++ G Y D+WS+G EL GKP
Sbjct: 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 59/183 (32%), Positives = 84/183 (45%), Gaps = 34/183 (18%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 224
+ QL L++ HSR +LHRDIK N+ + + G++KL DFG++ S+T L VV
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVV 164
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
T +Y PEL Y D+WS+GCV EL K +G +E KI K G P
Sbjct: 165 GTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYP 221
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343
+P Y S LR NL+ +LL +P +R + + L S
Sbjct: 222 -------PIP--------SQYSSELR-----------NLVSSLLQKDPEERPSIAQILQS 255
Query: 344 EYF 346
+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 57/205 (27%)
Query: 160 LKKIKC--------YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
++K Y ++L LE+ HS+G++HRD+K N+L++ + +K+ DFG A
Sbjct: 93 IRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152
Query: 212 NTGH-------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 252
+ R+ S V T Y PELL G S DLW++GC+
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCI 211
Query: 253 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 312
++L GKP +G E KI KL S P ++
Sbjct: 212 IYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNF-------------------------P 246
Query: 313 KDLPTTAVNLIETLLSVEPYKRATA 337
D A +LIE LL ++P R
Sbjct: 247 PD----AKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 55/173 (31%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTS 221
+ Y +++ LE+ HS G+++RD+K N+L++ +G +KL DFGLA S+ G R +
Sbjct: 95 ARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNT 152
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
T Y PE+LLG YG +VD WS+G + E+L GKP E KI K
Sbjct: 153 FCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---- 207
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ P + L A +LI LL +P KR
Sbjct: 208 ------DPLRFP-------------------EFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 56/180 (31%), Positives = 84/180 (46%), Gaps = 29/180 (16%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ Y Q+L GLE+ H R +HRDIKG+N+LV+ GV+KLADFG+A S
Sbjct: 104 IRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSF 161
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
+ ++ PE++ YG + D+WS+GC E+ GKP +++E + +FK+ G
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKI-GRS 217
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342
+ P P L A + I L +P R TA+ L
Sbjct: 218 KE--------------LPPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 43/115 (37%), Positives = 65/115 (56%), Gaps = 6/115 (5%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+ Y+ Q+L GL + H +GV+HRDIK +N+L +GV+KLADFG+A N + +
Sbjct: 101 VAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV- 159
Query: 223 VVTLWYRPPELLLGATDYGPSV--DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
V T ++ PE++ + G S D+WS+GC ELL G P + L +I
Sbjct: 160 VGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 39/206 (18%)
Query: 140 QGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 199
GT + L+ G+I+ I+ Y QLL GL + HS G++HRDIK +N+ +++ GV
Sbjct: 83 GGTLEEL-----LEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV 137
Query: 200 LKLADFG----LANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVF 253
+KL DFG L N + T + + S T Y PE++ G +G + D+WS+GCV
Sbjct: 138 IKLGDFGCAVKLKNNTTTMGEE-VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196
Query: 254 AELLIGKPILQGRTEVEQLHKI-FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 312
E+ GK +E++ +I F + KP P L
Sbjct: 197 LEMATGKRPW---SELDNEFQIMFHVGAGH----------------KPPIPDSLQLSPEG 237
Query: 313 KDLPTTAVNLIETLLSVEPYKRATAS 338
KD ++ L +P KR TAS
Sbjct: 238 KD-------FLDRCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 57/193 (29%), Positives = 84/193 (43%), Gaps = 31/193 (16%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226
++L GLE+ HS+ V+HRDIK N+L++ +G +KLADFG A S V T
Sbjct: 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTP 180
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286
++ PE++ DYGP VD+WS+G + E+ G+P + L I G PP
Sbjct: 181 YWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--- 235
Query: 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
L + + P+ FKD + L +P KR +A L +
Sbjct: 236 -----LKNPEKWSPE----------FKD-------FLNKCLVKDPEKRPSAEELLQHPFL 273
Query: 347 STKPYACDLSSLP 359
AC
Sbjct: 274 KK---ACPKEEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 17/162 (10%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQ 217
++ ++ Q+L GL + H+RG++HRDIKG+N+LV+N+G +K++DFG+ AN +T
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
S ++++ PE ++ T Y D+WS+GC+ E+L GK + QL IFK
Sbjct: 168 ARPSLQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGK---HPFPDCTQLQAIFK 223
Query: 278 LCG----SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 315
+ P + ++ F+ D + R T +L
Sbjct: 224 IGENASPEIPSNISSEAIDFLEKTFEI----DHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 45/121 (37%), Positives = 66/121 (54%), Gaps = 6/121 (4%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y Q+L G+E+ HS ++HRDIKG+N+L ++ G +KL DFG + T + V
Sbjct: 109 YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
T ++ PE++ G YG D+WSVGC E+L KP E E + IFK+ P
Sbjct: 169 GTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 224
Query: 284 D 284
+
Sbjct: 225 N 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 35/174 (20%)
Query: 169 QLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223
QLL L CH+R VLHRD+K +N+ ++ +KL DFGLA + V
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYV 171
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
T +Y PE L + Y D+WS+GC+ EL P R +++ KI
Sbjct: 172 GTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-------- 222
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
K ++P+ Y S L E +I+++L+V+P KR +
Sbjct: 223 -KEGKFRRIPYR--------YSSELNE-----------VIKSMLNVDPDKRPST 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 58/180 (32%), Positives = 81/180 (45%), Gaps = 35/180 (19%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
K Y+ +++ G+E H RG++HRDIK NLL++ G LKL DFGL+ R L ++
Sbjct: 99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------RNGLENK 151
Query: 223 --VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
V T Y PE +LG D D WS+GCV E L G P T
Sbjct: 152 KFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET------------- 197
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
PD + + + P+ E + AV+LI LL ++P KR A+
Sbjct: 198 --PDAVFD--NILSRRINWPE--------EVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 2/123 (1%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--GHRQPLT 220
++ + Q+L GL + HS+G+LHRD+K NLLV+ +G+ K++DFG++ S+ + Q ++
Sbjct: 110 VRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
+ W P + + Y VD+WS+GCV E+ G+ + + K+
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229
Query: 281 SPP 283
+PP
Sbjct: 230 APP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 69/198 (34%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK------------------------- 164
+ F+ LEK+G+G+Y SV++A +TG++VA+K +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 165 ---CYM--NQLLHGLEHC-----------------------------------HSRGVLH 184
Y L +E+C HS +H
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 185 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPS 243
RDIK N+L+N EG KLADFG++ + V+ T ++ PE++ Y
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNK 179
Query: 244 VDLWSVGCVFAELLIGKP 261
D+WS+G E+ GKP
Sbjct: 180 ADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 47/125 (37%), Positives = 66/125 (52%), Gaps = 7/125 (5%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA---NFSNTGHRQPLTS 221
Y QLL GL + H ++HRD+KG+NLL+++ G L++ADFG A TG +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+ T+ + PE+L G YG S D+WSVGCV E+ KP L IFK+ +
Sbjct: 168 LLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226
Query: 282 --PPD 284
P
Sbjct: 227 TTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 62/197 (31%), Positives = 82/197 (41%), Gaps = 53/197 (26%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR----Q 217
I Y Q+L GL++ H ++HRDIKG N+LVN GV+K++DFG T R
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG------TSKRLAGIN 163
Query: 218 PLTSRVV-TLWYRPPELL-LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
P T TL Y PE++ G YG D+WS+GC E+ GKP
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP-------------P 210
Query: 276 FKLCGSPPDDYWKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLS 328
F G P A +FK P+ P + L A N I
Sbjct: 211 FIELGE-----------PQAAMFKVGMFKIHPEIP---------ESLSAEAKNFILRCFE 250
Query: 329 VEPYKRATASAALASEY 345
+P KRA+A L +
Sbjct: 251 PDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 36/93 (38%), Positives = 57/93 (61%), Gaps = 3/93 (3%)
Query: 169 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 227
Q+L GL++ H+ R ++HRDIK SNLL+N++G +K+ADFG++ + V T+
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-LDQCNTFVGTVT 165
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
Y PE + G + Y + D+WS+G E +GK
Sbjct: 166 YMSPERIQGES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 26/187 (13%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTS 221
I + ++L GLE+ HS G +HRDIK N+L+ +G +K+ADFG+ A+ ++ G R
Sbjct: 104 IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 222 RVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ T + PE++ Y D+WS G EL G ++ L L
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQ 221
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
PP L +K Y S R+ +I L +P KR TA
Sbjct: 222 NDPPS-------LETGADYK---KYSKSFRK-----------MISLCLQKDPSKRPTAEE 260
Query: 340 ALASEYF 346
L ++F
Sbjct: 261 LLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 29/172 (16%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+K ++ +++ LE+ HS+G++HRDIK N+L++ +G + + DF +A TS
Sbjct: 102 VKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTST 159
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T Y PE+L Y +VD WS+G E L GK +G +
Sbjct: 160 SGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RT 205
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
D + + L+ + A++ I LL +P KR
Sbjct: 206 IRDQIRAKQETADVLYPATWSTE-------------AIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 53/204 (25%), Positives = 81/204 (39%), Gaps = 76/204 (37%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI--------------------KC------ 165
F LE IG+G++ V++A D T ++VA+K I +C
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 166 -YMNQLLHG------LEHC---------------------------------HSRGVLHR 185
Y L G +E+C H G +HR
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 186 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR----VVTLWYRPPELLLGATDYG 241
DIK +N+L++ EG +KLADFG++ G S+ V T ++ PE++ + Y
Sbjct: 123 DIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYD 176
Query: 242 PSVDLWSVGCVFAELLIGKPILQG 265
D+WS+G EL G+P L
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 50/177 (28%), Positives = 75/177 (42%), Gaps = 30/177 (16%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y+ Q++ + + H G+LHRDIK N+ + G++KL DFG++ + + T V T
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
+Y PEL G Y D+W++GCV ELL K + + KI + +P
Sbjct: 165 PYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS 223
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342
Y S L L+ +LL +P KR TA L
Sbjct: 224 -----------------VYSSELIS-----------LVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E + G+ + V +D G+I A+ + + L LE HS V+HRDIK N+L+
Sbjct: 95 MEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSNQVIHRDIKSDNILL 148
Query: 195 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+G +KL DFG T + ++ V T ++ PE++ YGP VD+WS+G +
Sbjct: 149 GMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAI 206
Query: 255 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314
E++ G+P + L+ I AT P+ L F+D
Sbjct: 207 EMVEGEPPYLNENPLRALYLI-------------------ATNGTPELQNPEKLSAIFRD 247
Query: 315 LPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYACDLSSL-PIYPPSKEI 367
+ L ++ KR +A L + KP LSSL P+ +KE
Sbjct: 248 -------FLNRCLEMDVEKRGSAKELLQHPFLKIAKP----LSSLTPLIAAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 41/131 (31%), Positives = 60/131 (45%), Gaps = 28/131 (21%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVV 224
YM ++ ++ H G +HRD+K N L++ G +KL DFGL+ + S V
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVG 160
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 284
+ Y PE+L G Y +VD WS+GC+ E L G P GS P+
Sbjct: 161 SPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFP---------------PFSGSTPN 204
Query: 285 D------YWKK 289
+ YWK+
Sbjct: 205 ETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 42/116 (36%), Positives = 65/116 (56%), Gaps = 2/116 (1%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
L + Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ + G +
Sbjct: 95 LPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
T T Y PE+LLG Y SVD WS G + E+LIG+ G E E I
Sbjct: 155 TF-CGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 33/187 (17%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SN 212
+++ + I Y QL LEH HS+ ++HRDIK +N+ + GV+KL D GL F S
Sbjct: 100 KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQ 271
T S V T +Y PE + Y D+WS+GC+ E+ + P + +
Sbjct: 160 TTAAH---SLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
Query: 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
L K + C PP P Y LR+ L+ ++ +P
Sbjct: 216 LCKKIEKCDYPP---------------LPADHYSEELRD-----------LVSRCINPDP 249
Query: 332 YKRATAS 338
KR S
Sbjct: 250 EKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPL 219
Y Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG----I 166
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
S T ++ PE++ G YG D+WSV C E+L KP E E + IFK+
Sbjct: 167 KSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIA 222
Query: 280 GSPPDDYWKKSKLPHATL-----FKPQQPYDSSLRETFKDLP 316
P K LP F Q + R T + L
Sbjct: 223 TQP-----TKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 46/123 (37%), Positives = 66/123 (53%), Gaps = 14/123 (11%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPL 219
Y Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG +
Sbjct: 111 YTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG----M 166
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
S T ++ PE++ G YG D+WSVGC E+L KP E E + IFK+
Sbjct: 167 KSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIA 222
Query: 280 GSP 282
P
Sbjct: 223 TQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 46/125 (36%), Positives = 67/125 (53%), Gaps = 14/125 (11%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPL 219
Y Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG R
Sbjct: 111 YTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR--- 167
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
S T ++ PE++ G YG D+WS+GC E+L KP E E + IFK+
Sbjct: 168 -SVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIA 222
Query: 280 GSPPD 284
P +
Sbjct: 223 TQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 42/183 (22%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLT 220
QLL GL+ H + +LHRD+K +N+L+ ++K+ D G++ N + T P
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH- 166
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
Y PE+ G Y D+WS+GC+ E+ P + R+ ++ L +K+
Sbjct: 167 -------YMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKVQR 215
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
K +P Y L+ N I ++L V+P R
Sbjct: 216 G------KYPPIPPI--------YSQDLQ-----------NFIRSMLQVKPKLRPNCDKI 250
Query: 341 LAS 343
LAS
Sbjct: 251 LAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 37/110 (33%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ GL+ H RG+++RD+K N+L+++EG +K+ADFG+ ++ T
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGT 159
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
Y PE+L YGP+VD W++G + E+L G+ +G E E I
Sbjct: 160 PDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 9/116 (7%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLT 220
Y Q+L G+ + H+ V+HRDIKG+N+++ G++KL DFG A + H L
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
S T ++ PE ++ + YG D+WS+GC E+ GKP L +++L +F
Sbjct: 167 SMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 3/121 (2%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y Q++ GLEH H R +++RD+K N+L+++ G ++++D GLA + + R T
Sbjct: 100 YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGT 157
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
Y PE+L G Y SVD +++GC E++ G+ + R E + ++ + +
Sbjct: 158 PGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE 216
Query: 286 Y 286
Y
Sbjct: 217 Y 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y+ ++ E+ H+RG+++RD+K NLL+++ G +KL DFG A +G + T
Sbjct: 98 YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCG 154
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
T Y PE++L Y SVD WS+G + ELL G+P
Sbjct: 155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 66/285 (23%), Positives = 98/285 (34%), Gaps = 101/285 (35%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK--------------------------- 164
+++LE IG+G Y +V+R + + TG++VALK I
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 165 -------CYMN--QLLHGLEHCHS---------------------RGVL----------- 183
Y+ +L +E+ R VL
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 184 -HRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELLLGATDY 240
HRDIK +N+LV N G +KL DFG+A N+ R T ++ PE++ Y
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG---TPYWMAPEVITEGKYY 179
Query: 241 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300
D+WS+G E+ G P + L KSK P
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIP--------KSKPPRL----E 223
Query: 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345
Y LRE + L EP +R +A L S++
Sbjct: 224 DNGYSKLLRE-----------FVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 44/129 (34%), Positives = 65/129 (50%), Gaps = 3/129 (2%)
Query: 156 KIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215
+++ K + Y QL LEH HSR V+HRDIK +N+ + GV+KL D GL F ++
Sbjct: 101 RLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-K 159
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHK 274
S V T +Y PE + Y D+WS+GC+ E+ + P + + L K
Sbjct: 160 TTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
Query: 275 IFKLCGSPP 283
+ C PP
Sbjct: 219 KIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 47/155 (30%), Positives = 65/155 (41%), Gaps = 32/155 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGH 215
Y+ +L+ L+ H G +HRDIK N+L++ +G +KLADFGL + N H
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 216 RQPLTSRVVTLW------------------YRPPELLLGATDYGPSVDLWSVGCVFAELL 257
V+ Y PE+L G T YG D WS+G + E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224
Query: 258 IGKPILQGRTEVEQLHKI--FKLC-GSPPDDYWKK 289
G P T E +KI +K PPD
Sbjct: 225 YGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSP 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 227
+ L GL + H G +HRDIKG+N+L+ +G +KLADFG+ A + T ++ S + T +
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPY 166
Query: 228 YRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP 261
+ PE+ Y D+W++G EL +P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 38/116 (32%), Positives = 64/116 (55%), Gaps = 2/116 (1%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
+ + Y +++ GL+ H +G+++RD+K N+L++ +G +K+ADFG+ + G +
Sbjct: 95 EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA- 153
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
++ T Y PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 154 STFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 40/122 (32%), Positives = 68/122 (55%), Gaps = 10/122 (8%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVT 225
+++ L GL+H H +HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V T
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGT 187
Query: 226 LWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
++ PE++ + Y D+WS+G EL G P L ++ + +FK+ +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRN 244
Query: 282 PP 283
PP
Sbjct: 245 PP 246
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 43/126 (34%), Positives = 71/126 (56%), Gaps = 6/126 (4%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+++ Y +++ LEH H G+++RDIK N+L+++EG + L DFGL+ + ++ S
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP--ILQGR--TEVEQLHKIFK 277
T+ Y PE++ G +G +VD WS+G + ELL G L+G T+ E +I K
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK 225
Query: 278 LCGSPP 283
PP
Sbjct: 226 C--DPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-13
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E + G+ + V +D G+I A+ + + L LE HS V+HRDIK N+L+
Sbjct: 96 MEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 195 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+G +KL DFG T + ++ V T ++ PE++ YGP VD+WS+G +
Sbjct: 150 GMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAI 207
Query: 255 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314
E++ G+P + L+ I AT P+ L F+D
Sbjct: 208 EMIEGEPPYLNENPLRALYLI-------------------ATNGTPELQNPEKLSAIFRD 248
Query: 315 LPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYACDLSSL-PIYPPSKE 366
+ L ++ KR +A L ++ KP LSSL P+ +KE
Sbjct: 249 -------FLNRCLDMDVEKRGSAKELLQHQFLKIAKP----LSSLTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 45/138 (32%), Positives = 59/138 (42%), Gaps = 31/138 (22%)
Query: 160 LKKIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFG--------LANF 210
L KI +L GL + H ++HRD+K SN+LVN+ G +KL DFG LA
Sbjct: 102 LGKI---AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK----PILQGR 266
+ G T Y PE + G DY D+WS+G EL G+ P
Sbjct: 158 TFVG----------TSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206
Query: 267 TEV-EQLHKIFKLCGSPP 283
+ E L I PP
Sbjct: 207 DGIFELLQYIVN--EPPP 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 3/129 (2%)
Query: 156 KIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215
+++ + + Y QL +EH HSR V+HRDIK +N+ + GV+KL D GL F ++
Sbjct: 101 RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-K 159
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHK 274
S V T +Y PE + Y D+WS+GC+ E+ + P + + L +
Sbjct: 160 TTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ 218
Query: 275 IFKLCGSPP 283
+ C PP
Sbjct: 219 KIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 33/198 (16%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLT 220
+I +L L H++GV+HRDIK ++L+ ++G +KL+DFG A S R+
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--K 173
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
S V T ++ PE ++ YG VD+WS+G + E++ G+P ++ + +I
Sbjct: 174 SLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-- 230
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
PP K K H LR ++ +L +P +RATA+
Sbjct: 231 LPP-----KLKNLHKV--------SPRLRS-----------FLDRMLVRDPAQRATAAEL 266
Query: 341 LASEYFSTKPYACDLSSL 358
L + + A SS+
Sbjct: 267 LNHPFLAK---AGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 43/134 (32%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNT 213
GK+ I + Q+ G++H H + VLHRDIK N+ + G +KL DFG A ++
Sbjct: 94 GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
G + V T +Y PPE+ Y D+WS+GC+ EL K Q + +
Sbjct: 154 GAYA--CTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
Query: 274 KIFKLCGSP-PDDY 286
K+ + P P Y
Sbjct: 211 KVCQGSYKPLPSHY 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 42/110 (38%), Positives = 70/110 (63%), Gaps = 6/110 (5%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
K+++ Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P
Sbjct: 97 KEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPH 153
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 268
S V T Y PE+L T Y S D +S+GC+ +LL G P Q +T+
Sbjct: 154 AS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ GLE H +++RD+K N+L+++ G ++++D GLA G + + RV T
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ Y PE ++ Y S D W +GC+ E++ GK + R E
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 33/101 (32%), Positives = 59/101 (58%), Gaps = 1/101 (0%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
+++ Y+ +++ L+H H G+++RDIK N+L+++EG + L DFGL+ +
Sbjct: 104 ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 220 TSRVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIG 259
S T+ Y PE++ G + + +VD WS+G + ELL G
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 41/132 (31%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKG 189
+ F +E + G+ + V +D +I A+ + + L LE H+ V+HRDIK
Sbjct: 90 ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR------ECLQALEFLHANQVIHRDIKS 143
Query: 190 SNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 249
N+L+ +G +KL DFG T + ++ V T ++ PE++ YGP VD+WS+
Sbjct: 144 DNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSL 201
Query: 250 GCVFAELLIGKP 261
G + E++ G+P
Sbjct: 202 GIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 44/119 (36%), Positives = 61/119 (51%), Gaps = 6/119 (5%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLT 220
+I + Q+ GL+H H R +LHRDIK N+ ++ G V KL DFG+A N T
Sbjct: 102 QILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
V T +Y PE+ Y D+WS+GCV EL K +G + QL + K+C
Sbjct: 162 C-VGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 8/127 (6%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E + G+ + V +D G+I A+ + + L L+ HS V+HRDIK N+L+
Sbjct: 95 MEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALDFLHSNQVIHRDIKSDNILL 148
Query: 195 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+G +KL DFG T + ++ V T ++ PE++ YGP VD+WS+G +
Sbjct: 149 GMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAI 206
Query: 255 ELLIGKP 261
E++ G+P
Sbjct: 207 EMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 40/110 (36%), Positives = 68/110 (61%), Gaps = 6/110 (5%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
+++ Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P
Sbjct: 97 AEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPH 153
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 268
S V T Y PE+L Y S D +S+GC+ +LL G P Q +T+
Sbjct: 154 AS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 40/98 (40%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
L GL + HS +HRDIK N+L+ G +KLADFG A+ + P S V T ++
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177
Query: 229 RPPELLLGATD---YGPSVDLWSVGCVFAELLIGKPIL 263
PE++L A D Y VD+WS+G EL KP L
Sbjct: 178 MAPEVIL-AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 2/110 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ GL+ HS+G+++RD+K N++++ +G +K+ADFG+ + G + ++ T
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGT 159
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
Y PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 22/198 (11%)
Query: 170 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 229
+L +++ H ++HRDIK N+ +N+ G + L DFG A F + T+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 230 PPELLLGATD-YGPSVDLWSVGCVFAEL------LIGKPILQGRTEVE-QLHKIFKLCGS 281
PELL A D YGP+VD+WS G V E+ L K L G + + Q+ I + G+
Sbjct: 251 APELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308
Query: 282 PPDDYWKKSKLPHATLFK---------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 332
P+++ A L + ++P L +LP LI +L+ + +
Sbjct: 309 HPNEFPID---AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365
Query: 333 KRATASAALASEYFSTKP 350
R +A A L F P
Sbjct: 366 HRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 50/187 (26%), Positives = 71/187 (37%), Gaps = 56/187 (29%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------- 216
Y+ + + ++ H G +HRDIK NLL++ +G +KL+DFGL HR
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 217 -----------QPLTS-RVVTLW----------------YRPPELLLGATDYGPSVDLWS 248
+P++S R W Y PE+ L T Y D WS
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWS 224
Query: 249 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSL 308
+G + E+L+G P E KI WK+ TL P + L
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQETYRKIIN---------WKE------TLQFPD---EVPL 266
Query: 309 RETFKDL 315
KDL
Sbjct: 267 SPEAKDL 273
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 35/114 (30%), Positives = 60/114 (52%), Gaps = 13/114 (11%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++++ LE+ HS+ +++RD+K N+L++ EG +KL DFG A + L R T
Sbjct: 106 YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWT 157
Query: 226 LW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
L Y PE ++ + + +VD W++G + E+L+G P KI
Sbjct: 158 LCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 2/115 (1%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+K Y+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ S H + S
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSF 158
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T+ Y PE ++ + S D WS G + E+L G QG+ E + I K
Sbjct: 159 CGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPL 219
++I +L L + HS+GV+HRDIK ++L+ +G +KL+DFG A S ++
Sbjct: 117 EQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-- 174
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
S V T ++ PE ++ T YG VD+WS+G + E++ G+P + V+ + +L
Sbjct: 175 KSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLR 230
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
SPP P P LR+ +E +L+ EP +RATA
Sbjct: 231 DSPP---------PKLKNAHKISPV---LRD-----------FLERMLTREPQERATAQE 267
Query: 340 AL 341
L
Sbjct: 268 LL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
L GL + HS ++HRDIK N+L+ G +KLADFG A+ S+ P S V T ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 231 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
PE++L + Y VD+WS+G EL KP L + L+ I
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 8/125 (6%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ Q+L L HS V+HRD+K N+L+ +G +KLADFG++ N Q +
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTF 163
Query: 223 VVTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
+ T ++ PE++ T Y D+WS+G EL +P E+ + + K+
Sbjct: 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKI 220
Query: 279 CGSPP 283
S P
Sbjct: 221 LKSEP 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 11/116 (9%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVT 225
+ + L GL + H V+HRDIKG N+L+ +KL DFG+ A +T R+ + + T
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGT 176
Query: 226 LWYRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
++ PE++ A D P D+WS+G EL GKP L + L KI
Sbjct: 177 PYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ GL++ H +++RD+K NLL++ EG +K+ADFGL G ++ T
Sbjct: 106 YAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
+ PE+L T Y +VD W +G + E+L+G+ G E E
Sbjct: 165 PEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 3/103 (2%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++L GLE H ++RD+K N+L+++ G ++++D GLA G + + RV T
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ Y PE +L Y S D W +GC+ E++ G+ +GR E
Sbjct: 165 VGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 38/113 (33%), Positives = 65/113 (57%), Gaps = 4/113 (3%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y++++ LEH H +G+++RD+K N+L++ +G +KL DFGL S H +T
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCG 162
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T+ Y PE+L+ + +G +VD WS+G + ++L G P + + KI K
Sbjct: 163 TIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 37/93 (39%), Positives = 58/93 (62%), Gaps = 4/93 (4%)
Query: 170 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 228
+L L H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S V T ++
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYW 182
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
PE L+ YGP VD+WS+G + E++ G+P
Sbjct: 183 MAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 42/128 (32%), Positives = 73/128 (57%), Gaps = 10/128 (7%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E +G G+ + RA D +I + K ++L GL++ HS +HRDIK +N+L+
Sbjct: 81 MEYLGGGSALDLLRAGPFDEFQIATMLK------EILKGLDYLHSEKKIHRDIKAANVLL 134
Query: 195 NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 253
+ +G +KLADFG+A ++T ++ + V T ++ PE++ + Y D+WS+G
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITA 191
Query: 254 AELLIGKP 261
EL G+P
Sbjct: 192 IELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 10/118 (8%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYR 229
L GL+H H+ ++HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V T ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWM 195
Query: 230 PPELLLGATDYGPS----VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
PE++ Y S D+WS+G EL G P L ++ + +FK+ +PP
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPRNPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 13/100 (13%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y Q++ LE+ HS +++RD+K NLL++++G +K+ DFG A + R T
Sbjct: 106 YAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYT 157
Query: 226 LW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
L Y PE++L YG +VD W++G + E+L G P
Sbjct: 158 LCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 32/183 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPL 219
I + Q+L L H H++ +LHRD+K N+L++ ++ V+K+ DFG++ +
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKA 158
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ V T Y PEL G Y D+W++GCV EL K + + KI
Sbjct: 159 YTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT 217
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+P D Y LR+ LI ++L+++P KR S
Sbjct: 218 FAPISDR-----------------YSPDLRQ-----------LILSMLNLDPSKRPQLSQ 249
Query: 340 ALA 342
+A
Sbjct: 250 IMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQ 217
L + + Y +LL LE+ H V++RD+K N+L++ +G + L DFGL N +
Sbjct: 92 LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T Y PELLLG Y +VD W++G + E+L G P E KI +
Sbjct: 152 TFCG---TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
Query: 278 LCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLS---VEPY 332
PD + + +K L P + + + K+ P + + LL P+
Sbjct: 208 EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPF 267
Query: 333 KRATASAA----LASEYFSTKP 350
K A +SA E+ KP
Sbjct: 268 KPAVSSAIDTSNFDEEFTREKP 289
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 8/109 (7%)
Query: 148 RARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
R R L ++ A+ + QLL +++ H G++HRDIK N+LVN + L DFG
Sbjct: 253 RLRPLGLAQVTAVAR------QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 208 ANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAE 255
A F+ P + T+ PE+L G Y PSVD+WS G V E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 39/112 (34%), Positives = 61/112 (54%), Gaps = 6/112 (5%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y ++ GL HS+G+++RD+K N++++ EG +K+ADFG+ + G T+R
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFC 162
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
T Y PE++ YG SVD W+ G + E+L G+P G E E I
Sbjct: 163 GTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 22/33 (66%), Positives = 29/33 (87%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+EKLEK+G+GTY V++ARD TG+IVALKKI+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR 33
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 2/92 (2%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
Q+ L+H H R +LHRDIK N+ + +G +KL DFG+A N+ T + T +Y
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYY 167
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
PE+ Y D+W++GCV E+ K
Sbjct: 168 LSPEICENRP-YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 43/121 (35%), Positives = 63/121 (52%), Gaps = 15/121 (12%)
Query: 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN---FSNT-----GH 215
+ Y + + LE+ H+ G++HRD+K NLL+ + G +KL DFGL+ S T GH
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 216 -----RQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
R+ L +V T Y PE++L YG VD W++G + E L+G G T
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 270 E 270
E
Sbjct: 223 E 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 41/127 (32%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y ++ GL H RG+++RD+K N+++++EG +K+ADFG+ +T+R
Sbjct: 106 YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFC 162
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
T Y PE ++ YG SVD W+ G + E+L G+P G E E I + S P
Sbjct: 163 GTPDYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
Query: 284 DDYWKKS 290
K++
Sbjct: 222 KSLSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
L GL + HS ++HRDIK N+L+ G +KLADFG A+ ++ P S V T ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 231 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
PE++L + Y VD+WS+G EL KP L + L+ I
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ L+ HS G +HRD+K N+L++ G LKLADFG + + V T
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGT 206
Query: 226 LWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIGKP 261
Y PE+L G YG D WSVG E+L+G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 35/206 (16%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVV 224
Y+ +L+ + H G +HRDIK N+L++ G +KLADFG A + V
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVG 165
Query: 225 TLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T Y PE+L G YG D WS+G + E++ G+ T + + I
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI---- 221
Query: 280 GSPPDDYWKKSKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+ K P+ P SS ++LI++LL +R
Sbjct: 222 ------------MNFQRFLKFPEDPKVSS----------DFLDLIQSLLC-GQKERLGYE 258
Query: 339 AALASEYFSTKPYACDLSSLPIYPPS 364
+FS + +SLP + P+
Sbjct: 259 GLCCHPFFSKIDWNNIRNSLPPFVPT 284
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 39/115 (33%), Positives = 60/115 (52%), Gaps = 11/115 (9%)
Query: 150 RDLD--------TGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 201
RDLD TGK ++ ++ + QLL G+ + H R +LHRD+K N+ + N +LK
Sbjct: 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLK 145
Query: 202 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
+ DFG++ G T+ T +Y PE L Y D+WS+GC+ E+
Sbjct: 146 IGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 18/33 (54%), Positives = 28/33 (84%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+EK+ +IG+GTY V++AR+ TG++VALKKI+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR 33
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 37/114 (32%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y ++ L H +G+++RD+K N+L+++EG KLADFG+ G T+
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC---KEGIFNGKTTSTFC 157
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T Y PE +L YGPSVD W++G + E+L G + E + I
Sbjct: 158 GTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
L GL + HS ++HRD+K N+L++ G++KL DFG A+ P V T ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMA 179
Query: 231 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDY 286
PE++L + Y VD+WS+G EL KP L + L+ I + SP +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGH 238
Query: 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
W + F+ DS L++ +D PT+ V L + E
Sbjct: 239 WSEY-------FR--NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 36/124 (29%), Positives = 68/124 (54%), Gaps = 3/124 (2%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ GLE H +++RD+K N+L+++ G ++++D GLA G Q + RV T
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
+ Y PE++ Y S D W++GC+ E++ G+ Q R + + ++ +L ++
Sbjct: 165 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223
Query: 286 YWKK 289
Y +K
Sbjct: 224 YSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 33/142 (23%)
Query: 173 GLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRV 223
LE+ HS+ V+HRD+K SN+L+N G +KL DFG +A + G +
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP------ 168
Query: 224 VTLWYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLC 279
Y PE + + Y D+WS+G EL G+ P +T +QL ++ +
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-- 222
Query: 280 GSPPDDYWKKSKLPHATLFKPQ 301
P +LP F P+
Sbjct: 223 EPSP-------QLPAEK-FSPE 236
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 39/100 (39%), Positives = 54/100 (54%), Gaps = 13/100 (13%)
Query: 170 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS----RVVT 225
++ GL + S +LHRD+K SN+LVN G +KL DFG++ Q + S V T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGT 156
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQ 264
Y PE + G YG D+WS+G F EL +G+ P Q
Sbjct: 157 NAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 32/100 (32%), Positives = 58/100 (58%), Gaps = 1/100 (1%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
++++ Y +++ LEH H G+++RDIK N+L+++ G + L DFGL+ + +
Sbjct: 105 QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 221 SRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIG 259
S T+ Y P+++ G + +VD WS+G + ELL G
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 31/186 (16%)
Query: 170 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWY 228
+L L + H++GV+HRDIK ++L+ ++G +KL+DFG + P +V T ++
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYW 184
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288
PE ++ YG VD+WS+G + E++ G+P ++ + +I D+
Sbjct: 185 MAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RDNLPP 236
Query: 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS- 347
+ K H SS+ F DL +L EP +RATA L +
Sbjct: 237 RVKDSHKV---------SSVLRGFLDL----------MLVREPSQRATAQELLQHPFLKL 277
Query: 348 TKPYAC 353
P +C
Sbjct: 278 AGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 32/101 (31%), Positives = 58/101 (57%), Gaps = 3/101 (2%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
++++ Y Q+ G+ H HS +++RD+K N+L++++G +L+D GLA G + +
Sbjct: 94 MERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTI 151
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
T R T Y PE+L Y VD +++GC E++ G+
Sbjct: 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 16/116 (13%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTS 221
Q+L GL H HS+ +LHRDIK NL ++ +K+ D G+A NF+NT
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-------- 160
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
V T +Y PE L Y D+W++G V E GK + + KI +
Sbjct: 161 IVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ L H GV++RD+K N+L++ EG KLADFG+ + T+ T
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGT 159
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
Y PE +L +YGPSVD W++G + E++ G+P + E + I
Sbjct: 160 PDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 11/181 (6%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E +G G+ + + L+ I + + ++L GL++ HS +HRDIK +N+L+
Sbjct: 81 MEYLGGGSALDLLKPGPLEETYIATI------LREILKGLDYLHSERKIHRDIKAANVLL 134
Query: 195 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+ +G +KLADFG+A + T W P + A D+ D+WS+G
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF--KADIWSLGITAI 192
Query: 255 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314
EL G+P + L I K SPP + SK P + D R T K+
Sbjct: 193 ELAKGEPPNSDLHPMRVLFLIPK--NSPPTLEGQYSK-PFKEFVEACLNKDPRFRPTAKE 249
Query: 315 L 315
L
Sbjct: 250 L 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 8/104 (7%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
Q+L G+ + H R ++HRDIK SNLL+N+ +K+ADFG++ P S V T+ Y
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSVGTIAY 234
Query: 229 RPPE-----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGR 266
PE L GA D G + D+WS+G E +G+ P GR
Sbjct: 235 MSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 22/35 (62%), Positives = 28/35 (80%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
D +EKL +I +GTY V+RARD TG+IVALKK+K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK 39
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 13/182 (7%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E +G G+ + LD +I + + ++L GL++ HS +HRDIK +N+L+
Sbjct: 81 MEYLGGGSALDLLEPGPLDETQIATI------LREILKGLDYLHSEKKIHRDIKAANVLL 134
Query: 195 NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 253
+ G +KLADFG+A ++T ++ + V T ++ PE ++ + Y D+WS+G
Sbjct: 135 SEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITA 191
Query: 254 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 313
EL G+P +E+ + +F + + P P + + S R T K
Sbjct: 192 IELAKGEP---PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 248
Query: 314 DL 315
+L
Sbjct: 249 EL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 37/111 (33%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
L ++ ++ + Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL
Sbjct: 86 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--- 142
Query: 212 NTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
G T + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ K Y+ +L+ LEH H +++RD+K N+L++ G + L DFGL+ +N +
Sbjct: 96 DRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTN 154
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 259
+ T Y PE+LL Y VD WS+G + E+ G
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 39/134 (29%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+I+ Q+L L++ HS ++HRD+K N+L+ +G +KLADFG++ N Q S
Sbjct: 111 QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDS 169
Query: 222 RVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ T ++ PE+++ T Y D+WS+G E+ +P E+ + + K
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLK 226
Query: 278 LCGSPPDDYWKKSK 291
+ S P + SK
Sbjct: 227 IAKSEPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 2/112 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ GL HS+G+++RD+K N+++++EG +K+ADFG+ N + T
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
Y PE ++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 165 PDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 135 LEKIGQGTYSSVF---RARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 191
+E G+ S++ + R G+ V K + +L GL + HSR ++HRDIK SN
Sbjct: 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES----VLKGLSYLHSRKIIHRDIKPSN 135
Query: 192 LLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 251
+L+ +G +KL DFG++ T T +Y PE + G Y + D+WS+G
Sbjct: 136 ILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQGKP-YSITSDVWSLGL 191
Query: 252 VFAEL 256
E+
Sbjct: 192 TLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 35/82 (42%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 182 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 241
++HRD+K SN+LVN+ G +KL DFG+ S S V T Y PE L G T Y
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG-THYT 176
Query: 242 PSVDLWSVGCVFAELLIGK-PI 262
D+WS+G E+ IG+ PI
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 215
+ L ++ + Q+ G+ + HS+ +HRD+ N+L++N+ ++K+ DFGLA GH
Sbjct: 104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163
Query: 216 ---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
R+ S V WY L + + D+WS G ELL
Sbjct: 164 YRVREDGDSPV--FWYAVE--CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 42/106 (39%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHR 216
V K K Y +++ L+ HS G++HRD+K N+L++ G LKLADFG TG
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 217 QPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIG 259
+ T+ V T Y PE+L G YG D WSVG E+L+G
Sbjct: 199 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 44/125 (35%), Positives = 59/125 (47%), Gaps = 5/125 (4%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ L+ HS G +HRD+K N+L++ G LKLADFG N + V T
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 226 LWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF--KLCG 280
Y PE+L G YG D WSVG E+L+G + V KI K
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266
Query: 281 SPPDD 285
+ PDD
Sbjct: 267 TFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 31/75 (41%), Positives = 46/75 (61%), Gaps = 12/75 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 191
++K+EKIG+GTY V++ARD TG+IVALKKI+ LE GV I+ +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR---------LET-EDEGVPSTAIREIS 50
Query: 192 LL--VNNEGVLKLAD 204
LL +N+ +++L D
Sbjct: 51 LLKELNHPNIVRLLD 65
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 25/40 (62%), Positives = 34/40 (85%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQ 169
DA+EKLEKIG+GTY V++ARD +TGK+VALKK + M++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE 40
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 48/158 (30%), Positives = 67/158 (42%), Gaps = 47/158 (29%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------------- 208
Y+ +L +E H G +HRDIK N+L++ +G +KL DFGL
Sbjct: 106 YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165
Query: 209 ------NFSN---------TGHR-QPLTSR-------------VVTLWYRPPELLLGATD 239
+FSN G R +PL R V T Y PE+LL T
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTG 224
Query: 240 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
Y D WSVG + E+L+G+P +T +E K+
Sbjct: 225 YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 30/179 (16%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 227
Q++ L+ HSR ++HRD+K +N+ + G++KL DFG + +S++ +S T +
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287
Y PE L Y D+WS+G + ELL LH+ FK P
Sbjct: 237 YLAPE-LWERKRYSKKADMWSLGVILYELL-------------TLHRPFK---GP----- 274
Query: 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346
+ ++ L+ P+ + K L++ LLS P R T L +E+
Sbjct: 275 SQREIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 32/213 (15%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E G G+ ++ TG + L+ I + L GL + HS+G +HRDIKG+N+L+
Sbjct: 85 MEYCGGGSLQDIYHV----TGPLSELQ-IAYVCRETLQGLAYLHSKGKMHRDIKGANILL 139
Query: 195 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCV 252
+ G +KLADFG+A T S + T ++ PE+ + Y D+W+VG
Sbjct: 140 TDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGIT 198
Query: 253 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 312
EL +P + + L + K PP K K ++ F
Sbjct: 199 AIELAELQPPMFDLHPMRALFLMSKSNFQPPK---LKDKTKWSSTFH------------- 242
Query: 313 KDLPTTAVNLIETLLSVEPYKRATASAALASEY 345
N ++ L+ P KR TA L +
Sbjct: 243 --------NFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 46/152 (30%), Positives = 61/152 (40%), Gaps = 43/152 (28%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----------SNTG 214
Y+ +L +E H G +HRDIK N+L++ +G +KL DFGL
Sbjct: 106 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 215 HRQ------------------PLTSR-------------VVTLWYRPPELLLGATDYGPS 243
HRQ PL R V T Y PE+LL T Y
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQL 224
Query: 244 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
D WSVG + E+L+G+P T E K+
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTS 221
Y +++ L + HS V++RD+K NL+++ +G +K+ DFGL + T + +
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKT 154
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 155 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ G R T+
Sbjct: 101 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFC 157
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y Q++ GLEH H R +++RD+K N+L++N+G ++++D GLA G + T
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGT 160
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ PELL G +Y SVD +++G E++ + + R E
Sbjct: 161 PGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 23/43 (53%), Positives = 32/43 (74%), Gaps = 2/43 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGL 174
FEKL +IG+GTY V+RARD +G+IVALKK++ M+ G+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGI 49
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---- 215
LK++ + +Q+ G+++ S+ +HRD+ N+LV +E ++K++DFGLA
Sbjct: 108 LKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 216 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
++P S + WY PE L + S D+WS G EL
Sbjct: 168 VKEPGESPI--FWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 215
+ LK+ Y Q+ G+++ SR +HRD+ N+LV +E +K+ DFGL T
Sbjct: 106 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165
Query: 216 ---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ L S V WY PE L+ + Y S D+WS G ELL
Sbjct: 166 YTVKDDLDSPV--FWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 39/122 (31%), Positives = 63/122 (51%), Gaps = 14/122 (11%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 227
++L GL H H+ V+HRDIKG N+L+ +KL DFG+ A T R+ + + T +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 186
Query: 228 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+ PE++ A D P D+WS+G E+ G P L ++ + +F + +
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRN 241
Query: 282 PP 283
PP
Sbjct: 242 PP 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y ++ L H RG+++RD+K N+L++ EG +KL D+G+ G R T+
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFC 157
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 35/223 (15%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS---NTGHRQ------PLTS 221
L GL + H G +HR+IK S++L++ +G++ L+ GL++ G + P S
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
V W P L Y D++SVG EL G+ Q + L + K
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---G 225
Query: 282 PPDDYWKKSKLPH--ATLFKPQQPYDSSLRETF-------------------KDLPTTAV 320
PP + P + + Q DS + E+ K
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 321 NLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 363
NL+E L +P KR +AS+ L+ +F S L + PP
Sbjct: 286 NLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/192 (26%), Positives = 75/192 (39%), Gaps = 49/192 (25%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH 215
Y+ + + ++ H G +HRDIK NLL++ +G +KL+DFGL + N H
Sbjct: 106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 216 ------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 251
RQ S V T Y PE+ + T Y D WS+G
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGV 224
Query: 252 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 311
+ E+LIG P T E K+ WK++ +F P+ P ++
Sbjct: 225 IMYEMLIGYPPFCSETPQETYRKVMN---------WKET-----LVFPPEVPISEKAKDL 270
Query: 312 FKDLPTTAVNLI 323
T + N I
Sbjct: 271 ILRFCTDSENRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223
+ Y+ +++ + H +HRDIK N+L++ G ++LADFG N + V
Sbjct: 105 RFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164
Query: 224 VTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
T Y PE+L D YGP D WS+G E+L G+ + VE KI
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 13/102 (12%)
Query: 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223
K Y +L+ E+ HS+ +++RD+K NLL++N+G +K+ DFG A + + R
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRT 172
Query: 224 VTLW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
TL Y PE ++ + +G +VD W++G + E + G P
Sbjct: 173 FTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 227
++L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T +
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 176
Query: 228 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPIL 263
+ PE++ A D P DLWS+G E+ G P L
Sbjct: 177 WMAPEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 8/134 (5%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+I+ Q L L + H ++HRD+K N+L +G +KLADFG++ NT Q S
Sbjct: 104 QIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDS 162
Query: 222 RVVTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ T ++ PE+++ T Y D+WS+G E+ +P E+ + + K
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLK 219
Query: 278 LCGSPPDDYWKKSK 291
+ S P + S+
Sbjct: 220 IAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 53/184 (28%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH 215
Y+ + + ++ H G +HRDIK NLL++++G +KL+DFGL + N H
Sbjct: 106 YIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
Query: 216 ------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC 251
RQ S V T Y PE+ + T Y D WS+G
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGV 224
Query: 252 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 311
+ E+LIG P T E K+ WK++ +F P+ P + E
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKVMN---------WKET-----LIFPPEVP----ISEK 266
Query: 312 FKDL 315
KDL
Sbjct: 267 AKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 13/100 (13%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y Q++ E+ S +++RD+K NLL++ +G +K+ DFG A +T R T
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--------RTYT 187
Query: 226 LWYRP----PELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
L P PE+LL +G + D W++G E+L+G P
Sbjct: 188 LCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
+E G G+ ++ TG + + I + L GL + HS+G +HRDIKG+N+L+
Sbjct: 85 MEFCGGGSLQDIYHV----TGPLSESQ-IAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139
Query: 195 NNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPEL--LLGATDYGPSVDLWSVGC 251
+ G +KLADFG+ A + T ++ S + T ++ PE+ + Y D+W+VG
Sbjct: 140 TDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197
Query: 252 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
EL +P + + L + K PP
Sbjct: 198 TAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 48/155 (30%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLW 227
LH L+ H GV+HRD+K SN+L++ G +KL DFG++ S R +
Sbjct: 127 LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA----- 179
Query: 228 YRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 283
Y PE + Y D+WS+G EL G+ P +TE E L KI + PP
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE--EPP 237
Query: 284 DDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLP 316
LP F P D L + + P
Sbjct: 238 -------SLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 53/226 (23%), Positives = 85/226 (37%), Gaps = 57/226 (25%)
Query: 147 FRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206
FR GK ++ + + Y ++L LE+ H G+++RD+K N+L++ G + L+DF
Sbjct: 89 FRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFD 148
Query: 207 LA---------------NFSNTGHRQPLTSRVV-------------TLWYRPPELLLGAT 238
L+ S + S T Y PE++ G
Sbjct: 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD- 207
Query: 239 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298
+G +VD W++G + E+L G +G E I +
Sbjct: 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL-----------------KKEVT 250
Query: 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 344
P P SS +A +LI LL +P KR S A+E
Sbjct: 251 FPGSPPVSS----------SARDLIRKLLVKDPSKR-LGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLW 227
Q+L + H HS+ ++HRDIK +N+L+ + G++KL DFG + ++ T + T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
Y PE+ Y D++S+G + ELL K G E +HK
Sbjct: 211 YVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ L H RG+++RD+K N+L++ +G +KL D+G+ G ++ T
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGT 159
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
Y PE+L G +YG SVD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 51/209 (24%), Positives = 77/209 (36%), Gaps = 52/209 (24%)
Query: 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS-NTGHRQPLTSRV 223
Q+L GL + H++ ++HRD+K N+ +N+ + + D G A F L V
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
T PE+L Y D+WS G V E+L P IF+ S P
Sbjct: 221 ET---NAPEVLARDK-YNSKADIWSAGIVLFEML-AYP-----------STIFEDPPSTP 264
Query: 284 DDYWKKSKLPHATLFK------------PQQPYDSSLRETF------------------- 312
++Y K H+ L K P+ P S L F
Sbjct: 265 EEYVKSC---HSHLLKIISTLKVHPEEFPRDP-GSRLVRGFIEYASLERQPYTRYPCFQR 320
Query: 313 KDLPTTAVNLIETLLSVEPYKRATASAAL 341
+LP L+ +L+ + R +A L
Sbjct: 321 VNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 20/33 (60%), Positives = 29/33 (87%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F+K+EKIG+GTY V++AR+ TG++VALKKI+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR 34
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 6/116 (5%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVV 224
Y+ +++ ++ H +HRDIK N+L++ G ++LADFG G Q + V
Sbjct: 107 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VG 165
Query: 225 TLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE+L D YGP D WS+G E+L G+ + VE KI
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 19/121 (15%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 221
+ +E+ S G +HRD+ N LV + V+K++DFGLA + S+ G + P+
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK- 166
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE---VEQLHKIFK 277
+ PPE+ + + D+WS G + E+ GK + + VE + ++
Sbjct: 167 ------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219
Query: 278 L 278
L
Sbjct: 220 L 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH-----RQP 218
M Q+L L H++G++HRD+K N++V+ GV K+ DFG+
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 219 LTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
T+ V+ T Y PE L G P+ DL++ G +F E L G+ ++QG + E L++
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 135 LEKIGQGTYSSVFRAR-------DLDTGKI----VALKKIKCYMNQLLHGLEHCHSRGVL 183
+E +G RAR DT K+ + K + Q+ G+E+ S+ +
Sbjct: 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI 156
Query: 184 HRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242
HRD+ N+LV + V+K+ADFGLA + N + + T+ + + + PE L Y
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTH 215
Query: 243 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
D+WS G + E+ VE+L K+ K
Sbjct: 216 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 49/136 (36%), Positives = 69/136 (50%), Gaps = 13/136 (9%)
Query: 170 LLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
+L GL + + ++HRD+K SN+LVN+ G +KL DFG+ S S V T Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSY 168
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYW 287
PE L G T Y D+WS+G EL IG+ PI + ++L IF G P D
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD-- 220
Query: 288 KKSKLPHATLFKPQQP 303
+ PH+ +P+ P
Sbjct: 221 GEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 20/33 (60%), Positives = 30/33 (90%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+EK +K+G+GTY+ V++ARD +TG+IVA+KKIK
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK 34
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 2/115 (1%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+ + Y ++ L + HS +++RD+K N+L++++G + L DFGL N H ++
Sbjct: 97 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTST 155
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE +L Y +VD W +G V E+L G P R E I
Sbjct: 156 FCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 32/109 (29%), Positives = 60/109 (55%), Gaps = 2/109 (1%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
L ++ + + + Y +++ L++ HS +++RD+K NL+++ +G +K+ DFGL
Sbjct: 86 LSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
T + + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 146 IT-DAATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 21/33 (63%), Positives = 28/33 (84%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++KL KIG+GTY V++ARD TG+IVA+KKIK
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK 33
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQP 218
LK+ + M QLL +E+ H + ++HRDIK N+ +N +G + L DFG A F R+
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK--EREA 323
Query: 219 LT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
V T+ PE+L G Y D+WS G + ++L
Sbjct: 324 FDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 3/103 (2%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +L GLE +++RD+K N+L+++ G ++++D GLA G + RV T
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGT 164
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ Y PE++ Y S D W +GC+ E++ G+ + R E
Sbjct: 165 VGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 33/116 (28%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 232
G+E+ S+ ++HRD+ N+LV+ +GV K++DFGLA G S++ W P
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEA 168
Query: 233 LLLGATDYGPSVDLWSVGCVFAELL-IGK---PILQGRTEVEQLHKIFKLCGSPPD 284
L + D+WS G + E+ G+ P + + E + K +++ PP+
Sbjct: 169 LKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223
+ Y+ +++ ++ H G +HRDIK N+L++ G ++LADFG V
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV 164
Query: 224 VTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
T Y PE+L D YGP D WS+G E+L G+ + VE KI
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 36/111 (32%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 227
Q+ G+E+ S+ +HRD+ N+LV V+K+ADFGLA + +N + + T+ + +
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 277
+ PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 205 WMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 34/112 (30%), Positives = 62/112 (55%), Gaps = 7/112 (6%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
L ++ + + + Y +++ L++ HS + V++RD+K NL+++ +G +K+ DFGL
Sbjct: 86 LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-- 143
Query: 211 SNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
G + T + T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 144 -KEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 169 QLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 227
Q++ L + H + ++HRD+ +N+++ + + + DFGLA LTS V T+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
Y PE++ YG D+W+ GC+ ++ +P
Sbjct: 179 YSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 35/82 (42%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 182 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 241
++HRD+K SN+LVN+ G +KL DFG+ S S V T Y PE L G T Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG-THYS 180
Query: 242 PSVDLWSVGCVFAELLIGK-PI 262
D+WS+G E+ IG+ PI
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 22/127 (17%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
L + + Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 101 LSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK 160
Query: 220 TSRVVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
+ + W PE L + D+WS G + L +IF L
Sbjct: 161 RGGKLPIRWM-APESLKEGK-FTSKSDVWSFGVL-------------------LWEIFTL 199
Query: 279 CGSPPDD 285
P
Sbjct: 200 GEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 31/132 (23%), Positives = 52/132 (39%), Gaps = 22/132 (16%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214
K ++L + + Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 97 PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156
Query: 215 HRQPLTSRVVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
+ + + W PE L + D+WS G + L
Sbjct: 157 DYYKVKGGKLPIRWM-APESLKEGK-FTSKSDVWSFGVL-------------------LW 195
Query: 274 KIFKLCGSPPDD 285
+IF L P
Sbjct: 196 EIFTLGEEPYPG 207
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 2/110 (1%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ L + HS +++RD+K N+L++++G + L DFGL H + ++ T
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGT 159
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
Y PE+L Y +VD W +G V E+L G P R E I
Sbjct: 160 PEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 168 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTS 221
++ GL + ++ ++HRDIK SN+LVN+ G +KL DFG++ + ++T
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-------- 161
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
V T Y PE + G Y D+WS+G EL +GK
Sbjct: 162 FVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 37/113 (32%), Positives = 51/113 (45%), Gaps = 7/113 (6%)
Query: 170 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWY 228
LL L + H RG++HRD+K N+ ++ L DFG A + P TL
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 229 RPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPIL---QGRTEVEQLHKIFK 277
PELL A D Y D+WS G V E+ + L Q ++ QL I +
Sbjct: 254 NSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH----- 215
+K+ Y +Q+ G+E+ S+ +HRD+ N+LV +E +K+ DFGL
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSV--DLWSVGCVFAEL 256
R+P S + WY P L T+ SV D+WS G V EL
Sbjct: 168 REPGESPI--FWYAPESL----TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 39/156 (25%), Positives = 57/156 (36%), Gaps = 47/156 (30%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLT 220
YM + + +E H G +HRDIK N+L++ G +KL+DFGL+ + +++ L
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 221 SRVVT-------------------------LW----------------YRPPELLLGATD 239
+ W Y PE+ L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QG 224
Query: 240 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
YG D WS+G + E LIG P E KI
Sbjct: 225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 43/129 (33%), Positives = 56/129 (43%), Gaps = 27/129 (20%)
Query: 169 QLLHGLEHCHS-------RGVLHRDIKGSNLLV-----------------NNEGVLKLAD 204
QLLH L +CH+ VLHRD+K N+ + N + K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 205 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPIL 263
FGL+ N G S V T +Y PELLL T Y D+W++GC+ EL GK
Sbjct: 186 FGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 264 QGRTEVEQL 272
QL
Sbjct: 244 HKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 20/34 (58%), Positives = 25/34 (73%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+EKL KIGQGT+ VF+AR T +IVALKK+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV 45
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 20/35 (57%), Positives = 28/35 (80%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
D +EK+EKIG+GTY V++ARD T + +ALKKI+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR 36
|
Length = 294 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 19/103 (18%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------NFSNT 213
+ LL G+E+ S+ +HRD+ N LV + V+K++DFGL+ ++
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK 163
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
L R W PE L + D+WS G + E+
Sbjct: 164 KTGGKLPIR----WM-APESLKDGI-FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 6/117 (5%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
+ + Y ++ L + HS +++RD+K N+L++++G + L DFGL T+
Sbjct: 97 RARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTT 155
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ----LHK 274
T Y PE++ Y +VD W +G V E+L G P R E LHK
Sbjct: 156 FCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 33/74 (44%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTS 221
IK M Q+L GL H G++HRDIK NLLV +G +K+ DFG A TG + PL
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 222 RVVTLWYRPPELLL 235
++ Y PPE L+
Sbjct: 371 -MLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 18/33 (54%), Positives = 29/33 (87%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+E+L +IG+G Y +V++ARDL+TG+ VALKK++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR 33
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 227
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + + + + T+ + +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 277
+ PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 208 WMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 18/33 (54%), Positives = 27/33 (81%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ K+EKIG+GTY V++ R+ TG+IVA+KKI+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR 34
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 15/35 (42%), Positives = 23/35 (65%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +E L +G+G Y V + R+ TG+IVA+KK K
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK 35
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 19/33 (57%), Positives = 24/33 (72%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
FE LEKIG+G + V++AR TGK VA+K IK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK 34
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 30/191 (15%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214
GK++ ++ + Q+ L++ H + +LHRD+K N+ + ++K+ D G+A
Sbjct: 96 GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN- 154
Query: 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
++ + T +Y PE L Y D+W++GC E+ K + +++
Sbjct: 155 QCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR 213
Query: 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
I + KL P P KD LI T+LS P KR
Sbjct: 214 II------------EGKL-------PPMP---------KDYSPELGELIATMLSKRPEKR 245
Query: 335 ATASAALASEY 345
+ + L Y
Sbjct: 246 PSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 16/96 (16%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 225
G+ + S+ +HRD+ N LV+++G +K++DFGL+ + S+ G + P+
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR----- 166
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 260
+ PPE+LL + + D+W+ G + E+ +GK
Sbjct: 167 --WSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +E +++IG GTY V++ARD+ TG++VA+K IK
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK 37
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 156 KIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNT 213
K++ L+ + CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + +
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ + +R+ W P + Y D+WS G + E+
Sbjct: 234 DYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 13/108 (12%)
Query: 182 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP---PELLLGAT 238
++HRD+K SN+L++ G +KL DFG++ G ++ RP PE + +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 239 DYGPSV--DLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 283
G V D+WS+G E+ GK P + + +QL ++ K G PP
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 18/33 (54%), Positives = 27/33 (81%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK 162
+ +EKL KIG+G+Y VF+ R+ +TG+IVA+KK
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK 33
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 7/108 (6%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
D G L K+ + Q+ G+ R +HRD++ +N+LV+ V K+ADFGLA
Sbjct: 94 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAELL 257
+ + PE A ++G D+WS G + E++
Sbjct: 154 DNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 27/170 (15%)
Query: 125 VPLRADAFEK-----LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHS 179
VPL A E+ E +G+G+ + D GK + L ++ Q+ G+ +
Sbjct: 64 VPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER 120
Query: 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPE 232
+HRD++ +N+LV + V K+ADFGLA + G + P+ W P
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEA 174
Query: 233 LLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKL 278
L G + D+WS G + EL+ + P + R +EQ+ + +++
Sbjct: 175 ALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---- 210
G+ + L + Q+ G+ + +HRD++ +N+LV + V K+ADFGLA
Sbjct: 96 GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155
Query: 211 ---SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPIL 263
+ G + P+ W P L G + D+WS G + EL+ + P +
Sbjct: 156 EYTARQGAKFPIK------WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGM 207
Query: 264 QGRTEVEQLHKIFKL-C--GSPPDDY------WKK 289
R +EQ+ + +++ C P + WKK
Sbjct: 208 NNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--TGHRQPLTSRVVTL 226
Q+ G+E+ SR +HRD+ N+LV + V+K+ADFGLA + +++ R+
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-------GKPILQGRTEVEQLHKIFKLC 279
W P L Y D+WS G + E+ G P+ + + + H++ K
Sbjct: 202 WMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPS 259
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 315
+ Y + HA P Q R TFK L
Sbjct: 260 NCTHELYMLMRECWHAV---PTQ------RPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 20/41 (48%), Positives = 30/41 (73%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
W D F+ + +IG+GTY V++ARD DTG++VALKK++
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR 41
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 17/49 (34%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ LL G+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 101 LKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 19/94 (20%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 225
G+E+ +HRD+ N LV++ GV+K++DFG+ + S++G + P+
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----- 166
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGC----VFAE 255
+ PPE+ + Y D+WS G VF E
Sbjct: 167 --WSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/156 (27%), Positives = 62/156 (39%), Gaps = 47/156 (30%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------------- 208
Y+ +L +E H G +HRDIK N+L++ +G +KL DFGL
Sbjct: 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165
Query: 209 -------------NFSN---------------TGHRQPLTSRVV-TLWYRPPELLLGATD 239
+ SN H++ L +V T Y PE+LL
Sbjct: 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKG 224
Query: 240 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
Y D WSVG + E+L+G+P T E K+
Sbjct: 225 YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 226
Q+ G+E+ S +HRD+ N LV +K++DFGL+ +S +R S +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
W P +L G + D+WS G V E+
Sbjct: 192 WMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH 215
+ ++ + CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ ++R+ W P + Y D+WS G + E+
Sbjct: 231 VRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 20/143 (13%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-- 210
+ GK + L ++ Q+ G+ + +HRD++ +N+LV V K+ADFGLA
Sbjct: 94 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
Query: 211 -----SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKP 261
+ G + P+ W P L G + D+WS G + EL + P
Sbjct: 154 DNEYTARQGAKFPIK------WTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYP 205
Query: 262 ILQGRTEVEQLHKIFKLCGSPPD 284
+ R ++Q+ + +++ PP+
Sbjct: 206 GMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 19/43 (44%), Positives = 33/43 (76%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
Y++++ L++ H G++HRD+K N+L++NEG +KL DFGL+
Sbjct: 109 YISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 17/32 (53%), Positives = 26/32 (81%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+E L K+G+GT+ V++AR + TG++VALKKI
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKI 41
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 18/33 (54%), Positives = 29/33 (87%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F++LEK+G+GTY++V++ R+ TG+IVALK+I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH 34
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 16/33 (48%), Positives = 23/33 (69%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
FE +E IG+GTY V++AR TG++VA+K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK 37
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ + + HS +++RD+K N+L++++G + L DFGL + ++ T
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGT 159
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----LHKIFKLCG 280
Y PE +L Y +VD W +G V E+L G P R +V Q LHK +L G
Sbjct: 160 PEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPG 217
Query: 281 S 281
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 16/126 (12%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-- 210
D G V L K+ + Q+ G+ + + +HRD++ +N+LV+ + K+ADFGLA
Sbjct: 95 DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154
Query: 211 -----SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQ 264
+ G + P+ W P + G+ + D+WS G + E++ GK
Sbjct: 155 DNEYTAREGAKFPIK------WTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYP 206
Query: 265 GRTEVE 270
G + +
Sbjct: 207 GMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 17/90 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCY--MNQ-----------LLHGLEH 176
F+ +KIG+G +S V++A L G++VALKK++ + M+ LL L+H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 177 CHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206
+ L I+ + L + VL+LAD G
Sbjct: 62 PNVIKYLASFIENNELNI----VLELADAG 87
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 26/102 (25%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+K + +++ L+ H G++ RD+ +N+L+++ G ++L F +S
Sbjct: 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEV--EDSCDGE 142
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 264
V Y PE + G ++ + D WS+G + ELL GK +++
Sbjct: 143 AVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 16/46 (34%), Positives = 31/46 (67%), Gaps = 4/46 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHC 177
++ ++++G GT+ SV+ AR+ +TG++VA+KK M + + E C
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK----MKKKFYSWEEC 42
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 9/65 (13%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 197
+G+G + +V+ ARD TGK VA+K IK + L R+I+ L N+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS--------SLLEELLREIEILKKL-NHP 51
Query: 198 GVLKL 202
++KL
Sbjct: 52 NIVKL 56
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
R T+ V T YR PE++LG + S D+WS+GC+ EL GK + +E LH +
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
Query: 276 FKLCGSPPDDY 286
K G P ++
Sbjct: 358 EKTLGRLPSEW 368
|
Length = 467 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 26/73 (35%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 191
++ L +IG+G + VF+A+D +TG+ VALKK+ L LE L R+IK
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKV------ALRRLEGGIPNQAL-REIKALQ 54
Query: 192 LLVNNEGVLKLAD 204
+ V+KL D
Sbjct: 55 -ACQHPYVVKLLD 66
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 37/118 (31%), Positives = 52/118 (44%), Gaps = 27/118 (22%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 226
Q+ G+E S+ +HRD+ N+LV + V+K+ADFGLA +R+ R+
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 227 WYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
W P L D Y D+WS G +L L +IF L GSP
Sbjct: 200 WMAPEALF----DRVYTHQSDVWSFG-----------VL--------LWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 4/99 (4%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQ 217
L+ + Y Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + +
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
+R+ W P + Y D+WS G + E+
Sbjct: 232 KGDARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 25/120 (20%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 225
G+ + S V+HRD+ N LV V+K++DFG+ F S+TG + P+
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----- 166
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGC----VFAELLIGKPILQGRTE---VEQLHKIFKL 278
W P Y D+WS G VF+E GK + R+ VE ++ F+L
Sbjct: 167 -WSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSE---GKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 24/84 (28%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 232
G+E+ + +HRD+ N+LV+ + V K++DFGLA ++ G + ++ W P
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEA 170
Query: 233 LLLGATDYGPSVDLWSVGCVFAEL 256
L + D+WS G + E+
Sbjct: 171 LREK--KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 2/93 (2%)
Query: 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRV 223
C Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N + + + +
Sbjct: 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDA 193
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
+ + + PPE + Y D+W+ G V E+
Sbjct: 194 IPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 12/33 (36%), Positives = 25/33 (75%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + E +G+G++ SV+ A D DTG+++A+K ++
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE 34
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 15/37 (40%), Positives = 23/37 (62%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMN 168
E+++ +GQG+ V++ R TGKI ALKKI +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD 39
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 4e-05
Identities = 16/32 (50%), Positives = 24/32 (75%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+E L+K+G+G Y V++A D T ++VALKKI
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI 40
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 20/90 (22%), Positives = 43/90 (47%), Gaps = 2/90 (2%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 227
++ G+ + ++ +HRD+ N +V + +K+ DFG+ + T + + ++ +
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ PE L + D+WS G V E+
Sbjct: 187 WMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 19/128 (14%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTL 226
G+ + S+ +HRD+ N LV VLK++DFG++ +S++G +Q +
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIK 159
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAEL----LIGKPILQGRTEVEQLHKIFKLCGSP 282
W P L G Y D+WS G + E + P + + EQ+ K +++
Sbjct: 160 WTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ 217
Query: 283 --PDDYWK 288
PDD +K
Sbjct: 218 KCPDDVYK 225
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 8/127 (6%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
GK + L ++ Q+ G+ + SR +HRD+ N+LV V K+ADFGLA
Sbjct: 95 GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTE 268
+ + PE A +YG D+WS G + E++ G+ G T
Sbjct: 155 DDEYTAREGAKFPIKWTAPE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210
Query: 269 VEQLHKI 275
E L ++
Sbjct: 211 REVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 27/108 (25%)
Query: 168 NQLLHGL-----EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQ 217
++ GL EH ++HRD+K +N+LVN G +KL DFG+ A+ + T
Sbjct: 109 YAVVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--- 161
Query: 218 PLTSRVVTLWYRPPELL--LGATD---YGPSVDLWSVGCVFAELLIGK 260
+ Y PE + G Y D+WS+G E+ +G+
Sbjct: 162 -----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 21/102 (20%)
Query: 168 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-------FSNT 213
+LL G+E+ S+ +HRD+ N LV VLK++DFG++ +
Sbjct: 93 KKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 255
G +Q + W P L G Y D+WS G + E
Sbjct: 153 GLKQ-----IPIKWTAPEALNYGR--YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 9e-05
Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 17/98 (17%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNT-----GHRQPLTSR 222
QL+ L H ++H DIK N+L + + + L D+GL T G
Sbjct: 117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-------- 168
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
TL Y PE + G +Y S D W+VG + ELL GK
Sbjct: 169 --TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 11/30 (36%), Positives = 21/30 (70%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
F+ + IG+G++S+V A++ +T K A+K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIK 32
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTL 226
G+E+ S+ +HRD+ N LV + VLK++DFG++ +++TG + ++
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK----QIPVK 161
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAE 255
W P L G Y D+WS G + E
Sbjct: 162 WTAPEALNYGR--YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 16/115 (13%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 221
Q+ G+ + ++ +HRD+ N+LV + K+ADFGLA + G + P+
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK- 169
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 275
W P L + D+WS G + E++ G+ G T E L ++
Sbjct: 170 -----WTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 18/102 (17%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN----------------TGHR 216
+E+ HS+GVLHRD+K N+L+ G + + D+G A F
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 217 QPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ ++V T Y PE LLG S D++++G + ++L
Sbjct: 185 MTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 22/129 (17%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-- 210
G + + K+ Q+ G+ + +HRD++ +N+LV+ K+ADFGLA
Sbjct: 94 PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153
Query: 211 -----SNTGHRQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKP 261
+ G + P+ W P A +YG D+WS G + E++ G+
Sbjct: 154 DNEYTAREGAKFPIK------WTAPE-----AINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 262 ILQGRTEVE 270
G T E
Sbjct: 203 PYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 15/38 (39%), Positives = 25/38 (65%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQ 169
+E + +IG G Y +V++ARD +G VALK ++ N+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE 39
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 11/33 (33%), Positives = 21/33 (63%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+E +++IG+G++ V+ R GK+ LK+I
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID 34
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 14/73 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCY--MNQ-----------LLHGLEHCH 178
+E LE IG+G++ +V + R GKI+ K+I Y M + +L L+H +
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 179 SRGVLHRDIKGSN 191
R I SN
Sbjct: 61 IVRYYDRIIDRSN 73
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 4/47 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI-KCYM---NQLLH 172
D FE ++ IG+G + V+ RD DTG++ A+K + K M NQ+ H
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH 47
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 25/99 (25%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQ 217
+ Q+ G+ S+ +HRD+ N+L+ + ++K+ DFGLA N+ G
Sbjct: 145 SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG--- 201
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
+R+ W P + Y D+WS G + E+
Sbjct: 202 --NARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 16/46 (34%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 166 YM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
YM Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 21/150 (14%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 232
+E+ + +HRD+ N+LV+ + V K++DFGL +++ T ++ W P
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEA 170
Query: 233 LLLGATDYGPSVDLWSVGCVFAELL-IGK------PILQGRTEVEQLHKIFKLCGSPPDD 285
L + D+WS G + E+ G+ P+ VE+ +K+ G PP
Sbjct: 171 LR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDL 315
Y + K D++ R +F L
Sbjct: 229 Y---------DVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 26/117 (22%), Positives = 54/117 (46%), Gaps = 4/117 (3%)
Query: 143 YSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 202
+S + +R + + L+ + +M + G+E+ +R +HRD+ N ++ + + +
Sbjct: 95 HSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV 154
Query: 203 ADFGLAN--FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
ADFGL+ +S +RQ +++ W L Y D+W+ G E+
Sbjct: 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES--LADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 226
Q+ G+E+ S +H+D+ N+L+ + +K++D GL+ +S +R S +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W P ++ G + D+WS G V E+
Sbjct: 192 WMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 16/27 (59%), Positives = 21/27 (77%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKIK 164
+G+GTY V +A D TGKIVA+KK+K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK 43
|
Length = 335 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 54/226 (23%), Positives = 83/226 (36%), Gaps = 49/226 (21%)
Query: 170 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ--------PLT 220
+L L++ H G +HR +K S++L++ +G + L+ GL +N S H Q P
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKY 167
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK------PILQGRTEVEQLHK 274
S V W P L Y D++SVG EL G P Q E
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE------ 221
Query: 275 IFKLCGS----------PPDDYWKK----------SKLPHATLFKPQQPYDSSLRETFKD 314
KL G+ P ++ K + + +P +SS +
Sbjct: 222 --KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPYNRT 278
Query: 315 LPTTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLP 359
+ +E L P R +AS L +F K A + +LP
Sbjct: 279 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLW 227
G+++ +HRD+ N+LVN+ V K++DFGL+ F S+ + L ++ W
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELL 257
P + + + D+WS G V E++
Sbjct: 178 TAPEAIAY--RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 3/108 (2%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
Q+ G+ + + +HRD+ N+LV + V K+ADFGLA ++ W
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 275
P G + D+WS G + E+ G+ G E +I
Sbjct: 172 APEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 26/103 (25%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 157 IVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSN- 212
+ + +K +Q+ G+ + S+ +HRD+ N+L+ N K++DFG++ +
Sbjct: 91 EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
Query: 213 -----TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 250
T R PL WY P + G D+WS G
Sbjct: 151 YYRATTAGRWPLK------WYAPECINYGKFSS--KSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 15/30 (50%), Positives = 21/30 (70%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
L KIG+GT+S V +A+ TGK A+K +K
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMK 33
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++ LEKIG+G V++A D TGK VA+KK++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR 53
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSRVV 224
Y QL L + S+ +HRDI N+LV++ +KL DFGL+ + + + + ++
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVG-CVFAELLIGKPILQGRTEVEQLHKIFK------ 277
W P + + + D+W G C++ L++G QG + + +I
Sbjct: 172 IKWMAPES--INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM 229
Query: 278 --LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 318
C PP Y +L YD S R F +L
Sbjct: 230 PPNC--PPTLY---------SLMTKCWAYDPSKRPRFTELKAQ 261
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 21/122 (17%)
Query: 149 ARDLDTGKIVALKKIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLK 201
A+ L G+ VA ++ + Q+L G+ + S +HRD+ N LV V+K
Sbjct: 105 AKILAGGEDVAPGQLT--LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162
Query: 202 LADFGLA------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 255
+ DFG++ ++ G R L R + PPE +L + D+WS G V E
Sbjct: 163 IGDFGMSRDIYSTDYYRVGGRTMLPIR-----WMPPESIL-YRKFTTESDIWSFGVVLWE 216
Query: 256 LL 257
+
Sbjct: 217 IF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRV 223
+M + G+E+ S+ +HRD+ N ++N + +ADFGL+ +S +RQ S++
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W L Y D+W+ G E++
Sbjct: 178 PVKWLALES--LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 16/96 (16%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH------RQPLT 220
Q+ G+ + H RGV+H+DI N +++ E +K+ D L+ F H +P+
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
W L+ +Y + D+WS G + EL
Sbjct: 185 ------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 17/94 (18%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQPLTSRV 223
G+++ G +HRD+ N+LVN+ V K++DFGL A ++ G + P+
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR--- 174
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W P + + + D+WS G V E++
Sbjct: 175 ---WTAPEA--IAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 166 YMN-QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224
YM Q+ G+++ S +HRD+ N LV N +K+ADFG++ +G + R V
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192
Query: 225 --TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 258
W +LLG + + D+W+ G E+
Sbjct: 193 LPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 16/33 (48%), Positives = 27/33 (81%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
FE +++IG GTY V++AR+++TG++ A+K IK
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK 43
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 16/93 (17%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL--------ANFSNTGHRQPLTSRVV 224
G+++ +HRD+ N+LVN+ V K++DFGL A ++ G + P+
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI----- 172
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W P + + + D+WS G V E++
Sbjct: 173 -RWTAPEAIAYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 8e-04
Identities = 16/32 (50%), Positives = 20/32 (62%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+E L+ IG G Y V A D TG+ VA+KKI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI 33
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 23/100 (23%), Positives = 45/100 (45%), Gaps = 17/100 (17%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQ 217
+ + G+++ +HRD+ N+LVN+ K++DFGL ++ +G +
Sbjct: 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
P+ W P + + + D+WS G V E++
Sbjct: 173 PIR------WTAPEA--IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 24/93 (25%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRV 223
+M + G+E+ S+ +HRD+ N ++N + +ADFGL+ ++ +RQ +++
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
W L Y D+WS G E+
Sbjct: 177 PVKWIAIES--LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 16/37 (43%), Positives = 28/37 (75%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + + KL+K+G+GTY++VF+ R T +VALK+I+
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR 39
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 10/67 (14%)
Query: 152 LDTGKIVALKKIKCY--------MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 203
+T +I K+IKC M +L LE+ H G+ H DIK N++V+ +
Sbjct: 111 ENTKEI--FKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168
Query: 204 DFGLANF 210
D+G+A+
Sbjct: 169 DYGIASH 175
|
Length = 294 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 13/96 (13%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQ-----PLTSRVV 224
L+ L++ HS+G +HR +K S++L++ +G + L+ + + G RQ S V
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 225 TLWYRPPELL----LGATDYGPSVDLWSVGCVFAEL 256
L + PE+L G Y D++SVG EL
Sbjct: 171 NLPWLSPEVLQQNLQG---YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 165 CYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223
+M Q+ G+++ S +HRD+ N LV +K+ADFG++ +G + R
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRA 192
Query: 224 V--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
V W +LLG + + D+W+ G E+L
Sbjct: 193 VLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTL 226
Q+ G+ + + ++HRD+ N+LV +K+ DFGLA + ++ +V
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W +L Y D+WS G EL+
Sbjct: 177 WMALESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQ 217
++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++ +S +R
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK-PILQ-GRTEV 269
+ + W PPE ++ + D+WS G + E+ GK P Q TEV
Sbjct: 182 GGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 17/37 (45%), Positives = 28/37 (75%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + + KLEK+G+GTY++VF+ R T +VALK+I+
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR 40
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 14/32 (43%), Positives = 25/32 (78%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++ KIG GT+ V+ A +LDTG+++A+K+I+
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR 34
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 15/33 (45%), Positives = 26/33 (78%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+E ++++G GTY V++AR+L TG++ A+K IK
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK 43
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 19/106 (17%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---------SNTGHRQ 217
M+Q+ G+++ + +HRD+ N+L+ N+ K++DFGL+ + + +
Sbjct: 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 261
PL WY P + + D+WS G E KP
Sbjct: 161 PLK------WYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSN---TGHRQPLTS 221
Q+ G++ S+ +HRD+ N+L+ + V K+ DFGLA N SN G+ +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN-----A 274
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 260
R+ W P + Y D+WS G + E+ +GK
Sbjct: 275 RLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 2/90 (2%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 227
Q+ G+ + S+ +HRD+ N LV ++K+ DFG++ + +T + + ++ +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 228 YRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ PPE ++ + D+WS+G V E+
Sbjct: 188 WMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTL 226
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA + +V
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W +L Y D+WS G EL+
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 25/109 (22%), Positives = 51/109 (46%), Gaps = 3/109 (2%)
Query: 149 ARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
A T ++ +++ + + G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159
Query: 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
++ + R+ W L + Y + D+WS G + E++
Sbjct: 160 RGQEVYVKKTM-GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 67/229 (29%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPL 219
K I+ M Q+L L+ HS G++HRD+K N++ + G K+ D G A
Sbjct: 255 KIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA----------- 303
Query: 220 TSRVVTLWYRPPELLLG-----------------------ATDYGPSV---------DLW 247
V + Y P E LL AT P + D++
Sbjct: 304 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363
Query: 248 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY----WKKSKLPHATLFKPQQP 303
S G +F ++ P L+ + + Q ++ K DY W+K P A+
Sbjct: 364 SAGLIFLQMAF--PNLRSDSNLIQFNRQLKRN-----DYDLVAWRKLVEPRAS------- 409
Query: 304 YDSSLRETFK--DLPTTA-VNLIETLLSVEPYKRATASAALASEYFSTK 349
LR F+ DL A L+++++ + +R +A AALA YF +
Sbjct: 410 --PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE 456
|
Length = 566 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 13/112 (11%)
Query: 172 HGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN--FSNTGHRQPLTSRVV 224
LE H +HRD+ N LV+ +G V+K+ DFGLA + + +R+ +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 275
W P LL G + D+WS G + E+L +G+ E L +
Sbjct: 177 VRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 20/104 (19%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQPLT 220
Q+ G+ + R ++HRD+ N+LV + +K+ DFGLA ++ G + P+
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 221 SRVVT-LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 261
+ + YR + D+WS G EL+ GKP
Sbjct: 177 WMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 24/109 (22%), Positives = 51/109 (46%), Gaps = 3/109 (2%)
Query: 149 ARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
A++ T + +++ + + + G+++ + +HRD+ N+LV K+ADFGL+
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166
Query: 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
++ + R+ W L + Y D+WS G + E++
Sbjct: 167 RGEEVYVKKTM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 8/93 (8%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-- 226
Q+ G+E S+ +HRD+ N+L+ ++K+ DFGLA + H S+ T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFLP 302
Query: 227 --WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
W P + Y D+WS G + E+
Sbjct: 303 VKWMAPESIF--DNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 634 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.9 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.88 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.86 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.84 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.84 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.81 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.7 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.39 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.35 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.35 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.23 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.21 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.21 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.94 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.69 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.83 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.43 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.36 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.34 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.32 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.89 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.66 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.08 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 95.95 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.56 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 95.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 93.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.71 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.65 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 90.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 90.82 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 90.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 89.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 89.49 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 89.38 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 89.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 89.11 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 88.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 88.82 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 88.04 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 87.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 87.27 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 87.2 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 87.19 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.98 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 86.81 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 86.45 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 86.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 86.06 | |
| PLN02236 | 344 | choline kinase | 84.59 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 83.3 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 81.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 81.63 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-63 Score=521.93 Aligned_cols=320 Identities=66% Similarity=1.126 Sum_probs=295.3
Q ss_pred ccccCCccccccchhhccccchhhhhhhhhhccCcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------
Q 006714 90 SFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------- 162 (634)
Q Consensus 90 s~r~g~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------- 162 (634)
..+.+...+..+++..+++||+|+...+++++++|++...+.|+.+++||+|+||.||+|++..+|+.||||+
T Consensus 77 ~~~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~ 156 (560)
T KOG0600|consen 77 GSRPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK 156 (560)
T ss_pred ccCCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC
Confidence 5577888888899999999999999999999999999999999999999999999999999999999999997
Q ss_pred ---------------------------------------------------------------HHHHHHHHHHHHHHHHH
Q 006714 163 ---------------------------------------------------------------IKCYMNQLLHGLEHCHS 179 (634)
Q Consensus 163 ---------------------------------------------------------------i~~i~~Qll~aL~yLHs 179 (634)
|++||+||+.||+|||.
T Consensus 157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence 78999999999999999
Q ss_pred CCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 259 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG 259 (634)
+||+|||||.+|||||++|.+||+|||+|+++.......++..+.|+||+|||+|++...|+.++|+||+||||.||+.|
T Consensus 237 ~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 237 RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 99999999999999999999999999999998887777889999999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHH
Q 006714 260 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339 (634)
Q Consensus 260 ~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e 339 (634)
+|+|++.++.++++.|+++||.|.+++|+..++|+...+++..+|...+++.+..+++.+++||..||.+||.+|.||.+
T Consensus 317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccccCCCCCCCCCCCCCCCCCChhhHhhhHHHHHHhhhcCCccccccccccccccCCCCCCChhHHH
Q 006714 340 ALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVA 409 (634)
Q Consensus 340 lL~hpwf~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 409 (634)
+|.|+||++.|++|+++.+|.|++++|+++|.+.+.++.......+.....+..+.+........+.+..
T Consensus 397 aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~~~~~~~~~~r~~p~~~~~~~~~ 466 (560)
T KOG0600|consen 397 ALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRRIRERGDRGSRAIPAQPANAESQ 466 (560)
T ss_pred HhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccccccccccccccCCCCCCCCCHHHh
Confidence 9999999999999999999999999999999999888876644444333333345555555554444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=387.96 Aligned_cols=237 Identities=47% Similarity=0.802 Sum_probs=214.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|+++.+|++|+||.||+|+|+.|+++||+|.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4789999999999999999999999999999997
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+++++.|+|.||+|||.+.|+|||||++|+|+++.|.+||+|||+|+.+... ..+
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~ 233 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKP 233 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-ccc
Confidence 5789999999999999999999999999999999999999999999988754 456
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc-c
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT-L 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~-~ 297 (634)
++..+.|+||+|||++++...|+.++|+||+|||+.||++++|+|.+..+.+++.+|+..+|.|.+.+|+........ .
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 788899999999999999999999999999999999999999999999999999999999999999999986554433 3
Q ss_pred CCCCCCCCchhhhhcCCC--cHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCCCCCCCChh
Q 006714 298 FKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKE 366 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~--s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~p~~~~~~~ 366 (634)
+.........++..|..+ ++...+||..+|.+||.+|.||+|+|+|+||...|.|++|..+|.||...+
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 333333345667777655 499999999999999999999999999999999999999999999988554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=371.21 Aligned_cols=231 Identities=47% Similarity=0.834 Sum_probs=205.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|..+++||+|+||.||+|+|..||+.||||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 589999999999999999999999999999997
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
|+.|+.+++.||+|||.+.|+||||||.|+||+.+|.+||+|||+++.+...... .+.
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-~~~ 160 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-QTH 160 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-ccc
Confidence 5789999999999999999999999999999999999999999999988754433 344
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc-CCCCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~-~l~~~~~~~~ 300 (634)
.+.|.||+|||++++...|+..+||||+|||+.||+.+.|.|+|.++.+++..|+..+|+|.++.|+.. .++....+.
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~- 239 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ- 239 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-
Confidence 478999999999999999999999999999999999999999999999999999999999999999874 455444433
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCCCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 363 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~p~~~~ 363 (634)
.. ....+...|...+.++.|||.+||.+||.+|+|+.|+|+|+||++.|.|++++.+|....
T Consensus 240 ~~-P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 240 QF-PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred cC-CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 11 123344478889999999999999999999999999999999999999999888876433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.99 Aligned_cols=219 Identities=37% Similarity=0.687 Sum_probs=194.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
++.|+.+.++|+|+||+||+|++++||+.||||+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 3689999999999999999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.|++|++.|+.|||++++|||||||+||||+.++.+||||||+|+.... +....+
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YT 159 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYT 159 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhh
Confidence 578999999999999999999999999999999999999999999998764 345678
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc-CC-CCcccC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KL-PHATLF 298 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~-~l-~~~~~~ 298 (634)
.++.|.||+|||++.+...|+..+|||++||++.||++|.|+|++..+.+++..|...+|...+.-.... .. .....-
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 8999999999999999999999999999999999999999999999999999999999999886643321 11 122223
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.|...-...++..++.++..+.||+..||..||.+|++.+++|.|+||..
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 34445556788899999999999999999999999999999999999954
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=379.81 Aligned_cols=221 Identities=40% Similarity=0.727 Sum_probs=202.5
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+.+++|.++++||.|+||.||+|+.+.++..||||.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346899999999999999999999999999999997
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
|+.||.||++||+|+|.+|+.||||||+|||+.....|||+|||+|+.... ..
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--kp 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--KP 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--CC
Confidence 567999999999999999999999999999999888999999999997764 35
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc-cCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~-~~l~~~~ 296 (634)
+.+.++-|.||+|||+|+....|+.++|||++|||++|+.+-+|+|+|.++.+++.+|++.+|.|..+.|.. ..+....
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 678899999999999999889999999999999999999999999999999999999999999999999987 4555555
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.|...+.....+..+++..+.++.+||.+||.|||.+||||.++|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 56656666677888888999999999999999999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=353.92 Aligned_cols=223 Identities=39% Similarity=0.661 Sum_probs=194.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|..++.||.|+||.|+.|.+..+|+.||||+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 467778999999999999999999999999998
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC-CC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HR 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~ 216 (634)
++.+++|||.||.|+|+.+|+||||||.|||++.+..+||+|||+|+..... ..
T Consensus 102 YiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 3458899999999999999999999999999999999999999999977532 23
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
..++.++.|.||+|||++.....|+.++||||+||||.||++|+++|.|.+...++..|++.+|.|+++.+.......+.
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 44578899999999999998889999999999999999999999999999999999999999999999887765533332
Q ss_pred cCCC--CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 297 LFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 297 ~~~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.+.. .......+...|+..++.+++||++||.+||.+|+|++|+|+||||..+..|
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 2211 1222345678889999999999999999999999999999999999987543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.84 Aligned_cols=222 Identities=47% Similarity=0.823 Sum_probs=194.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
...|+.+++||+|+||+||+|+++.+|+.||+|+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3578999999999999999999999999999997
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
|+.++.||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 577999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
.... ....+..++|.||+|||++.+...|+..+||||+|||++||++++++|++..+.+++..|++.+|.|.+..|+..
T Consensus 170 ~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 6533 234577788999999999999889999999999999999999999999999999999999999999999999874
Q ss_pred C-CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 291 K-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 291 ~-l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
. ++.....-+.......+....+...++..+|+.+||+++|.+|+|+..+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 3 333332222222234555666677789999999999999999999999999999998654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=347.61 Aligned_cols=197 Identities=34% Similarity=0.501 Sum_probs=168.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..+.|.+.+.||+|+||.|-+|.++.|++.||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45778999999999999999999999999999998
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC---CceEEecccccccc
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFS 211 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~---g~vkL~DFGla~~~ 211 (634)
.+.|++|||.||.|||++||+||||||+||||..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 24589999999999999999999999999999766 67999999999988
Q ss_pred CCCCCCCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHH-HHHHHHHhcCCCCchhhh
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e-~l~~i~~~~g~pp~~~~~ 288 (634)
... ..+.+.|||+.|.|||++.. ...+..++|||||||+||-+|+|.+||....... ..++|.+.-...-...|
T Consensus 330 g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w- 406 (475)
T KOG0615|consen 330 GEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW- 406 (475)
T ss_pred ccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh-
Confidence 743 55688999999999999965 2335568999999999999999999998765544 56666554333322333
Q ss_pred ccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 289 ~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
..+++++++||..||..||++|||+.|+|+||||+..+.
T Consensus 407 ------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 407 ------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 568999999999999999999999999999999998653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=348.97 Aligned_cols=195 Identities=34% Similarity=0.579 Sum_probs=175.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
...+|.+.+.||+|+|++||+|+++.+++.||||+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999999999999999998
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
.+.|+.||+.||+|||++|||||||||+||||+.+++++|+|||.|+.+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 3568999999999999999999999999999999999999999999866532211
Q ss_pred ------------CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCch
Q 006714 218 ------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 218 ------------~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~ 285 (634)
...+.+||..|.+||+|.. ...+..+|||+||||||.|+.|.|||.+.++.-++++|+++...+|
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp-- 307 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP-- 307 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--
Confidence 1245899999999999976 6778999999999999999999999999999999999999766555
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
+.+++.+.|||+++|..||.+|+|+.+|-+||||....|.
T Consensus 308 ---------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 308 ---------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred ---------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 4678999999999999999999999999999999987664
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.46 Aligned_cols=217 Identities=41% Similarity=0.687 Sum_probs=188.5
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|+-.+++|.|+||.||.|...++++.||||+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 68999999999999999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~~~ 219 (634)
|+-|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+....+. +.
T Consensus 105 P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e--pn 182 (364)
T KOG0658|consen 105 PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE--PN 182 (364)
T ss_pred hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC--Cc
Confidence 45689999999999999999999999999999977 899999999999876543 34
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
.++..+..|+|||++++...|+.++||||.||++.||+.|+|+|.|.+..+++..|++.+|.|+.+..............
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~ 262 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKF 262 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccC
Confidence 67788999999999999999999999999999999999999999999999999999999999999887665443322222
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
++.......+-....+++++.+||.++|.++|.+|.++.|+|.||||...
T Consensus 263 p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 263 PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 22221111222457889999999999999999999999999999999865
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.08 Aligned_cols=218 Identities=30% Similarity=0.585 Sum_probs=179.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
-+|+|++.||+|+||.|.+|.|..|++.||||+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 379999999999999999999999999999997
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC--ceEEeccccccccCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~ 215 (634)
++.|+.|||.+|.+||+.+|||+||||+||||.+.+ .|||+|||.+++.....
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 567999999999999999999999999999996543 69999999998776432
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
..++.+..|+|||+|++ ..|+.++||||||||++||++|.|+|+|.++.+++..|++.+|.||...++...-.+.
T Consensus 346 ----ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 346 ----YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred ----eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 36777999999999998 7899999999999999999999999999999999999999999999876554322111
Q ss_pred ccCC--------------------------------CCCC-CCchhhhhcC-CCcHHHHHHHHHhhccCcCCCcCHHHHH
Q 006714 296 TLFK--------------------------------PQQP-YDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAAL 341 (634)
Q Consensus 296 ~~~~--------------------------------~~~~-~~~~l~~~~~-~~s~~l~dLL~~mL~~DP~kRpTa~elL 341 (634)
.+-. ...+ ....+...+. .-...++|||.+||.+||.+|+|+.++|
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 1000 0011 1112222222 2345689999999999999999999999
Q ss_pred hccccCCCCCC
Q 006714 342 ASEYFSTKPYA 352 (634)
Q Consensus 342 ~hpwf~~~~~~ 352 (634)
+||||+.....
T Consensus 501 ~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 501 NHPFLTGTSLE 511 (586)
T ss_pred cCccccccccc
Confidence 99999976443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=333.52 Aligned_cols=195 Identities=33% Similarity=0.546 Sum_probs=172.0
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|+++++||+|+||.||+++.++|++.||+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45799999999999999999999999999999997
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++-|+.+|+.||.|||+.|||||||||+||||+.+|+|+|+|||+++...... ..
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~ 181 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DA 181 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Cc
Confidence 45689999999999999999999999999999999999999999998554332 33
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
..+.|||+.|||||++.+ ..|+.++|+|||||++|||++|.+||.+.+.....++|.+.-...++
T Consensus 182 t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-------------- 246 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-------------- 246 (357)
T ss_pred cccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC--------------
Confidence 456899999999999987 68999999999999999999999999999999999988764311111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc----CHHHHHhccccCCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALASEYFSTKPYA 352 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp----Ta~elL~hpwf~~~~~~ 352 (634)
..++.++++||.++|..||++|. .+.+|-+||||....|.
T Consensus 247 --------------~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 247 --------------GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred --------------ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 23788999999999999999995 68999999999987663
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=348.10 Aligned_cols=189 Identities=33% Similarity=0.554 Sum_probs=171.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|+..+.||+|+|+.||.+++..+|+.||+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 479999999999999999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.|++||+.||.|||+++|||||||..||||+++.+|||+|||+|.....+. ....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKK 176 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cccc
Confidence 56799999999999999999999999999999999999999999999877543 2336
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
+.||||.|+|||++.. ..++..+||||+|||||.||+|+|||...+-.+.+.+|...-...|
T Consensus 177 TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P----------------- 238 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP----------------- 238 (592)
T ss_pred eecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-----------------
Confidence 7899999999999985 7789999999999999999999999999999999999876543333
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..++.++++||.+||..||.+|||+++||.|+||+..
T Consensus 239 ------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 239 ------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 3688999999999999999999999999999999553
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.02 Aligned_cols=211 Identities=35% Similarity=0.538 Sum_probs=175.6
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|+++..||+|+||.||+|+.+.||.+||+|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 4567999999999999999999999999999999998
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC---
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--- 213 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~--- 213 (634)
++.|+.+++.||+.||..|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 456999999999999999999999999999999999999999999842110
Q ss_pred -------------------CCCC------------------------CcccccccccCCCcccccCCCCCCCccccccch
Q 006714 214 -------------------GHRQ------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 250 (634)
Q Consensus 214 -------------------~~~~------------------------~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG 250 (634)
.... ...+.+|||.|||||+|++ ..|+..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHH
Confidence 0000 1123589999999999998 6699999999999
Q ss_pred hhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccC
Q 006714 251 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330 (634)
Q Consensus 251 ~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~D 330 (634)
||+||||.|.|||.+.+..+...+|+..-... ..|. -..++++++|||.+||+ |
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l--------~fP~-----------------~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETL--------KFPE-----------------EVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc--------cCCC-----------------cCcccHHHHHHHHHHhc-C
Confidence 99999999999999999999999997632111 1110 13467899999999999 9
Q ss_pred cCCCcC---HHHHHhccccCCCCCCCCCCCCCCCCC
Q 006714 331 PYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 363 (634)
Q Consensus 331 P~kRpT---a~elL~hpwf~~~~~~~~~~~~p~~~~ 363 (634)
|.+|.- ++||-+||||+...|..-....|.|.|
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence 999985 999999999999888665444444444
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=297.94 Aligned_cols=218 Identities=47% Similarity=0.835 Sum_probs=192.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|..+++||+|+||+||++++.++++.||+|.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 468889999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.+|.|++.||.|||+++++||||||.|+||+.+|.+||+|||+++.+..... ....
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa 160 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA 160 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence 456899999999999999999999999999999999999999999987764322 2344
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhcc-CCCCcccCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~-~l~~~~~~~ 299 (634)
.+.|+||++|.++++..-|+...|+||.|||+.||.. |+|+|++.+..+++.+|+..+|.|.++.|+.. +++.. ..-
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy-k~y 239 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY-KPY 239 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC-ccc
Confidence 5779999999999998999999999999999999986 89999999999999999999999999999874 44433 333
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
|..+...++....+.+...-+|||+++|.-+|.+|++++++|+||||.+.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 44444566777788888899999999999999999999999999999863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=322.67 Aligned_cols=191 Identities=31% Similarity=0.476 Sum_probs=164.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++.+.+..||+|..|+||+|+|+.|++.+|+|.
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 34688999999999999999999999999999997
Q ss_pred -----------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+-.++.++++||.|||+ ++||||||||+||||+..|.|||||||.+...... .
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 23588999999999996 89999999999999999999999999999877653 4
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC-----ChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-----TEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~-----~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
..+.+||..|||||.+.+ ..|+.++||||||++|+||++|+.||... ...+++..| +..+|+..
T Consensus 234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~ppP~l------- 302 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDEPPPRL------- 302 (364)
T ss_pred cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcCCCCCC-------
Confidence 578899999999999988 78999999999999999999999999764 344445444 33333211
Q ss_pred CcccCCCCCCCCchhhhhcC-CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~-~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.. .+++++++||..||+.||.+|||+.|+|+|||++...
T Consensus 303 ------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 303 ------------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ------------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 12 4899999999999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.77 Aligned_cols=193 Identities=26% Similarity=0.454 Sum_probs=174.8
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
...++|+++..||.|+||.|.+++++.+|..||+|+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 556899999999999999999999999999999997
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++-|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 3569999999999999999999999999999999999999999999877642
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
..+.|||+.|+|||++.. ..|+.++|+|+|||++|||+.|.+||...+...++++|++.--.+|
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP-------------- 261 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP-------------- 261 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--------------
Confidence 467899999999999987 7899999999999999999999999999999999999988654444
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYAC 353 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~~~ 353 (634)
..++.++++||..+|+.|-.+|. ...+|..||||+...|..
T Consensus 262 ---------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 262 ---------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred ---------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 35789999999999999999993 468999999999876643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=317.65 Aligned_cols=216 Identities=43% Similarity=0.799 Sum_probs=179.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||.|+||+||+|++..+++.||+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4689999999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~ 162 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSN 162 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccccC
Confidence 34578899999999999999999999999999999999999999987554322 22234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc--ccCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~--~~~~ 299 (634)
..+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.++.+.|+....... ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 56789999999987656789999999999999999999999999999999999999999999988876432211 1111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
+... ...+......++.++++||.+||++||.+|||+.|+|+||||
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYR-AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccC-CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1111 112223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=310.11 Aligned_cols=217 Identities=31% Similarity=0.481 Sum_probs=183.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|++.+.||+|.|+.||++.+..+|+.+|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4789999999999999999999999999999998
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCCC
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~~ 217 (634)
+-.+++|||++|.|||.++|||||+||+|+||.. ..-+||+|||++..... ..
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--g~ 167 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--GE 167 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC--cc
Confidence 2348899999999999999999999999999943 34699999999988773 34
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+|||.||+||++.. ..|+..+|||+.|||||-|+.|.+||.+.+...+++.|++.-...+..+|
T Consensus 168 ~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w---------- 236 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW---------- 236 (355)
T ss_pred ccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc----------
Confidence 4577899999999999986 78999999999999999999999999999999999999887666655555
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCCCCCCCChhhHhhhHHHHHH
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARR 377 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~r 377 (634)
+.+++++++|+++||..||.+|+|+.|+|+|||+.+..--. -...-...++...+.+++|
T Consensus 237 ---------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~A-----s~~H~~dtvd~lrkfNarR 296 (355)
T KOG0033|consen 237 ---------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVA-----SAIHRQDTVDCLKKFNARR 296 (355)
T ss_pred ---------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHH-----HHhhhHHHHHHHHHhhHHH
Confidence 57899999999999999999999999999999998642110 0122344555656666655
Q ss_pred h
Q 006714 378 K 378 (634)
Q Consensus 378 ~ 378 (634)
+
T Consensus 297 K 297 (355)
T KOG0033|consen 297 K 297 (355)
T ss_pred H
Confidence 4
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.84 Aligned_cols=223 Identities=43% Similarity=0.758 Sum_probs=182.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCC----cEEehHH-------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKK------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg----~~vAlK~------------------------------------------- 162 (634)
..|+++.+||+|+||.||+|...++. +.+|||+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 47999999999999999999665543 3689997
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC----CceEEeccccc
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLA 208 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~----g~vkL~DFGla 208 (634)
++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 56799999999999999999999999999999877 89999999999
Q ss_pred cccCCCCCC--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---------hHHHHHHHHH
Q 006714 209 NFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFK 277 (634)
Q Consensus 209 ~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---------~~e~l~~i~~ 277 (634)
+.+...... .....+.|.||+|||++++...|+.++|||++|||+.||++-.|+|.+.. ..+++.+|++
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 987654322 23456779999999999999999999999999999999999999998743 4678999999
Q ss_pred hcCCCCchhhhcc-CCCCc-ccCC-CC-CCCCc-hhh---hhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 278 LCGSPPDDYWKKS-KLPHA-TLFK-PQ-QPYDS-SLR---ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 278 ~~g~pp~~~~~~~-~l~~~-~~~~-~~-~~~~~-~l~---~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+|.|.+..|+.. ++|+. ..+. .. .-++. .+. ...+.-++...+||.+||++||.+|+|++++|+|+||+..
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 9999999999874 44443 1111 00 01111 122 2223446669999999999999999999999999999998
Q ss_pred CCC
Q 006714 350 PYA 352 (634)
Q Consensus 350 ~~~ 352 (634)
+.|
T Consensus 344 ~lp 346 (438)
T KOG0666|consen 344 PLP 346 (438)
T ss_pred CCC
Confidence 765
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.38 Aligned_cols=221 Identities=26% Similarity=0.390 Sum_probs=173.5
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||+||+|.+..+++.||||+
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 345789999999999999999999999999999994
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCC----------------
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG---------------- 198 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g---------------- 198 (634)
++.|+.||+.||.|||. .|||||||||+||||+.++
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 34578899999999998 5999999999999998665
Q ss_pred ceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHh
Q 006714 199 VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278 (634)
Q Consensus 199 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~ 278 (634)
.+||+|||++..... .....++|+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..+.+.
T Consensus 286 ~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 286 RVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred eEEECCCCccccCcc----ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 499999998764322 2245678999999999987 67899999999999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCcc-c------CCCCCCCCchhhhhc-------CCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 279 CGSPPDDYWKKSKLPHAT-L------FKPQQPYDSSLRETF-------KDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 279 ~g~pp~~~~~~~~l~~~~-~------~~~~~~~~~~l~~~~-------~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
++.+|..++..+...... . +.+... ...+.... ....+.+.|||.+||++||.+|||+.|||+||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 999887765432211100 0 000000 00000000 01246688999999999999999999999999
Q ss_pred ccCCCCCCC
Q 006714 345 YFSTKPYAC 353 (634)
Q Consensus 345 wf~~~~~~~ 353 (634)
||......|
T Consensus 440 ~~~~~~~~~ 448 (467)
T PTZ00284 440 YVLKYYPEC 448 (467)
T ss_pred cccccCCcc
Confidence 998754333
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.15 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=199.8
Q ss_pred cCccCCCCcccccccCCccccccchhhccccchhhhhhhhhhccCcccccCCCeeEEEEecccCceeEEEEEECCCCcEE
Q 006714 79 SGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIV 158 (634)
Q Consensus 79 s~~~~~~~~~~s~r~g~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~v 158 (634)
++.....+....|+.|+||++..||.|..+ +|.+.++||+|.|+|||+|.|..+.++|
T Consensus 49 g~~~~eqE~~~dY~kGGYHpV~IGD~F~~g----------------------RY~v~rKLGWGHFSTVWLawDtq~~r~V 106 (590)
T KOG1290|consen 49 GSDDEEQEDPEDYRKGGYHPVRIGDVFNGG----------------------RYHVQRKLGWGHFSTVWLAWDTQNKRYV 106 (590)
T ss_pred cCCcccccChhhhhcCCCceeeccccccCc----------------------eEEEEEeccccccceeEEEeeccCCeEE
Confidence 334445677889999999999999998864 9999999999999999999999999999
Q ss_pred ehHH----------------------------------------------------------------------------
Q 006714 159 ALKK---------------------------------------------------------------------------- 162 (634)
Q Consensus 159 AlK~---------------------------------------------------------------------------- 162 (634)
|+|+
T Consensus 107 AlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl 186 (590)
T KOG1290|consen 107 ALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPL 186 (590)
T ss_pred EEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcH
Confidence 9997
Q ss_pred --HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCC------------------------------------------
Q 006714 163 --IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------------------------------------------ 197 (634)
Q Consensus 163 --i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~------------------------------------------ 197 (634)
|+.|++|||.||.|||.. ||||.||||+||||..+
T Consensus 187 ~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s 266 (590)
T KOG1290|consen 187 SCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMS 266 (590)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccc
Confidence 678999999999999986 99999999999998300
Q ss_pred --------------------------------------------------------------------------------
Q 006714 198 -------------------------------------------------------------------------------- 197 (634)
Q Consensus 198 -------------------------------------------------------------------------------- 197 (634)
T Consensus 267 ~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~ 346 (590)
T KOG1290|consen 267 KSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNN 346 (590)
T ss_pred hhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCcccccccc
Confidence
Q ss_pred --------------------------------------------CceEEeccccccccCCCCCCCcccccccccCCCccc
Q 006714 198 --------------------------------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 233 (634)
Q Consensus 198 --------------------------------------------g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 233 (634)
-.|||+|||.|++... .++.-+.|..|+|||+
T Consensus 347 ~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEV 422 (590)
T KOG1290|consen 347 TSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEV 422 (590)
T ss_pred ccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcce
Confidence 0267888888877643 3455677899999999
Q ss_pred ccCCCCCCCccccccchhhHHHHhhCCCCCCC------CChHHHHHHHHHhcCCCCchhhhc-----------cCCCCcc
Q 006714 234 LLGATDYGPSVDLWSVGCVFAELLIGKPILQG------RTEVEQLHKIFKLCGSPPDDYWKK-----------SKLPHAT 296 (634)
Q Consensus 234 l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~------~~~~e~l~~i~~~~g~pp~~~~~~-----------~~l~~~~ 296 (634)
+.+ ..|+..+||||++|++|||+||..+|.. ..+.+.+..|+++||..|..+... ..+.+..
T Consensus 423 llG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~ 501 (590)
T KOG1290|consen 423 LLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIR 501 (590)
T ss_pred eec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceeccc
Confidence 998 6799999999999999999999999964 347889999999999998643322 3344444
Q ss_pred cCCCCCCCCchhhhhcC---CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 297 LFKPQQPYDSSLRETFK---DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~---~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.+++ ++....|.+.+. ....++.+||.-||+++|++||||.++|+|||++..+.+
T Consensus 502 ~LK~-WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 502 RLKP-WPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccCC-CcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 4433 233344555553 224567899999999999999999999999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.50 Aligned_cols=197 Identities=29% Similarity=0.469 Sum_probs=175.3
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
..+..++|.++.+||+|+||.|+++..+.++++||||+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 45677999999999999999999999999999999997
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++-|+..|+.||+|||++||||||||.+|||||.+|++||+|||+++......
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 45699999999999999999999999999999999999999999998654222
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
....+.|||+.|||||++.+ ..|+.++|+|+|||+|||||.|.+||.+.++.+++..|+..--..|
T Consensus 523 -~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP------------ 588 (694)
T KOG0694|consen 523 -DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP------------ 588 (694)
T ss_pred -CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 34577899999999999987 7899999999999999999999999999999999999965321111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 352 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~~ 352 (634)
..++.++++||++||..||++|.- +.+|..||||+...|.
T Consensus 589 -----------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 589 -----------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred -----------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 357899999999999999999986 5889999999987764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.01 Aligned_cols=224 Identities=46% Similarity=0.815 Sum_probs=188.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
...|+.+.+||+|.||.||+|+...+++.||+|+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4579999999999999999999999999999997
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
|+++|++|+.||.|+|.+.|+|||+|+.|+||+.++.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 67899999999999999999999999999999999999999999997554
Q ss_pred CC---CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 213 TG---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 213 ~~---~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.. .....+..+.|+||++||.+++...|+.+.|||..|||+.||+++.|.|.+.++..+++.|..+||....+.|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 32 223356678899999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cC-CCCcccC--CCCCC-CCchhhhhcCC--CcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 290 SK-LPHATLF--KPQQP-YDSSLRETFKD--LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 290 ~~-l~~~~~~--~~~~~-~~~~l~~~~~~--~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.. ++..... .|... ..+.+....+. -++++.|||+.||.+||.+|++++++|+|.||...|.|
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 43 2222111 11110 01122222221 25688999999999999999999999999999987765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.06 Aligned_cols=216 Identities=38% Similarity=0.661 Sum_probs=174.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||++++..+++.||+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 35689999999999999999999999999999999999999999998765433333344
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC---cccC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH---ATLF 298 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~---~~~~ 298 (634)
..+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+....... ...+
T Consensus 161 ~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 578999999999976 568899999999999999999999999988888888888888887766554321110 0000
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
................++.++.+||.+||++||.+|||++++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000001111122234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.62 Aligned_cols=220 Identities=37% Similarity=0.635 Sum_probs=177.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
..+|++.++||+|+||.||+|.+..+++.||||+
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 4689999999999999999999999999999985
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~ 214 (634)
++.|+.||+.||.|||+++|+||||||+||||+.++ .+||+|||++......
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 234667999999999999999999999999998665 6999999999865432
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. .....++|+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+..+.+..++..++.++.+.+.......
T Consensus 225 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 302 (440)
T PTZ00036 225 Q--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY 302 (440)
T ss_pred C--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence 2 22345779999999998776678999999999999999999999999999999999999999998877665422111
Q ss_pred cccCCCCCCCCchhhhhc-CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~-~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.....+. .....+...+ ...++++++||.+||.+||.+|||+.|+|+||||.....
T Consensus 303 ~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 303 ADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 1110011 1112223333 357889999999999999999999999999999987543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=311.60 Aligned_cols=221 Identities=42% Similarity=0.758 Sum_probs=174.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4789999999999999999999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++....... .....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 162 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSN 162 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCC
Confidence 45688999999999999999999999999999999999999999987543222 22234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC-hHHHHHHHHHhcCCCCchhhhccCC-CCcccCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-~~e~l~~i~~~~g~pp~~~~~~~~l-~~~~~~~ 299 (634)
..+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..++...+.+....|..... +......
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 5678999999998765678899999999999999999999998754 4566777777788887777654321 1100000
Q ss_pred CCCCCCchhhhhcC--CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 300 PQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 300 ~~~~~~~~l~~~~~--~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
........+...+. .++..+.+||.+||++||.+|||+.|+|+||||+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00001112222222 3567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=308.47 Aligned_cols=212 Identities=43% Similarity=0.765 Sum_probs=173.9
Q ss_pred CCeeEEEEecccCceeEEEEEECC-CCcEEehHH----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~-tg~~vAlK~---------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++.. +++.||+|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999864 467888874
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 3457889999999999999999999999999999999999999999765
Q ss_pred CCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
... .......+++.|+|||++.+ ..++.++|||||||++|||++|.+||.+.++.+.+..++..++.+....|....
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 22344567999999999876 568899999999999999999999999999999999999988887776665422
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......+... ....+....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111111111 1123344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.75 Aligned_cols=233 Identities=47% Similarity=0.836 Sum_probs=194.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||.|+||.||++.+..+++.||+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4689999999999999999999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 34588999999999999999999999999999999999999999997665322 12
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC-CCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l-~~~~~ 297 (634)
......+..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.... +....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23334578899999987656788999999999999999999999999999999999999999988888765322 22222
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCCCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYP 362 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~p~~~ 362 (634)
+.........+...+..+++.+.+||.+||.+||++|||+.++|.||||...+.+|.+..+|.+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 22111112234444556789999999999999999999999999999999999999988888765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=324.35 Aligned_cols=225 Identities=26% Similarity=0.411 Sum_probs=172.2
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+...+|++++.||+|+||.||+|++..+++.||||.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~ 168 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD 168 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCC
Confidence 445689999999999999999999999999999996
Q ss_pred ---------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccccc
Q 006714 163 ---------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 227 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 227 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.++|+|||++..............++|+.
T Consensus 169 L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 248 (391)
T PHA03212 169 LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248 (391)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccC
Confidence 35688999999999999999999999999999999999999999997543322223345678999
Q ss_pred CCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC-------ChHHHHHHHHHhcCCCCchhhhccCCCCcccC--
Q 006714 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF-- 298 (634)
Q Consensus 228 Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~-------~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~-- 298 (634)
|+|||++.+ ..++.++|||||||+||||++|..||... ....++..++...+.++.++...........+
T Consensus 249 y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 249 TNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 999999876 67899999999999999999999776532 23456777888777776544211000000000
Q ss_pred ----CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 299 ----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 299 ----~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
....+...........++.++.+||.+||++||.+|||+.|+|+||||...+.+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000001111111223467789999999999999999999999999999886543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.70 Aligned_cols=211 Identities=42% Similarity=0.763 Sum_probs=175.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||+|+||+||+|+++.+++.||+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999984
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 345788999999999999999999999999999999999999999976543
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+.+++...+.+....|......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 12234567899999999876 56899999999999999999999999999998999999988888776666532111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
....+.+ .....+....+.++..+.+||.+||++||.+|||+.++|.||||
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSP--RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCC--CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111111 11223445556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.43 Aligned_cols=191 Identities=33% Similarity=0.502 Sum_probs=168.9
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..+.|++.+.||+|+||+|++|++..++..||+|+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45689999999999999999999999999999875
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 214 (634)
++.+++||+.||+|||++||+||||||+||||+.+ +++||+|||++.... .
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~ 173 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G 173 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence 35699999999999999999999999999999999 999999999998774 2
Q ss_pred CCCCcccccccccCCCcccccCCC-CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~-~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
....+.+.+||+.|+|||++.+.. ..+.++|||||||+||.|++|+.||...+...++.+|.......|
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p---------- 243 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP---------- 243 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC----------
Confidence 335567889999999999998855 346899999999999999999999999888888888765433322
Q ss_pred CcccCCCCCCCCchhhhhcCCC-cHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~-s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..+ ++++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 244 -------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 -------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 234 899999999999999999999999999999997
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.80 Aligned_cols=221 Identities=40% Similarity=0.753 Sum_probs=181.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|.++++||+|+||+||++++..+++.||+|.
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4789999999999999999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.++|+|||++........ ....
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 163 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSN 163 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cccc
Confidence 345788999999999999999999999999999999999999999875433221 2233
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc-CCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL-FKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~-~~~ 300 (634)
..+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.++.+.|+......... +..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 4668999999998765678999999999999999999999999999999999999999999988886543221100 000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.......+......+++++.+||.+||.+||.+|||+.|+|.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00001122234456889999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.89 Aligned_cols=222 Identities=32% Similarity=0.548 Sum_probs=176.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++++..+++.||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4689999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~ 180 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 180 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--C
Confidence 2357889999999999999999999999999999999999999999765432 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+..+++..........
T Consensus 181 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 181 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 2244577999999999976 678999999999999999999999999999999999999988888776655422110000
Q ss_pred CCCCCCC-------------CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 298 FKPQQPY-------------DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 298 ~~~~~~~-------------~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
......+ ...........+..+++||.+||.+||.+|||+.++|+||||..+..+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence 0000000 0000111123456789999999999999999999999999998754333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.01 Aligned_cols=217 Identities=38% Similarity=0.674 Sum_probs=178.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||.|+||+||+|.+..+++.||+|+
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 689999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 171 (343)
T cd07878 95 VYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--- 171 (343)
T ss_pred EEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC---
Confidence 3457889999999999999999999999999999999999999999765432
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.+.+..........
T Consensus 172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 2345789999999999775678999999999999999999999999998888888988888877766554322111111
Q ss_pred CCC--CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+.. .......+...+...++.+.+||.+||.+||.+|||+.|+|.||||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 01111233445566788899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.42 Aligned_cols=221 Identities=37% Similarity=0.620 Sum_probs=177.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.++||+|+||.||+|++..+++.||||+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 59999999999999999999999999999984
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC--C
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--R 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~ 216 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 34588899999999999999999999999999999999999999997543221 1
Q ss_pred CCcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.++...+........
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 122345789999999988642 4688999999999999999999999999998888888888888887766544221110
Q ss_pred ccC--CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 296 TLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~--~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
..+ .........+...++.+++.+.+||.+||..||++|||+.|+|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 00001112233455678899999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.88 Aligned_cols=219 Identities=35% Similarity=0.606 Sum_probs=173.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++++..+++.||+|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3689999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 177 (359)
T cd07876 100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--F 177 (359)
T ss_pred eeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--c
Confidence 2347889999999999999999999999999999999999999999754332 1
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+++.++.++..++..........
T Consensus 178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 2244577999999999976 678899999999999999999999999999888888998888888766554321000000
Q ss_pred --CCCCCC---CC--------chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 --FKPQQP---YD--------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 --~~~~~~---~~--------~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+..+ +. ..........++.+.+||.+||.+||.+|||+.|+|+||||..+-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 000000 00 000111123467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.48 Aligned_cols=192 Identities=28% Similarity=0.478 Sum_probs=172.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.-|++.+.||.|+-|.|-+|++..||+.+|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 468899999999999999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
..+|+.||+.||.|||..+|+||||||+|+||+..+.|||+|||+|.....+ ..+.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLLE 169 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--cccc
Confidence 3569999999999999999999999999999999999999999999866543 4567
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
+.||.+.|.+||++.+..+.+.++||||+|||||.||+|+.||++.+-..++.++.......|
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----------------- 232 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----------------- 232 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC-----------------
Confidence 789999999999999977779999999999999999999999998888888888765433333
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
..++.++.+||.+||.+||++|+|.+||++|||+....-+
T Consensus 233 ------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 233 ------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 5789999999999999999999999999999999876443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.71 Aligned_cols=220 Identities=38% Similarity=0.617 Sum_probs=177.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.++||+|+||+||++++..+++.||||+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 48899999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..........
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~ 160 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence 34578899999999999999999999999999999999999999998654433333
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc-cc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~-~~ 297 (634)
.....+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...++.++.+.+........ ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 240 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence 34456789999999998766689999999999999999999999999999999999999999887665432110000 00
Q ss_pred C--CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 F--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~--~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
. ....+....+.......++++.+||.+||++||.+|||+.|+|.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 0000111111122345688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=298.68 Aligned_cols=195 Identities=33% Similarity=0.486 Sum_probs=174.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|+-.+.||.|..++|-++.++.+++.+|+|+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 468888999999999999999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
.+.||+||+.|++|||.++||||||||+|||++++.+++|+|||+++.+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 3579999999999999999999999999999999999999999999988755
Q ss_pred CCCCcccccccccCCCcccccC-----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 215 HRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~-----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
..+...|||+.|+|||.+.. ...|+..+|+|++|||+|.|+.|.|||......-.+..|++....+..+.|
T Consensus 177 --ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW-- 252 (411)
T KOG0599|consen 177 --EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW-- 252 (411)
T ss_pred --hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch--
Confidence 45678899999999999853 356889999999999999999999999999998899999887666655555
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.+++...+|||.+||+.||.+|+|++|+|+||||.....
T Consensus 253 -----------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 253 -----------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred -----------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 578889999999999999999999999999999976543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.96 Aligned_cols=216 Identities=28% Similarity=0.501 Sum_probs=173.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
..+|+|+..||+|+||.|..+.|..++..||||+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 4699999999999999999999999999999998
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC--------------------
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------------------- 196 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-------------------- 196 (634)
|+.+.+||+.++.|||+.+++|.||||+|||+..
T Consensus 168 ivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k 247 (415)
T KOG0671|consen 168 IVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK 247 (415)
T ss_pred EEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence 5678999999999999999999999999999832
Q ss_pred CCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHH
Q 006714 197 EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 197 ~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~ 276 (634)
+..|+|+|||.|.+..... ...+.|..|+|||++++ ..++..+||||+||||+||++|..+|+..++.+.+..|.
T Consensus 248 s~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 248 STAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred CcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 2358999999998765433 55677999999999998 789999999999999999999999999999999999999
Q ss_pred HhcCCCCchhhhcc---------CCCCcccCCCC-----CCCCchhhhhc---CCCcHHHHHHHHHhhccCcCCCcCHHH
Q 006714 277 KLCGSPPDDYWKKS---------KLPHATLFKPQ-----QPYDSSLRETF---KDLPTTAVNLIETLLSVEPYKRATASA 339 (634)
Q Consensus 277 ~~~g~pp~~~~~~~---------~l~~~~~~~~~-----~~~~~~l~~~~---~~~s~~l~dLL~~mL~~DP~kRpTa~e 339 (634)
..+|++|....... ++......... ......+.... .....++.|||++||.+||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 99998887654433 11110000000 00001111111 122345899999999999999999999
Q ss_pred HHhccccCCC
Q 006714 340 ALASEYFSTK 349 (634)
Q Consensus 340 lL~hpwf~~~ 349 (634)
+|.||||+..
T Consensus 403 AL~HpFF~~~ 412 (415)
T KOG0671|consen 403 ALSHPFFARL 412 (415)
T ss_pred HhcCHHhhcC
Confidence 9999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.51 Aligned_cols=179 Identities=35% Similarity=0.570 Sum_probs=157.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|+|+++||+|+||+||+++++.+|+.||+|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 479999999999999999999999999999996
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHH--CC--ceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHS--RG--VLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs--~g--IvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
|++|+.||+.||.+||. .. |+||||||.||+|+.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 67899999999999999 44 999999999999999999999999999988
Q ss_pred CCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
... .....+.+|||.||+||++.. ..|+.++|||||||++|||+.-++||.+.+-.++-.+|.+. ..+|-..
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~----- 250 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD----- 250 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH-----
Confidence 653 345678899999999999987 78999999999999999999999999999777777777553 3322100
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa 337 (634)
..++.++..||..||.+||+.||+.
T Consensus 251 ---------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ---------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2467889999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.07 Aligned_cols=194 Identities=31% Similarity=0.493 Sum_probs=169.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|+++..||+|.||.|-+|++..+++.||||+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 4789999999999999999999999999999997
Q ss_pred ------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccc
Q 006714 163 ------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206 (634)
Q Consensus 163 ------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFG 206 (634)
.+.|++.++.||+|||.+|||||||||+|+||+.+|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 46799999999999999999999999999999999999999999
Q ss_pred cccccCCC----CCCCcccccccccCCCcccccC---CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhc
Q 006714 207 LANFSNTG----HRQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279 (634)
Q Consensus 207 la~~~~~~----~~~~~~~~~gt~~Y~APE~l~~---~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~ 279 (634)
.+...... ....+...+||+.|+|||++.+ ....+.+.|||||||+||.|+.|+.||.+....+++.+|+..-
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 99866322 1123344689999999999876 2345789999999999999999999999999999999997743
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 280 g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
-.+|+ .+++.+.++|||.+||++||.+|+++.+|..|||....
T Consensus 336 L~fP~---------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFPE---------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCCC---------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 33321 23578899999999999999999999999999999764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.19 Aligned_cols=219 Identities=33% Similarity=0.565 Sum_probs=173.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++.+..+++.||||+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4699999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 96 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 173 (355)
T cd07874 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 173 (355)
T ss_pred eeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc--c
Confidence 2347889999999999999999999999999999999999999999765432 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+++..........
T Consensus 174 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred ccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 2244577999999999876 568999999999999999999999999999888888888888887766554321100000
Q ss_pred CCCCCC---------CC----chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKPQQP---------YD----SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~~~~---------~~----~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
...... .. ..........+..+.+||.+||..||.+|||+.|+|+||||..+-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 000000 00 000111123467889999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.01 Aligned_cols=192 Identities=30% Similarity=0.548 Sum_probs=168.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
...|....+||+|+-|.||.|+...+++.||||+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3579999999999999999999999999999996
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
|.++++++|.||+|||.+||+|||||.+|||+..+|.+||+|||++..+..... ...+.+
T Consensus 352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmV 430 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMV 430 (550)
T ss_pred cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccccc
Confidence 567999999999999999999999999999999999999999999987765443 346789
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
||++|||||++.. ..|++++||||||++++||+-|.|||-..+....+..|... |.|...
T Consensus 431 GTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk------------------ 490 (550)
T KOG0578|consen 431 GTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK------------------ 490 (550)
T ss_pred CCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC------------------
Confidence 9999999999976 78999999999999999999999999988777777776442 333211
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....+++.+++||.+||+.|+.+|++|.|||+||||+.
T Consensus 491 -------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 -------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 12468999999999999999999999999999999954
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.71 Aligned_cols=192 Identities=33% Similarity=0.544 Sum_probs=170.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
+++|.+.+.||+|+||.||+++.+.+.+.||||.
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 3689999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.|++.||.|||+++|+|||+||.||||...+.+|+||||+|+..... ....+.
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vlts 159 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTS 159 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeee
Confidence 5678999999999999999999999999999999999999999999877653 345677
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..||+.|||||++.+ ..|+..+|+||||||+|||++|+|||......+.+..|...--.+|
T Consensus 160 ikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p------------------ 220 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP------------------ 220 (808)
T ss_pred ccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc------------------
Confidence 789999999999986 8899999999999999999999999998888887777755322221
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
..++..+++||+.+|..||.+|+|..++|.|||++..-.
T Consensus 221 -----------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 221 -----------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred -----------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 357889999999999999999999999999999987543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=297.65 Aligned_cols=220 Identities=41% Similarity=0.755 Sum_probs=178.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||.|+||.||++++..+++.||+|.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 4789999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .....
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 163 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSN 163 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Ccccc
Confidence 34578899999999999999999999999999999999999999987544322 11233
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC-cccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~-~~~~~~ 300 (634)
..+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+++..+...++.+....|+...... ...+..
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 4568899999998765668899999999999999999999999999889999999999888888776531110 000000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.......+......+++.+.+||.+||++||.+|||+.|+|+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1111122233345688899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.98 Aligned_cols=235 Identities=27% Similarity=0.435 Sum_probs=190.5
Q ss_pred hhhhhhhhccCcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------
Q 006714 113 LSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------ 162 (634)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------ 162 (634)
+.....+...+++|+..+.|...++||+|+||.||-++.+.||+.||+|.
T Consensus 168 f~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi 247 (591)
T KOG0986|consen 168 FTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI 247 (591)
T ss_pred HHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE
Confidence 33344445556678899999999999999999999999999999999997
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceE
Q 006714 163 -----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 201 (634)
Q Consensus 163 -----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vk 201 (634)
+.-|+.+|+.||++||..+||+|||||+|||||+.|+|+
T Consensus 248 VslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 248 VSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred EEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeE
Confidence 356899999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCC
Q 006714 202 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 202 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
|+|+|+|..+... .+....+||..|||||++.+ ..|+...|+|+|||+||||+.|+.||....+......+-.....
T Consensus 328 ISDLGLAvei~~g--~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~ 404 (591)
T KOG0986|consen 328 ISDLGLAVEIPEG--KPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE 404 (591)
T ss_pred eeccceEEecCCC--CccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc
Confidence 9999999988765 34466799999999999987 55999999999999999999999999765443322222221111
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCCCCC--
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYACD-- 354 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~~~~-- 354 (634)
-+. +....+++++++|++.+|..||.+|.. ++++-+||||++..|.--
T Consensus 405 ~~~-------------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rlea 459 (591)
T KOG0986|consen 405 DPE-------------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEA 459 (591)
T ss_pred chh-------------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhc
Confidence 111 112468999999999999999999974 789999999999876542
Q ss_pred -CCCCCCCCCChhhHhhhHHHH
Q 006714 355 -LSSLPIYPPSKEIDAKHREDA 375 (634)
Q Consensus 355 -~~~~p~~~~~~~~~~~~~~~~ 375 (634)
--+.|..|++..+.++...+.
T Consensus 460 gml~PPfiPdp~aVyakDv~DI 481 (591)
T KOG0986|consen 460 GMLEPPFIPDPGAVYAKDVLDI 481 (591)
T ss_pred cCCCCCCCCCccccchhhhhhh
Confidence 234567788888888765544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.03 Aligned_cols=193 Identities=26% Similarity=0.450 Sum_probs=158.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++++.||+|+||+||++.+..+++.||+|+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999984
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--ee
Confidence 34578899999999999999999999999999999999999999997654321 22
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+...+.....
T Consensus 159 ~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 222 (285)
T cd05631 159 RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--------------- 222 (285)
T ss_pred cCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc---------------
Confidence 34578999999999976 67899999999999999999999999876654433333322211110
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
.....++..+.+||.+||+.||.+||+ ++++++||||....+
T Consensus 223 ----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 223 ----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred ----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 111357889999999999999999997 899999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.53 Aligned_cols=206 Identities=29% Similarity=0.457 Sum_probs=169.8
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+++..+.|++.++||.|.-++||+|+.+.++.+||||+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 45667899999999999999999999999999999997
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
|..|++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+.......
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 56689999999999999999999999999999999999999999876443322
Q ss_pred C---CCcccccccccCCCcccc-cCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 216 R---QPLTSRVVTLWYRPPELL-LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 216 ~---~~~~~~~gt~~Y~APE~l-~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
. ..+...++|++|||||++ .....|+.++||||||++..||.+|..||......+.+..-++ +.||...
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~----- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL----- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc-----
Confidence 1 122566899999999994 4556799999999999999999999999998887776654433 3343111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
. ...-.+..+.++..++.+|..||..||.+||||+++|+|+||+..
T Consensus 254 -------t-----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 -------T-----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred -------c-----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0 001122335677899999999999999999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.69 Aligned_cols=212 Identities=38% Similarity=0.701 Sum_probs=162.0
Q ss_pred EEEecccCceeEEEEEEC--CCCcEEehHH--------------------------------------------------
Q 006714 135 LEKIGQGTYSSVFRARDL--DTGKIVALKK-------------------------------------------------- 162 (634)
Q Consensus 135 ~~~LG~G~fg~Vy~a~d~--~tg~~vAlK~-------------------------------------------------- 162 (634)
..+||+|+||+||+|+++ .+++.||+|.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 368999999999999975 4667888884
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee----cCCCceEEeccccccccCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl----~~~g~vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++......
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 24578999999999999999999999999999 45578999999999765432
Q ss_pred CC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh---------HHHHHHHHHhcCCCC
Q 006714 215 HR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPP 283 (634)
Q Consensus 215 ~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---------~e~l~~i~~~~g~pp 283 (634)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||..... ..++..++..++.+.
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (317)
T cd07868 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 245 (317)
T ss_pred CccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCC
Confidence 21 1223457799999999998766789999999999999999999999975432 467788889999888
Q ss_pred chhhhccCC-CCcccC----C----CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 284 DDYWKKSKL-PHATLF----K----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 284 ~~~~~~~~l-~~~~~~----~----~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
...|..... +..... . ........+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 246 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 877765321 110000 0 00000111111122346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.91 Aligned_cols=189 Identities=28% Similarity=0.401 Sum_probs=161.2
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||.||+|++..+++.||+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999984
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 3457889999999999999999999999999999999999999999765432
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 172 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---------------- 234 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF---------------- 234 (329)
T ss_pred cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC----------------
Confidence 134578999999999876 567899999999999999999999999887776666664321100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKP 350 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~ 350 (634)
...++..+.+||.+||+.||.+|++ +.+|+.||||....
T Consensus 235 -------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 235 -------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred -------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 0236778999999999999999997 79999999998743
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=297.27 Aligned_cols=188 Identities=28% Similarity=0.416 Sum_probs=161.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||+|++..+++.||+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----cc
Confidence 2457889999999999999999999999999999999999999998765432 23
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 157 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------------ 217 (291)
T cd05612 157 TLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF------------------ 217 (291)
T ss_pred cccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC------------------
Confidence 4568999999999876 568899999999999999999999999888777777665421111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
...++..+.+||.+||..||.+|++ +++++.||||....+
T Consensus 218 -----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 218 -----------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred -----------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 1245788999999999999999995 999999999987544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.07 Aligned_cols=195 Identities=35% Similarity=0.562 Sum_probs=163.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 479999999999999999999999999999995
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-----
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH----- 215 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~----- 215 (634)
++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 34588999999999999999999999999999999999999999997654332
Q ss_pred -----------------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHH
Q 006714 216 -----------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272 (634)
Q Consensus 216 -----------------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l 272 (634)
........+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 112234568999999999987 57899999999999999999999999988877777
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-HHHHHhccccCCCCC
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTKPY 351 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-a~elL~hpwf~~~~~ 351 (634)
..+........ + .....+++.+.+||.+||. ||.+|++ +.++|+||||....+
T Consensus 240 ~~i~~~~~~~~--------~-----------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 240 NKIINWKESLR--------F-----------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHhccCCccc--------C-----------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 66654211110 0 0012368899999999997 9999999 999999999987655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=292.26 Aligned_cols=215 Identities=45% Similarity=0.803 Sum_probs=174.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||.|+||.||+|++..++..||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYT 159 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cccc
Confidence 34589999999999999999999999999999999999999999987554321 1223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|.............
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 34568899999998765667899999999999999999999999998888888888888888777775432211111000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.......+......+++++.+||.+||+.||.+|||+.+||.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1111122334445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.13 Aligned_cols=215 Identities=45% Similarity=0.774 Sum_probs=173.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||.|+||.||+|++..+|+.||+|.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 58999999999999999999999999999884
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 159 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAE 159 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCCC
Confidence 35688999999999999999999999999999999999999999987654322 122334
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCC-CCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~p-f~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..++..++.++...|............+.
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 5688999999987756678999999999999999998766 567777788888888888887776654221111111122
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......+.+..+.+++++.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 222223345556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.72 Aligned_cols=191 Identities=34% Similarity=0.516 Sum_probs=154.3
Q ss_pred CeeEEEEecccCceeEEEEEEC---CCCcEEehHH---------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~--------------------------------------------- 162 (634)
+|+++++||+|+||+||++++. .+++.||+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 4788899984
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 355888999999999999999999999999999999999999999976543333
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChH----HHHHHHHHhcCCCCchhhhccCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV----EQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~----e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
......++|+.|+|||++.+...++.++|||||||+||||++|..||...... .....+.... +
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~---------- 228 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--P---------- 228 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--C----------
Confidence 33345678999999999986556789999999999999999999999753321 2222221110 0
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 350 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~ 350 (634)
.....++..+.+||.+||..||++|| +++++++||||+...
T Consensus 229 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 229 -----------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00134678899999999999999999 889999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.60 Aligned_cols=196 Identities=32% Similarity=0.512 Sum_probs=163.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||.||+|++..+++.||||+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 379999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 345888999999999999999999999999999999999999999976543 234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+ ..++.++|||||||++|||++|.+||...+..+.+..+...........
T Consensus 157 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------- 221 (333)
T cd05600 157 SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV-------------- 221 (333)
T ss_pred CcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC--------------
Confidence 5578999999999986 5789999999999999999999999998887776666543211110000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
. ......+++++.+||.+||..+|.+||++.+++.||||....+
T Consensus 222 -~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 222 -Y------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred -C------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 0 0000357889999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.12 Aligned_cols=184 Identities=28% Similarity=0.448 Sum_probs=154.7
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||+|++..+++.||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999999999999984
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......++|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCc
Confidence 34578899999999999999999999999999999999999999987533221 2234457899
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|+|||++.+ ..++.++|||||||++|||++|..||...+....+..+.......
T Consensus 160 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------ 214 (323)
T cd05571 160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------------------------ 214 (323)
T ss_pred cccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC------------------------
Confidence 9999999876 678999999999999999999999998877766665553311110
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 350 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~ 350 (634)
...+++++.+||.+||..||.+|| ++.++|+||||....
T Consensus 215 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 215 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred -----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 135788999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.47 Aligned_cols=196 Identities=27% Similarity=0.427 Sum_probs=162.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||++++..+++.||+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++...........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 345788999999999999999999999999999999999999999976654332222
Q ss_pred ccccccccCCCcccccC-----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 220 TSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~-----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
....+|+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+.+++....... .
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------~-- 230 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--------F-- 230 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC--------C--
Confidence 34467999999999863 34578899999999999999999999998887777776654311000 0
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.....++..+.+||..||. ||.+|||+.+++.||||....+
T Consensus 231 ---------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 231 ---------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 0013478889999999998 9999999999999999987544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.93 Aligned_cols=193 Identities=32% Similarity=0.508 Sum_probs=157.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|...+.||+|+||+||++.+.++|..+|+|.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 468889999999999999999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccccCC--CCCC
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNT--GHRQ 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~--~~~~ 217 (634)
|+.|.+||++||.|||++||||+||||+||||+. ++.+||+|||++..... ....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 5679999999999999999999999999999999 79999999999986653 2222
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC-ChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~-~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......||+.|||||++........++|||||||++.||+||.+||... ...+.+..+......|
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-------------- 242 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-------------- 242 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--------------
Confidence 3346788999999999985222335999999999999999999999873 3333333332211011
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+++++++||.+||..||.+||||.++|.|||....
T Consensus 243 -------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 -------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1224689999999999999999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.30 Aligned_cols=195 Identities=32% Similarity=0.525 Sum_probs=160.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC---
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--- 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--- 217 (634)
++.|+.||+.||+|||+++|+||||||+||||+.++.++|+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 4568899999999999999999999999999999999999999998654221100
Q ss_pred ----------------------------------CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCC
Q 006714 218 ----------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 263 (634)
Q Consensus 218 ----------------------------------~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf 263 (634)
.....+||+.|+|||++.. ..++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCC
Confidence 1113468999999999876 67899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC---HHHH
Q 006714 264 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAA 340 (634)
Q Consensus 264 ~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~el 340 (634)
...+..+.+..+........ . + ....+++.+.+||.+||. +|.+|++ +.++
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~--------~----------~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQ--------F----------P-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCCHHHHHHHHHcCCCccC--------C----------C-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 98887777666643211110 0 0 001468899999999997 9999998 9999
Q ss_pred HhccccCCCCC
Q 006714 341 LASEYFSTKPY 351 (634)
Q Consensus 341 L~hpwf~~~~~ 351 (634)
|.||||....+
T Consensus 294 l~h~~~~~~~~ 304 (364)
T cd05599 294 KSHPFFKGVDW 304 (364)
T ss_pred hcCCCcCCCCH
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.45 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=166.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||++++..+++.||+|+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4566899999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 3457889999999999999999999999999999999999999999765433222
Q ss_pred CcccccccccCCCcccccCC---CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 218 PLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~---~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.....++|+.|+|||++.+. ..++.++|||||||+||||++|.+||.+.+....+.++......+..
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 268 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF---------- 268 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC----------
Confidence 33456789999999998652 24788999999999999999999999998887777776542211100
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 351 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~ 351 (634)
.....++.++.+||.+||..+|.+ |+|+.++++||||+...|
T Consensus 269 ---------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 269 ---------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred ---------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 001246889999999999999988 999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.52 Aligned_cols=195 Identities=30% Similarity=0.472 Sum_probs=159.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC----
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 216 (634)
++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 356889999999999999999999999999999999999999999875432110
Q ss_pred ------------------------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC
Q 006714 217 ------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 266 (634)
Q Consensus 217 ------------------------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~ 266 (634)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01124578999999999976 67899999999999999999999999998
Q ss_pred ChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcC---CCcCHHHHHhc
Q 006714 267 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY---KRATASAALAS 343 (634)
Q Consensus 267 ~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~---kRpTa~elL~h 343 (634)
+..+.+.++........ + . ....+++++++||.+|+. +|. .||+++||++|
T Consensus 240 ~~~~~~~~i~~~~~~~~--------------~------p-----~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 TPQETYKKVMNWKETLI--------------F------P-----PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CHHHHHHHHHcCcCccc--------------C------C-----CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 88777777754221110 0 0 002367889999999875 555 45899999999
Q ss_pred cccCCCCC
Q 006714 344 EYFSTKPY 351 (634)
Q Consensus 344 pwf~~~~~ 351 (634)
|||....|
T Consensus 294 p~f~~~~~ 301 (363)
T cd05628 294 PFFEGVDW 301 (363)
T ss_pred CCCCCCCH
Confidence 99998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=285.26 Aligned_cols=219 Identities=39% Similarity=0.615 Sum_probs=183.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+.+--+.||.|+||.||.+.|..+|+.||+|+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 45566889999999999999999999999997
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++-+++||++||.|||+.+|+||||||.|+|++.+..+||||||+++....+....
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 45688999999999999999999999999999999999999999999887776677
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
++..+.|.+|+|||++++...|+.++||||+|||+.||+..+.+|......++++.|.+++|.|..+.++..+.-.....
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 78888899999999999999999999999999999999999999999999999999999999999887765332111111
Q ss_pred CCCCCCCchhhhhcC-----CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFK-----DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~-----~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.......+.+..++. .-..+..+++..||.+||.+|++..++|.|+|+...
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111112222221 233567899999999999999999999999998654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.34 Aligned_cols=189 Identities=30% Similarity=0.471 Sum_probs=160.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||+|+||.||+|++..+++.||||+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Ccee
Confidence 34578899999999999999999999999999999999999999986432211 1223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......
T Consensus 160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~------------------ 220 (324)
T cd05587 160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY------------------ 220 (324)
T ss_pred eecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 4578999999999976 568899999999999999999999999888877777765422111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH-----HHHHhccccCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKP 350 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa-----~elL~hpwf~~~~ 350 (634)
...++..+.+||.+||..||.+|+++ .++++||||....
T Consensus 221 -----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 221 -----------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 13467889999999999999999986 8999999998743
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=295.62 Aligned_cols=194 Identities=29% Similarity=0.513 Sum_probs=166.7
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.++||+|+|++||+|+++.++..||||.
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34789999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC------CceEEeccccccccCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE------GVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~------g~vkL~DFGla~~~~~ 213 (634)
++.+|.||+.||++||+++||||||||.||||+.. -.+||+|||+|+....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 46699999999999999999999999999999764 4689999999998874
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. ....+.||++.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..+.+..+.+.-...+
T Consensus 168 ~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~---------- 234 (429)
T KOG0595|consen 168 G--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP---------- 234 (429)
T ss_pred h--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC----------
Confidence 3 34567899999999999975 7899999999999999999999999999999988886644221111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....++..+.+|+..+|..+|.+|.+..+-+.|+++...+
T Consensus 235 ----------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 ----------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ----------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 00123556677999999999999999999999999998764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.72 Aligned_cols=190 Identities=28% Similarity=0.454 Sum_probs=161.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||+|+||.||+|++..+++.||||+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cccc
Confidence 34588999999999999999999999999999999999999999987543221 1223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+.......|
T Consensus 160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----------------- 221 (323)
T cd05616 160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------------- 221 (323)
T ss_pred cCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 4578999999999976 6789999999999999999999999999888777777754321111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
..++.++.+||.+||+.||.+|++ ..++++||||....|
T Consensus 222 ------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 222 ------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred ------------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 346788999999999999999998 489999999987544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=295.65 Aligned_cols=209 Identities=28% Similarity=0.405 Sum_probs=176.3
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
..+..+.|++++.||.|.-|+||+|+...++..+|+|+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34566899999999999999999999999999999997
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++-|+.+++.||+|||..|||+|||||+||||.++|+|-|+||.++.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 466999999999999999999999999999999999999999998742110
Q ss_pred ---------------------------------C-C---------------------CCCcccccccccCCCcccccCCC
Q 006714 214 ---------------------------------G-H---------------------RQPLTSRVVTLWYRPPELLLGAT 238 (634)
Q Consensus 214 ---------------------------------~-~---------------------~~~~~~~~gt~~Y~APE~l~~~~ 238 (634)
. . .....+.+||-.|+|||++.+ .
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~ 310 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-E 310 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-C
Confidence 0 0 011234588999999999998 5
Q ss_pred CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHH
Q 006714 239 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 318 (634)
Q Consensus 239 ~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~ 318 (634)
..+.++|+|+|||+|||||.|..||.+.+..+.+.+|+..--.+|.. +.++..
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~---------------------------~~vs~~ 363 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE---------------------------PEVSSA 363 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC---------------------------CcchhH
Confidence 67999999999999999999999999999999999997643333321 256788
Q ss_pred HHHHHHHhhccCcCCCcC----HHHHHhccccCCCCCCCCCCCCCCC
Q 006714 319 AVNLIETLLSVEPYKRAT----ASAALASEYFSTKPYACDLSSLPIY 361 (634)
Q Consensus 319 l~dLL~~mL~~DP~kRpT----a~elL~hpwf~~~~~~~~~~~~p~~ 361 (634)
++|||+++|.+||.+|.. |.||-+||||....|+.--...|.+
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 999999999999999999 9999999999999888654444433
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=286.03 Aligned_cols=217 Identities=42% Similarity=0.788 Sum_probs=178.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||+|.+..+++.|++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999999999999986
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 346888999999999999999999999999999999999999999886654332223445
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC-CCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l-~~~~~~~~~ 301 (634)
.++..|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+.+..+...++.+....|..... .........
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence 6789999999987656678999999999999999999999999999999999999888887766654322 111111111
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
......+...++..+..+.+||.+||..||.+|||+.++|.||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1112234555677889999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=300.64 Aligned_cols=201 Identities=28% Similarity=0.430 Sum_probs=164.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||++++..+++.||+|+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 4456899999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 3458889999999999999999999999999999999999999999866433322
Q ss_pred CcccccccccCCCcccccCC---CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 218 PLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~---~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.....++|+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+..++.....+..
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 268 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF---------- 268 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC----------
Confidence 33456789999999998653 23788999999999999999999999998887777777553221110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 351 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~ 351 (634)
.....++..+++||..||..++.+ |+|+.|+|+||||+...+
T Consensus 269 ---------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 269 ---------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred ---------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 000246888999999999865543 899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.77 Aligned_cols=194 Identities=34% Similarity=0.507 Sum_probs=157.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|+++++||+|+||+||+|++..+++.||+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC------
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------ 215 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~------ 215 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 35578899999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHH
Q 006714 216 ----------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 255 (634)
Q Consensus 216 ----------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLye 255 (634)
.......+||+.|+|||++.+ ..|+.++|||||||+|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHH
Confidence 001123468999999999876 678999999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc
Q 006714 256 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335 (634)
Q Consensus 256 LltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp 335 (634)
|++|++||.+.+..+....+......... .....+++++.+||.+|+ .||.+|+
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHI-------------------------PPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCC-------------------------CCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 99999999988877766666432111110 001357889999999986 5999999
Q ss_pred C---HHHHHhccccCCCCC
Q 006714 336 T---ASAALASEYFSTKPY 351 (634)
Q Consensus 336 T---a~elL~hpwf~~~~~ 351 (634)
+ +.+++.||||....+
T Consensus 295 ~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 295 GKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred CCCCHHHHhcCCCcCCcCh
Confidence 7 999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=300.53 Aligned_cols=195 Identities=33% Similarity=0.482 Sum_probs=156.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++++.||+|+||+||+|++..+++.||||+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC------
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------ 215 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~------ 215 (634)
++.++.||+.||.|||+.+|+||||||+||||+.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 35588899999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHH
Q 006714 216 ----------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 255 (634)
Q Consensus 216 ----------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLye 255 (634)
.......+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHH
Confidence 001123578999999999876 668999999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhcc--CcCC
Q 006714 256 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV--EPYK 333 (634)
Q Consensus 256 LltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~--DP~k 333 (634)
|++|.+||...+..+....+......+.. .....+++++.+||.+||.. +|..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHI-------------------------PPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCC-------------------------CCCCCCCHHHHHHHHHHccCcccccC
Confidence 99999999988776666655432111100 00124788999999996654 4555
Q ss_pred CcCHHHHHhccccCCCCC
Q 006714 334 RATASAALASEYFSTKPY 351 (634)
Q Consensus 334 RpTa~elL~hpwf~~~~~ 351 (634)
|+++.+++.||||....+
T Consensus 296 R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 296 RNGADDIKAHPFFSEVDF 313 (381)
T ss_pred CCCHHHHhcCcccCCCCh
Confidence 999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.65 Aligned_cols=189 Identities=28% Similarity=0.433 Sum_probs=160.7
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++++.||+|+||.||++.+..+++.||||+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 7899999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-Cccc
Confidence 34588999999999999999999999999999999999999999986533221 2224
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 160 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~------------------ 220 (324)
T cd05589 160 TFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY------------------ 220 (324)
T ss_pred ccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 4678999999999876 678899999999999999999999999988877777664421111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
...++..+.+||.+||..||.+|| ++.++++||||....+
T Consensus 221 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 221 -----------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 134688899999999999999999 7999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.95 Aligned_cols=197 Identities=29% Similarity=0.486 Sum_probs=171.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHHH------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI------------------------------------------ 163 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i------------------------------------------ 163 (634)
.+.+++|+.+++||+|+||.|.+++.+.++++||||++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34568999999999999999999999999999999982
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 164 ---------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 164 ---------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+.|...|+.||.|||+++||+||||.+|+|||.+|+|||+|||+++..-.. .
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-G 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc-c
Confidence 347789999999999999999999999999999999999999999754322 2
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
....+.|||+.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+...++..|+-.-..+|
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP------------- 388 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP------------- 388 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC-------------
Confidence 34567899999999999986 7899999999999999999999999999888877777754332222
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYAC 353 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~~~ 353 (634)
..++++++.||..+|..||.+|.. +.||.+|+||....|..
T Consensus 389 ----------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 389 ----------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred ----------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 468999999999999999999974 89999999999877643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.93 Aligned_cols=192 Identities=27% Similarity=0.412 Sum_probs=162.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC-cEEehHH------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKK------------------------------------------ 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-~~vAlK~------------------------------------------ 162 (634)
.+..++|++++.||.|+||.||+|.+..++ ..||+|+
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 445679999999999999999999876655 6788874
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 3468899999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
....++|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.......|
T Consensus 185 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------ 248 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP------------ 248 (340)
T ss_pred ---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 234578999999999976 5688999999999999999999999998887777666654221111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++.+.+||.+||+.||.+|+ |++++++||||....|
T Consensus 249 -----------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 249 -----------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred -----------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 34678899999999999999995 8999999999987654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.16 Aligned_cols=218 Identities=48% Similarity=0.902 Sum_probs=178.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.++||.|+||.||+|.+..+++.|+||+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4799999999999999999999999999999884
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 34578899999999999999999999999999999999999999987543
Q ss_pred CCCC----------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCC
Q 006714 213 TGHR----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282 (634)
Q Consensus 213 ~~~~----------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~p 282 (634)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......++..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2211 112334568889999998765668899999999999999999999999999999999999988888
Q ss_pred CchhhhccCC-CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 283 PDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 283 p~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
++..|..... +..............+...+..+.+.+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 7766654322 111111112223344555667778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=301.16 Aligned_cols=194 Identities=32% Similarity=0.478 Sum_probs=157.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|+++++||+|+||+||+|++..+++.||||+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 79999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC-------
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG------- 214 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~------- 214 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.++|+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 3457889999999999999999999999999999999999999997422100
Q ss_pred -----------------------------------CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC
Q 006714 215 -----------------------------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 259 (634)
Q Consensus 215 -----------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG 259 (634)
........+||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhC
Confidence 0001123478999999999976 6689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc---C
Q 006714 260 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---T 336 (634)
Q Consensus 260 ~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp---T 336 (634)
.+||.+....+....+......... .....++.++.+||.+|+ .+|.+|+ |
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHI-------------------------PSQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccC-------------------------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 9999988776665555331111000 001357888999999977 5999999 9
Q ss_pred HHHHHhccccCCCCC
Q 006714 337 ASAALASEYFSTKPY 351 (634)
Q Consensus 337 a~elL~hpwf~~~~~ 351 (634)
+.++++||||....+
T Consensus 295 ~~ell~h~~~~~~~~ 309 (376)
T cd05598 295 ADEIKAHPFFKGIDF 309 (376)
T ss_pred HHHHhCCCCcCCCCH
Confidence 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=290.77 Aligned_cols=183 Identities=38% Similarity=0.690 Sum_probs=136.7
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCcee----cCCCceEEeccccccccCCCCC--CCcccccccccCCCcccccCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGA 237 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl----~~~g~vkL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~ 237 (634)
+.++.||+.||.|||+++|+|+||||+|||+ +.++.+||+|||++........ .......+|+.|+|||++.+.
T Consensus 111 ~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred HHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCC
Confidence 3578899999999999999999999999999 4567899999999986643221 122345679999999999775
Q ss_pred CCCCCccccccchhhHHHHhhCCCCCCCCCh---------HHHHHHHHHhcCCCCchhhhccCCCC-ccc----CCCCC-
Q 006714 238 TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSKLPH-ATL----FKPQQ- 302 (634)
Q Consensus 238 ~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---------~e~l~~i~~~~g~pp~~~~~~~~l~~-~~~----~~~~~- 302 (634)
..++.++|||||||++|||++|.+||....+ ..++..++..++.+....|....... ... +....
T Consensus 191 ~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (317)
T cd07867 191 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTY 270 (317)
T ss_pred CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhccccc
Confidence 6689999999999999999999999975432 45677788888888887776532110 000 00000
Q ss_pred ---CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 303 ---PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 303 ---~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....+.......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 271 ANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00001111112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=297.93 Aligned_cols=189 Identities=32% Similarity=0.501 Sum_probs=160.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|..+++||+|.||.||+|.+..+++.||+|+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 468899999999999999999999999999997
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++++++.||.|||.++.+|||||+.||||..+|.+||+|||.+.......... .+.
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf 171 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF 171 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence 12367899999999999999999999999999999999999999998776544433 778
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
+||+.|||||++.+ ..|+.++||||||++.+||++|.||+........+..|-+ .+
T Consensus 172 vGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~-------------------- 227 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SA-------------------- 227 (467)
T ss_pred cccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CC--------------------
Confidence 99999999999985 7899999999999999999999999987665322222211 00
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.+.+. ..+++.+++||..||..||+.||+|.+||+|+|++.
T Consensus 228 --PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 228 --PPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred --CCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 11111 267899999999999999999999999999999987
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.79 Aligned_cols=201 Identities=29% Similarity=0.438 Sum_probs=164.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|++..+++.||+|+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 4556899999999999999999999999999999974
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 3457889999999999999999999999999999999999999999866543322
Q ss_pred CcccccccccCCCcccccCC---CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 218 PLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~---~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.....++|+.|+|||++... ..++.++|||||||+||||++|.+||.+.+....+..|+.....++.
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 268 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF---------- 268 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC----------
Confidence 33456789999999998652 23789999999999999999999999998887777777543211110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 351 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~ 351 (634)
.....++..+.+||..||..++.+ |+++.++++|+||...++
T Consensus 269 ---------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 269 ---------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred ---------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 001357889999999999844433 789999999999988554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.23 Aligned_cols=216 Identities=23% Similarity=0.346 Sum_probs=159.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|++++.||+|+||.||+|++..+++.||+|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~ 145 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYT 145 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHH
Confidence 479999999999999999999999999999995
Q ss_pred -------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCC
Q 006714 163 -------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 229 (634)
Q Consensus 163 -------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~ 229 (634)
+..|+.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ......+|+.|+
T Consensus 146 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~ 223 (357)
T PHA03209 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETN 223 (357)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--cccccccccccc
Confidence 45688999999999999999999999999999999999999999987543221 223456899999
Q ss_pred CcccccCCCCCCCccccccchhhHHHHhhCC-CCCCCCC---------hHHHHHHHHHhcCCCCchhhhccCCCCc-cc-
Q 006714 230 PPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHA-TL- 297 (634)
Q Consensus 230 APE~l~~~~~~s~~sDIWSLG~iLyeLltG~-~pf~~~~---------~~e~l~~i~~~~g~pp~~~~~~~~l~~~-~~- 297 (634)
|||++.+ ..++.++|||||||++|||+++. ++|.... ....+..++..++..+..+......... ..
T Consensus 224 aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (357)
T PHA03209 224 APEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFI 302 (357)
T ss_pred CCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHH
Confidence 9999976 56899999999999999999854 4554321 1334455555555544433211000000 00
Q ss_pred ---CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 298 ---FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 298 ---~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.....++..........++.++.+||.+||++||.+|||+.|||+||||++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000001111001111256778899999999999999999999999999975
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=298.34 Aligned_cols=194 Identities=32% Similarity=0.508 Sum_probs=156.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||++++..+++.||||+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC----
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 216 (634)
++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 345789999999999999999999999999999999999999999853211000
Q ss_pred ---------C---------------------------------CcccccccccCCCcccccCCCCCCCccccccchhhHH
Q 006714 217 ---------Q---------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254 (634)
Q Consensus 217 ---------~---------------------------------~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLy 254 (634)
. .....+||+.|+|||++.+ ..++.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhh
Confidence 0 0012468999999999876 67899999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCC
Q 006714 255 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334 (634)
Q Consensus 255 eLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kR 334 (634)
||++|.+||.+.+..+.+..+........ ++ ....++.++.+||.+||. +|.+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~p-----------------~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLY--------FP-----------------DDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccC--------CC-----------------CCCCCCHHHHHHHHHHhc-CHhhc
Confidence 99999999998887777666654211110 00 012467889999999998 77775
Q ss_pred ---cCHHHHHhccccCCCC
Q 006714 335 ---ATASAALASEYFSTKP 350 (634)
Q Consensus 335 ---pTa~elL~hpwf~~~~ 350 (634)
+|+.++|.||||....
T Consensus 294 ~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 294 LGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 5999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.89 Aligned_cols=197 Identities=28% Similarity=0.420 Sum_probs=155.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||++++..+++.||||+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3578999999999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 231 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGT 231 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccccccC
Confidence 35689999999999999999999999999999999999999999997654321 223445789
Q ss_pred ccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 226 LWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 226 ~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..|+|||++.. ...++.++|||||||++|||++|+.||......+....+........
T Consensus 232 ~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 293 (353)
T PLN00034 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP------------------ 293 (353)
T ss_pred ccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC------------------
Confidence 99999998743 12345689999999999999999999974332222221111110000
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
......++.++.+||.+||..||++|||+.|+|+||||.....
T Consensus 294 -------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 294 -------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 0011356788999999999999999999999999999988643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=272.77 Aligned_cols=188 Identities=34% Similarity=0.532 Sum_probs=169.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|-||.||+|+.++++-.||+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45899999999999999999999999999999997
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
...|+.|++.||.|||..+||||||||+|+|++..+.+||+|||.+......
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-- 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-- 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC--
Confidence 2459999999999999999999999999999999999999999999766532
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
...+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||......+.+.+|.+.-...|
T Consensus 178 -kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------- 242 (281)
T KOG0580|consen 178 -KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------- 242 (281)
T ss_pred -CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-------------
Confidence 3367799999999999987 6789999999999999999999999999999999999977543333
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..++..+.|||.+||..+|.+|.+..|++.|||...
T Consensus 243 ----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 ----------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 467899999999999999999999999999999865
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=293.44 Aligned_cols=185 Identities=28% Similarity=0.461 Sum_probs=154.1
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||++++..+++.||+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999999999999985
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......++|+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTP 159 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCc
Confidence 35688999999999999999999999999999999999999999987543221 2223457899
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 160 ~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------------- 213 (328)
T cd05593 160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK------------------------- 213 (328)
T ss_pred CccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc-------------------------
Confidence 9999999876 56899999999999999999999999887766655554321100
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
....++.++.+||.+||..||.+|+ ++.++++||||....|
T Consensus 214 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 214 ----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0135788899999999999999997 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=283.80 Aligned_cols=222 Identities=46% Similarity=0.789 Sum_probs=180.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||+|.+..+++.|+||.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 48899999999999999999998899999875
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKM 159 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-ccc
Confidence 35688999999999999999999999999999999999999999997665432 122
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+..+.+.+.++...++.+....|......... ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 238 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY-VE 238 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc-cc
Confidence 33355788999999876567889999999999999999999999998888888888888888877776543221111 11
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 354 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~ 354 (634)
........+...+...+..+.+||.+||.+||.+|||+.|+|.|+||.+.+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 1111122334455677899999999999999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=297.17 Aligned_cols=196 Identities=31% Similarity=0.491 Sum_probs=159.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC----
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 216 (634)
++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 346889999999999999999999999999999999999999999864421100
Q ss_pred ------------------------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC
Q 006714 217 ------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 266 (634)
Q Consensus 217 ------------------------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~ 266 (634)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCC
Confidence 01123578999999999876 67899999999999999999999999988
Q ss_pred ChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc---CHHHHHhc
Q 006714 267 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALAS 343 (634)
Q Consensus 267 ~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp---Ta~elL~h 343 (634)
+..+.+..+........ + . ....+++++.+||.+|+ .||.+|+ ++.++++|
T Consensus 240 ~~~~~~~~i~~~~~~~~--------------~------p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 240 TPQETYRKVMNWKETLV--------------F------P-----PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CHHHHHHHHHcCCCcee--------------c------C-----CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 88777766653211100 0 0 00236788999999987 5999998 48999999
Q ss_pred cccCCCCCC
Q 006714 344 EYFSTKPYA 352 (634)
Q Consensus 344 pwf~~~~~~ 352 (634)
|||....|.
T Consensus 294 p~f~~~~~~ 302 (360)
T cd05627 294 PFFEGVDWG 302 (360)
T ss_pred CCCCCCCHH
Confidence 999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=290.40 Aligned_cols=222 Identities=36% Similarity=0.612 Sum_probs=176.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.++||+|+||.||++++..+++.||||+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 3689999999999999999999999999999984
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 216 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 163 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence 345788999999999999999999999999999999999999999876543211
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.++.+.+.........
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (336)
T cd07849 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243 (336)
T ss_pred CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhh
Confidence 12233567899999998866566889999999999999999999999998888888888888888776655432211110
Q ss_pred cCCC--CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 297 LFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 297 ~~~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+.. .......+...++.++.++.+||.+||+.||.+|||+.++|+||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 00111122333456788999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=292.57 Aligned_cols=185 Identities=28% Similarity=0.465 Sum_probs=156.0
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ......++|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGT 159 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccC
Confidence 34588899999999999999999999999999999999999999987543221 223445789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 215 (320)
T cd05590 160 PDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----------------------- 215 (320)
T ss_pred ccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----------------------
Confidence 99999999876 678899999999999999999999999988877777764321111
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH------HHHHhccccCCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 351 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa------~elL~hpwf~~~~~ 351 (634)
...++.++.+||.+||+.||.+|+++ .+++.||||....|
T Consensus 216 ------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 216 ------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 12467889999999999999999998 99999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=290.54 Aligned_cols=181 Identities=33% Similarity=0.505 Sum_probs=152.7
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||+|+||+||+|++..+++.||+|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999999999999994
Q ss_pred --------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccC
Q 006714 163 --------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228 (634)
Q Consensus 163 --------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y 228 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ......++|+.|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEY 159 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCccc
Confidence 34588899999999999999999999999999999999999999987543221 222445789999
Q ss_pred CCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchh
Q 006714 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSL 308 (634)
Q Consensus 229 ~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l 308 (634)
+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 160 ~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--------------------------- 211 (312)
T cd05585 160 LAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--------------------------- 211 (312)
T ss_pred CCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC---------------------------
Confidence 99999976 67899999999999999999999999988777666665432111
Q ss_pred hhhcCCCcHHHHHHHHHhhccCcCCCc---CHHHHHhccccCCC
Q 006714 309 RETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTK 349 (634)
Q Consensus 309 ~~~~~~~s~~l~dLL~~mL~~DP~kRp---Ta~elL~hpwf~~~ 349 (634)
....+++.+.+||.+||..||.+|| ++.++|.||||...
T Consensus 212 --~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 212 --FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred --CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0135678899999999999999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.09 Aligned_cols=220 Identities=33% Similarity=0.584 Sum_probs=174.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||+|++..+++.||||.
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 3689999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||+|||.+||+|+||||+|||++.++.++|+|||++.......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 172 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 172 (353)
T ss_pred cEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--
Confidence 23468899999999999999999999999999999999999999997654322
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+...++.++.+++..........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 1234466889999999876 678999999999999999999999999998888899999999988876654422111000
Q ss_pred CCCC--------------CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 298 FKPQ--------------QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~--------------~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.... ..+...........+..+.+||.+||++||.+|||+.|+|.||||..|-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0000 00000000111235677899999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.42 Aligned_cols=198 Identities=28% Similarity=0.448 Sum_probs=159.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||++++..+++.||+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.++|+|||++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 345888999999999999999999999999999999999999999876543322222
Q ss_pred ccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 220 TSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
...++|+.|+|||++.. ...++.++|||||||++|+|++|+.||......+.+..+........
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 228 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ------------ 228 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc------------
Confidence 33468999999999863 24578899999999999999999999998877776666643211110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~ 351 (634)
+......+++.+.+||.+||..++.+ |+++.++|+||||....|
T Consensus 229 ------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 229 ------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred ------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 00111347889999999999765544 889999999999987544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.31 Aligned_cols=196 Identities=36% Similarity=0.561 Sum_probs=173.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|++.+.||.|.||.||+|+++.+|+.+|+|.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3579999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC----CceEEeccccccccCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~----g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++.....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-- 191 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--
Confidence 23478899999999999999999999999999543 4799999999998876
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.++...+.+|...-..++.++|
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w-------- 262 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW-------- 262 (382)
T ss_pred CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc--------
Confidence 345678899999999999975 68999999999999999999999999999999988888776555554444
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
..++..+++||..||..||.+|+|+.++|+|||++.....
T Consensus 263 -----------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 263 -----------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred -----------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 5789999999999999999999999999999999875433
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=280.38 Aligned_cols=212 Identities=39% Similarity=0.695 Sum_probs=172.1
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|+++++||+|+||.||++.+..+++.||+|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+++|+|+||+|+||+++. +.++|+|||++....... ....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~~ 157 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYTE 157 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcCC
Confidence 3568899999999999999999999999999999 999999999997654322 2233
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..++..|+|||++.....++.++|||||||++|||++|.+||.+.+..+.+..+....+.++..+...........+...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 45688999999876545678899999999999999999999999999888898888888877655332221111111111
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......+......++..+.+||.+||.+||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111223344455778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=282.30 Aligned_cols=214 Identities=44% Similarity=0.780 Sum_probs=172.5
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||.|+||.||+|++..+++.||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTH 159 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccccc
Confidence 34578899999999999999999999999999999999999999987554321 12233
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC-CcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~-~~~~~~~ 300 (634)
..+++.|+|||++.+...++.++|||||||++|+|++|..||...++.+.+.++++..+.++...|...... ......+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 456788999999876555788999999999999999999999999988888888888888877666432111 0000000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
. .....+......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 240 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 K-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred c-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 11122334445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.92 Aligned_cols=184 Identities=28% Similarity=0.479 Sum_probs=154.1
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||+|++..+++.||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999984
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCC
Confidence 34588999999999999999999999999999999999999999997543222 223455789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 215 (316)
T cd05592 160 PDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF----------------------- 215 (316)
T ss_pred ccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence 99999999876 568999999999999999999999999888777666654321100
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH-HHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa-~elL~hpwf~~~~ 350 (634)
...++.++.+||.+||..||.+||++ .++++||||....
T Consensus 216 ------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 216 ------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 12467889999999999999999986 5888999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=318.59 Aligned_cols=210 Identities=32% Similarity=0.467 Sum_probs=180.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|+|++.||+|+||.|.+++++.|+++||+|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 4567899999999999999999999999999999998
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.+.....+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 356888999999999999999999999999999999999999999988776666
Q ss_pred CCcccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHh--cCCCCchhhhcc
Q 006714 217 QPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL--CGSPPDDYWKKS 290 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~--~g~pp~~~~~~~ 290 (634)
......+|||-|++||+|.. ...|+..+|+|||||++|||++|..||...+-.+.+-+|+.. ...+|++
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~----- 305 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE----- 305 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc-----
Confidence 66677899999999999852 256899999999999999999999999999999999999875 2223311
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC---HHHHHhccccCCCCCCCCCCCCCCCCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 363 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~elL~hpwf~~~~~~~~~~~~p~~~~ 363 (634)
..+|+++++||+++|+ +|+.|.. ++++-.||||...+|.---...|.|.|
T Consensus 306 ----------------------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 306 ----------------------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred ----------------------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 2489999999999884 7888888 999999999999988543334444433
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.74 Aligned_cols=185 Identities=29% Similarity=0.463 Sum_probs=156.0
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||+|++..+++.||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999984
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.++|+|||++....... ......++|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGT 159 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccccC
Confidence 34578999999999999999999999999999999999999999987543221 222445689
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.......+
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p---------------------- 216 (321)
T cd05591 160 PDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP---------------------- 216 (321)
T ss_pred ccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------------------
Confidence 99999999876 6789999999999999999999999999888887777654211111
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCc-------CHHHHHhccccCCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRA-------TASAALASEYFSTKPY 351 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-------Ta~elL~hpwf~~~~~ 351 (634)
..++.++.+||.+||..||.+|+ ++.++++||||....|
T Consensus 217 -------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 217 -------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred -------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 23678899999999999999999 9999999999977543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=281.20 Aligned_cols=217 Identities=41% Similarity=0.771 Sum_probs=172.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||.|+||+||++.+..+++.||||.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4789999999999999999999998999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........ ....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSN 162 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cccc
Confidence 355788999999999999999999999999999999999999999875432211 1122
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC-hHHHHHHHHHhcCCCCchhhhccCCCCc-ccCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-~~e~l~~i~~~~g~pp~~~~~~~~l~~~-~~~~ 299 (634)
..++..|+|||++.+...++.++|||||||++|+|++|.+||.... ..+.+..+.+..+.+....|........ ....
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 3457889999998765668899999999999999999999998766 5677778888888888777765332111 1111
Q ss_pred CCCCCCchhhhhcCCCc--HHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s--~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
........+...+..++ ..+.+||.+||++||.+|||+.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11111222334444555 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=289.23 Aligned_cols=190 Identities=29% Similarity=0.478 Sum_probs=160.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||+||+|++..+++.||||+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 48899999999999999999999999999994
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTR 159 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cccc
Confidence 34588999999999999999999999999999999999999999987543221 1223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.......+
T Consensus 160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----------------- 221 (323)
T cd05615 160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----------------- 221 (323)
T ss_pred CccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 4568999999999876 6689999999999999999999999999888777777654221111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
..++.++.+||.+||..||.+|++ ..++++||||....|
T Consensus 222 ------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 222 ------------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred ------------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 346788999999999999999997 589999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=289.25 Aligned_cols=219 Identities=25% Similarity=0.335 Sum_probs=159.6
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||.||++++..++..||+|+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 345799999999999999999999999999999984
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+. +|+|+||||+|||++.++.++|+|||++...... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence 346888999999999986 6999999999999999999999999998755432 1
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc-CCCCc--
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHA-- 295 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~-~l~~~-- 295 (634)
.....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...........+... .....
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 234568999999999976 56899999999999999999999999877655433322111100000000000 00000
Q ss_pred ccC----CCCCCCCc---hh----h---h--hcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 TLF----KPQQPYDS---SL----R---E--TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~~~----~~~~~~~~---~l----~---~--~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
... ....+... .+ . . ....+++++++||.+||.+||++|||+.+||+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 00000000 00 0 0 012467889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-33 Score=296.09 Aligned_cols=218 Identities=34% Similarity=0.604 Sum_probs=178.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++.-.+|+|....|+|-|++|.+|+|...+..||||+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 3445799999999999999999999999999999997
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEecccccccc
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFS 211 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~ 211 (634)
|+.|++||+.||..|-..||+|.||||+|||+++. ..+||||||.|.+.
T Consensus 508 HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 45699999999999999999999999999999875 46899999999887
Q ss_pred CCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.... .+.+.....|+|||++++ ..|+...|+||+||+||||+||+.+|+|.++..++..++++-|.+|........
T Consensus 588 ~ene---itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 588 SENE---ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cccc---ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 6543 356677889999999998 789999999999999999999999999999999999999999999976655432
Q ss_pred CCCccc----------------------CCCCCCCCchhhhhcC---CC-------cHHHHHHHHHhhccCcCCCcCHHH
Q 006714 292 LPHATL----------------------FKPQQPYDSSLRETFK---DL-------PTTAVNLIETLLSVEPYKRATASA 339 (634)
Q Consensus 292 l~~~~~----------------------~~~~~~~~~~l~~~~~---~~-------s~~l~dLL~~mL~~DP~kRpTa~e 339 (634)
+...-+ +....| ...+...+. .+ -..+.+||.+||.+||++|+|+.+
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkP-tkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKP-TKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCc-chhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 211100 000001 011111111 12 245899999999999999999999
Q ss_pred HHhccccCC
Q 006714 340 ALASEYFST 348 (634)
Q Consensus 340 lL~hpwf~~ 348 (634)
+|.||||+.
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999975
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=290.93 Aligned_cols=184 Identities=29% Similarity=0.464 Sum_probs=154.8
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||++++..+++.||+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999999999999999985
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... .......+|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCc
Confidence 35688999999999999999999999999999999999999999987532221 2223456899
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.......
T Consensus 160 ~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------ 214 (323)
T cd05595 160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------------------ 214 (323)
T ss_pred CcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------------------
Confidence 9999999876 578999999999999999999999998887776666654321111
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 350 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~ 350 (634)
...+++++.+||.+||..||.+|+ ++.++|+|+||....
T Consensus 215 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 215 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 135688999999999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=289.81 Aligned_cols=198 Identities=26% Similarity=0.418 Sum_probs=160.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||++++..+++.||+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999999999999984
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 345788999999999999999999999999999999999999999875543322222
Q ss_pred ccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 220 TSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
...+||+.|+|||++.. ...++.++|||||||+||||++|+.||...+..+.+..+.......+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 228 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ------------ 228 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc------------
Confidence 34578999999999862 34578999999999999999999999998887777776654211110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~ 351 (634)
+......+++++.+||.+||..++.+ |+++.++++||||....|
T Consensus 229 ------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 229 ------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred ------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 00112357889999999999765554 789999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=295.01 Aligned_cols=192 Identities=31% Similarity=0.562 Sum_probs=173.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.-|.+.+.||+|.|..|-+|++.-||..||||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 468899999999999999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee-cCCCceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl-~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
.++|+.||+.|+.|||+..+|||||||+||.+ ..-|.+||.|||++..+..+ ..+
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL 175 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKL 175 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--chh
Confidence 36799999999999999999999999999876 55689999999999877654 456
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
++.||.+.|.|||+|++.....+++||||||||||.|++|++||+..++.+.+.+|+.+-...|
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP---------------- 239 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP---------------- 239 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----------------
Confidence 7889999999999999977667899999999999999999999999999999999988765555
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
..++.++++||..||..||.+|.+.++|..|+|++....+
T Consensus 240 -------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 240 -------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred -------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 3678999999999999999999999999999999876443
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=291.52 Aligned_cols=185 Identities=26% Similarity=0.457 Sum_probs=154.0
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||++++..+++.||+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999999999999985
Q ss_pred ----------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGT 159 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCC
Confidence 34588999999999997 799999999999999999999999999987543221 122345689
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+....+.......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 215 (325)
T cd05594 160 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----------------------- 215 (325)
T ss_pred cccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCC-----------------------
Confidence 99999999876 578999999999999999999999998877766655553211111
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
...+++++.+||.+||..||.+|+ ++.++|+||||....+
T Consensus 216 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 216 ------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 134678899999999999999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=289.77 Aligned_cols=184 Identities=28% Similarity=0.428 Sum_probs=154.8
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-CccccccCC
Confidence 34588999999999999999999999999999999999999999987533221 223445789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------------ 214 (323)
T cd05575 160 PEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR------------------------ 214 (323)
T ss_pred hhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC------------------------
Confidence 99999999876 67899999999999999999999999988777766666432100
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH----HHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~elL~hpwf~~~~ 350 (634)
....++..+.+||.+||+.||.+||++ .+++.||||....
T Consensus 215 -----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 215 -----LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 113568889999999999999999997 6999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=293.97 Aligned_cols=220 Identities=24% Similarity=0.348 Sum_probs=166.4
Q ss_pred CCCeeEEEEecccCceeEEEEEEC--CCCcEEehHH--------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDL--DTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~--~tg~~vAlK~-------------------------------------------- 162 (634)
..+|++++.||.|+||.||+|... .+++.|++|.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCC
Confidence 358999999999999999999764 3567788885
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-Cccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVT 225 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt 225 (634)
+..|+.||+.||.|||++||+||||||+||||+.++.++|+|||++......... ......+|
T Consensus 171 ~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt 250 (392)
T PHA03207 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250 (392)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccc
Confidence 3568899999999999999999999999999999999999999999765433221 22345789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhccCCCC-------c
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPH-------A 295 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~~~l~~-------~ 295 (634)
+.|+|||++.. ..|+.++|||||||+||||++|+.||.+.. ....+..+++.++..+.++........ .
T Consensus 251 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (392)
T PHA03207 251 LETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYA 329 (392)
T ss_pred cCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhc
Confidence 99999999876 668999999999999999999999997643 456677777777665544322110000 0
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
...++.......+. -..++.++.+||.+||.+||.+|||+.|+|.||||...|+
T Consensus 330 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 330 IVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00011011111111 1245778999999999999999999999999999988654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=277.96 Aligned_cols=215 Identities=39% Similarity=0.732 Sum_probs=169.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++..||+|+||.||++++..+++.||+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+++|+|+||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 456899999999999999999999999999999999999999999986644321 1223
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchh---hhccCCCCcccC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY---WKKSKLPHATLF 298 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~---~~~~~l~~~~~~ 298 (634)
..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+...... +...... ....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF-KGLS 238 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc-cccc
Confidence 45678899999987656688999999999999999999999998888777777766555433221 1110100 0011
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.+.......+...+..++..+.+||.+||..||++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 111111223444566789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=289.10 Aligned_cols=184 Identities=28% Similarity=0.469 Sum_probs=153.1
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||+|++..+++.||+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999984
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .......++|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccCCC
Confidence 3457889999999999999999999999999999999999999998643221 1223456789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~----------------------- 215 (316)
T cd05620 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY----------------------- 215 (316)
T ss_pred cCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------------
Confidence 99999999976 678999999999999999999999999887766666553211000
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH-HHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa-~elL~hpwf~~~~ 350 (634)
...++.++.+||.+||..||.+|+++ +++++||||....
T Consensus 216 ------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 216 ------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 12367889999999999999999998 5888999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=280.24 Aligned_cols=216 Identities=48% Similarity=0.844 Sum_probs=173.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||++.+..+++.||||+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999995
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANF 210 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~ 210 (634)
+..++.||+.||.|||+++|+|+||+|+|||++. ++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 2347889999999999999999999999999998 88999999999875
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
..... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..++..++.++...|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 53321 11223356888999999876566889999999999999999999999999999988899888888777666432
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.........+.. ....+....+.++..+.+||.+||..||.+|||+.|+|.||||+
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111110000110 11223344467899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=280.46 Aligned_cols=219 Identities=46% Similarity=0.811 Sum_probs=176.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|.||+||++.+..+++.||+|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 589999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.++.||+.||+|||+++|+|+||+|+|||++. ++.+||+|||++....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTF 160 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-ccc
Confidence 2357789999999999999999999999999985 4579999999997554321 122
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC-CCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~-l~~~~~~ 298 (634)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++...+.+....|.... ++.....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 334568899999998765568899999999999999999999999998888888999888888888876422 1111111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+.. ....+....+.+++.+.+||.+||+.||++||++.++|.||||....
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1111 11223333456889999999999999999999999999999998754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=291.53 Aligned_cols=184 Identities=29% Similarity=0.446 Sum_probs=153.2
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||+|+||+||+|++..+++.||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.++|+|||++....... ......++|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGT 159 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCccCC
Confidence 34588899999999999999999999999999999999999999987543221 223456789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 217 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP---------------------- 217 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC----------------------
Confidence 9999999997655689999999999999999999999988877666655532111110
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCc----CHHHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp----Ta~elL~hpwf~~~~ 350 (634)
...+++++.+||.+||..||.+|| ++.++++||||....
T Consensus 218 ------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 ------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred ------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 023678899999999999999998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=283.08 Aligned_cols=216 Identities=50% Similarity=0.873 Sum_probs=177.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||+|.+..+++.|++|.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 589999999999999999999998999998874
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... ...
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~ 163 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPY 163 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-ccc
Confidence 34688999999999999999999999999999999999999999987665432 222
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC-CCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~-l~~~~~~ 298 (634)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||......+.+.+++..++.+....|.... ++.....
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 334568889999998765567899999999999999999999999999999999999999988888776532 2222211
Q ss_pred CCCCCCCchhhhhcCC--CcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 299 KPQQPYDSSLRETFKD--LPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~--~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.........+...++. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111122233444444 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=281.40 Aligned_cols=219 Identities=50% Similarity=0.926 Sum_probs=178.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||.|+||+||++.+..+++.||+|.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45789999999999999999999999999999875
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 34577899999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 210 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
...............+..|++||.+.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 66543322223345577899999887655678899999999999999999999999888899999999888888777654
Q ss_pred cCC-CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 290 SKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 290 ~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
... +..............+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 322 111111112222234455566789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=281.21 Aligned_cols=218 Identities=45% Similarity=0.772 Sum_probs=172.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||.||+|.+..+++.||||.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4689999999999999999999999999999984
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 35688899999999999999999999999999999999999999997654
Q ss_pred CCCC---CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 213 TGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 213 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++..+.+.|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1122345678899999987655678899999999999999999999999988888888888888888776654
Q ss_pred cCCCCc-ccCCCCCCCCchhhhhc--CCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 290 SKLPHA-TLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 290 ~~l~~~-~~~~~~~~~~~~l~~~~--~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
...... ..+.............+ ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 321110 00110111111111111 1235778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=301.87 Aligned_cols=217 Identities=26% Similarity=0.368 Sum_probs=159.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
...|.+.+.||+|+||.||++++..+++.||||.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~ 247 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLY 247 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHH
Confidence 3579999999999999999999999999999994
Q ss_pred --------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-Cccccccccc
Q 006714 163 --------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLW 227 (634)
Q Consensus 163 --------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~ 227 (634)
+..|+.||+.||.|||++||+||||||+||||+.++.++|+|||+++........ .....++|+.
T Consensus 248 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 327 (461)
T PHA03211 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327 (461)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcC
Confidence 3568999999999999999999999999999999999999999999765432211 1224568999
Q ss_pred CCCcccccCCCCCCCccccccchhhHHHHhhCCCCC-CCC------ChHHHHHHHHHhcCCCCchhhhc--------cCC
Q 006714 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGR------TEVEQLHKIFKLCGSPPDDYWKK--------SKL 292 (634)
Q Consensus 228 Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf-~~~------~~~e~l~~i~~~~g~pp~~~~~~--------~~l 292 (634)
|+|||++.+ ..++.++||||||||||||++|..++ ... ....++.+++........++-.. ...
T Consensus 328 Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~ 406 (461)
T PHA03211 328 TNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH 406 (461)
T ss_pred CcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh
Confidence 999999976 56899999999999999999987544 322 11334455554433322211100 000
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.......+. +.......+..++..+.+||.+||++||.+|||+.|||+||||+.
T Consensus 407 ~~~~~~~~~--~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 407 RAARNRRPA--YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhhcccCCc--cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000 011111222356778999999999999999999999999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=281.75 Aligned_cols=194 Identities=27% Similarity=0.462 Sum_probs=159.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++.++||+|+||+||++.+..+++.||+|+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999884
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+.+|+|+||||+|||+++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--cc
Confidence 34578899999999999999999999999999999999999999987654322 22
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+.
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 222 (285)
T cd05605 159 RGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE--------------- 222 (285)
T ss_pred ccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc---------------
Confidence 34567899999999876 56889999999999999999999999887655444443322111110
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 352 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~~ 352 (634)
.....++..+.+||.+||..||.+|| ++.+++.||||....+.
T Consensus 223 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 223 ----------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ----------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 01134788899999999999999999 99999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=286.18 Aligned_cols=229 Identities=45% Similarity=0.837 Sum_probs=184.0
Q ss_pred CCeeEE-EEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
++|.++ +.||.|+||+||+|++..+++.||||+
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 578754 679999999999999998999998882
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 23578899999999999999999999999999999999999999987
Q ss_pred ccCCC-------------CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHH
Q 006714 210 FSNTG-------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 210 ~~~~~-------------~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~ 276 (634)
..... .........++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55411 01112233457889999998775567899999999999999999999999999999999999
Q ss_pred HhcCCCCchhhhccCC-CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCC
Q 006714 277 KLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 355 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~ 355 (634)
..++.++...|..... +....+.. .....+...+...+..+.+||.+||..||++|||++++|.||||+..+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~ 325 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTP--RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDP 325 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCc--CCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCc
Confidence 9998888776654321 11111111 11223344556778999999999999999999999999999999999888877
Q ss_pred CCCCC
Q 006714 356 SSLPI 360 (634)
Q Consensus 356 ~~~p~ 360 (634)
.++|.
T Consensus 326 ~~~~~ 330 (335)
T PTZ00024 326 SQLPF 330 (335)
T ss_pred ccCCh
Confidence 66654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=274.95 Aligned_cols=217 Identities=38% Similarity=0.704 Sum_probs=173.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||+|.+..+++.|++|.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 379999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 34588899999999999999999999999999999999999999988765443323345
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC-ccc-CC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATL-FK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~-~~~-~~ 299 (634)
..++..|+|||++.....++.++|||||||++|+|++|.+||.+....+.+..+...++..+...+....... ... ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 5678899999999875478899999999999999999999999988888888888777776655443221100 000 00
Q ss_pred CCCCCCchhhhhcCC-CcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~-~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
+.......+...+.. ++.++.+||.+||..||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 111111222333333 48999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=277.00 Aligned_cols=215 Identities=60% Similarity=1.068 Sum_probs=179.3
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++++.||.|+||.||++.+..+++.||+|.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999998898898875
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||..+++|+||+|+|||++.++.++|+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 34588899999999999999999999999999999999999999998665433222334
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC-CCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l-~~~~~~~~ 300 (634)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||...+....+..+...++.++...|..... .....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 45688899999887656688999999999999999999999999998899999999988888777765322 22223333
Q ss_pred CCCCCchhhhhcCCC-cHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 301 QQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~-s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.......+...+..+ +..+.+||.+||..||.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 344444555566665 8999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.58 Aligned_cols=216 Identities=37% Similarity=0.697 Sum_probs=171.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||.||+|.+..+++.||+|.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999998999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 34578899999999999999999999999999999999999999987654332 22334
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC--CcccCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP--HATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~--~~~~~~ 299 (634)
..++..|+|||++.+...++.++|||||||++|+|++|.+||......+.+..+....+............. ......
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 567889999999876556788999999999999999999999988888888888776665443211110000 000111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
+.......+...++.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 11222233445567889999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=275.52 Aligned_cols=192 Identities=31% Similarity=0.503 Sum_probs=156.6
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++.+.||+|+||+||++++..+++.||+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999996
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.+||+++|+|+||||+|||++.++.++|+|||++..... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 467899999999999999999999999999999999999999999875421 223334567
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
++..|+|||++.....++.++|||||||++|+|++|..||...........+...........+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 223 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------------- 223 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc----------------
Confidence 7899999999873367899999999999999999999999987544444444333221111100
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......+..+.+||..||+.||.+|||+.++++||||
T Consensus 224 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 ------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001224789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=286.59 Aligned_cols=221 Identities=38% Similarity=0.680 Sum_probs=180.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||.|+||.||++++..+++.||+|+
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 4689999999999999999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-- 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-- 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--
Confidence 2347789999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+++.++.........
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 234466889999999876456789999999999999999999999999888889999998888887776544322111
Q ss_pred cCCCC--CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 297 LFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 297 ~~~~~--~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
.+... ......+...+..+++.+.+||.+||+.||.+|||+.+||.||||..+..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 11000 0111223344456789999999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=286.97 Aligned_cols=198 Identities=27% Similarity=0.425 Sum_probs=160.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||++++..+++.||+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999984
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 345788999999999999999999999999999999999999999976543322222
Q ss_pred ccccccccCCCcccccCC----CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 220 TSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~----~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
...++|+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+..+.+..+......++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 228 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ------------ 228 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc------------
Confidence 335689999999988642 3578899999999999999999999998877776666643211110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~ 351 (634)
+...+..+++++.+||.+||..++.+ |++++++++||||....|
T Consensus 229 ------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 229 ------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred ------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 00112357889999999999976655 579999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=287.02 Aligned_cols=223 Identities=35% Similarity=0.611 Sum_probs=180.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||++.+..+++.||+|+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 216 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 356788999999999999999999999999999999999999999875543221
Q ss_pred -CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 -~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......++..|+|||++.....++.++|||||||++|+|++|++||.+.+...++..+....+.++...+........
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~ 244 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence 1123446788999999986655688999999999999999999999999998889999999999888776543221111
Q ss_pred ccC--CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 296 TLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 296 ~~~--~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
... .........+...++.+++.+.+||.+||+.||.+|||+.++|.||||...+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 000 000111112334456779999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=303.54 Aligned_cols=192 Identities=26% Similarity=0.403 Sum_probs=161.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34799999999999999999999999999999995
Q ss_pred -----------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccc
Q 006714 163 -----------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 -----------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 123678999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchh
Q 006714 208 ANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 208 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~ 286 (634)
++...... .......+||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.+..+.+..+......+
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---- 264 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP---- 264 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC----
Confidence 87654321 122344678999999999976 668999999999999999999999999887776666654321110
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 287 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....+++++.+||..||+.||.+||++.++|+|||++.
T Consensus 265 ------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 ------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 11357889999999999999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=277.10 Aligned_cols=215 Identities=40% Similarity=0.763 Sum_probs=175.3
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|+++++||.|+||.||+|++..+++.||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 159 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSN 159 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cccc
Confidence 345889999999999999999999999999999999999999999875543221 1233
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..++..|++||++.+...++.++|||+|||++|+|++|.+||.+.+..+.+..++.....+....|..............
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 45688899999987656678999999999999999999999999998899999998888888777765432211111111
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
..........++.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111122334445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=285.87 Aligned_cols=222 Identities=39% Similarity=0.623 Sum_probs=178.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|.+++.||.|+||+||++++..+++.||||.
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 589999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 163 (337)
T cd07858 85 YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-D 163 (337)
T ss_pred EEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-c
Confidence 24578899999999999999999999999999999999999999997654322 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......++..|+|||.+.....++.++|||||||++|+|++|++||.+.+....+..+....+.++...|..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 23345678899999988754568899999999999999999999999988888888888888888766553322111110
Q ss_pred CCC--CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 298 FKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 298 ~~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
+.. .......+...++.+++.+.+||.+||+.||.+|||+.++|+||||....-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 0001112334456789999999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=284.77 Aligned_cols=217 Identities=38% Similarity=0.664 Sum_probs=176.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|.+...||+|+||.||+|++..+++.||||+
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 689999999999999999999998999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 170 (342)
T ss_pred EEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----
Confidence 2347789999999999999999999999999999999999999998754321
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....++..|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+...+++.........+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07879 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250 (342)
T ss_pred CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence 23346688899999987655688999999999999999999999999888888888888888777766654332211111
Q ss_pred CC--CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 299 KP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 299 ~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.. .......+...++.++..+.+||.+||+.||.+|||+.++|.||||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 01112223344566788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=286.44 Aligned_cols=184 Identities=28% Similarity=0.420 Sum_probs=154.8
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||+|+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++....... ......++|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCC
Confidence 34578999999999999999999999999999999999999999987543221 223455789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------------------ 214 (325)
T cd05602 160 PEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------------------------ 214 (325)
T ss_pred ccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC------------------------
Confidence 99999999876 67889999999999999999999999988877777666442110
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH----HHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATAS----AALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~----elL~hpwf~~~~ 350 (634)
....++..+.+||.+||+.||.+|+++. ++++|+||....
T Consensus 215 -----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 215 -----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred -----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 1135788899999999999999999875 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=276.08 Aligned_cols=214 Identities=42% Similarity=0.750 Sum_probs=166.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|.+++.||+|+||.||+|.+..+++.|++|.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 689999999999999999999999999999985
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
++.++.||+.||.|||.++|+|+||||+|||++.++.++|+|||++....... ......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 163 (291)
T cd07870 85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSE 163 (291)
T ss_pred ccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCCCc
Confidence 34578899999999999999999999999999999999999999987543321 112334
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC-hHHHHHHHHHhcCCCCchhhhccCCCCc---ccC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHA---TLF 298 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-~~e~l~~i~~~~g~pp~~~~~~~~l~~~---~~~ 298 (634)
.+++.|+|||++.+...++.++|||||||++|+|++|.+||.... ..+.+..+....+.|.+..|........ ..+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 568899999998765567889999999999999999999997654 4566777777777777665543221110 001
Q ss_pred CCCCCCCchhhhhcC--CCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 299 KPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~--~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
... ....+...+. ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 244 ~~~--~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 244 LPC--KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccc--CCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0111222222 236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=284.41 Aligned_cols=185 Identities=32% Similarity=0.533 Sum_probs=153.1
Q ss_pred EEEecccCceeEEEEEEC---CCCcEEehHH-------------------------------------------------
Q 006714 135 LEKIGQGTYSSVFRARDL---DTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 135 ~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~------------------------------------------------- 162 (634)
++.||+|+||.||++++. .+++.||+|+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 4688899884
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++....... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT 159 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccccc
Confidence 23478899999999999999999999999999999999999999987543221 22234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.++|+.|+|||++.+ ..++.++|||||||++|||++|.+||...+....+..+......
T Consensus 160 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~-------------------- 218 (323)
T cd05584 160 FCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN-------------------- 218 (323)
T ss_pred cCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 578999999999876 56789999999999999999999999988877766666432111
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 350 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~ 350 (634)
....+++.+.+||.+||..||++|| ++.+++.||||....
T Consensus 219 ---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 219 ---------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ---------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 1134678899999999999999999 899999999998743
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=275.84 Aligned_cols=214 Identities=46% Similarity=0.806 Sum_probs=172.1
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++++.||.|++|.||++.+..++..|++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 7789999999999999999999999999984
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+++++|+||+|+|||++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 159 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHE 159 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCcc
Confidence 345888999999999999999999999999999999999999999875543211 12233
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
.++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+.++++..+.+....|...............
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 55888999998876556788999999999999999999999999888888888888888887776543221110000000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
............++..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01112233446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=279.09 Aligned_cols=188 Identities=27% Similarity=0.418 Sum_probs=151.0
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||+|+||+||++.+..+++.||+|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999985
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........ ......+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCC
Confidence 245788999999999999999999999999999999999999999876543222 2234567
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......+.
T Consensus 160 ~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------- 218 (280)
T cd05608 160 TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-------------------- 218 (280)
T ss_pred CcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--------------------
Confidence 899999999986 57889999999999999999999999865433222222211111100
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 352 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~~ 352 (634)
.....++..+.+||.+||+.||++|| |++++++||||+...+.
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 219 -----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred -----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 01135788999999999999999999 89999999999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=284.84 Aligned_cols=185 Identities=30% Similarity=0.508 Sum_probs=153.8
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999994
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ......++|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCC
Confidence 34588999999999999999999999999999999999999999987532211 122345689
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +.
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~---------------------- 214 (316)
T cd05619 160 PDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC---------------------- 214 (316)
T ss_pred ccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC----------------------
Confidence 99999999876 568999999999999999999999999887766665553211 00
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH-HHHhccccCCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 351 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~-elL~hpwf~~~~~ 351 (634)
....++.++.+||.+||..||.+||++. +++.||||....+
T Consensus 215 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 215 -----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 0023677899999999999999999996 8999999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=303.53 Aligned_cols=217 Identities=24% Similarity=0.370 Sum_probs=158.0
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCC----CcEEehHH---------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT----GKIVALKK--------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~t----g~~vAlK~--------------------------------------- 162 (634)
.+..++|++.++||+|+||.||+|++..+ +..||+|+
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence 34578999999999999999999999888 88888883
Q ss_pred -------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCce
Q 006714 163 -------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 193 (634)
Q Consensus 163 -------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NIL 193 (634)
+..++.||+.||.|||+++|+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 1146788999999999999999999999999
Q ss_pred ecC-CCceEEeccccccccCCCCCCCcccccccccCCCcccccCCC---------------------CCCCccccccchh
Q 006714 194 VNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---------------------DYGPSVDLWSVGC 251 (634)
Q Consensus 194 l~~-~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---------------------~~s~~sDIWSLG~ 251 (634)
|+. ++.+||+|||++..............++++.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 985 578999999999765443333345567899999999763211 2345679999999
Q ss_pred hHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCc
Q 006714 252 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331 (634)
Q Consensus 252 iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP 331 (634)
|||||+++.. ........+..++..++.....+..... .. .. +......+.+......+.+||.+||++||
T Consensus 368 iL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~---~~---~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 368 IFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLVAWRKLVE-PR---AS---PDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHhCcC--CCchHHHHHHHHHHhcCCcHHHHHHhhc-cc---cc---hhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999998554 4445555566666555443322221111 00 00 00001112223345567899999999999
Q ss_pred CCCcCHHHHHhccccCCCCC
Q 006714 332 YKRATASAALASEYFSTKPY 351 (634)
Q Consensus 332 ~kRpTa~elL~hpwf~~~~~ 351 (634)
.+|||+.++|+||||+....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999987643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=272.91 Aligned_cols=194 Identities=27% Similarity=0.391 Sum_probs=165.1
Q ss_pred CCCeeEE-EEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
.++|.|- .+||-|-.|.|..+.++.|++.+|+|+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 3577776 679999999999999999999999998
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~ 216 (634)
+-.|++||..|+.|||+.+|.||||||+|+|... +..+||+|||+|+.....
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-- 217 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-- 217 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC--
Confidence 2359999999999999999999999999999954 457999999999866532
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh----HHHHHHHHHhcCCCCchhhhccCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~----~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
..+.+.|.|++|.|||++-. ..|+..+|+||||||+|-||+|.|||..... ...-.+|......+|++.|
T Consensus 218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW----- 291 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW----- 291 (400)
T ss_pred ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH-----
Confidence 34466788999999998854 6799999999999999999999999976543 3445566555556666655
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..++++++|||+.||..+|.+|.|+.++++|||++...
T Consensus 292 --------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 292 --------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred --------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 46899999999999999999999999999999998754
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=285.02 Aligned_cols=185 Identities=28% Similarity=0.482 Sum_probs=154.7
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999984
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ......+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGT 159 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecC
Confidence 34588899999999999999999999999999999999999999986532221 122345689
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~----------------------- 215 (318)
T cd05570 160 PDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY----------------------- 215 (318)
T ss_pred ccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence 99999999976 678999999999999999999999999887766666553311000
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH-----HHHHhccccCCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPY 351 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa-----~elL~hpwf~~~~~ 351 (634)
...++..+.+||.+||..||.+|||+ .+++.||||....|
T Consensus 216 ------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 216 ------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 12467889999999999999999999 99999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=285.77 Aligned_cols=184 Identities=27% Similarity=0.393 Sum_probs=153.9
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCC
Confidence 35588999999999999999999999999999999999999999987532211 222455789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.....
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~------------------------- 213 (325)
T cd05604 160 PEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL------------------------- 213 (325)
T ss_pred hhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-------------------------
Confidence 99999999876 6688999999999999999999999998877776666543110
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH----HHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~elL~hpwf~~~~ 350 (634)
...+.++..+.+||.+||..||.+||++ .+++.||||....
T Consensus 214 ----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 214 ----VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ----cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0013467889999999999999999976 6999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.49 Aligned_cols=218 Identities=38% Similarity=0.684 Sum_probs=176.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++.+..+++.||||+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4789999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-- 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-- 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--
Confidence 2347889999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.....+++.|++||.+.+...++.++|||||||++|+|++|.+||...+....+..++...+.++.+++.........
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred --ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 123456889999999876456889999999999999999999999998888888888887777776665443221111
Q ss_pred cCCCC--CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 297 LFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 297 ~~~~~--~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+... ......+......++..+.+||.+||+.||.+|||+.++|.||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 10000 0011123344567888999999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.92 Aligned_cols=185 Identities=27% Similarity=0.450 Sum_probs=147.7
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999885
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCC
Confidence 34588899999999999999999999999999999999999999987532211 122345789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---------hHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---------~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.....
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------------- 222 (329)
T cd05618 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------------- 222 (329)
T ss_pred ccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------------
Confidence 99999999976 678899999999999999999999995311 1111111111000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC------HHHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT------a~elL~hpwf~~~~~ 351 (634)
.....++..+.+||.+||+.||.+||| +.++++||||....|
T Consensus 223 -------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 223 -------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 011356788999999999999999998 589999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=281.32 Aligned_cols=220 Identities=41% Similarity=0.667 Sum_probs=180.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||+|++..+++.|+||+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58999999999999999999998899999984
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 216 (634)
+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 234788999999999999999999999999999999999999999986654321
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.++.+.|.........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence 12344567889999999987547899999999999999999999999999999999999999988887766532222111
Q ss_pred cCC--CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 297 LFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 297 ~~~--~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+. ........+...+..++..+.+||.+||++||.+|||+.++|.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 110 111112234455667899999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=265.81 Aligned_cols=194 Identities=27% Similarity=0.446 Sum_probs=161.4
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++.+++..||.|+.|+||+++.+.+|..+|||+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 34678899999999999999999999999999997
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+-++...++.||.||.++ +|||||+||+|||||..|++||||||++-...+.. .
T Consensus 170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A 247 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A 247 (391)
T ss_pred HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence 112455678999999976 99999999999999999999999999997665432 2
Q ss_pred cccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCC-CChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 219 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.+...|.+.|||||.+.- ...|+..+||||||++|+||.||+.||.+ .++.+.+.++.+. .||.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~----------- 314 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL----------- 314 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC-----------
Confidence 244578899999999842 35689999999999999999999999987 4677888888662 2220
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.++. ..+++.+.+|+..||..|+.+||...++|+|||+..+
T Consensus 315 ------L~~~-------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 315 ------LPGH-------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ------CCcc-------cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 0111 2489999999999999999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=278.97 Aligned_cols=195 Identities=30% Similarity=0.484 Sum_probs=172.2
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHHH-------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI------------------------------------------- 163 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i------------------------------------------- 163 (634)
+.+.+|.++.+||+|+||.|.++..+.+.+.||||++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4456899999999999999999999999999999981
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 164 ---------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 164 ---------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
.-|+.+|+-||-|||++|||+||||.+||||+.+|+|||+|||+++.--.+ .
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-G 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-C
Confidence 237788999999999999999999999999999999999999999754332 2
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
....+.|||+.|+|||++.- .+|+.++|+||+||+|||||.|++||.+.++.++++.|++..-..|
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP------------- 570 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP------------- 570 (683)
T ss_pred cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc-------------
Confidence 34467899999999999874 7899999999999999999999999999999999999987544433
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH-----HHHHhccccCCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYA 352 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa-----~elL~hpwf~~~~~~ 352 (634)
+.++.++.+++..+|...|.+|..+ .+|-.||||+...|.
T Consensus 571 ----------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 571 ----------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 5789999999999999999999864 689999999987764
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=277.92 Aligned_cols=192 Identities=27% Similarity=0.474 Sum_probs=154.3
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++.+.||+|+||+||++.+..+++.||+|.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999874
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cc
Confidence 24578899999999999999999999999999999999999999987654322 12
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...............+...+.
T Consensus 159 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------- 222 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE--------------- 222 (285)
T ss_pred cCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh---------------
Confidence 34467999999999976 56899999999999999999999999865432211111111100000
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKP 350 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~ 350 (634)
.....+++++.+||.+||+.||.+||| +.|+++||||....
T Consensus 223 ----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 223 ----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred ----------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 011356788999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=282.63 Aligned_cols=221 Identities=35% Similarity=0.590 Sum_probs=168.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||.|+||.||+|.+..+++.||+|+
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 589999999999999999999999999999874
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANF 210 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~ 210 (634)
++.++.||+.||.|||++||+|+||||+|||++. ++.++|+|||++..
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccccee
Confidence 2346789999999999999999999999999974 55789999999875
Q ss_pred cCCCCC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhh
Q 006714 211 SNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 211 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~ 288 (634)
...... .......++..|+|||++.....++.++|||||||++|+|++|+.||...+..+.+..+...........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07854 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244 (342)
T ss_pred cCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 532111 111233568889999987665668899999999999999999999999888887777776654433332222
Q ss_pred ccCCC-CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 289 KSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 289 ~~~l~-~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..... ..............+...+..++.++.+||.+||+.||.+|||+.++|.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 11000 000000111222334445567889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=282.63 Aligned_cols=184 Identities=26% Similarity=0.389 Sum_probs=152.5
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||+|++..+++.||+|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......++|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCC
Confidence 34578899999999999999999999999999999999999999987532211 222445789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|||++|.+||...+.......+......
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------------------ 214 (321)
T cd05603 160 PEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ------------------------ 214 (321)
T ss_pred cccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC------------------------
Confidence 99999999876 56889999999999999999999999988776666655331100
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCH----HHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~elL~hpwf~~~~ 350 (634)
.....+..+.+||.+||+.||.+|+++ .++++|+||....
T Consensus 215 -----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 215 -----LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred -----CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 013457789999999999999999875 5999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.52 Aligned_cols=185 Identities=26% Similarity=0.437 Sum_probs=147.9
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||+|++..+++.||+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .......++|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccccCC
Confidence 3468899999999999999999999999999999999999999998643221 1223445789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh--------HH-HHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--------VE-QLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--------~e-~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+ ....+.....
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 222 (329)
T cd05588 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------------- 222 (329)
T ss_pred ccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------------
Confidence 99999999976 6788999999999999999999999963211 11 1111111000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC------HHHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT------a~elL~hpwf~~~~~ 351 (634)
.....++..+.+||.+||+.||.+|+| +.++++||||....|
T Consensus 223 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 223 -------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred -------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 011346788999999999999999987 799999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=282.17 Aligned_cols=219 Identities=38% Similarity=0.648 Sum_probs=174.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++.+..+++.||+|+
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 3789999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus 96 ~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-- 173 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 173 (345)
T ss_pred cEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--
Confidence 2347889999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.....++..|+|||++.+...++.++|||||||++|+|++|++||........+..+....+.++...+.........
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 174 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred --ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 233466889999999876566889999999999999999999999988888888888887777766655432211100
Q ss_pred cCCC--CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 297 LFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.+.. .......+...+...++.+.+||..||+.||.+|||+.++|.||||.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000 000011122223356888999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=301.01 Aligned_cols=182 Identities=25% Similarity=0.312 Sum_probs=132.0
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCc
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
+.|+.||+.||.|||+++||||||||+||||+.++.+||+|||++..+...........++|+.|+|||++.+ ..|+.+
T Consensus 270 ~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 348 (501)
T PHA03210 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEI 348 (501)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcH
Confidence 3488899999999999999999999999999999999999999998765433333344678999999999976 678999
Q ss_pred cccccchhhHHHHhhCCCC-CCC--CChHHHHHHHHHhcCCCCchhhhc----cCCCCcccCCCCCCCCchhhhhc--CC
Q 006714 244 VDLWSVGCVFAELLIGKPI-LQG--RTEVEQLHKIFKLCGSPPDDYWKK----SKLPHATLFKPQQPYDSSLRETF--KD 314 (634)
Q Consensus 244 sDIWSLG~iLyeLltG~~p-f~~--~~~~e~l~~i~~~~g~pp~~~~~~----~~l~~~~~~~~~~~~~~~l~~~~--~~ 314 (634)
+|||||||+||||++|..+ |.. .....++.+++..+..+..++... ........+.... ..+...+ ..
T Consensus 349 ~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~---~~~~~~~~~~~ 425 (501)
T PHA03210 349 TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG---HSVPPLIRNLG 425 (501)
T ss_pred HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc---cchhhHHHhcC
Confidence 9999999999999998754 432 234556666666554433322110 0000000000000 0111111 24
Q ss_pred CcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 315 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 315 ~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
++..+.+||.+||.+||.+|||+.|+|.||||...
T Consensus 426 ~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 426 LPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred CChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 67889999999999999999999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.03 Aligned_cols=193 Identities=26% Similarity=0.470 Sum_probs=159.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++.+.||.|+||+||++.+..+++.||+|+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence 34578899999999999999999999999999999999999999987554321 22
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+..........
T Consensus 159 ~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-------------- 223 (285)
T cd05632 159 RGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV-------------- 223 (285)
T ss_pred cCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--------------
Confidence 34568999999999876 568999999999999999999999998876655554443322111110
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
....++..+.+||..||..||++||| +.+++.|+||...++
T Consensus 224 -----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 224 -----------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred -----------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 11356788999999999999999999 899999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=269.77 Aligned_cols=214 Identities=47% Similarity=0.829 Sum_probs=175.3
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++.+.||.|.||.||++++..+++.|++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 6788999999999999999999999999984
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 159 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEV 159 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCccc
Confidence 345788999999999999999999999999999999999999999876543221 223345
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
.+..|+|||.+.....++.++|||||||++|+|++|.+||...+..+.+.++...++.+.+..|................
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 57889999998765578899999999999999999999999999999999999999998888776543221111111111
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
........++.++..+.+||.+||..||++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1122344556678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=279.36 Aligned_cols=220 Identities=36% Similarity=0.635 Sum_probs=175.8
Q ss_pred CeeEEEEecccCceeEEEEEECCC--CcEEehHH----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDT--GKIVALKK---------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~t--g~~vAlK~---------------------------------------------- 162 (634)
+|++.+.||+|+||.||++++..+ +..||+|.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 489999999999999999999888 88899984
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 345788999999999999999999999999999999999999999975543211
Q ss_pred ---CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 217 ---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 ---~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.......++..|+|||++.+...++.++|||||||++|+|++|.+||........+..++..++.++.+.+.....+
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 11233467899999998876566889999999999999999999999999989999999999998887665443222
Q ss_pred CcccCC--CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 294 HATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 294 ~~~~~~--~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
....+. ........+......++..+.+||.+||+.||.+|||+.++|.||||..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 110000 000001122333455688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=279.13 Aligned_cols=186 Identities=30% Similarity=0.516 Sum_probs=166.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||+|+||.|-+|++...|+.||||.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 589999999999999999999999999999996
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
.+.|++||+.|+.|||.++++|||||.+|||||.++++||+|||++..+... ..++
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--cHHH
Confidence 3569999999999999999999999999999999999999999999988654 4568
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
++||.+.|.+||++.+...-++.+|.|||||+||.|+.|..||++.+...++.+|-.....-
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE------------------ 272 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE------------------ 272 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC------------------
Confidence 89999999999999986666899999999999999999999999999888888875432111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
+..+.++.-||+.||.+||++|.|+.+|..|-|.+
T Consensus 273 ------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 ------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 23466788999999999999999999999998875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=281.63 Aligned_cols=185 Identities=32% Similarity=0.500 Sum_probs=154.5
Q ss_pred EEEecccCceeEEEEEEC---CCCcEEehHH-------------------------------------------------
Q 006714 135 LEKIGQGTYSSVFRARDL---DTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 135 ~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~------------------------------------------------- 162 (634)
++.||+|+||.||++++. .+++.||+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999873 5788999885
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++....... ......+
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 159 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFC 159 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceeccc
Confidence 35688999999999999999999999999999999999999999987654321 2223457
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 160 g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~--------------------- 217 (318)
T cd05582 160 GTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM--------------------- 217 (318)
T ss_pred CChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999876 567899999999999999999999999888777776664421111
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKP 350 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~ 350 (634)
...+++.+.+||.+||+.||.+||| +.+++.||||....
T Consensus 218 --------p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 218 --------PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred --------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 1346788999999999999999999 78899999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=275.72 Aligned_cols=216 Identities=41% Similarity=0.728 Sum_probs=167.2
Q ss_pred CeeEEEEecccCceeEEEEEECC--CCcEEehHH----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLD--TGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~--tg~~vAlK~---------------------------------------------- 162 (634)
+|++.++||+|+||.||+|.+.. +++.||||.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 889999984
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC----CCceEEecccccc
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN----EGVLKLADFGLAN 209 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~----~g~vkL~DFGla~ 209 (634)
++.++.||+.||.|||+.+|+|+||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 2457889999999999999999999999999998 8999999999987
Q ss_pred ccCCCCC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh---------HHHHHHHHHh
Q 006714 210 FSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKL 278 (634)
Q Consensus 210 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---------~e~l~~i~~~ 278 (634)
....... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+... ...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543222 1123346688999999987756788999999999999999999999986543 2456777777
Q ss_pred cCCCCchhhhcc-CCCCccc---CCCCCCCC-chhhhh---cCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 279 CGSPPDDYWKKS-KLPHATL---FKPQQPYD-SSLRET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 279 ~g~pp~~~~~~~-~l~~~~~---~~~~~~~~-~~l~~~---~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
++.+....|... .++.... ......+. ..+... ....+..+.+||.+||.+||++|||+.|++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 877776665431 1111111 00011111 112121 23678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.72 Aligned_cols=193 Identities=27% Similarity=0.475 Sum_probs=162.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|+|+..||.|+||.||+|.++.++-..|.|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 568999999999999999999998887777776
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
|..+++|+|.||.|||+++|||||||..|||+..+|.|+|+|||.+..... ......++
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsF 190 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSF 190 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhccc
Confidence 456889999999999999999999999999999999999999999754332 12334567
Q ss_pred cccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 223 VVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 223 ~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
+||++|||||++.+ ..+|++++||||||++|.||..+.||....+....+-+|.+. .||. ++
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT------------Ll 256 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT------------LL 256 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc------------cc
Confidence 99999999999853 467999999999999999999999999988888877777552 1110 00
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+..+.|||.+||..||..||++.+||+||||++.
T Consensus 257 ------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 257 ------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 113456789999999999999999999999999999874
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=280.06 Aligned_cols=186 Identities=26% Similarity=0.457 Sum_probs=148.8
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||+||+|++..+++.||+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......++|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGT 159 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCC
Confidence 35688999999999999999999999999999999999999999987532211 222446789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC------hHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~------~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
+.|+|||++.+ ..++.++|||||||+||+|++|.+||.... ..+.+..+... .+.
T Consensus 160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~---------------- 220 (327)
T cd05617 160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPI---------------- 220 (327)
T ss_pred cccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCC----------------
Confidence 99999999876 678999999999999999999999996422 11222222110 000
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC------HHHHHhccccCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 351 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT------a~elL~hpwf~~~~~ 351 (634)
.....++..+.+||.+||..||.+|++ +.+++.||||....|
T Consensus 221 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 221 ----------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 011346788999999999999999998 579999999987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=270.01 Aligned_cols=214 Identities=50% Similarity=0.859 Sum_probs=173.6
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++.+.||.|+||.||++.+..+++.+++|.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999998999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 159 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYV 159 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCcc
Confidence 34588999999999999999999999999999999999999999987665432 1223345
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC-CcccCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKPQQ 302 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~-~~~~~~~~~ 302 (634)
++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|...... .........
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 6888999999877547899999999999999999999999999998999998888888877766553221 000000001
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
............++..+.+||.+||..||.+||++.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11112233445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=288.25 Aligned_cols=190 Identities=29% Similarity=0.466 Sum_probs=172.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|++++.||+|+||.+++++++...+.|++|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 5789999999999999999999999999999997
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
|..|+.||+.||.|||++.|+|||||+.|||++.++.|+|.|||+|+...... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-S 161 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-h
Confidence 56799999999999999999999999999999999999999999999887543 3
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
...+.+||+.||+||++.+ .+|+.++|||||||++|||++-+++|.+.+-..+..+|+..+..|..
T Consensus 162 ~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------- 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------- 227 (426)
T ss_pred hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-------------
Confidence 4567899999999999987 78999999999999999999999999999999999999887644432
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..++.+++.||..||..+|..||++.++|.+|.+..
T Consensus 228 ---------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 ---------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ---------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 356888999999999999999999999999987764
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=266.36 Aligned_cols=189 Identities=31% Similarity=0.510 Sum_probs=154.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++.+.||.|+||.||++.+..+++.||+|.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999999999999873
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 34578999999999999999999999999999999999999999987553321111
Q ss_pred c--ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 219 L--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 219 ~--~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
. ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+......+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 226 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP-------------- 226 (263)
T ss_pred ccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--------------
Confidence 1 23456788999999987 558899999999999999999999998765555444432211000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++..+.+||.+||..+|.+|||+.++|+|+||
T Consensus 227 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 -------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 1113567889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.82 Aligned_cols=186 Identities=26% Similarity=0.442 Sum_probs=155.6
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++++.||.|+||.||++.+..+++.|++|.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 49999999999999999999999999999875
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Ccc
Confidence 34688899999999999999999999999999999999999999987654322 222
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..... +
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~---------------- 220 (257)
T cd08223 160 STLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--P---------------- 220 (257)
T ss_pred ccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--C----------------
Confidence 34467889999999876 5678899999999999999999999987776555544433211 0
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....+++.+.+||.+||+.||.+|||+.++|.||||
T Consensus 221 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 ----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0013467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=279.18 Aligned_cols=221 Identities=40% Similarity=0.663 Sum_probs=176.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||+|.+..+++.||+|.
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4689999999999999999999998899999884
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC---
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--- 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--- 216 (634)
++.++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 86 LVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred EEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence 234788999999999999999999999999999999999999999876543221
Q ss_pred -CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 -~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......++..|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+....+.++...+.....+..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFA 245 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhH
Confidence 1223456788999999887656688999999999999999999999999888888888888888777655543221111
Q ss_pred c-cC-CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 T-LF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~-~~-~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
. .+ .........+...++.++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 246 ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 00 000111122334456688999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.19 Aligned_cols=198 Identities=31% Similarity=0.455 Sum_probs=162.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||+|.+..+++.||||.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 379999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 216 (634)
+..++.||+.+|.|||+++|+|+||||+||||+.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 344788999999999999999999999999999999999999999865432111
Q ss_pred --------------------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH
Q 006714 217 --------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270 (634)
Q Consensus 217 --------------------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e 270 (634)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123357888999999876 567899999999999999999999998887776
Q ss_pred HHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC----HHHHHhcccc
Q 006714 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT----ASAALASEYF 346 (634)
Q Consensus 271 ~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT----a~elL~hpwf 346 (634)
.+..+.......+ ....++..+.+||.+||..||++||| +.++|.||||
T Consensus 240 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 240 TFSNILKKEVTFP---------------------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred HHHHHhcCCccCC---------------------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 6665542111100 01226889999999999999999999 9999999999
Q ss_pred CCCCCCCCC
Q 006714 347 STKPYACDL 355 (634)
Q Consensus 347 ~~~~~~~~~ 355 (634)
+...|+.-.
T Consensus 293 ~~~~~~~~~ 301 (316)
T cd05574 293 RGVNWALIR 301 (316)
T ss_pred hcCChhhcc
Confidence 987776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=266.17 Aligned_cols=213 Identities=41% Similarity=0.742 Sum_probs=172.4
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++.+.||.|+||+||+|++..+++.|+||.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988899999874
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~ 158 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PYTDY 158 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--CcCCC
Confidence 24577899999999999999999999999999999999999999997654322 22345
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc-CCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL-FKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~-~~~~ 301 (634)
.++..|+|||++.....++.++|+|||||++|+|++|.+||......+.+.++...++.+....|.......... ....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 678899999998665668899999999999999999999999999999999999988888877665432111110 0000
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......+...+...+..+.+||++||..||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 011112334444557889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=266.11 Aligned_cols=210 Identities=43% Similarity=0.801 Sum_probs=169.1
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|++.+.||.|+||.||++++..+++.||+|.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999985
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 3458889999999999999999999999999999999999999998765432
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+.+++.....+....|.......
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2 1233456888999999876 568899999999999999999999999999999999998877666554443322111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
...+.. ............++..+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPS--YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhccc--ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 111111 11112234445677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=284.42 Aligned_cols=197 Identities=30% Similarity=0.545 Sum_probs=150.8
Q ss_pred cccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------
Q 006714 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 124 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------- 162 (634)
.+.+....|+++++||.||-+.||++..-. ...||+|.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 344556789999999999999999999644 45666665
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
++.|.+|||.++.++|.+||||.||||.|+|+ -.|.+||+|||+|..+..+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 46688999999999999999999999999998 4679999999999877654
Q ss_pred CC-CCcccccccccCCCcccccCC----------CCCCCccccccchhhHHHHhhCCCCCCCCC-hHHHHHHHHHhcCCC
Q 006714 215 HR-QPLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSP 282 (634)
Q Consensus 215 ~~-~~~~~~~gt~~Y~APE~l~~~----------~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-~~e~l~~i~~~~g~p 282 (634)
.. ....+.+||+.||+||.+... -..+.++||||||||||+|+.|++||.... ....+..|. .|
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~----~P 588 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT----DP 588 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc----CC
Confidence 33 223456899999999998531 114678999999999999999999996432 122222221 11
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhcCCC--cHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 283 p~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~--s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.. .-.|+.+ ..++++|++.||..||.+|||+.++|+|||++-.+
T Consensus 589 ~~------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 589 NH------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred Cc------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 10 0111222 23389999999999999999999999999998644
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=278.41 Aligned_cols=218 Identities=28% Similarity=0.423 Sum_probs=157.0
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++.++||.|+||.||++.+..++..+|+|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 345799999999999999999999999999999874
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++...... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence 346788999999999985 7999999999999999999999999998755322 1
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHh--cCCCCchhhhccCCCCc-
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL--CGSPPDDYWKKSKLPHA- 295 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~--~g~pp~~~~~~~~l~~~- 295 (634)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.. .++.. .+.+.............
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccc
Confidence 233467899999999876 56889999999999999999999999876543332 22211 11111000000000000
Q ss_pred --ccCCCCC-CCCc--hh-----hh---h--cCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 --TLFKPQQ-PYDS--SL-----RE---T--FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 --~~~~~~~-~~~~--~l-----~~---~--~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+.+.. +... .+ .. . ...++.++.+||.+||++||.+|||+.|+|.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000 0000 00 00 0 01357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=269.67 Aligned_cols=188 Identities=26% Similarity=0.439 Sum_probs=148.0
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||+|+||+||++++..+++.||+|.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999874
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
+..++.||+.||+|||+.+|+|+||||+|||++.++.++|+|||++....... ......++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCC
Confidence 24577899999999999999999999999999999999999999987654322 223446789
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 159 ~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 214 (277)
T cd05607 159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE----------------------- 214 (277)
T ss_pred CccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-----------------------
Confidence 9999999876 4589999999999999999999999976433221111111100000
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCcCH----HHHHhccccCCCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPYA 352 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~elL~hpwf~~~~~~ 352 (634)
+......++.++.+||.+||+.||.+||++ ++++.||||....++
T Consensus 215 -~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 215 -VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred -cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 000113578889999999999999999999 778899999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=286.51 Aligned_cols=187 Identities=34% Similarity=0.610 Sum_probs=151.1
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
-+||+|+||+||-|+|..|...+|||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 469999999999999999999999996
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccccCCCCCCCccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..|.+||++||.|||++.|||||||.+||||+. .|.+||+|||-++....- .....+..||
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGT 739 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGT 739 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccccc
Confidence 3458899999999999999999999999999964 689999999999766432 1223467889
Q ss_pred ccCCCccccc-CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 226 LWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 226 ~~Y~APE~l~-~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
+.|||||++- +...|+.++|||||||++.||.||+|||....... ..|++. .+++...+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-----------------GmyKvHP~- 799 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-----------------GMYKVHPP- 799 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-----------------cceecCCC-
Confidence 9999999994 55679999999999999999999999996543221 112211 11111111
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....++.+++.||.+|+.+||.+||+|.++|..||++..
T Consensus 800 ------iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 800 ------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ------CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 124578889999999999999999999999999999865
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.09 Aligned_cols=191 Identities=25% Similarity=0.391 Sum_probs=159.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCC-CcEEehHH---------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~t-g~~vAlK~--------------------------------------------- 162 (634)
...|.+.+.||+|+||.||+|.+..+ +..|++|.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 34699999999999999999998877 77888874
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~- 216 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++........
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 234788999999999999999999999999999999999999999986643221
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-------------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 22345578999999999876 678999999999999999999999999888777766664421110
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....++..+.+||.+||..||.+|||+.++|.|+|+..
T Consensus 291 --------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 291 --------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred --------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 01246788999999999999999999999999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=286.89 Aligned_cols=187 Identities=27% Similarity=0.463 Sum_probs=160.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|++...||.|+|+.|-.+.+..+++.+++|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 4789999999999999999999999999999997
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee-cCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl-~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..|+.||+.||.|||++|||||||||+|||+ +..++++|+|||.++..... +.+.+.|
T Consensus 401 ~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t 476 (612)
T KOG0603|consen 401 GELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALT 476 (612)
T ss_pred cHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchh
Confidence 23489999999999999999999999999999 68899999999999876543 3445668
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
..|.|||++.. ..|+.++||||||++||+||+|+.||...... ..|...++.++..
T Consensus 477 ~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s-------------------- 532 (612)
T KOG0603|consen 477 LQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS-------------------- 532 (612)
T ss_pred hcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc--------------------
Confidence 99999999984 78999999999999999999999999876655 2333333333211
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+++++++||..||++||.+|+++.+++.||||...+
T Consensus 533 -------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 -------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred -------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 36899999999999999999999999999999994443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=268.47 Aligned_cols=193 Identities=28% Similarity=0.462 Sum_probs=156.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|+++++||+|+||.||++++..+++.|++|.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 679999999999999999999999999999886
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++....... ......
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 170 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSF 170 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccccee
Confidence 35688999999999999999999999999999999999999999986543221 112344
Q ss_pred cccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 223 VVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 223 ~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++.... ++.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------------- 234 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT-------------- 234 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Ccc--------------
Confidence 56889999999852 2446889999999999999999999998766555444442210 000
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......++.++.+||.+||..||++||++.++|+||||...
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 235 ----------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred ----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00013467789999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=265.78 Aligned_cols=191 Identities=27% Similarity=0.458 Sum_probs=153.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||++++..+++.||||.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||++ +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 346888999999999998 99999999999999999999999999987654321
Q ss_pred CcccccccccCCCcccccCC---CCCCCccccccchhhHHHHhhCCCCCCCC-ChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 218 PLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~---~~~s~~sDIWSLG~iLyeLltG~~pf~~~-~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
......++..|+|||++.+. ..++.++|+|||||++|+|++|..||... ...+.+..+... ..+ .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-~-------- 227 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP-Q-------- 227 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-C--------
Confidence 11234568889999988542 34688999999999999999999999653 223333333221 000 0
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
. ....++.++.+||.+||..+|.+|||+.+++.||||...
T Consensus 228 --------~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 228 --------L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 002367889999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=281.81 Aligned_cols=187 Identities=34% Similarity=0.543 Sum_probs=162.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|.-++.||+|+||.||.|++..+.+.||||+
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47788999999999999999999999999997
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
|..|..+.|.||.|||+++.||||||..||||++.|.|||+|||.+.... +.++
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----PAns 181 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----PANS 181 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----chhc
Confidence 34577889999999999999999999999999999999999999987664 3478
Q ss_pred ccccccCCCccccc--CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 222 RVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~--~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
++|||+|||||+++ ....|+-++||||||++..||.-.+||+...+....+..|...- +|.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPt---------------- 244 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPT---------------- 244 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCC----------------
Confidence 89999999999985 45679999999999999999999999999888888777775531 111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+. -...+..+..|+..||..-|.+|||.+++|.|+|....
T Consensus 245 --------Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 245 --------LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred --------CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 00 13457889999999999999999999999999998764
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=266.40 Aligned_cols=189 Identities=30% Similarity=0.491 Sum_probs=152.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++.+.||.|+||.||+|++..+++.||+|+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 579999999999999999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++.......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 34588899999999999999999999999999999999999999987654321
Q ss_pred CCCcccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 216 RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.......+++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+... +..
T Consensus 166 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~------- 234 (272)
T cd06637 166 -GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAP------- 234 (272)
T ss_pred -ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCC-------
Confidence 12234567889999999853 235788999999999999999999999765544333322110 000
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 235 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 -----------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -----------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00012467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=272.30 Aligned_cols=219 Identities=39% Similarity=0.672 Sum_probs=176.7
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||.|+||.||++.+..+++.||+|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 35789999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+.+|+|+||+|.|||++.++.++|+|||++...... ..
T Consensus 88 v~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~ 163 (328)
T cd07856 88 VTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MT 163 (328)
T ss_pred EeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----cC
Confidence 3457889999999999999999999999999999999999999998754321 23
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...++..|+|||++.+...++.++|||||||++|+|++|.+||...........+.+.++.++++++..........+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 34567889999988665668899999999999999999999999988888888888888888877665322111100000
Q ss_pred --CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 301 --QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 301 --~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.........+.++.+++.+.+||.+||+.+|++|||+.++|.||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00011122344456789999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=267.38 Aligned_cols=193 Identities=26% Similarity=0.390 Sum_probs=153.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||++++..+++.||+|.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 368999999999999999999999999999985
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...... .....+++.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~ 157 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTN 157 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCCh
Confidence 3568899999999999999999999999999999999999999998765432 123456789
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHH---HHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ---LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~---l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
.|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+......... +.
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-- 219 (279)
T cd06619 158 AYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP---------------PV-- 219 (279)
T ss_pred hhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC---------------CC--
Confidence 9999999876 5688999999999999999999999965321110 0111111100000 00
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......++++.+||.+||..||.+||++.++|.||||...
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 220 ------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0012467889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=266.94 Aligned_cols=189 Identities=29% Similarity=0.485 Sum_probs=153.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++.+.||.|+||.||++++..+++.||+|+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 589999999999999999999999999999985
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++.......
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence 24577899999999999999999999999999999999999999987553221
Q ss_pred CCCcccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 216 RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.......+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.... +.
T Consensus 176 -~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~------- 244 (282)
T cd06636 176 -GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---PP------- 244 (282)
T ss_pred -cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---CC-------
Confidence 12234567889999998753 2457889999999999999999999997765544433321110 00
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......++..+.+||.+||..||.+|||+.|||+||||
T Consensus 245 -----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 -----------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -----------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00013567889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=261.98 Aligned_cols=194 Identities=30% Similarity=0.476 Sum_probs=157.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||+||++.+..++..+++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 479999999999999999999988899998885
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC--
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-- 217 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-- 217 (634)
+..++.||+.||.|||+++|+|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 2457889999999999999999999999999999999999999998765533221
Q ss_pred -CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 -PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 -~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......++..|++||++.....++.++|+|||||++|+|++|..||...+....+..+... .+..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~---------- 227 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL---------- 227 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc----------
Confidence 1233467889999999876447889999999999999999999999877665555554332 11000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
. ....+..+++.+.+||.+||..||.+|||+.+||.||||
T Consensus 228 --------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 --------E--TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------C--CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 000124678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=266.25 Aligned_cols=189 Identities=30% Similarity=0.464 Sum_probs=159.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||++.+..+++.||+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||+|.||||+.++.++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 3457889999999999999999999999999999999999999998766443 23
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 217 (290)
T cd05580 157 TLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF------------------ 217 (290)
T ss_pred CCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC------------------
Confidence 3467889999999876 567889999999999999999999998877655555553211000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 352 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~~ 352 (634)
...++..+.+||.+||..||.+|+ ++.|+++||||....|.
T Consensus 218 -----------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 218 -----------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred -----------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 124578899999999999999999 99999999999886653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=302.29 Aligned_cols=194 Identities=31% Similarity=0.484 Sum_probs=156.3
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
...++|+++++||+|+||+||+|++..++..||+|+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 445799999999999999999999999999998874
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHC-------CceeccCCCCCceecC---------
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSR-------GVLHRDIKGSNLLVNN--------- 196 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~-------gIvHrDLKp~NILl~~--------- 196 (634)
++.|+.||+.||.|||.. +|||+||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 356889999999999995 4999999999999954
Q ss_pred --------CCceEEeccccccccCCCCCCCcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCC
Q 006714 197 --------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRT 267 (634)
Q Consensus 197 --------~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~ 267 (634)
...+||+|||++....... .....++|+.|+|||++.+. ..++.++||||||||||+|++|.+||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999997654322 22345789999999998642 457899999999999999999999998766
Q ss_pred hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 268 ~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
....+..++.....++ +..++.++.+||..||.++|.+|||+.++|.|+||.
T Consensus 248 ~~~qli~~lk~~p~lp----------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 248 NFSQLISELKRGPDLP----------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cHHHHHHHHhcCCCCC----------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 5544443332110000 124578899999999999999999999999999998
Q ss_pred CCC
Q 006714 348 TKP 350 (634)
Q Consensus 348 ~~~ 350 (634)
...
T Consensus 300 ~i~ 302 (1021)
T PTZ00266 300 NVG 302 (1021)
T ss_pred hcC
Confidence 653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=262.98 Aligned_cols=215 Identities=36% Similarity=0.621 Sum_probs=178.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|.-+..++.|.- .|.-|.|.-+++.||+|+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 58999999999998 888999999999999997
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.|++.|+.|||+.||+||||||+||++..+..+||.|||+++..... ..
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 4678999999999999999999999999999999999999999999866543 45
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.+.++.|..|+|||++.+. .|...+||||+|||+.||++|..+|.+.+..++..++.+.+|.|.+.+.+..........
T Consensus 174 mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred cCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 6788899999999999984 499999999999999999999999999999999999999999999988765321111111
Q ss_pred --CCCCCCCchhhhhcC------------CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 --KPQQPYDSSLRETFK------------DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 --~~~~~~~~~l~~~~~------------~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.++... ..+.+.++ .-+..+.+|+.+||..||++|.++.++|.||||+-|
T Consensus 253 ~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 253 ENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred hcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 111111 11111221 224568999999999999999999999999999954
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=273.09 Aligned_cols=149 Identities=25% Similarity=0.363 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... ......+++.|+|||++.+ ..++.++
T Consensus 179 ~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~s 257 (338)
T cd05102 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQS 257 (338)
T ss_pred HHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCccc
Confidence 4569999999999999999999999999999999999999999765332211 1122344678999999876 6689999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||+||||++ |.+||.+....+.+...+... ..+ .....+++.+.+||
T Consensus 258 DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~l~~li 310 (338)
T cd05102 258 DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-TRM--------------------------RAPENATPEIYRIM 310 (338)
T ss_pred CHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-CCC--------------------------CCCCCCCHHHHHHH
Confidence 99999999999997 999998765443333332211 000 00134678899999
Q ss_pred HHhhccCcCCCcCHHHHHh
Q 006714 324 ETLLSVEPYKRATASAALA 342 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~ 342 (634)
.+||..||.+|||+.+|++
T Consensus 311 ~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 311 LACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=266.56 Aligned_cols=192 Identities=31% Similarity=0.521 Sum_probs=158.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||.|+||+||++.+..+++.|++|.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 579999999999999999999999999999985
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++........ ......+
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 177 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 177 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCC
Confidence 356888999999999999999999999999999999999999999876543221 1233467
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+... ..++.
T Consensus 178 ~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~-------------------- 235 (296)
T cd06655 178 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-------------------- 235 (296)
T ss_pred CccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc--------------------
Confidence 889999999876 56789999999999999999999999887766555444321 11100
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 236 -----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 0113567889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=267.13 Aligned_cols=192 Identities=30% Similarity=0.533 Sum_probs=156.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++++.||+|+||.||++++..+++.|++|.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 589999999999999999999999999999985
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||..+|+|+||||+|||++.++.++|+|||++........ ......+
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 178 (296)
T cd06654 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 178 (296)
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccC
Confidence 346888999999999999999999999999999999999999999875433211 1233467
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
++.|+|||.+.+ ..++.++|||||||++|+|++|.+||........+..+... ..++.
T Consensus 179 ~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------------------- 236 (296)
T cd06654 179 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------------------- 236 (296)
T ss_pred CccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCC--------------------
Confidence 889999998876 56789999999999999999999999877654443333211 11100
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 237 -----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0013467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=264.96 Aligned_cols=192 Identities=24% Similarity=0.388 Sum_probs=156.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
-|++++.||.|+||.||++.+..++..+++|.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 47899999999999999999999999888874
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++....... .......
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 164 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI 164 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccccc
Confidence 34588899999999999999999999999999999999999999986543221 1223446
Q ss_pred ccccCCCccccc----CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 224 VTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 224 gt~~Y~APE~l~----~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
+++.|+|||++. ....++.++|||||||++|+|++|.+||...+..+.+..+........
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 228 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL---------------- 228 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC----------------
Confidence 788999999884 224577899999999999999999999988776665555533211000
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 229 ----------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0012467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=264.66 Aligned_cols=193 Identities=24% Similarity=0.427 Sum_probs=155.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||++++..+++.||+|.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 479999999999999999999998999999984
Q ss_pred -----------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+ .+|+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 35578899999999997 599999999999999999999999999987553221
Q ss_pred cccccccccCCCcccccCC-----CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 219 LTSRVVTLWYRPPELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~-----~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||...........+.......+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 228 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP--------- 228 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC---------
Confidence 2334567889999988542 23578999999999999999999999776554444433322211111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....++.++.+||.+||..+|.+||++.+++.||||....
T Consensus 229 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 229 ----------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ----------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 01134788899999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=267.56 Aligned_cols=196 Identities=22% Similarity=0.360 Sum_probs=154.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++.+..+++.||+|.
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 3578889999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 234778999999999975 99999999999999999999999999987554321
Q ss_pred CCCcccccccccCCCcccccCC--CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~--~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.... .....+.+.....+...
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~------- 231 (288)
T cd06616 163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL------- 231 (288)
T ss_pred --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-------
Confidence 11334568889999998764 368899999999999999999999997654 22222222211111000
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
. ......++.++.+||.+||..||.+|||+.+++.||||...
T Consensus 232 ---------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 232 ---------S-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ---------C-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 0 00013478889999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=256.13 Aligned_cols=186 Identities=28% Similarity=0.445 Sum_probs=155.6
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|.+.+.||+|+||.||++.+..+++.|++|.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 48899999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FAN 159 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hhh
Confidence 345788999999999999999999999999999999999999999876543321 223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 220 (256)
T cd08529 160 TIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP------------------ 220 (256)
T ss_pred ccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 3467889999999876 568899999999999999999999998887666555553321100
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
....++..+.++|.+||+.+|++||++.++|.|||+
T Consensus 221 ----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 ----------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 012467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=265.26 Aligned_cols=197 Identities=30% Similarity=0.472 Sum_probs=158.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||++.+..+++.|++|.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC----
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 216 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 345788999999999999999999999999999999999999998863211100
Q ss_pred ----------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchh
Q 006714 217 ----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 217 ----------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~ 286 (634)
.......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 237 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-- 237 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC--
Confidence 01112356788999999876 56889999999999999999999999887776666655432111110
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC---HHHHHhccccCCCCCCC
Q 006714 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYAC 353 (634)
Q Consensus 287 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~elL~hpwf~~~~~~~ 353 (634)
....++..+.+||.+||..||.+||+ +.++|+||||...+++.
T Consensus 238 ------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 238 ------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 00246788999999999999999998 79999999998766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=262.53 Aligned_cols=192 Identities=29% Similarity=0.485 Sum_probs=154.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||++.+..+++.+|+|.
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 4789999999999999999999999999999885
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++.....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 234788999999999999999999999999999999999999999876543
Q ss_pred CCCCCcccccccccCCCcccccCCC----CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~----~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.... .....++..|+|||++.... .++.++|||||||++|+|++|++||........+..+... ++...
T Consensus 181 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~--- 253 (291)
T cd06639 181 TRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTL--- 253 (291)
T ss_pred cccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCCC---
Confidence 2211 12345788899999875422 3678999999999999999999999877665555444221 11000
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.....++..+.+||.+||..||++||++.+||+||||+
T Consensus 254 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 --------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00123566799999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=266.84 Aligned_cols=215 Identities=26% Similarity=0.335 Sum_probs=155.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||++.+..++..+|+|.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999999999998888874
Q ss_pred --------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+ ++|+|+||+|+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---cccc
Confidence 34688899999999998 59999999999999999999999999998654322 1234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.+++..|+|||++.+ ..++.++|||||||++|+|++|..||...+... +..++......... ...............
T Consensus 158 ~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (308)
T cd06615 158 FVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEA-KESHRPVSGHPPDSP 234 (308)
T ss_pred CCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccc-cCCcccccCCCCCcc
Confidence 567889999999876 568899999999999999999999997665333 22222211110000 000000000000000
Q ss_pred C--CCCchhhh---------hcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 302 Q--PYDSSLRE---------TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 302 ~--~~~~~l~~---------~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
. .....+.. ....++.++.+||.+||..||++|||+.++|.||||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0 00000000 0013678899999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=262.90 Aligned_cols=191 Identities=32% Similarity=0.535 Sum_probs=157.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||++++..+++.||+|.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 479999999999999999999999999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccccccc
Confidence 45688999999999999999999999999999999999999999997665432 1223446
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
++..|++||++.+ ..++.++|||||||++|+|++|.+||...+.......+.... ++
T Consensus 160 ~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~-------------------- 216 (274)
T cd06609 160 GTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PP-------------------- 216 (274)
T ss_pred CCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CC--------------------
Confidence 6888999999876 458999999999999999999999998766554444432211 00
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+.. ..++..+.+||.+||..||++|||+.+++.||||...
T Consensus 217 ---~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 ---SLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ---CCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0000 1267889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=264.57 Aligned_cols=193 Identities=21% Similarity=0.221 Sum_probs=146.2
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCC---CcEEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~t---g~~vAlK~------------------------------------------ 162 (634)
..++|++.+.||+|+||+||+|.+..+ +..+++|+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999998776 44555542
Q ss_pred --------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEec
Q 006714 163 --------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 204 (634)
Q Consensus 163 --------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~D 204 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred EeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 235788999999999999999999999999999999999999
Q ss_pred cccccccCCCCC------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHh
Q 006714 205 FGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278 (634)
Q Consensus 205 FGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~ 278 (634)
||++........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......+......
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999976532211 11123468999999998876 66899999999999999999999999876432222111110
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 279 ~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+++..... -...+...++.+.+++..|+..+|++||++.++++
T Consensus 249 ------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000000 00012456788999999999999999999999975
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=267.99 Aligned_cols=192 Identities=30% Similarity=0.526 Sum_probs=155.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++++.||.|+||.||++.+..+++.||+|.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 689999999999999999999999999999985
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.+|.|||+.+|+|+||||+|||++.++.++|+|||++........ ......+
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~ 177 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 177 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCcccC
Confidence 345788999999999999999999999999999999999999999876543221 1233467
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
++.|++||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+.. .+.++.
T Consensus 178 ~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~-------------------- 235 (297)
T cd06656 178 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL-------------------- 235 (297)
T ss_pred CccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC--------------------
Confidence 889999999876 6678999999999999999999999977554332222111 011100
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 236 -----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 0113467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=273.35 Aligned_cols=186 Identities=30% Similarity=0.447 Sum_probs=153.5
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcE-EehHH-------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI-VALKK------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~-vAlK~------------------------------------------- 162 (634)
+..+...+.+.||.|+||+||++.+. |.. ||+|+
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 34456677778999999999999984 445 88884
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCC-ceeccCCCCCceecCCC-ceEEeccccccccC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEG-VLKLADFGLANFSN 212 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~g-IvHrDLKp~NILl~~~g-~vkL~DFGla~~~~ 212 (634)
+..++.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 3468999999999999999 99999999999999997 99999999998765
Q ss_pred CCCCCCcccccccccCCCcccccC-CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
... ...+...||+.|||||++.+ ...|+.++||||||++||||++|..||...........+......|+.
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~------- 267 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI------- 267 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC-------
Confidence 432 23344788999999999985 267999999999999999999999999999886666665543333321
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...+++.+..||..||..||.+||++.+++.
T Consensus 268 --------------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 --------------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1237889999999999999999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=269.72 Aligned_cols=213 Identities=24% Similarity=0.340 Sum_probs=150.9
Q ss_pred EEEEeccc--CceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 134 KLEKIGQG--TYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 134 i~~~LG~G--~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
++++||+| +|++||++++..+++.||+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 789999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-----
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----- 216 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~----- 216 (634)
++.++.||+.||.|||+++|+|+||||+|||++.++.++|+||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 356889999999999999999999999999999999999999986543221100
Q ss_pred -CCcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCc---------h
Q 006714 217 -QPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD---------D 285 (634)
Q Consensus 217 -~~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~---------~ 285 (634)
.......++..|+|||++.+. ..++.++|||||||++|||++|.+||........+..... +..+. +
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 239 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhh
Confidence 011223457789999998653 4588999999999999999999999987655444333322 11110 0
Q ss_pred hhh-cc-C------CCCcccCC-CC-CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 286 YWK-KS-K------LPHATLFK-PQ-QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 286 ~~~-~~-~------l~~~~~~~-~~-~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.+. .. . ........ .. .............+++.+.+||.+||++||++|||+.+||+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000 00 0 00000000 00 00001111222356788999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=264.52 Aligned_cols=194 Identities=28% Similarity=0.477 Sum_probs=157.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||.|+||+||++.+..++..||+|.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 3689999999999999999999988999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++........ ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 162 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDT 162 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccce
Confidence 356889999999999999999999999999999999999999998865433211 1233
Q ss_pred ccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 222 RVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
..+++.|++||++.. ...++.++|||||||++|+|++|.+||........+..+.... ++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------------- 227 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PPT------------- 227 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CCC-------------
Confidence 467889999998752 2446789999999999999999999998876655555443211 000
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......++..+.+||..||..||.+||++.++|+||||...
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 -----------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00012467789999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.31 Aligned_cols=195 Identities=31% Similarity=0.500 Sum_probs=154.7
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
.+...++|++++.||+|+||.||++.+..+++.+|+|+
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 33456799999999999999999999999999999985
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 23477899999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCcccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCch
Q 006714 210 FSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 210 ~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~ 285 (634)
...... .......+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+... .++.
T Consensus 173 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~~- 248 (286)
T cd06638 173 QLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPPT- 248 (286)
T ss_pred ecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCCc-
Confidence 654322 12234467899999998753 234788999999999999999999999876554433322110 0000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
. .....++..+.+||.+||+.||++|||+.|||+|+||
T Consensus 249 -----------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 -----------L------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------c------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 0012346789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=265.87 Aligned_cols=195 Identities=28% Similarity=0.458 Sum_probs=158.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|.....||+|+||.||++.+..++..||||.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 456667889999999999999999999999985
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .......+
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 180 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVG 180 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeec
Confidence 35688999999999999999999999999999999999999999987543322 12234567
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
+..|+|||++.+ ..++.++|||||||++|||++|..||...+....+..+........
T Consensus 181 ~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 238 (292)
T cd06658 181 TPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--------------------- 238 (292)
T ss_pred CccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc---------------------
Confidence 899999999865 5688999999999999999999999988776655544432111000
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.....++..+.+||.+||..||.+|||+.++|+||||...+.+
T Consensus 239 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 239 -----KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred -----ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0012467789999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=264.08 Aligned_cols=184 Identities=29% Similarity=0.481 Sum_probs=147.9
Q ss_pred EecccCceeEEEEEECCCCcEEehHH------------------------------------------------------
Q 006714 137 KIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------ 162 (634)
Q Consensus 137 ~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------ 162 (634)
.||+|+||.||++.+..+++.||+|.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999984
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .....+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcCC
Confidence 34588999999999999999999999999999999999999999986553321 123467
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh--HHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
+..|+|||.+.....++.++|||||||++|+|++|..||..... ...+..+.. ..+
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~------------------- 215 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVN------------------- 215 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCC-------------------
Confidence 89999999886545688999999999999999999999975432 111111110 000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
......++.++.+||.+||..||.+|+ |+.++++||||+...+
T Consensus 216 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 216 ------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred ------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 011235788999999999999999999 6999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=259.17 Aligned_cols=189 Identities=30% Similarity=0.504 Sum_probs=150.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||+|+||.||++.+..++..|++|+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 379999999999999999999999999998883
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 215 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 215 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 24588999999999999999999999999999999999999999987543211
Q ss_pred -CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 -~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+...... +
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~----------- 228 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-P----------- 228 (266)
T ss_pred cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-C-----------
Confidence 111123456888999999876 56889999999999999999999999876554444433211100 0
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.....+++.+.+|| .||..+|++|||+.|+|.||||+
T Consensus 229 ---------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 ---------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00124567788888 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=254.16 Aligned_cols=218 Identities=32% Similarity=0.634 Sum_probs=172.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++++|+|-|+.||.+++..+.+.+.||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4799999999999999999999999999888876
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCCCCCCcccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
|+.|+.|||.||.|||++||+|||+||.|++|+.. ..++|+|+|+|.+..... ..+-.+.
T Consensus 117 v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~--eYnVRVA 194 (338)
T KOG0668|consen 117 VNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYNVRVA 194 (338)
T ss_pred hccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc--eeeeeee
Confidence 56789999999999999999999999999999865 469999999998876542 3355667
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCC-CCCCChHHHHHHHHHhcCCCCc-hhhhccCCCCcccCCC--
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPD-DYWKKSKLPHATLFKP-- 300 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~p-f~~~~~~e~l~~i~~~~g~pp~-~~~~~~~l~~~~~~~~-- 300 (634)
+..|--||++.....|+...|+|||||+|..|+..+.| |.|.++.+++-+|.+.+|.-.- .+.....+.....+..
T Consensus 195 SRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~ 274 (338)
T KOG0668|consen 195 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDIL 274 (338)
T ss_pred hhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHh
Confidence 88899999999888999999999999999999997755 5788999999999999886432 1222222211111111
Q ss_pred ----CCCCCchhhhhc-CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 301 ----QQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 301 ----~~~~~~~l~~~~-~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..++...+.... .-.+++++|||.++|.+|-.+|+||.|++.||||..
T Consensus 275 ~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 275 GRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 111111111111 234699999999999999999999999999999975
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=257.15 Aligned_cols=187 Identities=30% Similarity=0.607 Sum_probs=152.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|.+...||.|+||.||+|.+..+++.||+|.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999999988899999872
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||+|||+++|+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 34688999999999999999999999999999999999999999987654211
Q ss_pred C-----CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 216 R-----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 216 ~-----~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+..... +
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------- 230 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS--P------- 230 (267)
T ss_pred ccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC--C-------
Confidence 1 11122356788999999876 5678899999999999999999999987766554444322110 0
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++..+.+||.+||+.||.+||++.++|+||||
T Consensus 231 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 -------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=257.51 Aligned_cols=192 Identities=31% Similarity=0.493 Sum_probs=153.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||.|+||.||+|.+..+++.+++|+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 34799999999999999999999998888888875
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 2237789999999999999999999999999999999999999998765
Q ss_pred CCCCCCCcccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhh
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~ 287 (634)
.... .......++..|+|||++.. ...++.++|||||||+||+|++|.+||........+..+... ++..
T Consensus 164 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-- 237 (275)
T cd06608 164 DSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPT-- 237 (275)
T ss_pred ccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCC--
Confidence 4322 12234567889999998753 234678999999999999999999999876555554444221 1000
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
+ .....++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 238 --------------------~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 --------------------L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------------------C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0012367789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=260.65 Aligned_cols=187 Identities=26% Similarity=0.384 Sum_probs=150.9
Q ss_pred CCeeEEEEe--cccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 130 DAFEKLEKI--GQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~L--G~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
+.|++.+.+ |.|+||.||+++++.++..+|+|.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 93 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence 467777776 999999999999999999999886
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCCCCcccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+.+|+|+||+|+|||++.++ .++|+|||++...... ....+
T Consensus 94 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~ 168 (267)
T PHA03390 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDG 168 (267)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCC
Confidence 456899999999999999999999999999999988 9999999998765432 22356
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHH-HHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~-l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
+..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ...
T Consensus 169 ~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-------------------- 226 (267)
T PHA03390 169 TLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK-------------------- 226 (267)
T ss_pred CCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc--------------------
Confidence 889999999976 5688999999999999999999999986543322 11111111 000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-HHHHHhccccCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFST 348 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-a~elL~hpwf~~ 348 (634)
....+.+++.+.+||.+||+.||.+||+ ++++|+||||..
T Consensus 227 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 227 -----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -----CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0111357889999999999999999996 599999999963
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.79 Aligned_cols=184 Identities=28% Similarity=0.487 Sum_probs=148.5
Q ss_pred EecccCceeEEEEEECCCCcEEehHH------------------------------------------------------
Q 006714 137 KIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------ 162 (634)
Q Consensus 137 ~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------ 162 (634)
.||+|+||.||++++..+++.||+|.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999999999999999984
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++....... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcCC
Confidence 35588999999999999999999999999999999999999999987553321 233467
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH--HHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE--QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e--~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
+..|+|||++.+...++.++|||||||++|+|++|..||....... ....... ...
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~------------------- 215 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TMA------------------- 215 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---ccC-------------------
Confidence 8999999998764568899999999999999999999997653211 1111110 000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
......++..+.+||.+||..||.+|| ++.++++||||....+
T Consensus 216 ------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 216 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred ------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 001134678999999999999999999 9999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=254.79 Aligned_cols=186 Identities=27% Similarity=0.502 Sum_probs=155.5
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||+|+||.||++++..+++.|++|.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 59999999999999999999999999999884
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+++++|+||+|+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LAR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhh
Confidence 345788999999999999999999999999999999999999999876543221 112
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+.+..+.... .+
T Consensus 160 ~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~----------------- 219 (256)
T cd08218 160 TCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YP----------------- 219 (256)
T ss_pred hccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CC-----------------
Confidence 3456788999999876 567889999999999999999999998777666665553321 11
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++.++.+||.+||+.+|.+||++.++|+||||
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 ---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=260.28 Aligned_cols=191 Identities=32% Similarity=0.511 Sum_probs=150.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||++++..+++.||+|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 579999999999999999999999999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... .......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 167 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFI 167 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cccCccc
Confidence 34578899999999999999999999999999999999999999987653221 1123346
Q ss_pred ccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 224 VTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 224 gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
+++.|+|||.+.. ...++.++|||||||++|+|++|.+||......+....+......++ .
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~ 230 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP-----------------K 230 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC-----------------C
Confidence 7889999998742 24477899999999999999999999865543322222211100000 0
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
+ .....++..+.+||.+||..||++|||+++||+|+|
T Consensus 231 ------~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 231 ------L-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------C-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0 001246788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=261.32 Aligned_cols=191 Identities=31% Similarity=0.509 Sum_probs=151.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||+|++..+++.||+|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 589999999999999999999999999999984
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||++||+|+||||+|||++.++.++|+|||++....... .......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 167 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFI 167 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccccccc
Confidence 34588899999999999999999999999999999999999999987554321 1223456
Q ss_pred ccccCCCccccc--CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 224 VTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 224 gt~~Y~APE~l~--~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
++..|+|||++. ....++.++|||||||++|+|++|.+||........+..+......++ .
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~--------------- 230 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--K--------------- 230 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--c---------------
Confidence 789999999874 224578899999999999999999999876554333333221110000 0
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
+ .....++..+.+||.+||..||++|||+.++|+|||
T Consensus 231 ------~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 ------L-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------c-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 001235778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=255.91 Aligned_cols=189 Identities=31% Similarity=0.521 Sum_probs=153.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||++.+..+++.|++|.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 689999999999999999999998888999885
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 161 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIG 161 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccccC
Confidence 356889999999999999999999999999999999999999999876643321 1233456
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
+..|+|||++.+ ..++.++|||||||++|+|++|++||...........+... .+..
T Consensus 162 ~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~------------------- 218 (256)
T cd06612 162 TPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPT------------------- 218 (256)
T ss_pred CccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCCC-------------------
Confidence 888999999876 56889999999999999999999999876554433222110 0000
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 219 ----~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 219 ----LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00012467789999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=256.66 Aligned_cols=187 Identities=36% Similarity=0.600 Sum_probs=156.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||++.+..+++.|++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 479999999999999999999999999999884
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC---
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--- 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--- 216 (634)
+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 356889999999999999999999999999999999999999999876543221
Q ss_pred ----------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcC
Q 006714 217 ----------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280 (634)
Q Consensus 217 ----------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g 280 (634)
.......++..|++||++.. ..++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11223456788999998876 5578899999999999999999999998876666655543211
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH----HHHHhcccc
Q 006714 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYF 346 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~elL~hpwf 346 (634)
..+ ..+++.+.+||.+||+.||.+|||+ .++|+||||
T Consensus 240 ~~~-----------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFP-----------------------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCC-----------------------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 111 2457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=256.27 Aligned_cols=188 Identities=29% Similarity=0.529 Sum_probs=151.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||+||++.+ .+++.+|+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478899999999999999986 4788888883
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC----
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---- 214 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~---- 214 (634)
+..++.||+.+|+|||+.+|+|+||+|+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 3458899999999999999999999999999999999999999998754211
Q ss_pred -CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 215 -HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 215 -~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 228 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP---------- 228 (265)
T ss_pred cccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC----------
Confidence 1111233457889999999876 5678999999999999999999999987665554444332211111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++.++.+||.+||..+|.+|||+.++|.||||
T Consensus 229 ----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 ----------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0113567889999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=279.50 Aligned_cols=191 Identities=21% Similarity=0.326 Sum_probs=151.1
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+++..+.+.+...||+|.||+||++++.. .||||+
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 45666788999999999999999999843 488886
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC-C
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-H 215 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 215 (634)
+..|++||++|+.|||.++|||+|||..||||.+++.|||+|||++...... .
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 4579999999999999999999999999999999999999999998643211 1
Q ss_pred CCCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
........+.+.|||||++.. ..+|++.+|||||||++|||++|..||.....+.++..+-.....
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~------------ 611 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM------------ 611 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC------------
Confidence 122334456788999999853 457899999999999999999999999854444433332111111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
..+.....+.+.++++|+..||.+++++||++.+||.
T Consensus 612 ------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 612 ------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1122333567889999999999999999999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=256.35 Aligned_cols=184 Identities=34% Similarity=0.539 Sum_probs=151.6
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||.|+||.||+|.+..+++.||+|.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999999999999985
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++...... ....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----ccCCCC
Confidence 3568899999999999999999999999999999999999999998754321 234567
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
..|++||.+.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.......+.
T Consensus 157 ~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (260)
T cd05611 157 PDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE--------------------- 214 (260)
T ss_pred cCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC---------------------
Confidence 88999999876 44889999999999999999999999887776665555332111110
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcC---HHHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~elL~hpwf~~~~ 350 (634)
.....++..+.+||.+||+.||++||| +.|+|.||||.+..
T Consensus 215 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 215 ----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 011257889999999999999999995 58999999998743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=255.14 Aligned_cols=193 Identities=30% Similarity=0.587 Sum_probs=153.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|.+.+.||.|+||.||++.+..+++.||+|.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 58899999999999999999998999999983
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 3457889999999999999999999999999999999999999998754322
Q ss_pred CC-CCcccccccccCCCcccccCCC-CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 215 HR-QPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 215 ~~-~~~~~~~gt~~Y~APE~l~~~~-~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. .......++..|++||++.... .++.++|+|||||++|+|++|..||......+.+..+......++
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 232 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--------- 232 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc---------
Confidence 11 1123345688899999987533 478899999999999999999999976555444433322111110
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
........++..+.+||.+||..||.+|||+.++|+||||
T Consensus 233 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 --------------IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0011124578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=251.22 Aligned_cols=185 Identities=29% Similarity=0.487 Sum_probs=153.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||.||++.+..+++.+|+|.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 59999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.+ +.++|+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--A 158 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--c
Confidence 34578899999999999999999999999999755 4589999999976643321 2
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd08220 159 YTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP----------------- 220 (256)
T ss_pred cccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-----------------
Confidence 23456889999999876 567889999999999999999999998877665555543311100
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
....++..+.+||..||..||.+|||+.|+|+||||
T Consensus 221 -----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 -----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 012467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=253.08 Aligned_cols=191 Identities=32% Similarity=0.520 Sum_probs=154.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||+|.+..+++.+++|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 689999999999999999999998999999985
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++....... ......
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 161 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSF 161 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hccccc
Confidence 34588999999999999999999999999999999999999999987654321 112334
Q ss_pred cccccCCCcccccCC--CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 223 VVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~--~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
.++..|++||++... ..++.++|||||||++|+|++|.+||...+.......+......++.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 225 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK---------------- 225 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc----------------
Confidence 668889999998652 26788999999999999999999999887765554444321111100
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
+ ......+.++.+||.+||..||.+|||+.++|.|+|
T Consensus 226 -------~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 -------L-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -------c-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 001235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=262.78 Aligned_cols=194 Identities=30% Similarity=0.505 Sum_probs=158.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|+....||+|+||.||++.+..+++.||+|.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 346667789999999999999998999999986
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... .......+
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 179 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG 179 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence 35688999999999999999999999999999999999999999987544322 11234567
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
+..|+|||++.+ ..++.++|||||||++|+|++|.+||......+.+..+... ++ ..+
T Consensus 180 ~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~~~----------------- 237 (297)
T cd06659 180 TPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-PKL----------------- 237 (297)
T ss_pred CccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-CCc-----------------
Confidence 899999999876 56889999999999999999999999877766655544221 10 000
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.....++..+.+||.+||+.||.+||++.++++||||.....
T Consensus 238 -----~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 238 -----KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred -----cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 011346788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=252.01 Aligned_cols=191 Identities=34% Similarity=0.552 Sum_probs=151.3
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||.||++.+..+++.|++|.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 58999999999999999999988899999886
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC---c
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP---L 219 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~---~ 219 (634)
+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++.......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 34588999999999999999999999999999999999999999987664332211 1
Q ss_pred ccccccccCCCcccccCCC--CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 220 TSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~--~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
....++..|++||++.+.. .++.++|||||||++|+|++|..||............... +..+.
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~------------- 226 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP------------- 226 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC-------------
Confidence 1345688999999987532 3788999999999999999999999765432222221111 11110
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
. .....++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 227 ----~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 ----I-------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----C-------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0012457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=254.17 Aligned_cols=187 Identities=20% Similarity=0.299 Sum_probs=151.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
...+|.+.++||+|+||.||+|.+..+++.||+|.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 34579999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+++|+|+||||+|||++.++.++|+|||++............
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 3457899999999999999999999999999999999999999998765433221111
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .+
T Consensus 164 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----------------- 224 (263)
T cd05052 164 GAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-RM----------------- 224 (263)
T ss_pred CCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CC-----------------
Confidence 2223567999998876 668899999999999999998 999998877665555543211 00
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.....++..+.+||.+||..||++|||+.++++.
T Consensus 225 ----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 225 ----------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0113567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=247.10 Aligned_cols=196 Identities=29% Similarity=0.441 Sum_probs=150.2
Q ss_pred CcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------
Q 006714 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 123 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------- 162 (634)
+.+-+...+|+|.+.||+|+|+-||+++...+++.||+|+
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3445567899999999999999999999999999999997
Q ss_pred -----------------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCceEEecc
Q 006714 163 -----------------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADF 205 (634)
Q Consensus 163 -----------------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~vkL~DF 205 (634)
+..|+.+|++||++||+.. ++||||||.|||+.+++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 4568999999999999998 999999999999999999999999
Q ss_pred ccccccCCC---CC-----CCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHH
Q 006714 206 GLANFSNTG---HR-----QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275 (634)
Q Consensus 206 Gla~~~~~~---~~-----~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i 275 (634)
|.++...-. .. +.......|..|+|||++.- ....+.++|||||||+||+|+.|..||+. +
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~ 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------I 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------H
Confidence 998754321 00 01122345889999998843 23468899999999999999999999952 2
Q ss_pred HHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 276 ~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
++.-++..-.. ...+..+.. -..+++.+.+||+.||+.||.+||++.++|.+
T Consensus 245 ~~~GgSlaLAv-----------~n~q~s~P~-----~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 245 YQQGGSLALAV-----------QNAQISIPN-----SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hhcCCeEEEee-----------eccccccCC-----CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22222211100 000000000 02378899999999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=274.08 Aligned_cols=190 Identities=28% Similarity=0.447 Sum_probs=160.3
Q ss_pred CeeEE--EEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 131 AFEKL--EKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~--~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
-|+|. +.||.|.||+||-++++.+|+.||||+
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 36665 789999999999999999999999997
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC---CceEEeccccccccCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~ 216 (634)
.+.++.|||.||.|||-++|+|+||||+||||... -++||||||+|+++.+..
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 13477899999999999999999999999999644 469999999999987643
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
...+.+||+.|+|||++.. ..|+...|+||+|||+|--+.|..||.... ++-.+|.+.....|..-|
T Consensus 722 -FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW--------- 788 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPW--------- 788 (888)
T ss_pred -hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCch---------
Confidence 3467899999999999987 789999999999999999999999997543 333344333333333333
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.++++.++|||..+|+..-.+|.|++..|.|||++++.
T Consensus 789 ----------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 789 ----------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ----------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 57899999999999999999999999999999999853
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=253.65 Aligned_cols=185 Identities=31% Similarity=0.475 Sum_probs=152.0
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||++++..+++.||+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccc
Confidence 34588999999999999999999999999999999999999999987654332 1234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh--HHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
..++..|+|||++.. ..++.++|+|||||++|+|++|..||..... .+.+...... ..
T Consensus 159 ~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~---------------- 218 (258)
T cd05578 159 TSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---AD---------------- 218 (258)
T ss_pred cCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---cc----------------
Confidence 456888999999876 5588999999999999999999999987664 2222221110 00
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH--HHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA--SAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa--~elL~hpwf 346 (634)
......++..+.+||.+||..||.+||++ .|+++||||
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 219 ---------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00113467889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=251.88 Aligned_cols=186 Identities=31% Similarity=0.495 Sum_probs=154.3
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||.|+||.||++.+..+++.|++|.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999875
Q ss_pred --------------------------HHHHHHHHHHHHHHHH-----HCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 --------------------------IKCYMNQLLHGLEHCH-----SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLH-----s~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+..++.||+.||.||| +.+|+|+||+|+|||++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 2457889999999999 999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
..... ......++..|+|||++.. ..++.++|+|||||++|+|++|..||...+..+....+.... .+
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--FR-------- 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--CC--------
Confidence 54322 1234467899999999876 557899999999999999999999998877554444432210 00
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++..+.+||.+||..+|.+|||+.+||+|||+
T Consensus 229 ------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 ------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0113467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=292.20 Aligned_cols=157 Identities=33% Similarity=0.514 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC-----------------CCCCCCccccccc
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-----------------TGHRQPLTSRVVT 225 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~-----------------~~~~~~~~~~~gt 225 (634)
++.+++||++||.|+|++|||||||||.||+|+.++.|||+|||+++... .......+..+||
T Consensus 699 ~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT 778 (1351)
T KOG1035|consen 699 AWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT 778 (1351)
T ss_pred HHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence 46799999999999999999999999999999999999999999997611 0111245677999
Q ss_pred ccCCCcccccCCC--CCCCccccccchhhHHHHhhCCCCCCC-CChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 226 LWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 226 ~~Y~APE~l~~~~--~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
.-|+|||++.+.. .|+.++||||||+|||||+. ||.. +.....+..+.. +..|.+
T Consensus 779 alYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~--g~iP~~----------------- 836 (1351)
T KOG1035|consen 779 ALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK--GSIPEP----------------- 836 (1351)
T ss_pred eeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc--CCCCCC-----------------
Confidence 9999999997755 69999999999999999995 3643 233333444321 222211
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
...+..--+.-..+|+.||+.||.+||||.|+|++.||-
T Consensus 837 ------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 ------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 000112234456899999999999999999999999985
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=253.39 Aligned_cols=189 Identities=30% Similarity=0.511 Sum_probs=152.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||+|+||.||++++..+++.||||.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999973
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 345888999999999999999999999999999999999999999875432111
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||........+..+.. .+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~--------- 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNP--------- 228 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCCC---------
Confidence 11233457889999999876 5678999999999999999999999987655444433321 11100
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.....++..+.++|.+|| .+|.+||+++++++|||+.
T Consensus 229 ---------------~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 ---------------VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 011345678899999999 5999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=262.06 Aligned_cols=187 Identities=21% Similarity=0.364 Sum_probs=148.0
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcE----EehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~----vAlK~----------------------------------------- 162 (634)
...+|++++.||+|+||+||+|++..++.. ||+|+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~ 84 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 84 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCce
Confidence 346899999999999999999998766654 78875
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 245788999999999999999999999999999999999999999986653322
Q ss_pred C-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. .......+..|++||++.+ ..++.++|||||||++|||++ |.+||.+....+.. .++.....++.
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~---------- 232 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ---------- 232 (316)
T ss_pred ceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC----------
Confidence 1 1122233667999999876 678999999999999999997 99999877655433 33222111110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...++.++.+||.+||..||.+|||+.+++.+
T Consensus 233 -----------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 -----------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12356778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=252.92 Aligned_cols=186 Identities=20% Similarity=0.358 Sum_probs=150.1
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||.||+|.+. ++..||+|.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45579999999999999999999964 456688874
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++...........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 245788999999999999999999999999999999999999999976643322222
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 162 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 224 (261)
T cd05072 162 EGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---------------- 224 (261)
T ss_pred CCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 23344678999999875 567889999999999999998 999998877766666653321100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++.++.+||.+||..+|++|||++++++
T Consensus 225 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 ------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=258.21 Aligned_cols=196 Identities=27% Similarity=0.431 Sum_probs=155.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++.+.||.|+||.||++.+..+++.||||.
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 4556899999999999999999999998899999986
Q ss_pred -------------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.+|.|||+ .+|+|+||+|+|||++.++.++|+|||++........
T Consensus 91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 23588899999999997 5999999999999999999999999999876543221
Q ss_pred CCcccccccccCCCcccccCC---CCCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCCchhhhccCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~---~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..++... .+.
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~-------- 238 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPS-------- 238 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCC--------
Confidence 1223467889999998653 2478899999999999999999999976432 33333332211 000
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+ ....++.++.+||.+||..||.+|||+.+++.||||..+
T Consensus 239 ---------~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 239 ---------LP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred ---------CC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 001467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=253.80 Aligned_cols=198 Identities=26% Similarity=0.411 Sum_probs=161.5
Q ss_pred eeEE-EEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 132 FEKL-EKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 132 Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
|.+. +.||+|+|+.|--+....++..||||+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 4433 679999999999999999999999998
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccccccccCC------C
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNT------G 214 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGla~~~~~------~ 214 (634)
...+.+.|+.||.|||.+||.||||||+|||..... .+|||||.+..-+.. .
T Consensus 159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 234778899999999999999999999999986554 489999988753221 1
Q ss_pred CCCCcccccccccCCCccccc----CCCCCCCccccccchhhHHHHhhCCCCCCCCC---------------hHHHHHHH
Q 006714 215 HRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------------EVEQLHKI 275 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~----~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---------------~~e~l~~i 275 (634)
....+.+.+|...|||||+.. ....|+.++|+||||||||-||.|.+||.+.- ...+++.|
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 122344568889999999863 23468999999999999999999999997642 34556677
Q ss_pred HHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCC
Q 006714 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 354 (634)
Q Consensus 276 ~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~ 354 (634)
.+....+|+..| ..++.+++|||..+|..|+.+|.++.++|+|||++.....+.
T Consensus 319 QEGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 319 QEGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred hccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence 776677777666 578999999999999999999999999999999987654443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=256.96 Aligned_cols=186 Identities=23% Similarity=0.338 Sum_probs=150.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCC-----cEEehHH-----------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKK----------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-----~~vAlK~----------------------------------------- 162 (634)
.++|++++.||+|+||.||++.+...+ ..|++|.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468999999999999999999976554 5688875
Q ss_pred ---------------H---------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCce
Q 006714 163 ---------------I---------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 200 (634)
Q Consensus 163 ---------------i---------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~v 200 (634)
+ ..++.||+.||.|||+++|+|+||||+|||++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 1 2478999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHh
Q 006714 201 KLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL 278 (634)
Q Consensus 201 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~ 278 (634)
+|+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875432211 12233455788999998876 568999999999999999998 99999887776665555331
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 279 ~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
... .....++.++.+|+.+||+.||.+|||+.+++++
T Consensus 243 ~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 QLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 0113578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=256.59 Aligned_cols=192 Identities=30% Similarity=0.522 Sum_probs=156.6
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|.....||.|+||.||++.+..+++.+++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 56677899999999999999998999999874
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 178 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 178 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence 345889999999999999999999999999999999999999998865443211 12334578
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+.+..+.... ++.
T Consensus 179 ~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~--------------------- 234 (285)
T cd06648 179 PYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PPK--------------------- 234 (285)
T ss_pred ccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CCC---------------------
Confidence 89999999876 568899999999999999999999998877666655543321 000
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+ .....++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 235 --~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 235 --L-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred --C-cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0 00123678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=250.19 Aligned_cols=198 Identities=28% Similarity=0.463 Sum_probs=164.1
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHHH-----------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI----------------------------------------- 163 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i----------------------------------------- 163 (634)
..+..++|.++++||+|+|..|.+++.+.|.+.||+|++
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 345678999999999999999999999999999999982
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 164 -----------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 164 -----------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+.|...|+.||.|||++|||+||||.+||||+..|++||+|+|+++..-..
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 347778999999999999999999999999999999999999999754322
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC--------CChHHHHHHHHHhcCCCCchh
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG--------RTEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~--------~~~~e~l~~i~~~~g~pp~~~ 286 (634)
.....+.|||+.|+|||++.+ ..|++.+|+|+|||++|||+.|+.||.- +++.-+++-|++.....|
T Consensus 405 -gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip--- 479 (593)
T KOG0695|consen 405 -GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP--- 479 (593)
T ss_pred -CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc---
Confidence 234567899999999999988 7899999999999999999999999962 223334444444322222
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC------HHHHHhccccCCCCCCC
Q 006714 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPYAC 353 (634)
Q Consensus 287 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT------a~elL~hpwf~~~~~~~ 353 (634)
..++-.+..+|+..|+.||.+|.. ..++-.|+||+...|..
T Consensus 480 --------------------------rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 480 --------------------------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred --------------------------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 345667788999999999999964 68999999999776643
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=256.45 Aligned_cols=189 Identities=30% Similarity=0.451 Sum_probs=152.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||++.+..+++.|++|.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 468999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---K 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---h
Confidence 34588899999999999 9999999999999999999999999999865532211 1
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC-----hHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-----~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
...++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.. .....
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~---------- 223 (265)
T cd06605 158 TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPR---------- 223 (265)
T ss_pred cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCC----------
Confidence 2566888999999876 578899999999999999999999996542 2222222211 11000
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+. ...++..+.+||..||..||.+|||+.++|.||||+.+
T Consensus 224 ------------~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 224 ------------LP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ------------CC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 01267889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.38 Aligned_cols=186 Identities=27% Similarity=0.490 Sum_probs=156.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++++.||.|+||.||.+++..+++.+++|.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 59999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-ccc
Confidence 345788999999999999999999999999999999999999999876543321 223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+... .++.
T Consensus 160 ~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~---------------- 220 (256)
T cd08221 160 TVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTP---------------- 220 (256)
T ss_pred ccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCC----------------
Confidence 4567899999999876 45788999999999999999999999887776666665431 1110
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
....++..+.+||.+||..||.+||++.++|+|+|+
T Consensus 221 ----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 ----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 013567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.36 Aligned_cols=188 Identities=33% Similarity=0.536 Sum_probs=154.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|++++.||+|+||+||++.+..+++.||+|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 479999999999999999999998999999884
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++...... .
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~ 169 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----N 169 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----C
Confidence 3447889999999999999999999999999999999999999998755432 2
Q ss_pred cccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 221 SRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
...++..|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+... .++.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~-------------- 233 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT-------------- 233 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC--------------
Confidence 3456788999998852 355788999999999999999999999877665544443211 0000
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+ ....++..+.+||.+||..||.+||++.+++.||||...
T Consensus 234 ---------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 ---------L--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ---------C--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0 001356789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=253.83 Aligned_cols=186 Identities=17% Similarity=0.228 Sum_probs=148.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~------------------------------------------ 162 (634)
...+|++.+.||+|+||.||++.+. ..+..||+|.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4468999999999999999999865 3456888875
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||+|||+++|+|+||||+||||+.++.++|+|||.+........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 456889999999999999999999999999999999999999998765432211
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......++..|+|||++.+ ..++.++|||||||++|||++ |.+||......+.+..+......+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 228 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP------------- 228 (266)
T ss_pred hcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-------------
Confidence 11112234578999999876 678999999999999999775 999999888777666653321111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+|+..||..+|.+|||+.+|++
T Consensus 229 ---------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ---------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=253.21 Aligned_cols=192 Identities=33% Similarity=0.566 Sum_probs=150.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||.||++.+..+++.||+|+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48889999999999999999999999999874
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCC-
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR- 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~- 216 (634)
+..++.||+.||.|||++||+|+||+|+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 345789999999999999999999999999998775 599999999876543211
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 228 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----------- 228 (268)
T ss_pred CCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----------
Confidence 11123456889999999876 5678999999999999999999999975443322222222110000
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.......+++++.+||.+||..||.+|||+.++|+||||+
T Consensus 229 -------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 -------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0011134678899999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=254.81 Aligned_cols=186 Identities=19% Similarity=0.317 Sum_probs=147.2
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCc----EEehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~----~vAlK~----------------------------------------- 162 (634)
..++|+++++||.|+||+||+|++..++. .||+|+
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ 84 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcE
Confidence 45789999999999999999999877776 378885
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||||+|||+++++.+||+|||++........
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 345789999999999999999999999999999999999999999976643221
Q ss_pred C-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. ......++..|++||.+.+ ..++.++|||||||++|||++ |.+||...........+ .....++.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~---------- 232 (279)
T cd05109 165 EYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLPQ---------- 232 (279)
T ss_pred eeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC----------
Confidence 1 1112233577999999876 568899999999999999998 89999876655444333 22111110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...++..+.+||.+||..||++||++.+++.
T Consensus 233 -----------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 233 -----------------PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246778999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=250.08 Aligned_cols=187 Identities=35% Similarity=0.555 Sum_probs=152.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||.||+|.+..+++.|++|.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988899998884
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--cc
Confidence 34578899999999999999999999999999999999999999987654332 12
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....++..|++||.+.....++.++|+|||||++|+|++|.+||......+....+.... ..+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~---------------- 221 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELP---------------- 221 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCC----------------
Confidence 345678889999998653348899999999999999999999998766544444432211 000
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....+++.+.+||.+||..+|.+|||+.++|.||||
T Consensus 222 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 222 ----------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0113467889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.52 Aligned_cols=195 Identities=19% Similarity=0.311 Sum_probs=152.3
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECC-----CCcEEehHH---------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKK--------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~-----tg~~vAlK~--------------------------------------- 162 (634)
+..++|++.++||+|+||.||+|.++. .+..||+|.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345799999999999999999997642 345788884
Q ss_pred --------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEec
Q 006714 163 --------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 204 (634)
Q Consensus 163 --------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~D 204 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 123778999999999999999999999999999999999999
Q ss_pred cccccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006714 205 FGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 282 (634)
Q Consensus 205 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~p 282 (634)
||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+.+..+.... .+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~ 240 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-YL 240 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC
Confidence 9998754322111 1122234677999999876 568899999999999999998 788998877666555443210 00
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh------ccccCCCC
Q 006714 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA------SEYFSTKP 350 (634)
Q Consensus 283 p~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~------hpwf~~~~ 350 (634)
+ ....+++.+.+||.+||+.||.+|||+.++++ ||||....
T Consensus 241 ~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 241 D---------------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred C---------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 0 01245688999999999999999999999987 89998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=251.77 Aligned_cols=184 Identities=29% Similarity=0.457 Sum_probs=149.7
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||.|+||.||++++..+++.|++|+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999998899999885
Q ss_pred --------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccC
Q 006714 163 --------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228 (634)
Q Consensus 163 --------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y 228 (634)
+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCc
Confidence 34578899999999999999999999999999999999999999997665432 12334678899
Q ss_pred CCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC--hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 229 ~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~--~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
++||.+.. ..++.++|+|||||++|+|++|..||.... ..+.+..+......+.
T Consensus 159 ~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------- 214 (262)
T cd05572 159 VAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE----------------------- 214 (262)
T ss_pred cChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC-----------------------
Confidence 99999865 567899999999999999999999998766 4444444432111110
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
.....++.+.+||.+||..||.+||| +.|+++||||+...|
T Consensus 215 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 215 ----FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ----CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 00234778999999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=266.88 Aligned_cols=193 Identities=28% Similarity=0.513 Sum_probs=158.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+-|.|+++||+|+||.||+|.++++|..||||+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 358899999999999999999999999999997
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
|..+++..|.||+|||...-||||||..||||+.+|..||+|||.+-.+.+. ....++..|
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTVIG 191 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTVIG 191 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCcccc
Confidence 3457788899999999999999999999999999999999999999765432 223467789
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
|+.|||||++.. ..|+..+||||||++..||..|+|||........+..| --.||+.+
T Consensus 192 TPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPTF------------------ 249 (502)
T KOG0574|consen 192 TPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPTF------------------ 249 (502)
T ss_pred CcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCCC------------------
Confidence 999999999976 67899999999999999999999999765433222111 11122111
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
......+.++.|||+.||..+|++|.||.++++|||.++.+
T Consensus 250 -----~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 -----KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred -----CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11134578899999999999999999999999999998753
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=258.95 Aligned_cols=192 Identities=31% Similarity=0.530 Sum_probs=155.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||++.+..+++.|++|.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 689999999999999999999988999999885
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 177 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 177 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccC
Confidence 345888999999999999999999999999999999999999998875543222 1233457
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
++.|++||.+.. ..++.++|+|||||++|+|++|.+||...+..+.+..+... +.+.
T Consensus 178 ~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~--------------------- 234 (293)
T cd06647 178 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------------- 234 (293)
T ss_pred ChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC---------------------
Confidence 888999999876 56789999999999999999999999876654433322110 0000
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......++..+.+||.+||..+|.+||++.++|.|+||...
T Consensus 235 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00112467789999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=247.46 Aligned_cols=186 Identities=32% Similarity=0.516 Sum_probs=154.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||++.+..++..|++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58999999999999999999998899999975
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 23578899999999999999999999999999999999999999997665432 12
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....+++.|+|||.+.. ..++.++|+||||+++|+|++|..||......+....+......
T Consensus 160 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 221 (258)
T cd08215 160 AKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP----------------- 221 (258)
T ss_pred ecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC-----------------
Confidence 233467888999998876 56889999999999999999999999877655555544321100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++..+.++|..||..+|++|||+.++|+||||
T Consensus 222 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 222 -----------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0012567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=255.40 Aligned_cols=191 Identities=32% Similarity=0.560 Sum_probs=154.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++++.||.|+||.||+|.+..+++.|++|.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRST 160 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cccc
Confidence 345788999999999999999999999999999999999999999876654322 2234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..++..|+|||.+.+...++.++|+|||||++|+|++|.+||...........+... .++ .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~-----------------~ 221 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP-----------------R 221 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC-----------------C
Confidence 467889999999876556789999999999999999999999876543332221110 000 0
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+. ...++.++.+||.+||..||.+|||+.+++.|+||+..
T Consensus 222 ------~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 222 ------LE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred ------CC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 00 01267889999999999999999999999999999774
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=249.47 Aligned_cols=183 Identities=27% Similarity=0.473 Sum_probs=151.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||++.+..+++.|++|.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999984
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-ccccc
Confidence 34578999999999999999999999999999999999999999987654321 12234
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+......+
T Consensus 160 ~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 219 (255)
T cd08219 160 YVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP------------------- 219 (255)
T ss_pred ccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 567888999999876 568899999999999999999999998877655555443211110
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....++..+.+||.+||+.||.+|||+.++|.-
T Consensus 220 ---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 012456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=248.14 Aligned_cols=186 Identities=30% Similarity=0.514 Sum_probs=152.3
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||.||++.+..++..||+|.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58999999999999999999999998888885
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++ .++|+|||.+....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccc
Confidence 245778999999999999999999999999998875 46999999987664322 122
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+++.|+|||++.. ..++.++|+|||||++|+|++|..||...+..+....+.... .
T Consensus 160 ~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------------- 219 (257)
T cd08225 160 YTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY--F----------------- 219 (257)
T ss_pred cccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--C-----------------
Confidence 23457888999998875 467899999999999999999999998776655554433211 0
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......++..+.++|.+||..+|++|||+.++|.||||
T Consensus 220 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 ---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00113567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=250.68 Aligned_cols=185 Identities=25% Similarity=0.346 Sum_probs=148.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.++||+|+||+||+|++..+ ..||+|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence 346899999999999999999998665 4588885
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++.............
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 34578899999999999999999999999999999999999999997654332222223
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++..|++||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+..... ++
T Consensus 163 ~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~----------------- 223 (262)
T cd05071 163 AKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP----------------- 223 (262)
T ss_pred CcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CC-----------------
Confidence 345678999998865 568999999999999999999 8899988776666555432110 00
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||+.||.+|||+.++++
T Consensus 224 ----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.58 Aligned_cols=190 Identities=33% Similarity=0.529 Sum_probs=155.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||+|.+..+++.|++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 379999999999999999999999999999985
Q ss_pred --------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNT 159 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccc
Confidence 35688999999999999 99999999999999999999999999998766433221 124
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
..++..|+|||.+.. ..++.++|+|||||++|+|++|.+||.... ..+....+... ...
T Consensus 160 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~-------------- 221 (264)
T cd06623 160 FVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPP-------------- 221 (264)
T ss_pred eeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CCC--------------
Confidence 456889999999876 578899999999999999999999997764 33333333211 000
Q ss_pred CCCCCCCchhhhhcCC-CcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~-~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..... ++..+.+||..||..+|.+|||+.++|+||||+..
T Consensus 222 -----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 222 -----------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -----------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 00123 67889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=248.98 Aligned_cols=185 Identities=34% Similarity=0.571 Sum_probs=150.9
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||.|+||.||++.+..+++.|++|.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999985
Q ss_pred --------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-------CCccc
Q 006714 163 --------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPLTS 221 (634)
Q Consensus 163 --------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-------~~~~~ 221 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 345889999999999999999999999999999999999999999875433211 01233
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..++..|++||.+.. ..++.++|||||||++|+|++|..||......+....+......++.
T Consensus 161 ~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 222 (265)
T cd05579 161 IVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE----------------- 222 (265)
T ss_pred cccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc-----------------
Confidence 456788999999876 45788999999999999999999999888777666665431111110
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH---HHHHhccccCCCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALASEYFSTKP 350 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa---~elL~hpwf~~~~ 350 (634)
...++..+.+||.+||+.+|.+|||+ .++|+||||+...
T Consensus 223 ----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 223 ----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 01257889999999999999999999 9999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=255.07 Aligned_cols=187 Identities=30% Similarity=0.475 Sum_probs=148.1
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||+|+||+||+|.+..+++.||+|+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999874
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
+..++.||+.+|.|||+++|+|+||+|+|||++.++.++|+|||++...... .......++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccCCC
Confidence 3457889999999999999999999999999999999999999998765432 1223345678
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|++||++.+ ..++.++|||||||++|+|++|+.||...........+.......+
T Consensus 159 ~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 214 (277)
T cd05577 159 GYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA----------------------- 214 (277)
T ss_pred CcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc-----------------------
Confidence 8999999876 4588999999999999999999999976544222222211110000
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 352 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~~ 352 (634)
......+++.+.+||.+||..||.+|| ++.+++.||||....|.
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 215 --VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred --ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 011134688999999999999999999 99999999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=250.17 Aligned_cols=191 Identities=34% Similarity=0.506 Sum_probs=146.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.+.....||+|+||.||++++..++..|++|.
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 3455566789999999999999999999999984
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++. ++.++|+|||++....... ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~ 165 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PC 165 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Cc
Confidence 2346789999999999999999999999999976 6789999999987553221 11
Q ss_pred cccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++..|+|||++... ..++.++|||||||++|+|++|.+||...................
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 230 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH--------------- 230 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC---------------
Confidence 2234568899999998542 347889999999999999999999997543221111100000000
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
......+++++.+||.+||..+|.+|||+.+++.||||
T Consensus 231 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 231 -----------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.11 Aligned_cols=196 Identities=30% Similarity=0.487 Sum_probs=152.9
Q ss_pred CeeEEEEecccCceeEEEEEEC---CCCcEEehHH---------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~--------------------------------------------- 162 (634)
.|++.+.||.|+||.||+|++. .+++.||+|.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999975 4788899884
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 344677999999999999999999999999999999999999999876544332
Q ss_pred CCcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......++..|++||.+... ..++.++|||||||++|+|++|..||...........+...+.....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 229 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----------- 229 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-----------
Confidence 333345678899999998642 34678999999999999999999999754332222222221100000
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
+ ....++..+.+||.+||..||.+|| ++.+++.||||....|
T Consensus 230 -------~-------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 230 -------P-------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -------C-------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0 0134678899999999999999997 8999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=250.36 Aligned_cols=186 Identities=23% Similarity=0.364 Sum_probs=148.6
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||.||+|.+. .+..||+|.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~ 81 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEY 81 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEe
Confidence 34578999999999999999999865 455678875
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 3567889999999999999999999999999999999999999999765432222112
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++..|+|||++.. ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... .++
T Consensus 162 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------- 223 (260)
T cd05070 162 GAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMP---------------- 223 (260)
T ss_pred CCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC----------------
Confidence 2234567999998865 568899999999999999999 899998877766666553211 000
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+..+.+||.+||..||.+|||+.++++
T Consensus 224 -----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 224 -----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 01356788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=257.11 Aligned_cols=187 Identities=20% Similarity=0.324 Sum_probs=148.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCC-----CcEEehHH----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKK---------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~t-----g~~vAlK~---------------------------------------- 162 (634)
...+|+++++||.|+||.||++.+..+ ++.||||.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 346799999999999999999987543 46788886
Q ss_pred -------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc
Q 006714 163 -------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 199 (634)
Q Consensus 163 -------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~ 199 (634)
+..++.||+.||.|||+++|+|+||||+|||+++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 1236679999999999999999999999999999999
Q ss_pred eEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHH
Q 006714 200 LKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFK 277 (634)
Q Consensus 200 vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~ 277 (634)
+||+|||++........ .......+++.|+|||.+.. ..++.++|||||||++|||++ |.+||.+....+.+..+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875533221 11223344678999999875 568899999999999999998 8899988777666666543
Q ss_pred hcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 278 ~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+ ....++..+.+|+..||+.+|.+||++.+|+..
T Consensus 242 ~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLP----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCC----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 21110 013578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=249.17 Aligned_cols=186 Identities=21% Similarity=0.352 Sum_probs=149.9
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||.||+|.+. +++.||+|.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence 34578999999999999999999864 567899985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 2457889999999999999999999999999999999999999999765532222222
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+......+
T Consensus 162 ~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 223 (260)
T cd05067 162 GAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------------- 223 (260)
T ss_pred CCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----------------
Confidence 3344678999998865 567899999999999999998 999998877666655543211100
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++.++.+||.+||..+|++|||+++++.
T Consensus 224 -----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 -----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=263.82 Aligned_cols=200 Identities=27% Similarity=0.437 Sum_probs=172.4
Q ss_pred CcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHHH---------------------------------------
Q 006714 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI--------------------------------------- 163 (634)
Q Consensus 123 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i--------------------------------------- 163 (634)
.+..+...+++++..||-|+||.|=++........+|+|++
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 44455667899999999999999999997666556999972
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 164 ------------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 164 ------------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+.|+..+++|++|||.+|||+|||||+|+||+.+|.+||.|||+|+.+..
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 23667889999999999999999999999999999999999999998876
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
+. ...+.|||+.|.|||++++ ...+.++|+|+||+++||||+|.|||.+.+....+..|++.+...
T Consensus 573 g~--KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------- 638 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------- 638 (732)
T ss_pred CC--ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----------
Confidence 54 3477899999999999987 567899999999999999999999999999999999998754221
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 352 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~~ 352 (634)
+....++..+.+||+++...+|.+|.. +.+|-.|.||....|.
T Consensus 639 ----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 639 ----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 112467888999999999999999986 8999999999886664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=268.65 Aligned_cols=187 Identities=22% Similarity=0.378 Sum_probs=156.2
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
..+..+.+..++.||+|.||.||++.+..+ ..||+|.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 344455677789999999999999998543 3577775
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..|+.||++|++||+++++|||||-..||||+++..+||+|||+|+...++...
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 4568999999999999999999999999999999999999999999966655443
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.....-....|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.+..+.+....|.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~------------- 425 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR------------- 425 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-------------
Confidence 3333344778999999975 679999999999999999999 9999999999999998865432221
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHH
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL 341 (634)
...+|+.+.+||..||..+|++|||++.+.
T Consensus 426 ---------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 ---------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 146899999999999999999999998665
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=255.03 Aligned_cols=191 Identities=31% Similarity=0.522 Sum_probs=155.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|+++++||.|+||.||+|.+..++..||+|.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 368899999999999999999998999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||+++++|+||+|+|||++.++.++|+|||++....... .......
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 162 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccccccc
Confidence 34688899999999999999999999999999999999999999987654322 1223345
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+... .++
T Consensus 163 ~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-------------------- 219 (277)
T cd06640 163 GTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NPP-------------------- 219 (277)
T ss_pred CcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CCC--------------------
Confidence 6888999999876 56789999999999999999999999876654443332110 000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....++..+.+||.+||..+|.+||++.++|.|+||....
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 220 ------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 01124677899999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=255.18 Aligned_cols=156 Identities=19% Similarity=0.227 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++........ .......++..|+|||++.. ..++.+
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 220 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTA 220 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCch
Confidence 4788999999999999999999999999999999999999999875533221 11122344778999999876 568999
Q ss_pred cccccchhhHHHHhh--CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 244 VDLWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 244 sDIWSLG~iLyeLlt--G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
+|||||||++|+|++ +..||...+..+.+..+........... .......++..+.+
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~ 279 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPCPQGLYE 279 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCCCHHHHH
Confidence 999999999999986 5678887766665555433211110000 00011356788999
Q ss_pred HHHHhhccCcCCCcCHHHHHh
Q 006714 322 LIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~ 342 (634)
||.+||..||.+|||+.+|.+
T Consensus 280 li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 280 LMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHccCCchhCcCHHHHHH
Confidence 999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=243.01 Aligned_cols=186 Identities=36% Similarity=0.561 Sum_probs=152.3
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||.|+||.||++.+..+++.|++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48899999999999999999988899998885
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||.++++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 345888999999999999999999999999999999999999999876654321 23456
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
++..|++||.+.. ..++.++|||||||++|+|++|.+||...+....+..+... ..+...
T Consensus 159 ~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~----------------- 218 (253)
T cd05122 159 GTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPGLR----------------- 218 (253)
T ss_pred cCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCCcC-----------------
Confidence 6888999999876 45788999999999999999999999877555444443221 110000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
....++..+.+||.+||..||.+|||+.++|.|||
T Consensus 219 -------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 219 -------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=247.23 Aligned_cols=185 Identities=24% Similarity=0.355 Sum_probs=148.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.++||.|+||.||++.+..+ ..+|+|.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFM 82 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcC
Confidence 346899999999999999999997655 3578874
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+.+|+|+||+|+|||+++++.++|+|||++.............
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 34578899999999999999999999999999999999999999997654332222222
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+.... .++
T Consensus 163 ~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~----------------- 223 (260)
T cd05069 163 AKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RMP----------------- 223 (260)
T ss_pred CccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC-----------------
Confidence 344677999998865 568899999999999999999 999999887776666553321 000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||..||.+||+++++++
T Consensus 224 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 ----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=281.84 Aligned_cols=102 Identities=32% Similarity=0.473 Sum_probs=83.3
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+....+.+..++......+.
T Consensus 541 vGT~~Y~APE~l~~-~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~------------------ 601 (669)
T cd05610 541 LGTPDYLAPELLLG-KPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE------------------ 601 (669)
T ss_pred eeCccccCHHHcCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCc------------------
Confidence 45889999999987 56899999999999999999999999998887777776442111110
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
....++..+.++|..||..||.+|||+.++|+||||....+
T Consensus 602 --------~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~~~~~ 642 (669)
T cd05610 602 --------GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDW 642 (669)
T ss_pred --------ccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHhhcCCCH
Confidence 01246788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=253.77 Aligned_cols=194 Identities=28% Similarity=0.430 Sum_probs=152.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||++.+..+++.||+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 45789999999999999999999999999999984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.+|.|||+ ++|+|+||+|+|||++.++.++|+|||++....... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 34678899999999997 599999999999999999999999999986543221 1
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH----HHH---HHHHh-cCCCCchhhhccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE----QLH---KIFKL-CGSPPDDYWKKSK 291 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e----~l~---~i~~~-~g~pp~~~~~~~~ 291 (634)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+ ... .++.. ....+.
T Consensus 160 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (284)
T cd06620 160 DTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------- 231 (284)
T ss_pred CccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-------
Confidence 23467899999999876 578899999999999999999999998654321 001 11110 000000
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+ ...++..+.+||.+||..||.+|||+.|+++|+||...
T Consensus 232 ---------~~~--------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 ---------RLP--------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ---------CCC--------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000 01367789999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=246.20 Aligned_cols=184 Identities=21% Similarity=0.341 Sum_probs=148.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||++++.. +..+|+|.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 3579999999999999999998754 55788874
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 345888999999999999999999999999999999999999999875533222111222
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+........
T Consensus 162 ~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------ 222 (256)
T cd05114 162 KFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------------------ 222 (256)
T ss_pred CCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC------------------
Confidence 34567999999875 568899999999999999999 8999988887777766644211000
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+..+.+||.+||..||.+|||+.++++
T Consensus 223 ----------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 223 ----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0124677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=247.71 Aligned_cols=186 Identities=22% Similarity=0.318 Sum_probs=148.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCC---CcEEehHH-------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKK------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~t---g~~vAlK~------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|.+..+ ...||+|.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 46899999999999999999998644 45788875
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 3467899999999999999999999999999999999999999999876421111
Q ss_pred -CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 218 -PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 218 -~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......++.|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 229 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP------------ 229 (266)
T ss_pred eeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 1112233578999998875 568899999999999999997 9999987776666555533211110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||.+||..+|++||++.+++++
T Consensus 230 ----------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 ----------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=255.29 Aligned_cols=192 Identities=30% Similarity=0.495 Sum_probs=155.6
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|+...+||+|+||.||++.+..+++.||+|+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 4445789999999999999999999999885
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++........ ......+++
T Consensus 102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~ 180 (292)
T cd06657 102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTP 180 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCc
Confidence 345889999999999999999999999999999999999999999865543221 123346788
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|++||.+.. ..++.++|+|||||++|+|++|.+||.+....+.+..+.......
T Consensus 181 ~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------------------ 235 (292)
T cd06657 181 YWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK------------------------ 235 (292)
T ss_pred cccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc------------------------
Confidence 9999998865 567889999999999999999999998876665555443211000
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
+ .....++..+.+||.+||..||.+||++.++|.||||.....
T Consensus 236 -~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 236 -L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -c-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 0 011346788999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=250.99 Aligned_cols=193 Identities=28% Similarity=0.424 Sum_probs=151.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.++||.|+||.||++.+..+++.||+|.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.+|.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 235788999999999999999999999999999999999999999865433211
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC-----hHHHHHHHHHhcCCCCchhhhccC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-----~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
....++..|++||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+... ... ..
T Consensus 161 ---~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~-~~---- 228 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP-EL---- 228 (287)
T ss_pred ---ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch-hh----
Confidence 23356788999998875 678899999999999999999999997652 12222222110 000 00
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
... ...-...++.+.+||.+||..||.+|||+.|++.||||..
T Consensus 229 -------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 229 -------KDE-------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -------ccC-------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000 0000134678899999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=248.27 Aligned_cols=186 Identities=32% Similarity=0.501 Sum_probs=148.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||+|++..+++.||||.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 589999999999999999999999999999983
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 245788999999999999999999999999999999999999999876543221
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ...+...+.....++.
T Consensus 162 -~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL----------- 228 (267)
T ss_pred -HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-----------
Confidence 1223457888999999876 5678899999999999999999999865432 2222222222222211
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....++..+.+||.+||..+|.+||++.++|+.
T Consensus 229 ---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 ---------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ---------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012456789999999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=254.63 Aligned_cols=188 Identities=31% Similarity=0.490 Sum_probs=154.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|..+++||+|+||+||+|++..+++.|++|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 347888999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++..... ..
T Consensus 101 e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~ 175 (313)
T cd06633 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN 175 (313)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence 345788999999999999999999999999999999999999998864322 23
Q ss_pred cccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 221 SRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
...++..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.... .+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------------- 239 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPT-------------- 239 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC--------------
Confidence 4467889999999842 2457889999999999999999999998877666555543211 110
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||+.+|.+||++.++|.||||...
T Consensus 240 -----------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 240 -----------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0012456779999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=279.46 Aligned_cols=185 Identities=24% Similarity=0.408 Sum_probs=149.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+++|.++|.+|||+.||+|++...+..||+|.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 578999999999999999999998889999997
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
|.+||.|+++||.+||... |||||||-|||||+.++.+||||||.+.-.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 6789999999999999997 999999999999999999999999998643
Q ss_pred CCCCCCC--------cccccccccCCCcccc--cCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCC
Q 006714 212 NTGHRQP--------LTSRVVTLWYRPPELL--LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 212 ~~~~~~~--------~~~~~gt~~Y~APE~l--~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
....... -.....|+.|++||++ .....++.++|||+|||+||.||+...||.......++.- -..
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng----~Y~ 272 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG----NYS 272 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec----ccc
Confidence 2221100 0112348999999987 3346789999999999999999999999986543222111 111
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
+| .++.++..+.+||..||+.||.+||++-+++.+-+
T Consensus 273 ~P---------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 273 FP---------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CC---------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 11 12467888999999999999999999999987643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=245.36 Aligned_cols=186 Identities=22% Similarity=0.345 Sum_probs=149.0
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++.+.||+|+||.||++.+. +++.||+|.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34568999999999999999999975 456788885
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 346888999999999999999999999999999999999999999986653221111
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+..... ++
T Consensus 162 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--------------- 224 (261)
T cd05068 162 EGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MP--------------- 224 (261)
T ss_pred CCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC---------------
Confidence 11222457999998876 668899999999999999999 9999988877666665533211 00
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||+.||.+||++.+++.
T Consensus 225 ------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 ------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=255.04 Aligned_cols=190 Identities=32% Similarity=0.500 Sum_probs=153.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++++.||.|+||.||++.+..++..||+|.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 468888999999999999999998999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++........ ......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhccc
Confidence 345889999999999999999999999999999999999999999876543221 112345
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+... .++
T Consensus 163 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-------------------- 219 (277)
T cd06642 163 GTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPP-------------------- 219 (277)
T ss_pred CcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CCC--------------------
Confidence 6888999999876 56889999999999999999999999765544333322110 000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..+|.+|||+.++|.||||...
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 220 ------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0012467789999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=249.93 Aligned_cols=187 Identities=18% Similarity=0.285 Sum_probs=146.4
Q ss_pred cCCCeeEEEEecccCceeEEEEEECC-----CCcEEehHH----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKK---------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~-----tg~~vAlK~---------------------------------------- 162 (634)
..++|++.+.||+|+||.||++.+.. ++..||+|.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998642 346688874
Q ss_pred -------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecc
Q 006714 163 -------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 205 (634)
Q Consensus 163 -------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DF 205 (634)
+..++.||+.||.|||+.+++|+||||+|||++.++.++|+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 1235678999999999999999999999999999999999999
Q ss_pred ccccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 006714 206 GLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPP 283 (634)
Q Consensus 206 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp 283 (634)
|++......... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+..... +
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~- 240 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-L- 240 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C-
Confidence 998754322111 1112244678999999876 568999999999999999998 7899988776655554433110 0
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 284 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.....++..+.+||.+||+.||.+|||+.|++.+
T Consensus 241 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 --------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=243.06 Aligned_cols=186 Identities=31% Similarity=0.560 Sum_probs=154.0
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.+.||+|+||.||++++..+++.|++|.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998999999875
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASV 159 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cccc
Confidence 3568899999999999999999999999999999999999999999866543221 2334
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
.++..|++||.+.+ ..++.++|||+||+++|+|++|.+||...........+... ..+
T Consensus 160 ~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------------------- 217 (254)
T cd06627 160 VGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--DHP------------------- 217 (254)
T ss_pred ccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--CCC-------------------
Confidence 56888999999876 44789999999999999999999999876654444443210 000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++..+.+||.+||..+|++|||+.++|.||||
T Consensus 218 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 -------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0113567889999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=247.77 Aligned_cols=188 Identities=20% Similarity=0.320 Sum_probs=149.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC-----cEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-----~~vAlK~-------------------------------------- 162 (634)
++..++|++.+.||+|+||.||++.+.... ..||+|.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 355679999999999999999999986443 7788886
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEe
Q 006714 163 ---------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 203 (634)
Q Consensus 163 ---------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~ 203 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 12367799999999999999999999999999999999999
Q ss_pred ccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCC
Q 006714 204 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 204 DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
|||++........ .......++..|+|||.+.. ..++.++|||||||++|||++ |.+||...+..+....+.. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCC
Confidence 9999875543221 11223345778999998875 568899999999999999998 9999988776665555431 111
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
++ ....++..+.+||.+||+.+|.+|||+.++++
T Consensus 240 ~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LD---------------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC---------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 10 01235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=249.62 Aligned_cols=186 Identities=18% Similarity=0.298 Sum_probs=146.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcE----EehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~----vAlK~----------------------------------------- 162 (634)
..++|++++.||+|+||+||+|.+..++.. +++|.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ 84 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccE
Confidence 346899999999999999999998777763 66654
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||++........
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 345889999999999999999999999999999999999999999976543222
Q ss_pred C-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. ......++..|++||.+.+ ..++.++|||||||++|||++ |..||.+.........+ .....++.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~---------- 232 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQ---------- 232 (279)
T ss_pred ccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC----------
Confidence 1 1223345678999999876 568999999999999999998 99999887655433332 21111110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+.++.+++.+||..||.+|||+.|+++
T Consensus 233 -----------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 -----------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=263.68 Aligned_cols=149 Identities=23% Similarity=0.341 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC-cccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
|+.||+.||.|||+++|+||||||+|||++.++.++|+|||++.......... .....+++.|+|||++.. ..++.++
T Consensus 217 i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 295 (374)
T cd05106 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQS 295 (374)
T ss_pred HHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccc
Confidence 56889999999999999999999999999999999999999987654322111 112234567999999876 6789999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|+|++ |.+||........+..+......+. ....+++++.+||
T Consensus 296 DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li 348 (374)
T cd05106 296 DVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS---------------------------RPDFAPPEIYSIM 348 (374)
T ss_pred cHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc---------------------------CCCCCCHHHHHHH
Confidence 99999999999997 9999987655444444433211110 0023578899999
Q ss_pred HHhhccCcCCCcCHHHHHh
Q 006714 324 ETLLSVEPYKRATASAALA 342 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~ 342 (634)
.+||+.||.+|||+.++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=260.41 Aligned_cols=150 Identities=23% Similarity=0.328 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+||||||+||||+.++.++|+|||++......... ......++..|+|||++.+ ..++.++
T Consensus 178 ~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 256 (337)
T cd05054 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQS 256 (337)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccc
Confidence 4578999999999999999999999999999999999999999765432211 1122344678999999876 6789999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||+||||++ |.+||.+....+.+...+.....+. .....++++.+|+
T Consensus 257 Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~ 309 (337)
T cd05054 257 DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---------------------------APEYATPEIYSIM 309 (337)
T ss_pred cHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC---------------------------CCccCCHHHHHHH
Confidence 99999999999997 9999987554443333322110000 0124567899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
.+||+.+|++||++.++++|
T Consensus 310 ~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=250.76 Aligned_cols=190 Identities=33% Similarity=0.514 Sum_probs=155.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+-|++++.||.|+||.||++.+..+++.||||+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 358899999999999999999988999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++....... .......
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcccc
Confidence 35688999999999999999999999999999999999999999987554321 1122345
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+... .++
T Consensus 163 ~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------------------- 219 (277)
T cd06641 163 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPP-------------------- 219 (277)
T ss_pred CCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCC--------------------
Confidence 6888999998875 56788999999999999999999999876655444443211 000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++.++.+||.+||..+|.+||++.++|+||||...
T Consensus 220 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0113467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=245.93 Aligned_cols=187 Identities=23% Similarity=0.339 Sum_probs=150.6
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++.++||+|+||+||++.+. .++.|+||.
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 355689999999999999999999975 456788875
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||+|+||||+.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 34688899999999999999999999999999999999999999987654321111
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 225 (261)
T cd05034 161 REGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-------------- 225 (261)
T ss_pred hhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 122233567999999876 568899999999999999998 9999988877776666643211110
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+..+.++|.+||..||.+||++.+++.
T Consensus 226 --------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 --------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1235778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=249.81 Aligned_cols=186 Identities=23% Similarity=0.347 Sum_probs=147.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECC-----CCcEEehHH-----------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKK----------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~-----tg~~vAlK~----------------------------------------- 162 (634)
.+.|.+.+.||+|+||.||+|.+.. ++..|++|.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4689999999999999999999977 677888885
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFG 206 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFG 206 (634)
+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 234788999999999999999999999999998654 59999999
Q ss_pred cccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCc
Q 006714 207 LANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPD 284 (634)
Q Consensus 207 la~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~ 284 (634)
++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+... ..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~- 241 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLD- 241 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC-
Confidence 99765322111 1112223567999999876 568999999999999999997 99999887766655444221 0000
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 285 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 285 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....++..+.+||.+||..||++|||+.++|+|
T Consensus 242 --------------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 --------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 013467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=242.87 Aligned_cols=184 Identities=29% Similarity=0.500 Sum_probs=152.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|++.++||+|+||.||++.+..+++.+++|.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999999999999874
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 2357789999999999999999999999999999999999999999766543 1
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.... .+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------------- 219 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YP--------------- 219 (256)
T ss_pred cccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CC---------------
Confidence 223456889999999876 667889999999999999999999998877655444432211 00
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++.++.+||.+||..+|.+|||+.++|+||++
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 -----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0012467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=259.44 Aligned_cols=211 Identities=26% Similarity=0.364 Sum_probs=147.4
Q ss_pred EEeccc--CceeEEEEEECCCCcEEehHH---------------------------------------------------
Q 006714 136 EKIGQG--TYSSVFRARDLDTGKIVALKK--------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G--~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------------- 162 (634)
..||.| +|++||++++..+++.||+|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 999999999999999999986
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC------
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ------ 217 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~------ 217 (634)
+..++.||+.||+|||+++|+||||||+|||++.++.++|+||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 2358889999999999999999999999999999999999999865322111000
Q ss_pred CcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc-
Q 006714 218 PLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA- 295 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~- 295 (634)
......++..|++||++.+. ..++.++|||||||++|+|++|.+||........+..++......+ |.....+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 240 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP---LDITTFPCEE 240 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC---ccccccchhh
Confidence 00112235679999998753 3478999999999999999999999988766555444433221111 110000000
Q ss_pred -cc---------------CC----CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 -TL---------------FK----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 -~~---------------~~----~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.. .. ...............++..+.+||.+||++||.+|||+.++|+||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 00 00000000001113467789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=246.72 Aligned_cols=150 Identities=19% Similarity=0.258 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC-cccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......... ......+..|+|||.+.. ..++.+
T Consensus 117 ~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~ 195 (273)
T cd05035 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSK 195 (273)
T ss_pred HHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcc
Confidence 467899999999999999999999999999999999999999987654322111 111233567999998865 668899
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||||||++|||++ |.+||.+....+.+..+.... .+ .....++..+.+|
T Consensus 196 ~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~l 247 (273)
T cd05035 196 SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--RL--------------------------KQPEDCLDELYDL 247 (273)
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCcCCCHHHHHH
Confidence 999999999999999 899998877766555543211 00 0113467889999
Q ss_pred HHHhhccCcCCCcCHHHHHhc
Q 006714 323 IETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~h 343 (634)
|.+||..||.+|||+.+++.+
T Consensus 248 i~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 248 MYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=249.93 Aligned_cols=185 Identities=22% Similarity=0.328 Sum_probs=147.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECC-----CCcEEehHH-----------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKK----------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~-----tg~~vAlK~----------------------------------------- 162 (634)
.++|.+++.||+|+||.||+|.+.. +++.||+|.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4689999999999999999998753 357788876
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEE
Q 006714 163 ----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 202 (634)
Q Consensus 163 ----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL 202 (634)
+..++.||+.+|.|||+++|+|+||||+|||++.++.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 0235789999999999999999999999999999999999
Q ss_pred eccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcC
Q 006714 203 ADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 280 (634)
Q Consensus 203 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g 280 (634)
+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875432211 11123344678999999876 668999999999999999998 9999988777666655532111
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.. ....++..+.+||.+||..||.+|||+.|+++
T Consensus 243 ~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQ----------------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CC----------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=246.09 Aligned_cols=188 Identities=29% Similarity=0.500 Sum_probs=152.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||+|+||.||++++..+++.||+|.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999973
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 215 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 215 (634)
+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 34578899999999999999999999999999999999999999987543211
Q ss_pred -CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 -~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
........++..|+|||++.+ ..++.++|+|||||++|+|++|++||......+.+.++. ..+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCCC---------
Confidence 111223457889999999876 567899999999999999999999998766555444432 111100
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....+++.+.++|.+||. +|..|||+.++|.|||.
T Consensus 229 ---------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ---------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0113577889999999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=247.47 Aligned_cols=183 Identities=22% Similarity=0.332 Sum_probs=150.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
..+|+++++||.|+||+||+|++.. ++.+++|.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3579999999999999999999877 78888886
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++......... ..
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~ 162 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SS 162 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-cc
Confidence 3458889999999999999999999999999999999999999999765432211 12
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++..|++||++.. ..++.++|||||||++|+|++ |..||......+.+..+..... ++
T Consensus 163 ~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~---------------- 224 (261)
T cd05148 163 DKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-MP---------------- 224 (261)
T ss_pred CCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-CC----------------
Confidence 3344677999998875 568899999999999999998 8999988877777666643211 10
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 225 -----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 -----------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=254.68 Aligned_cols=188 Identities=30% Similarity=0.504 Sum_probs=153.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
..|.+++.||+|+||+||++++..++..|++|.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 468889999999999999999998998888875
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+++++|+||+|+|||++.++.++|+|||++...... .
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~ 169 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----c
Confidence 3457889999999999999999999999999999999999999998765432 2
Q ss_pred cccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 221 SRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
...++..|+|||++.+ ...++.++|||||||++|+|++|..||...+..+.+..+..... +.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~--------------- 233 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA--------------- 233 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CC---------------
Confidence 3456888999999752 24578899999999999999999999977655544444332110 00
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 234 -----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 234 -----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -----------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0012467789999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=246.98 Aligned_cols=151 Identities=20% Similarity=0.254 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC-cccccccccCCCcccccCCCCCCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......... ......++.|++||.+.+ ..++.
T Consensus 115 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~ 193 (272)
T cd05075 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTT 193 (272)
T ss_pred HHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcCh
Confidence 3577899999999999999999999999999999999999999998654322111 112234678999999876 56899
Q ss_pred ccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 243 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 243 ~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
++|||||||++|+|++ |.+||.+....+....+.... .++ ....++..+.+
T Consensus 194 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~ 245 (272)
T cd05075 194 KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLK---------------------------QPPDCLDGLYS 245 (272)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCC---------------------------CCCCCCHHHHH
Confidence 9999999999999999 899998877665555443210 000 01346778999
Q ss_pred HHHHhhccCcCCCcCHHHHHhc
Q 006714 322 LIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~h 343 (634)
||.+||..||.+|||+.+|+++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 246 LMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=248.67 Aligned_cols=196 Identities=30% Similarity=0.478 Sum_probs=148.6
Q ss_pred CeeEEEEecccCceeEEEEEEC---CCCcEEehHH---------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~--------------------------------------------- 162 (634)
+|++.+.||+|+||.||++++. .+++.||||.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 4567777774
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.+|.|||+.+++|+||+|.|||++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 345778999999999999999999999999999999999999999876543322
Q ss_pred CCcccccccccCCCcccccCCC-CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~-~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......++..|++||.+.+.. .++.++||||||+++|+|++|..||...........+.+......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 228 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK------------ 228 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC------------
Confidence 2222345788999999986532 367899999999999999999999964332211111111100000
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC---HHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~elL~hpwf~~~~~ 351 (634)
......++..+.+||.+||+.||++||| +.++|+||||+...|
T Consensus 229 -------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 229 -------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred -------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 0001246778999999999999999998 577899999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=245.22 Aligned_cols=185 Identities=21% Similarity=0.316 Sum_probs=147.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||++.+.. +..+|+|.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3579999999999999999998754 44588874
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..............
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 456899999999999999999999999999999999999999999875543221111222
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 162 ~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 222 (256)
T cd05113 162 KFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR------------------ 222 (256)
T ss_pred ccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC------------------
Confidence 34577999999875 568899999999999999998 9999987776666555533211100
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+..+.+||.+||..||.+|||+.+||.+
T Consensus 223 ----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 ----------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 02356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=253.31 Aligned_cols=187 Identities=32% Similarity=0.508 Sum_probs=154.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|.+.+.||+|+||.||++++..++..||+|+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~ 180 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NS 180 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----cc
Confidence 3457889999999999999999999999999999999999999998654322 23
Q ss_pred ccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 222 RVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
..++..|+|||++.. ...++.++|||||||++|+|++|.+||........+..+......+.
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---------------- 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC----------------
Confidence 456888999998742 24578899999999999999999999987766665555543211110
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....+++.+.+||.+||+.+|.+|||+.++++|+|+...
T Consensus 245 -----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 245 -----------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -----------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 012456789999999999999999999999999999663
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=246.15 Aligned_cols=184 Identities=22% Similarity=0.324 Sum_probs=146.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++.+.||+|+||.||++.+. ++..+|+|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 47999999999999999999875 456788875
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...............
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 162 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK 162 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence 3458899999999999999999999999999999999999999998765432211111222
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 163 ~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 220 (256)
T cd05059 163 FPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL--------------------- 220 (256)
T ss_pred CCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---------------------
Confidence 3457999999876 568899999999999999998 89999887776665554321100
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.....++..+.+|+.+||..+|++|||+.++++.
T Consensus 221 -------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 -------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=247.64 Aligned_cols=187 Identities=20% Similarity=0.359 Sum_probs=147.4
Q ss_pred cCCCeeEEEEecccCceeEEEEEEC----CCCcEEehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDL----DTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~----~tg~~vAlK~----------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|.+. .++..|++|.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4468999999999999999999853 4556788875
Q ss_pred ---------------H----------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc
Q 006714 163 ---------------I----------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 199 (634)
Q Consensus 163 ---------------i----------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~ 199 (634)
+ ..++.||+.||.|||+++|+|+||||+|||++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 1 126679999999999999999999999999999999
Q ss_pred eEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHH
Q 006714 200 LKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFK 277 (634)
Q Consensus 200 vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~ 277 (634)
++|+|||++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999976533211 11223344677999999876 568899999999999999998 9999988766555554432
Q ss_pred hcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 278 ~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. .++ ....+++.+.+||..||+.||.+||++.+|+++
T Consensus 242 ~~-~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQ-LLP---------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CC-cCC---------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11 000 113467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=263.86 Aligned_cols=196 Identities=32% Similarity=0.539 Sum_probs=159.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
....|..++.||-|+||.|.+++..+|...||+|.
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34579999999999999999999999999999996
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccccc-------
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS------- 211 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~------- 211 (634)
++.|+.+|..|+++.|..|+|||||||+|||||.+|+|||+||||+.-+
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 3458889999999999999999999999999999999999999998411
Q ss_pred --CCCC--------------------------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHh
Q 006714 212 --NTGH--------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257 (634)
Q Consensus 212 --~~~~--------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLl 257 (634)
..+. .......+||+.|+|||+|.. ..|+..+|+||.|||||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHh
Confidence 1100 001234588999999999986 77999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCchhhhc-cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC
Q 006714 258 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336 (634)
Q Consensus 258 tG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~-~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT 336 (634)
.|++||...+..+...+++. |.. ..+ .....++.++.+||.++ +.+++.|..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n---------w~~~l~~-----------------~~~~~ls~e~~~li~kL-c~sad~RLG 918 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN---------WRNFLHI-----------------PYQGNLSKEALDLIQKL-CCSADSRLG 918 (1034)
T ss_pred hCCCCccCCCCCcceeeeee---------hhhcccc-----------------ccccccCHHHHHHHHHH-hcChhhhhc
Confidence 99999998887666555533 111 000 11247899999999985 568888875
Q ss_pred ---HHHHHhccccCCCCC
Q 006714 337 ---ASAALASEYFSTKPY 351 (634)
Q Consensus 337 ---a~elL~hpwf~~~~~ 351 (634)
+++|-.||||+...|
T Consensus 919 kng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred ccchhhhhcCccccccch
Confidence 778999999998765
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=283.85 Aligned_cols=192 Identities=32% Similarity=0.528 Sum_probs=157.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
-+++...+||.|.||.||-|.+..+|...|+|.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 368888999999999999999999999999997
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC---CC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QP 218 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---~~ 218 (634)
.+-|..|++.||.|||++|||||||||.||||+.+|.+|++|||.|..+..... ..
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 234778999999999999999999999999999999999999999987654321 22
Q ss_pred cccccccccCCCcccccCCC--CCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 219 LTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~--~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.....||+.|||||++.+.. ...-+.|||||||++.||+||+.||...+. ..++..+ ...-.|
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-~~gh~P------------- 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-AAGHKP------------- 1460 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-hccCCC-------------
Confidence 35678999999999997633 356789999999999999999999976443 3333332 211111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+.| ..++.+..|||..||..||++|+++.|||+|-|-+..
T Consensus 1461 -----q~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 -----QIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----CCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 111 2478899999999999999999999999999997654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=247.67 Aligned_cols=189 Identities=24% Similarity=0.355 Sum_probs=147.6
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC-----cEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-----~~vAlK~-------------------------------------- 162 (634)
.+..++|++.+.||+|+||.||++.+.... ..+|+|.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 345578999999999999999999876433 5677774
Q ss_pred -------------------H---------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecC
Q 006714 163 -------------------I---------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 196 (634)
Q Consensus 163 -------------------i---------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~ 196 (634)
+ ..++.||+.||.|||+++|+|+||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 1 236789999999999999999999999999999
Q ss_pred CCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHH
Q 006714 197 EGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHK 274 (634)
Q Consensus 197 ~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~ 274 (634)
++.++|+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999765432111 1112223567999998865 668899999999999999997 9999988776665554
Q ss_pred HHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 275 i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+..... + ......+..+.+||.+||..||.+|||+.++|++
T Consensus 247 ~~~~~~-~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR-M---------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc-C---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 432110 0 0012457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=247.45 Aligned_cols=185 Identities=21% Similarity=0.313 Sum_probs=146.5
Q ss_pred CCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH-----------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~----------------------------------------- 162 (634)
.++|.+.+.||+|+||.||++.+. .++..+|+|.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 468999999999999999999852 3455677775
Q ss_pred --------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEec
Q 006714 163 --------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 204 (634)
Q Consensus 163 --------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~D 204 (634)
+..++.||+.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 134788999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006714 205 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 282 (634)
Q Consensus 205 FGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~p 282 (634)
||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.... .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~--~ 240 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR--V 240 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--c
Confidence 999875533211 11122334678999999876 668899999999999999998 999998877766666553321 0
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 283 p~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+ .....++.++.+||.+||+.||.+|||+.+++.
T Consensus 241 ~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 L--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred C--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 001246788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=265.46 Aligned_cols=191 Identities=28% Similarity=0.480 Sum_probs=165.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
...|.+...||.|.|+.|.++++..++..||||+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 3579999999999999999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
.+.++.|++.|++|||+++|+|||||.+||||+.+.++||+|||++.++... ....
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--cccc
Confidence 3458899999999999999999999999999999999999999999988744 4457
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
+.||++.|.|||++.+....++.+|+||||++||.|+.|..||++.+-.+.-...+......|
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp----------------- 275 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP----------------- 275 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc-----------------
Confidence 789999999999999977778999999999999999999999998765444333322111111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
--++.++.+||++||.++|.+|++++++..|.|.....
T Consensus 276 ------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 276 ------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 24678899999999999999999999999999998753
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=248.42 Aligned_cols=148 Identities=22% Similarity=0.297 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCcc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
.++.||+.||+|||+++|+|+||||+||||+.++.+||+|||++........ ......+..|+|||++.. ..++.++
T Consensus 123 ~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~ 199 (297)
T cd05089 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNY-SVYTTKS 199 (297)
T ss_pred HHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceec--cCCCCcCccccCchhhcc-CCCCchh
Confidence 4678899999999999999999999999999999999999999864322111 111122456999998875 5688999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|||++ |.+||......+....+...... .....++..+.+||
T Consensus 200 DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li 251 (297)
T cd05089 200 DVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM----------------------------EKPRNCDDEVYELM 251 (297)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHH
Confidence 99999999999997 99999887776655554321100 00134678899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
.+||..||.+|||++++++.
T Consensus 252 ~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 252 RQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=247.73 Aligned_cols=156 Identities=17% Similarity=0.209 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........ .......+++.|+|||++.. ..++.+
T Consensus 134 ~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 212 (296)
T cd05051 134 YMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTK 212 (296)
T ss_pred HHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCcc
Confidence 4678999999999999999999999999999999999999999875433221 11223345678999999876 568999
Q ss_pred cccccchhhHHHHhh--CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 244 VDLWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 244 sDIWSLG~iLyeLlt--G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
+|||||||++|+|++ +..||...+..+.+..+.......... ........++.++.+
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~ 271 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYE 271 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHH
Confidence 999999999999998 678888777666655554321111000 000011346788999
Q ss_pred HHHHhhccCcCCCcCHHHHHh
Q 006714 322 LIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~ 342 (634)
||.+||+.||.+|||+.+|++
T Consensus 272 li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 272 LMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccChhcCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=251.20 Aligned_cols=184 Identities=23% Similarity=0.324 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC------CCcccccccccCCCcccccC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLG 236 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~ 236 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+||+.+........ .......++..|+|||++..
T Consensus 103 ~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcC
Confidence 345889999999999999999999999999999999999999998864432111 11223345778999999865
Q ss_pred C-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc--------CCCCCCCCch
Q 006714 237 A-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL--------FKPQQPYDSS 307 (634)
Q Consensus 237 ~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~--------~~~~~~~~~~ 307 (634)
. ..++.++|||||||++|+|++|.+||........+..... +..+. .+.....+.... ..........
T Consensus 183 ~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd08216 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259 (314)
T ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhcCCcCcccccccccchhhhh
Confidence 3 3578999999999999999999999987665444332222 11111 011000000000 0000000000
Q ss_pred hhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 308 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 308 l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.......++.++.+||.+||.+||++|||+.++|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 011112456789999999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=265.09 Aligned_cols=187 Identities=28% Similarity=0.436 Sum_probs=155.1
Q ss_pred Ce-eEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 131 AF-EKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 131 ~Y-~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+| +...+||+|+|-+||+|.|..+|..||.-.
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 45 445789999999999999999998888754
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHC--CceeccCCCCCceecCC-CceEEeccccccccCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~--gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 214 (634)
++.|++|||.||.|||++ .|||||||.+||+|+.+ |.|||+|+|+|......
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 578999999999999999 59999999999999765 89999999999877643
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.....+|||.|||||++. ..|+..+||||||++++||+|+..||...+...++.+-+- -|..|..+.
T Consensus 200 ---~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~------- 266 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALS------- 266 (632)
T ss_pred ---ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhh-------
Confidence 335689999999999886 5899999999999999999999999987665554444332 133332221
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+--.+++++||.+||.. ...|+|+.|||.||||...
T Consensus 267 ------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 12367899999999999 9999999999999999875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=242.51 Aligned_cols=180 Identities=19% Similarity=0.336 Sum_probs=145.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||.||++.. .+..|++|.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 456899999999999999999976 467788875
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.+|.|||+++|+|+||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~ 157 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----C
Confidence 34688899999999999999999999999999999999999999987543321 2
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... .+
T Consensus 158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~---------------- 218 (256)
T cd05082 158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM---------------- 218 (256)
T ss_pred CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC----------------
Confidence 2233567999998875 568899999999999999997 999998766555544442210 00
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ----------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011356888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=240.47 Aligned_cols=186 Identities=22% Similarity=0.345 Sum_probs=147.9
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++.++||+|+||.||++.+. .+..+++|.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence 44579999999999999999999864 455688874
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 3457889999999999999999999999999999999999999998765432222222
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++..|+|||++.. ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 162 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------ 222 (260)
T cd05073 162 GAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------------------ 222 (260)
T ss_pred CCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC------------------
Confidence 2334567999999875 568889999999999999998 99999887766655544221100
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
......+.++.+|+.+||..||.+||++.+++.
T Consensus 223 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 ----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=240.78 Aligned_cols=185 Identities=23% Similarity=0.345 Sum_probs=147.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
..+|++.+.||.|+||.||++.+. .+..+|+|.
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 358999999999999999999875 366788875
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+++++|+||+|+||+++.++.++|+|||++..............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 355788999999999999999999999999999999999999999875543221111222
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..+..|+|||++.+ ..++.++|||||||++|||++ |.+||......+.+..+.+......
T Consensus 162 ~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 222 (256)
T cd05112 162 KFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK------------------ 222 (256)
T ss_pred ccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC------------------
Confidence 34578999998875 568899999999999999998 9999988776666665532110000
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+..+.+|+.+||..+|.+|||+.+++++
T Consensus 223 ----------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 223 ----------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 02356889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=238.31 Aligned_cols=189 Identities=35% Similarity=0.607 Sum_probs=151.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|.+.+.||+|+||.||++.+..+++.|++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48899999999999999999998999999885
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-Cc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~ 219 (634)
+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 3458899999999999999999999999999999999999999999866543210 12
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....++..|++||.+.. ..++.++|||||||++|+|++|..||...... ...+.......
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------------- 220 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSG----------------- 220 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccccC-----------------
Confidence 33466889999998876 45889999999999999999999999876521 11211111000
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
........++..+.+||.+||..||.+||++.++|.||||
T Consensus 221 -------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 -------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0001113457889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=244.20 Aligned_cols=184 Identities=34% Similarity=0.527 Sum_probs=146.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||++++..+++.|+||.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 579999999999999999999999999999984
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 23578899999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChH--HHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~--e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... +....+.. ...++.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~---------- 228 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPL---------- 228 (267)
T ss_pred cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCCC----------
Confidence 11233467889999999876 56788999999999999999999999754321 21222211 111100
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||..||.+|||+.+|++
T Consensus 229 ----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 229 ----------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 01246788999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=241.52 Aligned_cols=185 Identities=24% Similarity=0.464 Sum_probs=145.7
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|.+.++||+|+||.||++.+..++..+++|+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58999999999999999999876654332221
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.++.||+.||.|||+++|+|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 2347789999999999999999999999999975 579999999987654322
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... .++
T Consensus 160 ~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~------------ 223 (260)
T cd08222 160 D-LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP------------ 223 (260)
T ss_pred c-cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC------------
Confidence 1 1223456888999998865 56788999999999999999999999876665555444321 111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....++.++.+||.+||..||++||++.++|+||||
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 --------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred --------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0013467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=241.20 Aligned_cols=178 Identities=25% Similarity=0.375 Sum_probs=140.3
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
++||+|+||+||+|++..+++.||+|.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999999999999999994
Q ss_pred ---------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc-ccccccc
Q 006714 163 ---------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTL 226 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~-~~~~gt~ 226 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........... .....+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 355889999999999999999999999999999999999999999875432211100 1112245
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+.... .++
T Consensus 161 ~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~~~---------------------- 216 (252)
T cd05084 161 KWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-RLP---------------------- 216 (252)
T ss_pred eecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CCC----------------------
Confidence 6999999876 568899999999999999997 889997766554444432211 000
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||..||++|||+.++++
T Consensus 217 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 217 -----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01245778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=257.68 Aligned_cols=150 Identities=21% Similarity=0.338 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC-cccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......... .....++..|+|||++.+ ..++.++
T Consensus 219 ~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~s 297 (375)
T cd05104 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFES 297 (375)
T ss_pred HHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCC
Confidence 45699999999999999999999999999999999999999997654322111 112234567999999976 6789999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|||++ |.+||........+.+++.....+. .....+.++.+||
T Consensus 298 Di~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li 350 (375)
T cd05104 298 DVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML---------------------------SPECAPSEMYDIM 350 (375)
T ss_pred CHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC---------------------------CCCCCCHHHHHHH
Confidence 99999999999998 8899987654444333322110000 0123567899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
..||+.||++|||+.+|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=242.24 Aligned_cols=187 Identities=24% Similarity=0.360 Sum_probs=148.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCC---CcEEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~t---g~~vAlK~------------------------------------------ 162 (634)
..++|.+.++||+|+||.||+|.+... ...|+||.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~l 83 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWI 83 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEE
Confidence 346899999999999999999987654 34678775
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 3457889999999999999999999999999999999999999998765433221
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......++..|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+.+..+.... .++
T Consensus 164 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~------------- 228 (270)
T cd05056 164 KASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLP------------- 228 (270)
T ss_pred ecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCC-------------
Confidence 1122233567999998865 568899999999999999986 999998887766655543211 000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....++..+.+||.+||..+|.+|||+.+++..
T Consensus 229 --------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 229 --------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113567889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=249.05 Aligned_cols=186 Identities=24% Similarity=0.351 Sum_probs=144.0
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcE--EehHH------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKK------------------------------------------ 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~--vAlK~------------------------------------------ 162 (634)
+..++|++.+.||+|+||.||+|.+..++.. +++|.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 3457899999999999999999998777754 45542
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCce
Q 006714 163 ------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 200 (634)
Q Consensus 163 ------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~v 200 (634)
+..++.||+.||+|||++||+|+||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 12367799999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhc
Q 006714 201 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLC 279 (634)
Q Consensus 201 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~ 279 (634)
+|+|||++........ ......+..|+|||++.. ..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999863321111 111223567999998865 568899999999999999998 999998776655544431100
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 280 g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. .....++..+.+||.+||..+|.+||++.++|.+
T Consensus 241 --~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 --RL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --cC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0012357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=262.83 Aligned_cols=186 Identities=24% Similarity=0.363 Sum_probs=151.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..+...-++.||.|+.|.||+++. .++.||||+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 44445666788999999999999986 568899998
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~ 226 (634)
+..|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++...+. .....++||.
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTV 275 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTV 275 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhH
Confidence 2357889999999999999999999999999999999999999999876543 3446789999
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
.|||||++.. .+.+.++|||||||+|||||||..||...+...++.- .|.-. ..
T Consensus 276 aWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGsNs------L~--------------- 329 (904)
T KOG4721|consen 276 AWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSNS------LH--------------- 329 (904)
T ss_pred hhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEe----ccCCc------cc---------------
Confidence 9999999987 7789999999999999999999999976443221111 11110 00
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
......+|+.++-||+.||+-.|..||++.+||.|
T Consensus 330 --LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 330 --LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred --ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 01124678889999999999999999999999988
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=277.91 Aligned_cols=187 Identities=26% Similarity=0.378 Sum_probs=147.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.++||+|+||.||+|++..+++.||||+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999985
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 12356799999999999999999999999999999999999999997
Q ss_pred ccCCCC-----------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHH
Q 006714 210 FSNTGH-----------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272 (634)
Q Consensus 210 ~~~~~~-----------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l 272 (634)
...... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 652110 011123468999999999876 56899999999999999999999999775443322
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. .....+. . ...+..+++.+.+++.+||..||.+|++..+.|.+
T Consensus 241 ~~--~~i~~P~-~-----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YR--DVILSPI-E-----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hh--hhccChh-h-----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11 1111110 0 00123578889999999999999999887776654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=246.00 Aligned_cols=192 Identities=34% Similarity=0.564 Sum_probs=156.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|++...||+|+||.||++.+..++..|++|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 3579999999999999999999988888999874
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 176 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSV 176 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccc
Confidence 245889999999999999999999999999999999999999998865443211 11233
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
.++..|++||++.+ ..++.++|+|||||++|+|++|..||...........+.... .+..
T Consensus 177 ~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~------------------ 236 (286)
T cd06614 177 VGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPPL------------------ 236 (286)
T ss_pred cCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCC------------------
Confidence 46788999998876 568899999999999999999999998776655444443211 0000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.....++..+.+||.+||+.+|.+|||+.++|.|+||..
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 -------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001236788999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=241.14 Aligned_cols=186 Identities=22% Similarity=0.346 Sum_probs=148.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCc---EEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~------------------------------------------ 162 (634)
..++|+..+.||+|+||.||+|++..++. .+++|.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 45689999999999999999999876654 677775
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 345888999999999999999999999999999999999999999876543222
Q ss_pred CCccc--ccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 217 QPLTS--RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 ~~~~~--~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
..... ...+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+.... ..+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~--------- 231 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLPA--------- 231 (268)
T ss_pred cceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCCC---------
Confidence 11111 122456999998876 567899999999999999997 999998877766666654321 1110
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...++..+.+|+.+||..||.+||++.++++
T Consensus 232 ------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 ------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=237.74 Aligned_cols=178 Identities=35% Similarity=0.556 Sum_probs=147.2
Q ss_pred ecccCceeEEEEEECCCCcEEehHH-------------------------------------------------------
Q 006714 138 IGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------------- 162 (634)
Q Consensus 138 LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------------- 162 (634)
||.|+||.||++.+..+++.|++|+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999988899999874
Q ss_pred --------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccC
Q 006714 163 --------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228 (634)
Q Consensus 163 --------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y 228 (634)
+..++.||+.+|.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccc
Confidence 34578899999999999999999999999999999999999999987654321 122345668889
Q ss_pred CCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchh
Q 006714 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSL 308 (634)
Q Consensus 229 ~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l 308 (634)
++||.+.+ ..++.++|+|+|||++|+|++|..||...........+... .++
T Consensus 160 ~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------------------------- 211 (250)
T cd05123 160 LAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLR------------------------- 211 (250)
T ss_pred cChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCC-------------------------
Confidence 99999876 45788999999999999999999999877765555554331 110
Q ss_pred hhhcCCCcHHHHHHHHHhhccCcCCCcCH---HHHHhcccc
Q 006714 309 RETFKDLPTTAVNLIETLLSVEPYKRATA---SAALASEYF 346 (634)
Q Consensus 309 ~~~~~~~s~~l~dLL~~mL~~DP~kRpTa---~elL~hpwf 346 (634)
....++..+.+||.+||..||.+|||+ .+++.||||
T Consensus 212 --~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 --FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 012347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=238.70 Aligned_cols=184 Identities=35% Similarity=0.536 Sum_probs=146.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||+|.+..+++.||+|.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 589999999999999999999998999999983
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.+|.|||+.+|+|+||+|+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 345788999999999999999999999999999999999999999876543221
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh--HHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+..... ++
T Consensus 162 -~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~----------- 227 (267)
T cd08224 162 -AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-PP----------- 227 (267)
T ss_pred -ccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-CC-----------
Confidence 1233457888999999876 5688999999999999999999999965431 122222211000 00
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+ ...++..+.+||.+||..+|.+|||+.+|++
T Consensus 228 -------~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 -------LP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------CC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 0246778999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=242.82 Aligned_cols=187 Identities=19% Similarity=0.265 Sum_probs=146.9
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECC----CCcEEehHH----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLD----TGKIVALKK---------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~----tg~~vAlK~---------------------------------------- 162 (634)
+..++|++.+.||+|+||.||+|.+.. ++..|++|.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 445799999999999999999999876 256788874
Q ss_pred ------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccc
Q 006714 163 ------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206 (634)
Q Consensus 163 ------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFG 206 (634)
+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 23477899999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCc
Q 006714 207 LANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPD 284 (634)
Q Consensus 207 la~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~ 284 (634)
+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+... ..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~- 239 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA- 239 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCCC-
Confidence 99754322211 1122334677999999876 568899999999999999998 99999877655544333221 0000
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 285 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 285 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++++.+||.+||..||++|||+.++++
T Consensus 240 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 --------------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01245788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=244.30 Aligned_cols=149 Identities=22% Similarity=0.319 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+|||+++++.++|+|||++........ .......+++.|+|||++.+ ..++.+
T Consensus 126 ~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 204 (280)
T cd05092 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTE 204 (280)
T ss_pred HHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCch
Confidence 4678999999999999999999999999999999999999999875432211 11122234678999998876 568899
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||||||++|+|++ |.+||......+.+..+..... + .....+++.+.+|
T Consensus 205 ~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~~~l 256 (280)
T cd05092 205 SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE--L--------------------------ERPRTCPPEVYAI 256 (280)
T ss_pred hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc--C--------------------------CCCCCCCHHHHHH
Confidence 999999999999998 9999987776666555533210 0 0012467889999
Q ss_pred HHHhhccCcCCCcCHHHHHh
Q 006714 323 IETLLSVEPYKRATASAALA 342 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~ 342 (634)
|.+||+.||.+||++.+|+.
T Consensus 257 i~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 257 MQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=245.33 Aligned_cols=149 Identities=23% Similarity=0.322 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC-cccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......... .....+++.|+|||++.+ ..++.++
T Consensus 142 ~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 220 (304)
T cd05101 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQS 220 (304)
T ss_pred HHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchh
Confidence 46699999999999999999999999999999999999999997654322111 122234677999999876 5688999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|+|++ |..||.+.+..+....+.... .+ .....++..+.+||
T Consensus 221 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li 272 (304)
T cd05101 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RM---------------------------DKPANCTNELYMMM 272 (304)
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cC---------------------------CCCCCCCHHHHHHH
Confidence 99999999999998 889998877666555542211 00 00135678899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
.+||..+|.+|||+.++|+.
T Consensus 273 ~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 273 RDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHcccChhhCCCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=240.15 Aligned_cols=177 Identities=20% Similarity=0.266 Sum_probs=140.9
Q ss_pred EecccCceeEEEEEE--CCCCcEEehHH----------------------------------------------------
Q 006714 137 KIGQGTYSSVFRARD--LDTGKIVALKK---------------------------------------------------- 162 (634)
Q Consensus 137 ~LG~G~fg~Vy~a~d--~~tg~~vAlK~---------------------------------------------------- 162 (634)
+||+|+||.||+|.+ ..+++.+|+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999964 45678899885
Q ss_pred ---------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC--Cccccccc
Q 006714 163 ---------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVT 225 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+|+||||.|||++.++.++|+|||++......... ......++
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCC
Confidence 3568889999999999999999999999999999999999999999765432211 11122335
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
..|+|||.+.. ..++.++|||||||++|||++ |.+||......+....+.... .++
T Consensus 162 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~--------------------- 218 (257)
T cd05116 162 VKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RME--------------------- 218 (257)
T ss_pred ccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCC---------------------
Confidence 78999998865 568889999999999999997 999998877766666553211 000
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++++.+||.+||+.||.+||++.+|..
T Consensus 219 ------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 219 ------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 01347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=246.20 Aligned_cols=156 Identities=18% Similarity=0.226 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++........ .......++..|+|||++.. ..++.+
T Consensus 133 ~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 211 (295)
T cd05097 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTA 211 (295)
T ss_pred HHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCch
Confidence 3678999999999999999999999999999999999999999875432211 11122334678999998876 568999
Q ss_pred cccccchhhHHHHhh--CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 244 VDLWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 244 sDIWSLG~iLyeLlt--G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
+|||||||++|+|++ +..||...+..+.+..+.+........ ........+++.+.+
T Consensus 212 ~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~ 270 (295)
T cd05097 212 SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ---------------------IYLSQTPLCPSPVFK 270 (295)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc---------------------ccCCCCCCCCHHHHH
Confidence 999999999999988 668888777666655543321110000 000011246788999
Q ss_pred HHHHhhccCcCCCcCHHHHHh
Q 006714 322 LIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~ 342 (634)
||.+||..||.+|||+.+|++
T Consensus 271 li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 271 LMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=243.92 Aligned_cols=149 Identities=20% Similarity=0.301 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........ .......++..|+|||++.+ ..++.+
T Consensus 127 ~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 205 (291)
T cd05094 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTE 205 (291)
T ss_pred HHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCch
Confidence 4778999999999999999999999999999999999999999875543221 11223345788999999876 668899
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||||||++|+|++ |.+||......+.+..+.... .+ .....++..+.+|
T Consensus 206 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~l 257 (291)
T cd05094 206 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--VL--------------------------ERPRVCPKEVYDI 257 (291)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC--CC--------------------------CCCccCCHHHHHH
Confidence 999999999999998 999998877666555442211 00 0012457889999
Q ss_pred HHHhhccCcCCCcCHHHHHh
Q 006714 323 IETLLSVEPYKRATASAALA 342 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~ 342 (634)
|.+||..||.+|||+.++++
T Consensus 258 i~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 258 MLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHcccChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=239.87 Aligned_cols=185 Identities=25% Similarity=0.403 Sum_probs=146.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCc---EEehHH-------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~------------------------------------------- 162 (634)
..+|++.+.||+|+||.||+|.+..+++ .||||.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 3579999999999999999999877665 588876
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 3567889999999999999999999999999999999999999998765432211
Q ss_pred C-ccccc---ccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 218 P-LTSRV---VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 218 ~-~~~~~---gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
. ..... .+..|+|||.+.. ..++.++|||||||++|||++ |..||......+....+......+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 232 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP--------- 232 (269)
T ss_pred cccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC---------
Confidence 1 11111 1457999999875 668899999999999999886 9999988776665555532111000
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...++..+.+|+.+||..+|.+||++.+|+.
T Consensus 233 -------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 -------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=244.39 Aligned_cols=180 Identities=20% Similarity=0.200 Sum_probs=146.5
Q ss_pred CCeeEE--EEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 130 DAFEKL--EKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~--~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
+++++. ..|++|+++.||++.. +++.||||.
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 444444 6799999999999997 688999885
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
...++.|++.||.|||.. +++||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 245788999999999984 999999999999999999999999999876543
Q ss_pred CCCCCcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. ....++..|+|||++.+. ..++.++|||||||++|||++|..||...+..+.+..+......++.
T Consensus 176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 243 (283)
T PHA02988 176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL-------- 243 (283)
T ss_pred cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--------
Confidence 21 234678899999998642 56899999999999999999999999988877766665443222110
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++.+.+||.+||+.||.+|||+.++|.
T Consensus 244 -------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 -------------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0246788999999999999999999999985
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=252.31 Aligned_cols=150 Identities=24% Similarity=0.324 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 184 ~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 262 (343)
T cd05103 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQS 262 (343)
T ss_pred HHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchh
Confidence 356999999999999999999999999999999999999999876532211 11112234567999999876 5689999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|+|++ |..||........+...+.....++ ....+++.+.++|
T Consensus 263 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~ 315 (343)
T cd05103 263 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTM 315 (343)
T ss_pred hHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC---------------------------CCCCCCHHHHHHH
Confidence 99999999999997 9999976543333222221110000 0013567899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
..||..||.+|||+.+|++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=245.71 Aligned_cols=187 Identities=19% Similarity=0.316 Sum_probs=146.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCc----EEehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~----~vAlK~----------------------------------------- 162 (634)
..++|++++.||+|+||.||++.+..++. .||+|.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 84 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ 84 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCce
Confidence 44689999999999999999999887776 467764
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 345788999999999999999999999999999999999999999986543221
Q ss_pred C-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. ......++..|++||.+.+ ..++.++|||||||++|||++ |..||.+....+... +......++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~----------- 231 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLP----------- 231 (303)
T ss_pred ccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCC-----------
Confidence 1 1122334678999999875 668899999999999999997 889997765443332 222111111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.....+..+.+||..||..||++||++.+++..
T Consensus 232 ----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 ----------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012356778999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=246.02 Aligned_cols=189 Identities=21% Similarity=0.338 Sum_probs=147.6
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~-------------------------------------- 162 (634)
++..++|++.+.||+|+||.||++.+. .++..||+|.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 455679999999999999999999752 3455788774
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 345788999999999999999999999999999999999999999875
Q ss_pred cCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhh
Q 006714 211 SNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 211 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~ 288 (634)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+..+......+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----- 264 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA----- 264 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC-----
Confidence 5432211 1112234678999999876 568899999999999999998 9999987765554444432110000
Q ss_pred ccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 289 ~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....++.+.+||.+||..+|++|||+.+++.
T Consensus 265 ----------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 ----------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=246.10 Aligned_cols=150 Identities=23% Similarity=0.320 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC-cccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++.......... .....+++.|+|||++.+ ..++.+
T Consensus 144 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 222 (307)
T cd05098 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQ 222 (307)
T ss_pred HHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcH
Confidence 357899999999999999999999999999999999999999987554221111 111223467999999876 568899
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||||||++|+|++ |.+||.+....+....+.... .. +....++.++.+|
T Consensus 223 ~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~l 274 (307)
T cd05098 223 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH--RM--------------------------DKPSNCTNELYMM 274 (307)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC--CC--------------------------CCCCcCCHHHHHH
Confidence 999999999999998 889998766554444432210 00 0113467889999
Q ss_pred HHHhhccCcCCCcCHHHHHhc
Q 006714 323 IETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~h 343 (634)
|.+||..+|.+|||+.+++++
T Consensus 275 i~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 275 MRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcccChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=235.94 Aligned_cols=182 Identities=23% Similarity=0.356 Sum_probs=147.0
Q ss_pred eeEEEEecccCceeEEEEEECCCC----cEEehHH---------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTG----KIVALKK--------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg----~~vAlK~--------------------------------------------- 162 (634)
|++.+.||.|+||.||++.+...+ ..||+|.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457889999999999999998766 8898886
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 24578899999999999999999999999999999999999999997665432211
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++..|++||.+.. ..++.++|||||||++|+|++ |.+||...+..+.+..+......
T Consensus 161 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 223 (258)
T smart00219 161 KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL---------------- 223 (258)
T ss_pred cccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC----------------
Confidence 111235688999998854 678899999999999999998 88999887776666655332100
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....++.++.++|.+||..||.+|||+.++++
T Consensus 224 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 ------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 001236788999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=244.79 Aligned_cols=148 Identities=24% Similarity=0.335 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 139 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 217 (314)
T cd05099 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQS 217 (314)
T ss_pred HHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccc
Confidence 467999999999999999999999999999999999999999975543211 11111223467999999876 6788999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|+|++ |..||.+....+.+..+.... .. .....++.++.+||
T Consensus 218 DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li 269 (314)
T cd05099 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH--RM--------------------------DKPSNCTHELYMLM 269 (314)
T ss_pred hhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCCCCCHHHHHHH
Confidence 99999999999999 899998877666555543210 00 00134677899999
Q ss_pred HHhhccCcCCCcCHHHHHh
Q 006714 324 ETLLSVEPYKRATASAALA 342 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~ 342 (634)
.+||..||.+|||+.++++
T Consensus 270 ~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 270 RECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=237.88 Aligned_cols=179 Identities=26% Similarity=0.405 Sum_probs=144.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||++.. +++.||+|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 36899999999999999999864 678899875
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++....... ....
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~ 158 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSK 158 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCCC
Confidence 34578899999999999999999999999999999999999999987543221 1223
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
.+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||...+..+....+.... .+
T Consensus 159 ~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-------------------- 216 (254)
T cd05083 159 LPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RM-------------------- 216 (254)
T ss_pred CCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CC--------------------
Confidence 3567999998865 568899999999999999997 999998877655544442211 00
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....++..+.+||.+||..+|.+||++.+++.
T Consensus 217 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 -------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=237.25 Aligned_cols=178 Identities=22% Similarity=0.290 Sum_probs=140.0
Q ss_pred EEecccCceeEEEEEECCCC---cEEehHH--------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTG---KIVALKK-------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg---~~vAlK~-------------------------------------------------- 162 (634)
++||+|+||.||+|.+..+. ..||+|.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999876554 6788775
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc--ccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TSRVV 224 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~--~~~~g 224 (634)
+..++.||+.+|.|||..+|+|+||||+|||++.++.++|+|||++........... ....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccc
Confidence 356889999999999999999999999999999999999999999876543322111 11122
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
+..|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+....+.... ..
T Consensus 161 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~--------------------- 217 (257)
T cd05060 161 PLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RL--------------------- 217 (257)
T ss_pred cccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cC---------------------
Confidence 457999998875 568999999999999999997 999998877655544442210 00
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 218 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=247.93 Aligned_cols=149 Identities=23% Similarity=0.321 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+++........ ......++..|+|||++.+ ..++.++
T Consensus 139 ~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 217 (334)
T cd05100 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQS 217 (334)
T ss_pred HHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchh
Confidence 5679999999999999999999999999999999999999998765432111 1122233567999999876 6688999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|||++ |.+||.+.+..+.+..+..... + .....++..+.+||
T Consensus 218 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li 269 (334)
T cd05100 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR-M---------------------------DKPANCTHELYMIM 269 (334)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCCCCCCHHHHHHH
Confidence 99999999999998 8899988776665555432110 0 00134677899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
.+||..+|.+|||+.++|.+
T Consensus 270 ~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 270 RECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcccChhhCcCHHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=238.97 Aligned_cols=185 Identities=22% Similarity=0.340 Sum_probs=146.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCc---EEehHH-------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~------------------------------------------- 162 (634)
.++|++.+.||.|+||.||+|++..++. .+|+|.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3589999999999999999999865443 678874
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 3568889999999999999999999999999999999999999999766433221
Q ss_pred Cc--ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 218 PL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 218 ~~--~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.. .....+..|++||.+.+ ..++.++|+|||||++|+|++ |..||......+....+.+... ++
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~----------- 229 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LP----------- 229 (267)
T ss_pred eeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CC-----------
Confidence 11 11222567999999876 568999999999999999886 9999988776665555533211 00
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 230 ----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 ----------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ----------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=241.85 Aligned_cols=186 Identities=25% Similarity=0.380 Sum_probs=146.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECC-----CCcEEehHH----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKK---------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~-----tg~~vAlK~---------------------------------------- 162 (634)
..++|++...||+|+||.||+|.+.. ++..||+|+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 34689999999999999999998743 567888885
Q ss_pred ----------------H---------------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCce
Q 006714 163 ----------------I---------------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 193 (634)
Q Consensus 163 ----------------i---------------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NIL 193 (634)
+ ..++.||+.||.|||+++|+|+||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 1 258889999999999999999999999999
Q ss_pred ecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHH
Q 006714 194 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 271 (634)
Q Consensus 194 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~ 271 (634)
++.++.++|+|||++........ ........++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999875432211 11122233567999998876 568999999999999999997 8889987776665
Q ss_pred HHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 272 l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+..+..... + .....++..+.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNV-L---------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCC-C---------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 555432110 0 001346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=243.32 Aligned_cols=201 Identities=23% Similarity=0.374 Sum_probs=157.3
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHHHH----------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---------------------------------------- 164 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i~---------------------------------------- 164 (634)
.++..++.+-+..||.|.||+|++..++.+|+.+|||.|+
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 3456678888999999999999999999999999999710
Q ss_pred --------------------------------HHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEecccccccc
Q 006714 165 --------------------------------CYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 165 --------------------------------~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
.|....+.||.||.+. .||||||||+||||+..|.+||||||++-..
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 1122346799999976 8999999999999999999999999998765
Q ss_pred CCCCCCCcccccccccCCCcccccCCC-CCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCCchhhhc
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp~~~~~~ 289 (634)
... ...+...|...|||||.+.... .|+.++|+||||++|||+.||..||.+.+. .+++.+++ .|.||.-..+
T Consensus 219 v~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~~- 293 (361)
T KOG1006|consen 219 VDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLFD- 293 (361)
T ss_pred HHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecCc-
Confidence 432 2224457788899999996533 499999999999999999999999987544 33333332 2333321110
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
...-+++..+..+|..||..|-..||...+++.+||+....
T Consensus 294 --------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 294 --------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred --------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 11125788899999999999999999999999999998753
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=236.00 Aligned_cols=180 Identities=23% Similarity=0.360 Sum_probs=146.2
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||.|+||.||++.+ .++.||+|.
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 346899999999999999999987 478889886
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----D 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc----c
Confidence 34588999999999999999999999999999999999999999997663321 1
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+.... .+
T Consensus 158 ~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~----------------- 218 (256)
T cd05039 158 SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM----------------- 218 (256)
T ss_pred cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC-----------------
Confidence 2233567999998875 567889999999999999997 999998776655544442210 00
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+++.+.+||.+||..+|++|||+.++++
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 ----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=239.22 Aligned_cols=168 Identities=24% Similarity=0.392 Sum_probs=135.4
Q ss_pred cCceeEEEEEECCCCcEEehHH----------------------------------------------------------
Q 006714 141 GTYSSVFRARDLDTGKIVALKK---------------------------------------------------------- 162 (634)
Q Consensus 141 G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------------------- 162 (634)
|.|+.||++++..+++.||+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 8999999999999999999997
Q ss_pred ---HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCC
Q 006714 163 ---IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 239 (634)
Q Consensus 163 ---i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 239 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...... .....++..|+|||.+.. ..
T Consensus 84 ~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~ 158 (237)
T cd05576 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGI-SE 158 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCC-CC
Confidence 3558889999999999999999999999999999999999999987654432 122344677999998865 56
Q ss_pred CCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHH
Q 006714 240 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 319 (634)
Q Consensus 240 ~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l 319 (634)
++.++|||||||++|+|++|..||...... + .. . . . ......+++.+
T Consensus 159 ~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~----~-~----~-------~~~~~~~~~~~ 205 (237)
T cd05576 159 ETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT----H-T----T-------LNIPEWVSEEA 205 (237)
T ss_pred CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc----c-c----c-------cCCcccCCHHH
Confidence 788999999999999999999887432110 0 00 0 0 0 00113467889
Q ss_pred HHHHHHhhccCcCCCcCH-----HHHHhcccc
Q 006714 320 VNLIETLLSVEPYKRATA-----SAALASEYF 346 (634)
Q Consensus 320 ~dLL~~mL~~DP~kRpTa-----~elL~hpwf 346 (634)
.+||.+||+.||.+|||+ ++++.||||
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=242.61 Aligned_cols=156 Identities=17% Similarity=0.240 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......... .......++.|++||.+.. ..++.+
T Consensus 134 ~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~ 212 (296)
T cd05095 134 FMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTA 212 (296)
T ss_pred HHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccch
Confidence 46789999999999999999999999999999999999999998755332111 1122233577999998765 568999
Q ss_pred cccccchhhHHHHhh--CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 244 VDLWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 244 sDIWSLG~iLyeLlt--G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
+|||||||++|||++ +..||...+..+.+.......... .. ... ......++..+.+
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~---~~~----------~~~~~~~~~~~~~ 271 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQ--------GR---QVY----------LPKPALCPDSLYK 271 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhc--------cc---ccc----------CCCCCCCCHHHHH
Confidence 999999999999998 778887766655544332211000 00 000 0011346688999
Q ss_pred HHHHhhccCcCCCcCHHHHHh
Q 006714 322 LIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~ 342 (634)
||..||..||.+|||+.+|++
T Consensus 272 li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 272 LMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=241.62 Aligned_cols=149 Identities=21% Similarity=0.275 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||+.||.|||+++|+|+||||+||||++++.++|+|||++......... ......++..|+|||.+.+ ..++.+
T Consensus 131 ~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~ 209 (290)
T cd05045 131 SFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQ 209 (290)
T ss_pred HHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchH
Confidence 56789999999999999999999999999999999999999998754322111 1122234678999998865 568899
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||||||++|+|++ |.+||.+....+....+.... .++ ....++.++.+|
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~ 261 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY-RME---------------------------RPENCSEEMYNL 261 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC---------------------------CCCCCCHHHHHH
Confidence 999999999999998 999998876655444332211 000 013467889999
Q ss_pred HHHhhccCcCCCcCHHHHHh
Q 006714 323 IETLLSVEPYKRATASAALA 342 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~ 342 (634)
|..||+.||.+||++.+++.
T Consensus 262 i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 262 MLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=238.55 Aligned_cols=186 Identities=22% Similarity=0.347 Sum_probs=147.0
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCc----EEehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~----~vAlK~----------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|.++.++. .||+|.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ 84 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceE
Confidence 34689999999999999999999877665 477764
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 356889999999999999999999999999999999999999999976543221
Q ss_pred CC-cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~-~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.. ......+..|++||.+.. ..++.++|||||||++|||++ |.+||.+....+....+... ..++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~----------- 231 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLP----------- 231 (279)
T ss_pred ceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCC-----------
Confidence 11 111223567999998865 568899999999999999998 99999887766655544321 1111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+..+.++|.+||..||.+|||+.++++
T Consensus 232 ----------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 ----------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01235677899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=233.99 Aligned_cols=151 Identities=24% Similarity=0.340 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||.+........ .......++..|+|||.+.. ..++.
T Consensus 108 ~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 186 (262)
T cd00192 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTS 186 (262)
T ss_pred HHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc-CCcch
Confidence 45788999999999999999999999999999999999999999986654321 11233456788999998876 47899
Q ss_pred ccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 243 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 243 ~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
++|||||||++|+|++ |..||......+....+.... .. .....++.++.+
T Consensus 187 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~ 238 (262)
T cd00192 187 KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RL--------------------------PKPEYCPDELYE 238 (262)
T ss_pred hhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCccCChHHHH
Confidence 9999999999999999 699999887766666554310 00 011345788999
Q ss_pred HHHHhhccCcCCCcCHHHHHhc
Q 006714 322 LIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~h 343 (634)
||.+||..||.+|||+.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.83 Aligned_cols=198 Identities=23% Similarity=0.341 Sum_probs=141.6
Q ss_pred CCe-eEEEEecccCceeEEEEE----ECCCCcEEehHH------------------------------------------
Q 006714 130 DAF-EKLEKIGQGTYSSVFRAR----DLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 130 ~~Y-~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~------------------------------------------ 162 (634)
++| ++++.||+|+||+||++. ...++..||+|.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 355 999999999999998865 345677888885
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 356889999999999999999999999999999999999999999876543221
Q ss_pred C--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhc-CCCCchhhhccCCC
Q 006714 217 Q--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC-GSPPDDYWKKSKLP 293 (634)
Q Consensus 217 ~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~-g~pp~~~~~~~~l~ 293 (634)
. ......++..|++||.+.. ..++.++|||||||++|+|++|..||...... +..+.... +......+.. ..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~ 237 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIE--LL 237 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhh--hh
Confidence 1 1112234667999998875 56889999999999999999999998654321 11111100 0000000000 00
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.. .. . ......++..+.+|+..||..||++|||+.+++.
T Consensus 238 ~~-~~--~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ER-GM--R-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hc-CC--C-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00 0 0011356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=237.59 Aligned_cols=145 Identities=21% Similarity=0.240 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc--------eEEeccccccccCCCCCCCcccccccccCCCccccc
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 235 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~--------vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 235 (634)
..++.||+.||.|||+++|+|+||||+|||++.++. ++|+|||++...... ....+++.|+|||++.
T Consensus 103 ~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~ 177 (258)
T cd05078 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIE 177 (258)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhcc
Confidence 457899999999999999999999999999977654 699999988654321 2345678899999997
Q ss_pred CCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCC
Q 006714 236 GATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314 (634)
Q Consensus 236 ~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 314 (634)
+...++.++|||||||++|+|++| .+||...+........ ...... ...
T Consensus 178 ~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~-----------------------------~~~ 227 (258)
T cd05078 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQL-----------------------------PAP 227 (258)
T ss_pred CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-HccccC-----------------------------CCC
Confidence 655688999999999999999998 4666655444332221 110000 013
Q ss_pred CcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 315 LPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 315 ~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.+.++.+||.+||+.||++|||+.++|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 44678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=234.38 Aligned_cols=177 Identities=24% Similarity=0.358 Sum_probs=139.6
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
++||+|+||.||++.+.. ++.|++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999877 88999985
Q ss_pred ---------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc-ccccccc
Q 006714 163 ---------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTL 226 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~-~~~~gt~ 226 (634)
+..++.|++.+|.|||+++|+|+||+|+|||++.++.++|+|||++........... .....+.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 345778999999999999999999999999999999999999999875542211111 1122356
Q ss_pred cCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 227 ~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... .++
T Consensus 160 ~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~---------------------- 215 (251)
T cd05041 160 KWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP---------------------- 215 (251)
T ss_pred ccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC----------------------
Confidence 7999998876 568999999999999999998 889998776655444432210 000
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||..+|.+|||+.|+|+
T Consensus 216 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 -----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=236.58 Aligned_cols=187 Identities=20% Similarity=0.359 Sum_probs=146.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCC-----CcEEehHH-----------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKK----------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~t-----g~~vAlK~----------------------------------------- 162 (634)
.++|+++..||.|+||+||+|+.+.+ .+.|++|.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 36899999999999999999997543 45688875
Q ss_pred -----------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccc
Q 006714 163 -----------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 -----------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
+..++.||+.+|.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 234778999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchh
Q 006714 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 208 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~ 286 (634)
+...............++..|++||.+.+ ..++.++|||||||++|+|++ |..||........+..+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~----- 237 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE----- 237 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-----
Confidence 86543322222233455778999998876 457889999999999999998 78899776665555444221100
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 287 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
| .....++..+.+||.+||..||.+|||+.+++..
T Consensus 238 ~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0013567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=232.86 Aligned_cols=177 Identities=23% Similarity=0.349 Sum_probs=140.0
Q ss_pred EEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------------- 162 (634)
+.||+|+||.||++... ++..||+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999854 677888885
Q ss_pred ---------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccccc
Q 006714 163 ---------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 227 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 227 (634)
+..++.||+.+|.|||+++++|+||+|+||+++.++.++|+|||++................+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 34678899999999999999999999999999999999999999987544322111122233567
Q ss_pred CCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCc
Q 006714 228 YRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 228 Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
|+|||++.. ..++.++|||||||++|+|++ |..||...........+..... +
T Consensus 160 y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~------------------------ 213 (250)
T cd05085 160 WTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-M------------------------ 213 (250)
T ss_pred ccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-C------------------------
Confidence 999999865 568899999999999999998 9999988776655554422110 0
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....++..+.+|+.+||..+|++|||+.++++
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 ---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=235.59 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC---CCcccccccccCCCcccccCCCCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDY 240 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~ 240 (634)
..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++........ .......++..|+|||.+.. ..+
T Consensus 101 ~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 179 (262)
T cd05058 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKF 179 (262)
T ss_pred HHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-Ccc
Confidence 34678999999999999999999999999999999999999999875432111 11112334678999998876 568
Q ss_pred CCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHH
Q 006714 241 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 319 (634)
Q Consensus 241 s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l 319 (634)
+.++|||||||++|||++ |.+||...+..+....+.... .++ ....++..+
T Consensus 180 ~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~ 231 (262)
T cd05058 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLL---------------------------QPEYCPDPL 231 (262)
T ss_pred chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCC---------------------------CCCcCCHHH
Confidence 899999999999999999 577887766555444432210 000 002357789
Q ss_pred HHHHHHhhccCcCCCcCHHHHHhc
Q 006714 320 VNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 320 ~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.+||..||..+|++||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=255.50 Aligned_cols=167 Identities=25% Similarity=0.364 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCC------
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD------ 239 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~------ 239 (634)
++.||+.+|.|||.++|+||||||+|||++.++.++|+|||++...............+++.|+|||++.....
T Consensus 314 i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~ 393 (507)
T PLN03224 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPA 393 (507)
T ss_pred HHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccch
Confidence 56789999999999999999999999999999999999999997554322211122234789999998753211
Q ss_pred -------------C--CCccccccchhhHHHHhhCCC-CCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 240 -------------Y--GPSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 240 -------------~--s~~sDIWSLG~iLyeLltG~~-pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
| ....||||+|||||+|+++.. ||........ .++.... ....|...... .
T Consensus 394 ~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~~-~~~~~r~~~~~---------~ 460 (507)
T PLN03224 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYDN-DLNRWRMYKGQ---------K 460 (507)
T ss_pred hhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhccc-hHHHHHhhccc---------C
Confidence 1 234799999999999999874 6654321111 1110000 00112111100 0
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCc---CCCcCHHHHHhccccCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEP---YKRATASAALASEYFST 348 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP---~kRpTa~elL~hpwf~~ 348 (634)
+. ...+...++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 461 ~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 01235678999999999999876 68999999999999964
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=236.99 Aligned_cols=183 Identities=24% Similarity=0.442 Sum_probs=148.3
Q ss_pred CeeEEEEecccCceeEEEEEECC-CCcEEehHH-----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLD-TGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~-tg~~vAlK~----------------------------------------------- 162 (634)
.|++.+.||+|+||.||++.+.. +++.+|+|.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 677888762
Q ss_pred ----------------------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEecccc
Q 006714 163 ----------------------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 ----------------------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
++.++.||+.+|.|||+ .+|+|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 34577899999999996 6899999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhh
Q 006714 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 208 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~ 287 (634)
+....... ......++..|++||.+.+ ..++.++|||||||++|+|++|.+||...........+......+..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 234 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--- 234 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC---
Confidence 97655432 2344567889999999976 56889999999999999999999999876665555544332111100
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||.+||..||.+||++.|+..+
T Consensus 235 ------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 ------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 02457889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=237.73 Aligned_cols=200 Identities=23% Similarity=0.333 Sum_probs=141.3
Q ss_pred CCeeEEEEecccCceeEEEEE----ECCCCcEEehHH-------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~------------------------------------------- 162 (634)
.+|++++.||+|+||+||++. +..+++.||+|.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 589999999999999999997 445788899986
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 345788999999999999999999999999999999999999999986543221
Q ss_pred CC--cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~--~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.. ......+..|+|||++.+ ..++.++|||||||++|||+++..++..... .....+..... .+...+....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~--- 237 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQ-GQMIVYHLIE--- 237 (284)
T ss_pred ceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccc-cccchHHHHH---
Confidence 11 111223456999999876 5688999999999999999998776543321 11111100000 0000000000
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...... .......++..+.+||.+||..+|++|||+.++++
T Consensus 238 --~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 --LLKNNG-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred --HHhcCC-----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000000 00012356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=238.76 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=142.3
Q ss_pred CCeeEEEEecccCceeEEEEEE----CCCCcEEehHH-------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARD----LDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d----~~tg~~vAlK~------------------------------------------- 162 (634)
..|++++.||+|+||.||+++. ..++..||+|.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3589999999999999999974 45678899885
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 34578899999999999999999999999999999999999999987654322
Q ss_pred C--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. .......++..|+|||++.+ ..++.++|||||||++|+|+++..++..... .+.+..+....+.......
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred cceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHHHHH-
Confidence 1 11123345678999999876 5688999999999999999998766432211 1111111111000000000
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...... ........++..+.+||.+||+.||.+|||+.+++++
T Consensus 237 --~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 --RVLEEG-----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred --HHHHcC-----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000000 0001123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=236.92 Aligned_cols=151 Identities=21% Similarity=0.277 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++......... ......+++.|++||.+.. ..++.
T Consensus 116 ~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~ 194 (273)
T cd05074 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTT 194 (273)
T ss_pred HHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-Cccch
Confidence 457789999999999999999999999999999999999999998765432211 1122234567999998875 56788
Q ss_pred ccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 243 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 243 ~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
++|||||||++|+|++ |.+||...+..+....+.... .+. ....++..+.+
T Consensus 195 ~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~ 246 (273)
T cd05074 195 HSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLK---------------------------QPPDCLEDVYE 246 (273)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCC---------------------------CCCCCCHHHHH
Confidence 9999999999999999 899998777655544443210 000 00246778999
Q ss_pred HHHHhhccCcCCCcCHHHHHhc
Q 006714 322 LIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~h 343 (634)
|+.+||..+|.+|||+.+++.+
T Consensus 247 l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 247 LMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=234.24 Aligned_cols=151 Identities=19% Similarity=0.221 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC--cccccccccCCCcccccCCCCC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDY 240 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~ 240 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......... .....++..|+|||++.. ..+
T Consensus 97 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 175 (257)
T cd05115 97 VVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKF 175 (257)
T ss_pred HHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCC
Confidence 45688999999999999999999999999999999999999999987554322111 111222567999998875 568
Q ss_pred CCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHH
Q 006714 241 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 319 (634)
Q Consensus 241 s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l 319 (634)
+.++|||||||++|+|++ |.+||......+....+.... .++ .....++++
T Consensus 176 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~l 227 (257)
T cd05115 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLD---------------------------CPAECPPEM 227 (257)
T ss_pred CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCC---------------------------CCCCCCHHH
Confidence 899999999999999996 999998877766555443211 000 013467889
Q ss_pred HHHHHHhhccCcCCCcCHHHHHh
Q 006714 320 VNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 320 ~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+||.+||..||++||++.++++
T Consensus 228 ~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 228 YALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=234.79 Aligned_cols=146 Identities=19% Similarity=0.264 Sum_probs=112.6
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc-------eEEeccccccccCCCCCCCcccccccccCCCccccc
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 235 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~-------vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 235 (634)
+..++.||+.||+|||+++|+|+||||+||||+.++. ++|+|||++...... ....++..|+|||++.
T Consensus 107 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 107 KFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVE 181 (262)
T ss_pred HHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhc
Confidence 3568899999999999999999999999999986654 899999998654321 2345678899999887
Q ss_pred CCCCCCCccccccchhhHHHHh-hCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCC
Q 006714 236 GATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314 (634)
Q Consensus 236 ~~~~~s~~sDIWSLG~iLyeLl-tG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 314 (634)
....++.++|||||||++|+|+ .|..||......+.. .+...... ....
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~-----------------------------~~~~ 231 (262)
T cd05077 182 DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM-----------------------------LVTP 231 (262)
T ss_pred CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc-----------------------------CCCC
Confidence 5567899999999999999998 588888765433322 11110000 0112
Q ss_pred CcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 315 LPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 315 ~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.++++.+||.+||+.||.+||++.+||.+
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 35678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=245.65 Aligned_cols=226 Identities=31% Similarity=0.550 Sum_probs=165.0
Q ss_pred CcccccCCCeeEEEEecccCceeEEEEEECC---CCcEEehHH-------------------------------------
Q 006714 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKK------------------------------------- 162 (634)
Q Consensus 123 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~---tg~~vAlK~------------------------------------- 162 (634)
..++...+.|.++++||.|+|++||++.+.. ..++||+|.
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3345556789999999999999999999987 788999996
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCC---
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNT--- 213 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~--- 213 (634)
++.|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 56799999999999999999999999999999764 5678999999861100
Q ss_pred -----C-------C----------------------------CCCcccccccccCCCcccccCCCCCCCccccccchhhH
Q 006714 214 -----G-------H----------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 253 (634)
Q Consensus 214 -----~-------~----------------------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iL 253 (634)
. . ........||+.|+|||++.....-+.++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0 00011246799999999999888889999999999999
Q ss_pred HHHhhCCCCCC-CCChHHHHHHHHHhcCCC--------Cch--hhhccCCCCcc--------c-CCCCCCCC---chhhh
Q 006714 254 AELLIGKPILQ-GRTEVEQLHKIFKLCGSP--------PDD--YWKKSKLPHAT--------L-FKPQQPYD---SSLRE 310 (634)
Q Consensus 254 yeLltG~~pf~-~~~~~e~l~~i~~~~g~p--------p~~--~~~~~~l~~~~--------~-~~~~~~~~---~~l~~ 310 (634)
+-+++++.||. ..++.+.+..|+...|.. +.. .|.....+... . .......+ .....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999987764 455555555555444432 112 33321111100 0 00000100 12222
Q ss_pred hcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 311 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 311 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....++..+.+||.+||..||.+|+||+++|.||||..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 33445668999999999999999999999999999984
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=249.54 Aligned_cols=149 Identities=21% Similarity=0.297 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++
T Consensus 242 ~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 320 (400)
T cd05105 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLS 320 (400)
T ss_pred HHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchh
Confidence 567899999999999999999999999999999999999999876543221 11223345678999999876 5689999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|+|++ |..||........+...+.....++ ....++..+.+||
T Consensus 321 DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li 373 (400)
T cd05105 321 DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA---------------------------KPDHATQEVYDIM 373 (400)
T ss_pred hHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHH
Confidence 99999999999997 8899987654433333222110100 0134678899999
Q ss_pred HHhhccCcCCCcCHHHHHh
Q 006714 324 ETLLSVEPYKRATASAALA 342 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~ 342 (634)
.+||..||++|||+.+|.+
T Consensus 374 ~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 374 VKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHCccCHhHCcCHHHHHH
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-27 Score=247.92 Aligned_cols=197 Identities=26% Similarity=0.447 Sum_probs=156.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
+...++|-+++.||+|+|+.||+|.|....++||+|+
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 4557899999999999999999999999999999997
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHC--CceeccCCCCCceecC---CCceEEeccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNN---EGVLKLADFG 206 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~--gIvHrDLKp~NILl~~---~g~vkL~DFG 206 (634)
++.|+.||+.||.||.+. .|||-||||.||||-+ .|.|||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 456899999999999987 6999999999999943 4679999999
Q ss_pred cccccCCCCCC------CcccccccccCCCcccccC---CCCCCCccccccchhhHHHHhhCCCCCCCCC-hHHHHHH--
Q 006714 207 LANFSNTGHRQ------PLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHK-- 274 (634)
Q Consensus 207 la~~~~~~~~~------~~~~~~gt~~Y~APE~l~~---~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-~~e~l~~-- 274 (634)
+++....+... ......||.||++||.+.- ...++.++||||+|||+|.++.|+.||...- ..++++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99877654322 2334578999999999853 3457899999999999999999999996543 2222221
Q ss_pred HHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 275 i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
|++.. . ..|. .-+.++.++++||++||.+.-++|+.+.++..||||.-
T Consensus 699 IlkAt-----------E----VqFP-----------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKAT-----------E----VQFP-----------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcce-----------e----ccCC-----------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11100 0 0000 01457899999999999999999999999999999964
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=229.81 Aligned_cols=151 Identities=23% Similarity=0.316 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC--CcccccccccCCCcccccCCCCCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYG 241 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~s 241 (634)
..++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++......... ......++..|+|||.+.. ..++
T Consensus 100 ~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~ 178 (257)
T cd05040 100 CDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFS 178 (257)
T ss_pred HHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcC
Confidence 457789999999999999999999999999999999999999999766432111 1112345678999998875 5688
Q ss_pred CccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHH
Q 006714 242 PSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 320 (634)
Q Consensus 242 ~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 320 (634)
.++|||||||++|+|++ |.+||...+..+.+..+.......+ ....++..+.
T Consensus 179 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~ 231 (257)
T cd05040 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE---------------------------RPEACPQDIY 231 (257)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC---------------------------CCccCCHHHH
Confidence 99999999999999998 9999988877776666543111000 0124678899
Q ss_pred HHHHHhhccCcCCCcCHHHHHh
Q 006714 321 NLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 321 dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+||.+||..+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=232.38 Aligned_cols=155 Identities=17% Similarity=0.225 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccC------
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLG------ 236 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~------ 236 (634)
..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++........ .......+++.|+|||++..
T Consensus 103 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (269)
T cd05042 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLL 182 (269)
T ss_pred HHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccccc
Confidence 35778999999999999999999999999999999999999999865432211 11122334677999998742
Q ss_pred CCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCC
Q 006714 237 ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 315 (634)
Q Consensus 237 ~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 315 (634)
...++.++|||||||++|||++ |.+||....+.+.+..+.......... ......+
T Consensus 183 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~ 239 (269)
T cd05042 183 PKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-----------------------PQLDLKY 239 (269)
T ss_pred ccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC-----------------------CcccccC
Confidence 2356789999999999999999 788998877766666554432111000 0011356
Q ss_pred cHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 316 PTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 316 s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+..+.+++..|+ .||++|||+++|++
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 778889999988 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=230.28 Aligned_cols=149 Identities=22% Similarity=0.331 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-----ceEEeccccccccCCCCC-CCcccccccccCCCcccccCCC
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGAT 238 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-----~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~ 238 (634)
.++.||+.||.|||+.+|+|+||+|+|||++.++ .++|+|||++........ ........+..|+|||++.+ .
T Consensus 110 ~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 188 (269)
T cd05044 110 DICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-G 188 (269)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-C
Confidence 3678999999999999999999999999998877 899999999875432211 11122244678999999876 5
Q ss_pred CCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcH
Q 006714 239 DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 317 (634)
Q Consensus 239 ~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~ 317 (634)
.++.++|||||||++|+|++ |..||...+..+....+.... .+ .....++.
T Consensus 189 ~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~ 240 (269)
T cd05044 189 KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL---------------------------QKPENCPD 240 (269)
T ss_pred CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc---------------------------CCcccchH
Confidence 68999999999999999998 999998777665554442110 00 01134678
Q ss_pred HHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 318 TAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 318 ~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+.+||.+||..+|.+||++.++++
T Consensus 241 ~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 241 KIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=232.75 Aligned_cols=148 Identities=23% Similarity=0.319 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCc
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++........ ......+..|+|||++.. ..++.+
T Consensus 115 ~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~~y~apE~~~~-~~~~~~ 191 (270)
T cd05047 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTN 191 (270)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhh--ccCCCCccccCChHHHcc-CCCCch
Confidence 34678899999999999999999999999999999999999999853221111 111223567999998865 668899
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||||||++|||++ |..||.+.+..+.+..+.... .. +....++.++.+|
T Consensus 192 ~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~l 243 (270)
T cd05047 192 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL--------------------------EKPLNCDDEVYDL 243 (270)
T ss_pred hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--CC--------------------------CCCCcCCHHHHHH
Confidence 999999999999997 999998776665555442210 00 0012457789999
Q ss_pred HHHhhccCcCCCcCHHHHHh
Q 006714 323 IETLLSVEPYKRATASAALA 342 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~ 342 (634)
|.+||..||.+|||+.+++.
T Consensus 244 i~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 244 MRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHcccChhhCCCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=235.00 Aligned_cols=181 Identities=28% Similarity=0.421 Sum_probs=142.3
Q ss_pred eEEEEecccCceeEEEEEEC----CCCcEEehHH----------------------------------------------
Q 006714 133 EKLEKIGQGTYSSVFRARDL----DTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 133 ~i~~~LG~G~fg~Vy~a~d~----~tg~~vAlK~---------------------------------------------- 162 (634)
.+.+.||.|.||.||+|... ..+..|+||.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57899999999999999987 3456788875
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~ 218 (634)
+..++.||+.||.|||+++|+|+||++.|||++.++.+||+|||++........ ..
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 456899999999999999999999999999999999999999999976632111 11
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.........|+|||.+.. ..++.++||||||+++|||++ |..||...+..+....+.+....+
T Consensus 162 ~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~--------------- 225 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP--------------- 225 (259)
T ss_dssp STTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---------------
T ss_pred cccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce---------------
Confidence 122345778999999876 458999999999999999999 789998888777777763321111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||..||..||.+|||+.+|++
T Consensus 226 -------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 -------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11357888999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.10 Aligned_cols=144 Identities=24% Similarity=0.285 Sum_probs=110.6
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-------ceEEeccccccccCCCCCCCcccccccccCCCcccccC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 236 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-------~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 236 (634)
..++.||+.||.|||+++|+|+||||+|||++.++ .++|+|||++...... ....++..|+|||++..
T Consensus 104 ~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 104 LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-----EERVERIPWIAPECIRN 178 (259)
T ss_pred HHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc-----cccccCCCccChhhhcC
Confidence 45788999999999999999999999999998887 7999999998765431 22345677999999876
Q ss_pred C-CCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCC
Q 006714 237 A-TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314 (634)
Q Consensus 237 ~-~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 314 (634)
. ..++.++|||||||++|+|++ |..||...+..+....+.. ....+ ..
T Consensus 179 ~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~-----------------------------~~ 228 (259)
T cd05037 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLP-----------------------------MP 228 (259)
T ss_pred CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCC-----------------------------CC
Confidence 3 368899999999999999999 5777866543322222110 00000 01
Q ss_pred CcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 315 LPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 315 ~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+.+||.+||..+|.+|||+.++|+
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1267899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=230.09 Aligned_cols=188 Identities=22% Similarity=0.359 Sum_probs=141.2
Q ss_pred CCeeEEEEecccCceeEEEEEECC----CCcEEehHH-------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLD----TGKIVALKK------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~----tg~~vAlK~------------------------------------------- 162 (634)
.+|++++.||+|+||.||++.... +++.||+|.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 578999999999999999998643 477888884
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 34588899999999999999999999999999999999999999998665322
Q ss_pred CCC--cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHH-----------HHHHHHhcCCC
Q 006714 216 RQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----------LHKIFKLCGSP 282 (634)
Q Consensus 216 ~~~--~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~-----------l~~i~~~~g~p 282 (634)
... ......+..|++||.+.. ..++.++|||||||++|||++|..||........ ...+...+...
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 111 112233566999998876 5688999999999999999999988865322110 11111100000
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 283 p~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
. . ......++.++.+||.+||..||.+|||+.|+++
T Consensus 243 ~-------------------~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 243 E-------------------R-----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred C-------------------c-----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0 0001245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=246.04 Aligned_cols=150 Identities=21% Similarity=0.270 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
|+.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++
T Consensus 244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 322 (401)
T cd05107 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLS 322 (401)
T ss_pred HHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHh
Confidence 456999999999999999999999999999999999999999976432211 11223345788999999876 5688999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|||++ |..||......+.+...+.....++ ....++.++.+||
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li 375 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA---------------------------KPAHASDEIYEIM 375 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHH
Confidence 99999999999998 8899987665554444332110000 0134678899999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
.+||..+|.+||++.+||..
T Consensus 376 ~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 376 QKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=227.72 Aligned_cols=154 Identities=21% Similarity=0.282 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCC------
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA------ 237 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~------ 237 (634)
.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......... ......++..|+|||++.+.
T Consensus 104 ~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 183 (269)
T cd05087 104 RMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLV 183 (269)
T ss_pred HHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccc
Confidence 46789999999999999999999999999999999999999998654322111 11223457789999988532
Q ss_pred CCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCc
Q 006714 238 TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 316 (634)
Q Consensus 238 ~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s 316 (634)
..++.++|||||||++|||++ |.+||......+.+........... + .+ ......+
T Consensus 184 ~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~-----~~---------~~~~~~~ 240 (269)
T cd05087 184 VDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL---------P-----KP---------RLKLPLS 240 (269)
T ss_pred cCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC---------C-----CC---------ccCCCCC
Confidence 135789999999999999996 9999987665554433222110000 0 00 0012356
Q ss_pred HHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 317 TTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 317 ~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+.+.+||..|+ .+|++|||+.+|+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 77899999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=252.22 Aligned_cols=199 Identities=30% Similarity=0.503 Sum_probs=166.1
Q ss_pred CcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------
Q 006714 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 123 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------- 162 (634)
..++...+.|+|.+.||.|.||.||+++++.+++..|+|+
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3456678899999999999999999999999999999997
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
|.+|++.++.||.+||.+.++|||||-.|||++.++.|||+|||++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 56789999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCcccccccccCCCcccccCC----CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCch
Q 006714 210 FSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 210 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~ 285 (634)
...... ....+.+||++|||||++... ..|+..+|+||||++..||.-|.||+...-....+..| ...||+.
T Consensus 172 QldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPk 247 (953)
T KOG0587|consen 172 QLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPK 247 (953)
T ss_pred eeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcc
Confidence 765432 234567899999999999653 34678899999999999999999999877665544443 2222211
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
. ......+..+.+||..||..|-.+||+..++|+|||++.
T Consensus 248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1 112345788999999999999999999999999999984
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.73 Aligned_cols=146 Identities=23% Similarity=0.313 Sum_probs=111.8
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-------ceEEeccccccccCCCCCCCcccccccccCCCccccc
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 235 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-------~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 235 (634)
+..++.||+.||+|||+++|+|+||||+|||++..+ .++|+|||++...... ....++..|+|||.+.
T Consensus 119 ~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhc
Confidence 345889999999999999999999999999997543 4899999987543221 2234577899999887
Q ss_pred CCCCCCCccccccchhhHHHHh-hCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCC
Q 006714 236 GATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314 (634)
Q Consensus 236 ~~~~~s~~sDIWSLG~iLyeLl-tG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 314 (634)
+...++.++|||||||++|||+ +|.+||......+....+ ......+ ..
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~-----------------------------~~ 243 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-EKKHRLP-----------------------------EP 243 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-HhccCCC-----------------------------CC
Confidence 6566899999999999999985 689999876554432221 1100000 12
Q ss_pred CcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 315 LPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 315 ~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.++.+.+||.+||+.+|++|||+.++|++
T Consensus 244 ~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 244 SCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 34678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=225.32 Aligned_cols=155 Identities=21% Similarity=0.315 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-CCCcccccccccCCCcccccCC-----
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA----- 237 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~----- 237 (634)
+.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++....... ........++..|+|||++...
T Consensus 102 ~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (268)
T cd05086 102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181 (268)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccc
Confidence 4577899999999999999999999999999999999999999986432211 1112334568889999987531
Q ss_pred -CCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCC
Q 006714 238 -TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 315 (634)
Q Consensus 238 -~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~ 315 (634)
..++.++|||||||++|||++ +.+||...++.+.+..+....... .+.+. ....+
T Consensus 182 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--------------~~~~~---------~~~~~ 238 (268)
T cd05086 182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK--------------LFKPQ---------LELPY 238 (268)
T ss_pred cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc--------------cCCCc---------cCCCC
Confidence 235778999999999999997 578888777776666654321110 00000 01236
Q ss_pred cHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 316 PTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 316 s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
++.+.+||..|| .+|.+|||+.+|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 678899999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=248.38 Aligned_cols=133 Identities=34% Similarity=0.586 Sum_probs=118.6
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|+.-+.||+|+||.||+++++.+|+.||||.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 46778999999999999999999999999997
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec--CCC--ceEEeccccccc
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEG--VLKLADFGLANF 210 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~--~~g--~vkL~DFGla~~ 210 (634)
+..++..|..||.|||++||+||||||.||++- .+| ..||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 345788899999999999999999999999983 333 479999999998
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 265 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~ 265 (634)
..++. .+.+.+||..|.+||++.....|+..+|+|||||++|+++||..||..
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 87653 678899999999999998557899999999999999999999999954
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=256.34 Aligned_cols=187 Identities=21% Similarity=0.344 Sum_probs=154.1
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCc-----EEehHH---------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKK--------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~-----~vAlK~--------------------------------------- 162 (634)
+..+..+..+.||+|.||.||.+....... .||||.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445678899999999999999998754332 388886
Q ss_pred -----------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccc
Q 006714 163 -----------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 -----------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
+..++.||+.|+.||+++++|||||...|+||+....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 456889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccc-cccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCch
Q 006714 208 ANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 208 a~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~ 285 (634)
|+.+........... .....|||||.+.. ..++.++|||||||+|||+++ |..||.+.++.+++....+.- ..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~-- 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD-- 924 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC--
Confidence 984433222211222 33578999999986 789999999999999999999 899999999998888765532 221
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||..||..+|++||++..|++
T Consensus 925 -------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 -------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11468889999999999999999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=249.59 Aligned_cols=188 Identities=24% Similarity=0.375 Sum_probs=157.7
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH-------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~------------------------------------- 162 (634)
.++...+.+.++.||+|.||.||+|+.. .+...||||.
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4555678889999999999999999864 2346799997
Q ss_pred --------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC
Q 006714 163 --------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 198 (634)
Q Consensus 163 --------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g 198 (634)
+..|+.||+.|++||-++.+|||||-..|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 356899999999999999999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCcc-cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHH
Q 006714 199 VLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 199 ~vkL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~ 276 (634)
.|||+|||+++..-........ .....+.|||||.|+- ..|+.++||||+||+|||+++ |..||.+.++.+.++.|.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999865433222222 2344788999999985 789999999999999999998 999999999999999885
Q ss_pred HhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHH
Q 006714 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL 341 (634)
+.. +.+....+|.++.+||..||+.+|.+||++.||-
T Consensus 720 ~g~----------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQ----------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCC----------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 521 1223357899999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=214.02 Aligned_cols=160 Identities=40% Similarity=0.622 Sum_probs=125.3
Q ss_pred ehHHHHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCC
Q 006714 159 ALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 238 (634)
Q Consensus 159 AlK~i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 238 (634)
..+.+..++.+|+.+|.|||..+|+|+||+|.||+++.++.++|+|||++....... ......++..|++||.+.. .
T Consensus 85 ~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~-~ 161 (244)
T smart00220 85 SEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLG-K 161 (244)
T ss_pred CHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHcc-C
Confidence 344466789999999999999999999999999999999999999999998665432 2234566888999998875 5
Q ss_pred CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHH
Q 006714 239 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 318 (634)
Q Consensus 239 ~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~ 318 (634)
.++.++|||+||+++|+|++|..||......+.+............ .....++..
T Consensus 162 ~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~ 216 (244)
T smart00220 162 GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-------------------------PPEWKISPE 216 (244)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------cccccCCHH
Confidence 6788999999999999999999999874333333332221111100 000116788
Q ss_pred HHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 319 AVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 319 l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
+.+++.+||..+|.+||++.++++||||
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=236.86 Aligned_cols=189 Identities=25% Similarity=0.356 Sum_probs=152.3
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCc---E-EehHH--------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGK---I-VALKK-------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~-vAlK~-------------------------------------- 162 (634)
+.+..++..+.++||+|+||.||+++.+..+. . ||+|.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 45666777788999999999999999765432 3 78886
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 235788999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
........ ........|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|.......+.
T Consensus 312 ~~~~~~~~-~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~----- 384 (474)
T KOG0194|consen 312 GSQYVMKK-FLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI----- 384 (474)
T ss_pred Ccceeecc-ccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-----
Confidence 54111111 11234688999999986 589999999999999999999 78999999999988888553222211
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+..+..++.+|+..||++|||+.++.+
T Consensus 385 ----------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 ----------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1246778899999999999999999998874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=238.10 Aligned_cols=192 Identities=22% Similarity=0.301 Sum_probs=156.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCC-Cc--EEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT-GK--IVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~t-g~--~vAlK~---------------------------------------- 162 (634)
-|..+...+.++||+|.||.|+++.+... |+ .||||.
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~ 185 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPA 185 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchh
Confidence 34456677889999999999999998643 33 588886
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..|+.||+.||.||..+++|||||-..||||-....|||+|||+.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 3569999999999999999999999999999998999999999999877654
Q ss_pred CCCC--cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 215 HRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 215 ~~~~--~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.... .........|+|||.|.. ..++.++|+|++||+||||++ |..||.+....+++++|-+.-
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------------ 332 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------------ 332 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc------------
Confidence 3321 112233677999999976 789999999999999999998 789999999999988884211
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.....+.+++++.+++..||..+|.+|||+..|.+.-++
T Consensus 333 ----------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 333 ----------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ----------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 111235789999999999999999999999998754444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-25 Score=210.35 Aligned_cols=151 Identities=30% Similarity=0.520 Sum_probs=129.3
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+++..++...+..||.|+||.|-+.++..+|..+|+|.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 56667888899999999999999999999999999996
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
+-+|+..++.||.|||++ .|||||+||+||||+.+|++||||||++-.+.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 235788899999999998 89999999999999999999999999997765
Q ss_pred CCCCCCcccccccccCCCcccccC---CCCCCCccccccchhhHHHHhhCCCCCCC-CChHHHHHHHHH
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFK 277 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~---~~~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~e~l~~i~~ 277 (634)
+.-. .+...|...|||||.+.. ...|+.++||||||++++||.+++.||.. .+..+++.++++
T Consensus 201 dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 4321 122456788999999853 34689999999999999999999999975 578888888866
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=241.20 Aligned_cols=187 Identities=29% Similarity=0.404 Sum_probs=141.9
Q ss_pred eeEEEEecccCceeE-EEEEECCCCcEEehHH------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSV-FRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~V-y~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
|.--+.+|.|+-|+| |++.. .++.||||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh
Confidence 334467899999875 88886 688999997
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---C--CceEEeccccccccCCCCC--
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---E--GVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~--g~vkL~DFGla~~~~~~~~-- 216 (634)
.+.++.|++.||++||+.+||||||||.||||.. + ..++|+|||+++....+..
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 1347889999999999999999999999999965 3 3689999999987765433
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.......||-.|+|||++.. ..-+.++|||||||++|+.++| ..||...-.. ..+|+....
T Consensus 669 ~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~--------------- 730 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNY--------------- 730 (903)
T ss_pred hcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCcc---------------
Confidence 23445678999999999976 3446799999999999999996 7898653322 122322100
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
++..+-.....++.|||.+||++||..||+|.++|.||+|-++
T Consensus 731 -----------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 731 -----------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred -----------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 0001111112278999999999999999999999999999653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=255.33 Aligned_cols=163 Identities=17% Similarity=0.227 Sum_probs=117.9
Q ss_pred cEEehHHHHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-------------------CceEEeccccccccCCCCC
Q 006714 156 KIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-------------------GVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 156 ~~vAlK~i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-------------------g~vkL~DFGla~~~~~~~~ 216 (634)
..+....++.|+.||+.||.|||++||+||||||+||||+.. +.+||+|||+++.......
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~ 154 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSE 154 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccc
Confidence 457788899999999999999999999999999999999543 4556666666643211000
Q ss_pred ---------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCC
Q 006714 217 ---------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 217 ---------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
......++|++|||||++.+ ..|+.++|||||||+||||+++.+|+.... ..+..+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~ 230 (793)
T PLN00181 155 RRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-L 230 (793)
T ss_pred cchhhhhccccCCCcccccccCCCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-c
Confidence 00112457899999999886 568999999999999999999988875322 1222221110 0
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
++ .. ......+.+++..||.+||.+|||+.|||+||||...
T Consensus 231 ~~-~~--------------------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 231 PP-QI--------------------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred Ch-hh--------------------------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 00 00 0112346789999999999999999999999999763
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=234.42 Aligned_cols=149 Identities=23% Similarity=0.340 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCc
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
..|+.||+.||.|||+..+|||||-..|||+....++||+|||+++...+............+.|||||.+. ...++.+
T Consensus 494 ~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtA 572 (974)
T KOG4257|consen 494 TLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTA 572 (974)
T ss_pred HHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccc-hhcccch
Confidence 458899999999999999999999999999999999999999999988776544444334477899999885 4779999
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|||.|||++||++. |..||.+-.+.+.+-.|.+.-. + ...+.+|+.+..|
T Consensus 573 SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-l---------------------------P~P~nCPp~LYsl 624 (974)
T KOG4257|consen 573 SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-L---------------------------PCPPNCPPALYSL 624 (974)
T ss_pred hhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-C---------------------------CCCCCCChHHHHH
Confidence 999999999999887 9999998777666555433211 1 1225789999999
Q ss_pred HHHhhccCcCCCcCHHHHH
Q 006714 323 IETLLSVEPYKRATASAAL 341 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL 341 (634)
+.+||.+||.+||++.+|.
T Consensus 625 mskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHhccCcccCCcHHHHH
Confidence 9999999999999987764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-24 Score=228.48 Aligned_cols=195 Identities=26% Similarity=0.386 Sum_probs=139.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|..-..||+|+||+||++... ++..||||.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 68888899999999999999954 458899984
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCC---ceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRG---VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~g---IvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
..+|+.+++.||+|||+.. |||||||++|||||.+...||+|||+|...... ..
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~ 232 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DT 232 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-cc
Confidence 1268999999999999964 999999999999999999999999999665431 11
Q ss_pred Ccccc-cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 218 PLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 218 ~~~~~-~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
..... .||..|++||++.. ...+.++||||||++|+||++|+.+..... ...........+... ++
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--------~~- 302 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--------KL- 302 (361)
T ss_pred ceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--------ch-
Confidence 11222 78999999999976 678999999999999999999998876432 111111111111110 00
Q ss_pred CcccCCCCCCCCchhhhhcC--CCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 294 HATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~--~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+.... ..+. ..-..+..+...|++.+|.+||++.|++.
T Consensus 303 -~eiiD~~l~~-----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 303 -REIVDPRLKE-----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -hheeCCCccC-----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0111111000 0011 11223678889999999999999999754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=237.09 Aligned_cols=190 Identities=22% Similarity=0.338 Sum_probs=165.0
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCc---EEehHH---------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK--------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~--------------------------------------- 162 (634)
.++......|.++||.|-||.|++++.+..++ .||||.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 36777788999999999999999999877664 599986
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..+++.|+.|+.||-++++|||||...|||++.+-.+||+|||+++.+.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 345788999999999999999999999999999999999999999998876
Q ss_pred CCCCCcccccc--cccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 214 GHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 214 ~~~~~~~~~~g--t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
+.....++.-| .+.|.|||.+.- ..++.++||||+|++|||.+. |..||...++.+.+..|.+....||+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------ 856 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------ 856 (996)
T ss_pred CCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC------
Confidence 65444444433 678999999975 779999999999999999876 99999999999999999887666553
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.++|..+..|+..||++|-..||++.+|+.+
T Consensus 857 ----------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 ----------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ----------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3689999999999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=226.69 Aligned_cols=189 Identities=19% Similarity=0.290 Sum_probs=154.1
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+++...+....++||-|.||.||.+.+++..-.||||.
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 34455566777999999999999999999989999996
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||..|++||..+++|||||-..|+|+.++..+||+|||++++...+...
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 3457789999999999999999999999999999999999999999988765433
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
........+.|.|||-|.- ..++.++|||+|||+|||+.| |-.||++.+-.+.+..+.+.. .
T Consensus 422 AHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-R--------------- 484 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-R--------------- 484 (1157)
T ss_pred cccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-c---------------
Confidence 3333334778999998863 678999999999999999998 889999987665554443211 0
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+....+++.+.+||+.||+|+|.+||++.|+-+
T Consensus 485 ------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 485 ------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 0112478999999999999999999999988753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=203.78 Aligned_cols=157 Identities=22% Similarity=0.284 Sum_probs=119.7
Q ss_pred CcEEehHHHHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccc
Q 006714 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 234 (634)
Q Consensus 155 g~~vAlK~i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 234 (634)
+..+....++.++.||+.||.|||+++ ||+|||++.++.+++ ||++...... ...+|+.|+|||++
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~~~y~aPE~~ 76 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVDPYFMAPEVI 76 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCcccccChHHh
Confidence 345677889999999999999999998 999999999999999 9998765432 22578999999999
Q ss_pred cCCCCCCCccccccchhhHHHHhhCCCCCCCCChH-HHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcC
Q 006714 235 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 313 (634)
Q Consensus 235 ~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~-e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 313 (634)
.+ ..|+.++|||||||++|||++|.+||...... ..+..+........ . ... ....
T Consensus 77 ~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~----------------~~~---~~~~ 133 (176)
T smart00750 77 QG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---P----------------RDR---SNLE 133 (176)
T ss_pred cC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---c----------------ccc---ccHH
Confidence 76 67899999999999999999999999765432 22333322111100 0 000 0001
Q ss_pred CCcH--HHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 314 DLPT--TAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 314 ~~s~--~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.++. .+.+||.+||..||.+|||+.++++|+|+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 2223 6899999999999999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-23 Score=219.67 Aligned_cols=195 Identities=19% Similarity=0.237 Sum_probs=157.0
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
.++..+...+.++||+|.||.|.+|.- ..+..||+|+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 344557889999999999999999984 4468999997
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
...|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++..-...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 13488999999999999999999999999999999999999999998554333
Q ss_pred CC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh--CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 216 RQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 216 ~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt--G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. .....+..+.|||+|.+.- ..++.++|+|+||+++||+++ ...||...++.+..++....+...+...
T Consensus 692 yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~------ 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV------ 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce------
Confidence 22 2233455789999999875 679999999999999999865 6789998888887777665544333211
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
......-++..+.+||.+|+..|-++||+++++..
T Consensus 765 ---------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 ---------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ---------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11122457888999999999999999999999854
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-23 Score=217.93 Aligned_cols=133 Identities=32% Similarity=0.478 Sum_probs=111.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+..++++.||+|.||.||+|.. +++.||||+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 45678889999999999999986 569999998
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHC---------CceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~---------gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+..++..|++||+|||+. .|+|||||..||||..|+++.|+|||+|..+
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 356888999999999984 5999999999999999999999999999866
Q ss_pred CCCC-CCCcccccccccCCCcccccCCCCCC-----CccccccchhhHHHHhhCCCCC
Q 006714 212 NTGH-RQPLTSRVVTLWYRPPELLLGATDYG-----PSVDLWSVGCVFAELLIGKPIL 263 (634)
Q Consensus 212 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~s-----~~sDIWSLG~iLyeLltG~~pf 263 (634)
.... .......+||..|||||+|.+..++. ...||||+|.+||||++....+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 5332 22334578999999999998765554 3689999999999999875443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=220.84 Aligned_cols=194 Identities=32% Similarity=0.484 Sum_probs=160.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+.+..+|.|+||.||+++|+.+++..|+|+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 689999999999999999999999999999997
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
|..+.+..+.+|.|||++|=+|||||-.|||+++.|.+||+|||.+-.+...- ....+..
T Consensus 95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Krksfi 173 (829)
T KOG0576|consen 95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFI 173 (829)
T ss_pred CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hhhhccc
Confidence 34467788999999999999999999999999999999999999986554321 2235678
Q ss_pred ccccCCCcccc--cCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 224 VTLWYRPPELL--LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 224 gt~~Y~APE~l--~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
||++|||||+. .....|...+|||++|+...|+-.-++|....-....+..+-+....||.-
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l---------------- 237 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL---------------- 237 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc----------------
Confidence 99999999985 234679999999999999999999888877766666666665544444310
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
+.-...++.+-+|++.+|..+|.+|||++.+|.|||...
T Consensus 238 --------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 238 --------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 001234677899999999999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=231.18 Aligned_cols=197 Identities=29% Similarity=0.445 Sum_probs=165.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH-----HHH------------------------HHHHHHHHHHHHHH
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-----IKC------------------------YMNQLLHGLEHCHS 179 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-----i~~------------------------i~~Qll~aL~yLHs 179 (634)
.++|+.++.|-.|+||.||+++|+.+.+.+|+|+ |.+ .=.+++.+++|||+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~Eylh~ 161 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAVEYLHS 161 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHhHhhcc
Confidence 4689999999999999999999999999999965 111 11256789999999
Q ss_pred CCceeccCCCCCceecCCCceEEeccccccccCCCC--------------CCCcccccccccCCCcccccCCCCCCCccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--------------RQPLTSRVVTLWYRPPELLLGATDYGPSVD 245 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sD 245 (634)
.+|+|||+||+|+||..-|++|+.|||+.+...... .......++|+.|+|||++.. ..|+..+|
T Consensus 162 ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvd 240 (1205)
T KOG0606|consen 162 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVD 240 (1205)
T ss_pred CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCcc
Confidence 999999999999999999999999999986432110 011234588999999999986 67999999
Q ss_pred cccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 006714 246 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 325 (634)
Q Consensus 246 IWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 325 (634)
+|++|+|+||.+.|..||.+.+..+++..++......++.. ..+++++.+||..
T Consensus 241 wwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d--------------------------ea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 241 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED--------------------------EALPPEAQDLIEQ 294 (1205)
T ss_pred HHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC--------------------------cCCCHHHHHHHHH
Confidence 99999999999999999999999999999877655555433 3578999999999
Q ss_pred hhccCcCCCc---CHHHHHhccccCCCCCC
Q 006714 326 LLSVEPYKRA---TASAALASEYFSTKPYA 352 (634)
Q Consensus 326 mL~~DP~kRp---Ta~elL~hpwf~~~~~~ 352 (634)
+|..+|..|. .+-++-+|+||+...|-
T Consensus 295 LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 295 LLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHhChHhhcccchhhhhhhccceeecccc
Confidence 9999999995 47788899999987665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=240.61 Aligned_cols=193 Identities=19% Similarity=0.287 Sum_probs=135.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|...+.||+|+||.||+|++..++..||+|.
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 46677899999999999999998999999985
Q ss_pred -----------HHHHHHHHHHHHHHHH---HCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccC
Q 006714 163 -----------IKCYMNQLLHGLEHCH---SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228 (634)
Q Consensus 163 -----------i~~i~~Qll~aL~yLH---s~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y 228 (634)
+..++.||+.||+||| ..+|+||||||+|||++.++..++. |+........ ....+++.|
T Consensus 771 ~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y 844 (968)
T PLN00113 771 SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAY 844 (968)
T ss_pred HHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccc
Confidence 2458899999999999 6699999999999999988887775 5554332211 223668899
Q ss_pred CCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCC-CCchhhhccCCCCcccCCCCCCCCc
Q 006714 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGS-PPDDYWKKSKLPHATLFKPQQPYDS 306 (634)
Q Consensus 229 ~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~-pp~~~~~~~~l~~~~~~~~~~~~~~ 306 (634)
+|||++.+ ..|+.++|||||||++|||++|+.||..... ...+......... .....| ..+......
T Consensus 845 ~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~ 913 (968)
T PLN00113 845 VAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW----------IDPSIRGDV 913 (968)
T ss_pred cCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe----------eCccccCCC
Confidence 99999876 6789999999999999999999999853211 0111111111100 000000 000000000
Q ss_pred hhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 307 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
. .......++.+|+.+||+.||.+|||+.|+++.
T Consensus 914 ~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 S---VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred C---ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0 001123457889999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-22 Score=201.33 Aligned_cols=180 Identities=27% Similarity=0.401 Sum_probs=138.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.|.|.|.+.||+|.||.+.+|+++.++..++||.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3789999999999999999999999999999996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC--CCceEEeccccccccCCCCCCCcc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
.+.++.||+.||.|||+.++||||||.+||||-. .-.|||||||+.+..+... .
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV----~ 178 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV----K 178 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee----h
Confidence 3679999999999999999999999999999933 3479999999987654321 1
Q ss_pred cccccccCCCcccccCC----CCCCCccccccchhhHHHHhhCCCCCCCCChHH-HHHHHHHhcCCCCchhhhccCCCCc
Q 006714 221 SRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~----~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e-~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
..--+..|.+||++... ....+..|||.||+|+|.+|+|.+||+.....+ -+...++ |..
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~---------w~~------ 243 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ---------WLK------ 243 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------Hhc------
Confidence 12236679999986431 224678999999999999999999997432211 1111111 111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kR 334 (634)
.....+...|..+++.+..+.++-|..+|++|
T Consensus 244 -------rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 244 -------RKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred -------ccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 11123445667889999999999999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-22 Score=208.17 Aligned_cols=187 Identities=27% Similarity=0.361 Sum_probs=135.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
..+..+.+.||+|.||.||++++ .|+.||||+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 35788999999999999999998 689999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHC--------CceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~--------gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
..+++..++.||+|||.. .|.|||||..|||+..++.+.|+|||+|....
T Consensus 288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 356888999999999975 49999999999999999999999999997554
Q ss_pred CC---CCCCcccccccccCCCcccccCCCCC-----CCccccccchhhHHHHhhC----------CCCCCCCC----hHH
Q 006714 213 TG---HRQPLTSRVVTLWYRPPELLLGATDY-----GPSVDLWSVGCVFAELLIG----------KPILQGRT----EVE 270 (634)
Q Consensus 213 ~~---~~~~~~~~~gt~~Y~APE~l~~~~~~-----s~~sDIWSLG~iLyeLltG----------~~pf~~~~----~~e 270 (634)
.. -....+..+||..|||||+|....+. =..+||||||+++||++.. ++||.+.. ..+
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 33 22455778999999999998542221 1258999999999999763 35665422 222
Q ss_pred HHHHHHHh--cCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHH
Q 006714 271 QLHKIFKL--CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340 (634)
Q Consensus 271 ~l~~i~~~--~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~el 340 (634)
.+.+++-. +.+..+..|.. ...-..+..||+.||..||.-|.||--|
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s-----------------------~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKS-----------------------DPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHhcceeecccCCCCCccccc-----------------------CHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 22222111 11111111110 0111346789999999999999998554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-21 Score=217.37 Aligned_cols=149 Identities=24% Similarity=0.371 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc--ccccCCCcccccCCCCCCC
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV--VTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~--gt~~Y~APE~l~~~~~~s~ 242 (634)
.++.||+.|++||++..+|||||-..||||..+..+||+|||+++.............. ....|||||.+.. ..|+.
T Consensus 422 sfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~ 500 (609)
T KOG0200|consen 422 SFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTS 500 (609)
T ss_pred HHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Ccccc
Confidence 47889999999999999999999999999999999999999999865443222111111 3456999999987 78999
Q ss_pred ccccccchhhHHHHhh-CCCCCCCCC-hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHH
Q 006714 243 SVDLWSVGCVFAELLI-GKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 320 (634)
Q Consensus 243 ~sDIWSLG~iLyeLlt-G~~pf~~~~-~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 320 (634)
++||||+|++||||++ |..||.+.. ..+.+..+.. .... +....++.++.
T Consensus 501 kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r~---------------------------~~P~~c~~eiY 552 (609)
T KOG0200|consen 501 KSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNRM---------------------------EQPEHCSDEIY 552 (609)
T ss_pred cchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCCC---------------------------CCCCCCCHHHH
Confidence 9999999999999998 889998855 4444332222 1111 11235688999
Q ss_pred HHHHHhhccCcCCCcCHHHHHh
Q 006714 321 NLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 321 dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+|+..|++.+|++||++.++.+
T Consensus 553 ~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 553 DLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhCCCcccCCCHHHHHH
Confidence 9999999999999999999873
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=211.47 Aligned_cols=183 Identities=20% Similarity=0.296 Sum_probs=144.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcE----EehHH--------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKI----VALKK-------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~----vAlK~-------------------------------------------- 162 (634)
.....++||+|+||+||++.+...++. ||||+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvt 776 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVT 776 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHH
Confidence 455668999999999999999766654 66664
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..|..||++||.|||++.++||||-..|||+.....+||.|||+++....+.....
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 345889999999999999999999999999999999999999999998765544322
Q ss_pred c-cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 220 T-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 220 ~-~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
. .....+.|||-|.+.. ..|+.++|||||||++|||+| |..|+.+....++-..+ +.-...+
T Consensus 857 ~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-e~geRLs-------------- 920 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-EKGERLS-------------- 920 (1177)
T ss_pred ccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-hccccCC--------------
Confidence 2 2223667899998875 789999999999999999998 88999887765543333 2211111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
..+..+-++..+|.+||..|+..||+++++..
T Consensus 921 -------------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 921 -------------QPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------------CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11356778899999999999999999998864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=208.60 Aligned_cols=148 Identities=30% Similarity=0.534 Sum_probs=127.7
Q ss_pred hhhhhhhccCcc--cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------
Q 006714 114 SAVAGEAIQGWV--PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------- 162 (634)
Q Consensus 114 ~~~~~~~~~~~~--~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------- 162 (634)
.+...+...+|. .....+|..+..||.|+||.|++|.++++...|.||.
T Consensus 543 ~a~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~ 622 (772)
T KOG1152|consen 543 KAVEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILAT 622 (772)
T ss_pred cccCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHH
Confidence 344444444442 3345679999999999999999999999999999986
Q ss_pred -------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCce
Q 006714 163 -------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 193 (634)
Q Consensus 163 -------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NIL 193 (634)
.+.|++|++.|+++||+.||||||||-+||+
T Consensus 623 l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvi 702 (772)
T KOG1152|consen 623 LNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVI 702 (772)
T ss_pred hhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEE
Confidence 3569999999999999999999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCC
Q 006714 194 VNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 264 (634)
Q Consensus 194 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~ 264 (634)
++.+|.+||+|||.+.....+ ++...+||..|.|||++.+....+..-|||+||++||.++....||.
T Consensus 703 vd~~g~~klidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 703 VDSNGFVKLIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EecCCeEEEeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999877654 34667899999999999987777889999999999999999888875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=194.92 Aligned_cols=149 Identities=24% Similarity=0.346 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc-ccccccccCCCcccccCCCCCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPS 243 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~s~~ 243 (634)
.++.||..|++|||.++|||.||-..|++|++.-++||+|=.+++..-......+ ........||+||.+.. ..|+.+
T Consensus 400 ~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssa 478 (563)
T KOG1024|consen 400 LMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSA 478 (563)
T ss_pred HHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcch
Confidence 4778999999999999999999999999999999999999998875443322211 12223677999999987 789999
Q ss_pred cccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 244 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 244 sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+|+||||++||||++ |+.|+...+..+....+.+.. +..+| -++|+++..+
T Consensus 479 sDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-------------------RlaQP---------~NCPDeLf~v 530 (563)
T KOG1024|consen 479 SDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-------------------RLAQP---------FNCPDELFTV 530 (563)
T ss_pred hhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-------------------eecCC---------CCCcHHHHHH
Confidence 999999999999998 889999888888777664421 11111 3689999999
Q ss_pred HHHhhccCcCCCcCHHHHHh
Q 006714 323 IETLLSVEPYKRATASAALA 342 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~ 342 (634)
|..||..+|++||+.+|+..
T Consensus 531 MacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 531 MACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHhcCcccCCCHHHHHH
Confidence 99999999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=213.91 Aligned_cols=168 Identities=28% Similarity=0.440 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC---CCcccccccccCCCcccccCCCC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATD 239 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~ 239 (634)
+.++++||+.||.|||..||.|||||++|||+..++.+||+|||.+..+..... ......+|...|+|||++.+...
T Consensus 422 ~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~y 501 (601)
T KOG0590|consen 422 ADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEY 501 (601)
T ss_pred hhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccccc
Confidence 346899999999999999999999999999999999999999999876543322 34456788999999999987555
Q ss_pred CCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHH
Q 006714 240 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 319 (634)
Q Consensus 240 ~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l 319 (634)
....+||||.|++++.|++|+.||......+....... ..............+..++...
T Consensus 502 dpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~lp~~~ 561 (601)
T KOG0590|consen 502 DPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------------------YSDQRNIFEGPNRLLSLLPRET 561 (601)
T ss_pred CcchhhhhhccceEEEEecCCCccccccccccchhhhc--------------------cccccccccChHHHHHhchhhH
Confidence 56789999999999999999999865433222110000 0000011122334456788999
Q ss_pred HHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 320 VNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 320 ~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+.+|.+||++||.+|+|+++||+.+||+...
T Consensus 562 ~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 562 RIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 9999999999999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=175.60 Aligned_cols=121 Identities=39% Similarity=0.633 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 241 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s 241 (634)
+..++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+||+.+........ ..........|++||.+.....++
T Consensus 94 ~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~ 172 (215)
T cd00180 94 ILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYS 172 (215)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCC
Confidence 3457889999999999999999999999999998 89999999999976654321 123345578899999887633778
Q ss_pred CccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 242 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 242 ~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
.+.|+|+||+++++| ..+.+
T Consensus 173 ~~~D~~~lg~~~~~l------------------------------------------------------------~~~~~ 192 (215)
T cd00180 173 EKSDIWSLGVILYEL------------------------------------------------------------PELKD 192 (215)
T ss_pred chhhhHHHHHHHHHH------------------------------------------------------------HHHHH
Confidence 999999999999998 23678
Q ss_pred HHHHhhccCcCCCcCHHHHHhcc
Q 006714 322 LIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~hp 344 (634)
+|..||..||.+||++.++++|+
T Consensus 193 ~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 193 LIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHhhCCcccCcCHHHHhhCC
Confidence 99999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.1e-19 Score=172.57 Aligned_cols=144 Identities=40% Similarity=0.669 Sum_probs=117.8
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|.+.+.||.|+|++||++.+..+++.+++|.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999988888888775
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.|++.+|.+||.++++|+||+|.||+++.++.++|+|||++...............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 2346789999999999999999999999999999999999999998866543211223446
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC-CChH-HHHHHH
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEV-EQLHKI 275 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~-e~l~~i 275 (634)
++..|++||.+.....++.++|+|+||+++|+|++|++||.. .... ...+.|
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 678899999884445677899999999999999999999977 4444 344444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-19 Score=185.73 Aligned_cols=167 Identities=28% Similarity=0.434 Sum_probs=120.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.+...+.||.|+|+.||.++|..|++.+|+|+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778999999999999999999999999986
Q ss_pred -----------------------------------------------------H-HHHHHHHHHHHHHHHHCCceeccCC
Q 006714 163 -----------------------------------------------------I-KCYMNQLLHGLEHCHSRGVLHRDIK 188 (634)
Q Consensus 163 -----------------------------------------------------i-~~i~~Qll~aL~yLHs~gIvHrDLK 188 (634)
+ ..+..|++..+++||..||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1 1244799999999999999999999
Q ss_pred CCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCC-------CCCCCccccccchhhHHHHhhCCC
Q 006714 189 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKP 261 (634)
Q Consensus 189 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~~s~~sDIWSLG~iLyeLltG~~ 261 (634)
|+|+|++.+|.++|+||+.....+... .....+..|.|||..... ..++.+.|.|+||+++|.|+++..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999998876554321 112345779999976431 246889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCC
Q 006714 262 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334 (634)
Q Consensus 262 pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kR 334 (634)
||.......... | .+. .+.++|+.++.||..||+.||.+|
T Consensus 249 Pf~~~~~~~~~~-------------~-------------------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPE-------------W-------------------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSG-------------G-------------------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccccc-------------c-------------------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 997543211000 0 111 223688999999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-19 Score=195.44 Aligned_cols=149 Identities=30% Similarity=0.464 Sum_probs=126.4
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
++.+...++.+++++|+.+|+|+|+|++||+++.+|++++.|||+++..-... ..|||..|||||++. ....
T Consensus 99 ~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~~cgt~eymApEI~~---gh~~ 170 (612)
T KOG0603|consen 99 VAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----IACGTYEYRAPEIIN---GHLS 170 (612)
T ss_pred HHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----hcccchhhhhhHhhh---ccCC
Confidence 34578899999999999999999999999999999999999999998665432 228899999999987 3578
Q ss_pred ccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 243 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 243 ~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
++|+||||+++|+|++|..||.+ +....|.+..-..| ..++..+.++
T Consensus 171 a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p-----------------------------~~l~~~a~~~ 217 (612)
T KOG0603|consen 171 AADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP-----------------------------RELSAEARSL 217 (612)
T ss_pred cccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-----------------------------hhhhHHHHHH
Confidence 89999999999999999999988 77777766443333 3456778999
Q ss_pred HHHhhccCcCCCcC-----HHHHHhccccCCCCCC
Q 006714 323 IETLLSVEPYKRAT-----ASAALASEYFSTKPYA 352 (634)
Q Consensus 323 L~~mL~~DP~kRpT-----a~elL~hpwf~~~~~~ 352 (634)
+..|+..+|..|.- +.|+++|+||....|-
T Consensus 218 ~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 99999999999976 4899999999987553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=167.21 Aligned_cols=184 Identities=23% Similarity=0.297 Sum_probs=142.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
....|.++++||.|+||.+|++....+|..||||.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45689999999999999999999999999999997
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC---CceEEeccccccccCCCCC---
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHR--- 216 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~--- 216 (634)
+..++.|++.-|+|+|.+++|||||||+|+|..-. ..+.|+|||+++.+.+...
T Consensus 93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H 172 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH 172 (341)
T ss_pred cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence 34577899999999999999999999999998533 4689999999986543221
Q ss_pred ---CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH---HHHHHHHhcCCCCchhhhcc
Q 006714 217 ---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE---QLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 217 ---~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e---~l~~i~~~~g~pp~~~~~~~ 290 (634)
..-....||..|.+-....+ ..-+...|+-|+|.+|..+..|..||++..... ..++|.+.--
T Consensus 173 Ipyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~---------- 241 (341)
T KOG1163|consen 173 IPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM---------- 241 (341)
T ss_pred CccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc----------
Confidence 12234578999998877765 345778999999999999999999999865443 3444443221
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT 336 (634)
...+..+++.+|.++...|.-|=..--++-|.
T Consensus 242 --------------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 242 --------------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred --------------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 12345556788888888887776666566565
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=168.98 Aligned_cols=144 Identities=28% Similarity=0.408 Sum_probs=121.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|.|.++||+|+||.++++.+.-++++||||.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGP 108 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGP 108 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCc
Confidence 69999999999999999999999999999996
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-----CceEEeccccccccCCCCC----
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-----g~vkL~DFGla~~~~~~~~---- 216 (634)
+..++.||+.-++|+|++.+|+|||||+|+||... ..|.|+|||+|+.+.+...
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI 188 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI 188 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence 45689999999999999999999999999999644 3589999999987654322
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHH
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKI 275 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i 275 (634)
....+..||..||+-...++ ..-+...|+-|||.++++.|-|..||.+.. ..+.+++|
T Consensus 189 PYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 189 PYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 12245678999999998887 556889999999999999999999998753 44444444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-17 Score=170.93 Aligned_cols=188 Identities=27% Similarity=0.249 Sum_probs=138.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCC-cEEehHH-----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTG-KIVALKK----------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg-~~vAlK~----------------------------------------------- 162 (634)
+|.+.++||+|+||.||++.+..++ ..+|+|.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999987764 4566664
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-----CceEEecccccc--c
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLAN--F 210 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-----g~vkL~DFGla~--~ 210 (634)
+..++.|++.+|++||+.|++||||||.|+++... ..+.|.|||+++ .
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 34588899999999999999999999999999754 469999999998 3
Q ss_pred cCCCCC----CC---cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCC
Q 006714 211 SNTGHR----QP---LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283 (634)
Q Consensus 211 ~~~~~~----~~---~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp 283 (634)
...... .. .....||..|.++.+..+ ...+...|+||++.++.+|+.|..||.+........++.+......
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~ 257 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL 257 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence 221111 11 123458999999998877 6678999999999999999999999977654333333322111100
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 284 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. ......+..+..++..+-..+...+|....+...
T Consensus 258 ~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 258 TD------------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cc------------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 00 0112345667777777777888888887766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=160.66 Aligned_cols=167 Identities=33% Similarity=0.499 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCCC-----CcccccccccCCCcccccC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ-----PLTSRVVTLWYRPPELLLG 236 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~ 236 (634)
+..++.|++.+|.|+|..+++||||||+|||++..+ .++++|||++......... .....+++..|++||.+.+
T Consensus 103 ~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence 456889999999999999999999999999999988 7999999999755433221 2456788999999999976
Q ss_pred C--CCCCCccccccchhhHHHHhhCCCCCCCCCh---HHHHHHHHHhcCCC-CchhhhccCCCCcccCCCCCCCCchhhh
Q 006714 237 A--TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSP-PDDYWKKSKLPHATLFKPQQPYDSSLRE 310 (634)
Q Consensus 237 ~--~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---~e~l~~i~~~~g~p-p~~~~~~~~l~~~~~~~~~~~~~~~l~~ 310 (634)
. ..+....|+|++|+++++++++..||..... .......+.....+ .... . .....
T Consensus 183 ~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~--~~~~~- 244 (384)
T COG0515 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP---------------L--SPSNP- 244 (384)
T ss_pred CCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc---------------c--Ccccc-
Confidence 3 4678899999999999999999999887764 33333333332222 0000 0 00000
Q ss_pred hcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 311 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 311 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......+.+++..|+..+|..|.+..+.+.++|+...
T Consensus 245 --~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 245 --ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred --chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1223578899999999999999999999999776654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-17 Score=186.98 Aligned_cols=183 Identities=30% Similarity=0.428 Sum_probs=130.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|...+.||.+.|=.|.+|++.+ |. |.||+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 68889999999999999999753 43 66665
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc--cCCCCCCCcc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLT 220 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~--~~~~~~~~~~ 220 (634)
-+-|+.||+.||..||..||+|+|||.+||||..=+-+.|+||..-+. ...+....++
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 133788999999999999999999999999999988999999976542 2222211111
Q ss_pred cc----cccccCCCcccccCCC----------CCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCch
Q 006714 221 SR----VVTLWYRPPELLLGAT----------DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 221 ~~----~gt~~Y~APE~l~~~~----------~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~ 285 (634)
.+ .--.+|+|||.+.... ..+++.||||+||+++||++ |+|||.- .+++.....-.
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~~-- 252 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGNA-- 252 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccCc--
Confidence 11 2246799999885411 15678999999999999998 7999952 22221100000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.....+.+.. -+..+++||..|++.||++|.+|++.|+-
T Consensus 253 -----------------~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 -----------------DDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -----------------cCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0001111111 23468999999999999999999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=179.24 Aligned_cols=148 Identities=30% Similarity=0.507 Sum_probs=109.1
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-----CCCcccccccccCCCcccccCCC
Q 006714 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPELLLGAT 238 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~ 238 (634)
..++.|+..+++| ++.+|+|+||.||++..+..+||.|||+........ ....+..++|.+||+||.|.+ .
T Consensus 362 ~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~ 437 (516)
T KOG1033|consen 362 LDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-Q 437 (516)
T ss_pred HHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-h
Confidence 4578899999999 999999999999999999999999999987655433 223456688999999999997 7
Q ss_pred CCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcH
Q 006714 239 DYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 317 (634)
Q Consensus 239 ~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~ 317 (634)
.|+.++|||+||+|||||+.- ...|.. ...+..+. -+..|+.+| .-.+
T Consensus 438 ~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r--~g~ip~~~~--------------------------~d~p 486 (516)
T KOG1033|consen 438 QYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIR--DGIIPPEFL--------------------------QDYP 486 (516)
T ss_pred hhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhh--cCCCChHHh--------------------------hcCc
Confidence 899999999999999999972 112111 01111111 122222222 1123
Q ss_pred HHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 318 TAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 318 ~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
.-.+||..||.+.|.+||++.+.--|+|.
T Consensus 487 ~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 487 EEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 35689999999999999988877777764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-16 Score=164.30 Aligned_cols=151 Identities=25% Similarity=0.342 Sum_probs=105.2
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCcee--cCCC--ceEEeccccccccCCCCC-----CCcccccccccCCCccccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEG--VLKLADFGLANFSNTGHR-----QPLTSRVVTLWYRPPELLL 235 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl--~~~g--~vkL~DFGla~~~~~~~~-----~~~~~~~gt~~Y~APE~l~ 235 (634)
-++.|+++|+.|||.+||.|||||.+|||| ++|+ .+.|+|||++--.....- ...-..-|.-..||||+..
T Consensus 345 ~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 378899999999999999999999999998 3443 478999998753322111 1112334577789999875
Q ss_pred CCCC-----CCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhh
Q 006714 236 GATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 310 (634)
Q Consensus 236 ~~~~-----~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~ 310 (634)
.... .-.++|.|+.|.+.||++....||.+..+.-.-..- +.. ..+..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----------Yqe----------------~qLPa 477 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----------YQE----------------SQLPA 477 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----------hhh----------------hhCCC
Confidence 3221 124789999999999999999999774322110000 000 11122
Q ss_pred hcCCCcHHHHHHHHHhhccCcCCCcCH---HHHHh
Q 006714 311 TFKDLPTTAVNLIETLLSVEPYKRATA---SAALA 342 (634)
Q Consensus 311 ~~~~~s~~l~dLL~~mL~~DP~kRpTa---~elL~ 342 (634)
+...+++.+++|+..+|+.||++|+++ ..+|+
T Consensus 478 lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 478 LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 235688999999999999999999985 44554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.8e-16 Score=167.12 Aligned_cols=110 Identities=21% Similarity=0.288 Sum_probs=89.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECC-CCcEEehHH------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKK------------------------------------------ 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~-tg~~vAlK~------------------------------------------ 162 (634)
+...++|.+.+.||+|+||+||+|++.. +++.||||+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~ 93 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKD 93 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCc
Confidence 3446789999999999999999999876 677778863
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccC-CCCCceecCCCceEEeccccccccCCCCCC-----
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSNTGHRQ----- 217 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDL-Kp~NILl~~~g~vkL~DFGla~~~~~~~~~----- 217 (634)
...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 94 ~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~ 173 (365)
T PRK09188 94 GLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAA 173 (365)
T ss_pred EEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhh
Confidence 1357889999999999999999999 999999998999999999999865432211
Q ss_pred --CcccccccccCCCccccc
Q 006714 218 --PLTSRVVTLWYRPPELLL 235 (634)
Q Consensus 218 --~~~~~~gt~~Y~APE~l~ 235 (634)
..+...+++.|++||++.
T Consensus 174 ~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 174 YEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred hhhhhhhhccCccCCcccCC
Confidence 113456688899999885
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.3e-15 Score=172.07 Aligned_cols=134 Identities=28% Similarity=0.424 Sum_probs=113.8
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+++..+.|.|-+.||+|+||+||+|.+.+ ++.||||+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 45667899999999999999999999876 99999997
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-------CCceEEecccccccc
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFGLANFS 211 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-------~g~vkL~DFGla~~~ 211 (634)
+..+..|||..|++||.++|||+||||+|+||.. .--++|+|||.+...
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 3457889999999999999999999999999942 235899999998643
Q ss_pred CC-CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCC
Q 006714 212 NT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260 (634)
Q Consensus 212 ~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~ 260 (634)
.. .....+...+.|-.+-++|+..+ ..+++.+|.|.|+.+++-||.|+
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 32 12234566777889999998887 78999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=3e-13 Score=136.39 Aligned_cols=112 Identities=14% Similarity=0.191 Sum_probs=87.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|.+++.||.|+||.||++.+ ++..++||+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46999999999999999999765 466788886
Q ss_pred ----------------------H-------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ----------------------I-------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ----------------------i-------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+ ...+.+|+.+|..||..||+|+||||+|||++.++ ++|+|||.......
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e 186 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQ 186 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccc
Confidence 1 12466899999999999999999999999999888 99999998765432
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHh
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLl 257 (634)
... .. .+++. ..|+.++|+|+||+++..+.
T Consensus 187 ~~a---~d----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 187 RKA---KD----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhh---HH----------HHHHH-hHhcccccccceeEeehHHH
Confidence 110 00 02222 45678999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.9e-13 Score=132.05 Aligned_cols=103 Identities=20% Similarity=0.176 Sum_probs=75.7
Q ss_pred HHHHHHHHHHHHHHHCCceeccC-CCCCceecCCCceEEeccccccccCCCCCC----C--------cccccccccCCCc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSNTGHRQ----P--------LTSRVVTLWYRPP 231 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDL-Kp~NILl~~~g~vkL~DFGla~~~~~~~~~----~--------~~~~~gt~~Y~AP 231 (634)
.++.|++.+|.+||.+||+|+|| ||+|||++.++.++|+|||++......... . ..-...++.|+.|
T Consensus 95 ~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~ 174 (218)
T PRK12274 95 AYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTP 174 (218)
T ss_pred HHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCH
Confidence 47789999999999999999999 799999999999999999999855432210 0 0001136667777
Q ss_pred ccccCCCCCC-CccccccchhhHHHHhhCCCCCCCCC
Q 006714 232 ELLLGATDYG-PSVDLWSVGCVFAELLIGKPILQGRT 267 (634)
Q Consensus 232 E~l~~~~~~s-~~sDIWSLG~iLyeLltG~~pf~~~~ 267 (634)
+...-....+ ...++++.|+.+|.++|+..++.+.+
T Consensus 175 ~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 175 VERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 6542211222 45688899999999999998876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.7e-14 Score=159.26 Aligned_cols=161 Identities=33% Similarity=0.520 Sum_probs=126.7
Q ss_pred HHHHHHHHHHHHHHH-HCCceeccCCCCCceecCCC-ceEEeccccccccCC--CCCCCcccccc-cccCCCcccccCCC
Q 006714 164 KCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNT--GHRQPLTSRVV-TLWYRPPELLLGAT 238 (634)
Q Consensus 164 ~~i~~Qll~aL~yLH-s~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~--~~~~~~~~~~g-t~~Y~APE~l~~~~ 238 (634)
..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+.. +........++ ++.|+|||.+.+..
T Consensus 126 ~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~ 205 (601)
T KOG0590|consen 126 SRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA 205 (601)
T ss_pred hhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchh
Confidence 468999999999999 99999999999999999999 999999999986654 33344556678 99999999998755
Q ss_pred CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHH
Q 006714 239 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 318 (634)
Q Consensus 239 ~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~ 318 (634)
......|+||+|+++.-|++|..|+.......... ..|...+ .......+..++..
T Consensus 206 ~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~~-------------~~~~~~~~~~~~~~ 261 (601)
T KOG0590|consen 206 YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSNK-------------GRFTQLPWNSISDQ 261 (601)
T ss_pred hcCCCcccccccccccccccCCCCccccccccccc-----------eeecccc-------------cccccCccccCChh
Confidence 66889999999999999999998876433222000 0011000 00012223567888
Q ss_pred HHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 319 AVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 319 l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..+++.++|..+|..|.+..++-.++|+..
T Consensus 262 ~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 262 AHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.9e-13 Score=129.47 Aligned_cols=48 Identities=19% Similarity=0.281 Sum_probs=43.4
Q ss_pred HHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 164 KCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
..++.|++.+|.+||. +||+|+||||+|||++ ++.++|+|||++....
T Consensus 120 ~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 120 EELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 3477899999999999 9999999999999998 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.8e-13 Score=130.63 Aligned_cols=48 Identities=19% Similarity=0.254 Sum_probs=42.1
Q ss_pred HHHHHHHHHHHHHH-HHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 164 KCYMNQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 164 ~~i~~Qll~aL~yL-Hs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
..++.||+.+|.|| |..||+||||||+|||++ ++.++|+|||++....
T Consensus 120 ~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 120 RELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 34678999999999 799999999999999998 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.1e-11 Score=134.22 Aligned_cols=185 Identities=25% Similarity=0.367 Sum_probs=125.2
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCCceecCCCceEEecccccc
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGV-LHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i~~i~~Qll~aL~yLHs~gI-vHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.+.|.+...+|+.-.+....+.+ +.-.....+++.|+.||.|||.-.| .|+.|+..|++++....+||+|||+..
T Consensus 22 ~~~i~~~c~rGsl~D~i~~~~~~----~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~ 97 (484)
T KOG1023|consen 22 MIVIWEYCSRGSLLDILSNEDIK----LDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNS 97 (484)
T ss_pred eEEEEeeecCccHHhHHhccccC----ccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcc
Confidence 34555556666655554442222 2223456788999999999999866 999999999999999999999999987
Q ss_pred ccCCC-CCCCcccccccccCCCcccccCCCC------CCCccccccchhhHHHHhhCCCCCCCCC----hHHHHHHHHHh
Q 006714 210 FSNTG-HRQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKL 278 (634)
Q Consensus 210 ~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~------~s~~sDIWSLG~iLyeLltG~~pf~~~~----~~e~l~~i~~~ 278 (634)
..... .........-...|.|||++..... .+.+.||||||++++|+++...||.... ..+.+..+.+
T Consensus 98 ~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~- 176 (484)
T KOG1023|consen 98 LLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK- 176 (484)
T ss_pred cccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-
Confidence 66421 0011111223566999999875311 3667999999999999999999997632 2234444333
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHH
Q 006714 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341 (634)
Q Consensus 279 ~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL 341 (634)
.+..+ +.+.+... ..+++++..++..|+..+|.+||++.++-
T Consensus 177 ~~~~~--------------------~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 177 GGSNP--------------------FRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cCCCC--------------------cCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 11111 11111111 14566899999999999999999998875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=125.92 Aligned_cols=81 Identities=21% Similarity=0.223 Sum_probs=71.0
Q ss_pred CeeEEEEecccCceeEEEEE-ECCCCcEEehHH-----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRAR-DLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~-d~~tg~~vAlK~----------------------------------------------- 162 (634)
-|.+.+.||+|+||.||+|. +..+|+.||||+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 667888888772
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHHHHCC-ceeccCCCCCceecCCCce
Q 006714 163 -----------------------------------------IKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEGVL 200 (634)
Q Consensus 163 -----------------------------------------i~~i~~Qll~aL~yLHs~g-IvHrDLKp~NILl~~~g~v 200 (634)
+..++.||+.+|.+||.+| |+|+||||+|||++ ++.+
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i 187 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKV 187 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCE
Confidence 1357889999999999999 99999999999998 7899
Q ss_pred EEeccccccccC
Q 006714 201 KLADFGLANFSN 212 (634)
Q Consensus 201 kL~DFGla~~~~ 212 (634)
+|+|||++....
T Consensus 188 ~LiDFg~a~~~~ 199 (237)
T smart00090 188 VIIDVSQSVELD 199 (237)
T ss_pred EEEEChhhhccC
Confidence 999999886443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-11 Score=122.86 Aligned_cols=143 Identities=14% Similarity=0.151 Sum_probs=105.0
Q ss_pred HHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCceEEe--ccccccccCCCCCCCcccccccccCCCcccccCCCC
Q 006714 164 KCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 239 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 239 (634)
..++..|+.|+.|||+.. |.---|....++||++.+.+|. |--++... ....-.+.||+||.+.....
T Consensus 292 v~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe--------~gr~y~pawmspealqrkpe 363 (448)
T KOG0195|consen 292 VRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--------VGRAYSPAWMSPEALQRKPE 363 (448)
T ss_pred HHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec--------cccccCcccCCHHHHhcCch
Confidence 468889999999999973 4455688899999998776653 43332211 12233678999999976333
Q ss_pred C--CCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcH
Q 006714 240 Y--GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 317 (634)
Q Consensus 240 ~--s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~ 317 (634)
. -.++|+|||+++||||.|...||......+.-.+|.-.-- .....+.++.
T Consensus 364 d~n~raadmwsfaillwel~trevpfadlspmecgmkialegl---------------------------rv~ippgis~ 416 (448)
T KOG0195|consen 364 DLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL---------------------------RVHIPPGISR 416 (448)
T ss_pred hcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc---------------------------cccCCCCccH
Confidence 2 3579999999999999999999998887776655532110 0112257888
Q ss_pred HHHHHHHHhhccCcCCCcCHHHHH
Q 006714 318 TAVNLIETLLSVEPYKRATASAAL 341 (634)
Q Consensus 318 ~l~dLL~~mL~~DP~kRpTa~elL 341 (634)
.+..|+.-|++.||.+||.+..++
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-11 Score=116.96 Aligned_cols=81 Identities=25% Similarity=0.353 Sum_probs=71.0
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|.+.+.||.|+||.||++.+. +++.||||+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999874 788999871
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
...++.+|+.+|.+||..||+|+||+|+||||+.++.++|+|||++..
T Consensus 95 i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 95 FPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 123678999999999999999999999999999999999999999865
Q ss_pred cC
Q 006714 211 SN 212 (634)
Q Consensus 211 ~~ 212 (634)
..
T Consensus 175 ~~ 176 (198)
T cd05144 175 TD 176 (198)
T ss_pred CC
Confidence 44
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.7e-11 Score=136.71 Aligned_cols=199 Identities=28% Similarity=0.344 Sum_probs=156.2
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..+.+.+++-+-.|.++.++.+.-..++...++|.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45788999999999999999998777776666665
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC----
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---- 214 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~---- 214 (634)
.+.++..+..+++|||...++|+|++|.|+|+..++..++.||+........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 1235567788999999999999999999999999999999999843211100
Q ss_pred -C--------------------C-----CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh
Q 006714 215 -H--------------------R-----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268 (634)
Q Consensus 215 -~--------------------~-----~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~ 268 (634)
. . ......++|+.|.+||.+.+ ......+|+|++|++++|.++|.+||...+.
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0 01123467999999999987 5567889999999999999999999999988
Q ss_pred HHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH---HHHhccc
Q 006714 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEY 345 (634)
Q Consensus 269 ~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~---elL~hpw 345 (634)
...+..|.......+. -....+..+.+++..+|..+|.+|..+. ++-.|+|
T Consensus 1041 q~~f~ni~~~~~~~p~--------------------------g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPE--------------------------GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred hhhhhccccCCCCCCC--------------------------CccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence 8887777543222211 1134678899999999999999999987 8899999
Q ss_pred cCCCCCCC
Q 006714 346 FSTKPYAC 353 (634)
Q Consensus 346 f~~~~~~~ 353 (634)
|+..+|..
T Consensus 1095 ~~~~~~~~ 1102 (1205)
T KOG0606|consen 1095 FQDVDWEN 1102 (1205)
T ss_pred cCCCCccc
Confidence 99877754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-10 Score=112.92 Aligned_cols=47 Identities=23% Similarity=0.340 Sum_probs=42.2
Q ss_pred HHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 165 CYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
.++.+++.++.+||. .+|+|+||||+|||++ ++.++|+|||.+....
T Consensus 118 ~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 118 ELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred HHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 367788999999999 9999999999999999 8899999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.8e-11 Score=129.64 Aligned_cols=188 Identities=26% Similarity=0.352 Sum_probs=144.4
Q ss_pred CCeeEEEEecc--cCceeEEEEEE--CCCCcEEehHH-------------------------------------------
Q 006714 130 DAFEKLEKIGQ--GTYSSVFRARD--LDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~--G~fg~Vy~a~d--~~tg~~vAlK~------------------------------------------- 162 (634)
..|.+...+|. |.+|.||.++. ..+...+|+|.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 46788899999 99999999998 88899999986
Q ss_pred --------------------------HHHHHHHHHH----HHHHHHHCCceeccCCCCCceecCC-CceEEecccccccc
Q 006714 163 --------------------------IKCYMNQLLH----GLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFS 211 (634)
Q Consensus 163 --------------------------i~~i~~Qll~----aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~ 211 (634)
++.++.++.. ||.++|..+|+|-|+||.||++..+ ..++++||++...+
T Consensus 194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 4567778888 9999999999999999999999988 88999999999877
Q ss_pred CCCCCCCc----ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC--ChHHHHHHHHHhcCCCCch
Q 006714 212 NTGHRQPL----TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 212 ~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~--~~~e~l~~i~~~~g~pp~~ 285 (634)
........ ....+...|++||++.+ -++...|||+||.++.+..++..++... +...++..+. .+
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip-- 344 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IP-- 344 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cc--
Confidence 65432111 11134567999998865 5789999999999999998887555432 1111111110 11
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+.+...+.++..++..||..+|..|++++.+++|++....
T Consensus 345 -----------------------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 345 -----------------------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -----------------------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 11223445566669999999999999999999999998754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.6e-10 Score=125.00 Aligned_cols=155 Identities=25% Similarity=0.354 Sum_probs=114.4
Q ss_pred HHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc--------cccccccCCCcccccCCCC
Q 006714 169 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT--------SRVVTLWYRPPELLLGATD 239 (634)
Q Consensus 169 Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~--------~~~gt~~Y~APE~l~~~~~ 239 (634)
+...||.|+|.. ++||++|.|++|.++..+..||+.|+++.........++. .......|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999987 8999999999999999999999999987644332111111 1122567999999987 66
Q ss_pred CCCccccccchhhHHHHh-hCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHH
Q 006714 240 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 318 (634)
Q Consensus 240 ~s~~sDIWSLG~iLyeLl-tG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~ 318 (634)
.+.++|+|||||++|.+. .|++.+...........-....+... ...-..++.+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~-------------------------~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA-------------------------FGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc-------------------------ccccccCcHH
Confidence 789999999999999999 67777765543332222211111000 0011578999
Q ss_pred HHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 319 AVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 319 l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+++=|.++|..++..||++.+++..|||.+.
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 9999999999999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.3e-10 Score=108.97 Aligned_cols=45 Identities=33% Similarity=0.584 Sum_probs=41.7
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
.++.+|+.+|.+||..+++|+||+|.|||++ ++.++|+|||++..
T Consensus 99 ~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 99 ELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6778999999999999999999999999998 78899999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-09 Score=121.36 Aligned_cols=46 Identities=30% Similarity=0.540 Sum_probs=41.9
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
.++.||+.+|.|||+.+|+||||||+|||+ .++.++|+|||++...
T Consensus 432 ~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 432 ELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 467899999999999999999999999999 6779999999998653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-09 Score=104.11 Aligned_cols=45 Identities=29% Similarity=0.558 Sum_probs=42.1
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
.++.||+.+|.+||+.+|+|+||+|.|||++ ++.++|+|||++..
T Consensus 94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 5789999999999999999999999999998 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.8e-09 Score=104.35 Aligned_cols=42 Identities=19% Similarity=0.161 Sum_probs=35.7
Q ss_pred HHHHHHHHH-HHHHHCCceeccCCCCCceecCC----CceEEecccc
Q 006714 166 YMNQLLHGL-EHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGL 207 (634)
Q Consensus 166 i~~Qll~aL-~yLHs~gIvHrDLKp~NILl~~~----g~vkL~DFGl 207 (634)
++.|++.++ +|||+++|+||||||+|||++.. ..++|+||+.
T Consensus 109 ~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 109 QLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred HHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 467888888 99999999999999999999743 3799999543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-08 Score=111.54 Aligned_cols=186 Identities=23% Similarity=0.262 Sum_probs=136.3
Q ss_pred ccCCCeeEEEEecccCceeEEEEEEC-CCCcEEehHH-------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~-~tg~~vAlK~------------------------------------------- 162 (634)
....+|..+..||.|.|+.|+.+... .++..|++|.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 33568999999999999999998755 6788899987
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~ 215 (634)
++.+..|++.++.++|+..++|+|++|+||++..+ +..++.||++........
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence 34577899999999999999999999999999876 778999999886322111
Q ss_pred CCCcccccccccCC-CcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 RQPLTSRVVTLWYR-PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~-APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.......++. ..|++.....+..+.|+++||..+.+.+++.+.-...... ..|..
T Consensus 422 ----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~----------------- 477 (524)
T KOG0601|consen 422 ----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRS----------------- 477 (524)
T ss_pred ----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeec-----------------
Confidence 1112234455 3666666677889999999999999999987654322211 11100
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
............+..+...|+..++..|+.+.++..|.-|..
T Consensus 478 ------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 478 ------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 001112334467788999999999999999999988876643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.7e-08 Score=102.87 Aligned_cols=160 Identities=18% Similarity=0.174 Sum_probs=104.6
Q ss_pred EEehHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCceecCCCceEEeccccccccCC--CCC-CCcccccccccCCCc
Q 006714 157 IVALKKIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--GHR-QPLTSRVVTLWYRPP 231 (634)
Q Consensus 157 ~vAlK~i~~i~~Qll~aL~yLHs~--gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~--~~~-~~~~~~~gt~~Y~AP 231 (634)
..-+|-.++|+.||+.||.|||+. -|+|++|..+.|++..++.|||.--........ ... .......+-+.|.+|
T Consensus 172 a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~ 251 (458)
T KOG1266|consen 172 ALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAP 251 (458)
T ss_pred hhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccC
Confidence 344455788999999999999998 599999999999999999888754221110000 000 000112335778899
Q ss_pred ccccCCCCCCCccccccchhhHHHHhhCCCC-CCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhh
Q 006714 232 ELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 310 (634)
Q Consensus 232 E~l~~~~~~s~~sDIWSLG~iLyeLltG~~p-f~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~ 310 (634)
|.=.. .+.+.++|||+||....+|..+..- -.+....+....|......
T Consensus 252 ~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~----------------------------- 301 (458)
T KOG1266|consen 252 ESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG----------------------------- 301 (458)
T ss_pred CcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee-----------------------------
Confidence 86543 4567789999999999999887532 2222222222222111100
Q ss_pred hcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 311 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 311 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....-.+++.+||+..|..||++.++|.||.+-..
T Consensus 302 ---len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 302 ---LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred ---ccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 011112468999999999999999999999987653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.3e-08 Score=89.21 Aligned_cols=48 Identities=25% Similarity=0.385 Sum_probs=42.4
Q ss_pred HHHHHHHHHHHHHHHHC---CceeccCCCCCceecCCCceEEecccccccc
Q 006714 164 KCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~---gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
..++.+++.+|.+||.. +++|+||+|.|||++..+.++|+||+.+...
T Consensus 89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 45778899999999985 6999999999999998889999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.1e-07 Score=103.16 Aligned_cols=46 Identities=24% Similarity=0.412 Sum_probs=38.7
Q ss_pred HHHHHH-HHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 167 MNQLLH-GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 167 ~~Qll~-aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
+.+++. .+..+|..|++|+|+||.||+++.++.++|+|||++....
T Consensus 262 a~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 262 AENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 334444 4678999999999999999999999999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.5e-07 Score=94.48 Aligned_cols=45 Identities=24% Similarity=0.457 Sum_probs=41.9
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
.+.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+..
T Consensus 147 ~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 147 QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 467899999999999999999999999999888999999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.5e-07 Score=84.32 Aligned_cols=44 Identities=27% Similarity=0.419 Sum_probs=39.3
Q ss_pred HHHHHHHHHHHHHHHCCc-----eeccCCCCCceecCCCceEEecccccc
Q 006714 165 CYMNQLLHGLEHCHSRGV-----LHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gI-----vHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++.+++.+|..||..++ +|+|++|.|||++ ++.++|+||+.+.
T Consensus 87 ~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 87 ENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 467799999999999985 9999999999998 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.2e-07 Score=102.68 Aligned_cols=38 Identities=24% Similarity=0.422 Sum_probs=32.6
Q ss_pred HHHHCCceeccCCCCCceecCCC----ceEEeccccccccCC
Q 006714 176 HCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 213 (634)
Q Consensus 176 yLHs~gIvHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 213 (634)
.+...|++|+|+||.|||++.++ .++++|||++.....
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34567999999999999999888 899999999876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=86.98 Aligned_cols=78 Identities=15% Similarity=0.180 Sum_probs=55.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCceecCCCceEEecccc
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i~~i~~Qll~aL~yL-Hs~gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
.+.+-+++.||.++..... ..+. ....+.+..++.|++.+|..| |..||||+||++.|||+. ++.+.|+|||.
T Consensus 97 ~~~~lvME~Ig~~~~~~~~-Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~q 170 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPK-LKDA----KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQ 170 (197)
T ss_pred cCCEEEEEEcCCCCccchh-hhcc----ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCC
Confidence 3466777888765432111 1111 122344567789999999998 899999999999999996 46899999998
Q ss_pred ccccC
Q 006714 208 ANFSN 212 (634)
Q Consensus 208 a~~~~ 212 (634)
+....
T Consensus 171 av~~~ 175 (197)
T cd05146 171 SVEPT 175 (197)
T ss_pred ceeCC
Confidence 86543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.7e-06 Score=88.05 Aligned_cols=166 Identities=17% Similarity=0.205 Sum_probs=107.9
Q ss_pred EehHHHHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCccccc-C
Q 006714 158 VALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-G 236 (634)
Q Consensus 158 vAlK~i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-~ 236 (634)
++-..+....+.|+.+...||+.|.+-+|+.++|||+++++.+.|.|-..-.... ........++...|.+||.-. +
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~--ng~~~~cpVg~~eftPPElQ~~~ 191 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA--NGTLHLCPVGVSEFTPPELQTLP 191 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc--CCceEecccCccccCCHHHhccc
Confidence 4455577889999999999999999999999999999999999999844322221 223334567889999999753 1
Q ss_pred ---CCCCCCccccccchhhHHHHhhC-CCCCCCCChH----HHH-HHHHHhcCCCCchhhhccCCCCcccCCCCCCCC-c
Q 006714 237 ---ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEV----EQL-HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-S 306 (634)
Q Consensus 237 ---~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~----e~l-~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~-~ 306 (634)
.-.-+...|.|.||+++|+|+.| +.||.+.... .-+ ..|.... +..+. .....+. .
T Consensus 192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~------------f~ya~--~~~~g~~p~ 257 (637)
T COG4248 192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR------------FAYAS--DQRRGLKPP 257 (637)
T ss_pred cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce------------eeech--hccCCCCCC
Confidence 12235678999999999999997 8999764210 000 0111100 00000 0000011 1
Q ss_pred hhhhhcCCCcHHHHHHHHHhhcc--CcCCCcCHHH
Q 006714 307 SLRETFKDLPTTAVNLIETLLSV--EPYKRATASA 339 (634)
Q Consensus 307 ~l~~~~~~~s~~l~dLL~~mL~~--DP~kRpTa~e 339 (634)
....-+..+++++..|..+|+.. ++.-|||++.
T Consensus 258 P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 258 PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11122356788999999999874 3568999753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.1e-05 Score=91.03 Aligned_cols=111 Identities=22% Similarity=0.324 Sum_probs=77.5
Q ss_pred eEEEEEECCCCcEEehHH-----HHHHHHHHHHHHHHHH-HCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 145 SVFRARDLDTGKIVALKK-----IKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 145 ~Vy~a~d~~tg~~vAlK~-----i~~i~~Qll~aL~yLH-s~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
..|++..+-.--..++|. +.--+.||+.||.||| ..+++|++|.-..|+|+..|..||.+|.++........ .
T Consensus 83 ~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~ 161 (690)
T KOG1243|consen 83 TLYLVTERVRPLETVLKELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-P 161 (690)
T ss_pred ceEEEeeccccHHHHHHHhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-c
Confidence 667776532211122343 4456889999999998 56899999999999999999999999998865433221 1
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 259 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG 259 (634)
......-..|..|+.+.. -....|.|-|||++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 111222334667775532 12568999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=4.2e-05 Score=74.17 Aligned_cols=46 Identities=26% Similarity=0.481 Sum_probs=39.6
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccccccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANF 210 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGla~~ 210 (634)
.++.+|-..|.-||.++|||+||..+||||..++ .+.|+|||++..
T Consensus 117 ~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 117 ELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 5777888899999999999999999999997654 358999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=3.2e-05 Score=75.13 Aligned_cols=46 Identities=26% Similarity=0.512 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
.++..+-.-+.-||..||+|+||.++||++... .+.++|||++.+.
T Consensus 96 ~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 96 DLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred HHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 366677778899999999999999999999765 4999999998643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00023 Score=73.08 Aligned_cols=77 Identities=30% Similarity=0.411 Sum_probs=65.8
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
+.+..+||-|-=+.||.|.+. .|..+|||.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999976 688999996
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..++..|+.-+.-+-..||||+||.+-|||++++|.+.|+||-.+.
T Consensus 172 ~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 172 KVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred CCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 23467777777777778999999999999999999999999997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00019 Score=71.53 Aligned_cols=48 Identities=25% Similarity=0.425 Sum_probs=43.5
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccccccc
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANF 210 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGla~~ 210 (634)
...++.+|...+.-||.+||+|+||++.|||++.++ .+.|+||+.+..
T Consensus 120 ~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 120 RRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 567899999999999999999999999999998887 799999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0014 Score=72.46 Aligned_cols=127 Identities=20% Similarity=0.251 Sum_probs=91.8
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
+|.|+.||..||.++|+.|+.-+-|.+.+||++.+..|+|...|+......+.. |.+.. -.
T Consensus 395 lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------~~le~----~Q 455 (655)
T KOG3741|consen 395 LWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------EPLES----QQ 455 (655)
T ss_pred HHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------cchhH----Hh
Confidence 688999999999999999999999999999999888888887776654443220 11222 23
Q ss_pred ccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHH
Q 006714 243 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 322 (634)
Q Consensus 243 ~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 322 (634)
+-|.=.||.+++.|.+|..--...+.... ..+......++.+++++
T Consensus 456 q~D~~~lG~ll~aLAt~~~ns~~~d~~~~----------------------------------s~~~~I~~~yS~D~rn~ 501 (655)
T KOG3741|consen 456 QNDLRDLGLLLLALATGTENSNRTDSTQS----------------------------------SHLTRITTTYSTDLRNV 501 (655)
T ss_pred hhhHHHHHHHHHHHhhcccccccccchHH----------------------------------HHHHHhhhhhhHHHHHH
Confidence 46888999999999998632111111110 01222334678889999
Q ss_pred HHHhhccCcCCCcCHHHHHhc
Q 006714 323 IETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 323 L~~mL~~DP~kRpTa~elL~h 343 (634)
|.-+...++.+ -++.++|.+
T Consensus 502 v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 502 VEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHhcCccc-ccHHHHHHH
Confidence 99999999987 688888865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00023 Score=74.05 Aligned_cols=48 Identities=19% Similarity=0.258 Sum_probs=42.6
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-------CCceEEecccccc
Q 006714 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFGLAN 209 (634)
Q Consensus 162 ~i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-------~g~vkL~DFGla~ 209 (634)
....++.+|+..+.-||..||+|+||++.||||+. +..+.|+||+.+.
T Consensus 139 ~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 139 LKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 45678999999999999999999999999999975 4679999999774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00057 Score=67.28 Aligned_cols=49 Identities=29% Similarity=0.468 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHHHH-HHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 IKCYMNQLLHGLEH-CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 i~~i~~Qll~aL~y-LHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
...++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.+....
T Consensus 108 ~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 108 PKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 45678888885555 679999999999999999877 99999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00083 Score=75.80 Aligned_cols=39 Identities=28% Similarity=0.499 Sum_probs=33.1
Q ss_pred HHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 175 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 175 ~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
..+-..|++|.|.+|.||+++.++.+.+.|||+......
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 334457999999999999999999999999999866543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0023 Score=65.22 Aligned_cols=47 Identities=19% Similarity=0.296 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 165 CYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
.+..++++.+.-|-. .++||+||..-|||+. ++.+.|+||+.+....
T Consensus 170 ~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 170 GLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 456778888887777 8999999999999998 7899999999886544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0033 Score=62.01 Aligned_cols=30 Identities=30% Similarity=0.536 Sum_probs=25.7
Q ss_pred CceeccCCCCCceecC--CCceEEeccccccc
Q 006714 181 GVLHRDIKGSNLLVNN--EGVLKLADFGLANF 210 (634)
Q Consensus 181 gIvHrDLKp~NILl~~--~g~vkL~DFGla~~ 210 (634)
.++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 4689999999999988 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0053 Score=61.77 Aligned_cols=43 Identities=21% Similarity=0.395 Sum_probs=37.1
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+...|...|.-||..|++|+|++|.|+++.++ .++++||+...
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 44568889999999999999999999999855 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.0071 Score=72.57 Aligned_cols=146 Identities=20% Similarity=0.266 Sum_probs=97.3
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCC---CceecCCCceEEe--ccccccccCCCCCCCcccccccccCCCcccccC
Q 006714 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGS---NLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 236 (634)
Q Consensus 162 ~i~~i~~Qll~aL~yLHs~gIvHrDLKp~---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 236 (634)
.++.+..+++.||.|+|+..+.|.-|... +-.++..+.+.+. ||+........... ........+.++|....
T Consensus 287 ~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~ 364 (1351)
T KOG1035|consen 287 TLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKE 364 (1351)
T ss_pred HHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCcccccccccccc
Confidence 36778999999999999997766666555 4444556666666 88887665543221 22233555777887654
Q ss_pred CCCCC--CccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCC
Q 006714 237 ATDYG--PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314 (634)
Q Consensus 237 ~~~~s--~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~ 314 (634)
..+. ...|+|.+|.++..+..+..+-.-. ..+ ...+..
T Consensus 365 -~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~------~~~---------------------------------~~~l~~ 404 (1351)
T KOG1035|consen 365 -NTAKKSRLTDLWCLGLLLLQLSQGEDISEKS------AVP---------------------------------VSLLDV 404 (1351)
T ss_pred -ccchhhhhhHHHHHHHHHhhhhhcCcccccc------cch---------------------------------hhhhcc
Confidence 3333 3469999999999888876442110 000 001111
Q ss_pred Cc-HHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 315 LP-TTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 315 ~s-~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+ ....+++.+|+.-++++|+.+.++|.|+|.+..
T Consensus 405 ~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 405 LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 11 257789999999999999999999999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0018 Score=73.10 Aligned_cols=153 Identities=20% Similarity=0.130 Sum_probs=100.2
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 245 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sD 245 (634)
+.+.-+++|++||+.-=+|+| |||..+ +..++.||+....+.... ......+++.+++||+... ..+....|
T Consensus 341 ~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~-~~~~~~p~ 412 (829)
T KOG0576|consen 341 PLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQE-NTIDGCPD 412 (829)
T ss_pred hhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcc-cccccCCC
Confidence 334445678888888767888 888755 688999999876554332 3355678999999998876 66888999
Q ss_pred cccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC-CchhhhhcCCCcHHHHHHHH
Q 006714 246 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY-DSSLRETFKDLPTTAVNLIE 324 (634)
Q Consensus 246 IWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~-~~~l~~~~~~~s~~l~dLL~ 324 (634)
.|++++--.+|.-|-+|-.. |+.. .+.+.... ...+......-+..-.++..
T Consensus 413 ~~~~~~~~~~~ap~~pPr~~----------------P~~~-----------~~~~g~~p~s~~L~~~~aw~~~~~~~~~~ 465 (829)
T KOG0576|consen 413 SGSLAVSAIQMAPGLPPRSS----------------PPAV-----------LPMIGNGPNSPMLTDKSAWSPVFHRDFPA 465 (829)
T ss_pred ccCCCcchhhcCCCCCCCCC----------------Cccc-----------cCCCCCCCCccccchhhhcCcccccCCcc
Confidence 99999877777777776543 1100 00000000 00000000000011115778
Q ss_pred HhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 325 TLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 325 ~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
.||...|..+++...++.|.+|...+.-.
T Consensus 466 ~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 466 PCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred cccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 89999999999999999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.0082 Score=60.10 Aligned_cols=47 Identities=15% Similarity=0.171 Sum_probs=42.1
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc--eEEecccccc
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLAN 209 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~--vkL~DFGla~ 209 (634)
-..++.+|...|.-||..|+.|+|+-+.|||++.++. +.++||.-++
T Consensus 130 k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 130 RQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 3578999999999999999999999999999986667 9999997654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.022 Score=60.30 Aligned_cols=78 Identities=21% Similarity=0.307 Sum_probs=63.9
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
-|.+.+.||-|--+.||.+-+. .|+++++|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678899999999999999974 588999997
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..+...|+.-+--|-.+|+||+|+.-=||+|++++.++++||-...
T Consensus 172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 172 FPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 12244445556677888999999999999999999999999996543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.047 Score=54.37 Aligned_cols=37 Identities=35% Similarity=0.486 Sum_probs=31.5
Q ss_pred HHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccc
Q 006714 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208 (634)
Q Consensus 167 ~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla 208 (634)
+.+|++-|..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 457888899999999999999999986 3478999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.024 Score=64.24 Aligned_cols=35 Identities=29% Similarity=0.424 Sum_probs=29.4
Q ss_pred HCCceeccCCCCCceecC----CCceEEeccccccccCC
Q 006714 179 SRGVLHRDIKGSNLLVNN----EGVLKLADFGLANFSNT 213 (634)
Q Consensus 179 s~gIvHrDLKp~NILl~~----~g~vkL~DFGla~~~~~ 213 (634)
..|++|+|-+|.|||+.. ++.+.|.|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 468999999999999984 56799999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.068 Score=52.08 Aligned_cols=78 Identities=23% Similarity=0.286 Sum_probs=56.1
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
.++.+.|++|++|.||++.+ .+..+|+|+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~ 101 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhh
Confidence 35668899999999999987 566888886
Q ss_pred --H---HHHHHHHHHHHHHHHHCCceeccCC-CCCceecCCCceEEecccccccc
Q 006714 163 --I---KCYMNQLLHGLEHCHSRGVLHRDIK-GSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 --i---~~i~~Qll~aL~yLHs~gIvHrDLK-p~NILl~~~g~vkL~DFGla~~~ 211 (634)
+ ++.+..+++.---|-..||-|..|. |..++|-.++.+.|+||.-|.+.
T Consensus 102 ~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 102 LEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 0 2233345555445666799999996 55555555669999999988643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.13 Score=50.59 Aligned_cols=53 Identities=26% Similarity=0.196 Sum_probs=46.1
Q ss_pred ehHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCceecCCCceEEecccccccc
Q 006714 159 ALKKIKCYMNQLLHGLEHCHS---RGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 159 AlK~i~~i~~Qll~aL~yLHs---~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
..+...+|+.+|++.+++|+. ..+.-.|++++|+-+++++.+|++|...+...
T Consensus 57 ~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 57 PWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 556678999999999999998 35888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.14 E-value=0.052 Score=60.55 Aligned_cols=91 Identities=21% Similarity=0.239 Sum_probs=68.6
Q ss_pred CccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHH
Q 006714 242 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321 (634)
Q Consensus 242 ~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 321 (634)
+++|||++|.++.++..|...+...+..+.+..+.+....+..... ..........++..+.+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~ 172 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLP 172 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHH
Confidence 5999999999999999999999888888888877665332221100 00111222356777899
Q ss_pred HHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 322 LIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 322 LL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
++.+|+...|..||...++.+++-|...
T Consensus 173 ~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 173 LLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HhccCCccccccccchhHHhcCccHHHH
Confidence 9999999999999999999999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.10 E-value=0.23 Score=52.05 Aligned_cols=29 Identities=28% Similarity=0.509 Sum_probs=25.0
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.+++|+|+++.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.65 E-value=0.22 Score=52.53 Aligned_cols=30 Identities=37% Similarity=0.588 Sum_probs=26.5
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=90.82 E-value=0.25 Score=48.57 Aligned_cols=30 Identities=30% Similarity=0.557 Sum_probs=20.5
Q ss_pred CCceeccCCCCCceec-CCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVN-NEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~-~~g~vkL~DFGla~ 209 (634)
..++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3699999999999999 55666899998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.82 E-value=0.21 Score=50.19 Aligned_cols=30 Identities=23% Similarity=0.412 Sum_probs=26.1
Q ss_pred CCceeccCCCCCceecC-CCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNN-EGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~-~g~vkL~DFGla~ 209 (634)
..++|+|+.+.|||++. ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 36999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=90.48 E-value=0.31 Score=50.76 Aligned_cols=30 Identities=33% Similarity=0.564 Sum_probs=26.2
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999987777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=89.75 E-value=0.21 Score=50.51 Aligned_cols=30 Identities=30% Similarity=0.431 Sum_probs=25.3
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
..++|+|+++.|||++.....-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876556799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.49 E-value=0.46 Score=49.76 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=25.8
Q ss_pred CceeccCCCCCceecCC----CceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNE----GVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~----g~vkL~DFGla~ 209 (634)
.++|+||.+.|||++.+ +.+.|+||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 68999999999999874 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.38 E-value=0.21 Score=52.72 Aligned_cols=30 Identities=33% Similarity=0.550 Sum_probs=25.6
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++||+|+++.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999866556899998764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.16 E-value=0.35 Score=51.47 Aligned_cols=35 Identities=26% Similarity=0.267 Sum_probs=25.2
Q ss_pred HHHHHHHHHHHHHHHHH----CCceeccCCCCCceecCC
Q 006714 163 IKCYMNQLLHGLEHCHS----RGVLHRDIKGSNLLVNNE 197 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs----~gIvHrDLKp~NILl~~~ 197 (634)
++-++.||+.-.-.+-+ .+++|-||||+||||-+.
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 56677888765544433 369999999999999443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=89.11 E-value=0.11 Score=64.30 Aligned_cols=97 Identities=10% Similarity=-0.013 Sum_probs=72.5
Q ss_pred HHHHHHHHHHHHHHHC-----CceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCC
Q 006714 165 CYMNQLLHGLEHCHSR-----GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 239 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~-----gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 239 (634)
+...+.+.+..-+|.. -.+|++||+-|.+|..+..+++.++|+.+.... ........++++.|+.|++... -.
T Consensus 1339 ~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~-ik 1416 (2724)
T KOG1826|consen 1339 LRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNE-IK 1416 (2724)
T ss_pred HHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHH-Hh
Confidence 3344445666666654 268999999999999999999999999983332 2223344566788888887654 56
Q ss_pred CCCccccccchhhHHHHhhCCCCC
Q 006714 240 YGPSVDLWSVGCVFAELLIGKPIL 263 (634)
Q Consensus 240 ~s~~sDIWSLG~iLyeLltG~~pf 263 (634)
++.++|+|..+|.+|++..|.++|
T Consensus 1417 ~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhHHHHHHHHHHHHHHhcccHHH
Confidence 777799999999999999888776
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=88.98 E-value=0.59 Score=46.10 Aligned_cols=30 Identities=23% Similarity=0.408 Sum_probs=24.7
Q ss_pred CCceeccCCCCCceecCCC-----ceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g-----~vkL~DFGla~ 209 (634)
..++|+|+.+.||++..++ .+.|+||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999997543 58999998764
|
subfamily of choline kinases |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.82 E-value=1.6 Score=47.30 Aligned_cols=49 Identities=24% Similarity=0.405 Sum_probs=40.7
Q ss_pred HHHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEecccccccc
Q 006714 162 KIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 162 ~i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
.+..|+.+.+..|.-+... .+-||||...||||+ +|+|.|+||-+++..
T Consensus 322 e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 322 EELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred HHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 3667788877777666655 688999999999999 999999999999843
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.72 E-value=0.5 Score=49.23 Aligned_cols=47 Identities=28% Similarity=0.402 Sum_probs=35.7
Q ss_pred HHHHHHHHHHHHHHHHC--CceeccCCCCCceecCCCceEEeccccccc
Q 006714 164 KCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 164 ~~i~~Qll~aL~yLHs~--gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
...+..+-..+.-++.. -++|.|+.|+|+|+++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444555555555544 589999999999999989999999987753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=88.04 E-value=0.31 Score=49.33 Aligned_cols=28 Identities=29% Similarity=0.396 Sum_probs=25.1
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++|+|++|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999887 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.66 E-value=0.36 Score=47.59 Aligned_cols=29 Identities=34% Similarity=0.541 Sum_probs=24.9
Q ss_pred CceeccCCCCCceecCCCceEEeccccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
-.+|+|+.|.||++.+++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 358999999999998777 88999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=87.27 E-value=0.39 Score=48.56 Aligned_cols=30 Identities=23% Similarity=0.216 Sum_probs=26.1
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 358999999999999987778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.20 E-value=1.5 Score=48.28 Aligned_cols=29 Identities=31% Similarity=0.485 Sum_probs=24.1
Q ss_pred EEEEecccCceeEEEEEECCCCcEEehHH
Q 006714 134 KLEKIGQGTYSSVFRARDLDTGKIVALKK 162 (634)
Q Consensus 134 i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~ 162 (634)
.++.||.|....||++.+...++.|.||+
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQ 61 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQ 61 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEe
Confidence 37889999999999999844456789887
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=87.19 E-value=0.74 Score=48.63 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=27.2
Q ss_pred CceeccCCCCCceecCCCceEEeccccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.98 E-value=0.61 Score=50.07 Aligned_cols=28 Identities=25% Similarity=0.469 Sum_probs=24.9
Q ss_pred ceeccCCCCCceecCCCc-eEEecccccc
Q 006714 182 VLHRDIKGSNLLVNNEGV-LKLADFGLAN 209 (634)
Q Consensus 182 IvHrDLKp~NILl~~~g~-vkL~DFGla~ 209 (634)
|||+|+.|.|||++.+.. +-++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8899998663
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=86.81 E-value=1 Score=48.83 Aligned_cols=45 Identities=20% Similarity=0.259 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHH-HHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 166 YMNQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 166 i~~Qll~aL~yL-Hs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+-.|++.-+.-| |.+++||.||.--|+|+ .+|.+.|+|.+.+...
T Consensus 269 ~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 269 LYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred HHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccC
Confidence 444555555554 34589999999999998 5679999998876543
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=86.45 E-value=0.35 Score=51.79 Aligned_cols=50 Identities=24% Similarity=0.294 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHHH----HCCceeccCCCCCceecCCC------------------ceEEeccccccccC
Q 006714 163 IKCYMNQLLHGLEHCH----SRGVLHRDIKGSNLLVNNEG------------------VLKLADFGLANFSN 212 (634)
Q Consensus 163 i~~i~~Qll~aL~yLH----s~gIvHrDLKp~NILl~~~g------------------~vkL~DFGla~~~~ 212 (634)
++-++.||+.-.--+- ..+++|-||||+||||-+.. .++|.||.+++...
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 6677777765432232 33799999999999984322 35777888776544
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=86.13 E-value=0.56 Score=46.52 Aligned_cols=29 Identities=38% Similarity=0.647 Sum_probs=20.6
Q ss_pred CceeccCCCCCcee-cCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLV-NNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl-~~~g~vkL~DFGla~ 209 (634)
.++|.||.+.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58899999999999 788899999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=86.06 E-value=0.45 Score=48.63 Aligned_cols=28 Identities=43% Similarity=0.668 Sum_probs=24.8
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++|+|+.|.|||++.++ +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999998876 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=84.59 E-value=0.83 Score=49.28 Aligned_cols=30 Identities=20% Similarity=0.515 Sum_probs=25.8
Q ss_pred CCceeccCCCCCceecC-CCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNN-EGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~-~g~vkL~DFGla~ 209 (634)
..++|+||++.|||+++ ++.+.|+||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 36899999999999976 4679999998775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.30 E-value=1.2 Score=47.52 Aligned_cols=28 Identities=25% Similarity=0.204 Sum_probs=23.4
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3789999999999995 4 57899998653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=81.80 E-value=1.1 Score=45.54 Aligned_cols=37 Identities=32% Similarity=0.416 Sum_probs=31.9
Q ss_pred HHHHHHHHHC--CceeccCCCCCceecCCCceEEecccc
Q 006714 171 LHGLEHCHSR--GVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 171 l~aL~yLHs~--gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
+..|.-.|+. +.+|+|..|+||+-|..|.+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 5667888843 799999999999999999999999653
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=81.63 E-value=0.96 Score=47.22 Aligned_cols=31 Identities=19% Similarity=0.394 Sum_probs=25.4
Q ss_pred CceeccCCCCCceecCCCc-eEEecccccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGV-LKLADFGLANFS 211 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~-vkL~DFGla~~~ 211 (634)
.++|+|+++.|||++.++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999987555 569999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 634 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-38 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-38 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-38 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-38 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-38 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-38 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-37 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-37 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-36 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-36 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-36 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-36 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-36 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-36 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-36 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-36 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-36 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-36 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-36 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-36 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-36 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-36 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-36 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-36 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-36 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-36 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-36 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-36 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-36 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-36 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-36 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-36 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-36 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-36 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-36 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-36 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-36 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-36 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-36 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-36 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-36 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-36 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-36 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-36 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-36 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-34 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-34 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-34 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-34 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-33 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-33 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-32 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-32 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-31 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-31 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-31 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-31 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-30 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-30 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-30 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-30 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-30 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-30 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-30 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-30 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-30 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-30 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-30 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-30 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-30 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-30 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-30 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-30 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-30 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-30 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-30 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-30 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-30 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-30 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-30 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-30 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-30 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-30 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-30 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-30 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-30 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-30 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-30 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-30 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-30 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-30 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-30 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-30 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-30 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-30 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-30 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-30 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-29 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-29 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-29 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-29 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-29 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-29 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-29 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-29 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-29 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-29 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-29 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-29 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-29 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-29 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-29 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-29 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-29 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-29 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-29 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-29 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-29 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-29 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-29 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-29 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-29 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-29 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-29 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-29 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-29 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-29 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-29 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-29 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-29 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-29 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-29 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-29 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-29 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-29 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-29 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-29 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-29 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-29 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-29 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-29 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-29 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-29 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-29 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-29 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-29 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-29 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-29 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-29 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-29 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-29 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-29 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-29 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-29 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-29 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-29 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-29 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-29 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-29 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-29 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-28 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-28 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-28 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-28 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-28 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-28 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-28 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-28 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-28 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-27 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-27 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-27 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-26 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-26 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-25 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-25 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-25 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-25 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-24 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-24 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-24 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-24 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-24 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-24 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-24 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-24 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-24 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-24 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-24 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-24 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-24 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-24 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-24 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-24 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-24 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-24 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-24 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-24 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-24 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-24 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-24 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-24 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-24 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-24 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-23 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-22 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-21 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-21 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-21 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-21 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-21 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-21 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-21 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-21 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-21 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-21 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-21 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-21 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-21 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-21 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-21 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-21 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-21 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-21 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-21 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-21 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-21 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-20 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-16 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 2e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-04 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-117
Identities = 84/223 (37%), Positives = 118/223 (52%), Gaps = 8/223 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPL 219
IK M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T+RVVTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +LC
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 280 GSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRAT 336
GS + W + + +++ K A++LI+ LL ++P +R
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 337 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 379
+ AL ++F + P DL + + + RRK
Sbjct: 306 SDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP--PRRKH 346
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 20/46 (43%), Positives = 29/46 (63%)
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++++ +EKL KIGQGT+ VF+AR TG+ VALKK+
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL 51
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-109
Identities = 90/233 (38%), Positives = 123/233 (52%), Gaps = 7/233 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
IK YM L GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQ 172
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT WYR PELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232
Query: 283 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
++ W LP FK L F ++LI+ L P R TA+ AL
Sbjct: 233 TEEQWPDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
Query: 342 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE---DARRKKVGGRVRGAETRK 391
+YFS +P LP E + +RK+ +G +K
Sbjct: 291 KMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 20/40 (50%), Positives = 32/40 (80%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
V RA +EKL+ +G+G +++V++ARD +T +IVA+KKIK
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK 44
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 1e-93
Identities = 83/231 (35%), Positives = 119/231 (51%), Gaps = 9/231 (3%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFS 211
D G I+ + +K ++ QLL GL +CH + VLHRD+K NLL+N G LKLADFGLA S
Sbjct: 92 DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS 151
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 271
+ + VVTLWYRPP++LLG+TDY +D+W VGC+F E+ G+P+ G T EQ
Sbjct: 152 I--PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209
Query: 272 LHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
LH IF++ G+P ++ W + + +L L + +L+ LL E
Sbjct: 210 LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFE 269
Query: 331 PYKRATASAALASEYFSTKPYACDLSSLPIYP---PSKEIDAKHREDARRK 378
R +A A+ +F + LP KEI + R
Sbjct: 270 GRNRISAEDAMKHPFFLSLGERIH--KLPDTTSIFALKEIQLQKEASLRSA 318
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 14/35 (40%), Positives = 27/35 (77%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + KL+K+G+GTY++V++ + T +VALK+I+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR 36
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 2e-92
Identities = 75/211 (35%), Positives = 109/211 (51%), Gaps = 10/211 (4%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 221
+K + QLL GL CH +LHRD+K NLL+N G LKL DFGLA F +S
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSS 167
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
VVTLWYR P++L+G+ Y S+D+WS GC+ AE++ GKP+ G + EQL IF + G+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 282 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKD-----LPTTAVNLIETLLSVEPYKRA 335
P + W +KLP Q+P LR+ + L ++ + LL + P R
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 336 TASAALASEYFSTKPYACDLSSLPIYPPSKE 366
+A AL +F+ + + +
Sbjct: 287 SAKQALHHPWFAEYYHHASMGGSRSHHHHHH 317
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 16/37 (43%), Positives = 27/37 (72%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ F++LEK+G GTY++V++ + TG VALK++K
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK 39
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 20/35 (57%), Positives = 30/35 (85%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ F+K+EKIG+GTY V++AR+ TG++VALKKI+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR 37
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-90
Identities = 79/203 (38%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 152 LDTGKIVAL--KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA- 208
LD L + IK M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA
Sbjct: 109 LDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
Query: 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ ++ LT VVTLWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E
Sbjct: 169 IY---SYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE 224
Query: 269 VEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 327
+QL KIF L G PP+D W + LP P + ++ ++ + L+ +L
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAF--PPRGP-RPVQSVVPEMEESGAQLLLEML 281
Query: 328 SVEPYKRATASAALASEYFSTKP 350
+ P+KR +A AL Y
Sbjct: 282 TFNPHKRISAFRALQHSYLHKDE 304
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 16/43 (37%), Positives = 26/43 (60%), Gaps = 1/43 (2%)
Query: 123 GWVPLRA-DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
G + A +E + +IG G Y +V++ARD +G VALK ++
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR 43
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 3e-90
Identities = 81/211 (38%), Positives = 116/211 (54%), Gaps = 11/211 (5%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 221
IK M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 178
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
VVTLWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G
Sbjct: 179 VVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 282 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
P ++ W + LP + + D+ +L+ L+ P KR +A +A
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 341 LASEYFSTKPYACD--LSSLPIYPPSKEIDA 369
L+ YF + S LP + E++
Sbjct: 295 LSHPYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 16/36 (44%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKIK 164
+E + +IG+G Y VF+ARDL + G+ VALK+++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR 46
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 5e-90
Identities = 77/190 (40%), Positives = 108/190 (56%), Gaps = 4/190 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 221
IK Y+ QLL G+ HCH +LHRD+K NLL+N++G LKLADFGLA F + T
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTH 178
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
VVTLWYR P++L+G+ Y SVD+WS+GC+FAE++ GKP+ G T+ +QL KIF + G+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238
Query: 282 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
P W + +LP Q ++L+ +L +P KR +A A
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298
Query: 341 LASEYFSTKP 350
+ YF
Sbjct: 299 MNHPYFKDLD 308
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + ++KLEK+G+GTY V++A+D G+IVALK+I+
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR 54
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 8e-90
Identities = 74/187 (39%), Positives = 111/187 (59%), Gaps = 5/187 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 221
K ++ QLL+G+ +CH R VLHRD+K NLL+N EG LK+ADFGLA F + T
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTH 159
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+VTLWYR P++L+G+ Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 282 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
P W ++LP K L + ++L+ +L ++P +R TA A
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 341 LASEYFS 347
L YF
Sbjct: 279 LEHAYFK 285
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 16/35 (45%), Positives = 26/35 (74%), Gaps = 1/35 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + LEKIG+GTY V++A++ + G+ ALKKI+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR 35
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-89
Identities = 84/191 (43%), Positives = 114/191 (59%), Gaps = 6/191 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTS 221
+K ++ QLL GL CHSR VLHRD+K NLL+N G LKLA+FGLA F + ++
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSA 160
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCG 280
VVTLWYRPP++L GA Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 281 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+P ++ W +KLP + P P +SL L T +L++ LL P +R +A
Sbjct: 221 TPTEEQWPSMTKLPDYKPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 340 ALASEYFSTKP 350
AL YFS
Sbjct: 280 ALQHPYFSDFC 290
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 19/35 (54%), Positives = 30/35 (85%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+EKLEKIG+GTY +VF+A++ +T +IVALK+++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR 36
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 2e-88
Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 5/217 (2%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFS 211
+ V +K Q L + CH +HRD+K N+L+ V+KL DFG A +
Sbjct: 94 RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 271
G V T WYR PELL+G T YGP VD+W++GCVFAELL G P+ G+++V+Q
Sbjct: 154 --GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211
Query: 272 LHKIFKLCGSPPDDYWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
L+ I K G + + S + + K P L F ++ A+ L++ L +
Sbjct: 212 LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM 271
Query: 330 EPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKE 366
+P +R T L YF DL+ P
Sbjct: 272 DPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENL 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 18/35 (51%), Positives = 27/35 (77%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +EK+ KIG+G+Y VF+ R+ DTG+IVA+KK
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL 37
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 3e-88
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQ- 217
+K + Q+L G+ + H+ VLHRD+K +N+LV G +K+AD G A N+ +
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 218 -PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV------- 269
L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249
Query: 270 --EQLHKIFKLCGSPPDDYWKK-SKLPHATLFKP---QQPYDSS-----LRETFKDLPTT 318
+QL +IF + G P D W+ K+P + + Y + + + +
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309
Query: 319 AVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP---IYPPSKEIDAKHREDA 375
A +L++ LL+++P KR T+ A+ YF P YP + + + +D
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDK 369
Query: 376 ----RRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 406
+++ G T + ++ P++
Sbjct: 370 GDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 16/46 (34%), Positives = 23/46 (50%), Gaps = 3/46 (6%)
Query: 122 QGWVPLRADAFEKL-EKIGQGTYSSVFRARDLD--TGKIVALKKIK 164
D FE K+G+GTY V++A+ D K ALK+I+
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE 57
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 4e-88
Identities = 78/207 (37%), Positives = 119/207 (57%), Gaps = 9/207 (4%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFG 206
+D V+++ IK ++ QL++G+ CHSR LHRD+K NLL++ VLK+ DFG
Sbjct: 123 MDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
Query: 207 LA-NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 265
LA F + T ++TLWYRPPE+LLG+ Y SVD+WS+ C++AE+L+ P+ G
Sbjct: 183 LARAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240
Query: 266 RTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 324
+E++QL KIF++ G P D W + LP P+ + R L ++L+
Sbjct: 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLT 300
Query: 325 TLLSVEPYKRATASAALASEYFSTKPY 351
+L ++P KR +A AL YFS +
Sbjct: 301 AMLEMDPVKRISAKNALEHPYFSHNDF 327
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 14/35 (40%), Positives = 25/35 (71%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
D + ++ K+G+GTY V++A D T + VA+K+I+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR 68
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-87
Identities = 66/226 (29%), Positives = 117/226 (51%), Gaps = 13/226 (5%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFS 211
+ + ++ Y+ Q+++G+ CHS ++HRDIK N+LV+ GV+KL DFG A +
Sbjct: 116 LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 271
G + V T WYR PELL+G YG +VD+W++GC+ E+ +G+P+ G ++++Q
Sbjct: 176 APG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233
Query: 272 LHKIFKLCGSPPDDYWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
L+ I G+ + + +K P + P+ L + L ++L + L +
Sbjct: 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293
Query: 330 EPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDA 375
+P KR + L ++F +A S+E+ K ++DA
Sbjct: 294 DPDKRPFCAELLHHDFFQMDGFAER--------FSQELQLKVQKDA 331
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 15/35 (42%), Positives = 24/35 (68%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +E L +G+G+Y V + R+ DTG+IVA+KK
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-71
Identities = 77/187 (41%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTS 221
+K YM QL L + HS G+ HRDIK NLL++ + VLKL DFG A G +P S
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVS 215
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+ + +YR PEL+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 282 PPDDYWKKSKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
P + ++ P+ T FK PQ + P A+ L LL P R T A
Sbjct: 276 PTREQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 341 LASEYFS 347
A +F
Sbjct: 335 CAHSFFD 341
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 79 SGRASSNSESLSFRLGNLHKYIEGEQVAAGWPA-WLSAVAGEAIQGWVPLRADAFEKLEK 137
SGR + S + S + +V+ ++ V QG + ++ +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKI---KCYMN---QLLHGLEHC 177
IG G++ V++A+ D+G++VA+KK+ K + N Q++ L+HC
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHC 107
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-69
Identities = 76/187 (40%), Positives = 105/187 (56%), Gaps = 5/187 (2%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTS 221
IK YM QLL L + HS G+ HRDIK NLL++ GVLKL DFG A G +P S
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVS 200
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+ + +YR PEL+ GAT+Y ++D+WS GCV AEL+ G+P+ G + ++QL +I K+ G+
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAA 340
P + K+ P+ K Q + F P A++LI LL P R TA A
Sbjct: 261 PSREQI-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319
Query: 341 LASEYFS 347
L +F
Sbjct: 320 LCHPFFD 326
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 14/53 (26%), Positives = 32/53 (60%), Gaps = 7/53 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI---KCYMN---QLLHGLEHCH 178
+ + IG G++ VF+A+ +++ + VA+KK+ K + N Q++ ++H +
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPN 93
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-67
Identities = 73/188 (38%), Positives = 107/188 (56%), Gaps = 7/188 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTS 221
I Y+ QL + HS G+ HRDIK NLLVN + LKL DFG A +P +
Sbjct: 143 ISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVA 200
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+ + +YR PEL+LGAT+Y PS+DLWS+GCVF EL++GKP+ G T ++QL +I ++ G+
Sbjct: 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT 260
Query: 282 PPDDYWKKSKLPHATLFK-PQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASA 339
P + + PH T + P R+ + P+ A++L+E +L EP R
Sbjct: 261 PTKEQMIRMN-PHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318
Query: 340 ALASEYFS 347
A+A +F
Sbjct: 319 AMAHPFFD 326
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 14/58 (24%), Positives = 27/58 (46%), Gaps = 6/58 (10%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI---KCYMN---QLLHGLEHC 177
+ + + +G G++ V D+++GK ALKK+ Y N ++ L+H
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 7e-67
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 163 IKCYMNQLLHGLE--HCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPL 219
IK ++ QL+ + H S V HRDIK N+LVN G LKL DFG A + +P
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPN 188
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ + + +YR PEL+ G Y +VD+WSVGC+FAE+++G+PI +G QLH+I ++
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248
Query: 280 GSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
G P + +K H + P+ + + A +L+ LL P +R
Sbjct: 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308
Query: 337 ASAALASEYFSTKPYACDLSSLPIYPP 363
AL YF + LP
Sbjct: 309 PYEALCHPYFD--ELHDPATKLPNNKD 333
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 21/73 (28%), Positives = 29/73 (39%), Gaps = 9/73 (12%)
Query: 114 SAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI---KCYMN-- 168
S A A D F+ GQGT+ +V ++ TG VA+KK+ + N
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE 66
Query: 169 ----QLLHGLEHC 177
Q L L H
Sbjct: 67 LQIMQDLAVLHHP 79
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-63
Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTS 221
I+ YM ++L L++CHS G++HRD+K N+++++E L+L D+GLA F + G Q
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNV 189
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCG 280
RV + +++ PELL+ Y S+D+WS+GC+ A ++ K P G +QL +I K+ G
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249
Query: 281 SPP-DDYWKKSKLPHATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPY 332
+ DY K + F S R E + A++ ++ LL +
Sbjct: 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309
Query: 333 KRATASAALASEYFST 348
R TA A+ YF T
Sbjct: 310 SRLTAREAMEHPYFYT 325
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 12/35 (34%), Positives = 22/35 (62%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
D ++ + K+G+G YS VF A ++ + V +K +K
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 70
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-60
Identities = 75/210 (35%), Positives = 111/210 (52%), Gaps = 7/210 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLT 220
I ++ Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA + H LT
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
V T WYR PE++L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + G
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
SP + A + P+ + F + + A++L++ +L+ P+KR
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEID 368
ALA Y Y D S PI + D
Sbjct: 310 QALAHPYLE--QYY-DPSDEPIAEAPFKFD 336
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 14/40 (35%), Positives = 19/40 (47%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLL 171
+ L IG+G Y V A D VA+KKI + +Q
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY 68
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 9e-59
Identities = 74/214 (34%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ + Q+L GL++ HS GV+HRD+K NL VN + LK+ DFGLA ++ +T
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGY 183
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT WYR PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243
Query: 283 PDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
++ +K A + P + F A +L+E +L ++ KR TA+ A
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303
Query: 341 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 374
L +F P P +E +A+ D
Sbjct: 304 LTHPFFE-----------PFRDPEEETEAQQPFD 326
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+ +G G Y SV A D +G+ VA+KK+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL 57
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 9e-59
Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 9/203 (4%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ + Q+L GL + H+ G++HRD+K NL VN + LK+ DFGLA +++ +T
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGY 185
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT WYR PE++L Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+P
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245
Query: 283 PDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
P ++ ++ + A + P + AVNL+E +L ++ +R TA A
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 305
Query: 341 LASEYFSTKPYACDLSSLPIYPP 363
LA YF D P
Sbjct: 306 LAHPYFE--SLH-DTEDEPQVQK 325
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 13/32 (40%), Positives = 19/32 (59%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+ L+ +G G Y +V A D TG VA+KK+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL 58
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-59
Identities = 69/190 (36%), Positives = 105/190 (55%), Gaps = 6/190 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA--NFSNTGHRQPL 219
+ +M QLL GL++ HS VLHRD+K +NL +N E VLK+ DFGLA + H+ L
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ +VT WYR P LLL +Y ++D+W+ GC+FAE+L GK + G E+EQ+ I +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 280 GSPPDDYWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
++ ++ S +P +P L + + AV+ +E +L+ P R TA
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 338 SAALASEYFS 347
AL+ Y S
Sbjct: 301 EEALSHPYMS 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 14/32 (43%), Positives = 18/32 (56%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+ L+ +G G VF A D D K VA+KKI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI 44
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-58
Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 7/189 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ +M +L GL H GV+HRD+ N+L+ + + + DF LA T
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHY 193
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V WYR PEL++ + VD+WS GCV AE+ K + +G T QL+KI ++ G+P
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 283 PDDYWKKSKLPHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+ P A + P + A++LI +L P +R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 339 AALASEYFS 347
AL YF
Sbjct: 313 QALRHPYFE 321
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-58
Identities = 73/203 (35%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
++ + Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA + +T
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGY 189
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
V T WYR PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249
Query: 283 PDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
+ KK A + + F AV+L+E +L ++ KR TA+ A
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309
Query: 341 LASEYFSTKPYACDLSSLPIYPP 363
LA YF+ Y D P+ P
Sbjct: 310 LAHAYFA--QYH-DPDDEPVADP 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-57
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------NFSNT 213
I+ ++ Q L ++ H V+HRD+K SNLL+N+ LK+ DFGLA N T
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
G + + V T WYR PE++L + Y ++D+WS GC+ AEL + +PI GR QL
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 274 KIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVE 330
IF + G+P D + + P A + P L + F + ++L++ +L +
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 331 PYKRATASAALASEYFSTKPYACDLSSLPIYPP 363
P KR TA AL Y Y D + P P
Sbjct: 294 PAKRITAKEALEHPYLQ--TYH-DPNDEPEGEP 323
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/40 (37%), Positives = 22/40 (55%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLL 171
F+ +G+G Y V A TG+IVA+KKI+ + L
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF 52
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 6e-55
Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 41/239 (17%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------- 208
+ + QL+ +++ HS G+LHRD+K SN+L+N E +K+ADFGL+
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 209 ------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 262
+ + LT V T WYR PE+LLG+T Y +D+WS+GC+ E+L GKPI
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 263 LQGRTEVEQLHKIFKLCGSPPDDYW----------------KKSKLPHATLFKPQQPYDS 306
G + + QL +I + P ++ +K ++ + + +
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290
Query: 307 SLRETFKDLPTT--AVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 363
L + A++L++ LL P KR +A+ AL + S + + + P
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS--IFH-NPNEEPNCDH 346
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 14/32 (43%), Positives = 25/32 (78%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+E ++K+G+G Y V+++ D TG++VA+KKI
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI 42
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-55
Identities = 72/271 (26%), Positives = 111/271 (40%), Gaps = 70/271 (25%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------- 208
IK + LL G+++ HS G+LHRD+K +N LVN + +K+ DFGLA
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 209 ------------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 256
++ LT VVT WYR PEL+L +Y ++D+WS+GC+FAEL
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 257 L-----------IGKPILQG--------------------RTEVEQLHKIFKLCGSPPDD 285
L P+ G R +QL+ IF + G+P ++
Sbjct: 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE 337
Query: 286 YWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343
+ + A + P L E F A++L++ +L P KR T + LA
Sbjct: 338 DIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 344 EYFSTKPYACDLSSLPIYPPSKEIDAKHRED 374
+F + E +A +
Sbjct: 398 PFFK-----------EVRIAEVETNATEKVR 417
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 13/32 (40%), Positives = 18/32 (56%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+E IG G+Y V A D ++VA+KKI
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+ + Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPY 186
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT +YR PE++LG Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P
Sbjct: 187 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 283 PDDYWKK---------SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIET 325
++ KK P ++ + E K + A +L+
Sbjct: 246 CPEFMKKLQPTVRTYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 301
Query: 326 LLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID 368
+L ++ KR + AL Y + + D S PP
Sbjct: 302 MLVIDASKRISVDEALQHPYIN--VWY-DPSEAEAPPPKIPDK 341
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-52
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
+ + Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPY 223
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
VVT +YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P
Sbjct: 224 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 283 PDDYWKK---------SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIET 325
++ KK P + + E K + A +L+
Sbjct: 283 CPEFMKKLQPTVRNYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 326 LLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSK 365
+L ++P KR + AL Y + + D + + PP
Sbjct: 339 MLVIDPAKRISVDDALQHPYIN--VWY-DPAEVEAPPPQI 375
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 11/32 (34%), Positives = 17/32 (53%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
++ L+ IG G V A D + VA+KK+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL 95
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 6e-51
Identities = 71/263 (26%), Positives = 109/263 (41%), Gaps = 62/263 (23%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------- 208
IK + LL G H G++HRD+K +N L+N + +K+ DFGLA
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 209 -------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-- 259
N ++ LTS VVT WYR PEL+L +Y S+D+WS GC+FAELL
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 260 ---------KPILQG-----------------RTEVEQLHKIFKLCGSPPDDYWKKSKLP 293
P+ G ++ +QL+ IF + G+P +D K P
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310
Query: 294 HATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351
+ P+ +L++ + + +NL+E++L P KR T AL Y
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK---- 366
Query: 352 ACDLSSLPIYPPSKEIDAKHRED 374
+ E + +
Sbjct: 367 -------DVRKKKLENFSTKKII 382
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 13/32 (40%), Positives = 20/32 (62%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+ IG+G+Y V+ A D +T K VA+KK+
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQ 217
L ++ + + +L L+ H ++H D+K N+L+ +G +K+ DFG + + + Q
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----Q 254
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ + + + +YR PE++LGA YG +D+WS+GC+ AELL G P+L G E +QL + +
Sbjct: 255 RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313
Query: 278 LCGSPPDDYWKKSK----------LPHATLFKPQQ------PYDSSLRETFKDLPTTA-- 319
L G P SK P S R + P +
Sbjct: 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW 373
Query: 320 ------------VNLIETLLSVEPYKRATASAALASEYFSTKP 350
++ ++ L +P R T AL + +
Sbjct: 374 GNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/41 (31%), Positives = 23/41 (56%), Gaps = 3/41 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---CYMNQ 169
+E L+ IG+G++ V +A D + VALK ++ + Q
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ 139
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 40/201 (19%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------------- 208
+ Q+L L + HS+G++HRD+K N+ ++ +K+ DFGLA
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ + G LTS + T Y E+L G Y +D++S+G +F E++ P G
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMER 234
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
V L K+ + P D+ + +I L+
Sbjct: 235 VNILKKLRSVSIEFPPDFD-------------------------DNKMKVEKKIIRLLID 269
Query: 329 VEPYKRATASAALASEYFSTK 349
+P KR A L S + K
Sbjct: 270 HDPNKRPGARTLLNSGWLPVK 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 12/33 (36%), Positives = 21/33 (63%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
FE++ +GQG + V +AR+ + A+KKI+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR 40
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 32/199 (16%), Positives = 55/199 (27%), Gaps = 27/199 (13%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209
+ + QL+ + S+G++H NL + +G L L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
T + V + Y P E L + +++ W +G +
Sbjct: 243 KVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV------------ 286
Query: 269 VEQLHKIFKLCGSPP-DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 327
C P K DS + LP LI L
Sbjct: 287 ---------WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337
Query: 328 SVEPYKRATASAALASEYF 346
+ + +R A+ + F
Sbjct: 338 NFDRRRRLLPLEAMETPEF 356
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 8/90 (8%)
Query: 110 PAWLSAVAGEAIQGWVPLRADA--------FEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
A + AV D+ + +E + G S VF RD++ + ALK
Sbjct: 34 AAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALK 93
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 191
LE H + G +
Sbjct: 94 VFTMGAENSRSELERLHEATFAAARLLGES 123
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 44/202 (21%), Positives = 76/202 (37%), Gaps = 40/202 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPL 219
+ K Y +L + H G++H D+K +N L+ + G+LKL DFG+AN
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185
Query: 220 TSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE- 268
S+V T+ Y PPE + + P D+WS+GC+ + GK Q
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
+ +LH I + ++ ++++ L
Sbjct: 246 ISKLHAIID--PNHEIEFP-------------------------DIPEKDLQDVLKCCLK 278
Query: 329 VEPYKRATASAALASEYFSTKP 350
+P +R + LA Y +
Sbjct: 279 RDPKQRISIPELLAHPYVQIQT 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 48/253 (18%), Positives = 89/253 (35%), Gaps = 40/253 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPL 219
+ K Y +L + H G++H D+K +N L+ + G+LKL DFG+AN
Sbjct: 108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 166
Query: 220 TSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE- 268
S+V T+ Y PPE + + P D+WS+GC+ + GK Q
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
+ +LH I + ++ ++++ L
Sbjct: 227 ISKLHAIID--PNHEIEFPDI-------------------------PEKDLQDVLKCCLK 259
Query: 329 VEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAE 388
+P +R + LA Y + + + + K + + + +
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLY 319
Query: 389 TRKTTRKSHGMSK 401
+ +SH S
Sbjct: 320 EHYSGGESHNSSS 332
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
K + Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA
Sbjct: 131 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190
Query: 211 SNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
G R T Y PE+L + VD+WS+GC+ LL+GKP +
Sbjct: 191 VEYDGER--KKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247
Query: 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
E +I K +Y +P K + A +LI+ +L
Sbjct: 248 ETYLRIKKN------EY----SIP-------------------KHINPVAASLIQKMLQT 278
Query: 330 EPYKRATASAALASEYFST--KPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 381
+P R T + L E+F++ P ++ L I PP I + + RK +
Sbjct: 279 DPTARPTINELLNDEFFTSGYIPARLPITCLTI-PPRFSIAPSSLDPSNRKPLT 331
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 44/227 (19%)
Query: 160 LKKIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGH 215
L + + Q+ L + ++H D+K N+L+ N +K+ DFG +
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
Q + + + +YR PE+LLG Y ++D+WS+GC+ E+ G+P+ G EV+Q++KI
Sbjct: 213 -QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
Query: 276 FKLCGSPPDDYWKKS---------------------------------KLPHATLFKPQQ 302
++ G PP ++ KL + +
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330
Query: 303 PYDSSLRETFKDLPTTA--VNLIETLLSVEPYKRATASAALASEYFS 347
P E+ + +LI +L +P R AL +F
Sbjct: 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 15/44 (34%), Positives = 24/44 (54%), Gaps = 3/44 (6%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK---CYMNQ 169
D +E IG+G++ V +A D + VA+K IK ++NQ
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ 96
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 50/227 (22%), Positives = 84/227 (37%), Gaps = 43/227 (18%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------L 200
L I+ Q+ + HS + H D+K N L V ++ +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 201 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
K+ DFG A + + + ++ V T YR PE++L + D+WS+GC+ E +G
Sbjct: 177 KVVDFGSATYDD----EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGF 231
Query: 261 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETF----K 313
+ E L + ++ G P +K++ F + SS K
Sbjct: 232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRACK 289
Query: 314 DLPT----------TAVNLIETLLSVEPYKRATASAALASEYFSTKP 350
L +LI+ +L +P KR T AL +F
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 21/197 (10%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 216
+ + ++ G+ H G++HR+IK N++ + + V KL DFG A
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-- 169
Query: 217 QPLTSRVVTLWYRPPELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQG 265
+ S T Y P++ A YG +VDLWS+G F G
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 266 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 325
R E ++KI S +K++ + P SL + L ++
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLAN 285
Query: 326 LLSVEPYKRATASAALA 342
+L + K A
Sbjct: 286 ILEADQEKCWGFDQFFA 302
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 11/35 (31%), Positives = 18/35 (51%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + +GQG ++VFR R TG + A+K
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN 43
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 48/253 (18%), Positives = 86/253 (33%), Gaps = 40/253 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPL 219
+ K Y +L + H G++H D+K +N L+ + G+LKL DFG+AN
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 213
Query: 220 TSRVVTLWYRPPELLLGATD----------YGPSVDLWSVGCVFAELLIGKPILQGRTE- 268
S+V + Y PPE + + P D+WS+GC+ + GK Q
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
+ +LH I P ++++ L
Sbjct: 274 ISKLHAIIDPNHEIE--------FP-------------------DIPEKDLQDVLKCCLK 306
Query: 329 VEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAE 388
+P +R + LA Y + + + + K + + + +
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLY 366
Query: 389 TRKTTRKSHGMSK 401
+ +SH S
Sbjct: 367 EHYSGGESHNSSS 379
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 41/226 (18%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------L 200
L ++ QL H L H + H D+K N L VN+E +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 201 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
++ADFG A F + + T+ V T YRPPE++L + D+WS+GC+ E G
Sbjct: 182 RVADFGSATFDH----EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGF 236
Query: 261 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH----------------ATLFKPQQPY 304
+ Q E L + K+ G P +++ + + +P
Sbjct: 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296
Query: 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350
S + + + +L+ +L +P +R T + AL +F+
Sbjct: 297 KSYMLQDSLEHVQL-FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
K + Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA
Sbjct: 105 LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164
Query: 211 SNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
G R T Y PE+L + VD+WS+GC+ LL+GKP +
Sbjct: 165 VEYDGER--KKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
E +I K +Y +P K + A +LI+ +L
Sbjct: 222 ETYLRIKKN------EY----SIP-------------------KHINPVAASLIQKMLQT 252
Query: 330 EPYKRATASAALASEYFST--KPYACDLSSLPIYPP 363
+P R T + L E+F++ P ++ L I P
Sbjct: 253 DPTARPTINELLNDEFFTSGYIPARLPITCLTIPPR 288
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 47/229 (20%), Positives = 87/229 (37%), Gaps = 47/229 (20%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------- 199
++ IK Y ++L L + + H D+K N LL +
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 200 -----LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+KL DFG A F + S + T YR PE++L + S D+WS GCV A
Sbjct: 196 TKSTGIKLIDFGCATFKS----DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLA 250
Query: 255 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPYDSSL 308
EL G + + +E L + + P + ++ + + + K P ++S
Sbjct: 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310
Query: 309 RETFKDLPTTA-----------VNLIETLLSVEPYKRATASAALASEYF 346
+ K + + + ++L ++P R + + L ++
Sbjct: 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 10/33 (30%), Positives = 18/33 (54%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F + K+G GT+ V + +D K A+K ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR 69
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 33/248 (13%)
Query: 160 LKKIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------GVLKLADFGLANFSN 212
L +K QLL GL++ H R G++H DIK N+L+ +K+AD G A + +
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT----- 267
+ T+ + T YR PE+LLGA +G D+WS C+ EL+ G + +
Sbjct: 190 ----EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 268 -EVEQLHKIFKLCGSPP----------DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 316
+ + + +I +L G P ++ L P + L E +K
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 317 TTA---VNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS--SLPIYPPSKEIDAKH 371
A + + +L ++P KRA A + + ++ +Y +I
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364
Query: 372 REDARRKK 379
E K+
Sbjct: 365 EEVRDHKR 372
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 6/66 (9%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKC---YMNQLLH---GLEHCHSRGVLHRDIK 188
+ K+G G +S+V+ A+D+ VA+K ++ Y L+ + D
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 189 GSNLLV 194
G+N ++
Sbjct: 84 GANHIL 89
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 44/192 (22%), Positives = 76/192 (39%), Gaps = 42/192 (21%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTG 214
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL +
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
T +V T Y PE + G +Y VD++S+G + ELL T++E++
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFS-----TQMERVRI 282
Query: 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
I + + K P F +++ +LS P +R
Sbjct: 283 ITDV---------RNLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTER 317
Query: 335 ATASAALASEYF 346
A+ + + F
Sbjct: 318 PEATDIIENAIF 329
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 10/38 (26%), Positives = 21/38 (55%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQ 169
FE ++ +G+G + VF A++ A+K+I+ +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE 45
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 21/197 (10%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 216
+ + ++ G+ H G++HR+IK N++ + + V KL DFG A
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-- 169
Query: 217 QPLTSRVVTLWYRPPELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQG 265
+ S T Y P++ A YG +VDLWS+G F G
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 266 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 325
R E ++KI S +K++ + P SL + L ++
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLAN 285
Query: 326 LLSVEPYKRATASAALA 342
+L + K A
Sbjct: 286 ILEADQEKCWGFDQFFA 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 11/35 (31%), Positives = 18/35 (51%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + +GQG ++VFR R TG + A+K
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN 43
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 47/190 (24%), Positives = 75/190 (39%), Gaps = 38/190 (20%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
Q+ G+++ HS+ +++RD+K SN+ + + +K+ DFGL + N G R
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T TL Y PE + DYG VDL+++G + AELL T E L
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDL- 231
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+ + +D + L++ LLS +P R S
Sbjct: 232 --------RDGIIS--------DIFDKKEK-----------TLLQKLLSKKPEDRPNTSE 264
Query: 340 ALASEYFSTK 349
L + K
Sbjct: 265 ILRTLTVWKK 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKC 165
F+++E IG G + VF+A+ GK +K++K
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY 46
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 52/254 (20%), Positives = 94/254 (37%), Gaps = 35/254 (13%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
+I + Q+ L+H H R +LHRDIK N+ + +G ++L DFG+A ++T
Sbjct: 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--A 182
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ + T +Y PE+ Y D+W++GCV EL K + + + KI
Sbjct: 183 RACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-- 239
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
GS P + Y LR +L+ L P R + ++
Sbjct: 240 GSFP-------PVS--------LHYSYDLR-----------SLVSQLFKRNPRDRPSVNS 273
Query: 340 ALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGM 399
L + + + L + +K K R + + + +
Sbjct: 274 ILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK---RPASGQNSISVMPAQKI 330
Query: 400 SKLAPVEDVAVRTQ 413
+K A + + +
Sbjct: 331 TKPAAKYGIPLAYK 344
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 31/181 (17%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
+M+Q++ G+ + HS G+LHRD+ SNLL+ +K+ADFGLA H + T T
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGT 175
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
Y PE+ + +G D+WS+GC+F LLIG+P T L+K+ D
Sbjct: 176 PNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------D 228
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345
Y ++P L A +LI LL P R + S+ L +
Sbjct: 229 Y----EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265
Query: 346 F 346
Sbjct: 266 M 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 44/213 (20%), Positives = 84/213 (39%), Gaps = 22/213 (10%)
Query: 164 KCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
KC + +L+ + H+ + + HRD+K SN+L++ G +KL+DFG + + + S
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS- 210
Query: 223 VVTLWYRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KIFKLCG 280
T + PPE + Y G VD+WS+G + + + +L I
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT--- 267
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
+ + P + + L ++ ++ L P +R T+ A
Sbjct: 268 ---KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 341 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 373
L E+ + + SKE+ K ++
Sbjct: 321 LKHEWLADTNIE------DLREFSKELYKKRKK 347
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 41/191 (21%), Positives = 67/191 (35%), Gaps = 11/191 (5%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ 217
I+ ++ + L + H ++HRD+K N+++ + K+ D G A + G +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T V TL Y PELL Y +VD WS G + E + G + Q H +
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ L A F P + L ++ +L +R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK---LERWLQCMLMWHQRQRGTD 292
Query: 338 SAALASEYFST 348
F
Sbjct: 293 PQNPNVGCFQA 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 13/47 (27%), Positives = 21/47 (44%)
Query: 118 GEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
G +E E++G G + V R DTG+ VA+K+ +
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR 48
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 32/206 (15%), Positives = 62/206 (30%), Gaps = 49/206 (23%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Q++ L H G++H ++ +++++ G + L F V+
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS 265
Query: 226 LWYRPPELL----------LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
+ PPEL T S D W++G V + + + I
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325
Query: 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
F+ C K++P L+E L R
Sbjct: 326 FRSC---------------------------------KNIPQPVRALLEGFLRYPKEDRL 352
Query: 336 TASAALASEYFSTKPYACDLSSLPIY 361
A+ + + + ++LP+Y
Sbjct: 353 LPLQAMETPEY-EQLRTELSAALPLY 377
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 6/32 (18%), Positives = 12/32 (37%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+ +GQ + A D +TG+ +
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVP 106
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 39/196 (19%), Positives = 69/196 (35%), Gaps = 36/196 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGH 215
+ + Q GL H HS ++HRD+K N+L++ ++DFGL G
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 216 R--QPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELL-IGKPILQGRTEVE 270
+ T + PE+L +VD++S GCVF ++ G + +
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
+ + + A LIE +++++
Sbjct: 238 ANILLGACSLDCLHPEKHEDVI--------------------------ARELIEKMIAMD 271
Query: 331 PYKRATASAALASEYF 346
P KR +A L +F
Sbjct: 272 PQKRPSAKHVLKHPFF 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 37/191 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
++ Y+ L L H HS+G++H D+K +N+ + G KL DFGL G +
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-- 214
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ Y PELL G YG + D++S+G E+ + E ++ +
Sbjct: 215 -VQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQ-- 266
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
G P ++ S LR +++ +L +P RATA A
Sbjct: 267 GYLPPEFTAG--------------LSSELR-----------SVLVMMLEPDPKLRATAEA 301
Query: 340 ALASEYFSTKP 350
LA +P
Sbjct: 302 LLALPVL-RQP 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 11/35 (31%), Positives = 23/35 (65%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+F++L ++G G+Y VF+ R + G++ A+K+
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM 91
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 35/191 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215
+ + M QL L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
+ V T +Y PE + Y D+WS+GC+ EL P ++ E KI
Sbjct: 171 SF-AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ G ++P Y L +I +L+++ Y R
Sbjct: 229 RE--GKFR-------RIP--------YRYSDELN-----------EIITRMLNLKDYHRP 260
Query: 336 TASAALASEYF 346
+ L +
Sbjct: 261 SVEEILENPLI 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 14/39 (35%), Positives = 21/39 (53%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
P RA+ +E L IG G+Y + R GKI+ K++
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD 40
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 44/198 (22%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------N 209
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
+ T +V T Y PE + G Y VD++S+G + ELL P T++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PF---STQM 231
Query: 270 EQLHKIFKLC-GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
E++ + + P + +K +++ +LS
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYP--------------------------CEYVMVQDMLS 265
Query: 329 VEPYKRATASAALASEYF 346
P +R A + + F
Sbjct: 266 PSPMERPEAINIIENAVF 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 11/60 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMN-----------QLLHGLEHCH 178
FE ++ +G+G + VF A++ A+K+I+ + L LEH
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 33/183 (18%)
Query: 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223
Y+ +L + L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R L
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-- 169
Query: 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
TL Y PPE++ G + VDLWS+G + E L+GKP + T E +I ++
Sbjct: 170 -TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 222
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343
++ P + A +LI LL P +R L
Sbjct: 223 -EF----TFP-------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258
Query: 344 EYF 346
+
Sbjct: 259 PWI 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 11/33 (33%), Positives = 20/33 (60%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
FE +G+G + +V+ AR+ + I+ALK +
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 43
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 48/189 (25%), Positives = 75/189 (39%), Gaps = 35/189 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANF---SNTGH 215
K I M Q+ L + H++G+ HRDIK N L N +KL DFGL+ N G
Sbjct: 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227
Query: 216 RQPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
+T++ T ++ PE+L + YGP D WS G + LL+G G + + + +
Sbjct: 228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ 287
Query: 275 IFKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 332
+ + + L A +L+ LL+
Sbjct: 288 VLN--KKLCFENPNY-------------------------NVLSPLARDLLSNLLNRNVD 320
Query: 333 KRATASAAL 341
+R A AL
Sbjct: 321 ERFDAMRAL 329
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 11/35 (31%), Positives = 16/35 (45%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ IGQG+Y V A + T I A+K +
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 47/212 (22%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------------LKLADFGL 207
+ Q+ G+ H HS ++HRD+K N+LV+ + ++DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 208 ANFSNTGH---RQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELL- 257
++G R L + T +R PELL + + S+D++S+GCVF +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 258 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 317
GK + E I + L + +D SL D
Sbjct: 235 KGKHPFGDKYSRES--NIIR----------GIFSLDE-----MKCLHDRSLIAEATD--- 274
Query: 318 TAVNLIETLLSVEPYKRATASAALASEYFSTK 349
LI ++ +P KR TA L F K
Sbjct: 275 ----LISQMIDHDPLKRPTAMKVLRHPLFWPK 302
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 41/203 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
+M +L L +CH R V+HRDIK NLL+ +G LK+ADFG + + + R+ + T
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---T 175
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
L Y PPE++ G + VDLW G + E L+G P + E +I + D
Sbjct: 176 LDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------D 228
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345
K P L + +LI LL P +R + +
Sbjct: 229 L----KFP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
Query: 346 F--STKPYACDLSSLPIYPPSKE 366
+++ LP S +
Sbjct: 266 VKANSRRV------LPPVYQSTQ 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217
M Q+L G+ + H ++HRDIK N+L+ N +K+ DFGL++F +
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--Y 203
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
L R+ T +Y PE+L Y D+WS G + LL G P G+ + + + K+ K
Sbjct: 204 KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ WK + A LI+ +L+ + KR TA
Sbjct: 262 GKYYFDFNDWKN-------------------------ISDEAKELIKLMLTYDYNKRCTA 296
Query: 338 SAALASEYFSTKPYACDLSSLPIYP 362
AL S + + S
Sbjct: 297 EEALNSRWIKKYANNINKSDQKTLC 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 10/35 (28%), Positives = 19/35 (54%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+++ K+ K+G G Y V ++ + A+K IK
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 51/184 (27%), Positives = 73/184 (39%), Gaps = 33/184 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
+ + Y QL LEH HSR V+HRDIK +N+ + GV+KL D GL FS+
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAA 193
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQL-HKIFK 277
S V T +Y PE + Y D+WS+GC+ E+ + G + L KI +
Sbjct: 194 HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
P P Y LR L+ ++ +P KR
Sbjct: 253 --CDYPP--------------LPSDHYSEELR-----------QLVNMCINPDPEKRPDV 285
Query: 338 SAAL 341
+
Sbjct: 286 TYVY 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217
+ Q+L G+ + H ++HRD+K NLL+ + + +++ DFGL+ +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--K 183
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ ++ T +Y PE+L G Y D+WS G + LL G P G E + L K+ K
Sbjct: 184 KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ WKK + +A +LI +L+ P R +A
Sbjct: 242 GKYTFELPQWKK-------------------------VSESAKDLIRKMLTYVPSMRISA 276
Query: 338 SAALASEYFSTKPYACDLSSLPI 360
AL E+ T +P
Sbjct: 277 RDALDHEWIQTYTKEQISVDVPS 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 10/35 (28%), Positives = 19/35 (54%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
D ++ +G+G++ V +D TG+ A+K I
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-28
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 32/184 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217
+ Q+L G+ + H ++HRD+K NLL+ + + ++K+ DFGL+ +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--K 193
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ R+ T +Y PE+L Y D+WS+G + LL G P G+T+ E L K+ K
Sbjct: 194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ WK + A +LI+ +L + +R +A
Sbjct: 252 GKYTFDSPEWKN-------------------------VSEGAKDLIKQMLQFDSQRRISA 286
Query: 338 SAAL 341
AL
Sbjct: 287 QQAL 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 11/35 (31%), Positives = 20/35 (57%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +++++K+G G Y V RD T A+K I+
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 24/185 (12%), Positives = 50/185 (27%), Gaps = 37/185 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Q++ L H G++H ++ +++++ G + L F P+
Sbjct: 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP 275
Query: 226 LWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
+L T + D W++G + + IF+ C
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-- 333
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
K++P L+E L R A+
Sbjct: 334 -------------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362
Query: 342 ASEYF 346
+ +
Sbjct: 363 ETPEY 367
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 6/30 (20%), Positives = 12/30 (40%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
+ +GQ + A D +TG+ +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVH 109
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/189 (27%), Positives = 80/189 (42%), Gaps = 36/189 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
K+ + M LL + H ++HRD+K N+L++++ +KL DFG + + G + L
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLR 181
Query: 221 SRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
T Y PE++ + + YG VD+WS G + LL G P R ++ L I
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
Query: 276 FKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 333
+ G+ W +T KD L+ L V+P K
Sbjct: 242 --MSGNYQFGSPEWD------------------DYSDTVKD-------LVSRFLVVQPQK 274
Query: 334 RATASAALA 342
R TA ALA
Sbjct: 275 RYTAEEALA 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 14/59 (23%), Positives = 22/59 (37%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIK 188
+ +E E +G+G S V R T K A+K I E R +++
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 32/184 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217
+ Q+ G+ + H ++HRD+K N+L+ + + +K+ DFGL+
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ R+ T +Y PE+L G Y D+WS G + LL G P G+ E + L ++
Sbjct: 179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ W+ + A +LI +L+ P R TA
Sbjct: 237 GKYAFDLPQWRT-------------------------ISDDAKDLIRKMLTFHPSLRITA 271
Query: 338 SAAL 341
+ L
Sbjct: 272 TQCL 275
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 8/35 (22%), Positives = 19/35 (54%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + + +G+G++ V + +D T + A+K I
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 38/188 (20%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 217
+ Q+ G+ + H ++HRD+K N+L+ ++ +K+ DFGL+
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ R+ T +Y PE+L G Y D+WS G + LL G P G+ E + L ++
Sbjct: 179 KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 278 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
G W+ S A +LI +L+ P R
Sbjct: 235 ETGKYAFDLPQWRTISD--------------------------DAKDLIRKMLTFHPSLR 268
Query: 335 ATASAALA 342
TA+ L
Sbjct: 269 ITATQCLE 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 51/188 (27%), Positives = 78/188 (41%), Gaps = 37/188 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 217
+ Q+L + +CHS G++HR++K NLL+ ++ +KLADFGLA N +
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--E 162
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T Y PE+L Y VD+W+ G + LL+G P + +I
Sbjct: 163 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-- 219
Query: 278 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
G+ P W + A +LI+++L+V P KR
Sbjct: 220 KAGAYDYPSPEWDTVTP--------------------------EAKSLIDSMLTVNPKKR 253
Query: 335 ATASAALA 342
TA AL
Sbjct: 254 ITADQALK 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 58/204 (28%), Positives = 83/204 (40%), Gaps = 38/204 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 217
M +L + +CH V HRD+K N L + LKL DFGLA G +
Sbjct: 106 SDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--K 163
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ ++V T +Y P++L G YGP D WS G + LL G P T+ E + KI
Sbjct: 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-- 219
Query: 278 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
G+ P+ W S A +LI LL+ P +R
Sbjct: 220 REGTFTFPEKDWLNVSP--------------------------QAESLIRRLLTKSPKQR 253
Query: 335 ATASAALASEYFSTKPYACDLSSL 358
T+ AL E+F + + + L
Sbjct: 254 ITSLQALEHEWFEKQLSSSPRNLL 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 44/181 (24%), Positives = 67/181 (37%), Gaps = 32/181 (17%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL-KLADFG----LANFSNTGHRQ 217
Y+ Q L GLE+ H+R +LH D+K N+L++++G L DFG L
Sbjct: 152 ALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T + PE+++G VD+WS C+ +L G T+ + K
Sbjct: 212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLK 267
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ PP P + S I+ L EP RA+A
Sbjct: 268 IASEPP----------------PIREIPPSCAPLTAQ-------AIQEGLRKEPVHRASA 304
Query: 338 S 338
Sbjct: 305 M 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 10/33 (30%), Positives = 19/33 (57%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++G+G++ V R +D TG A+KK++
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 43/185 (23%), Positives = 74/185 (40%), Gaps = 33/185 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217
+ M Q+++ L + HS+ V+H+D+K N+L + +K+ DFGLA + +
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--E 181
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
T+ T Y PE+ D D+WS G V LL G G + E K
Sbjct: 182 HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-- 237
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ + + L AV+L++ +L+ +P +R +A
Sbjct: 238 ----------TYKEP--------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273
Query: 338 SAALA 342
+ L
Sbjct: 274 AQVLH 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 48/185 (25%), Positives = 71/185 (38%), Gaps = 38/185 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSR 222
M + ++ HS + HRD+K NLL ++ VLKL DFG A + L +
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTP 189
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG 280
T +Y PE +LG Y S D+WS+G + LL G P T + + G
Sbjct: 190 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248
Query: 281 SP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
P+ W + S+ A LI LL +P +R T
Sbjct: 249 QYGFPNPEWSEVSE--------------------------DAKQLIRLLLKTDPTERLTI 282
Query: 338 SAALA 342
+ +
Sbjct: 283 TQFMN 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 47/214 (21%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKK-IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 193
+E++ G+ S++ R++ G + ++ I Y Q+L GL++ H ++HRDIKG N+L
Sbjct: 98 MEQVPGGSLSALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154
Query: 194 VNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVGC 251
+N GVLK++DFG + G + TL Y PE++ YG + D+WS+GC
Sbjct: 155 INTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 252 VFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-------PQQPY 304
E+ GKP P + + P A +FK P+ P
Sbjct: 214 TIIEMATGKP--------------------P----FYELGEPQAAMFKVGMFKVHPEIPE 249
Query: 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
S K I +P KRA A+
Sbjct: 250 SMS--AEAKA-------FILKCFEPDPDKRACAN 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 11/31 (35%), Positives = 17/31 (54%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+G+GTY V+ RDL +A+K+I
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP 56
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 33/204 (16%), Positives = 69/204 (33%), Gaps = 55/204 (26%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL-------------------K 201
++K + Q+ GL + HS ++H DIK SN+ ++ + K
Sbjct: 115 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 202 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
+ D G + E+L + P D++++ +P
Sbjct: 175 IGDLGHV-----TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 262 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321
+ + +Q H+I + G P +P L + F +
Sbjct: 230 LPR---NGDQWHEIRQ--GRLPR-------IP------------QVLSQEFTE------- 258
Query: 322 LIETLLSVEPYKRATASAALASEY 345
L++ ++ +P +R +A A +
Sbjct: 259 LLKVMIHPDPERRPSAMALVKHSV 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 15/33 (45%), Positives = 20/33 (60%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F +LEKIG G + SVF+ G I A+K+ K
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK 45
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 47/183 (25%), Positives = 74/183 (40%), Gaps = 38/183 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSR 222
+ Q+L +++ H G++HRD+K NLL + + DFGL+ G +++
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTA 167
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T Y PE+L Y +VD WS+G + LL G P TE + KI + G
Sbjct: 168 CGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYY 224
Query: 283 --PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+W S+ +A + I LL +P +R T
Sbjct: 225 EFESPFWDDISE--------------------------SAKDFICHLLEKDPNERYTCEK 258
Query: 340 ALA 342
AL+
Sbjct: 259 ALS 261
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 15/35 (42%), Positives = 20/35 (57%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F +E +G G +S VF + TGK+ ALK IK
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK 43
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 58/283 (20%), Positives = 90/283 (31%), Gaps = 99/283 (34%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCY--------------MNQLLH--- 172
D ++ LE++G G + V R + TG++ K I MNQL H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 173 --------------------------------------------------GLEHCHSRGV 182
GL+H H +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 183 LHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 240
+H DIK N++ +K+ DFGLA N + + T + PE++
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPV 227
Query: 241 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFK 299
G D+W++G + LL G G ++E L + + +D + S
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE------- 280
Query: 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342
A + I+ LL EP KR T AL
Sbjct: 281 -------------------AKDFIKNLLQKEPRKRLTVHDALE 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 53/189 (28%), Positives = 77/189 (40%), Gaps = 36/189 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
K+ + M LL + H+ ++HRD+K N+L+++ ++L+DFG + G + L
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLR 257
Query: 221 SRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275
T Y PE+L + D YG VDLW+ G + LL G P R ++ L I
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317
Query: 276 FKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 333
+ G W T KD LI LL V+P
Sbjct: 318 --MEGQYQFSSPEW------------------DDRSSTVKD-------LISRLLQVDPEA 350
Query: 334 RATASAALA 342
R TA AL
Sbjct: 351 RLTAEQALQ 359
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 48/203 (23%), Positives = 77/203 (37%), Gaps = 42/203 (20%)
Query: 164 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSR 222
+C+ Q++ ++HCHSRGV+HRDIK N+L++ G KL DFG H +P T
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDF 198
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T Y PPE + + +WS+G + L+ + +CG
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGIL-------------------LYDM--VCGDI 237
Query: 283 P-DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
P + ++ A L P + LI L+ +P R + L
Sbjct: 238 PFERD---QEILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 342 ASEYFSTKPYACDLSSLPIYPPS 364
+ P + P+
Sbjct: 283 LDPWM-QTPAEDVPLNPSKGGPA 304
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 40/198 (20%)
Query: 156 KIVALKKI-----KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGL 207
K+V K++ K Y Q+L +++ H G++HRD+K N+L++++ ++K+ DFG
Sbjct: 229 KVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIG-KPILQ 264
+ + + T Y PE+L+ Y +VD WS+G + L G P +
Sbjct: 289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 265 GRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323
RT+V +I + + W + S+ A++L+
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSE--------------------------KALDLV 380
Query: 324 ETLLSVEPYKRATASAAL 341
+ LL V+P R T AL
Sbjct: 381 KKLLVVDPKARFTTEEAL 398
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 33/205 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQ 217
K Y Q+L +++ H G++HRD+K N+L++++ ++K+ DFG +
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--S 171
Query: 218 PLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHK 274
+ + T Y PE+L+ Y +VD WS+G + L G P + RT+V +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
I + + W ++ A++L++ LL V+P R
Sbjct: 232 ITSGKYNFIPEVW-------------------------AEVSEKALDLVKKLLVVDPKAR 266
Query: 335 ATASAALASEYFSTKPYACDLSSLP 359
T AL + + L
Sbjct: 267 FTTEEALRHPWLQDEDMKRKFQDLL 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 36/188 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---- 216
+I + + GLE H++G HRD+K +N+L+ +EG L D G N +
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 217 ----QPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
Q ++ T+ YR PEL D+WS+GCV ++ G+ +
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
+ + + +P + S+L L+ ++++V+
Sbjct: 254 DSVAL-AVQN--------QLSIP------QSPRHSSALW-----------QLLNSMMTVD 287
Query: 331 PYKRATAS 338
P++R
Sbjct: 288 PHQRPHIP 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKC 165
+ ++K+G+G +S V L G ALK+I C
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC 64
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 56/269 (20%), Positives = 98/269 (36%), Gaps = 55/269 (20%)
Query: 156 KIVALKKIKCY--------MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLAD 204
+I + + + M + +++ HS + HRD+K NLL ++ +LKL D
Sbjct: 149 RIQD-RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207
Query: 205 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 264
FG A + + LT+ T +Y PE +LG Y S D+WS+G + LL G P
Sbjct: 208 FGFAKETTSH--NSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264
Query: 265 GRTEVEQLHKIFK--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTA 319
+ + G P+ W + S+
Sbjct: 265 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE--------------------------EV 298
Query: 320 VNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 379
LI LL EP +R T + + + P++ + K R + +++
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV---PQTPLHTSRVLKEDKERWEDVKEE 355
Query: 380 VGGRVRGAETRKTTRKSHGMSKLAPVEDV 408
+ + T R + K+ +ED
Sbjct: 356 MTSALA------TMRVDYEQIKIKKIEDA 378
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 64/377 (16%), Positives = 103/377 (27%), Gaps = 108/377 (28%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKC--------------YMNQLLH--- 172
D ++ E++G G + V R + TG A K + M+ L H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 173 --------------------------------------------------GLEHCHSRGV 182
GL H H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 183 LHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 240
+H D+K N++ LKL DFGL + Q + T + PE+ G
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG-KPV 333
Query: 241 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFK 299
G D+WSVG + LL G G + E L + + D + S+
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED------- 386
Query: 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 359
+ I LL +P R T AL + + +
Sbjct: 387 -------------------GKDFIRKLLLADPNTRMTIHQALEHPWLTP-----GNAPGR 422
Query: 360 IYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTR-KSHGMSKLAPVEDVAVRTQFAKKI 418
K R+ + K R ++ + ++ ++R F +
Sbjct: 423 DSQIPSSRYTKIRDSIKTKY---DAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRS 479
Query: 419 NGHSLHILKDDELSGRE 435
I+K E
Sbjct: 480 EAQPRFIVKPYGTEVGE 496
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 74/349 (21%), Positives = 110/349 (31%), Gaps = 116/349 (33%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGK-----------------------------IVAL 160
D +E E IG G+YS R T I+ L
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITL 81
Query: 161 K-----------------------KI---KCY--------MNQLLHGLEHCHSRGVLHRD 186
K KI K + + + +E+ H++GV+HRD
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 187 IKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242
+K SN+L N +++ DFG A L + T + PE+L Y
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANFVAPEVLER-QGYDA 199
Query: 243 SVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLF 298
+ D+WS+G + +L G T E L +I S YW S
Sbjct: 200 ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD------- 252
Query: 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 358
TA +L+ +L V+P++R TA+ L P+ L
Sbjct: 253 -------------------TAKDLVSKMLHVDPHQRLTAALVLRH------PWIVHWDQL 287
Query: 359 PIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH----GMSKLA 403
P Y +R+DA G + G S LA
Sbjct: 288 PQYQL-------NRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLA 329
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 37/183 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSR 222
+ Q+L + +CHS G++HR++K NLL+ ++ +KLADFGLA N +
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGF 190
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T Y PE+L Y VD+W+ G + LL+G P + +I G+
Sbjct: 191 AGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAY 247
Query: 283 --PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
P W + A +LI+++L+V P KR TA
Sbjct: 248 DYPSPEWDTVTP--------------------------EAKSLIDSMLTVNPKKRITADQ 281
Query: 340 ALA 342
AL
Sbjct: 282 ALK 284
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 34/187 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR 216
+ ++ Q+L G+ + HS+ + H D+K N+++ ++ V +KL DFG+A+ G
Sbjct: 108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-- 165
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
+ T + PE++ G D+WS+G + LL G G T+ E L I
Sbjct: 166 NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 277 KLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ ++Y+ S+L A + I LL +P +R
Sbjct: 225 AVNYDFDEEYFSNTSEL--------------------------AKDFIRRLLVKDPKRRM 258
Query: 336 TASAALA 342
T + +L
Sbjct: 259 TIAQSLE 265
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 63/296 (21%), Positives = 89/296 (30%), Gaps = 99/296 (33%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCY--------------MNQLLH----- 172
K E +G G + V + + TG +A K IK MNQL H
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 173 ------------------------------------------------GLEHCHSRGVLH 184
G+ H H +LH
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILH 210
Query: 185 RDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242
D+K N+L N +K+ DFGLA + L T + PE++
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNY-DFVSF 267
Query: 243 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQ 301
D+WSVG + LL G G + E L+ I D+ ++ S+
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE--------- 318
Query: 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 357
A I LL E R +AS AL + S LS+
Sbjct: 319 -----------------AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA 357
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 55/188 (29%), Positives = 75/188 (39%), Gaps = 39/188 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSR 222
M +L+ + H H GV+HRD+K NLL +E +K+ DFG A QPL +
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTP 169
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFK-- 277
TL Y PE LL Y S DLWS+G + +L G+ Q +I K
Sbjct: 170 CFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228
Query: 278 LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
G + WK S+ A +LI+ LL+V+P KR
Sbjct: 229 KKGDFSFEGEAWKNVSQ--------------------------EAKDLIQGLLTVDPNKR 262
Query: 335 ATASAALA 342
S
Sbjct: 263 LKMSGLRY 270
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 34/186 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHR 216
++ ++ Q+L+G+ + HS + H D+K N+++ + +K+ DFGLA+ + G
Sbjct: 114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-- 171
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
+ T + PE++ G D+WS+G + LL G G T+ E L +
Sbjct: 172 NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 277 KLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ D+Y+ S L A + I LL +P KR
Sbjct: 231 AVNYEFEDEYFSNTSAL--------------------------AKDFIRRLLVKDPKKRM 264
Query: 336 TASAAL 341
T +L
Sbjct: 265 TIQDSL 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 34/186 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 216
++ ++ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+ G
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-- 172
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
+ T + PE++ G D+WS+G + LL G G T+ E L I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 277 KLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ ++++ S+L A + I LL E KR
Sbjct: 232 SVSYDFDEEFFSHTSEL--------------------------AKDFIRKLLVKETRKRL 265
Query: 336 TASAAL 341
T AL
Sbjct: 266 TIQEAL 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 14/46 (30%), Positives = 21/46 (45%), Gaps = 4/46 (8%)
Query: 123 GWVPLRADAFEKL----EKIGQGTYSSVFRARDLDTGKIVALKKIK 164
G P + E E++G G ++ V + R+ TG A K IK
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK 46
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 47/254 (18%), Positives = 84/254 (33%), Gaps = 43/254 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQP 218
++I Y++Q+ L+ HS + H DI+ N++ +K+ +FG A G
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN 159
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
Y PE+ + D+WS+G + LL G T + + I
Sbjct: 160 FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+ ++ + K++ A++ ++ LL E R TAS
Sbjct: 219 EYTFDEEAF-------------------------KEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR-------GAETRK 391
AL + K + + + + KK V G R
Sbjct: 254 EALQHPWLKQKIERVSTKVI------RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRS 307
Query: 392 TTRKSHGMSKLAPV 405
S K+A +
Sbjct: 308 QKGVSVAKVKVASI 321
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 30/174 (17%)
Query: 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224
Y L+ G+E+ H + ++HRDIK SNLLV +G +K+ADFG++N L++ V
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVG 199
Query: 225 TLWYRPPELLLGAT-DY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T + PE L + G ++D+W++G + G+ + KI
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS----- 254
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
+ P D+ +LI +L P R
Sbjct: 255 -QAL----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRIV 286
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 45/206 (21%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVV 224
+ Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDG 210
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP- 283
T Y PPE + +G S +WS+G + ++ +CG P
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPF 249
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343
+ ++ +F Q+ + + +LI L++ P R T
Sbjct: 250 EH---DEEIIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 344 EYF---STKPYACDLSSLPIYP-PSK 365
+ ++ + P PSK
Sbjct: 295 PWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 54/183 (29%), Positives = 78/183 (42%), Gaps = 36/183 (19%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSR 222
+ Q+L + HCH GV+HR++K NLL+ ++ +KLADFGLA G +Q
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGF 173
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T Y PE+L YG VDLW+ G + LL+G P + +I G+
Sbjct: 174 AGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAY 230
Query: 283 --PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
P W + A +LI +L++ P KR TA+
Sbjct: 231 DFPSPEWDTVTP--------------------------EAKDLINKMLTINPSKRITAAE 264
Query: 340 ALA 342
AL
Sbjct: 265 ALK 267
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 9/35 (25%), Positives = 18/35 (51%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ ++ E++G+G +S V R + G+ A I
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN 45
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 32/210 (15%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVV 224
Y QL+ GLE+ HS+G++H+DIK NLL+ G LK++ G+A + +
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 225 TLWYRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
+ ++PPE+ G + G VD+WS G + G +G + I K
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------ 227
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343
Y +P D +L++ +L EP KR +
Sbjct: 228 GSY----AIP-------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 344 EYFSTKPYACDLSSLPIYPPSKEIDAKHRE 373
+F K + + +PI P D
Sbjct: 265 SWF-RKKHPPAEAPVPIPPSPDTKDRWRSM 293
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 35/186 (18%), Positives = 70/186 (37%), Gaps = 34/186 (18%)
Query: 156 KIVALKKIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSN 212
K++ +K ++ + Q+L GL+ H+R ++HRD+K N+ + G +K+ D GLA
Sbjct: 124 KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
+ + + T + PE + Y SVD+++ G E+ + Q+
Sbjct: 184 ASFAK---AVIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238
Query: 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 332
++ T +D K+ +IE +
Sbjct: 239 YRR-------------------VTSGVKPASFDKVAIPEVKE-------IIEGCIRQNKD 272
Query: 333 KRATAS 338
+R +
Sbjct: 273 ERYSIK 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 8/29 (27%), Positives = 19/29 (65%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+IG+G++ +V++ D +T VA +++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 34/186 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 216
++ ++ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+ G
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-- 172
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
+ T + PE++ G D+WS+G + LL G G T+ E L I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 277 KLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ ++++ + S+L A + I LL E KR
Sbjct: 232 AVSYDFDEEFFSQTSEL--------------------------AKDFIRKLLVKETRKRL 265
Query: 336 TASAAL 341
T AL
Sbjct: 266 TIQEAL 271
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 33/186 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQ 217
+ + Q+L G+ + H ++H D+K N+L+++ G +K+ DFG++
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--C 188
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
L + T Y PE+L + D+W++G + LL G E I +
Sbjct: 189 ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 278 LCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
+ ++ + S+L A + I++LL P KR T
Sbjct: 248 VNVDYSEETFSSVSQL--------------------------ATDFIQSLLVKNPEKRPT 281
Query: 337 ASAALA 342
A L+
Sbjct: 282 AEICLS 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 37/223 (16%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
+VA ++K Q++ +++CH + ++HRD+K NLL++ + +K+ADFG +N
Sbjct: 104 YLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
G L + Y PEL G GP VD+WS+G + L+ G G+ E
Sbjct: 164 FTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
++ + G ++ + T NL++ L +
Sbjct: 222 LRERVLR--GKYRIPFY---------------------------MSTDCENLLKRFLVLN 252
Query: 331 PYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 373
P KR T + + + D + P D K +
Sbjct: 253 PIKRGTLEQIMKDRWI-NAGHEEDELKPFVEPELDISDQKRID 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 38/202 (18%), Positives = 75/202 (37%), Gaps = 40/202 (19%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 228
QL+ + + + ++HRDIK N+++ + +KL DFG A + G + T+ Y
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEY 195
Query: 229 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDYW 287
PE+L+G GP +++WS+G L + P +
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCELE 234
Query: 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347
+ + A + P + ++L+ LL P +R T + +
Sbjct: 235 ETVE---AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV- 278
Query: 348 TKPYACDLSSLPIYPPSKEIDA 369
T+P + + ++
Sbjct: 279 TQPVNLADYTWEEVFRVNKPES 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 52/258 (20%), Positives = 85/258 (32%), Gaps = 39/258 (15%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQ---- 217
I + +L L++ H G +HR +K S++L++ +G + L+ + + G RQ
Sbjct: 130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 218 -PLTSRVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKP-------------I 262
V L + PE+L Y D++SVG EL G
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249
Query: 263 LQGRT-----------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 311
L G E + + S D S + P PY +
Sbjct: 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309
Query: 312 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLPIYPPSKEIDAK 370
F +E L P R +AS L +F K A + + P + + +
Sbjct: 310 FHH-------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362
Query: 371 HREDARRKKVGGRVRGAE 388
+ + G V E
Sbjct: 363 GSQSQDHSGIFGLVTNLE 380
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 12/38 (31%), Positives = 19/38 (50%), Gaps = 2/38 (5%)
Query: 129 ADAFEKLEKIGQG--TYSSVFRARDLDTGKIVALKKIK 164
+E L IG+G +V AR TG+ V +++I
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 41/201 (20%), Positives = 69/201 (34%), Gaps = 47/201 (23%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR------Q 217
+ + L+ H++G+ HRD+K N+L + +K+ DF L +
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 218 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
L + + Y PE++ A+ Y DLWS+G + IL
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-------IL---------- 219
Query: 274 KIFKLCGSPP----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT--------TAVN 321
L G PP A ++S + + P A +
Sbjct: 220 ----LSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKD 274
Query: 322 LIETLLSVEPYKRATASAALA 342
LI LL + +R +A+ L
Sbjct: 275 LISKLLVRDAKQRLSAAQVLQ 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 34/188 (18%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
+I + + +QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA
Sbjct: 95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154
Query: 211 SNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTE 268
+R+ L +++ TL Y PELL + VD+WS G V +L G+ P Q
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
++ + + +K + + + L+ +L
Sbjct: 215 CQEYSDWKE-----------------KKTYLNP----------WKKIDSAPLALLHKILV 247
Query: 329 VEPYKRAT 336
P R T
Sbjct: 248 ENPSARIT 255
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 31/170 (18%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y +++ LE+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 284
T Y PELL S DLW++GC+ +L+ G P + E KI K
Sbjct: 195 TAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------- 246
Query: 285 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ P + A +L+E LL ++ KR
Sbjct: 247 ---LEYDFP-------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 12/38 (31%), Positives = 25/38 (65%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
R + F+ + +G+G++S+V AR+L T + A+K ++
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 48/220 (21%), Positives = 79/220 (35%), Gaps = 35/220 (15%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
+I + + +QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA
Sbjct: 95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154
Query: 211 SNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTE 268
+R + L TL Y PELL + VD+WS G V +L G+ P Q
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
++ + + +K + + + L+ +L
Sbjct: 215 CQEYSDWKE-----------------KKTYLNP----------WKKIDSAPLALLHKILV 247
Query: 329 VEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID 368
P R T ++ KP +
Sbjct: 248 ENPSARITIPDIKKDRWY-NKPLKKGAKRPRVTSGGVSES 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 49/185 (26%), Positives = 72/185 (38%), Gaps = 40/185 (21%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSR 222
+ Q+L + + H G++HRD+K NLL LK+ADFGL+ + +
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTV 210
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG 280
T Y PE+L G YGP VD+WSVG + LL G +F+ L
Sbjct: 211 CGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNC 266
Query: 281 SP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+W + S A +L+ L+ ++P KR T
Sbjct: 267 EYYFISPWWDEVSL--------------------------NAKDLVRKLIVLDPKKRLTT 300
Query: 338 SAALA 342
AL
Sbjct: 301 FQALQ 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 40/191 (20%), Positives = 73/191 (38%), Gaps = 46/191 (24%)
Query: 163 IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ Q ++H H + ++HRD+K NLL++N+G +KL DFG A + +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 221 S-----------RVVTLWYRPPEL--LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
+ R T YR PE+ L G D+W++GC+ L + +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 327
++ ++ + + PP D + +LI +L
Sbjct: 258 KLRIVNGKYSI---PPHD-----------------TQYTVFH-----------SLIRAML 286
Query: 328 SVEPYKRATAS 338
V P +R + +
Sbjct: 287 QVNPEERLSIA 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 8/38 (21%), Positives = 20/38 (52%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQ 169
+ +G ++ V+ A+D+ +G+ ALK++ +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE 67
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 3e-22
Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 84/260 (32%)
Query: 163 IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------------------------ 197
+K + Q+L GL++ H++ ++H DIK N+L++
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 198 -------------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 232
+K+AD G A + + + + +R YR E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLE 263
Query: 233 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDY 286
+L+G+ Y D+WS C+ EL G + + + + + + I +L G P
Sbjct: 264 VLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 287 WKKSK-----------LPHATLFKPQ-------QPYDSSLRETFKDLPTTAVNLIETLLS 328
K L H T KP + Y+ S E + + +L
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT-----DFLLPMLE 377
Query: 329 VEPYKRATASAALASEYFST 348
+ P KRATA+ L + ++
Sbjct: 378 LIPEKRATAAECLRHPWLNS 397
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 36/198 (18%), Positives = 68/198 (34%), Gaps = 21/198 (10%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
E GT + K++ + + ++L+ +E H ++H DIK N ++
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205
Query: 195 NN-----------EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGP 242
N L L D G + T++ T ++ E+L +
Sbjct: 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNY 264
Query: 243 SVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301
+D + V +L G + ++ + +F+ P D W + H L P
Sbjct: 265 QIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMWN--EFFHVMLNIPD 320
Query: 302 ---QPYDSSLRETFKDLP 316
P LR+ K +
Sbjct: 321 CHHLPSLDLLRQKLKKVF 338
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 43/190 (22%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLA-NFSNTGHR 216
YM Q+L L +CH ++HRD+K +L+ N +KL FG+A +G
Sbjct: 130 AVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-- 187
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
RV T + PE++ YG VD+W G + LL G G E ++F
Sbjct: 188 LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLF 241
Query: 277 K--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
+ + G W S+ +A +L+ +L ++P
Sbjct: 242 EGIIKGKYKMNPRQWSHISE--------------------------SAKDLVRRMLMLDP 275
Query: 332 YKRATASAAL 341
+R T AL
Sbjct: 276 AERITVYEAL 285
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 13/35 (37%), Positives = 21/35 (60%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
D +E E IG+G +S V R + +TG+ A+K +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD 58
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 36/186 (19%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
I +++ Q+L +++CH V+HRD+K N+L++ K+ADFGL+N
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
+ G L + + Y PE++ G GP VD+WS G + LL G
Sbjct: 161 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
KI G + +P + L + L+ +L V+
Sbjct: 219 LFKKIRG--G----VF----YIP-------------------EYLNRSVATLLMHMLQVD 249
Query: 331 PYKRAT 336
P KRAT
Sbjct: 250 PLKRAT 255
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 30/202 (14%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTS 221
I + ++L GLE+ H G +HRD+K N+L+ +G +++ADFG++ F + G
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 222 R---VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
R V T + PE++ Y D+WS G EL G ++ L +
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ- 241
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEPYKRAT 336
PP +L Q + + ++F+ +I L +P KR T
Sbjct: 242 -NDPP------------SLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPT 281
Query: 337 ASAALASEYFSTKPYACDLSSL 358
A+ L ++F A + L
Sbjct: 282 AAELLRHKFFQK---AKNKEFL 300
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 12/38 (31%), Positives = 18/38 (47%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
+ D +E E IG G + V A + VA+K+I
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI 48
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 41/202 (20%), Positives = 65/202 (32%), Gaps = 67/202 (33%)
Query: 156 KIVALKKIKCY--------MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLAD 204
+I + + + M + +++ HS + HRD+K NLL ++ +LKL D
Sbjct: 105 RIQD-RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163
Query: 205 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 264
FG A E Y S D+WS+G + LL G P
Sbjct: 164 FGFA----------------------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFY 199
Query: 265 GRTEVEQLHKIFK--LCGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTA 319
+ + G P+ W + S+
Sbjct: 200 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE--------------------------EV 233
Query: 320 VNLIETLLSVEPYKRATASAAL 341
LI LL EP +R T + +
Sbjct: 234 KMLIRNLLKTEPTQRMTITEFM 255
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 36/186 (19%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
IV K++ + Q++ +E+CH ++HRD+K NLL+++ +K+ADFGL+N
Sbjct: 98 YIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
G+ L + + Y PE++ G GP VD+WS G V +L+G+
Sbjct: 158 MTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
K+ Y +P L A +LI ++ +
Sbjct: 216 LFKKVNS------CVY----VMP-------------------DFLSPGAQSLIRRMIVAD 246
Query: 331 PYKRAT 336
P +R T
Sbjct: 247 PMQRIT 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 149 ARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL- 207
D+ T + +I + L LE HS V+HRDIK N+L+ +G +KL DFG
Sbjct: 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
A + ++ ++ V T ++ PE++ YGP VD+WS+G + E++ G+P
Sbjct: 164 AQITPEQSKR--STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY---L 217
Query: 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 327
L ++ + + P L P++ L F+D + L
Sbjct: 218 NENPLRALYLIATNGT---------P--ELQNPEK-----LSAIFRD-------FLNRCL 254
Query: 328 SVEPYKRATASAALASEYFSTKPYACDLSSL 358
++ KR +A L ++ A LSSL
Sbjct: 255 EMDVEKRGSAKELLQHQFLKI---AKPLSSL 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 13/33 (39%), Positives = 23/33 (69%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + EKIGQG +V+ A D+ TG+ VA++++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 49/212 (23%), Positives = 74/212 (34%), Gaps = 36/212 (16%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226
QLL G+ +CHS + HRD+K N L+ + LK+ DFG + S + S V T
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 181
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG--SP 282
Y PE+LL G D+WS G +L+G + E K + L S
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342
PDD + +LI + +P R +
Sbjct: 242 PDDIR---------------------------ISPECCHLISRIFVADPATRISIPEIKT 274
Query: 343 SEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 374
+F K DL + + + +
Sbjct: 275 HSWF-LKNLPADLMNESNTGSQFQEPEQPMQS 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y Q++ GLEH H R +++RD+K N+L++++G ++++D GLA G + T
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGT 352
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
+ PELLLG +Y SVD +++G E++ + + R E + ++ +
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------- 403
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKR 334
L + T+ + + E LL +P KR
Sbjct: 404 ---------RVLEQA---------VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ GLE H +++RD+K N+L+++ G ++++D GLA + Q + RV T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGT 348
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
+ Y PE++ Y S D W++GC+ E++ G+ Q R + + ++
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ + + A +L LL +P +R
Sbjct: 399 ---RLVKEVPEEYSER-------------FSPQARSLCSQLLCKDPAER 431
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 37/218 (16%)
Query: 156 KIVALKKIK-----CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
I ++ Q+L G+++CH V+HRD+K N+L++ K+ADFGL+N
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
+ G L + + Y PE++ G GP VD+WS G + LL G
Sbjct: 166 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
KI G + P + L + ++L++ +L V+
Sbjct: 224 LFKKICD--G----IF----YTP-------------------QYLNPSVISLLKHMLQVD 254
Query: 331 PYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID 368
P KRAT E+F + L S ID
Sbjct: 255 PMKRATIKDIREHEWF-KQDLPKYLFPEDPSYSSTMID 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I + L GLE+ H +HRDIK N+L+N EG KLADFG+A T +
Sbjct: 127 IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTV 185
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
+ T ++ PE++ Y D+WS+G E+ GKP ++ + IF + +P
Sbjct: 186 IGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNP 241
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342
P P T KP+ + F D ++ L P +RATA+ L
Sbjct: 242 P---------P--TFRKPEL-----WSDNFTD-------FVKQCLVKSPEQRATATQLLQ 278
Query: 343 SEYFSTKPYACDLSSL-PIYPPSKEIDAKHREDARRKK 379
+ + A +S L + + ++ K +E +R++
Sbjct: 279 HPFVRS---AKGVSILRDLINEAMDVKLKRQESQQREE 313
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 16/35 (45%), Positives = 28/35 (80%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ F+ LEK+G+G+Y SV++A +TG+IVA+K++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTS 221
I +L L + H++GV+HRDIK ++L+ +G +KL+DFG A S ++ S
Sbjct: 143 IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KS 200
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
V T ++ PE++ + Y VD+WS+G + E++ G+P + + +L S
Sbjct: 201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDS 256
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341
PP P L + + +D +E +L +P +RATA L
Sbjct: 257 PP---------P--KLKNSHK-----VSPVLRDF-------LERMLVRDPQERATAQELL 293
Query: 342 ASEYFSTKPYACDLSSL 358
+ L
Sbjct: 294 DHPFLLQ---TGLPECL 307
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 11/33 (33%), Positives = 19/33 (57%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ KIG+G+ V AR+ +G+ VA+K +
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD 79
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 43/175 (24%), Positives = 65/175 (37%), Gaps = 31/175 (17%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y+ +++ ++ H G +HRDIK N+L++ G ++LADFG V T
Sbjct: 167 YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 226 LWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
Y PE+L YGP D W++G E+ G+ + E KI
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH-- 284
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
K L P + +P A + I+ LL P R
Sbjct: 285 --------YKEHLSL-----PLVD---------EGVPEEARDFIQRLLC-PPETR 316
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 37/174 (21%), Positives = 67/174 (38%), Gaps = 36/174 (20%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
++ +L+ L++ ++ ++HRD+K N+L++ G + + DF +A + +T+ T
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--AMLPRETQITTMAGT 177
Query: 226 LWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCG 280
Y PE+ Y +VD WS+G ELL G+ I + E +H
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--- 234
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
P V+L++ LL P +R
Sbjct: 235 -------TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 49/178 (27%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y+ ++ L H H +G+++RD+K N+++N++G +KL DFGL ++T G
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG-- 183
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T+ Y PE+L+ + + +VD WS+G + ++L G P G + + KI
Sbjct: 184 --------TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
K K LP L A +L++ LL R
Sbjct: 235 K----------CKLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 31/169 (18%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ + H + S T
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGT 189
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
+ Y PE++ + S D WS G + E+L G QG+ E + I K
Sbjct: 190 VEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-------- 240
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
K +P + L A +L+ L P R
Sbjct: 241 --AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 50/172 (29%), Positives = 68/172 (39%), Gaps = 29/172 (16%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ L+ HS G +HRD+K N+L++ G LKLADFG N + V T
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 226 LWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
Y PE+L G YG D WSVG E+L+G + V KI
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN----- 287
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
K+ L P D+ A NLI L+ + R
Sbjct: 288 -----HKNSLTF-----PDDN----------DISKEAKNLICAFLT-DREVR 318
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 34/200 (17%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I+ Q+L L HS+ ++HRD+K N+L+ EG ++LADFG++ N Q S
Sbjct: 119 IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSF 177
Query: 223 VVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
+ T ++ PE+++ T Y D+WS+G E+ +P E+ + + K+
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKI 234
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
S P P TL P S F+D ++ L P R +A+
Sbjct: 235 AKSDP---------P--TLLTP-----SKWSVEFRD-------FLKIALDKNPETRPSAA 271
Query: 339 AALASEYFSTKPYACDLSSL 358
L + S+ +L
Sbjct: 272 QLLEHPFVSS---ITSNKAL 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 10/36 (27%), Positives = 23/36 (63%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +E + ++G G + V++A++ +TG + A K I+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE 53
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + + V T
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGT 353
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
Y PE+L Y S D +S+GC+ +LL G + ++ H+I +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR-------- 404
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ P +L+E LL + +R
Sbjct: 405 -----MTLTMAVELPDS------------FSPELRSLLEGLLQRDVNRR 436
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 6/132 (4%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y+ +++ ++ H +HRDIK N+L++ G ++LADFG + V T
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 226 LWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI--FKLC 279
Y PE+L YGP D WS+G E+L G+ + VE KI K
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
Query: 280 GSPPDDYWKKSK 291
P S+
Sbjct: 300 FQFPTQVTDVSE 311
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 44/223 (19%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
I + L GL + HS ++HRD+K N+L++ G++KL DFG ++ +
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG---SASI-----MAPA 207
Query: 223 ---VVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
V T ++ PE++L + Y VD+WS+G EL KP L + + ++
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYH 264
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ + P L E F++ +++ L P R T+
Sbjct: 265 IAQNES---------P--ALQSGH------WSEYFRN-------FVDSCLQKIPQDRPTS 300
Query: 338 SAALASEYFSTKPYACDLSSL-PIYPPSKEIDAKHREDARRKK 379
L + + + + +K+ + RK
Sbjct: 301 EVLLKHRFVLR---ERPPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 13/36 (36%), Positives = 23/36 (63%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F L +IG G++ +V+ ARD+ ++VA+KK+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 149 ARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL- 207
A DL + +I + ++L GL++ HS +HRDIK +N+L++ G +KLADFG+
Sbjct: 107 ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
++T ++ + V T ++ PE++ + Y D+WS+G EL G+P +
Sbjct: 167 GQLTDTQIKR--NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPH---S 220
Query: 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 327
E+ + +F + + P P TL + + + K+ +E L
Sbjct: 221 ELHPMKVLFLIPKNNP---------P--TL-------EGNYSKPLKE-------FVEACL 255
Query: 328 SVEPYKRATASAALASEYFSTKPYACDLSSL-PIYPPSKEIDAKHRED 374
+ EP R TA L ++ A S L + K A+ D
Sbjct: 256 NKEPSFRPTAKELLKHKFI--LRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 17/36 (47%), Positives = 24/36 (66%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ F KLEKIG+G++ VF+ D T K+VA+K I
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID 56
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 49/178 (27%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL T G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG-- 167
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE+L DYG +VD W +G V E++ G+ + I
Sbjct: 168 --------TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
++ + P + L A +L+ LL +P +R
Sbjct: 219 M----------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 36/177 (20%)
Query: 169 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 226
++ L + GV+HRD+K SN+L++ G +KL DFG+ + +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188
Query: 227 WYRPPE----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGS 281
Y PE DY D+WS+G EL G+ P +T+ E L K+ +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE 246
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
PP LP F F+ ++ L+ + KR +
Sbjct: 247 PP-------LLPGHMGFSGD----------FQS-------FVKDCLTKDHRKRPKYN 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 13/44 (29%), Positives = 23/44 (52%), Gaps = 1/44 (2%)
Query: 121 IQGWV-PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
I G + E L ++G GT V++ R TG ++A+K++
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 49/178 (27%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y ++ L + HS +++RD+K N+L++++G + L DFGL + ++T G
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCG-- 201
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE+L Y +VD W +G V E+L G P R E I
Sbjct: 202 --------TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
K +L ++ +A +L+E LL + KR
Sbjct: 253 N----------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 49/178 (27%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y +++ L H +G+++RD+K N+L+++EG KLADFG+ + T G
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG-- 186
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE+L YGP+VD W++G + E+L G + E + I
Sbjct: 187 --------TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ P L A ++++ ++ P R
Sbjct: 238 N----------DEVVYP-------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 26/103 (25%), Positives = 48/103 (46%), Gaps = 10/103 (9%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV- 224
Y+ ++L L + HS G+++ D+K N+++ E + KL D G R +
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV------SRINSFGYLYG 239
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267
T ++ PE++ + D+++VG A L + P GR
Sbjct: 240 TPGFQAPEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 49/178 (27%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y ++ GL S+G+++RD+K N+++++EG +K+ADFG+ + T G
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG-- 183
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE++ YG SVD W+ G + E+L G+ +G E E I
Sbjct: 184 --------TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ P K + AV + + L++ P KR
Sbjct: 235 E----------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 28/171 (16%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+ + T
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 226 LWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF-KLCGSPP 283
+ Y P+++ G + +VD WS+G + ELL G E +I ++ S P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
P +++ A +LI+ LL +P KR
Sbjct: 284 -------PYP-------------------QEMSALAKDLIQRLLMKDPKKR 308
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 50/169 (29%), Positives = 75/169 (44%), Gaps = 31/169 (18%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ N + T
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGT 181
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
Y PE+LLG Y SVD WS G + E+LIG+ G+ E E H I
Sbjct: 182 PDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------- 232
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
P + L A +L+ L EP KR
Sbjct: 233 --DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV- 224
+ Q+ L+ H+ G HRD+K N+LV+ + L DFG+A+ ++ Q V
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVG 197
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
TL+Y PE + D++++ CV E L G P
Sbjct: 198 TLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSP 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 33/176 (18%)
Query: 169 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 226
+ L H ++HRDIK SN+L++ G +KL DFG+ ++ + T
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCR 189
Query: 227 WYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 282
Y PE + + Y D+WS+G EL G+ P + + +QL ++ K G P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP 247
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
P +L + ++ + S F + + L+ + KR
Sbjct: 248 P-------QLSN----SEEREFSPS----FIN-------FVNLCLTKDESKRPKYK 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 13/38 (34%), Positives = 23/38 (60%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
A+ + L +IG+G Y SV + +G+I+A+K+I
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI 55
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 224
+ L H G++HRD+K +N++++ +K+ DFG+A +++G+ T+ V+
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
T Y PE G + D++S+GCV E+L G+P
Sbjct: 181 GTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 32/170 (18%)
Query: 166 YMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224
Y +++ L++ HS + V++RD+K NL+++ +G +K+ DFGL + +
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCG 311
Query: 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 284
T Y PE+L DYG +VD W +G V E++ G+ + + I
Sbjct: 312 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------- 363
Query: 285 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
++ + P + L A +L+ LL +P +R
Sbjct: 364 ---EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 37/98 (37%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV 224
+ NQ+L G++H H ++HRDIK N+L+++ LK+ DFG+A S T Q T+ V+
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVL 173
Query: 225 -TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 261
T+ Y PE G D++S+G V E+L+G+P
Sbjct: 174 GTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 31/169 (18%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ GL S+G+++RD+K N+++++EG +K+ADFG+ N + T
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGT 505
Query: 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285
Y PE++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 506 PDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------- 556
Query: 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
P K + AV + + L++ P KR
Sbjct: 557 --HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 36/131 (27%), Positives = 57/131 (43%), Gaps = 14/131 (10%)
Query: 169 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 226
++ LEH HS V+HRD+K SN+L+N G +K+ DFG+ + +
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 227 WYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 282
Y PE + + Y D+WS+G EL I + P T +QL ++ +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPS 231
Query: 283 P---DDYWKKS 290
P D +
Sbjct: 232 PQLPADKFSAE 242
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 13/38 (34%), Positives = 26/38 (68%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
++AD E + ++G+G Y V + R + +G+I+A+K+I
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI 40
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 76/198 (38%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK--------------------------- 164
E E +G+G + V +A+ K VA+K+I+
Sbjct: 10 IEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 165 -------C----YM-----NQLLH----------------------GLEHCHSR---GVL 183
C Y +LH G+ + HS ++
Sbjct: 68 GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 184 HRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242
HRD+K NLL+ G VLK+ DFG A T +T+ + + PE+ G ++Y
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEG-SNYSE 182
Query: 243 SVDLWSVGCVFAELLIGK 260
D++S G + E++ +
Sbjct: 183 KCDVFSWGIILWEVITRR 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 42/189 (22%), Positives = 78/189 (41%), Gaps = 62/189 (32%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T G
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG-- 172
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 173 --------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--------------- 208
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAVNLIET 325
P + P ++ F + L A +++++
Sbjct: 209 ----------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 252
Query: 326 LLSVEPYKR 334
L+ +P +R
Sbjct: 253 FLNKDPKER 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 9/155 (5%)
Query: 169 QLLHGLEHCHSRG-VLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 226
++ GL + + ++HRD+K SN+LVN+ G +KL DFG++ ++ S V T
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTR 194
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286
Y PE L G T Y D+WS+G E+ +G+ + E +
Sbjct: 195 SYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 321
+ + P L + DS +L VN
Sbjct: 254 PPRPRTPGRPL--NKFGMDSRPPMAIFELLDYIVN 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 13/37 (35%), Positives = 21/37 (56%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI 163
L+ D FEK+ ++G G VF+ +G ++A K I
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTS 221
I ++L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NT 188
Query: 222 RVVTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKP 261
+ T ++ PE++ + Y DLWS+G E+ G P
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 14/36 (38%), Positives = 23/36 (63%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
A FE +E +G GTY V++ R + TG++ A+K +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD 58
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 6e-16
Identities = 36/173 (20%), Positives = 65/173 (37%), Gaps = 42/173 (24%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y ++ LE+ HS+ +++RD+K N+L++ G +K+ DFG A + T
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYT 162
Query: 226 LW----YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
L Y PE++ Y S+D WS G + E+L G ++ KI
Sbjct: 163 LCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---- 217
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
+ + P +L+ L++ + +R
Sbjct: 218 ------AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 42/189 (22%), Positives = 78/189 (41%), Gaps = 62/189 (32%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHR 216
Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T G
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG-- 215
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 216 --------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--------------- 251
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAVNLIET 325
P + P ++ F + L A +++++
Sbjct: 252 ----------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 295
Query: 326 LLSVEPYKR 334
L+ +P +R
Sbjct: 296 FLNKDPKER 304
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 42/173 (24%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225
Y Q++ E+ HS +++RD+K NLL++ +G +++ DFG A + + R T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWT 197
Query: 226 L----WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
L PE++L Y +VD W++G + E+ G P ++ KI
Sbjct: 198 LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---- 252
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 334
K + P + +L+ LL V+ KR
Sbjct: 253 ------GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 23/91 (25%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSRVVTLWYRPP 231
G+++ H++ ++HRD+K +N+ ++ + +K+ DFGLA S ++ + P
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 232 ELLLGATD--YGPSVDLWSVGCVFAELLIGK 260
E++ Y D+++ G V EL+ G+
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 37/211 (17%), Positives = 66/211 (31%), Gaps = 81/211 (38%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCY--------------MNQLLH 172
R E +G+G + + +TG+++ +K++ + M L H
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 173 -----------------------------------------------------GLEHCHS 179
G+ + HS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHRQPLTSRVVTL 226
++HRD+ N LV + +ADFGLA R+ + V
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
++ PE++ G Y VD++S G V E++
Sbjct: 187 YWMAPEMING-RSYDEKVDVFSFGIVLCEII 216
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 16/101 (15%)
Query: 173 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTS 221
GL H H+ + HRD+K N+LV G +AD GLA + + P +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 222 RVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 257
RV T Y PPE+L + D++S G + E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 5/113 (4%)
Query: 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224
Y+++ + GL+ H + HRDIK N+L+ N +ADFGLA G T V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 225 -TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
T Y PE+L GA D +D++++G V EL G + L
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 31/101 (30%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 173 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTS 221
GL H H + HRD+K N+LV G +AD GLA + S
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 222 RVVTLWYRPPELLLGATDYGPS-----VDLWSVGCVFAELL 257
RV T Y PE+L VD+W+ G V E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 29/101 (28%), Positives = 43/101 (42%), Gaps = 16/101 (15%)
Query: 173 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTS 221
GL H H + HRD+K N+LV G +AD GLA ++
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 222 RVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 257
RV T Y PE+L + + D++++G VF E+
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 173 GLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 230
G+ + H+R ++HR++K NLLV+ + +K+ DFGL+ + S T +
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMA 207
Query: 231 PELLLGATDYGPSVDLWSVGCVFAELLIGK 260
PE+L D++S G + EL +
Sbjct: 208 PEVLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 22/100 (22%), Positives = 46/100 (46%), Gaps = 13/100 (13%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWY 228
G+ + H++G+LH+D+K N+ +N G + + DFGL L + L +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 229 RPPELLLGATD--------YGPSVDLWSVGCVFAELLIGK 260
PE++ + + D++++G ++ EL +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 22/110 (20%)
Query: 173 GLEHCHS---------RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHR 216
GL + H+ + HRD+ N+LV N+G ++DFGL+
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 217 QPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGK 260
S V T+ Y PE+L GA + VD++++G ++ E+ +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 20/97 (20%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 172 HGLEHCHSRG--VLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQPLTSRVV 224
G+E+ ++ ++HRD++ N+ + + K+ADFGL+ S ++ +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLG 188
Query: 225 TLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGK 260
+ PE + + Y D +S + +L G+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 45/214 (21%), Positives = 71/214 (33%), Gaps = 93/214 (43%)
Query: 132 FEKL---EKIGQGTYSSVFRA--RDLDTGKIVALKKIK---------------------- 164
F +L E IG G + V+RA G VA+K +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 165 -------------C-----------YM-----NQLLHG------------------LEHC 177
C + N++L G + +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 178 HSRG---VLHRDIKGSNLLVNNEG--------VLKLADFGLANFSNTGHRQPLTSRVVTL 226
H ++HRD+K SN+L+ + +LK+ DFGLA HR S
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAY 178
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 260
+ PE++ + + D+WS G + ELL G+
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 19/117 (16%), Positives = 29/117 (24%), Gaps = 29/117 (24%)
Query: 167 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 226
M L + H GV S + V+ +G + LA
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174
Query: 227 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283
P P D+ +G LL+ + L L + P
Sbjct: 175 -TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 11/87 (12%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 176 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 235
H + + +++++ + +++ + + R+ + PE L
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQ 181
Query: 236 G--ATDYGPSVDLWSVGCVFAELLIGK 260
S D+WS + EL+ +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 41/166 (24%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANF- 210
+ +LK + +Q++ +E+ HS+ +HRD+K N L+ ++ + DFGLA
Sbjct: 99 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
Query: 211 --SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAEL 256
+ T P YR + L G Y S+ DL S+G V
Sbjct: 159 RDARTHQHIP---------YRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYF 208
Query: 257 LIGK---PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299
+G L+ T+ ++ +I + KK P L K
Sbjct: 209 NLGSLPWQGLKAATKRQKYERISE----------KKMSTPIEVLCK 244
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 2e-10
Identities = 31/201 (15%), Positives = 60/201 (29%), Gaps = 32/201 (15%)
Query: 156 KIVALKKIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214
K+ +L K ++QL L + HRD+ N+L+ + KL S
Sbjct: 156 KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI- 214
Query: 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274
P V++ DY S VF ++ + + + G + +
Sbjct: 215 ---PSCGLQVSII-----------DYTLSRLERDGIVVFCDVSMDEDLFTG--DGDYQFD 258
Query: 275 IFKLCGSPPDDYWKKSKLPH---------ATLFKPQQPYDSSLRETFKDLPTTAVNLIET 325
I++L ++ W + + K K + T
Sbjct: 259 IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT 318
Query: 326 LLSVEPYKRATASAALASEYF 346
+L+ +A+ L
Sbjct: 319 MLNFS-----SATDLLCQHSL 334
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 5e-07
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLH 184
+ ++ EKIG+G + VF+ VA+K I L++G +L
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 40/163 (24%), Positives = 61/163 (37%), Gaps = 43/163 (26%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-----NNEGVLKLADFGLANF---S 211
LK + QL+ +E+ HS+ +++RD+K N L+ + V+ + DF LA
Sbjct: 104 LKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIG 259
T P YR + L G Y S+ DL ++G +F L G
Sbjct: 164 ETKKHIP---------YREHKSLTGTARYM-SINTHLGKEQSRRDDLEALGHMFMYFLRG 213
Query: 260 K-P--ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299
P L+ T E+ KI K P L +
Sbjct: 214 SLPWQGLKADTLKERYQKIGD----------TKRATPIEVLCE 246
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 20/76 (26%), Positives = 34/76 (44%), Gaps = 13/76 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRG-VLHRDIKGS 190
F +KIG G + + ++L T + VA+K LE SR LH + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 191 NLLVNNEGVLKLADFG 206
L + +G+ ++ FG
Sbjct: 59 KQLGSGDGIPQVYYFG 74
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 26/116 (22%), Positives = 45/116 (38%), Gaps = 23/116 (19%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHR 216
+ ++L LE+ H +H DIK +NLL+ N + LAD+GL+ + G+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK 260
+ P + G ++ S+ D+ +G L GK
Sbjct: 210 KQYQ-------ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPP 231
G+ H +HRDIK +N+L++ K++DFGLA S + +TSR+V T Y P
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
Query: 232 ELLLG-ATDYGPSVDLWSVGCVFAELLIGKP 261
E L G T D++S G V E++ G P
Sbjct: 205 EALRGEITP---KSDIYSFGVVLLEIITGLP 232
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 42/187 (22%), Positives = 68/187 (36%), Gaps = 52/187 (27%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-----NNEGVLKLADFGLANF---S 211
+K + Q+L ++ H + +++RDIK N L+ N ++ + DFG+ F
Sbjct: 105 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIG 259
T P YR + L G Y S+ DL ++G VF L G
Sbjct: 165 VTKQHIP---------YREKKNLSGTARYM-SINTHLGREQSRRDDLEALGHVFMYFLRG 214
Query: 260 K---PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQ-----PYDSSLR 309
L+ T ++ +I + KK P L P++ Y +L
Sbjct: 215 SLPWQGLKAATNKQKYERIGE----------KKQSTPLRELCAGFPEEFYKYMHYARNLA 264
Query: 310 ETFKDLP 316
F P
Sbjct: 265 --FDATP 269
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 31/125 (24%), Positives = 47/125 (37%), Gaps = 26/125 (20%)
Query: 169 QLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 225
++L LE+ H +H DIK SNLL+N N + L D+GLA + G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----- 214
Query: 226 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK-P--ILQGRTEVE 270
P G ++ S+ DL +G + L G P +
Sbjct: 215 --ADPKRCHDGTIEFT-SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271
Query: 271 QLHKI 275
+ KI
Sbjct: 272 RDSKI 276
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPP 231
GL + H+R ++HRD+K N+L++ V K+ DFG++ + L++ V TL Y P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
Query: 232 ELLLGATDYGPS------VDLWSVGCVFAELLIGKPILQGRTEVEQLH 273
E Y D++S G V E+L + + E ++
Sbjct: 211 E-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 22/123 (17%), Positives = 43/123 (34%), Gaps = 27/123 (21%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFS 211
+++ + + +LL LE H +H ++ N+ V ++ + LA +G A +
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 212 NTGHRQPLTSRVVTLWYR--PPELLLGATDYGPSV------------DLWSVGCVFAELL 257
+G Y G ++ S+ DL S+G + L
Sbjct: 213 PSGKHVA---------YVEGSRSPHEGDLEFI-SMDLHKGCGPSRRSDLQSLGYCMLKWL 262
Query: 258 IGK 260
G
Sbjct: 263 YGF 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 15/107 (14%)
Query: 171 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--HRQPLTSRVV-TLW 227
LH +HC + ++HRD+K +N+L++ E + DFGLA + H +T+ V T+
Sbjct: 147 LH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIG 200
Query: 228 YRPPE-LLLG-ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQ 271
+ PE L G +++ D++ G + EL+ G + R +
Sbjct: 201 HIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 42/161 (26%), Positives = 62/161 (38%), Gaps = 41/161 (25%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANF---SNT 213
LK + +Q+++ +E HS+ LHRDIK N L+ + + DFGLA ++T
Sbjct: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
Query: 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK- 260
P YR + L G Y SV DL S+G V L G
Sbjct: 162 HQHIP---------YRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211
Query: 261 --PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299
L+ T+ ++ KI + KK L +
Sbjct: 212 PWQGLKAGTKKQKYEKISE----------KKVATSIEALCR 242
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 147 FRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206
+ GK + L ++ Q+ G+ + +HRD++ +N+LV V K+ADFG
Sbjct: 269 LKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 207 LANFSNTGHRQPLTSRVVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
LA + W P L G + D+WS G + EL
Sbjct: 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 375
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 68/513 (13%), Positives = 130/513 (25%), Gaps = 183/513 (35%)
Query: 260 KPILQGRTEVEQLHKIF-KLCGSPP------------DDY-WKKSKLPHATLFKPQQP-- 303
I+ + V ++F L +Y + S + + +QP
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT----EQRQPSM 107
Query: 304 ----YDSSLRETFKDLPTTA---VN-------LIETLLSVEPY------------KRATA 337
Y + D A V+ L + LL + P K A
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 338 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 397
S K I+ + + + + + + + + T+R H
Sbjct: 168 LDVCLSYKVQCKM------DFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 398 GMSKLAPVEDV--AVRTQFAKKINGHSLHILKD--------------------------D 429
+ + + +R K + L +L + D
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 430 ELSGREVQKPLVDNREEA----------SHVKNASHGDIPFS----GPLQVSTSSGFA-- 473
LS +D+ + D+P P ++S A
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI---IAES 336
Query: 474 -------WAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNY-------------- 512
W + + + +S +N LEP+ R +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESS----LNVLEPA---EYRKMFDRLSVFPPSAHIPT 389
Query: 513 --------DSRKHENGDIINGSRTDS-----------RGHDSLEAVKIAMLNQWSQLER- 552
D K + ++N S +K+ + N+ L R
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE-YALHRS 448
Query: 553 -------PDSFDASD--------------GYHSQELSLALYQREEMATKRN---NLGFQD 588
P +FD+ D G+H + + E M R + F +
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP----ERMTLFRMVFLDFRFLE 504
Query: 589 QGEKVEFSGPLLSQSHRIDELL---ERHERQIR 618
Q K+ + S I L + ++ I
Sbjct: 505 Q--KIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 3/104 (2%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214
GK + L ++ Q+ G+ + +HRD++ +N+LV V K+ADFGLA
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416
Query: 215 HRQPLTSRVVTL-WYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ W P L G + D+WS G + EL
Sbjct: 417 EYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 458
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214
+ V+ + Q+ +E+ + +HR++ N LV ++K+ADFGL+
Sbjct: 312 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
Query: 215 -HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ ++ W P L + D+W+ G + E+
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIA 413
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 15/36 (41%), Positives = 25/36 (69%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
G+E+ S+ +HRD+ N LV + VLK++DFG++
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 20/54 (37%), Positives = 33/54 (61%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ L+ + CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 13/54 (24%), Positives = 27/54 (50%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
++ + + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 15/54 (27%), Positives = 28/54 (51%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ V+ + Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 105 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 18/56 (32%), Positives = 33/56 (58%), Gaps = 7/56 (12%)
Query: 160 LKKIKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
L + + QLL G+ + H++ +HRD+ N+L++N+ ++K+ DFGLA
Sbjct: 126 LPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 18/49 (36%), Positives = 30/49 (61%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
K+ Y +Q+ G+E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 18/49 (36%), Positives = 30/49 (61%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
K+ Y +Q+ G+E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 144 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 19/49 (38%), Positives = 30/49 (61%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
LK+ Y Q+ G+++ SR +HRD+ N+LV +E +K+ DFGL
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 20/54 (37%), Positives = 31/54 (57%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
G L K+ + Q+ G+ R +HRD++ +N+LV+ V K+ADFGLA
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 18/54 (33%), Positives = 31/54 (57%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
G + + K+ Q+ G+ R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 20/49 (40%), Positives = 32/49 (65%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
++ Y +Q+ G+E+ SR +HRD+ N+LV +E +K+ADFGLA
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 16/59 (27%), Positives = 32/59 (54%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
R + + L+ + +M + G+E+ SR +HRD+ N ++ + + +ADFGL+
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 15/67 (22%), Positives = 33/67 (49%)
Query: 142 TYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 201
S + D + + + + + Q+ G+++ ++HRD+ N+LV +K
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190
Query: 202 LADFGLA 208
++DFGL+
Sbjct: 191 ISDFGLS 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 21/60 (35%), Positives = 35/60 (58%)
Query: 149 ARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
A + + L+ + CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 15/49 (30%), Positives = 23/49 (46%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
LL G+ + V+HRD+ N LV V+K++DFG+
Sbjct: 103 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 12/36 (33%), Positives = 21/36 (58%)
Query: 173 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
G+ S +HRD+ N LV+ + +K++DFG+
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 16/57 (28%), Positives = 31/57 (54%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
L + V K I ++Q+ G+++ +HRD+ N+L+ + K++DFGL+
Sbjct: 108 LQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 18/69 (26%), Positives = 32/69 (46%)
Query: 140 QGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 199
S A D + L+ + + Q+ G+ S+ +HRD+ N+L+ + +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 200 LKLADFGLA 208
K+ DFGLA
Sbjct: 184 TKICDFGLA 192
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 27/105 (25%), Positives = 45/105 (42%), Gaps = 15/105 (14%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SN 212
L + Y QL L + S+ +HRDI N+LV++ +KL DFGL+ +
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 257
+ + P+ W P + + + D+W G E+L
Sbjct: 550 SKGKLPI------KWMAPESINFRR--FTSASDVWMFGVCMWEIL 586
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 13/54 (24%), Positives = 27/54 (50%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
++ + + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 19/58 (32%), Positives = 34/58 (58%)
Query: 151 DLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ + ++ K + Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 12/43 (27%), Positives = 27/43 (62%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ Q+ G+ + G++HR++ N+L+ + +++ADFG+A
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 17/61 (27%), Positives = 34/61 (55%)
Query: 148 RARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
+R K + L+ + +M + G+E+ +R LHRD+ N ++ ++ + +ADFGL
Sbjct: 134 YSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
Query: 208 A 208
+
Sbjct: 194 S 194
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 12/61 (19%), Positives = 28/61 (45%)
Query: 148 RARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
+ +L K+ ++ G+ + ++ +HRD+ N +V + +K+ DFG+
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 208 A 208
Sbjct: 185 T 185
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 16/30 (53%), Positives = 24/30 (80%)
Query: 179 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
S+ LHRD+ N LVN++GV+K++DFGL+
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
Y Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 30/110 (27%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------NF 210
+ QL+ G+++ G +HRD+ N+L+N+ V K++DFGL +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYG---PSVDLWSVGCVFAELL 257
+ G + P+ W PE A Y + D+WS G V E++
Sbjct: 206 TTRGGKIPI------RWT-SPE----AIAYRKFTSASDVWSYGIVLWEVM 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/49 (32%), Positives = 28/49 (57%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ QL+ G+ + G +HRD+ N+LV++ V K++DFGL+
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 20/58 (34%), Positives = 32/58 (55%)
Query: 151 DLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ + + K + QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 14/43 (32%), Positives = 28/43 (65%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ Q+ G+++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
L + Y QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 15/49 (30%), Positives = 29/49 (59%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+K + + Q+ G+E+ + +HRD+ N +++ +K+ADFGLA
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 18/49 (36%), Positives = 25/49 (51%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
LLH G+ S+ +HRD+ N+L+ N V K+ DFGLA
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
QLLH G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 20/58 (34%), Positives = 32/58 (55%)
Query: 151 DLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ + + K + QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 13/43 (30%), Positives = 27/43 (62%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
++Q+ G+++ + +HRD+ N+L+ N K++DFGL+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 19/70 (27%), Positives = 37/70 (52%)
Query: 139 GQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 198
+ Y + R + + ++ + + C+ Q+ G+E + +HRD+ N+LV +
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209
Query: 199 VLKLADFGLA 208
V+K+ DFGLA
Sbjct: 210 VVKICDFGLA 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 12/43 (27%), Positives = 27/43 (62%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
++Q+ G+++ + +HR++ N+L+ N K++DFGL+
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 16/49 (32%), Positives = 29/49 (59%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ QL+ G+++ + +HRD+ N+LVN+ V K++DFGL+
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 14/43 (32%), Positives = 27/43 (62%)
Query: 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 16/49 (32%), Positives = 26/49 (53%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+ + Y Q+ + + S +HRDI N+LV + +KL DFGL+
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 14/49 (28%), Positives = 26/49 (53%), Gaps = 7/49 (14%)
Query: 167 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208
+H G+E+ S V+H+D+ N+LV ++ +K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 634 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.77 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.58 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.49 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.38 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.75 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.57 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.41 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.01 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 89.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 88.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 87.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 87.68 | |
| 2pk2_A | 358 | Cyclin-T1, protein TAT; TAR, twinning, transcripti | 86.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 86.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 84.97 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 84.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 83.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 80.32 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=400.99 Aligned_cols=224 Identities=36% Similarity=0.591 Sum_probs=188.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 689999999999999999999999999999996
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC--
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-- 214 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-- 214 (634)
++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~ 213 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence 5679999999999999999999999999999999999999999999865432
Q ss_pred -CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 215 -HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 215 -~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
......+.+||++|||||++.+...|+.++||||||||||||++|++||.+.+..+++..|+...+.|+...|......
T Consensus 214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~ 293 (398)
T 4b99_A 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293 (398)
T ss_dssp --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----
T ss_pred ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhh
Confidence 2234456799999999999988677899999999999999999999999999999999999999999998877553222
Q ss_pred CcccC--CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 294 HATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 294 ~~~~~--~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
....+ .........+...++.+++++++||.+||.+||.+|||+.|+|+||||+....+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 294 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred hhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 11110 0111122345667788999999999999999999999999999999999875443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=387.73 Aligned_cols=193 Identities=29% Similarity=0.486 Sum_probs=169.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|+++++||+|+||+||+|+++.+|+.||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 579999999999999999999999999999996
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ......+|
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~G 232 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 232 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCS
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccccccc
Confidence 56799999999999999999999999999999999999999999998765432 33456799
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
|+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|........
T Consensus 233 Tp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--------------------- 290 (346)
T 4fih_A 233 TPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--------------------- 290 (346)
T ss_dssp CGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC---------------------
T ss_pred CcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---------------------
Confidence 999999999876 6799999999999999999999999999999888888765321111
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+..+++++++||.+||+.||.+|||+.|||+||||+...
T Consensus 291 -----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 -----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 01245789999999999999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=381.95 Aligned_cols=194 Identities=30% Similarity=0.500 Sum_probs=171.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-CCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~ 218 (634)
++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+...... ...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 56799999999999999999999999999999999999999999998765332 334
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
..+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|......+|
T Consensus 191 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p--------------- 254 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP--------------- 254 (311)
T ss_dssp BCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred ccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 567799999999999986 6789999999999999999999999999999999888876422211
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHH------HHhccccCCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA------ALASEYFSTKPYA 352 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e------lL~hpwf~~~~~~ 352 (634)
..+++++++||.+||..||.+|||+.| |++||||+...|.
T Consensus 255 --------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 255 --------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp --------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred --------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 357889999999999999999999987 6899999887653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.07 Aligned_cols=189 Identities=29% Similarity=0.500 Sum_probs=154.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3689999999999999999999999999999995
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..... ....
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~ 169 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLK 169 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--CccC
Confidence 5679999999999999999999999999999999999999999999866543 2335
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
+.+||+.|||||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+.......|
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----------------- 232 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----------------- 232 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----------------
Confidence 678999999999998755567899999999999999999999999888888887765321111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 233 ------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 233 ------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 357899999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=388.53 Aligned_cols=193 Identities=29% Similarity=0.486 Sum_probs=170.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|+++++||+|+||+||+|+++.+|+.||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 579999999999999999999999999999996
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|....... ......+|
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~G 309 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 309 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEE
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cccccccc
Confidence 56799999999999999999999999999999999999999999998765432 33467799
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
|+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|........
T Consensus 310 Tp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--------------------- 367 (423)
T 4fie_A 310 TPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--------------------- 367 (423)
T ss_dssp CTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------------
T ss_pred CcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---------------------
Confidence 999999999976 6799999999999999999999999999999888888765321110
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+..+++++++||.+||..||.+|||+.|||+||||+...
T Consensus 368 -----~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 368 -----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp -----SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 11246889999999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.82 Aligned_cols=191 Identities=25% Similarity=0.487 Sum_probs=162.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
+++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4799999999999999999999999999999996
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 181 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-EL 181 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-cc
Confidence 45689999999999999999999999999999999999999999998664321 12
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++.+|......+
T Consensus 182 ~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------- 244 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---------------- 244 (350)
T ss_dssp HHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----------------
T ss_pred ccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------
Confidence 345689999999999987 679999999999999999999999999999999888887632111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....+++++.+||.+||+.||.+|||+.|||+||||+..
T Consensus 245 ------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 245 ------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 013578999999999999999999999999999999763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=371.03 Aligned_cols=192 Identities=32% Similarity=0.507 Sum_probs=166.5
Q ss_pred CCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH-------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++. .+++.||||+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 368999999999999999999984 4688999996
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...... .
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 181 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 181 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------C
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-c
Confidence 56799999999999999999999999999999999999999999998654322 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
...+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..|.+....+|
T Consensus 182 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p-------------- 246 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP-------------- 246 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred cccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--------------
Confidence 3456789999999999986 6799999999999999999999999999999999888876322111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||+.||.+||| ++|||+||||+...|
T Consensus 247 ---------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 247 ---------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 357899999999999999999998 589999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=378.98 Aligned_cols=224 Identities=31% Similarity=0.510 Sum_probs=171.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~---------------------------------------- 162 (634)
|-..++|++.++||+|+||+||+|+++ .+++.||||+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 344578999999999999999999874 4678999995
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCCC----
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGH---- 215 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~---- 215 (634)
++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 176 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176 (361)
T ss_dssp EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence 57899999999999999999999999999999876 799999999997543221
Q ss_pred -----------------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCC-CCCChHHH
Q 006714 216 -----------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQ 271 (634)
Q Consensus 216 -----------------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf-~~~~~~e~ 271 (634)
.......+||++|+|||++.+...|+.++||||||||+|||++|++|| .+.++.++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~ 256 (361)
T 4f9c_A 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTA 256 (361)
T ss_dssp GGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 112345689999999999988667999999999999999999999887 56778899
Q ss_pred HHHHHHhcCCCCchhhhccC---------CCCc----------------ccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 006714 272 LHKIFKLCGSPPDDYWKKSK---------LPHA----------------TLFKPQQPYDSSLRETFKDLPTTAVNLIETL 326 (634)
Q Consensus 272 l~~i~~~~g~pp~~~~~~~~---------l~~~----------------~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 326 (634)
+..|+..+|.++...+.... .+.. ..+...........+.+..++++++|||.+|
T Consensus 257 l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~l 336 (361)
T 4f9c_A 257 LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKL 336 (361)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHH
T ss_pred HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence 99999988865433222100 0000 0000000001111233467899999999999
Q ss_pred hccCcCCCcCHHHHHhccccCCC
Q 006714 327 LSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 327 L~~DP~kRpTa~elL~hpwf~~~ 349 (634)
|++||.+|+|++|+|+||||++.
T Consensus 337 L~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 337 LDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=358.73 Aligned_cols=188 Identities=23% Similarity=0.380 Sum_probs=156.8
Q ss_pred Ce-eEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 131 AF-EKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 131 ~Y-~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+| ++.++||+|+||+||+|++..++..||+|+
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 45 777889999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecC-CCceEEeccccccccCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~ 214 (634)
++.|+.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 4679999999999999998 999999999999974 78999999999986543
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
....+.+||+.|||||++.+ .|+.++|||||||+||||++|++||.+......+...+... ..+..
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~~--------- 250 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPAS--------- 250 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGG---------
T ss_pred --CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCCC---------
Confidence 23456789999999999865 59999999999999999999999998766555544443321 11111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 251 ----------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 251 ----------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ----------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ----------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 113567889999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.30 Aligned_cols=195 Identities=29% Similarity=0.376 Sum_probs=163.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|++.++||+|+||+||+|+++.+|+.||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 3679999999999999999999999999999996
Q ss_pred ---------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCC----CCcccc
Q 006714 163 ---------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR----QPLTSR 222 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~----~~~~~~ 222 (634)
++.|+.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+....... ......
T Consensus 137 L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~ 216 (336)
T 4g3f_A 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216 (336)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCcc
Confidence 567999999999999999999999999999999887 699999999987653321 112345
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|.... ++
T Consensus 217 ~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~------------------- 274 (336)
T 4g3f_A 217 PGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP------------------- 274 (336)
T ss_dssp CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG-------------------
T ss_pred ccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC-------------------
Confidence 79999999999987 679999999999999999999999999887777777765421 11
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHH-------------HhccccCCCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA-------------LASEYFSTKP 350 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~el-------------L~hpwf~~~~ 350 (634)
+.+..+.+++.+.+||.+||+.||.+|||+.|+ |+|||+....
T Consensus 275 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 275 -----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp -----GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred -----chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 112235789999999999999999999999998 5689987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.39 Aligned_cols=192 Identities=26% Similarity=0.436 Sum_probs=145.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 479999999999999999999999999999995
Q ss_pred -----------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccc
Q 006714 163 -----------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 -----------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 345889999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHH
Q 006714 208 ANFSNTGHR-----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 208 a~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~ 276 (634)
|+....... ...+..+||+.|||||++.+ ..|+.++|||||||+||||++ ||... .+....+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~ 238 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLT 238 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHH
Confidence 986643221 12244689999999999987 679999999999999999996 67543 22233222
Q ss_pred HhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.......+ ..+...++.+.+||.+||+.||.+|||+.|||+||||+...+|
T Consensus 239 ~~~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 239 DVRNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHhcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 22111110 1112345678899999999999999999999999999976554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=379.82 Aligned_cols=199 Identities=28% Similarity=0.403 Sum_probs=176.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 5799999999999999999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC--CceEEeccccccccCCCCCCCc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~--g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.|+.||+.||.|||+++|+||||||+||||+.+ +.+||+|||+++..... ...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~ 313 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSV 313 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--Cce
Confidence 46799999999999999999999999999999754 79999999999877543 334
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..|......++...
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 379 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------------- 379 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG-------------
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc-------------
Confidence 56789999999999987 6789999999999999999999999999999999999877654444333
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 355 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~ 355 (634)
+..+++++++||.+||..||.+|||+.|||+||||+...++...
T Consensus 380 ------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 380 ------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp ------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred ------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCch
Confidence 25688999999999999999999999999999999987665543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=379.28 Aligned_cols=195 Identities=28% Similarity=0.456 Sum_probs=166.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 6678999999999999999999999999999999995
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 467999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhcc
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
. ...+.+||+.|||||++.....|+.++||||||||||||++|.+||.+.+ ..++...+.......
T Consensus 345 ~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~-------- 413 (689)
T 3v5w_A 345 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL-------- 413 (689)
T ss_dssp C---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC--------
T ss_pred C---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC--------
Confidence 3 23567999999999999765679999999999999999999999997643 223333333211111
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 352 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~~ 352 (634)
...+++++++||.+||+.||.+|++ ++||++||||+...|.
T Consensus 414 ---------------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 414 ---------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp ---------------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred ---------------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 1357899999999999999999998 7999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.09 Aligned_cols=219 Identities=45% Similarity=0.781 Sum_probs=183.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 689999999999999999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 160 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCCS
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccccC
Confidence 45789999999999999999999999999999999999999999998665322 23345
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCC-CCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~-~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..+|+.|+|||++.+...++.++|||||||++|+|++|. |+|.+.+..+.+..++..++.++...|............+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 577999999999987566899999999999999999765 5578888899999999999999888876533211111112
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+....+....+.+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 2222333445556789999999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.37 Aligned_cols=216 Identities=41% Similarity=0.746 Sum_probs=183.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 4699999999999999999999999999999994
Q ss_pred ----------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccc
Q 006714 163 ----------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 208 (634)
Q Consensus 163 ----------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla 208 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 4568999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhh
Q 006714 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 209 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~ 288 (634)
...... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 866533 23355678999999999976 568999999999999999999999999999999999999999999988876
Q ss_pred ccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 289 ~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.........+.+. ....+....+.+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5332222222221 1234556667899999999999999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.86 Aligned_cols=224 Identities=37% Similarity=0.620 Sum_probs=171.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 689999999999999999999999999999994
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~- 216 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp EEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTC
T ss_pred EEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccc
Confidence 456899999999999999999999999999999999999999999986542211
Q ss_pred -------------------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-----------CC
Q 006714 217 -------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-----------GK 260 (634)
Q Consensus 217 -------------------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-----------G~ 260 (634)
...+..++|++|+|||++.....|+.++||||||||||||++ |.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~ 292 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence 123556789999999987665779999999999999999998 78
Q ss_pred CCCCCCC--------------------hHHHHHHHHHhcCCCCchhhhccCCCCcccCC--CCCCCCchhhhhcCCCcHH
Q 006714 261 PILQGRT--------------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTT 318 (634)
Q Consensus 261 ~pf~~~~--------------------~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~s~~ 318 (634)
++|.+.. ..+++..|++.++.++.+.+..........+. ........+.+.++.++++
T Consensus 293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 372 (458)
T 3rp9_A 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD 372 (458)
T ss_dssp CSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHH
T ss_pred ccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHH
Confidence 8887754 36788999999999998877654322111110 1111223456667888999
Q ss_pred HHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 319 AVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 319 l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
+++||.+||.+||.+|||+.|||+||||+...++.
T Consensus 373 ~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 99999999999999999999999999999876654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.61 Aligned_cols=219 Identities=42% Similarity=0.774 Sum_probs=182.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++. +++.||+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 479999999999999999999985 589999995
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 177 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYT 177 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C---
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cccc
Confidence 45689999999999999999999999999999999999999999998764322 2234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc-ccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~-~~~~ 299 (634)
..++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.++...|........ ....
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 457799999999998766789999999999999999999999999999999999999999988877765332111 0011
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
........+....+.+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 11112233455567789999999999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.99 Aligned_cols=217 Identities=40% Similarity=0.745 Sum_probs=175.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++ .+++.||+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 6789999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 159 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTH 159 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccccc
Confidence 45689999999999999999999999999999999999999999997654322 22344
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
..+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|..............
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 57799999999997756789999999999999999999999999999999999999999888777654221110000000
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
......+......+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 01112234445678999999999999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=343.76 Aligned_cols=221 Identities=36% Similarity=0.613 Sum_probs=171.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 689999999999999999999999999999994
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC------
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG------ 214 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~------ 214 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 89 v~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 168 (388)
T 3oz6_A 89 VFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168 (388)
T ss_dssp EEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred EecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence 3568899999999999999999999999999999999999999999765321
Q ss_pred --------------CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcC
Q 006714 215 --------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280 (634)
Q Consensus 215 --------------~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g 280 (634)
.....+..++|++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..|+..++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 248 (388)
T 3oz6_A 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248 (388)
T ss_dssp GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 112234568899999999998767899999999999999999999999999999999999999999
Q ss_pred CCCchhhhccCCCCcccCC---------CCCCCC---chhhh------hcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 281 SPPDDYWKKSKLPHATLFK---------PQQPYD---SSLRE------TFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~~~---------~~~~~~---~~l~~------~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.|+.+.+.....+....+. ...... ..+.. ....+++++.+||.+||.+||.+|||+.|+|+
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 9988776543322111000 000000 00000 01267899999999999999999999999999
Q ss_pred ccccCCCC
Q 006714 343 SEYFSTKP 350 (634)
Q Consensus 343 hpwf~~~~ 350 (634)
||||+...
T Consensus 329 Hp~~~~~~ 336 (388)
T 3oz6_A 329 HPFVSIFH 336 (388)
T ss_dssp STTTTTTC
T ss_pred CHHHHHhc
Confidence 99998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.86 Aligned_cols=221 Identities=39% Similarity=0.728 Sum_probs=180.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 689999999999999999999999999999995
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 160 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNE 160 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccccc
Confidence 45689999999999999999999999999999999999999999997654322 223445
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC-cccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~-~~~~~~~ 301 (634)
++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..++..++.++...|....... ...+...
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 779999999999876778999999999999999999999999999999999999999999888776432110 0011111
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
......+......+++++.+||.+||++||.+|||+.|||+||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 11122344556788999999999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.44 Aligned_cols=194 Identities=22% Similarity=0.344 Sum_probs=154.2
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+++..++|++.++||+|+||+||+|++.. .||||+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEE
Confidence 35667899999999999999999998643 588875
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC-C
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-H 215 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 215 (634)
+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+..... .
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 4579999999999999999999999999999999999999999999865432 2
Q ss_pred CCCcccccccccCCCcccccCC--CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~--~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.......+||+.|||||++.+. ..|+.++|||||||+||||++|++||.+.+....+..++.....+|.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--------- 258 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD--------- 258 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC---------
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC---------
Confidence 2334566899999999998642 35899999999999999999999999987776666665543222211
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
+......+++.+.+||.+||+.||++|||+.||+++-
T Consensus 259 --------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 259 --------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp --------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred --------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1122356889999999999999999999999987653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.26 Aligned_cols=219 Identities=33% Similarity=0.592 Sum_probs=174.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4689999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C--C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--c
Confidence 4568999999999999999999999999999999999999999999866542 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++|++|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+++..|++.++.|+.++|..........
T Consensus 219 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred ccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 3456788999999999987 579999999999999999999999999999999999999999999988775432100000
Q ss_pred CCCCCCC-CchhhhhcCC------------CcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKPQQPY-DSSLRETFKD------------LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~~~~~-~~~l~~~~~~------------~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
......+ ...+...++. .++++++||.+||.+||.+|||+.|+|+||||+.+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0000000 0111111111 267799999999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=332.17 Aligned_cols=222 Identities=39% Similarity=0.705 Sum_probs=168.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 3689999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 162 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV- 162 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-
Confidence 34577899999999999999999999999999999999999999998664322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|.........
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 22345578999999999987567899999999999999999999999999999999999999999988888653211110
Q ss_pred cCCCCCCCCchhh-----hhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLR-----ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~-----~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
...........+. .....++.++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0000001111111 112367899999999999999999999999999999997543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.68 Aligned_cols=220 Identities=36% Similarity=0.658 Sum_probs=179.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3689999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--
Confidence 4568899999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
....++|++|+|||++.+...++.++||||||||+|+|++|++||.+.+..+++..|++.++.++.+++.........
T Consensus 182 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred --cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 345678999999999987667999999999999999999999999999999999999999999998877653321110
Q ss_pred cCC--CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 297 LFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 297 ~~~--~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.+. ........+...+..+++.+.+||.+||.+||.+|||+.|+|+||||+....+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 000 00011223445567789999999999999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=342.04 Aligned_cols=218 Identities=39% Similarity=0.660 Sum_probs=180.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++++.||+|+||+||+|++..+++.||||+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 479999999999999999999999999999995
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||.|||+++|+||||||+||||+.+ +.+||+|||+++......
T Consensus 134 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-- 211 (420)
T 1j1b_A 134 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-- 211 (420)
T ss_dssp CCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred cccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC--
Confidence 34578999999999999999999999999999965 568999999998664332
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++|+.|+|||++.+...|+.++||||||||||||++|++||.+.+..+++.+|++.++.++.+.|..........
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~ 291 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 23456789999999999876679999999999999999999999999999999999999999999988776532211111
Q ss_pred CCCCCCCCchhhhhc-CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~-~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+... ...+...+ ..+++++++||.+||.+||.+|||+.|+|+||||....
T Consensus 292 ~~p~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 292 KFPQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccCccC-CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 111111 11222222 46789999999999999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.03 Aligned_cols=225 Identities=37% Similarity=0.627 Sum_probs=182.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 467999999999999999999999999999999999999999999986643221
Q ss_pred ---------------------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-----------CCCCCC
Q 006714 217 ---------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-----------GKPILQ 264 (634)
Q Consensus 217 ---------------------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-----------G~~pf~ 264 (634)
...+..++|++|+|||++.....|+.++||||||||||||++ |.++|.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~ 264 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence 123667889999999997666779999999999999999997 567776
Q ss_pred CCC-----------------hHHHHHHHHHhcCCCCchhhhccCCCCcccC--CCCCCCCchhhhhcCCCcHHHHHHHHH
Q 006714 265 GRT-----------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIET 325 (634)
Q Consensus 265 ~~~-----------------~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~--~~~~~~~~~l~~~~~~~s~~l~dLL~~ 325 (634)
+.+ ..+++..|++.+|.|+.+.+..........+ .........+...++.+++++++||.+
T Consensus 265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 344 (432)
T 3n9x_A 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344 (432)
T ss_dssp CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 654 4788999999999999887765433221110 111112234556677899999999999
Q ss_pred hhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 326 LLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 326 mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
||.+||.+|||+.|||+||||+...++.
T Consensus 345 mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 345 MLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999999999999999999999875543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.69 Aligned_cols=228 Identities=44% Similarity=0.761 Sum_probs=187.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 34789999999999999999999999999999984
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++.......
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 166 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 166 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence 46799999999999999999999999999999999999999999998664322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC-CCCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~-l~~~ 295 (634)
......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|.... ++..
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 233456789999999999775668999999999999999999999999999999999999999999888776532 2221
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 358 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~ 358 (634)
..+.. .....+...+..+++++.+||.+||..||.+|||+.|+|+||||+..+.+.....+
T Consensus 247 ~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~ 307 (346)
T 1ua2_A 247 VTFKS--FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307 (346)
T ss_dssp CCCCC--CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred ccccc--cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccC
Confidence 11111 11123455567889999999999999999999999999999999988766544333
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=334.80 Aligned_cols=221 Identities=36% Similarity=0.596 Sum_probs=184.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 689999999999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--C
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--Q 217 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~ 217 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++........ .
T Consensus 107 iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 186 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186 (364)
T ss_dssp EEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred EEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccc
Confidence 456899999999999999999999999999999999999999999986643221 1
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.++.+.+..........
T Consensus 187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T 3qyz_A 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266 (364)
T ss_dssp TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 23456789999999998765678999999999999999999999999999999999999999999887765432111100
Q ss_pred --CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 --FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 --~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..........+...+..+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00111112234556678899999999999999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.53 Aligned_cols=220 Identities=38% Similarity=0.637 Sum_probs=173.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 689999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 109 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--- 185 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185 (367)
T ss_dssp CEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc---
Confidence 4568999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
....++|++|+|||++.+...++.++||||||||+|+|++|++||.+.+..+++..|++.++.|+.+.+..........
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 186 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred -CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 3456789999999999876778999999999999999999999999999999999999999999988776533211110
Q ss_pred C--CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 298 F--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 298 ~--~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
+ .........+...+..+++.+.+||.+||.+||.+|||+.|+|+||||.....+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 0 0001112234566678899999999999999999999999999999999865544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=330.24 Aligned_cols=221 Identities=39% Similarity=0.763 Sum_probs=175.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 3689999999999999999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec-----CCCceEEeccccccccCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~-----~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||+++|+|+||||+||||+ .++.+||+|||++.......
T Consensus 113 e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~- 191 (329)
T 3gbz_A 113 EYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI- 191 (329)
T ss_dssp ECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc-
Confidence 467899999999999999999999999999994 44569999999998664322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC-CCc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHA 295 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l-~~~ 295 (634)
......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..++..++.++...|..... +..
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 2234457799999999998766789999999999999999999999999999999999999999988877754321 111
Q ss_pred ccCCCCCCCCchhhhh-cCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRET-FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~-~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
....+... ...+... ...+++++.+||.+||.+||.+|||+.|+|+||||+...|
T Consensus 272 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 272 KQSFPKFR-GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp CTTCCCCC-CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhc-cccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11111111 1122222 2347899999999999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.43 Aligned_cols=225 Identities=44% Similarity=0.754 Sum_probs=183.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4799999999999999999999999999999994
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 46789999999999999999999999999999999999999999997654
Q ss_pred CCC---CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 213 TGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 213 ~~~---~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
... .......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++...|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 221 22234567799999999998766789999999999999999999999999999999999999999998887765
Q ss_pred cCCCCc-ccCCCCCCCCchhhhhcC--CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 290 SKLPHA-TLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 290 ~~l~~~-~~~~~~~~~~~~l~~~~~--~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
...... ..+.........+...+. ..++.+.+||.+||.+||.+|||+.|+|+||||+..+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 322111 111111111111111111 2467899999999999999999999999999999876654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.80 Aligned_cols=218 Identities=39% Similarity=0.662 Sum_probs=180.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|++++.||+|+||+||+|++..+++ ||+|+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 579999999999999999999987766 77764
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec-CCCceEEeccccccccCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-- 196 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-- 196 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--
Confidence 456889999999999999999999999999998 78999999999998764332
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++|+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..+++.++.++.+.+..........
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH 276 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS
T ss_pred CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 23456789999999999876679999999999999999999999999999999999999999999987765432211111
Q ss_pred CCCCCCCCchhhhhc-CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 298 FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~-~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
..+... ...+...+ ..+++++.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 277 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 277 KFPQIR-PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred cccccc-CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 111111 12223333 458899999999999999999999999999999997644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.24 Aligned_cols=216 Identities=29% Similarity=0.544 Sum_probs=177.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4689999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc--eEEeccccccccCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTG 214 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||.|||+++|+||||||+||||+.++. +||+|||++......
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~ 255 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence 4568999999999999999999999999999999887 999999999765432
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
....++|+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..+++.++.++..++.......
T Consensus 256 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~ 330 (429)
T 3kvw_A 256 ----VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330 (429)
T ss_dssp ----CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred ----ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence 245678999999999987 568999999999999999999999999999999999999999999987765432110
Q ss_pred cccCCC-----------------------------CCCCCchhhhhc-CCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 295 ATLFKP-----------------------------QQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 295 ~~~~~~-----------------------------~~~~~~~l~~~~-~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
...... ..+....+...+ ...++.+.+||.+||++||.+|||+.|||+||
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence 000000 000111112222 34578899999999999999999999999999
Q ss_pred ccCCC
Q 006714 345 YFSTK 349 (634)
Q Consensus 345 wf~~~ 349 (634)
||+..
T Consensus 411 w~~~~ 415 (429)
T 3kvw_A 411 WLRRR 415 (429)
T ss_dssp TTC--
T ss_pred hhccC
Confidence 99874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.87 Aligned_cols=191 Identities=29% Similarity=0.501 Sum_probs=167.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||.||+|++..+++.||||+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4689999999999999999999999999999995
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cccc
Confidence 4568999999999999999999999999999999999999999999766543 2345
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.......|
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----------------- 234 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----------------- 234 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 668899999999998755456899999999999999999999999988888777765322211
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 235 ------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 235 ------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 24688999999999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.74 Aligned_cols=190 Identities=21% Similarity=0.321 Sum_probs=158.5
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH-------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~------------------------------------- 162 (634)
.++..++++++++||+|+||+||+|+.. .+++.||||+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3455678999999999999999999853 4678899996
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC
Q 006714 163 ----------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 196 (634)
Q Consensus 163 ----------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~ 196 (634)
+..|+.||+.||+|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 1357889999999999999999999999999999
Q ss_pred CCceEEeccccccccCCCC-CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHH
Q 006714 197 EGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHK 274 (634)
Q Consensus 197 ~g~vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~ 274 (634)
++.+||+|||+++...... .......+||+.|||||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998654322 223345678999999999986 679999999999999999998 8999999998888777
Q ss_pred HHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 275 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 275 i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+......+ ....+++.+.+||.+||+.||.+|||+.||+++
T Consensus 260 i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 75422111 113578899999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=330.84 Aligned_cols=218 Identities=37% Similarity=0.661 Sum_probs=180.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|++..+++.||||+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 45789999999999999999999999999999984
Q ss_pred ----------------------------------------------------------HHHHHHHHHHHHHHHHHCCcee
Q 006714 163 ----------------------------------------------------------IKCYMNQLLHGLEHCHSRGVLH 184 (634)
Q Consensus 163 ----------------------------------------------------------i~~i~~Qll~aL~yLHs~gIvH 184 (634)
++.++.||+.||.|||++||+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H 164 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICH 164 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCcc
Confidence 2347889999999999999999
Q ss_pred ccCCCCCceec-CCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCC
Q 006714 185 RDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 263 (634)
Q Consensus 185 rDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf 263 (634)
|||||+||||+ .++.+||+|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 99999999997 67899999999998664332 2345677999999999987667999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhh-cCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 264 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET-FKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 264 ~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~-~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+.+..+++..+++.++.++.+.+............+.... ..+... ...+++++.+||.+||.+||.+|||+.|+|+
T Consensus 243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA-KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC-CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCc-ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999887765432222221122221 222333 3458899999999999999999999999999
Q ss_pred ccccCC
Q 006714 343 SEYFST 348 (634)
Q Consensus 343 hpwf~~ 348 (634)
||||+.
T Consensus 322 hp~f~~ 327 (383)
T 3eb0_A 322 HPFFDH 327 (383)
T ss_dssp SGGGHH
T ss_pred CHHHHH
Confidence 999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.35 Aligned_cols=188 Identities=21% Similarity=0.308 Sum_probs=150.2
Q ss_pred ccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH---------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK--------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~--------------------------------------- 162 (634)
+..++|.+.++||+|+||+||+|++. .+++.||||+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 33468999999999999999999864 4688999996
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCce
Q 006714 163 ------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 200 (634)
Q Consensus 163 ------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~v 200 (634)
+..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 13588999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHh
Q 006714 201 KLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL 278 (634)
Q Consensus 201 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~ 278 (634)
||+|||+++....... ......++|+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986543322 22345678999999999986 679999999999999999998 89999999988888777553
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 279 ~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. ++ ....+++++.+||.+||+.||++|||+.||+++
T Consensus 277 ~~-~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 277 RE-LE---------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CC-CC---------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CC-CC---------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 21 11 013578899999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.08 Aligned_cols=191 Identities=20% Similarity=0.310 Sum_probs=156.7
Q ss_pred ccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH---------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK--------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~--------------------------------------- 162 (634)
+..++|.+.++||+|+||+||+|++. .++..||||+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45578999999999999999999875 3578899996
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEE
Q 006714 163 ----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 202 (634)
Q Consensus 163 ----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL 202 (634)
+..|+.||+.||.|||+++||||||||+||||+.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 2358899999999999999999999999999999999999
Q ss_pred eccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcC
Q 006714 203 ADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 280 (634)
Q Consensus 203 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g 280 (634)
+|||+++....... ......++|+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999986543222 12233568999999999986 679999999999999999998 8999999998888887765321
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.+ ....+++++.+||.+||+.||++|||+.+|+ +||+.
T Consensus 249 ~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 249 LQ----------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CC----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 11 0135788999999999999999999999994 56654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=318.06 Aligned_cols=222 Identities=37% Similarity=0.652 Sum_probs=176.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999999999999994
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 160 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYD 160 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cccC
Confidence 45689999999999999999999999999999999999999999998765322 2234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc--ccC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLF 298 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~--~~~ 298 (634)
..++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+.+.++......+........ ...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 557899999999998767789999999999999999999999999999999999888888776544332111100 001
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.+.......+...++.++..+.+||.+||.+||.+|||+.|||+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 11112223345556789999999999999999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.70 Aligned_cols=224 Identities=35% Similarity=0.623 Sum_probs=174.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 34799999999999999999999999999999995
Q ss_pred ------------------------------HHHHHHHHHHHHHHHH--HCCceeccCCCCCceecC-CCceEEecccccc
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCH--SRGVLHRDIKGSNLLVNN-EGVLKLADFGLAN 209 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLH--s~gIvHrDLKp~NILl~~-~g~vkL~DFGla~ 209 (634)
++.++.||+.||.||| ++||+|+||||+||||+. ++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 3468899999999999 999999999999999986 8999999999998
Q ss_pred ccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 210 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++.+.|..
T Consensus 181 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 181 KLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 765432 234557799999999997766689999999999999999999999999999999999999999999887765
Q ss_pred cCCCCccc--C-CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 290 SKLPHATL--F-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 290 ~~l~~~~~--~-~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
........ . ....++...+.......++++.+||.+||++||.+|||+.|+|+||||+....+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 43221111 1 1111111112222234678999999999999999999999999999999865543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.29 Aligned_cols=194 Identities=28% Similarity=0.482 Sum_probs=164.1
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 345799999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 45689999999999999999999999999999999999999999997543222
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++..|.......|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------- 244 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------------- 244 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 23355689999999999876 5689999999999999999999999999999988888876322221
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH------HHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa------~elL~hpwf~~~~~ 351 (634)
..+++.+.+||.+||..||.+||++ .+|++||||+...|
T Consensus 245 ----------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 245 ----------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ----------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 2478889999999999999999999 99999999998655
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=333.82 Aligned_cols=190 Identities=24% Similarity=0.353 Sum_probs=156.1
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCC-----CcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~t-----g~~vAlK~-------------------------------------- 162 (634)
++..++|++.++||+|+||+||+|++..+ ++.||||+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 45668999999999999999999997654 36799875
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec
Q 006714 163 -----------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195 (634)
Q Consensus 163 -----------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~ 195 (634)
+..|+.||+.||+|||+++||||||||+||||+
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 124778999999999999999999999999999
Q ss_pred CCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHH
Q 006714 196 NEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 273 (634)
Q Consensus 196 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~ 273 (634)
.++.+||+|||+|+....... ......++|+.|||||++.+ ..|+.++|||||||+||||++ |.+||.+....+.+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986654332 22345678999999999986 679999999999999999998 999999876555444
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.++.....++ ....+++++.+||.+||+.||.+|||+.||++|
T Consensus 299 ~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4443221111 013578899999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=323.86 Aligned_cols=193 Identities=29% Similarity=0.491 Sum_probs=167.7
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45799999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 161 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cc
Confidence 45688999999999999999999999999999999999999999997643222 23
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+.......|
T Consensus 162 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 225 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--------------- 225 (337)
T ss_dssp BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred ccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 456689999999999976 6789999999999999999999999999888877777755321111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+|| ++.||++||||....|
T Consensus 226 --------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 226 --------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp --------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 35788999999999999999999 9999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.55 Aligned_cols=214 Identities=26% Similarity=0.442 Sum_probs=173.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 4689999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---------------------
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--------------------- 196 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~--------------------- 196 (634)
++.++.||+.||.|||++||+||||||+||||+.
T Consensus 114 v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp EECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence 4568999999999999999999999999999975
Q ss_pred ----CCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHH
Q 006714 197 ----EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272 (634)
Q Consensus 197 ----~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l 272 (634)
++.+||+|||++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 788999999999865432 245578999999999987 67899999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccC------CCCCCC----Cchhh-------hhcCCCcHHHHHHHHHhhccCcCCCc
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPY----DSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRA 335 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~------~~~~~~----~~~l~-------~~~~~~s~~l~dLL~~mL~~DP~kRp 335 (634)
..+....+.++...+..........+ ....+. ..... ......++.+.+||.+||++||.+||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 99999988888766544221111000 000000 00000 00112357788999999999999999
Q ss_pred CHHHHHhccccC
Q 006714 336 TASAALASEYFS 347 (634)
Q Consensus 336 Ta~elL~hpwf~ 347 (634)
|+.|||+||||+
T Consensus 349 ta~elL~hp~f~ 360 (360)
T 3llt_A 349 SPAELLKHKFLE 360 (360)
T ss_dssp CHHHHTTSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999995
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=327.30 Aligned_cols=192 Identities=27% Similarity=0.423 Sum_probs=169.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||+|+++.+++.||+|+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 689999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC----ceEEeccccccccCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 213 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 467999999999999999999999999999998776 799999999987654
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++..+|
T Consensus 172 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 242 (361)
T 2yab_A 172 G--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF------ 242 (361)
T ss_dssp T--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH------
T ss_pred C--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc------
Confidence 3 22355678999999999876 67899999999999999999999999999999888888765544443333
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 243 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 -------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp -------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred -------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 5688999999999999999999999999999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.80 Aligned_cols=219 Identities=37% Similarity=0.637 Sum_probs=180.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|.+.+.||+|+||+||+|++..+++.||||+
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 689999999999999999999999999999995
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 122 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---- 197 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 197 (371)
T ss_dssp CEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------
T ss_pred EEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC----
Confidence 4568999999999999999999999999999999999999999999765432
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.++.+++..........+
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 277 (371)
T 4exu_A 198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277 (371)
T ss_dssp --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence 24457799999999998767789999999999999999999999999999999999999999998877654321110000
Q ss_pred --CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 299 --KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 299 --~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
.........+...+..+++.+.+||.+||++||.+|||+.|+|+||||+....+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 001111223445567789999999999999999999999999999999876443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.44 Aligned_cols=237 Identities=26% Similarity=0.475 Sum_probs=181.0
Q ss_pred CCCcccccccCCccccccchhhccccchhhhhhhhhhccCcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-
Q 006714 84 SNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK- 162 (634)
Q Consensus 84 ~~~~~~s~r~g~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~- 162 (634)
..+....|..++++++..|+.+. ++|+++++||+|+||+||+|++..+++.||||+
T Consensus 14 ~~e~~~~~~~~~~~~~~~g~~~~-----------------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 70 (397)
T 1wak_A 14 EQEDPNDYCKGGYHLVKIGDLFN-----------------------GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV 70 (397)
T ss_dssp --------CC--CCSSCTTCEET-----------------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred cccccccCCCCCceEEehhhhcC-----------------------CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEE
Confidence 33456677788888887776553 589999999999999999999999999999995
Q ss_pred -----------------------------------------------------------------------------HHH
Q 006714 163 -----------------------------------------------------------------------------IKC 165 (634)
Q Consensus 163 -----------------------------------------------------------------------------i~~ 165 (634)
++.
T Consensus 71 ~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 150 (397)
T 1wak_A 71 KSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150 (397)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHH
T ss_pred ecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHH
Confidence 456
Q ss_pred HHHHHHHHHHHHHHC-CceeccCCCCCceecCCC----------------------------------------------
Q 006714 166 YMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEG---------------------------------------------- 198 (634)
Q Consensus 166 i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g---------------------------------------------- 198 (634)
|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 151 i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (397)
T 1wak_A 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNA 230 (397)
T ss_dssp HHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGG
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccc
Confidence 899999999999998 999999999999998775
Q ss_pred ---ceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC------hH
Q 006714 199 ---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EV 269 (634)
Q Consensus 199 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~------~~ 269 (634)
.+||+|||++...... ....++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||...+ ..
T Consensus 231 ~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 305 (397)
T 1wak_A 231 EKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305 (397)
T ss_dssp GGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHH
T ss_pred cccceEecccccccccccc----CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchH
Confidence 7999999999876532 344578999999999987 568999999999999999999999998654 67
Q ss_pred HHHHHHHHhcCCCCchhhhccCCCCcccCC--------CCCCCC--chhhhh---cCCCcHHHHHHHHHhhccCcCCCcC
Q 006714 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFK--------PQQPYD--SSLRET---FKDLPTTAVNLIETLLSVEPYKRAT 336 (634)
Q Consensus 270 e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~--------~~~~~~--~~l~~~---~~~~s~~l~dLL~~mL~~DP~kRpT 336 (634)
+.+..+...++.++...+............ ...++. ..+.+. ...++..+.+||.+||++||.+|||
T Consensus 306 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 385 (397)
T 1wak_A 306 DHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385 (397)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC
T ss_pred HHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC
Confidence 788889999999887766443322111100 000000 011111 1234567899999999999999999
Q ss_pred HHHHHhccccCC
Q 006714 337 ASAALASEYFST 348 (634)
Q Consensus 337 a~elL~hpwf~~ 348 (634)
+.|||+||||+.
T Consensus 386 ~~e~l~hp~~~~ 397 (397)
T 1wak_A 386 AAECLRHPWLNS 397 (397)
T ss_dssp HHHHHTSGGGGC
T ss_pred HHHHhhCccccC
Confidence 999999999973
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.65 Aligned_cols=220 Identities=33% Similarity=0.578 Sum_probs=167.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3689999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--c
Confidence 3568999999999999999999999999999999999999999999765432 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+++..+++.++.+..+++..........
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 2345678999999999987 678999999999999999999999999999999999999999988877765421100000
Q ss_pred CCCCCCC-Cchhhhhc------------CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 298 FKPQQPY-DSSLRETF------------KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~~~~-~~~l~~~~------------~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
......+ ...+...+ ...+..+++||.+||.+||.+|||+.|+|+||||+.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 0000000 00111111 112678999999999999999999999999999987644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.96 Aligned_cols=216 Identities=27% Similarity=0.492 Sum_probs=172.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 3689999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHH--HCCceeccCCCCCceec--CCCceEEeccccccccC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCH--SRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLH--s~gIvHrDLKp~NILl~--~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.||| ..+|+||||||+||||+ .++.+||+|||++....
T Consensus 133 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 3568999999999999 57999999999999994 46789999999998764
Q ss_pred CCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. ....++|+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..+++..++..++.++...+.....
T Consensus 213 ~~----~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 213 QR----IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp CC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred cc----cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 32 245678999999999987 5689999999999999999999999999999999999999999888776543211
Q ss_pred --------CCccc---------CCCCCCCCchhhhhcCC------------------CcHHHHHHHHHhhccCcCCCcCH
Q 006714 293 --------PHATL---------FKPQQPYDSSLRETFKD------------------LPTTAVNLIETLLSVEPYKRATA 337 (634)
Q Consensus 293 --------~~~~~---------~~~~~~~~~~l~~~~~~------------------~s~~l~dLL~~mL~~DP~kRpTa 337 (634)
+.... .....+....+...+.. ..+.+++||.+||++||.+|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 00000 00000001111111110 12478999999999999999999
Q ss_pred HHHHhccccCCC
Q 006714 338 SAALASEYFSTK 349 (634)
Q Consensus 338 ~elL~hpwf~~~ 349 (634)
.|+|+||||+..
T Consensus 368 ~e~L~hp~f~~~ 379 (382)
T 2vx3_A 368 YYALQHSFFKKT 379 (382)
T ss_dssp HHHTTSGGGCC-
T ss_pred HHHhcCcccccC
Confidence 999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=336.71 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=172.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|+++++||+|+||+||+|+++.+++.||+|+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 3456899999999999999999999999999999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 45689999999999999999999999999999999999999999997665443
Q ss_pred CCCcccccccccCCCccccc----CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 216 RQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~----~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.......+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+..+.+.+|+.....+.
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------- 301 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-------- 301 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc--------
Confidence 33344568999999999986 235689999999999999999999999999999988888865321111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 352 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~~ 352 (634)
. ...+..+++++++||.+||+.+|.+ |++++|+++||||+...|.
T Consensus 302 ~----------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 302 F----------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp C----------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred C----------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 0 0112457899999999999999988 9999999999999987664
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.03 Aligned_cols=190 Identities=24% Similarity=0.409 Sum_probs=167.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 45789999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 4568899999999999999999999999999999999999999999865432
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+.......+
T Consensus 160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--------------- 223 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--------------- 223 (318)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 245678999999999876 6789999999999999999999999999988888888765321111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+|| +++++++||||+...|
T Consensus 224 --------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 224 --------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp --------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred --------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 34788999999999999999999 9999999999997655
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=332.56 Aligned_cols=202 Identities=30% Similarity=0.444 Sum_probs=172.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|+++++||+|+||+||+|+++.+++.||+|+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4567899999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 4568999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccccCCCcccccCCCC---CCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 218 PLTSRVVTLWYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~---~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.....+||+.|+|||++.+... |+.++|||||||+||||++|.+||.+.+..+.+.+|+.....+..
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 294 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF---------- 294 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC----------
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC----------
Confidence 3446789999999999976322 788999999999999999999999999998888888753211110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCC--CcCHHHHHhccccCCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 352 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k--RpTa~elL~hpwf~~~~~~ 352 (634)
.....+++++++||.+||..+|.+ |+++.||++||||+...|.
T Consensus 295 ---------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 295 ---------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp ---------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ---------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 001357899999999999999988 9999999999999986554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.18 Aligned_cols=195 Identities=31% Similarity=0.500 Sum_probs=167.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|+++.+++.||||+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 3456899999999999999999999999999999985
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 35689999999999999999999999999999999999999999997543222
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|.......+
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------ 238 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP------------ 238 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 22356688999999999986 6789999999999999999999999999988888887755321111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH-HHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~-elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+||++. +|++||||+...|
T Consensus 239 -----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 239 -----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 24788999999999999999999998 9999999998655
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.54 Aligned_cols=194 Identities=26% Similarity=0.439 Sum_probs=167.8
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++++.||+|+||+||+|++..+++.||||+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 456799999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 45689999999999999999999999999999999999999999997543222
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|.......|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------- 241 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------- 241 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 23355688999999999976 6789999999999999999999999999998888888866321111
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+||+ +.+|++||||+...|
T Consensus 242 ----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 242 ----------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 357889999999999999999994 799999999987655
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.22 Aligned_cols=194 Identities=24% Similarity=0.375 Sum_probs=170.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||+|.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 3689999999999999999999999999999985
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC--CCceEEeccccccccCCCCCCCcc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... ...
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 161 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccc
Confidence 4679999999999999999999999999999987 7899999999998765432 234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 162 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------- 226 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------------- 226 (321)
T ss_dssp EEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--------------
T ss_pred cccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh--------------
Confidence 5678999999999976 5678999999999999999999999999999888888877554443322
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+..++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 227 -----------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 227 -----------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -----------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -----------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 356889999999999999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.61 Aligned_cols=204 Identities=28% Similarity=0.433 Sum_probs=170.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 4556899999999999999999999999999999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 45688999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCCCcccccC------CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 216 RQPLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~------~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.......+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+.+.+|+.......
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------ 290 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS------ 290 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC------
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC------
Confidence 322345689999999999862 24689999999999999999999999999998888888865311100
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCC---cCHHHHHhccccCCCCCCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYFSTKPYACD 354 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kR---pTa~elL~hpwf~~~~~~~~ 354 (634)
+ ......+++++++||.+||. +|.+| ++++|+++||||+...|..-
T Consensus 291 --~----------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 291 --L----------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp --C----------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred --C----------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 0 00113678999999999999 99998 59999999999998877543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.25 Aligned_cols=194 Identities=27% Similarity=0.455 Sum_probs=161.6
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 345789999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 4568999999999999999999999999999999999999999999753322 2
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---------hHHHHHHHHHhcCCCCchhh
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---------~~e~l~~i~~~~g~pp~~~~ 287 (634)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.... .......+.......
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----- 281 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----- 281 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC-----
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC-----
Confidence 23456789999999999987 678999999999999999999999996432 222333333211111
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH------HHHHhccccCCCCC
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 351 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa------~elL~hpwf~~~~~ 351 (634)
...++.++.+||.+||+.||.+||++ .||++||||+...|
T Consensus 282 ------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 282 ------------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp ------------------------CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred ------------------------CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 13578899999999999999999995 89999999998655
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=316.90 Aligned_cols=225 Identities=34% Similarity=0.589 Sum_probs=179.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4789999999999999999999999999999995
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~- 217 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccc
Confidence 4568999999999999999999999999999999999999999999865432111
Q ss_pred --------CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 218 --------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 218 --------~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.....++|+.|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+.......
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T 2b9h_A 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249 (353)
T ss_dssp ----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTT
T ss_pred cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccc
Confidence 123357799999999987656789999999999999999999999999999999999998888776432111
Q ss_pred cC-CCCcc-cC-CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 290 SK-LPHAT-LF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 290 ~~-l~~~~-~~-~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
.. ..... .. .........+...+..+++.+.+||.+||..||.+|||+.|+|+||||+....+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 00 00000 00 0000112234555678899999999999999999999999999999999876544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.49 Aligned_cols=193 Identities=29% Similarity=0.500 Sum_probs=165.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 3689999999999999999999999999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .....+
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 177 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCcc
Confidence 467899999999999999999999999999999999999999999876654322 234567
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+........
T Consensus 178 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------- 236 (297)
T 3fxz_A 178 GTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------------------- 236 (297)
T ss_dssp SCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------------------
T ss_pred CCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence 8999999999986 6789999999999999999999999998888777766654321111
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 237 ------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0013578889999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.45 Aligned_cols=221 Identities=33% Similarity=0.681 Sum_probs=177.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|++..+++.||||+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 35799999999999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ...
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 181 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 181 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-ccc
Confidence 45689999999999999999999999999999999999999999997654322 223
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC-CC-Cccc
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LP-HATL 297 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~-l~-~~~~ 297 (634)
....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...+.... .+ ....
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 445789999999999875678999999999999999999999999999999999999888887655432210 00 0011
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+...........++.+++.+.+||.+||.+||.+|||+.|||+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 1112222334555667889999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.91 Aligned_cols=185 Identities=30% Similarity=0.509 Sum_probs=153.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 479999999999999999999999999999995
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++....... ...
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~ 214 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AGE 214 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CCc
Confidence 45689999999999999999999999999999999999999999987665432 234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+|+.|+|||++.+ .++.++|||||||++|||++|..+|...... ..+.. +..+
T Consensus 215 ~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~~~----------------- 270 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GYLP----------------- 270 (311)
T ss_dssp CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TCCC-----------------
T ss_pred ccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cCCC-----------------
Confidence 4568999999999875 6899999999999999999998776553322 22211 1111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
......+++++.+||.+||.+||.+|||+.|+|+||||++
T Consensus 271 --------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 --------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1223467899999999999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.06 Aligned_cols=225 Identities=38% Similarity=0.705 Sum_probs=164.9
Q ss_pred CCeeEE-EEecccCceeEEEEEEC--CCCcEEehHH--------------------------------------------
Q 006714 130 DAFEKL-EKIGQGTYSSVFRARDL--DTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~-~~LG~G~fg~Vy~a~d~--~tg~~vAlK~-------------------------------------------- 162 (634)
+.|++. ++||+|+||+||+|+++ .+++.||||+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 467774 47999999999999966 5688999985
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee----cCCCceEEeccccc
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLA 208 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl----~~~g~vkL~DFGla 208 (634)
++.|+.||+.||.|||+++|+||||||+|||| +.++.+||+|||++
T Consensus 100 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 100 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp ECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred eCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 34588899999999999999999999999999 67789999999999
Q ss_pred cccCCCCC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh---------HHHHHHHHH
Q 006714 209 NFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFK 277 (634)
Q Consensus 209 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---------~e~l~~i~~ 277 (634)
........ ......++|+.|+|||++.+...|+.++||||||||||+|++|.+||.+... .+++..|+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 86643211 2234567899999999998766789999999999999999999999987654 588999999
Q ss_pred hcCCCCchhhhccC-CCCccc----CC----CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 278 LCGSPPDDYWKKSK-LPHATL----FK----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 278 ~~g~pp~~~~~~~~-l~~~~~----~~----~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.++.++...|.... ++.... +. ........+.......++.+.+||.+||.+||.+|||+.|||+||||..
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 99999988886532 111100 00 0000001111222334788999999999999999999999999999999
Q ss_pred CCCCCC
Q 006714 349 KPYACD 354 (634)
Q Consensus 349 ~~~~~~ 354 (634)
.+++..
T Consensus 340 ~~~~~~ 345 (405)
T 3rgf_A 340 DPLPTS 345 (405)
T ss_dssp SSCCCS
T ss_pred CCCCcc
Confidence 876653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.32 Aligned_cols=232 Identities=30% Similarity=0.550 Sum_probs=176.9
Q ss_pred cccCCccccccchhhccccchhhhhhhhhhccCcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------
Q 006714 91 FRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------- 162 (634)
Q Consensus 91 ~r~g~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------- 162 (634)
|+.|++++...++.+.. ++|++++.||+|+||+||+|++..+++.||||+
T Consensus 2 y~~~~~~p~~~~~~~~~----------------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~ 59 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPYKD----------------------ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT 59 (373)
T ss_dssp -----CCCCCTTCEETT----------------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH
T ss_pred CCCCCceeeecCCcccC----------------------CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccch
Confidence 67788888888766543 589999999999999999999999999999984
Q ss_pred -------------------------------------------------------------------------HHHHHHH
Q 006714 163 -------------------------------------------------------------------------IKCYMNQ 169 (634)
Q Consensus 163 -------------------------------------------------------------------------i~~i~~Q 169 (634)
+..++.|
T Consensus 60 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~q 139 (373)
T 1q8y_A 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139 (373)
T ss_dssp HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred hhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHH
Confidence 3468899
Q ss_pred HHHHHHHHHHC-CceeccCCCCCceec------CCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCC
Q 006714 170 LLHGLEHCHSR-GVLHRDIKGSNLLVN------NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 170 ll~aL~yLHs~-gIvHrDLKp~NILl~------~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
|+.||.|||++ ||+|+||||+||||+ ..+.+||+|||++...... .....+|+.|+|||++.+ ..++.
T Consensus 140 i~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~ 214 (373)
T 1q8y_A 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGC 214 (373)
T ss_dssp HHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCT
T ss_pred HHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-CCCCc
Confidence 99999999998 999999999999994 3447999999999866532 234578999999999987 56899
Q ss_pred ccccccchhhHHHHhhCCCCCCCCC------hHHHHHHHHHhcCCCCchhhhccCCCCc-----ccCCCCC-----CCCc
Q 006714 243 SVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TLFKPQQ-----PYDS 306 (634)
Q Consensus 243 ~sDIWSLG~iLyeLltG~~pf~~~~------~~e~l~~i~~~~g~pp~~~~~~~~l~~~-----~~~~~~~-----~~~~ 306 (634)
++|||||||+||+|++|.+||.+.. ..+.+..++..++.+|..++...+.... ..+.... +...
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhh
Confidence 9999999999999999999998654 6678888999999988776654332110 0000000 0001
Q ss_pred hhhhhc---CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 307 SLRETF---KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 307 ~l~~~~---~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+...+ ..+++++.+||.+||+.||.+|||+.|||+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 111111 2346788999999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.64 Aligned_cols=195 Identities=28% Similarity=0.472 Sum_probs=161.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++++.||+|+||.||+|+++.+++.||||+
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 3456799999999999999999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 45689999999999999999999999999999999999999999997543221
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC---------ChHHHHHHHHHhcCCCCchh
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR---------TEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~---------~~~e~l~~i~~~~g~pp~~~ 286 (634)
......++|+.|+|||++.+ ..|+.++|||||||++|||++|.+||... ........+.......
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---- 238 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---- 238 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC----
T ss_pred -CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC----
Confidence 23355688999999999986 67899999999999999999999999752 2222333333211110
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH------HHHHhccccCCCCC
Q 006714 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 351 (634)
Q Consensus 287 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa------~elL~hpwf~~~~~ 351 (634)
...++..+.+||.+||..||.+||++ .++++||||+...|
T Consensus 239 -------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 239 -------------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp -------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 13578899999999999999999995 89999999998655
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.54 Aligned_cols=192 Identities=24% Similarity=0.439 Sum_probs=169.0
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|++..+++.||||+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3456899999999999999999999999999999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 4568999999999999999999999999999999999999999999866432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|.......|
T Consensus 195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------- 258 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------- 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 245688999999999986 6789999999999999999999999999988888888765321111
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
..++..+.+||.+||+.||.+||+ +.+|++||||....|
T Consensus 259 ----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 357889999999999999999998 999999999987655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.63 Aligned_cols=192 Identities=28% Similarity=0.423 Sum_probs=167.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||+|++..+++.||+|+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC----ceEEeccccccccCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 213 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++ .+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 467899999999999999999999999999998877 799999999987653
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 239 (326)
T 2y0a_A 171 GN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-------- 239 (326)
T ss_dssp TS--CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred CC--ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc--------
Confidence 32 2345678999999999875 678999999999999999999999999998888888876654333322
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..++..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 240 -----------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 240 -----------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -----------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -----------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 235678999999999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.64 Aligned_cols=218 Identities=37% Similarity=0.639 Sum_probs=178.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|.+.+.||+|+||+||+|++..+++.||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 689999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------
T ss_pred EEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC----
Confidence 4568999999999999999999999999999999999999999999765432
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++.+++..........+
T Consensus 180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259 (353)
T ss_dssp ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence 23457799999999988756789999999999999999999999999999999999999999998877654321100000
Q ss_pred --CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 299 --KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 299 --~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.........+...+..+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 00000111223344678999999999999999999999999999999987644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=308.40 Aligned_cols=218 Identities=42% Similarity=0.740 Sum_probs=181.9
Q ss_pred CCCeeEEEEecccCceeEEEEEEC-CCCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~-~tg~~vAlK~--------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++. .+++.||+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999995 6788999985
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 456889999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 5432 12344577999999999976 56899999999999999999999999999999999999999998888777543
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.......+... ....+......++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhccc--CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 22111111111 112344555778999999999999999999999999999999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=328.16 Aligned_cols=194 Identities=27% Similarity=0.477 Sum_probs=167.3
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|+++++||+|+||.||+|++..+++.||||+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 456789999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++.......
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 45689999999999998 999999999999999999999999999997543322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+..+.......+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------- 369 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP------------- 369 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 23355788999999999976 6789999999999999999999999999888888777765322211
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+|| |+.|+|+||||+...|
T Consensus 370 ----------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 370 ----------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 35788999999999999999999 9999999999997644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=321.38 Aligned_cols=193 Identities=27% Similarity=0.418 Sum_probs=168.0
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||.||+|+++.+++.||||+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34689999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~ 194 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S 194 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence 45689999999999999999999999999999999999999999997543221 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|.......
T Consensus 195 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------- 258 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--------------- 258 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC---------------
T ss_pred ccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC---------------
Confidence 3356689999999999976 678999999999999999999999999999888888886532111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH----HHHHhccccCCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~elL~hpwf~~~~~ 351 (634)
...++..+.+||.+||+.||.+||++ .++++||||+...|
T Consensus 259 --------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 259 --------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp --------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 13578899999999999999999996 79999999997655
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.47 Aligned_cols=193 Identities=32% Similarity=0.509 Sum_probs=166.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|.+..+++.||+|+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 589999999999999999999999999999975
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec---CCCceEEeccccccccCCCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++....... ..
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QA 169 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-CB
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-ce
Confidence 456899999999999999999999999999998 45789999999997665432 23
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 170 ~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 237 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW----------- 237 (444)
T ss_dssp CCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT-----------
T ss_pred eecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc-----------
Confidence 345688999999999876 67899999999999999999999999999998888888775544443322
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 238 --------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 238 --------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp --------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred --------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 4678999999999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=320.89 Aligned_cols=192 Identities=32% Similarity=0.512 Sum_probs=166.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||+|.+..+++.||+|+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 579999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccccccccCCCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|||++...... ..
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--~~ 186 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EA 186 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--CS
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--cc
Confidence 456899999999999999999999999999997654 5999999999876543 22
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 187 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 254 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW----------- 254 (362)
T ss_dssp CCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG-----------
T ss_pred cccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc-----------
Confidence 345678999999999876 67899999999999999999999999999888888887665444333222
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 255 --------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 255 --------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp --------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred --------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 4578899999999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.75 Aligned_cols=195 Identities=27% Similarity=0.426 Sum_probs=163.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|++..+++.||||+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456799999999999999999999999999999984
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 4678999999999999999999999999999999999999999999876533
Q ss_pred CCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhccC
Q 006714 217 QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
......+||+.|+|||++.. ...|+.++|||||||++|+|++|.+||.... ..+.+..+.......
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 239 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY--------- 239 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC---------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC---------
Confidence 23456789999999999864 2458899999999999999999999997543 233333332211111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-HHHHHhccccCCCCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTKPY 351 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-a~elL~hpwf~~~~~ 351 (634)
...++..+.+||.+||..||.+||+ +.++++||||....|
T Consensus 240 --------------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 240 --------------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp --------------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred --------------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 1356889999999999999999998 999999999998655
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.25 Aligned_cols=195 Identities=27% Similarity=0.411 Sum_probs=160.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3689999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-CCCcc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLT 220 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~ 220 (634)
++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 56799999999999999999999999999999999999999999997653221 22234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+...++.++|||||||++|+|++|..||....................
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 228 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----------------- 228 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-----------------
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-----------------
Confidence 567899999999998755457899999999999999999999987655332222221111100
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 229 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 1124578899999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.53 Aligned_cols=191 Identities=26% Similarity=0.411 Sum_probs=158.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999872
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec
Q 006714 163 -----------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195 (634)
Q Consensus 163 -----------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~ 195 (634)
++.++.||+.||.|||+++|+|+||||+||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 456899999999999999999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCC--CCCccccccchhhHHHHhhCCCCCCCCChHHHHH
Q 006714 196 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 273 (634)
Q Consensus 196 ~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~ 273 (634)
.++.+||+|||++....... .......+|+.|+|||++.+... ++.++|||||||++|+|++|..||..........
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp TTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 99999999999998665322 22344578999999999876332 4778999999999999999999999887766666
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.+.......+ ....+++.+.+||.+||..||.+|||+.|+|+||||+
T Consensus 251 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 251 KIKSQALEFP---------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHCCCCCC---------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHhcccCCCC---------------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 5544221111 0135788999999999999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.27 Aligned_cols=219 Identities=31% Similarity=0.579 Sum_probs=168.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 3689999999999999999999999999999996
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCCCCcccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
++.++.||+.||.|||++||+|+||||+||||+.++ .+||+|||++....... ......+
T Consensus 115 ~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~ 192 (330)
T 3nsz_A 115 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVA 192 (330)
T ss_dssp CCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCS
T ss_pred cCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccccccc
Confidence 466899999999999999999999999999999776 89999999998665432 2345578
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCC-CCCChHHHHHHHHHhcCCCCchh-hhccCCCCccc----C
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDDY-WKKSKLPHATL----F 298 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf-~~~~~~e~l~~i~~~~g~pp~~~-~~~~~l~~~~~----~ 298 (634)
+..|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+...++.+.... +.......... .
T Consensus 193 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (330)
T 3nsz_A 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272 (330)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHH
T ss_pred cccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhh
Confidence 999999999987677899999999999999999999888 45566677777766655432111 11111000000 0
Q ss_pred --CCCCCCCch-hhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 --KPQQPYDSS-LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 --~~~~~~~~~-l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+... .......+++++.+||.+||.+||.+|||+.|||+||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 000000000 001113378999999999999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=342.94 Aligned_cols=196 Identities=26% Similarity=0.434 Sum_probs=170.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|+++.+++.||||+
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3456899999999999999999999999999999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 45689999999999999999999999999999999999999999998643322
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..|+......|
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p------------ 562 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------ 562 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC------------
T ss_pred -cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 23456789999999999976 6789999999999999999999999999999998888865322221
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCH-----HHHHhccccCCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYA 352 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa-----~elL~hpwf~~~~~~ 352 (634)
..+++++.+||.+||..||.+||++ .||++||||+...|.
T Consensus 563 -----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 563 -----------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred -----------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 3578999999999999999999997 999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=311.13 Aligned_cols=194 Identities=31% Similarity=0.551 Sum_probs=162.8
Q ss_pred ccCCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH-----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~----------------------------------------- 162 (634)
+..++|++++.||+|+||.||+|++. .+++.||||+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 44579999999999999999999985 6889999984
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 356889999999999999999999999999999999999999999875432
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p---------- 241 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP---------- 241 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----------
T ss_pred CC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 21 22345678999999999976 6689999999999999999999999999988888888766422211
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..++..+.+||.+||..||.+|| ++.++|+||||+...|
T Consensus 242 -------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 242 -------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp -------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred -------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 34688999999999999999999 8999999999987644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.87 Aligned_cols=192 Identities=29% Similarity=0.459 Sum_probs=161.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 479999999999999999999999999999984
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc---eEEecccccccc
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFS 211 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~---vkL~DFGla~~~ 211 (634)
++.++.||+.||.|||+++|+||||||+||||+.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 3458899999999999999999999999999976554 999999999876
Q ss_pred CCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.... ......++|+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.. .+.+..+.......+..
T Consensus 184 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~------ 254 (351)
T 3c0i_A 184 GESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR------ 254 (351)
T ss_dssp CTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH------
T ss_pred cCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc------
Confidence 5432 22345678999999999976 568999999999999999999999998753 44555554433222222
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 255 -------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 -------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 224688999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.67 Aligned_cols=190 Identities=28% Similarity=0.475 Sum_probs=157.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4789999999999999999999999999999994
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~ 165 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLK 165 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTTC
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cccc
Confidence 4578999999999999999999999999999999999999999999866543 2335
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+ .
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~--------- 221 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------N--------- 221 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------C---------
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------H---------
Confidence 5678999999999987444478999999999999999999999764321111000 0
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.........+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 222 -----~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 222 -----SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00001123578999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.50 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=166.2
Q ss_pred CCeeEE-EEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
++|.+. +.||+|+||+||+|++..+++.||||+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 478888 899999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 5679999999999999999999999999999987 789999999999876533
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 188 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------- 255 (327)
T 3lm5_A 188 C--ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE--------- 255 (327)
T ss_dssp --------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---------
T ss_pred c--ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch---------
Confidence 2 2244578999999999876 678999999999999999999999999999888888876654443322
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
.+..+++.+.+||.+||..||.+|||+.+||+||||+...+..
T Consensus 256 ----------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 256 ----------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp ----------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred ----------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 1246788999999999999999999999999999999876643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.09 Aligned_cols=194 Identities=31% Similarity=0.484 Sum_probs=167.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|.+..+++.||+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3689999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc---eEEeccccccccCCCCCC
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~---vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++. +||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-- 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--
Confidence 4568999999999999999999999999999976655 9999999997665432
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+.......+...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------- 230 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE----------- 230 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT-----------
T ss_pred cccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh-----------
Confidence 2244678999999999976 6689999999999999999999999999888888877766443333211
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+..+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 231 --------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 231 --------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp --------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred --------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 246788999999999999999999999999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=309.90 Aligned_cols=224 Identities=34% Similarity=0.589 Sum_probs=171.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 689999999999999999999999999999994
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec-CCCceEEeccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF 210 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~-~~g~vkL~DFGla~~ 210 (634)
++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++..
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 345889999999999999999999999999997 567899999999986
Q ss_pred cCCCC--CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhh
Q 006714 211 SNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 211 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~ 288 (634)
..... ........+|..|+|||++.....++.++|||||||++|+|++|++||.+.+..+.+..+......+....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (320)
T 2i6l_A 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250 (320)
T ss_dssp C--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHH
T ss_pred cCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhh
Confidence 54321 1222345668999999998765678999999999999999999999999999999999988877666655443
Q ss_pred ccCCCCcc-cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 289 KSKLPHAT-LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 289 ~~~l~~~~-~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
........ ...........+......++.++.+||.+||..||.+|||+.|+|+||||+...+|.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 21100000 000000011223445567899999999999999999999999999999999876654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.25 Aligned_cols=215 Identities=25% Similarity=0.439 Sum_probs=172.4
Q ss_pred CCCeeEEEEecccCceeEEEEEE-CCCCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARD-LDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d-~~tg~~vAlK~--------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|.+ ..+++.||||+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 36899999999999999999998 56789999985
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-------------------
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN------------------- 196 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~------------------- 196 (634)
+..++.||+.||.|||+++|+|+||||+||||+.
T Consensus 93 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 4568999999999999999999999999999987
Q ss_pred CCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHH
Q 006714 197 EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 197 ~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~ 276 (634)
++.+||+|||++...... ....++|+.|+|||++.+ ..++.++|||||||++|||++|.+||...+..+.+..+.
T Consensus 173 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp CCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred CCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 667999999999865432 234578999999999986 678999999999999999999999999999999999999
Q ss_pred HhcCCCCchhhhccCCCCcccC-CCCCCCCch----h----------hhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHH
Q 006714 277 KLCGSPPDDYWKKSKLPHATLF-KPQQPYDSS----L----------RETFKDLPTTAVNLIETLLSVEPYKRATASAAL 341 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l~~~~~~-~~~~~~~~~----l----------~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL 341 (634)
..++.++..++........... ...+..... + .......++.+.+||.+||..||.+|||+.|+|
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 9898888776654322110000 000000000 0 000122357799999999999999999999999
Q ss_pred hccccCC
Q 006714 342 ASEYFST 348 (634)
Q Consensus 342 ~hpwf~~ 348 (634)
+||||+.
T Consensus 328 ~hp~f~~ 334 (339)
T 1z57_A 328 KHPFFDL 334 (339)
T ss_dssp TSGGGGG
T ss_pred cCHHHHH
Confidence 9999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.66 Aligned_cols=191 Identities=34% Similarity=0.535 Sum_probs=162.6
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++++.||+|+||+||+|++..++..||+|+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 345799999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 4568999999999999999999999999999999999999999998655432
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 227 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP-------------- 227 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------
T ss_pred cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC--------------
Confidence 2244577999999999876 6788999999999999999999999999888887777755322221
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+++.+.+||.+||..||.+|||+.|||+||||+...
T Consensus 228 ---------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 228 ---------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ---------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ---------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 24678899999999999999999999999999998743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.42 Aligned_cols=215 Identities=28% Similarity=0.489 Sum_probs=173.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCC-cEEehHH---------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-~~vAlK~--------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..++ +.||+|+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 368999999999999999999998877 6899985
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee-------------------cC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-------------------NN 196 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl-------------------~~ 196 (634)
++.++.||+.||.|||+++|+|+||||+|||| +.
T Consensus 98 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 98 CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred EEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence 45689999999999999999999999999999 56
Q ss_pred CCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHH
Q 006714 197 EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 197 ~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~ 276 (634)
++.+||+|||++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.
T Consensus 178 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp CCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 788999999999865432 244578999999999986 678999999999999999999999999999999999999
Q ss_pred HhcCCCCchhhhccCCCCcccCCCCCCCC--c----hhhhh----------cCCCcHHHHHHHHHhhccCcCCCcCHHHH
Q 006714 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYD--S----SLRET----------FKDLPTTAVNLIETLLSVEPYKRATASAA 340 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l~~~~~~~~~~~~~--~----~l~~~----------~~~~s~~l~dLL~~mL~~DP~kRpTa~el 340 (634)
..++.+|..++......... +.....+. . .+... ....+..+.+||.+||.+||.+|||+.|+
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYF-YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGE-ETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHcCCCcHHHhhhccchhhh-cccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 99998888766543221110 00000000 0 00000 01235678999999999999999999999
Q ss_pred HhccccCCC
Q 006714 341 LASEYFSTK 349 (634)
Q Consensus 341 L~hpwf~~~ 349 (634)
|+||||+..
T Consensus 332 l~hp~f~~~ 340 (355)
T 2eu9_A 332 LLHPFFAGL 340 (355)
T ss_dssp TTSGGGGGC
T ss_pred hcChhhcCC
Confidence 999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=311.20 Aligned_cols=194 Identities=31% Similarity=0.460 Sum_probs=154.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 3689999999999999999999999999999986
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCCCCccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||+++|+|+||||+||||+. ++.+||+|||++...... .....
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 209 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKT 209 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--ccccc
Confidence 4678999999999999999999999999999975 789999999999865432 22345
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH-HHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e-~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+ .+..+.......+..
T Consensus 210 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~--------------- 273 (349)
T 2w4o_A 210 VCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP--------------- 273 (349)
T ss_dssp ---CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT---------------
T ss_pred ccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc---------------
Confidence 678999999999976 568999999999999999999999997765544 455554432222211
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+..++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 274 ----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 274 ----------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ----------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1246789999999999999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.99 Aligned_cols=193 Identities=29% Similarity=0.427 Sum_probs=160.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999999999999999999999996
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC----CceEEeccccccccCCCCCCCcccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~----g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++....... ......
T Consensus 102 ~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 180 (342)
T 2qr7_A 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTP 180 (342)
T ss_dssp BHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCS
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-Cceecc
Confidence 45799999999999999999999999999998443 359999999998664332 223456
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC---CChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG---RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~---~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+ .+..+.+..+......++..+
T Consensus 181 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------- 246 (342)
T 2qr7_A 181 CYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY------------- 246 (342)
T ss_dssp SCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT-------------
T ss_pred CCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc-------------
Confidence 78999999999875 4578899999999999999999999986 344555555544322222222
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+..+++++.+||.+||..||.+|||+.++|+||||..+
T Consensus 247 ------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 247 ------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 24688999999999999999999999999999999765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.33 Aligned_cols=219 Identities=29% Similarity=0.489 Sum_probs=172.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|.+.. ++.||||+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4789999999999999999999865 88999982
Q ss_pred ------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccc
Q 006714 163 ------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 206 (634)
Q Consensus 163 ------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFG 206 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 45689999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchh
Q 006714 207 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 207 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~ 286 (634)
++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.++.+.
T Consensus 180 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 997544322 234457799999999998766789999999999999999999999999999999999999999888665
Q ss_pred hhccCCCCccc---CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 287 WKKSKLPHATL---FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 287 ~~~~~l~~~~~---~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+.....+.... ..........+......+++.+.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 43322111000 00011112234455567899999999999999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.90 Aligned_cols=194 Identities=26% Similarity=0.449 Sum_probs=151.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 3556899999999999999999999999999999995
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 356899999999999998 999999999999999999999999999976654
Q ss_pred CCCCCcccccccccCCCcccc---cCCCCCCCccccccchhhHHHHhhCCCCCCCC-ChHHHHHHHHHhcCCCCchhhhc
Q 006714 214 GHRQPLTSRVVTLWYRPPELL---LGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l---~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~-~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.. ......+|+.|+|||++ .....++.++|||||||++|+|++|..||... .....+..+........
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 234 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL------ 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC------
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc------
Confidence 32 22334689999999997 23456889999999999999999999999863 44444444433211100
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 235 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 ---------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 01357889999999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=306.81 Aligned_cols=192 Identities=28% Similarity=0.415 Sum_probs=167.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||+|++..+++.||+|+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 579999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC----ceEEeccccccccCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 213 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||++||+|+||||+|||++.++ .++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 467899999999999999999999999999999887 799999999987654
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 172 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 240 (321)
T 2a2a_A 172 GV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE-------- 240 (321)
T ss_dssp TC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH--------
T ss_pred cc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh--------
Confidence 32 2345578999999999876 678999999999999999999999999998888888776543333322
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 241 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 -----------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp -----------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred -----------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 235678899999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.79 Aligned_cols=194 Identities=28% Similarity=0.469 Sum_probs=166.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4689999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC--CCceEEeccccccccCCCCCCCc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||++||+||||||+||||+. ++.+||+|||++....... ..
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 207 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc--ce
Confidence 4679999999999999999999999999999974 4679999999998765432 23
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 208 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------- 272 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-------------- 272 (387)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS--------------
T ss_pred eeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------------
Confidence 44578999999999976 678999999999999999999999999998888888776543222211
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 273 -----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 273 -----------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 1246789999999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.81 Aligned_cols=192 Identities=30% Similarity=0.488 Sum_probs=167.2
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|.+.+.||+|+||.||+|++..+++.||||+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 345799999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++...... .
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~ 170 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E 170 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--c
Confidence 4679999999999999999999999999999999999999999999876543 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.......+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 236 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP-------------- 236 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC--------------
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC--------------
Confidence 334568899999999998754457899999999999999999999999888877777755322111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++++.+||.+||..||.+|||+.+||+||||+..
T Consensus 237 ---------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 ---------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 2467889999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.91 Aligned_cols=193 Identities=27% Similarity=0.409 Sum_probs=153.3
Q ss_pred CCCeeEE-EEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
.++|.++ +.||+|+||+||+|++..+++.||||+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 3578887 789999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||.|||+++|+||||||+||||+. ++.+||+|||++......
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-- 217 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 217 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence 4568999999999999999999999999999987 788999999999865432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH----HHHHHHHhcCCCCchhhhccCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE----QLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e----~l~~i~~~~g~pp~~~~~~~~l 292 (634)
......++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+..... ....+.......+.
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~-------- 288 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-------- 288 (400)
T ss_dssp ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT--------
T ss_pred CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC--------
Confidence 22345678999999999876 678999999999999999999999997654322 22333221111111
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+..+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 289 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 -----------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1124678999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=298.91 Aligned_cols=191 Identities=34% Similarity=0.506 Sum_probs=167.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||+|++..++..||+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 579999999999999999999999999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCCCCCcc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||||+|||+ +.++.++|+|||++....... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~ 166 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMR 166 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--chh
Confidence 46799999999999999999999999999999 778899999999998665432 234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+|+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+......++...|
T Consensus 167 ~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 231 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------- 231 (277)
T ss_dssp CCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-------------
T ss_pred ccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-------------
Confidence 5578999999999865 4899999999999999999999999999988888888765544443322
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 232 ------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 232 ------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 4678999999999999999999999999999999763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.26 Aligned_cols=194 Identities=28% Similarity=0.440 Sum_probs=148.0
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
...++|++++.||+|+||+||++++..+++.||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 345799999999999999999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc--eEEeccccccccCCCCCCCc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~~~~ 219 (634)
++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...... ...
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~ 174 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 174 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCC
Confidence 4678999999999999999999999999999987765 999999998744322 222
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChH----HHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV----EQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~----e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
...++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.... ..+..+.......+.
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 243 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD----------- 243 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT-----------
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC-----------
Confidence 45578999999999987444445599999999999999999999875543 233333221111110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
...+++.+.+||.+||..||.+|||+.|||+||||...
T Consensus 244 ----------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 244 ----------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ----------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ----------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 12578899999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.75 Aligned_cols=193 Identities=30% Similarity=0.516 Sum_probs=168.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence 45799999999999999999999999999999 567899999999998765432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.....++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 184 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 251 (484)
T 3nyv_A 184 -KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW--------- 251 (484)
T ss_dssp -SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG---------
T ss_pred -ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc---------
Confidence 3355678999999999975 5899999999999999999999999999999888888765443332222
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
..+++.+.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 252 ----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 252 ----------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ----------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ----------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 45789999999999999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=324.51 Aligned_cols=191 Identities=26% Similarity=0.495 Sum_probs=165.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 589999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec---CCCceEEeccccccccCCCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++...... ..
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TK 179 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--Cc
Confidence 457899999999999999999999999999995 4567999999999866543 22
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...|
T Consensus 180 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 246 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW----------- 246 (486)
T ss_dssp --CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG-----------
T ss_pred cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc-----------
Confidence 345678999999999975 5899999999999999999999999999998888888665433332222
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 247 --------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 247 --------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp --------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred --------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 4578999999999999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.39 Aligned_cols=192 Identities=31% Similarity=0.485 Sum_probs=165.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||.|+||.||+|++..+|+.||||+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999999999999993
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 4568999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCCCcccccC-----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 215 HRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~-----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
. .....++|+.|+|||++.+ ...++.++|||||||++|+|++|.+||........+..+......++...
T Consensus 254 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--- 328 (365)
T 2y7j_A 254 E--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE--- 328 (365)
T ss_dssp C--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH---
T ss_pred c--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc---
Confidence 2 2345678999999999853 23578899999999999999999999999888887777766443333222
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 329 ----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 ----------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ----------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 2467889999999999999999999999999999973
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.56 Aligned_cols=192 Identities=27% Similarity=0.452 Sum_probs=163.4
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|++.++||+|+||+||+|++..+++.||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 58899999999999999999999999999995
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 225 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt 225 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++....... .......+|
T Consensus 126 ~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 204 (321)
T 2c30_A 126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGT 204 (321)
T ss_dssp SCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSC
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccccCC
Confidence 46789999999999999999999999999999999999999999997665432 223456789
Q ss_pred ccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCC
Q 006714 226 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 305 (634)
Q Consensus 226 ~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~ 305 (634)
+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+.+..+........
T Consensus 205 ~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------- 261 (321)
T 2c30_A 205 PYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL---------------------- 261 (321)
T ss_dssp GGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------------------
T ss_pred ccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc----------------------
Confidence 99999999876 6789999999999999999999999998887777666644211000
Q ss_pred chhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 306 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 306 ~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....+++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 262 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 262 ----KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 00134688899999999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=313.95 Aligned_cols=225 Identities=21% Similarity=0.283 Sum_probs=159.7
Q ss_pred ccCCCeeEEEEeccc--CceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 127 LRADAFEKLEKIGQG--TYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G--~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
...++|+++++||+| +||+||+|++..+++.||||+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345799999999999 999999999999999999995
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 4568999999999999999999999999999999999999999987543211
Q ss_pred C------CCCcccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCC------
Q 006714 215 H------RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS------ 281 (634)
Q Consensus 215 ~------~~~~~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~------ 281 (634)
. .......++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+....+.+..++.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1 1122334779999999999763 46899999999999999999999999887665555444321110
Q ss_pred --CCchhhhcc-CCCCc----ccCC----CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 282 --PPDDYWKKS-KLPHA----TLFK----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 282 --pp~~~~~~~-~l~~~----~~~~----~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+........ ..... .... ...............+++.+.+||.+||++||.+|||+.|||+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000000000 00000 0000 000000111123356789999999999999999999999999999998764
Q ss_pred C
Q 006714 351 Y 351 (634)
Q Consensus 351 ~ 351 (634)
.
T Consensus 342 ~ 342 (389)
T 3gni_B 342 R 342 (389)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=299.01 Aligned_cols=189 Identities=28% Similarity=0.429 Sum_probs=155.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.++||+|+||+||+|++..++..||+|+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 689999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||| +.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 45689999999999999999999999999999 445789999999997654332
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......+|+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+........
T Consensus 182 --~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 245 (285)
T 3is5_A 182 --HSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------------ 245 (285)
T ss_dssp -------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred --cCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc------------
Confidence 234557899999999885 4688999999999999999999999999887776665543221111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.....+++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 246 --------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 --------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011346889999999999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.58 Aligned_cols=191 Identities=30% Similarity=0.496 Sum_probs=165.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+++.||||+
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 589999999999999999999999999999873
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEecccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGL 207 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGl 207 (634)
+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 456899999999999999999999999999998776 699999999
Q ss_pred ccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhh
Q 006714 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 208 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~ 287 (634)
+...... ......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 196 a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~- 270 (504)
T 3q5i_A 196 SSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND- 270 (504)
T ss_dssp CEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-
T ss_pred CEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc-
Confidence 9876543 23355678999999999864 589999999999999999999999999999888888876543333322
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+..+++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 271 ------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 271 ------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp ------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 25688999999999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.89 Aligned_cols=191 Identities=25% Similarity=0.322 Sum_probs=140.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|.+.++||+|+||+||+|++ +|+.||||+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4799999999999999999997 689999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHC--------CceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~--------gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.|++.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 356899999999999987 999999999999999999999999999986543
Q ss_pred CCC---CCcccccccccCCCcccccCCC-----CCCCccccccchhhHHHHhhCCCCCCCCCh--------------HHH
Q 006714 214 GHR---QPLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE--------------VEQ 271 (634)
Q Consensus 214 ~~~---~~~~~~~gt~~Y~APE~l~~~~-----~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--------------~e~ 271 (634)
... ......+||+.|||||++.+.. .|+.++|||||||+||||++|.+||..... .+.
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 322 1223467999999999997532 356789999999999999999887643221 111
Q ss_pred HHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 272 l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+...+...+ +++..+. .. .....+..+.+||.+||+.||.+|||+.||++.
T Consensus 241 ~~~~~~~~~-----------------~rp~~p~--~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 241 MRKVVCEQK-----------------LRPNIPN--RW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHTTSC-----------------CCCCCCG--GG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccc-----------------CCCCCCc--cc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111111000 0000000 00 001234578899999999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=313.61 Aligned_cols=190 Identities=29% Similarity=0.415 Sum_probs=158.8
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|...+.||+|+||.||+|++..+++.||+|+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3446789999999999999999999999985
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee--cCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl--~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.||.|||+++|+||||||+|||| +.++.+||+|||++....... .....
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 35688999999999999999999999999999 567789999999998765432 23445
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 302 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~ 302 (634)
++|+.|+|||++.. ..++.++|||||||+||+|++|.+||.+.+..+.+..+......++..
T Consensus 249 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~----------------- 310 (373)
T 2x4f_A 249 FGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE----------------- 310 (373)
T ss_dssp CSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-----------------
T ss_pred cCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-----------------
Confidence 78999999999875 678899999999999999999999999999998888887754333322
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 303 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 303 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 311 --------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 311 --------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 235678999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.97 Aligned_cols=190 Identities=31% Similarity=0.493 Sum_probs=164.2
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 445799999999999999999999999999999984
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 45689999999999999999999999999999999999999999987654321
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+.......
T Consensus 169 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 231 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF--------------- 231 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---------------
T ss_pred -cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC---------------
Confidence 234578999999999876 568899999999999999999999999888877776665421111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 232 --------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 --------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp --------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 13478899999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=322.98 Aligned_cols=191 Identities=30% Similarity=0.533 Sum_probs=163.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..++..||||+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 479999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC---CceEEeccccccccCCCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+||||||+||||+.. +.+||+|||++...... ..
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~~ 194 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KK 194 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--BC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--cc
Confidence 45689999999999999999999999999999764 45999999999876543 23
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 195 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 261 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW----------- 261 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG-----------
T ss_pred ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc-----------
Confidence 355678999999999864 6899999999999999999999999999999888888775544443332
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++.+.+||.+||.+||.+|||+.++|+||||+..
T Consensus 262 --------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 262 --------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp --------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred --------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 4678999999999999999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.71 Aligned_cols=161 Identities=27% Similarity=0.430 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCC--ceEEeccccccccCCC---CCCCcccccccccCCCcccccCC-CC
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGA-TD 239 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~-~~ 239 (634)
++.||+.||.|||+++|+|+||||+||||+.++ .+||+|||++...... .........+|+.|+|||++.+. ..
T Consensus 173 i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 788999999999999999999999999998776 8999999999754321 11223456789999999998642 56
Q ss_pred CCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHH
Q 006714 240 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 319 (634)
Q Consensus 240 ~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l 319 (634)
++.++|||||||++|+|++|..||.+.+..+.+..+......++.. .+..+++.+
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~ 307 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLA 307 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHH
Confidence 8899999999999999999999999999888888877643333221 123578899
Q ss_pred HHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 320 VNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 320 ~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.+||.+||..||.+|||+.++|+||||+....
T Consensus 308 ~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 308 RDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999999999999999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.14 Aligned_cols=194 Identities=31% Similarity=0.509 Sum_probs=157.5
Q ss_pred CCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH-------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++. .+++.||||+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 5889999985
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 4568899999999999999999999999999999999999999999866433
Q ss_pred CCCCcccccccccCCCcccccC-CCCCCCccccccchhhHHHHhhCCCCCCCCCh----HHHHHHHHHhcCCCCchhhhc
Q 006714 215 HRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~-~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~----~e~l~~i~~~~g~pp~~~~~~ 289 (634)
........++|+.|+|||++.+ ...++.++|||||||+||+|++|..||..... ......+......
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 284 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-------- 284 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--------
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC--------
Confidence 3333345678999999999975 24578999999999999999999999975432 2333333221100
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
....++..+.+||.+||..||.+|| |+.|+|+||||....|
T Consensus 285 ---------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 285 ---------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 0135788899999999999999999 9999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.14 Aligned_cols=193 Identities=32% Similarity=0.523 Sum_probs=140.8
Q ss_pred CCeeEE---EEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 130 DAFEKL---EKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~---~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
++|++. +.||+|+||+||+|++..+++.||||+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 367776 789999999999999999999999996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccccccccCCCCCCCc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|||++....... ...
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 467999999999999999999999999999997765 79999999998654332 233
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh-------HHHHHHHHHhcCCCCchhhhccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-------VEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-------~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
...++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||..... .+.+..+......++.+
T Consensus 167 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------- 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE------- 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH-------
T ss_pred cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc-------
Confidence 45677999999999876 6789999999999999999999999986543 34444443322222222
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 239 ------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 224688999999999999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.38 Aligned_cols=191 Identities=30% Similarity=0.480 Sum_probs=165.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 589999999999999999999999999999985
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCCCCCcc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++...... ...
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~ 165 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMS 165 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTH
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccc
Confidence 45689999999999999999999999999999 77889999999998754432 234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+......++..
T Consensus 166 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------- 229 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP--------------- 229 (304)
T ss_dssp HHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT---------------
T ss_pred cccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------
Confidence 4568999999999876 678999999999999999999999999988888877776643322211
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 230 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 230 ----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ----------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 124678999999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.91 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=152.0
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++++.||+|+||+||++.+ .+++.||||+
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 345567899999999999999999997 4688999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+||||+ ++.+||+|||++.......
T Consensus 83 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 456899999999999999999999999999996 6789999999998665332
Q ss_pred CC-CcccccccccCCCcccccC----------CCCCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCC
Q 006714 216 RQ-PLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPP 283 (634)
Q Consensus 216 ~~-~~~~~~gt~~Y~APE~l~~----------~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp 283 (634)
.. .....++|+.|+|||++.+ ...++.++|||||||++|+|++|++||..... ...+..++......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 240 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 240 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc-
Confidence 21 2345678999999999853 24678899999999999999999999987543 33333332211000
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 284 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
......+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 241 --------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 241 --------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp --------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred --------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 00123567899999999999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=324.41 Aligned_cols=195 Identities=28% Similarity=0.481 Sum_probs=165.0
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++++.||+|+||.||+|+++.+++.||||+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 4667899999999999999999999999999999985
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 34578999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC----hHHHHHHHHHhcCCCCchhhh
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~----~~e~l~~i~~~~g~pp~~~~~ 288 (634)
... ......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.. ..+....+.......
T Consensus 341 ~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~------ 412 (543)
T 3c4z_A 341 AGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY------ 412 (543)
T ss_dssp TTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC------
T ss_pred CCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC------
Confidence 432 22344589999999999987 678999999999999999999999998753 344444444321111
Q ss_pred ccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 289 ~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
...+++.+.+||.+||..||.+||+ +.+|++||||+...|
T Consensus 413 -----------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 413 -----------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp -----------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred -----------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 1357899999999999999999996 589999999998655
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=331.35 Aligned_cols=194 Identities=27% Similarity=0.509 Sum_probs=163.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++++.||+|+||.||+|++..+++.||||+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 4667899999999999999999999999999999985
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 4568899999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh----HHHHHHHHHhcCCCCchhhhcc
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~----~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+... .+....+... +..
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~~----- 407 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEE----- 407 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CCC-----
T ss_pred c--cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----ccc-----
Confidence 2 2345689999999999976 6789999999999999999999999987542 2333333221 100
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
....+++++.+||.+||..||.+|| ++.||++||||+...|
T Consensus 408 --------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 408 --------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred --------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 0135789999999999999999999 8999999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.84 Aligned_cols=191 Identities=30% Similarity=0.456 Sum_probs=155.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||.||+|.+..+++.||||+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 34799999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 45689999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....+++.|+|||++.+...++.++|||||||++|+|++|..||........+..+.......+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 231 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--------------- 231 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc---------------
Confidence 23456799999999998744446899999999999999999999998877776666644221111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 232 --------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 232 --------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 2467889999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.06 Aligned_cols=194 Identities=27% Similarity=0.429 Sum_probs=152.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 3689999999999999999999999999999974
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEeccccccccC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSN 212 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||+++|+||||||+||||+.++ .+||+|||++....
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 467899999999999999999999999999996544 59999999998765
Q ss_pred CCCCCCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHH-HHHHhcCCCCchhhhc
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KIFKLCGSPPDDYWKK 289 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~-~i~~~~g~pp~~~~~~ 289 (634)
.. ......++|+.|+|||++.+ ...|+.++|||||||++|+|++|.+||........+. .+........
T Consensus 294 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~------ 365 (419)
T 3i6u_A 294 ET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI------ 365 (419)
T ss_dssp -------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC------
T ss_pred CC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC------
Confidence 43 22345678999999999853 3567889999999999999999999998654433222 2322111111
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+.+..+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 366 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 -------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp -------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred -------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 22335688999999999999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.13 Aligned_cols=195 Identities=25% Similarity=0.375 Sum_probs=151.3
Q ss_pred CCeeEE-EEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
+.|++. +.||+|+||+||+|++..+++.||||+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 689996 789999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc---eEEeccccccccCCCC---
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH--- 215 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~---vkL~DFGla~~~~~~~--- 215 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++. +||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 4568999999999999999999999999999988765 9999999987543211
Q ss_pred ---CCCcccccccccCCCcccccCC----CCCCCccccccchhhHHHHhhCCCCCCCCCh---------------HHHHH
Q 006714 216 ---RQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------------VEQLH 273 (634)
Q Consensus 216 ---~~~~~~~~gt~~Y~APE~l~~~----~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---------------~e~l~ 273 (634)
.......++|+.|+|||++... ..++.++|||||||++|+|++|.+||.+... ...+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 1112345689999999998631 3478899999999999999999999987542 22333
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+.......+. ..+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 252 ~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 252 SIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 33332211111 1224678999999999999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=294.37 Aligned_cols=195 Identities=31% Similarity=0.438 Sum_probs=166.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||+|++..+++.||||+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4799999999999999999999999999999983
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 45689999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccCCCccccc-----CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhh
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~ 287 (634)
... ......+++.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+......++..
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 251 (298)
T 1phk_A 176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP-- 251 (298)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc--
Confidence 432 234557899999999885 23567899999999999999999999999988887777776543322211
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 252 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 252 -----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp -----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred -----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1235788999999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.61 Aligned_cols=188 Identities=30% Similarity=0.495 Sum_probs=161.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++++.||+|+||+||+|++..+++.||||+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 469999999999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++...... .
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----~ 208 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 208 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----C
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----C
Confidence 4568999999999999999999999999999999999999999999765432 3
Q ss_pred cccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 221 SRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
..++|+.|+|||++.. ...++.++|||||||++|||++|.+||...+..+.+..+........
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 273 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--------------- 273 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Confidence 4578999999999852 35688999999999999999999999998887777766654211100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 274 ------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 274 ------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 013567889999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.85 Aligned_cols=193 Identities=26% Similarity=0.411 Sum_probs=158.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||+|++..+++.||||+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 589999999999999999999999999999985
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-CCCccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTS 221 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~ 221 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 56799999999999999999999999999999999999999999997653221 122345
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH-HHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e-~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..+++.|+|||++.+...++.++|||||||++|+|++|..||....... .+..+.......
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 228 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------------ 228 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS------------------
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc------------------
Confidence 5789999999999764445778999999999999999999998765432 222222110000
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 229 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0123578899999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.72 Aligned_cols=195 Identities=26% Similarity=0.408 Sum_probs=159.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4789999999999999999999999999999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 45689999999999999999999999999999999999999999997654322
Q ss_pred C--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. ......++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......++
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 239 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 239 (311)
T ss_dssp -----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH----------
T ss_pred cccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc----------
Confidence 1 22234568999999999986 5789999999999999999999999999888777766655332222
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......+++++.+||.+||..||.+||++.++|.|+|+...
T Consensus 240 ---------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 12235688999999999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.94 Aligned_cols=190 Identities=34% Similarity=0.532 Sum_probs=136.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4689999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........ .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 168 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-K 168 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-c
Confidence 456899999999999999999999999999999999999999999986643221 2
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+.+..+...
T Consensus 169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 227 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-------------------- 227 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--------------------
T ss_pred ceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--------------------
Confidence 234567999999999876 56889999999999999999999999875543322221100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.. .....++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 228 --~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 --DY-------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp --CC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred --cc-------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 0113478899999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.46 Aligned_cols=192 Identities=28% Similarity=0.440 Sum_probs=161.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 589999999999999999999999999999884
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC----ceEEeccccccccCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 213 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 456899999999999999999999999999998877 799999999986643
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 165 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 232 (283)
T 3bhy_A 165 GN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE--------- 232 (283)
T ss_dssp ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH---------
T ss_pred CC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc---------
Confidence 32 2244568999999999876 67899999999999999999999999998888777776543322221
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 233 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 233 ----------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp ----------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 2235678899999999999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.46 Aligned_cols=183 Identities=23% Similarity=0.407 Sum_probs=155.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 589999999999999999999999999999984
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 4569999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
. .....++|+.|+|||++.+...++.++|||||||++|+|++|..||..... +.....
T Consensus 184 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~-------------- 241 (335)
T 3dls_A 184 K--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI-------------- 241 (335)
T ss_dssp C--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC--------------
T ss_pred C--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc--------------
Confidence 2 234567899999999998744458899999999999999999999965221 000000
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 242 ---------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 242 ---------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ---------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ---------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0012478899999999999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.27 Aligned_cols=193 Identities=27% Similarity=0.464 Sum_probs=152.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
..+|++++.||+|+||+||+|.+.. ++.||||+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3579999999999999999999865 88999985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~ 218 (634)
+..|+.||+.||.|||+++|+||||||+||||+ ++.+||+|||++........ ..
T Consensus 134 v~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 134 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp EEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 356889999999999999999999999999995 58999999999986653322 12
Q ss_pred cccccccccCCCcccccCC----------CCCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCCchhh
Q 006714 219 LTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~----------~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp~~~~ 287 (634)
....++|+.|+|||++.+. ..|+.++||||||||||+|++|.+||..... ...+..++.......
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~---- 288 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE---- 288 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC----
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC----
Confidence 3456789999999998641 3588999999999999999999999987543 344444432111000
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 289 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 289 -----------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -----------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -----------------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0123467899999999999999999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=294.89 Aligned_cols=195 Identities=29% Similarity=0.442 Sum_probs=165.8
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|++..+++.||+|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34689999999999999999999999999999884
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 171 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ER 171 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-cc
Confidence 45689999999999999999999999999999999999999999998664322 22
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.+..+.......
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 234 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---------------- 234 (294)
T ss_dssp BCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----------------
T ss_pred cccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC----------------
Confidence 344568999999999876 568899999999999999999999999888777666654321111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
...+++.+.+||.+||..||.+|||+.++|+||||.....+.
T Consensus 235 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 235 -------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred -------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 134678899999999999999999999999999998865543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.64 Aligned_cols=194 Identities=27% Similarity=0.362 Sum_probs=163.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||+|++..+++.||+|+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 3689999999999999999999999999999974
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 45688999999999999999999999999999999999999999998654321
Q ss_pred -CCCcccccccccCCCcccccCCC-CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 -RQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 -~~~~~~~~gt~~Y~APE~l~~~~-~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
........+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 232 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI----------- 232 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC-----------
Confidence 12223456799999999987532 24679999999999999999999999988777776665421111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
...+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 233 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 233 ------------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ------------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ------------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 1357888999999999999999999999999999987644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.51 Aligned_cols=191 Identities=22% Similarity=0.358 Sum_probs=157.2
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
....|++.+.||+|+||+||+|.+..++..||+|+
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34579999999999999999999999999999874
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceec-CCCceEEeccccccccC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~-~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||+++ |+|+||||+||||+ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 4568999999999999999 99999999999997 78899999999997654
Q ss_pred CCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.....+.
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 249 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--------- 249 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG---------
T ss_pred cc---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc---------
Confidence 32 2345578999999998864 589999999999999999999999988665554444332211110
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 250 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 250 -----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -----------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 1113467889999999999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=300.91 Aligned_cols=192 Identities=30% Similarity=0.447 Sum_probs=164.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||++++..+++.||+|+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3589999999999999999999999999999885
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++....... ...
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-ccc
Confidence 45689999999999999999999999999999999999999999998664322 223
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.+..+.......
T Consensus 199 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 260 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI----------------- 260 (335)
T ss_dssp CCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----------------
T ss_pred cccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC-----------------
Confidence 44578999999999976 568899999999999999999999999888777666664422111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
...+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 261 ------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 261 ------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 1346788999999999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.40 Aligned_cols=184 Identities=23% Similarity=0.337 Sum_probs=150.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 589999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-------------------
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE------------------- 197 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~------------------- 197 (634)
++.++.||+.||.|||+++|+|+||||+||||+.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 45689999999999999999999999999999844
Q ss_pred CceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHH
Q 006714 198 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277 (634)
Q Consensus 198 g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~ 277 (634)
..++|+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++..... ...+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~ 242 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQ 242 (289)
T ss_dssp CCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHT
T ss_pred eEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHc
Confidence 47999999999876542 2345799999999998755677899999999999999999988755432 222221
Q ss_pred hcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 278 ~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.. .+ .....+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 243 ~~--~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GR--LP--------------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TC--CC--------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CC--CC--------------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 10 00 0113578899999999999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.90 Aligned_cols=205 Identities=27% Similarity=0.418 Sum_probs=150.6
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3456899999999999999999999998999999985
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 345788999999999999999999999999999999999999999876
Q ss_pred cCCCCC----CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchh
Q 006714 211 SNTGHR----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 286 (634)
Q Consensus 211 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~ 286 (634)
...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||........+.............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 249 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET- 249 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc-
Confidence 543211 112345679999999998653468899999999999999999999998877665554443221110000
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 287 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 287 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..........++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 250 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 ------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 001112235678999999999999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.35 Aligned_cols=192 Identities=28% Similarity=0.433 Sum_probs=156.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||.||+|++..+++.||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 589999999999999999999999999999983
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc---eEEeccccccccCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNT 213 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~---vkL~DFGla~~~~~ 213 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++. +||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 4568999999999999999999999999999987654 99999999987643
Q ss_pred CCCCCcccccccccCCCccccc--CCCCCCCccccccchhhHHHHhhCCCCCCCCChHH-HHHHHHHhcCCCCchhhhcc
Q 006714 214 GHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~--~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e-~l~~i~~~~g~pp~~~~~~~ 290 (634)
. .......+|+.|+|||++. ....++.++|||||||++|+|++|.+||....... ....+.......
T Consensus 170 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 239 (322)
T 2ycf_A 170 T--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-------- 239 (322)
T ss_dssp C--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC--------
T ss_pred c--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc--------
Confidence 2 1223456799999999974 34568899999999999999999999997654332 222232211111
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 -----------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 -----------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 11233568899999999999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=296.97 Aligned_cols=153 Identities=27% Similarity=0.436 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-----------CCcccccccccCCCccc
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----------QPLTSRVVTLWYRPPEL 233 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~APE~ 233 (634)
.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++........ ......++|+.|+|||+
T Consensus 168 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 247 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247 (332)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHH
T ss_pred HHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHH
Confidence 4788999999999999999999999999999999999999999987654321 12234578999999999
Q ss_pred ccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcC
Q 006714 234 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 313 (634)
Q Consensus 234 l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 313 (634)
+.+ ..++.++|||||||++|+|++|..++.. ....+..+.. ...+ ..+.
T Consensus 248 ~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~--------------------------~~~~ 296 (332)
T 3qd2_B 248 IHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFP--------------------------LLFT 296 (332)
T ss_dssp HHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCC--------------------------HHHH
T ss_pred hcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCC--------------------------cccc
Confidence 986 6789999999999999999998766421 1111111111 1111 1112
Q ss_pred CCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 314 DLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 314 ~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 297 QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 34677899999999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.91 Aligned_cols=195 Identities=28% Similarity=0.465 Sum_probs=156.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||.||+|++..+++.||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 35789999999999999999999999999999995
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 356889999999999999999999999999999999999999999876543
Q ss_pred CCCCCcccccccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.. .......+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.......
T Consensus 182 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 253 (326)
T 2x7f_A 182 TV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR------- 253 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred Cc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc-------
Confidence 21 12234568999999999862 2568899999999999999999999998887776665554321100
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....++..+.+||.+||..||.+|||+.++|+||||+..+
T Consensus 254 --------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 254 --------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp --------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred --------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 00135788999999999999999999999999999998743
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=291.08 Aligned_cols=191 Identities=26% Similarity=0.477 Sum_probs=162.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 589999999999999999999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC---CceEEeccccccccCCCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++....... .
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--~ 179 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--K 179 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--S
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--c
Confidence 45689999999999999999999999999999654 469999999998665432 2
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
.....+++.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 180 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 243 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-------------- 243 (287)
T ss_dssp CSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------------
T ss_pred cccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--------------
Confidence 234567999999999875 4889999999999999999999999998888777776553222211
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 -----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -----------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1124678999999999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.98 Aligned_cols=182 Identities=19% Similarity=0.234 Sum_probs=149.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------H-------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------I------------- 163 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------i------------- 163 (634)
.++|++.+.||+|+||+||+|++..+++.||||+ |
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4789999999999999999999999999999985 1
Q ss_pred ---------------------------------------------------------HHHHHHHHHHHHHHHHCCceecc
Q 006714 164 ---------------------------------------------------------KCYMNQLLHGLEHCHSRGVLHRD 186 (634)
Q Consensus 164 ---------------------------------------------------------~~i~~Qll~aL~yLHs~gIvHrD 186 (634)
..|+.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 12678999999999999999999
Q ss_pred CCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCC----------CCCCCccccccchhhHHHH
Q 006714 187 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAEL 256 (634)
Q Consensus 187 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------~~~s~~sDIWSLG~iLyeL 256 (634)
|||+||||+.++.+||+|||++..... .....++ +.|+|||++.+. ..|+.++|||||||+||||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999986432 2345567 999999999763 2689999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC
Q 006714 257 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336 (634)
Q Consensus 257 ltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT 336 (634)
++|++||.+......+..+ ......+++++.+||.+||..||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999764422211111 1112467899999999999999999999
Q ss_pred HHHHHhccccCC
Q 006714 337 ASAALASEYFST 348 (634)
Q Consensus 337 a~elL~hpwf~~ 348 (634)
+.++|+||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.99 Aligned_cols=194 Identities=30% Similarity=0.462 Sum_probs=157.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 4689999999999999999999999999999995
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .......
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 186 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVI 186 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCccC
Confidence 45689999999999999999999999999999999999999999997654322 2234456
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
+++.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+........
T Consensus 187 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 245 (314)
T 3com_A 187 GTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-------------------- 245 (314)
T ss_dssp SCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------------------
T ss_pred CCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc--------------------
Confidence 7999999999876 5689999999999999999999999988777665554433210000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 246 ------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 246 ------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00134678899999999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.04 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=135.3
Q ss_pred CCCeeEEE-EecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKLE-KIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~-~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
.++|++++ .||+|+||+||+|++..+++.||||+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 46899976 59999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++......
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-- 184 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-- 184 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence 4679999999999999999999999999999976 455999999999765432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+........
T Consensus 185 -~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 249 (336)
T 3fhr_A 185 -ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ------------- 249 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------------
T ss_pred -ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc-------------
Confidence 2244567999999999865 5688899999999999999999999977654433222111100000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+ ......+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 250 -~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 -Y-------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -c-------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0 00001124678999999999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.63 Aligned_cols=192 Identities=29% Similarity=0.471 Sum_probs=149.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 579999999999999999999999999999985
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 345889999999999999999999999999999999999999999976
Q ss_pred cCCCC-------------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC-CChHHHHHHHH
Q 006714 211 SNTGH-------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIF 276 (634)
Q Consensus 211 ~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~e~l~~i~ 276 (634)
..... ........+++.|+|||++.+...++.++|||||||++|+|++ ||.. ....+.+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~ 242 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLR 242 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcc
Confidence 54211 1122445679999999999865578999999999999999998 4443 23333333333
Q ss_pred HhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......+.. .....+..+.+||.+||..||.+|||+.++|+||||...
T Consensus 243 ~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 243 SVSIEFPPD-------------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp STTCCCCTT-------------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred ccccccCcc-------------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 221111110 113567889999999999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=302.30 Aligned_cols=220 Identities=24% Similarity=0.332 Sum_probs=159.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 4556899999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+. +|+|+||||+||||+.++.++|+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 456899999999999996 9999999999999999999999999998654321
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcC-CCCchhhhccCC--CC
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG-SPPDDYWKKSKL--PH 294 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g-~pp~~~~~~~~l--~~ 294 (634)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+..... ......+..... ..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1234578999999999976 6789999999999999999999999988776554433321111 111100000000 00
Q ss_pred cccCCCCCCCC---chhh---------hhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 295 ATLFKPQQPYD---SSLR---------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 295 ~~~~~~~~~~~---~~l~---------~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
........+.. ..+. .....++.++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000000000 0000 0012468899999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.00 Aligned_cols=194 Identities=24% Similarity=0.388 Sum_probs=146.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|++..+++.||||+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 34689999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++....... .
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 180 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--A 180 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--c
Confidence 456899999999999995 99999999999999999999999999997654322 2
Q ss_pred cccccccccCCCccccc----CCCCCCCccccccchhhHHHHhhCCCCCCCC-ChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 219 LTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~----~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~-~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.....+++.|+|||++. ....++.++|||||||++|+|++|..||... ...+.+..+........
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 250 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL---------- 250 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC----------
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC----------
Confidence 23456899999999985 2356789999999999999999999999874 45555555544211100
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+++.+.+||.+||..||.+|||+.+||+||||+..
T Consensus 251 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 ----------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ----------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ----------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0013578899999999999999999999999999999763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.12 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=156.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 3689999999999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 456899999999999999999999999999999999999999999987654433334
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....++... .+
T Consensus 170 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~---------------- 230 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS--VP---------------- 230 (294)
T ss_dssp -----CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC--CC----------------
T ss_pred CccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc--CC----------------
Confidence 45678999999999987 668999999999999999999999999988776655544321 11
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.........+++.+.+||.+||..||.+||+..+.|.+.|..-
T Consensus 231 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 ------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp ------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0112233568899999999999999999997777777777654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.05 Aligned_cols=194 Identities=27% Similarity=0.435 Sum_probs=158.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 3689999999999999999999999999999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .....
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 176 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDS 176 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC---
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccccc
Confidence 45689999999999999999999999999999999999999999875321110 11133
Q ss_pred ccccccCCCccccc----CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 222 RVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 222 ~~gt~~Y~APE~l~----~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
..+|+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 242 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-------------- 242 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------------
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--------------
Confidence 46789999999984 335688999999999999999999999998887777666654211100
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 243 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 243 ------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 0013467889999999999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=289.14 Aligned_cols=190 Identities=33% Similarity=0.514 Sum_probs=162.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++++.||+|+||+||+|++..+++.||||+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 579999999999999999999999999999995
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccccc
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .......
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 180 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFV 180 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCC
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCccC
Confidence 45789999999999999999999999999999999999999999997654322 2224457
Q ss_pred ccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+.... ++
T Consensus 181 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------------- 237 (303)
T 3a7i_A 181 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--PP-------------------- 237 (303)
T ss_dssp SCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC--------------------
T ss_pred CCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--CC--------------------
Confidence 8999999999976 678899999999999999999999999887776665553321 10
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 238 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0113578889999999999999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.33 Aligned_cols=184 Identities=27% Similarity=0.426 Sum_probs=155.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 4689999999999999999999999999999984
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec-CCCceEEeccccccccC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~-~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||+++|+|+||||+||||+ .++.+||+|||++....
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 456889999999999999999999999999998 77899999999998765
Q ss_pred CCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. ......+|+.|+|||++.+...++.++|||||||++|+|++|..||..... +.... .
T Consensus 202 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~--~---------- 260 (320)
T 3a99_A 202 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ--V---------- 260 (320)
T ss_dssp SS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC--C----------
T ss_pred cc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccc--c----------
Confidence 42 224456899999999987645457889999999999999999999975321 11100 0
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.....+++++.+||.+||..||.+|||+.+||+||||+...
T Consensus 261 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 261 -----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -----------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00135788999999999999999999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.11 Aligned_cols=196 Identities=22% Similarity=0.270 Sum_probs=153.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------H----------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------I---------------------- 163 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------i---------------------- 163 (634)
..|+++++||+|+||+||+|++..+++.||||+ +
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 469999999999999999999999999999984 0
Q ss_pred -------------------------------------------------------HHHHHHHHHHHHHHHHCCceeccCC
Q 006714 164 -------------------------------------------------------KCYMNQLLHGLEHCHSRGVLHRDIK 188 (634)
Q Consensus 164 -------------------------------------------------------~~i~~Qll~aL~yLHs~gIvHrDLK 188 (634)
..++.||+.||.|||+++|+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 1334899999999999999999999
Q ss_pred CCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccC-CCCCCCccccccchhhHHHHhhCCCCCCCCC
Q 006714 189 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRT 267 (634)
Q Consensus 189 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~ 267 (634)
|+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred HHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999866432 124456799999999964 2468999999999999999999999997654
Q ss_pred hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 268 ~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
... ...|......... . .......+..+++.+.+||.+||++||.+|||+.++|+||||+
T Consensus 298 ~~~-------------~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 298 PGI-------------KGSWKRPSLRVPG--T-----DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp TTC-------------TTCCCBCCTTSCC--C-----CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred ccc-------------ccchhhhhhhhcc--c-----cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 210 0001100000000 0 0001112347899999999999999999999999999999997
Q ss_pred CC
Q 006714 348 TK 349 (634)
Q Consensus 348 ~~ 349 (634)
..
T Consensus 358 ~~ 359 (371)
T 3q60_A 358 QL 359 (371)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.39 Aligned_cols=210 Identities=23% Similarity=0.357 Sum_probs=158.4
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.++||+|+||+||+|++..+++.||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 34689999999999999999999999999999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee----cCCCceEEecccccccc
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl----~~~g~vkL~DFGla~~~ 211 (634)
++.++.||+.||.|||+++|+|+||||+|||| +.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 45689999999999999999999999999999 77788999999999876
Q ss_pred CCCCCCCcccccccccCCCcccccC-------CCCCCCccccccchhhHHHHhhCCCCCCCCC----hHHHHHHHHHhcC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLG-------ATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCG 280 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~----~~e~l~~i~~~~g 280 (634)
.... ......+|+.|+|||++.. ...++.++|||||||++|||++|..||.... ..+.+..+...
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 242 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG-- 242 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--
Confidence 5432 2345578999999998852 2578999999999999999999999997533 34444444432
Q ss_pred CCCchhhhccCCCCccc--CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 281 SPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~--~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
.|...|.......... +....+... .....++..+.+||.+||.+||.+|||+.|+|+||-
T Consensus 243 -~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 -KPSGAISGVQKAENGPIDWSGDMPVSC---SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp -CCTTCCEEEECSTTCCEEEESSCCTTC---SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred -CCcccchhhhcccCCccccCccCCccc---ccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2222222211100000 000000000 111345678899999999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=311.10 Aligned_cols=181 Identities=17% Similarity=0.201 Sum_probs=150.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHHH----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI---------------------------------------------- 163 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i---------------------------------------------- 163 (634)
..|.+.+.||+|+||+||+|++..+++.||||++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4688999999999999999999999999999841
Q ss_pred --------------------------------------------------------HHHHHHHHHHHHHHHHCCceeccC
Q 006714 164 --------------------------------------------------------KCYMNQLLHGLEHCHSRGVLHRDI 187 (634)
Q Consensus 164 --------------------------------------------------------~~i~~Qll~aL~yLHs~gIvHrDL 187 (634)
..++.||+.||.|||+++|+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 124589999999999999999999
Q ss_pred CCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCccccc---------CCCCCCCccccccchhhHHHHhh
Q 006714 188 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---------GATDYGPSVDLWSVGCVFAELLI 258 (634)
Q Consensus 188 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~---------~~~~~s~~sDIWSLG~iLyeLlt 258 (634)
||+||||+.++.+||+|||++...... ....++ +.|+|||++. ....|+.++|||||||+||||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998765432 344567 9999999983 33557889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH
Q 006714 259 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338 (634)
Q Consensus 259 G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~ 338 (634)
|+.||...+..+....+ ......+++.+.+||.+||..||.+|||+.
T Consensus 313 g~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhhHHHH---------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999765432211111 111236789999999999999999999999
Q ss_pred HHHhccccCC
Q 006714 339 AALASEYFST 348 (634)
Q Consensus 339 elL~hpwf~~ 348 (634)
++|+||||+.
T Consensus 360 ~~l~~~~~~~ 369 (413)
T 3dzo_A 360 QAMETPEYEQ 369 (413)
T ss_dssp HHTTSHHHHH
T ss_pred HHHhCHHHHH
Confidence 9999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=285.84 Aligned_cols=193 Identities=30% Similarity=0.451 Sum_probs=161.3
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
...++|++++.||+|+||+||++++..+++.||+|+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 345799999999999999999999999999999985
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCC-----ceeccCCCCCceecCCCceEEecccc
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~g-----IvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 3568899999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhh
Q 006714 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 208 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~ 287 (634)
+....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----- 235 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----- 235 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-----
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-----
Confidence 97664321 11233467999999999976 568899999999999999999999999888777666665421100
Q ss_pred hccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 288 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....++..+.+||.+||..||.+|||+.|||+|+|+...
T Consensus 236 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 -----------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 013578899999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=284.63 Aligned_cols=191 Identities=22% Similarity=0.293 Sum_probs=156.7
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 34689999999999999999999999999999995
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc-----eEEeccccccccCCCCC-
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHR- 216 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~-----vkL~DFGla~~~~~~~~- 216 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++. +||+|||++........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 4679999999999999999999999999999987765 99999999986654322
Q ss_pred -----CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC---ChHHHHHHHHHhcCCCCchhhh
Q 006714 217 -----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 217 -----~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~---~~~e~l~~i~~~~g~pp~~~~~ 288 (634)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+. ...+.+..+......++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 241 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP----- 241 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-----
T ss_pred ccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-----
Confidence 12345578999999999876 66899999999999999999999999874 34444444433221111
Q ss_pred ccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 289 ~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.......+++.+.+||..||..||.+|||+.+|++.
T Consensus 242 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 242 -------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp -------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred -------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 223335788999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=287.97 Aligned_cols=193 Identities=23% Similarity=0.330 Sum_probs=151.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++ +++.||||+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 44567999999999999999999987 678899986
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 3468899999999999999 9999999999999999999999999997554
Q ss_pred CCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------- 259 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--------- 259 (309)
T ss_dssp ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC---------
T ss_pred ccc-cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------
Confidence 321 22345678999999999986 6689999999999999999999999998887777666543221111
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh--ccccCCC
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFSTK 349 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~--hpwf~~~ 349 (634)
....+++.+.+||.+||..||.+|||+.++++ .+++...
T Consensus 260 ------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 260 ------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11357889999999999999999999999998 6777653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-33 Score=287.90 Aligned_cols=189 Identities=23% Similarity=0.328 Sum_probs=151.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 3689999999999999999999999999999994
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCCC----
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~---- 216 (634)
+..++.||+.||.|||+++|+|+||||+|||| +.++.+||+|||++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 45789999999999999999999999999999 7888999999999986544322
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChH---HHHHHHHHhcCCCCchhhhccC
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~---e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+.......+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 238 (296)
T 4hgt_A 168 PYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-------- 238 (296)
T ss_dssp CCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--------
T ss_pred CCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--------
Confidence 12235578999999999986 56899999999999999999999999764322 22222222111111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.......+++.+.+||..||+.||.+|||+.++++
T Consensus 239 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 12223567899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-33 Score=287.43 Aligned_cols=184 Identities=27% Similarity=0.477 Sum_probs=151.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||+|++..+++.||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 4689999999999999999999999999999985
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec-CCCceEEeccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF 210 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~-~~g~vkL~DFGla~~ 210 (634)
+..++.||+.||.|||+++|+|+||||+|||++ .++.++|+|||++..
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 356899999999999999999999999999998 789999999999987
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
.... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.... .+......
T Consensus 190 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~--------- 251 (312)
T 2iwi_A 190 LHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH--------- 251 (312)
T ss_dssp CCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC---------
T ss_pred cccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC---------
Confidence 6543 23455689999999998764444568999999999999999999997532 11111000
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
....++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 252 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 252 --------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred --------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0135788999999999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=281.69 Aligned_cols=188 Identities=22% Similarity=0.315 Sum_probs=157.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|++. +++.||+|+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 455679999999999999999999987 467799986
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 456899999999999999999999999999999999999999999986654332233
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+........
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK--------------- 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---------------
T ss_pred cCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---------------
Confidence 44456788999999875 568999999999999999999 9999999888887777654321111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||.+||..||.+|||+.++++|
T Consensus 229 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 -------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12467889999999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=288.81 Aligned_cols=208 Identities=24% Similarity=0.423 Sum_probs=161.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||.||+|++ +++.||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 347999999999999999999998 889999873
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceec
Q 006714 163 ----------------------------------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVN 195 (634)
Q Consensus 163 ----------------------------------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~ 195 (634)
++.++.||+.||.|||+ +||+|+||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 35689999999999999 9999999999999999
Q ss_pred CCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCC-ccccccchhhHHHHhhCCCCCCCCCh-HHHHH
Q 006714 196 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP-SVDLWSVGCVFAELLIGKPILQGRTE-VEQLH 273 (634)
Q Consensus 196 ~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~-~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~ 273 (634)
.++.++|+|||++...... ......+++.|+|||++.+...++. ++|||||||++|+|++|.+||..... .+.+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999999999999865432 2345578999999999987445655 99999999999999999999998776 55555
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.+.......+.... ....+. ...........++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 264 ~i~~~~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 264 NIRTKNIEYPLDRN--------HFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHTSCCCCCCCSSS--------SSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHhccCcCCccchh--------hhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 55433222221100 000000 00111222356889999999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=282.22 Aligned_cols=189 Identities=23% Similarity=0.327 Sum_probs=153.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 4689999999999999999999999999999995
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCCC----
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHR---- 216 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~---- 216 (634)
+..++.||+.||.|||+++|+|+||||+|||| +.++.+||+|||++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 45689999999999999999999999999999 4788999999999986554322
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhccC
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.......+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 238 (296)
T 3uzp_A 168 PYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-------- 238 (296)
T ss_dssp CCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--------
T ss_pred ccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--------
Confidence 11245578999999999986 568999999999999999999999998643 2233333332211111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11223567899999999999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=286.33 Aligned_cols=198 Identities=28% Similarity=0.468 Sum_probs=151.1
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++++.||+|+||.||++++. +++.||||+
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 4555678999999999999999999985 588899985
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||+++ +.+||+|||++.......
T Consensus 102 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 4568899999999999999999999999999964 899999999997654322
Q ss_pred C-CCcccccccccCCCcccccCC----------CCCCCccccccchhhHHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCC
Q 006714 216 R-QPLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPP 283 (634)
Q Consensus 216 ~-~~~~~~~gt~~Y~APE~l~~~----------~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp 283 (634)
. .......+++.|+|||++.+. ..++.++|||||||++|+|++|..||..... ...+..+.......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 259 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 259 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc-
Confidence 1 122345689999999998641 3578899999999999999999999976543 33333332211000
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 284 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
......+..+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 260 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 260 --------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp --------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred --------------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 001235788999999999999999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=279.11 Aligned_cols=189 Identities=21% Similarity=0.269 Sum_probs=157.7
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++++.||+|+||+||++.+. ++..||+|+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 3456689999999999999999999876 566799985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 45789999999999999999999999999999999999999999998765443333
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+........
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 226 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-------------- 226 (268)
T ss_dssp CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--------------
T ss_pred ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC--------------
Confidence 334455778999999875 568899999999999999999 9999998888777766644221111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||..||+.||.+|||+.++|++
T Consensus 227 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 --------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12357889999999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=288.10 Aligned_cols=195 Identities=20% Similarity=0.277 Sum_probs=144.0
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCc---EEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~---------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++..++. .||||+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456799999999999999999999887765 788884
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEE
Q 006714 163 ----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 202 (634)
Q Consensus 163 ----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL 202 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 3458899999999999999999999999999999999999
Q ss_pred eccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcC
Q 006714 203 ADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 280 (634)
Q Consensus 203 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g 280 (634)
+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999976543221 12223445788999999876 568999999999999999999 9999998887777766654221
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-------HHHHHhccccCCC
Q 006714 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-------ASAALASEYFSTK 349 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-------a~elL~hpwf~~~ 349 (634)
.+ ....+++.+.+||.+||..||.+||| +++++.|+|+...
T Consensus 258 ~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 LK----------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CC----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CC----------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 11 01357889999999999999999999 7888999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=298.23 Aligned_cols=195 Identities=19% Similarity=0.311 Sum_probs=158.1
Q ss_pred cccCCCeeEEEEecccCceeEEEEE-----ECCCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~-----d~~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|+ +..+++.||||+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3455799999999999999999999 455778899995
Q ss_pred ------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC---ceEEe
Q 006714 163 ------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLA 203 (634)
Q Consensus 163 ------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g---~vkL~ 203 (634)
+..++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 345889999999999999999999999999998554 59999
Q ss_pred ccccccccCCC-CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCC
Q 006714 204 DFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 204 DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
|||++...... .........+|+.|+|||++.+ ..++.++|||||||+||||++ |.+||......+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999744211 1122234567899999999876 578999999999999999998 99999998888777776543211
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+ ...++..+.+||.+||+.||.+|||+.+||++.++-..
T Consensus 306 ~~----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 306 DP----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11 13578889999999999999999999999999887543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-33 Score=291.63 Aligned_cols=199 Identities=25% Similarity=0.395 Sum_probs=138.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|.+..+++.||||+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 4556899999999999999999999999999999995
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHC-CceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~-gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
+..++.||+.||.|||++ +|+|+||||+||||+.++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 346889999999999999 99999999999999999999999999997664
Q ss_pred CCCCCCcccccccccCCCccccc---CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~---~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||....... ..+.......+
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~------ 247 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVKGDP------ 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCC------
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhcCCC------
Confidence 322 223346899999999984 23568899999999999999999999997643211 11100000000
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+.. .......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 248 ----------~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 248 ----------PQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----------CCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------CCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 000 001124578999999999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=287.14 Aligned_cols=188 Identities=23% Similarity=0.301 Sum_probs=152.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3689999999999999999999999999999995
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc-----eEEeccccccccCCCCCC-
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHRQ- 217 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~-----vkL~DFGla~~~~~~~~~- 217 (634)
+..++.||+.||.|||+++|+||||||+||||+.++. +||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~ 167 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc
Confidence 4568999999999999999999999999999998887 999999999865432211
Q ss_pred -----CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhc
Q 006714 218 -----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 218 -----~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.....++|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.. ..+.+..+.......+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~------ 240 (330)
T 2izr_A 168 HIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP------ 240 (330)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC------
T ss_pred cccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC------
Confidence 1245678999999999987 678999999999999999999999998743 3344444433211111
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.......++ ++.+||..||..||.+||++.+|++
T Consensus 241 ------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111223455 8999999999999999999988875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=280.69 Aligned_cols=189 Identities=21% Similarity=0.308 Sum_probs=155.3
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++++.||+|+||+||++.+. ++..||+|+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3456679999999999999999999876 567899986
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..........
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 46789999999999999999999999999999999999999999998665432222
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........
T Consensus 178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------------- 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--------------
T ss_pred ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC--------------
Confidence 233455788999999876 568999999999999999998 9999999888877777755322111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||.+||..||.+|||+.++|+|
T Consensus 243 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 --------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12457889999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=282.26 Aligned_cols=193 Identities=32% Similarity=0.515 Sum_probs=151.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|.....||+|+||+||+|++..+++.||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 455556689999999999999999999999985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-CCceEEeccccccccCCCCCCCc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||||+||||+. ++.++|+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~ 180 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCT 180 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccc
Confidence 3457899999999999999999999999999987 8899999999997664322 122
Q ss_pred ccccccccCCCcccccCC-CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~-~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+++.|+|||++.+. ..++.++|||||||++|+|++|..||...................+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 245 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP--------------- 245 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC---------------
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc---------------
Confidence 345679999999998642 2378899999999999999999999976543322111111111110
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 246 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 246 -----------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -----------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -----------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0113578899999999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=286.32 Aligned_cols=188 Identities=19% Similarity=0.272 Sum_probs=152.5
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcE----EehHH----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKK---------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~----vAlK~---------------------------------------- 162 (634)
+..++|++++.||+|+||+||+|++..+++. ||+|.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL 89 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcc
Confidence 3457999999999999999999999888876 56553
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 46789999999999999999999999999999999999999999998765433
Q ss_pred CC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 RQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 238 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---------- 238 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC----------
T ss_pred ccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC----------
Confidence 22 2344566789999999976 568999999999999999999 9999998776666555543211100
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...++.++.+||.+||..||.+|||+.+++++
T Consensus 239 ------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 ------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12356678899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=281.57 Aligned_cols=189 Identities=23% Similarity=0.365 Sum_probs=144.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCC---CcEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~t---g~~vAlK~---------------------------------------- 162 (634)
++..++|++.+.||+|+||+||+|++..+ +..||+|+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 90 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence 44567999999999999999999998654 45688874
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 45688999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+......+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~------------ 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------ 237 (281)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------------
T ss_pred ccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC------------
Confidence 222333455788999999875 568899999999999999996 999999887777666664321100
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+++.+.+||.+||..||.+|||+.+++++
T Consensus 238 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 ----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 113578899999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=288.06 Aligned_cols=187 Identities=22% Similarity=0.346 Sum_probs=147.4
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEE----ehHH----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIV----ALKK---------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~v----AlK~---------------------------------------- 162 (634)
+..++|+++++||+|+||+||+|++..+++.| ++|.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCc
Confidence 34579999999999999999999998888765 5442
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 45689999999999999999999999999999999999999999998664322
Q ss_pred C-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 R-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 240 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---------- 240 (327)
T ss_dssp --------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC----------
T ss_pred ccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2 12233445788999999986 678999999999999999999 9999998877666555533211110
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...++.++.+||.+||..||.+|||+.|+|+
T Consensus 241 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 ------------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1346788999999999999999999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=285.77 Aligned_cols=188 Identities=22% Similarity=0.305 Sum_probs=154.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCc---EEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~---------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++..+++ .||||+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 3456799999999999999999999986655 499985
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 4568999999999999999999999999999999999999999999876543
Q ss_pred CCCC--cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 215 HRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 215 ~~~~--~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+......+.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 275 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-------- 275 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC--------
T ss_pred ccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC--------
Confidence 2211 122344778999999975 568899999999999999999 9999999888887777754321111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...+++.+.+||..||..||.+|||+.+|++
T Consensus 276 --------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 --------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1357889999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=288.26 Aligned_cols=188 Identities=22% Similarity=0.341 Sum_probs=149.1
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEE----ehHH----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIV----ALKK---------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~v----AlK~---------------------------------------- 162 (634)
+..++|+++++||+|+||+||+|++..+++.+ |+|.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 91 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 44578999999999999999999998887754 6553
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 45689999999999999999999999999999999999999999998664332
Q ss_pred C-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 R-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+......+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------- 239 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------- 239 (327)
T ss_dssp C-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------
T ss_pred ccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-----------
Confidence 2 12233455789999999986 678999999999999999999 999998877666555443321111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....++..+.+||.+||..||.+|||+.++|++
T Consensus 240 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 -----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 013467889999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=289.98 Aligned_cols=188 Identities=23% Similarity=0.336 Sum_probs=153.1
Q ss_pred ccCCCeeEEEEecccCceeEEEEEEC-------CCCcEEehHH-------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKK------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~-------~tg~~vAlK~------------------------------------- 162 (634)
+..++|++.+.||+|+||+||+|++. .++..||||+
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 44579999999999999999999974 3456799985
Q ss_pred --------------------H---------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceec
Q 006714 163 --------------------I---------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195 (634)
Q Consensus 163 --------------------i---------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~ 195 (634)
+ ..++.||+.||.|||+++|+||||||+||||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 1 23688999999999999999999999999999
Q ss_pred CCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHH
Q 006714 196 NEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 273 (634)
Q Consensus 196 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~ 273 (634)
.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+....+.+.
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986543222 22233456789999999986 678999999999999999999 999999887766665
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.+...... .....++..+.+||.+||..||.+|||+.|++++
T Consensus 317 ~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 317 LLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55332100 0113578899999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=279.16 Aligned_cols=188 Identities=19% Similarity=0.293 Sum_probs=158.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|.+..++..||+|+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4556799999999999999999999999999999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..........
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 45688999999999999999999999999999999999999999998766443333
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......+.......
T Consensus 169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 232 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--------------- 232 (288)
T ss_dssp ETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---------------
T ss_pred ccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---------------
Confidence 344456788999999876 568999999999999999999 999998877666555553321110
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||..||..||.+|||+.++++
T Consensus 233 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 233 -------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 11357889999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=277.60 Aligned_cols=191 Identities=21% Similarity=0.371 Sum_probs=145.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++.++||+|+||+||++++.. .||+|+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEE
Confidence 4556799999999999999999998643 478774
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC-CC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HR 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~ 216 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++...... ..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 4578999999999999999999999999999999999999999999755421 12
Q ss_pred CCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.......+|+.|+|||++.. ...++.++|||||||++|+|++|..||......+.+..+.......+.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 246 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD---------- 246 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC----------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc----------
Confidence 22344578999999999862 356788999999999999999999999887766666555443222110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+......+++.+.+||.+||..||.+|||+.++|+
T Consensus 247 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122467899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.55 Aligned_cols=185 Identities=24% Similarity=0.360 Sum_probs=151.2
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++.+.||+|+||+||+|++..+++.||+|+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 445799999999999999999999999999999994
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCc-----eEEecccc
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGV-----LKLADFGL 207 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~-----vkL~DFGl 207 (634)
+..++.||+.||.|||+++ |+|+||||+||||+.++. +||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 96 PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 4568999999999999999 999999999999987776 99999999
Q ss_pred ccccCCCCCCCcccccccccCCCcccccC-CCCCCCccccccchhhHHHHhhCCCCCCCCChHHH--HHHHHHhcCCCCc
Q 006714 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ--LHKIFKLCGSPPD 284 (634)
Q Consensus 208 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~--l~~i~~~~g~pp~ 284 (634)
+..... ......+|+.|+|||++.. ...++.++|||||||++|+|++|..||........ ...+... +..+
T Consensus 176 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~- 249 (287)
T 4f0f_A 176 SQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GLRP- 249 (287)
T ss_dssp CBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CCCC-
T ss_pred cccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CCCC-
Confidence 975433 2345678999999999843 24578899999999999999999999987553332 3333221 1111
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 285 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 285 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 250 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 -------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011357889999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=303.13 Aligned_cols=190 Identities=24% Similarity=0.309 Sum_probs=156.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|+++++||+|+||.||+|++..+++.||||+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 34789999999999999999999999999999995
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee---cCCCceEEeccccccccCCCCCC--
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ-- 217 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~-- 217 (634)
++.|+.||+.||.|||+++|+||||||+|||| +.++.+||+|||++.........
T Consensus 85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 45689999999999999999999999999999 57889999999999866543221
Q ss_pred ----CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh---HHHHHHHHHhcCCCCchhhhcc
Q 006714 218 ----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 218 ----~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~---~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
.....++|+.|+|||++.+ ..++.++||||||||||||++|..||.+... .+.+..+.....
T Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------- 233 (483)
T 3sv0_A 165 IPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---------- 233 (483)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----------
T ss_pred cccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----------
Confidence 1235678999999999987 6789999999999999999999999987543 333444332211
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...+......++.++.+||..||..||.+||++.+|++
T Consensus 234 --------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 --------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01223344678999999999999999999999998775
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.14 Aligned_cols=187 Identities=27% Similarity=0.379 Sum_probs=142.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++...........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 456899999999999999999999999999999999999999999976654433334
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+ ......+
T Consensus 193 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~---------------- 254 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRP---------------- 254 (309)
T ss_dssp ----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCG----------------
T ss_pred cccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCc----------------
Confidence 45678999999999876 67889999999999999999999999887655333322 2111111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-CHHHHHh
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-TASAALA 342 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-Ta~elL~ 342 (634)
......++..+.+||.+||..||.+|| |++++++
T Consensus 255 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 255 ---------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 112246788999999999999999999 7777764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=283.00 Aligned_cols=187 Identities=22% Similarity=0.339 Sum_probs=148.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.++||+|+||+||+|++..+++.||+|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 45799999999999999999999999999999994
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC--
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-- 218 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-- 218 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++..........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 45689999999999999999999999999999999999999999998654332211
Q ss_pred -----------cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhh
Q 006714 219 -----------LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 287 (634)
Q Consensus 219 -----------~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~ 287 (634)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||..........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------------- 232 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------------- 232 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------------
T ss_pred cccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------------
Confidence 114578999999999986 678999999999999999999999886432100000
Q ss_pred hccCCCCcccCCCCCCCCchh-hhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 288 KKSKLPHATLFKPQQPYDSSL-RETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 288 ~~~~l~~~~~~~~~~~~~~~l-~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.......+ ......+++.+.+||.+||..||.+|||+.++++
T Consensus 233 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 -------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00000000 0112467888999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=288.50 Aligned_cols=192 Identities=21% Similarity=0.214 Sum_probs=148.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCC-----CcEEehHH-----------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKK----------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~t-----g~~vAlK~----------------------------------------- 162 (634)
.++|+++++||+|+||+||+|.+..+ ++.||||+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46899999999999999999998765 47788874
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec--CCCce
Q 006714 163 ----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVL 200 (634)
Q Consensus 163 ----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~--~~g~v 200 (634)
+..|+.||+.||.|||+++|+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 456899999999999999999999999999998 88999
Q ss_pred EEeccccccccCCCCC------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHH
Q 006714 201 KLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 274 (634)
Q Consensus 201 kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~ 274 (634)
||+|||++........ ......++|+.|+|||++.+ ..++.++|||||||+||||++|+.||.+......+..
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999976543211 11234558999999999986 5689999999999999999999999986433222222
Q ss_pred HHHh-cCCCCchhhhccCCCCcccCCCCCCCCchhhhhc--CCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 275 IFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 275 i~~~-~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~--~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.... ....... .+...+ ..+++++.+||..||..||.+||++.+|++
T Consensus 273 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIAS---------------------LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHH---------------------HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHH---------------------HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2111 1000000 011111 467899999999999999999999999885
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=286.85 Aligned_cols=150 Identities=24% Similarity=0.325 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCcc
Q 006714 166 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSV 244 (634)
Q Consensus 166 i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~s 244 (634)
++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++
T Consensus 198 ~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 276 (359)
T 3vhe_A 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQS 276 (359)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchh
Confidence 677999999999999999999999999999999999999999986543222 22334567889999999876 6789999
Q ss_pred ccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 006714 245 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323 (634)
Q Consensus 245 DIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 323 (634)
|||||||++|+|++ |.+||.+....+.+...+.....+. ....+++++.+||
T Consensus 277 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li 329 (359)
T 3vhe_A 277 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTM 329 (359)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHH
T ss_pred hhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHH
Confidence 99999999999998 9999988765555544443321111 0134678999999
Q ss_pred HHhhccCcCCCcCHHHHHhc
Q 006714 324 ETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 324 ~~mL~~DP~kRpTa~elL~h 343 (634)
..||..||.+|||+.|+++|
T Consensus 330 ~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 99999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=272.71 Aligned_cols=187 Identities=22% Similarity=0.320 Sum_probs=155.6
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++++.||+|+||.||++.+. +++.||+|+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 45679999999999999999999986 567899985
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++............
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 4568899999999999999999999999999999999999999999866432222223
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+........
T Consensus 164 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---------------- 226 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------------- 226 (267)
T ss_dssp STTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------
T ss_pred cccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC----------------
Confidence 3456788999999875 568899999999999999999 8999999888777776644211100
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...++..+.+||.+||..||.+|||+.+++++
T Consensus 227 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 227 ------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12467889999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=289.09 Aligned_cols=189 Identities=25% Similarity=0.350 Sum_probs=155.7
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++.+.||+|+||+||+|++..+++.||||+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34667899999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 456899999999999999999999999999999999999999999976543211
Q ss_pred CC-cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~-~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.. .....+++.|+|||++.. ..++.++|||||||++|||++ |.+||.+....+....+.... .++
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~----------- 335 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLP----------- 335 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCC-----------
T ss_pred eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC-----------
Confidence 11 112234778999999875 568899999999999999998 999999888776665553321 111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 336 ----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 ----------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01346788999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=271.50 Aligned_cols=185 Identities=25% Similarity=0.377 Sum_probs=147.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++ +++.||||+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 45568999999999999999999997 478899875
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCC---ceeccCCCCCceecC--------CCceEEecc
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRG---VLHRDIKGSNLLVNN--------EGVLKLADF 205 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~g---IvHrDLKp~NILl~~--------~g~vkL~DF 205 (634)
+..++.||+.||.|||+++ |+|+||||+|||++. ++.++|+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 4568999999999999999 899999999999986 678999999
Q ss_pred ccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCch
Q 006714 206 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 285 (634)
Q Consensus 206 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~ 285 (634)
|++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 234 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-- 234 (271)
T ss_dssp CC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--
T ss_pred Cccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--
Confidence 9997654322 234567999999999876 5689999999999999999999999998887766665543211111
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+++.+.+||.+||..||.+|||+.|++++
T Consensus 235 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 -------------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 113578899999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=295.06 Aligned_cols=194 Identities=25% Similarity=0.365 Sum_probs=144.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
...+|++.+.||+|+||+||. ....+++.||||+
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 345799999999999999764 3456789999996
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---C--CceEEeccccccccCCCCC--
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---E--GVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~--g~vkL~DFGla~~~~~~~~-- 216 (634)
+..++.||+.||.|||+++|+||||||+||||+. + ..+||+|||++........
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 3578999999999999999999999999999953 2 3578999999986653321
Q ss_pred CCcccccccccCCCcccccC--CCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 217 QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
......++|+.|+|||++.+ ...++.++|||||||++|||++ |.+||......... .+. +......+
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~~~~~------ 250 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACSLDCL------ 250 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCCCTTS------
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCCcccc------
Confidence 22345678999999999974 3457789999999999999999 89999655433322 211 11110000
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
......+..+.+||.+||+.||.+|||+.+||+||||..
T Consensus 251 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 ----------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 000123566889999999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=275.59 Aligned_cols=189 Identities=20% Similarity=0.261 Sum_probs=150.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECC---CCcEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~---tg~~vAlK~---------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++.. ++..||+|+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 87 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 87 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence 3455799999999999999999998654 334688885
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 45688999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
........+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+......+.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 235 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK----------- 235 (281)
T ss_dssp -----CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC-----------
T ss_pred ccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC-----------
Confidence 222334456788999999875 568899999999999999998 9999987776666555543211110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||.+||..||.+|||+.+++++
T Consensus 236 -----------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 -----------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 13467889999999999999999999999965
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=281.25 Aligned_cols=197 Identities=18% Similarity=0.288 Sum_probs=159.0
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++. .+++.||||+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345579999999999999999999876 3577899985
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEe
Q 006714 163 ---------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 203 (634)
Q Consensus 163 ---------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~ 203 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 23478899999999999999999999999999999999999
Q ss_pred ccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCC
Q 006714 204 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 204 DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999975533211 11223456888999999876 568999999999999999999 89999988877766666442110
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc------cccCCCCC
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS------EYFSTKPY 351 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h------pwf~~~~~ 351 (634)
. ....++..+.+||.+||..||.+|||+.+++++ ++|+...+
T Consensus 260 ~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 260 D----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred C----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 0 113578899999999999999999999999987 66655443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=277.85 Aligned_cols=183 Identities=22% Similarity=0.298 Sum_probs=147.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC-------cEEehHH------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG-------KIVALKK------------------------------------ 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-------~~vAlK~------------------------------------ 162 (634)
.+..++|++.+.||+|+||+||+|++..++ ..||+|+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 355679999999999999999999998877 4688885
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc--------eEEe
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------LKLA 203 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~--------vkL~ 203 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 4568999999999999999999999999999988876 9999
Q ss_pred ccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhcCCC
Q 006714 204 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSP 282 (634)
Q Consensus 204 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~g~p 282 (634)
|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...........+ ......
T Consensus 164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~~~~ 237 (289)
T 4fvq_A 164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRHQL 237 (289)
T ss_dssp CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCC
T ss_pred cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hccCCC
Confidence 9999865432 13345788999999997656689999999999999999995 5555555544433332 211111
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 283 p~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+ ...++.+.+||.+||..||.+|||+.+++++
T Consensus 238 ~-----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 P-----------------------------APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp C-----------------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 2346678999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=281.24 Aligned_cols=187 Identities=25% Similarity=0.424 Sum_probs=133.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
...+|++.++||+|+||+||+|++..+++.||||+
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34589999999999999999999999999999994
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCceEEeccccc
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLA 208 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~vkL~DFGla 208 (634)
+..++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 4568899999999999999 999999999999999999999999999
Q ss_pred cccCCCCCC-----------CcccccccccCCCccccc--CCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHH
Q 006714 209 NFSNTGHRQ-----------PLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 275 (634)
Q Consensus 209 ~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~--~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i 275 (634)
......... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||........+...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 866532211 112446799999999983 2356788999999999999999999999765433222111
Q ss_pred HHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 276 ~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
. ..+ .....+..+.+||.+||..||.+|||+.|+|++-+
T Consensus 266 ~----~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 266 Y----SIP---------------------------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp C----CCC---------------------------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c----cCC---------------------------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 000 01345667899999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.33 Aligned_cols=203 Identities=22% Similarity=0.351 Sum_probs=145.7
Q ss_pred ccCCCeeEEEEecccCceeEEEEE----ECCCCcEEehHH----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~---------------------------------------- 162 (634)
+..++|+++++||+|+||+||+|+ +..+++.||||+
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 345799999999999999999998 667899999995
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 456899999999999999999999999999999999999999999986643
Q ss_pred CCC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 214 GHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 214 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .. ...+..+...+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccccchhHHH
Confidence 321 11223446778999999876 56899999999999999999999988653221 11 111111110000000
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
... ...... .......+++++.+||..||..||.+|||+.|+++
T Consensus 241 ~~~--~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIE--LLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHH--HHHTTC-----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHH--HHhccC-----cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 000000 00012457899999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=287.89 Aligned_cols=208 Identities=24% Similarity=0.277 Sum_probs=150.0
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+-+..++|+++++||+|+||+||+|++. ++.||||+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3355679999999999999999999974 78999996
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHC----------CceeccCCCCCceecCCCceEEeccc
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSR----------GVLHRDIKGSNLLVNNEGVLKLADFG 206 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~----------gIvHrDLKp~NILl~~~g~vkL~DFG 206 (634)
+..++.||+.||.|||+. +|+|+||||+||||+.++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 456899999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-CCcccccccccCCCcccccCC----CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCC
Q 006714 207 LANFSNTGHR-QPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 207 la~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~----~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
++........ ......++|+.|+|||++.+. ..++.++|||||||++|||++|++||.+..+...+.........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9976543322 223446789999999998763 23456789999999999999999999765432111111111111
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhc--CCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~--~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+....+....... .. ...+...+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~--~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVVVHK--KK------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCHHHHHHHHTTS--CC------CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cchhhhhhhhhcc--cC------CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111111000000 00 00001111 123466999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=284.43 Aligned_cols=189 Identities=23% Similarity=0.317 Sum_probs=155.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCC-------CcEEehHH------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT-------GKIVALKK------------------------------------ 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~t-------g~~vAlK~------------------------------------ 162 (634)
.+..++|++.++||+|+||+||+|++..+ +..||||+
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 45568999999999999999999997543 35799885
Q ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee
Q 006714 163 ------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194 (634)
Q Consensus 163 ------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl 194 (634)
+..++.||+.||.|||+++|+||||||+||||
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 23578899999999999999999999999999
Q ss_pred cCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHH
Q 006714 195 NNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 272 (634)
Q Consensus 195 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l 272 (634)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986643221 22334456889999999986 678999999999999999999 99999988877766
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..+....... ....+++++.+||.+||..||.+|||+.+++++
T Consensus 304 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRMD----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCCC----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6664421110 013578899999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=292.12 Aligned_cols=195 Identities=29% Similarity=0.406 Sum_probs=146.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.+.|.+.+.||+|+||+||.+. ..+++.||||+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 3567778999999999998764 46799999995
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-------------CceEEecc
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-------------GVLKLADF 205 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-------------g~vkL~DF 205 (634)
+..++.||+.||.|||+++|+||||||+||||+.+ ..+||+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 13489999999999999999999999999999654 47999999
Q ss_pred ccccccCCCCCC---CcccccccccCCCcccccC------CCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHH
Q 006714 206 GLANFSNTGHRQ---PLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 275 (634)
Q Consensus 206 Gla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~------~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i 275 (634)
|++......... .....++|+.|+|||++.+ ...++.++|||||||++|||++ |.+||......+ ..+
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence 999876543221 2234578999999999865 2468899999999999999999 999997655433 233
Q ss_pred HHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 276 ~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.......+.. . .+ ....+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 251 ~~~~~~~~~~----------------~----~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 251 IRGIFSLDEM----------------K----CL--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHTCCCCCCC----------------T----TC--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hcCCCCcccc----------------c----cc--ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3221111100 0 00 00235678999999999999999999999999999964
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=271.46 Aligned_cols=187 Identities=21% Similarity=0.337 Sum_probs=155.6
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|++. ++..||+|+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 345579999999999999999999975 567899985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 456899999999999999999999999999999999999999999987654333333
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.......
T Consensus 168 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 230 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---------------- 230 (279)
T ss_dssp TTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred cCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC----------------
Confidence 34456788999999875 567899999999999999999 999999988877766664321100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 ------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01357889999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=277.24 Aligned_cols=192 Identities=29% Similarity=0.372 Sum_probs=146.9
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||+||+|++ +++.||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 347899999999999999999997 689999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHH--------HCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLH--------s~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+..++.||+.||.||| +++|+||||||+||||+.++.+||+|||++...
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 4578999999999999 999999999999999999999999999999755
Q ss_pred CCCCCC---CcccccccccCCCcccccCCC-----CCCCccccccchhhHHHHhhC----------CCCCCCCC----hH
Q 006714 212 NTGHRQ---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIG----------KPILQGRT----EV 269 (634)
Q Consensus 212 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~-----~~s~~sDIWSLG~iLyeLltG----------~~pf~~~~----~~ 269 (634)
...... .....++|+.|+|||++.+.. .++.++|||||||++|||++| .+||.... ..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 432221 123347899999999997633 234689999999999999999 88885432 22
Q ss_pred HHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 270 e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
..+..+.......+. . .. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~-----------------~--~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPN-----------------I--PN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHTTSCCCCC-----------------C--CG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hhhhHHHhccCCCCC-----------------C--Ch--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 333333221111110 0 00 0011235678999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=282.14 Aligned_cols=194 Identities=18% Similarity=0.179 Sum_probs=146.8
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECC---CCcEEehHH-----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~---tg~~vAlK~----------------------------------------- 162 (634)
+..++|++.+.||+|+||+||+|++.. ++..||||+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 777888874
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC--ceE
Q 006714 163 ---------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLK 201 (634)
Q Consensus 163 ---------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g--~vk 201 (634)
+..++.||+.||.|||+++|+||||||+||||+.++ .+|
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 456899999999999999999999999999998877 999
Q ss_pred EeccccccccCCCC------CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCC--ChHHHHH
Q 006714 202 LADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLH 273 (634)
Q Consensus 202 L~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~--~~~e~l~ 273 (634)
|+|||++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|..||... .......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999997653221 111244578999999999986 57899999999999999999999999652 2222222
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcC--CCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~--~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.........+.. +..... .+++.+.+||..||..||.+|||+.+|++.
T Consensus 273 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 222222222211 112222 688999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=293.00 Aligned_cols=188 Identities=22% Similarity=0.349 Sum_probs=156.8
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++.+.||+|+||+||+|.+. ++..||||+
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~ 261 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT 261 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEE
Confidence 3566789999999999999999999985 467799985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..........
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 34688999999999999999999999999999999999999999998764322222
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.. ..++.++|||||||+||||++ |.+||.+.+..+.+..+......+.
T Consensus 342 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------- 406 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------- 406 (454)
T ss_dssp TCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC--------------
T ss_pred cCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 233345788999999975 568999999999999999999 9999999988887777654321111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...+++.+.+||.+||..||.+|||+.+|+.
T Consensus 407 --------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 --------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1357889999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.06 Aligned_cols=195 Identities=18% Similarity=0.289 Sum_probs=153.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEE-----ECCCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~-----d~~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|+ +..+++.||||+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 4455799999999999999999999 556788999985
Q ss_pred ------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEe
Q 006714 163 ------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLA 203 (634)
Q Consensus 163 ------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~ 203 (634)
+..++.||+.||.|||+++|+|+||||+||||+. +..++|+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 3458899999999999999999999999999984 4469999
Q ss_pred ccccccccCCCC-CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCC
Q 006714 204 DFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 204 DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
|||++....... ........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 999987543221 122234466889999999876 568999999999999999998 99999988877766666442111
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
. ....++..+.+||.+||..||.+|||+.+++++.|+-..
T Consensus 265 ~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 265 D----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1 013578899999999999999999999999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=276.31 Aligned_cols=190 Identities=24% Similarity=0.352 Sum_probs=152.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEE-----CCCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d-----~~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++ ..+++.||||+
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34557999999999999999999985 45678899985
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec
Q 006714 163 -----------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195 (634)
Q Consensus 163 -----------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~ 195 (634)
+..++.||+.||.|||+++|+|+||||+||||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 234778999999999999999999999999999
Q ss_pred CCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHH
Q 006714 196 NEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 273 (634)
Q Consensus 196 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~ 273 (634)
.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999986543322 12234456889999999876 568999999999999999998 999998876544444
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..+.....+. ....+++.+.+||..||..||.+|||+.++++|
T Consensus 262 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3333211111 013467889999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=279.90 Aligned_cols=189 Identities=24% Similarity=0.364 Sum_probs=153.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++++.||+|+||.||+|++. .+++.||||+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 445689999999999999999999987 4558899985
Q ss_pred ------------------H-----------------------------------HHHHHHHHHHHHHHHHCCceeccCCC
Q 006714 163 ------------------I-----------------------------------KCYMNQLLHGLEHCHSRGVLHRDIKG 189 (634)
Q Consensus 163 ------------------i-----------------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp 189 (634)
+ ..++.||+.||.|||+++|+|+||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 1 12788999999999999999999999
Q ss_pred CCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCC
Q 006714 190 SNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT 267 (634)
Q Consensus 190 ~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~ 267 (634)
+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999975532211 12234466889999999876 568999999999999999999 999999988
Q ss_pred hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 268 ~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..+....+....... ....++..+.+||.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNILA----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcCC----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 877776664421100 113578899999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=275.00 Aligned_cols=189 Identities=19% Similarity=0.268 Sum_probs=153.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 445679999999999999999999983 4557899985
Q ss_pred ------------------H-----------------------------------HHHHHHHHHHHHHHHHCCceeccCCC
Q 006714 163 ------------------I-----------------------------------KCYMNQLLHGLEHCHSRGVLHRDIKG 189 (634)
Q Consensus 163 ------------------i-----------------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp 189 (634)
+ ..++.||+.||.|||+++|+|+||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 1 24788999999999999999999999
Q ss_pred CCceecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCC
Q 006714 190 SNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT 267 (634)
Q Consensus 190 ~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~ 267 (634)
+||||+.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999976643221 12233455788999999876 568899999999999999999 999998877
Q ss_pred hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 268 ~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.......+...... .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRM----------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66655554332100 0113578899999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.81 Aligned_cols=189 Identities=19% Similarity=0.290 Sum_probs=157.5
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++.++||+|+||.||+|++..++..||||+
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34566789999999999999999999998899999996
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 3568899999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+++.|+|||++.. ..++.++|||||||+||||++ |.+||.+.+..+....+......
T Consensus 375 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 438 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--------------- 438 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---------------
T ss_pred ecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2333455788999999875 568999999999999999999 99999988766655554332100
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+++.+.+||.+||..||.+|||+.+|++
T Consensus 439 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 -------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 011357889999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=273.44 Aligned_cols=190 Identities=22% Similarity=0.336 Sum_probs=154.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEE-----CCCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d-----~~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++ ..+++.||||+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 45567999999999999999999985 45778899985
Q ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee
Q 006714 163 ------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194 (634)
Q Consensus 163 ------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl 194 (634)
+..++.||+.||.|||+++|+|+||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 12477899999999999999999999999999
Q ss_pred cCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHH
Q 006714 195 NNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 272 (634)
Q Consensus 195 ~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l 272 (634)
+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999866543221 1223456788999999876 568999999999999999998 99999887665555
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..++.....+. ....++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCC---------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55444321111 013568899999999999999999999999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=278.34 Aligned_cols=192 Identities=20% Similarity=0.273 Sum_probs=154.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~-------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++. .++..||||+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345579999999999999999999973 4566899985
Q ss_pred -------------------H----------------------------------HHHHHHHHHHHHHHHHCCceeccCCC
Q 006714 163 -------------------I----------------------------------KCYMNQLLHGLEHCHSRGVLHRDIKG 189 (634)
Q Consensus 163 -------------------i----------------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp 189 (634)
+ ..++.||+.||.|||++||+|+||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 1 23788999999999999999999999
Q ss_pred CCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCC
Q 006714 190 SNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT 267 (634)
Q Consensus 190 ~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~ 267 (634)
+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999765432221 1233456788999999876 568999999999999999998 999998877
Q ss_pred hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 268 ~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
....+..++.....++ ....+++.+.+||.+||..||.+|||+.+++++-.
T Consensus 280 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 6555555544221111 01346889999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=280.60 Aligned_cols=194 Identities=15% Similarity=0.170 Sum_probs=150.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCC--------CcEEehHH--------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDT--------GKIVALKK-------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~t--------g~~vAlK~-------------------------------------- 162 (634)
.++|++.+.||+|+||+||+|++..+ ++.||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 47999999999999999999999874 78899884
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC--ce
Q 006714 163 ----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VL 200 (634)
Q Consensus 163 ----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g--~v 200 (634)
+..++.||+.||.|||+++|+||||||+||||+.++ .+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~ 200 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEE
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceE
Confidence 345889999999999999999999999999999988 89
Q ss_pred EEeccccccccCCCCC------CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC-hHHHHH
Q 006714 201 KLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLH 273 (634)
Q Consensus 201 kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~-~~e~l~ 273 (634)
||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.... ..+.+.
T Consensus 201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 279 (352)
T 2jii_A 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279 (352)
T ss_dssp EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence 9999999976543211 11234578999999999976 578999999999999999999999998753 333333
Q ss_pred HHHH-hcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 274 KIFK-LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 274 ~i~~-~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.... ....++ .+.. .......+++.+.+||.+||..||.+|||+.++++.
T Consensus 280 ~~~~~~~~~~~-~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 280 KQKQKFVDKPG-PFVG-------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHSCC-CEEC-------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhccCChh-hhhh-------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3222 211111 0000 001123578999999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=281.87 Aligned_cols=217 Identities=25% Similarity=0.330 Sum_probs=148.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|++ +++.||||+
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 45678999999999999999999987 688999996
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHC---------CceeccCCCCCceecCCCceEEecccc
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLKLADFGL 207 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~---------gIvHrDLKp~NILl~~~g~vkL~DFGl 207 (634)
+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 356899999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-------CCCcccccccccCCCcccccCC------CCCCCccccccchhhHHHHhhCCCCC-CCCChHHHHH
Q 006714 208 ANFSNTGH-------RQPLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLH 273 (634)
Q Consensus 208 a~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~------~~~s~~sDIWSLG~iLyeLltG~~pf-~~~~~~e~l~ 273 (634)
+....... .......++|+.|+|||++.+. ..++.++|||||||++|||++|..|| .+....+...
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 97654321 1122345789999999998752 23557899999999999999996554 3332111111
Q ss_pred HHHHhcCCCC-chhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHH------Hhcccc
Q 006714 274 KIFKLCGSPP-DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA------LASEYF 346 (634)
Q Consensus 274 ~i~~~~g~pp-~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~el------L~hpwf 346 (634)
.+....+..+ ...+...... ....+..+ .. ......+++.+.+||.+||..||.+|||+.|+ |.++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSR--EKQRPKFP--EA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTT--SCCCCCCC--TT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hhhcccCCCchHHHHHhhhcc--cccCCCCC--cc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 1111111111 1110000000 00000000 00 00012245679999999999999999999999 456777
Q ss_pred CCC
Q 006714 347 STK 349 (634)
Q Consensus 347 ~~~ 349 (634)
++.
T Consensus 322 ~~~ 324 (336)
T 3g2f_A 322 RNK 324 (336)
T ss_dssp C--
T ss_pred hcc
Confidence 664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=270.61 Aligned_cols=190 Identities=20% Similarity=0.232 Sum_probs=155.2
Q ss_pred ccCCCeeEEE-EecccCceeEEEEEEC--CCCcEEehHH-----------------------------------------
Q 006714 127 LRADAFEKLE-KIGQGTYSSVFRARDL--DTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~-~LG~G~fg~Vy~a~d~--~tg~~vAlK~----------------------------------------- 162 (634)
+..++|.+++ .||+|+||+||+|.+. .++..||||+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 85 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcE
Confidence 4557899988 9999999999999864 4677899986
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 457899999999999999999999999999999999999999999986643322
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+..... +
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-~----------- 232 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-M----------- 232 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-C-----------
T ss_pred eeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-C-----------
Confidence 11223345788999999875 568899999999999999998 9999998887776666543210 0
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpw 345 (634)
.....+++.+.+||..||..||.+|||+.+++++.+
T Consensus 233 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 233 ----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 011357889999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.94 Aligned_cols=187 Identities=26% Similarity=0.433 Sum_probs=144.0
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+..++|++.+.||+|+||+||++++ .++.||||+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~ 82 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAE 82 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCC
Confidence 3457899999999999999999997 478899985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHH---CCceeccCCCCCceecCCCc-eEEeccccccccCCCCCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHS---RGVLHRDIKGSNLLVNNEGV-LKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs---~gIvHrDLKp~NILl~~~g~-vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+ ++|+|+||||+||||+.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 34678899999999999 89999999999999988876 799999999755432
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCCh--HHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.. +..+
T Consensus 160 -~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~------------ 223 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP------------ 223 (307)
T ss_dssp ------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC------------
T ss_pred -cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC------------
Confidence 234468999999999976 6789999999999999999999999975432 222222211 1110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc-----cccCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS-----EYFST 348 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h-----pwf~~ 348 (634)
.....++..+.+||.+||..||.+|||+.+++++ .+|..
T Consensus 224 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 --------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp --------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred --------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1124578899999999999999999999999973 55544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=275.47 Aligned_cols=189 Identities=23% Similarity=0.329 Sum_probs=153.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-------CCCcEEehHH------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKK------------------------------------ 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-------~tg~~vAlK~------------------------------------ 162 (634)
.+..++|++.+.||+|+||+||+|++. .++..||||+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 455689999999999999999999986 4567899985
Q ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee
Q 006714 163 ------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194 (634)
Q Consensus 163 ------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl 194 (634)
+..++.||+.||.|||+++|+|+||||+||||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 13468899999999999999999999999999
Q ss_pred cCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHH
Q 006714 195 NNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 272 (634)
Q Consensus 195 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l 272 (634)
+.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999986654321 11233455788999999876 568899999999999999999 99999988877766
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..+....... ....++..+.+||..||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMD----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6654421110 013578899999999999999999999999965
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=273.69 Aligned_cols=190 Identities=21% Similarity=0.278 Sum_probs=148.7
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECC---CCcEEehHH---------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKK--------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~---tg~~vAlK~--------------------------------------- 162 (634)
+.+..++|.+.+.||+|+||+||+|++.. ++..||+|+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34456799999999999999999998765 455799885
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEE
Q 006714 163 ----------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 202 (634)
Q Consensus 163 ----------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL 202 (634)
++.++.||+.||.|||+++|+|+||||+||||+.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 3468899999999999999999999999999999999999
Q ss_pred eccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcC
Q 006714 203 ADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 280 (634)
Q Consensus 203 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g 280 (634)
+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999976543221 11233455788999999976 678999999999999999999 9999998877766666544211
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 281 ~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 ~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LK----------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CC----------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CC----------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 113578899999999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=288.65 Aligned_cols=194 Identities=24% Similarity=0.355 Sum_probs=154.4
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++.++||+|+||+||+|.+.. +..||||+
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~ 257 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 257 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence 34667889999999999999999999865 45699985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..........
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 35688999999999999999999999999999999999999999998665432222
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.. ..++.++|||||||+||||++ |.+||.+....+.+..+......+
T Consensus 338 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------------- 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------------- 401 (452)
T ss_dssp -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------------
T ss_pred ccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 233455788999999875 568999999999999999999 999999988887777764421111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc--cccCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS--EYFST 348 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h--pwf~~ 348 (634)
....+++.+.+||.+||..||.+|||+.+|++. .+|..
T Consensus 402 -------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 013578899999999999999999999999873 56654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=275.21 Aligned_cols=190 Identities=22% Similarity=0.327 Sum_probs=153.0
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCc-----EEehHH-------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKK------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~-----~vAlK~------------------------------------- 162 (634)
..+..++|++.+.||+|+||+||+|.+..+++ .||+|+
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34556899999999999999999999977664 788874
Q ss_pred ---------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC
Q 006714 163 ---------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 197 (634)
Q Consensus 163 ---------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~ 197 (634)
+..++.||+.||.|||+++|+|+||||+||||+.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 12467899999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHH
Q 006714 198 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 275 (634)
Q Consensus 198 g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i 275 (634)
+.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999976543221 11233456788999999876 568999999999999999998 99999887665555555
Q ss_pred HHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 276 ~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
......++. ...+++.+.+||..||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 280 VKDGYQMAQ---------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHTCCCCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCC---------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 443211110 1245788999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=291.98 Aligned_cols=206 Identities=24% Similarity=0.379 Sum_probs=153.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.++||+|+||+||+|++..+++.||||+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999999999999999995
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee----cCCCceEEeccccccccC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl----~~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||+++|+||||||+|||| +.++.+||+|||++....
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 45689999999999999999999999999999 777789999999998765
Q ss_pred CCCCCCcccccccccCCCcccccCC-------CCCCCccccccchhhHHHHhhCCCCCCCC----ChHHHHHHHHHhcCC
Q 006714 213 TGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKPILQGR----TEVEQLHKIFKLCGS 281 (634)
Q Consensus 213 ~~~~~~~~~~~gt~~Y~APE~l~~~-------~~~s~~sDIWSLG~iLyeLltG~~pf~~~----~~~e~l~~i~~~~g~ 281 (634)
... .....++|+.|+|||++.+. ..++.++|||||||++|||++|..||... ...+.+..+.. .
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~ 242 (396)
T 4eut_A 168 DDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---G 242 (396)
T ss_dssp CGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---S
T ss_pred CCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---C
Confidence 432 23456789999999988531 34678999999999999999999999643 33444444433 2
Q ss_pred CCchhhhccCCCCccc--CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 282 PPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~--~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.|...|.......... +....+... .....++..+.+||.+||.+||++|||+.++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSC---SLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTC---SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCccc---ccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2322222111100000 000001000 111245677899999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=266.76 Aligned_cols=185 Identities=21% Similarity=0.305 Sum_probs=148.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCc---EEehHH--------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK-------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~-------------------------------------------- 162 (634)
-.|++.++||+|+||+||+|++..++. .||+|+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 468888999999999999999766554 788885
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC--
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 215 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-- 215 (634)
+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 45788999999999999999999999999999999999999999997554321
Q ss_pred -CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 -~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
........+++.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+......+.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---------- 249 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---------- 249 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC----------
T ss_pred ccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC----------
Confidence 122234466889999999976 678999999999999999999 5666766666555555543221111
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||..||..||.+|||+.++++.
T Consensus 250 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 250 ------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 13467889999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=263.59 Aligned_cols=182 Identities=13% Similarity=0.209 Sum_probs=151.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||+|++ +++.||+|+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 34567999999999999999999998 478899985
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+||+++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 4678999999999999999 999999999999999999999999887543
Q ss_pred CCCCCCCcccccccccCCCcccccCCC--CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
.. ....+|+.|+|||++.+.. .++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 231 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------ 231 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC------
Confidence 22 3346789999999987622 223379999999999999999999999888777666654322111
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 232 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 ---------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11357889999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.59 Aligned_cols=203 Identities=21% Similarity=0.264 Sum_probs=151.6
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|++ .+++.||||+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 457999999999999999999985 4688999985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHC---CceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~---gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||++ +|+|+||||+||||+.++.+||+|||++.....
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence 356899999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC----hHHHHHHHHHhcCCCCchhhhc
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~----~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ....+...+......
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 258 (326)
T 3uim_A 187 KDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE------- 258 (326)
T ss_dssp SSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS-------
T ss_pred ccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc-------
Confidence 44444455568999999999876 568999999999999999999999995211 000111111100000
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
..+. ....... ........+..+.+||..||..||.+|||+.+||+|-.-
T Consensus 259 ~~~~--~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 259 KKLE--ALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CCST--TSSCTTC-----TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhh--hhcChhh-----ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 0000000 001112345779999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.35 Aligned_cols=186 Identities=34% Similarity=0.522 Sum_probs=138.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++.+.||+|+||.||+|.+..+++.||||+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4689999999999999999999999999999994
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 34688999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC--hHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~--~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .......+ .....++.
T Consensus 191 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--------- 258 (310)
T 2wqm_A 191 -TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPL--------- 258 (310)
T ss_dssp ---------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH-HTTCSCCC---------
T ss_pred -ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh-hcccCCCC---------
Confidence 12234567999999999876 678999999999999999999999997643 22222222 21111110
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+++++.+||.+||..||.+|||+.+++++
T Consensus 259 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 259 -----------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -----------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 013578899999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=270.66 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=148.1
Q ss_pred CCCeeEEEEecccCceeEEEEE----ECCCCcEEehHH------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~------------------------------------------ 162 (634)
.++|+++++||+|+||.||+|+ +..+++.||+|+
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4579999999999999999999 677899999985
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 4568999999999999999999999999999999999999999999876543
Q ss_pred CC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 215 HR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 215 ~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+.... ..+....+......... ..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-~~ 252 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQMTVT-RL 252 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGGHHH-HH
T ss_pred CcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccccCHH-HH
Confidence 22 22234567888999999876 567889999999999999999998764221 11111111111100000 00
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
........ .......+++.+.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000000 00011467899999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=272.90 Aligned_cols=176 Identities=25% Similarity=0.365 Sum_probs=138.4
Q ss_pred CCeeEE-EEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~-~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
++|.++ +.||+|+||.||+|++..+++.||||+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 578888 789999999999999999999999996
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCCC
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+|+||||+||||+. ++.++|+|||++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 172 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---- 172 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence 4579999999999999999999999999999988 78899999998854321
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
..++.++|||||||++|+|++|.+||...........+....
T Consensus 173 --------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~------------------ 214 (299)
T 3m2w_A 173 --------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------------------ 214 (299)
T ss_dssp --------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS------------------
T ss_pred --------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH------------------
Confidence 346788999999999999999999997655432211110000
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
.... .......+..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 215 ~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 215 RMGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CTTC---CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcc---ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000 0011122356899999999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.64 Aligned_cols=188 Identities=20% Similarity=0.330 Sum_probs=143.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~---------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++. .++..||||+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 445679999999999999999999986 4577899985
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 4568999999999999999999999999999999999999999999866543
Q ss_pred CCCCc--ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 215 HRQPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 215 ~~~~~--~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
..... ....+++.|+|||++.+ ..++.++|||||||+||||++ |..||......+.+..+......+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-------- 271 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-------- 271 (373)
T ss_dssp -------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC--------
T ss_pred CccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 22111 12234678999999876 578999999999999999997 9999998888777666644321111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...++..+.+||.+||..||.+|||+.++++
T Consensus 272 --------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 --------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1257889999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=267.47 Aligned_cols=183 Identities=27% Similarity=0.395 Sum_probs=151.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||.||+|++..+++.||+|+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 479999999999999999999999999999985
Q ss_pred ---------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ---------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ---------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 34688999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 210 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
...... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||... ......+... .
T Consensus 171 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~-------- 235 (284)
T 2a19_B 171 SLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I-------- 235 (284)
T ss_dssp ESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C--------
T ss_pred eccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c--------
Confidence 765432 2244568999999999976 66899999999999999999999887421 1111111110 0
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....++..+.+||.+||..||.+|||+.|++++.|+-.
T Consensus 236 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ---------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01346788999999999999999999999999988754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=273.42 Aligned_cols=189 Identities=20% Similarity=0.332 Sum_probs=147.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC----cEEehHH---------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKK--------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg----~~vAlK~--------------------------------------- 162 (634)
++..++|++.+.||+|+||+||+|++..++ ..||||+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 456689999999999999999999986553 3588885
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 456899999999999999999999999999999999999999999986653
Q ss_pred CCCC--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 214 GHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 214 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+......+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~------- 271 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------- 271 (333)
T ss_dssp -----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------
T ss_pred ccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-------
Confidence 3211 1122344778999999876 578999999999999999998 9999998887777666644211110
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...++..+.+||.+||..||.+||++.+++++
T Consensus 272 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 ---------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 13578899999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=270.11 Aligned_cols=188 Identities=27% Similarity=0.387 Sum_probs=147.7
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECC-CCc--EEehHH-----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLD-TGK--IVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~-tg~--~vAlK~----------------------------------------- 162 (634)
+..++|++++.||+|+||+||+|++.. +++ .||||+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 345789999999999999999998643 333 578874
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 4568899999999999999999999999999999999999999999876543
Q ss_pred CCC--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 215 HRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 215 ~~~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......++
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 245 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-------- 245 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--------
T ss_pred ccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--------
Confidence 221 1223456778999999876 567899999999999999999 9999999888877777654321111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||..||.+|||+.++++
T Consensus 246 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 -------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01357889999999999999999999999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=276.57 Aligned_cols=200 Identities=24% Similarity=0.297 Sum_probs=149.8
Q ss_pred cCCCeeEEEEecccCceeEEEEE----ECCCCcEEehHH-----------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~----------------------------------------- 162 (634)
..++|++++.||+|+||+||+|+ +..+++.||||+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 45799999999999999999999 577899999995
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 4568899999999999999999999999999999999999999999876533
Q ss_pred CC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCc--hhhhcc
Q 006714 215 HR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD--DYWKKS 290 (634)
Q Consensus 215 ~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~--~~~~~~ 290 (634)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ......+. ......
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSRLLELL 257 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHHHHHHh
Confidence 22 12233456888999999876 5678999999999999999999999865432211000 00000000 000000
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.. .. .......+++.+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~----~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EE----GQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HT----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hc----cc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00 000124678999999999999999999999999654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=266.19 Aligned_cols=182 Identities=19% Similarity=0.335 Sum_probs=145.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
.+..++|++++.||+|+||+||++.+ +++.||||+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 35567999999999999999999987 488999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 35688999999999999999999999999999999999999999987554321
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+..... +
T Consensus 172 -~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--------------- 233 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M--------------- 233 (278)
T ss_dssp -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-C---------------
T ss_pred -cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-C---------------
Confidence 23356888999999875 568899999999999999998 9999988776655555422110 0
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 234 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 234 ------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 011357889999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=275.60 Aligned_cols=188 Identities=24% Similarity=0.337 Sum_probs=152.2
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEE--ehHH----------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIV--ALKK---------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~v--AlK~---------------------------------------- 162 (634)
..+..++|++.+.||+|+||.||+|++..++..+ |+|.
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 3455689999999999999999999998888765 7764
Q ss_pred --------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC
Q 006714 163 --------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 198 (634)
Q Consensus 163 --------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g 198 (634)
++.++.||+.||.|||++||+|+||||+||||+.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 135789999999999999999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHH
Q 006714 199 VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFK 277 (634)
Q Consensus 199 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~ 277 (634)
.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 180 ~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 9999999998744321 11233355788999999875 567899999999999999998 9999998887776655533
Q ss_pred hcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 278 ~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.... .....+++.+.+||.+||..||.+|||+.++|++
T Consensus 257 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1100 0013578899999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.77 Aligned_cols=188 Identities=20% Similarity=0.244 Sum_probs=152.5
Q ss_pred cccCCCeeEEE-EecccCceeEEEEEE--CCCCcEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLE-KIGQGTYSSVFRARD--LDTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~-~LG~G~fg~Vy~a~d--~~tg~~vAlK~---------------------------------------- 162 (634)
.+..++|++.+ .||+|+||+||+|.+ ..+++.||||+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 91 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 91 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCC
Confidence 34457899999 999999999999954 56678899885
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 45689999999999999999999999999999999999999999998665432
Q ss_pred CC--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 216 RQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 216 ~~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.... .+.
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--------- 240 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMG--------- 240 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC---------
T ss_pred CcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC---------
Confidence 21 1122345688999999875 567889999999999999999 999999888777666554321 000
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 241 ------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11357889999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=271.71 Aligned_cols=190 Identities=25% Similarity=0.339 Sum_probs=142.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++. ++.||||+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 58999999999999999999984 88999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHC--------CceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~--------gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 115 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 194 (337)
T 3mdy_A 115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194 (337)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence 456899999999999999 999999999999999999999999999976543
Q ss_pred CCCC---CcccccccccCCCcccccCCCCCCCc------cccccchhhHHHHhhC----------CCCCCCCC----hHH
Q 006714 214 GHRQ---PLTSRVVTLWYRPPELLLGATDYGPS------VDLWSVGCVFAELLIG----------KPILQGRT----EVE 270 (634)
Q Consensus 214 ~~~~---~~~~~~gt~~Y~APE~l~~~~~~s~~------sDIWSLG~iLyeLltG----------~~pf~~~~----~~e 270 (634)
.... .....++|+.|+|||++.+ ..+... +|||||||++|||++| ..||.... ...
T Consensus 195 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 273 (337)
T 3mdy_A 195 DTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273 (337)
T ss_dssp --------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred ccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh
Confidence 2221 1234578999999999976 333443 8999999999999999 66664421 122
Q ss_pred HHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 271 ~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.+..+.......+ .. .. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~-----------------~~--~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 274 DMREIVCIKKLRP-----------------SF--PN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHTTSCCCC-----------------CC--CG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhHHHHhhhccCc-----------------cc--cc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222221111000 00 00 00112456789999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=268.16 Aligned_cols=186 Identities=20% Similarity=0.257 Sum_probs=147.3
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCC---cEEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg---~~vAlK~------------------------------------------ 162 (634)
...+|++.++||+|+||+||+|++..++ ..||+|.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3457999999999999999999976443 3577774
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 45688999999999999999999999999999999999999999997654322
Q ss_pred C---CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 216 R---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 216 ~---~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||......+....+......+.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 253 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------- 253 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC--------
T ss_pred hhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC--------
Confidence 1 12233456788999999876 568999999999999999999 7788887776666555544221111
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...+++.+.+||.+||..||.+|||+.++++
T Consensus 254 --------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 --------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1346788999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-31 Score=277.89 Aligned_cols=200 Identities=22% Similarity=0.286 Sum_probs=150.1
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++.+.||+|+||+||+|++ .+++.||||+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 357899999999999999999996 4688999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-C
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-R 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~ 216 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++....... .
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 45799999999999999999999999999999999999999999997654322 2
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHH---HHhcCCCCchhhhccCCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI---FKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i---~~~~g~pp~~~~~~~~l~ 293 (634)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+ ...... ..+.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 266 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN--------GQLE 266 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT--------TCCC
T ss_pred ccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc--------ccHH
Confidence 22344568999999999876 56899999999999999999999999764332111100 000000 0000
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
....+.. ........+..+.+||.+||..||.+|||+.|+|++-
T Consensus 267 --~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 267 --QIVDPNL-----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp --SSSSSSC-----TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HhcChhh-----ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000000 0011123567889999999999999999999999764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=284.50 Aligned_cols=183 Identities=20% Similarity=0.327 Sum_probs=152.0
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++++.||+|+||+||++.+. ++.||||+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 3567789999999999999999999984 77999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 35689999999999999999999999999999999999999999998554321
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..+......+
T Consensus 344 --~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------- 406 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-------------- 406 (450)
T ss_dssp -----CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC--------------
T ss_pred --cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 22355788999999976 678999999999999999998 999999877766666554321100
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 407 --------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 --------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11357899999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-31 Score=275.01 Aligned_cols=190 Identities=25% Similarity=0.401 Sum_probs=145.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
..++|++++.||+|+||.||++++..+++.||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 34689999999999999999999999999999994
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 356899999999999999999999999999999999999999999875432
Q ss_pred CCCC--------CcccccccccCCCcccccCCC--CCCCccccccchhhHHHHhhCCCCCCCCChH-HHHHHHHHhcCCC
Q 006714 214 GHRQ--------PLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSP 282 (634)
Q Consensus 214 ~~~~--------~~~~~~gt~~Y~APE~l~~~~--~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~-e~l~~i~~~~g~p 282 (634)
.... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||...... ..+..........
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence 1100 012234689999999987532 2688999999999999999999999531100 0011111100000
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 283 p~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
+ ....++..+.+||.+||..||.+|||+.+++++-
T Consensus 267 ~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 267 P---------------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp C---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C---------------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 0 0135788999999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=291.91 Aligned_cols=194 Identities=24% Similarity=0.355 Sum_probs=158.9
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
+.+..++|++.++||+|+||+||++++.. +..||||+
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~ 340 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 340 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence 34667889999999999999999999865 45699985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++..........
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 35688999999999999999999999999999999999999999998664322112
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.. ..++.++|||||||+||||++ |..||.+....+.+..+......+
T Consensus 421 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------------- 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------------- 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---------------
T ss_pred ccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 223345788999999875 568999999999999999999 999999988887777764421111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc--cccCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS--EYFST 348 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h--pwf~~ 348 (634)
....+++.+.+||.+||..||.+|||+.+|++. .+|..
T Consensus 485 -------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 013578899999999999999999999999874 56554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-31 Score=279.51 Aligned_cols=186 Identities=18% Similarity=0.250 Sum_probs=143.7
Q ss_pred ccccCCCeeEEEEecccCceeEEEE-----EECCCCcEEehHH-------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRA-----RDLDTGKIVALKK------------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a-----~d~~tg~~vAlK~------------------------------------- 162 (634)
+.+..++|++.++||+|+||+||+| .+..+++.||||+
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 4456689999999999999999999 4677899999995
Q ss_pred ----------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-----------C
Q 006714 163 ----------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----------E 197 (634)
Q Consensus 163 ----------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-----------~ 197 (634)
+..|+.||+.||+|||+++|+||||||+||||+. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 4568999999999999999999999999999988 8
Q ss_pred CceEEeccccccccCC-CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHH
Q 006714 198 GVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276 (634)
Q Consensus 198 g~vkL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~ 276 (634)
+.+||+|||++..... .........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~------- 291 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------- 291 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC-------
Confidence 9999999999965431 12233455678999999999987 56899999999999999999999998543210
Q ss_pred HhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 277 ~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
.|.... .+ . . ...++.+.+|+..||+.+|.+|++..+.|.+.
T Consensus 292 ---------~~~~~~-----~~------~----~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 ---------ECKPEG-----LF------R----R--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ---------EEEECS-----CC------T----T--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ---------ceeech-----hc------c----c--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000000 00 0 0 02356788999999999999997665555543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=266.02 Aligned_cols=187 Identities=18% Similarity=0.287 Sum_probs=147.2
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------ 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------ 162 (634)
.++..++|++.+.||+|+||+||+|++.. .||+|+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 34566899999999999999999999754 367664
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC-
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG- 214 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~- 214 (634)
+..++.||+.||.|||+++|+|+||||+|||++ ++.++|+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 567999999999999999999999999999998 679999999998654321
Q ss_pred ---CCCCcccccccccCCCcccccC--------CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCC
Q 006714 215 ---HRQPLTSRVVTLWYRPPELLLG--------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 283 (634)
Q Consensus 215 ---~~~~~~~~~gt~~Y~APE~l~~--------~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp 283 (634)
.........+++.|+|||++.. ...++.++|||||||++|+|++|..||...........+........
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 1122334467899999999864 23578899999999999999999999998887776666543211110
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 284 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 284 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++.++.+||.+||..||.+|||+.++++
T Consensus 264 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 ---------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ---------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ---------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00246778999999999999999999999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=277.35 Aligned_cols=187 Identities=20% Similarity=0.256 Sum_probs=140.5
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCC---cEEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg---~~vAlK~------------------------------------------ 162 (634)
....|++.+.||+|+||+||+|++..++ ..||+|.
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3446899999999999999999975432 3578874
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 45688999999999999999999999999999999999999999997654322
Q ss_pred CC---CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 216 RQ---PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 216 ~~---~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.. ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+......+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~--------- 316 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL--------- 316 (373)
T ss_dssp -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC---------
T ss_pred cccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 11 1233456788999999876 678999999999999999999 788998776655555443321100
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 317 -------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 -------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 013468889999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-31 Score=300.65 Aligned_cols=211 Identities=25% Similarity=0.319 Sum_probs=152.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.++||+|+||+||+|++..+++.||||+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 689999999999999999999999999999995
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCc---eEEeccccccc
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANF 210 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~---vkL~DFGla~~ 210 (634)
++.++.||+.||.|||++||+|+||||+||||+.++. ++|+|||++..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 4568999999999999999999999999999987664 89999999987
Q ss_pred cCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 211 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........+.......... ......
T Consensus 174 ~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~ 248 (676)
T 3qa8_A 174 LDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE--HIVVYD 248 (676)
T ss_dssp TTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCSCC
T ss_pred ccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch--hhhhhh
Confidence 65432 2345678999999999876 678999999999999999999999998765433221111000000 000000
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.......+....+. .......+++.+.+||..||.+||.+|||+.++|+||||+.
T Consensus 249 ~l~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 249 DLTGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00000001111111 11122346788999999999999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=268.04 Aligned_cols=187 Identities=23% Similarity=0.365 Sum_probs=142.8
Q ss_pred CeeEEEEecccCceeEEEEE----ECCCCcEEehHH--------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~-------------------------------------------- 162 (634)
.|+++++||+|+||+||++. +..+++.||||+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 34999999999999998875 345788999985
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 216 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++........
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp EEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred EEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 457899999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHH-----------HHHHHHHhcCCCCch
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-----------QLHKIFKLCGSPPDD 285 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e-----------~l~~i~~~~g~pp~~ 285 (634)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.......
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 267 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG--- 267 (318)
T ss_dssp EC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT---
T ss_pred ccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc---
Confidence 12233456888999999976 567889999999999999999999987532211 000111100000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 286 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 286 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
. .......+++.+.+||.+||..||.+|||+.++++
T Consensus 268 -----~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 268 -----E----------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -----C----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----c----------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 00111457889999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=290.91 Aligned_cols=188 Identities=23% Similarity=0.368 Sum_probs=152.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCC---CcEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~t---g~~vAlK~---------------------------------------- 162 (634)
.+..++|++.+.||+|+||+||+|++..+ +..||||+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 465 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 465 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCce
Confidence 34457899999999999999999998654 45688874
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 34688999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+......+
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC------------
T ss_pred ceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 333334456789999999875 578999999999999999997 999999988888777765432111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 613 ----------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 ----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01357889999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=289.46 Aligned_cols=184 Identities=20% Similarity=0.253 Sum_probs=147.2
Q ss_pred CCeeEE-EEecccCceeEEEEEE--CCCCcEEehHH--------------------------------------------
Q 006714 130 DAFEKL-EKIGQGTYSSVFRARD--LDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~-~~LG~G~fg~Vy~a~d--~~tg~~vAlK~-------------------------------------------- 162 (634)
..+.+. ++||+|+||+||+|.+ ..+++.||||+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv 447 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV 447 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 345554 4899999999999954 45678899985
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC--C
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--Q 217 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~ 217 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++........ .
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 457899999999999999999999999999999999999999999986654321 1
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+|+.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+......+
T Consensus 528 ~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-------------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------------- 592 (635)
T ss_dssp -------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------------
T ss_pred cccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 2233345788999999976 678999999999999999998 999999998887777765432110
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++++.+||..||..||.+|||+.+|++
T Consensus 593 --------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 --------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01357899999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=287.28 Aligned_cols=192 Identities=20% Similarity=0.240 Sum_probs=151.4
Q ss_pred ccCCCeeEEE-EecccCceeEEEEEEC--CCCcEEehHH-----------------------------------------
Q 006714 127 LRADAFEKLE-KIGQGTYSSVFRARDL--DTGKIVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~-~LG~G~fg~Vy~a~d~--~tg~~vAlK~----------------------------------------- 162 (634)
+..++|.+.+ +||+|+||+||+|.+. .++..||||+
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 411 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 411 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeE
Confidence 4456777777 8999999999999875 3456799986
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++........
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 456899999999999999999999999999999999999999999987643322
Q ss_pred CC--cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 217 QP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 ~~--~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. .....+++.|+|||++.. ..++.++|||||||+||||++ |..||.+.+..+.+..+......+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 559 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME----------- 559 (613)
T ss_dssp ----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC-----------
T ss_pred eeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 11 122234688999999975 578999999999999999998 999999988887777664421100
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHH---hccccC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL---ASEYFS 347 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL---~hpwf~ 347 (634)
....+++++.+||..||..||.+|||+.+|+ ++.|+.
T Consensus 560 -----------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 -----------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1135789999999999999999999999985 455554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=265.56 Aligned_cols=203 Identities=22% Similarity=0.356 Sum_probs=148.3
Q ss_pred ccCCCeeEEEEecccCceeEEEEE----ECCCCcEEehHH----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKK---------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~----d~~tg~~vAlK~---------------------------------------- 162 (634)
+..++|++++.||+|+||.||+|+ +..+++.||||+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 445789999999999999999998 467899999986
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 456889999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 214 GHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 214 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..... . +....+......+....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhccccchhhhHHH
Confidence 3221 1223355778999999876 5678999999999999999999988764211 1 11111111110000000
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+. ........ ......+++++.+||.+||..||.+|||+.++++
T Consensus 272 ~~--~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LI--ELLKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH--HHHHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH--HHhhcCCC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 00000000 0011357889999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=264.62 Aligned_cols=194 Identities=23% Similarity=0.296 Sum_probs=144.8
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|...++||+|+||+||+|.+ +++.||+|+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999986 678888884
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC-
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~- 217 (634)
+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 3468899999999999999999999999999999999999999999765432221
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+..............
T Consensus 191 ~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 260 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-------- 260 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH--------
T ss_pred cccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh--------
Confidence 1234568999999998865 478999999999999999999999987654433333322211111000000
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
... .+.......+..+.+||.+||..||.+|||+.+++++
T Consensus 261 ~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 IDK------KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCS------SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccc------cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0000112345778999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=263.88 Aligned_cols=191 Identities=24% Similarity=0.298 Sum_probs=144.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||++++ +++.||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 5899999999999999999998 588999985
Q ss_pred ---------------------HHHHHHHHHHHHHHHH--------HCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLH--------s~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.||| +++|+|+||||+||||+.++.+||+|||++.....
T Consensus 120 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 120 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199 (342)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred eecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence 4568999999999999 89999999999999999999999999999976543
Q ss_pred CCCC---CcccccccccCCCcccccCCCC-----CCCccccccchhhHHHHhhC----------CCCCCCCC----hHHH
Q 006714 214 GHRQ---PLTSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIG----------KPILQGRT----EVEQ 271 (634)
Q Consensus 214 ~~~~---~~~~~~gt~~Y~APE~l~~~~~-----~s~~sDIWSLG~iLyeLltG----------~~pf~~~~----~~e~ 271 (634)
.... ......+|+.|+|||++.+... ++.++|||||||++|+|++| ..||.... ..+.
T Consensus 200 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 279 (342)
T 1b6c_B 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279 (342)
T ss_dssp TTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred cccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHH
Confidence 3211 2244578999999999876322 23689999999999999999 67776542 1222
Q ss_pred HHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 272 l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+...+......+ .. .... ....++..+.+||.+||..||.+|||+.++++|
T Consensus 280 ~~~~~~~~~~~~-----------------~~--~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 280 MRKVVCEQKLRP-----------------NI--PNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHTTSCCCC-----------------CC--CGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCC-----------------CC--cccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 222211100000 00 0000 012345678999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=266.48 Aligned_cols=148 Identities=16% Similarity=0.135 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHHHH-HCCceeccCCCCCceecCCC--------------------ceEEeccccccccCCCCCCCccccc
Q 006714 165 CYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG--------------------VLKLADFGLANFSNTGHRQPLTSRV 223 (634)
Q Consensus 165 ~i~~Qll~aL~yLH-s~gIvHrDLKp~NILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~ 223 (634)
.|+.||+.||.||| +++|+||||||+||||+.++ .+||+|||+++.... ...+
T Consensus 165 ~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~ 238 (336)
T 2vuw_A 165 SILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVV 238 (336)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEE
T ss_pred HHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEE
Confidence 47889999999999 99999999999999999887 899999999986653 2457
Q ss_pred ccccCCCcccccCCCCCCCccccccchhh-HHHHhhCCCCCCCCCh-HHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 224 VTLWYRPPELLLGATDYGPSVDLWSVGCV-FAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 224 gt~~Y~APE~l~~~~~~s~~sDIWSLG~i-LyeLltG~~pf~~~~~-~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
||+.|+|||++.+.. +.++|||||+++ .++++.|..||..... ......+........
T Consensus 239 gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 298 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------------------ 298 (336)
T ss_dssp CCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS------------------
T ss_pred EeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc------------------
Confidence 899999999998633 789999998777 7888999999854221 112223322111110
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHH-hccccC
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL-ASEYFS 347 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL-~hpwf~ 347 (634)
......+..+++++.+||.+||++| |+.|+| +||||+
T Consensus 299 ----~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 ----KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ----CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ----ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0001122457889999999999987 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-28 Score=284.53 Aligned_cols=176 Identities=24% Similarity=0.338 Sum_probs=146.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECC-CCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~-tg~~vAlK~--------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++.. +++.||||+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999976 789999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..|+.||+.||.|||++||+||||||+||||+.+ .+||+|||++......
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--- 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---
Confidence 46789999999999999999999999999999875 8999999999876542
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
...++|+.|+|||++.+ .++.++|||||||+||+|++|.+||.+.... ..+
T Consensus 235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~-------------- 285 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLP-------------- 285 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCC--------------
T ss_pred --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccc--------------
Confidence 44578999999999875 3488999999999999999999888642100 000
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.... ....++.+.+||.+||..||.+||++.++|.|+|+.
T Consensus 286 ------~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ------EDDP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TTCH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------cccc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000 012457889999999999999999999999999885
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-28 Score=248.99 Aligned_cols=163 Identities=20% Similarity=0.130 Sum_probs=130.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|++..+++.||||+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------------
Confidence 35689999999999999999999999999999999999998543
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
|++ .++.++|||||||+||+|++|+.||.+.+..+.+... ....
T Consensus 175 ------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------------------~~~~ 218 (286)
T 3uqc_A 175 ------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------------------ERDT 218 (286)
T ss_dssp ------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------------CBCT
T ss_pred ------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------------HHHh
Confidence 333 2678999999999999999999999875432110000 0000
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.............+++.+.+||.+||..||.+| |+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000112234446789999999999999999999 99999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.9e-21 Score=216.17 Aligned_cols=96 Identities=19% Similarity=0.118 Sum_probs=67.3
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCC
Q 006714 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 242 (634)
Q Consensus 163 i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~ 242 (634)
...|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++...... ....+.+||+.|+|||++.+ .+..
T Consensus 341 ~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g--~~~~ 417 (569)
T 4azs_A 341 REKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE--NKSW 417 (569)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC--------
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC--CCCC
Confidence 35699999999999999999999999999999999999999999998765432 33456789999999999976 4667
Q ss_pred ccccccchhhHHHHhhCCC
Q 006714 243 SVDLWSVGCVFAELLIGKP 261 (634)
Q Consensus 243 ~sDIWSLG~iLyeLltG~~ 261 (634)
.+|+|++|+++++|+++..
T Consensus 418 ~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 418 NGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -----------CCCCTTHH
T ss_pred cccccccccchhhhccccc
Confidence 8999999999999877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=5.7e-17 Score=182.37 Aligned_cols=97 Identities=19% Similarity=0.228 Sum_probs=79.5
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC------CcccccccccCCCcccccC-C
Q 006714 165 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLG-A 237 (634)
Q Consensus 165 ~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~-~ 237 (634)
.++.||+.+|.|||+++|+||||||+|||++. .+||+|||+++........ .....++|+.|+|||++.. .
T Consensus 435 ~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~ 512 (540)
T 3en9_A 435 DIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL 512 (540)
T ss_dssp HHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH
Confidence 57899999999999999999999999999988 9999999999877542211 1235678999999999853 1
Q ss_pred CCCCCccccccchhhHHHHhhCCCCC
Q 006714 238 TDYGPSVDLWSVGCVFAELLIGKPIL 263 (634)
Q Consensus 238 ~~~s~~sDIWSLG~iLyeLltG~~pf 263 (634)
..|+..+|+|+..+-..+.+..+..|
T Consensus 513 ~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 513 EGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 34677889999988888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-14 Score=148.22 Aligned_cols=89 Identities=21% Similarity=0.185 Sum_probs=77.0
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHHH-----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKI----------------------------------------------- 163 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~i----------------------------------------------- 163 (634)
.|.+.+.||+|+||.||+|++ .+++.||||++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~ 169 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 169 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeE
Confidence 455669999999999999999 78989988742
Q ss_pred --------------------------HHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 164 --------------------------KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 164 --------------------------~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
..++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..
T Consensus 170 ~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------- 241 (282)
T 1zar_A 170 YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------- 241 (282)
T ss_dssp EEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-------
T ss_pred EeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-------
Confidence 34788999999999999999999999999999 99999999999863
Q ss_pred CcccccccccCCCccccc
Q 006714 218 PLTSRVVTLWYRPPELLL 235 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~ 235 (634)
+..|+|||++.
T Consensus 242 -------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 -------VGEEGWREILE 252 (282)
T ss_dssp -------TTSTTHHHHHH
T ss_pred -------CCCCCHHHHHH
Confidence 23478898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.5e-13 Score=135.43 Aligned_cols=79 Identities=20% Similarity=0.256 Sum_probs=70.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcE--EehHH----------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKI--VALKK---------------------------------------------- 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~--vAlK~---------------------------------------------- 162 (634)
-|++.+.||+|+||.||+|.+..+|+. ||||+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998778888 99981
Q ss_pred --------------------------------------------HHHHHHHHHHHHHHHH-HCCceeccCCCCCceecCC
Q 006714 163 --------------------------------------------IKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNE 197 (634)
Q Consensus 163 --------------------------------------------i~~i~~Qll~aL~yLH-s~gIvHrDLKp~NILl~~~ 197 (634)
+..++.||+.+|.||| ++||+||||||+|||++.
T Consensus 128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~- 206 (258)
T 1zth_A 128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID- 206 (258)
T ss_dssp HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-
T ss_pred HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-
Confidence 2347789999999999 999999999999999988
Q ss_pred CceEEecccccccc
Q 006714 198 GVLKLADFGLANFS 211 (634)
Q Consensus 198 g~vkL~DFGla~~~ 211 (634)
.++|+|||++...
T Consensus 207 -~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 -KVYFIDMGQAVTL 219 (258)
T ss_dssp -SEEECCCTTCEET
T ss_pred -cEEEEECcccccC
Confidence 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.27 E-value=3.6e-12 Score=137.08 Aligned_cols=79 Identities=22% Similarity=0.272 Sum_probs=70.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
-|+|..+||.|+||.||+|.+. +|+.||||+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999975 699999994
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC----------ce
Q 006714 163 --------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----------VL 200 (634)
Q Consensus 163 --------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g----------~v 200 (634)
...++.||+.+|.|||.+|||||||||.||||++++ .+
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~ 254 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTP 254 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccce
Confidence 345889999999999999999999999999998776 38
Q ss_pred EEeccccccc
Q 006714 201 KLADFGLANF 210 (634)
Q Consensus 201 kL~DFGla~~ 210 (634)
.|+||+.+..
T Consensus 255 ~iID~~Q~V~ 264 (397)
T 4gyi_A 255 IIIXFPQMVS 264 (397)
T ss_dssp EECCCTTCEE
T ss_pred EEEEeCCccc
Confidence 9999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=2.4e-05 Score=78.20 Aligned_cols=78 Identities=17% Similarity=0.218 Sum_probs=63.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++...++.|+.+.||++.. .+..+++|.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4688999999999999999974 356677764
Q ss_pred ---------------HHHHHHHHHHHHHHHHH------------------------------------------------
Q 006714 163 ---------------IKCYMNQLLHGLEHCHS------------------------------------------------ 179 (634)
Q Consensus 163 ---------------i~~i~~Qll~aL~yLHs------------------------------------------------ 179 (634)
...++.++..+|..||.
T Consensus 92 i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (263)
T 3tm0_A 92 ADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp CSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred cCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence 12477899999999999
Q ss_pred -----------CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 -----------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 -----------~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
..++|+|+++.|||+++...+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998663
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=4.4e-05 Score=75.44 Aligned_cols=28 Identities=29% Similarity=0.305 Sum_probs=24.5
Q ss_pred ceeccCCCCCceecCCCceEEecccccc
Q 006714 182 VLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 182 IvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
++|+||+|.|||++.+..+.|+||+.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00023 Score=73.03 Aligned_cols=78 Identities=17% Similarity=0.214 Sum_probs=48.4
Q ss_pred CceeccCCCCCceecC--CCceEEeccccccccCCCCCCCcccccccccC---CCcccc----cCCCC---------CCC
Q 006714 181 GVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWY---RPPELL----LGATD---------YGP 242 (634)
Q Consensus 181 gIvHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y---~APE~l----~~~~~---------~s~ 242 (634)
.++|+||++.|||++. ...+.|+||+.+...... ........+ ..|+.+ ..... ...
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~ 266 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRM 266 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHH
Confidence 3699999999999988 456789999988654321 111111111 222221 10000 112
Q ss_pred ccccccchhhHHHHhhCCCCC
Q 006714 243 SVDLWSVGCVFAELLIGKPIL 263 (634)
Q Consensus 243 ~sDIWSLG~iLyeLltG~~pf 263 (634)
-.++|+++.++|.+.+|.++|
T Consensus 267 ~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 267 KEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHcCCHHH
Confidence 258999999999999998775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0049 Score=64.48 Aligned_cols=32 Identities=22% Similarity=0.427 Sum_probs=26.6
Q ss_pred CCceeccCCCCCceecCCCc--eEEecccccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGV--LKLADFGLANFS 211 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~--vkL~DFGla~~~ 211 (634)
..++|+|+++.|||++.++. +.|+||+.+...
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999987653 689999988643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.021 Score=58.57 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=26.7
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999877889999998664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.00 E-value=0.2 Score=49.14 Aligned_cols=90 Identities=16% Similarity=0.075 Sum_probs=53.5
Q ss_pred CCCcEEehHH-------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 153 DTGKIVALKK-------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 153 ~tg~~vAlK~-------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
.+.+.|.++. +|.++.|.+..|.-+-. ..-...=+.|..|+|..+|.|-+.+ ..+.
T Consensus 28 ~~~~~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 28 SSRDALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp CCCSEEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred CccccccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 4455677765 57788888888766522 1112333456888999999887764 1110
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 258 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt 258 (634)
.....+.|||.+. ...+.+.=|||||++||.-+-
T Consensus 98 ----~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1122366888763 344677889999999998774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.30 E-value=0.1 Score=51.68 Aligned_cols=28 Identities=25% Similarity=0.380 Sum_probs=24.4
Q ss_pred ceeccCCCCCceecCCCceEEecccccc
Q 006714 182 VLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 182 IvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
++|+|+++.|||++.++.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 5899999999999887767799998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.42 E-value=0.064 Score=57.42 Aligned_cols=33 Identities=12% Similarity=0.412 Sum_probs=28.3
Q ss_pred HHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 178 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 178 Hs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
+...++|+||++.|||++.++ +.|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456899999999999998776 999999988644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=91.01 E-value=0.19 Score=50.59 Aligned_cols=31 Identities=13% Similarity=0.205 Sum_probs=26.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~ 162 (634)
...-++.+|.|..+.||++.. .+|+.|.+|+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~ 46 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKA 46 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEE
Confidence 566789999999999999984 5788888885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.15 E-value=0.14 Score=52.12 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=25.3
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.+++|+|+++.|||++.+..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999877656899998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=88.12 E-value=0.16 Score=52.16 Aligned_cols=32 Identities=31% Similarity=0.376 Sum_probs=27.2
Q ss_pred CCceeccCCCCCceecCC----CceEEecccccccc
Q 006714 180 RGVLHRDIKGSNLLVNNE----GVLKLADFGLANFS 211 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~----g~vkL~DFGla~~~ 211 (634)
..++|+|+++.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 67899999987644
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.97 E-value=0.27 Score=50.11 Aligned_cols=28 Identities=25% Similarity=0.208 Sum_probs=24.1
Q ss_pred CCceeccCCCCCceecCCCceEEecccccc
Q 006714 180 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 180 ~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 88999998654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=87.68 E-value=0.17 Score=52.50 Aligned_cols=32 Identities=16% Similarity=0.232 Sum_probs=26.3
Q ss_pred HCCceeccCCCCCceecCCCceEEeccccccc
Q 006714 179 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 179 s~gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
...++|+|+++.|||++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34799999999999998644578999988753
|
| >2pk2_A Cyclin-T1, protein TAT; TAR, twinning, transcription regulation P- TEFB, cell cycle; 2.67A {Homo sapiens} SCOP: a.74.1.1 a.74.1.1 PDB: 2w2h_C | Back alignment and structure |
|---|
Probab=86.51 E-value=0.14 Score=54.00 Aligned_cols=16 Identities=19% Similarity=0.297 Sum_probs=1.5
Q ss_pred ccccCCceeecCcccc
Q 006714 3 CVTSKQAVSVTPALDV 18 (634)
Q Consensus 3 ~~~~~~~~~~~~~~~~ 18 (634)
|+++.......++.+.
T Consensus 261 ~~~~~~~~~~~~~~~~ 276 (358)
T 2pk2_A 261 CEAAKKTKADDRGTDE 276 (358)
T ss_dssp TTC-------------
T ss_pred hhcccCCcccCccccc
Confidence 4455555555555443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=86.05 E-value=0.35 Score=49.35 Aligned_cols=31 Identities=29% Similarity=0.443 Sum_probs=25.5
Q ss_pred CceeccCCCCCceecC---CCc-eEEecccccccc
Q 006714 181 GVLHRDIKGSNLLVNN---EGV-LKLADFGLANFS 211 (634)
Q Consensus 181 gIvHrDLKp~NILl~~---~g~-vkL~DFGla~~~ 211 (634)
.++|+|+++.|||++. ++. +.|+||+.+...
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 6899999999999987 355 489999987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=84.97 E-value=0.66 Score=48.34 Aligned_cols=28 Identities=29% Similarity=0.521 Sum_probs=23.6
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++|+|+++.|||++.+. +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 689999999999997654 8999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.32 E-value=0.4 Score=49.71 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=26.6
Q ss_pred CceeccCCCCCceecCCCceEEeccccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 210 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~~ 210 (634)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 689999999999998878899999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=83.29 E-value=0.62 Score=48.99 Aligned_cols=30 Identities=17% Similarity=0.310 Sum_probs=24.9
Q ss_pred HCCceeccCCCCCceecCCCceEEecccccc
Q 006714 179 SRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 179 s~gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
...++|+|+++.|||++.+ .+.|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999765 48899997654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=80.32 E-value=0.93 Score=49.30 Aligned_cols=15 Identities=27% Similarity=0.368 Sum_probs=14.1
Q ss_pred CceeccCCCCCceec
Q 006714 181 GVLHRDIKGSNLLVN 195 (634)
Q Consensus 181 gIvHrDLKp~NILl~ 195 (634)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 634 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-09 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-09 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-08 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-09 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-07 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-07 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-08 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-08 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-08 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-08 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-08 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-09 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-08 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-10 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-08 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-33 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 0.003 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-10 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-09 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-06 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-08 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-08 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-07 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-07 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-08 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-04 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-08 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-05 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-04 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-08 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-24 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-05 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-05 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-04 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-05 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-04 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-04 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-04 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-05 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-07 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-07 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-05 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-21 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-05 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-04 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-04 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-05 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-20 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 0.001 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-04 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-51
Identities = 86/209 (41%), Positives = 116/209 (55%), Gaps = 4/209 (1%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
D ++ IK YM L GLE+ H +LHRD+K +NLL++ GVLKLADFGLA
Sbjct: 92 DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 272
+ +R T +VVT WYR PELL GA YG VD+W+VGC+ AELL+ P L G ++++QL
Sbjct: 152 SPNRAY-THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210
Query: 273 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
+IF+ G+P ++ W LP FK L F ++LI+ L P
Sbjct: 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNP 268
Query: 332 YKRATASAALASEYFSTKPYACDLSSLPI 360
R TA+ AL +YFS +P LP
Sbjct: 269 CARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.2 bits (137), Expect = 2e-09
Identities = 17/32 (53%), Positives = 28/32 (87%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
EKL+ +G+G +++V++ARD +T +IVA+KKIK
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK 32
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 8e-50
Identities = 83/199 (41%), Positives = 110/199 (55%), Gaps = 6/199 (3%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPL 219
IK M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
T+RVVTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +LC
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 280 GSPPDDYW---KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
GS + W +L Q R A++LI+ LL ++P +R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 337 ASAALASEYFSTKPYACDL 355
+ AL ++F + P DL
Sbjct: 299 SDDALNHDFFWSDPMPSDL 317
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.9 bits (131), Expect = 9e-09
Identities = 20/33 (60%), Positives = 25/33 (75%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+EKL KIGQGT+ VF+AR TG+ VALKK+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL 44
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 75/222 (33%), Positives = 114/222 (51%), Gaps = 7/222 (3%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQP 218
I ++ Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA + H
Sbjct: 109 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
LT V T WYR PE++L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I +
Sbjct: 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
GSP + A + P+ + F + + A++L++ +L+ P+KR
Sbjct: 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288
Query: 337 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 378
ALA Y D S PI + D + + + K
Sbjct: 289 VEQALAHPYLEQYY---DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 5e-08
Identities = 14/41 (34%), Positives = 19/41 (46%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQ 169
+ L IG+G Y V A D VA+KKI + +Q
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 47
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 6/230 (2%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209
++ + + ++ + Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA
Sbjct: 110 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
++ T V T WYR PE++L Y +VD+WSVGC+ AELL G+ + G +
Sbjct: 170 HTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 270 EQLHKIFKLCGSPPDDYWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 327
+QL I +L G+P + KK S+ + Q + F AV+L+E +L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 328 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARR 377
++ KR TA+ ALA YF+ D Y S E ++ +
Sbjct: 286 VLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 7/234 (2%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
L+ + + Y + + + +K YM QL L + HS G+ HRDIK NLL+
Sbjct: 98 LDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 195 NNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 253
+ + VLKL DFG A G +P S + + +YR PEL+ GATDY S+D+WS GCV
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 254 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 313
AELL+G+PI G + V+QL +I K+ G+P + ++ + PQ +
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 314 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEI 367
P A+ L LL P R T A A +F LP + +
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRDPNVKLPNGRDTPAL 325
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (131), Expect = 1e-08
Identities = 17/53 (32%), Positives = 34/53 (64%), Gaps = 6/53 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKI---KCYMN---QLLHGLEHCH 178
+ + IG G++ V++A+ D+G++VA+KK+ K + N Q++ L+HC+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 74
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 72/220 (32%), Positives = 119/220 (54%), Gaps = 6/220 (2%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+I+ + Q+L GL + H+ G++HRD+K NL VN + LK+ DFGLA ++ +T
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT 176
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
VVT WYR PE++L Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 281 SPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+PP ++ ++ + A + P + AVNL+E +L ++ +R TA
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 378
ALA YF + D + Y S + + ++ +R
Sbjct: 297 EALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 80/188 (42%), Positives = 107/188 (56%), Gaps = 2/188 (1%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ +K ++ QLL GL CHSR VLHRD+K NLL+N G LKLA+FGLA R +
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLC 279
+ VVTLWYRPP++L GA Y S+D+WS GC+FAEL P+ G +QL +IF+L
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
G+P ++ W P P +SL L T +L++ LL P +R +A
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 340 ALASEYFS 347
AL YFS
Sbjct: 280 ALQHPYFS 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (134), Expect = 4e-09
Identities = 19/33 (57%), Positives = 30/33 (90%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+EKLEKIG+GTY +VF+A++ +T +IVALK+++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR 36
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 1e-43
Identities = 71/186 (38%), Positives = 106/186 (56%), Gaps = 1/186 (0%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
K ++ QLL+G+ +CH R VLHRD+K NLL+N EG LK+ADFGLA R+
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
+VTLWYR P++L+G+ Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G
Sbjct: 160 -EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
+P W K L + ++L+ +L ++P +R TA A
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 341 LASEYF 346
L YF
Sbjct: 279 LEHAYF 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 51.0 bits (121), Expect = 2e-07
Identities = 16/35 (45%), Positives = 26/35 (74%), Gaps = 1/35 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + LEKIG+GTY V++A++ + G+ ALKKI+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR 35
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-43
Identities = 79/192 (41%), Positives = 107/192 (55%), Gaps = 3/192 (1%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
IK Y+ QLL GL CHS VLHRD+K NLL+N EG +KLADFGLA R T
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-T 160
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
VVTLWYR PE+LLG Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
+P + W + + L +L+ +L +P KR +A AA
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 341 LASEYFS--TKP 350
LA +F TKP
Sbjct: 281 LAHPFFQDVTKP 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 75/187 (40%), Positives = 107/187 (57%), Gaps = 5/187 (2%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
+ IK M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA +
Sbjct: 115 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
TS VVTLWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI +
Sbjct: 173 TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
G P ++ W + F + + + D+ +L+ L+ P KR +A +
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 340 ALASEYF 346
AL+ YF
Sbjct: 290 ALSHPYF 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (117), Expect = 6e-07
Identities = 16/34 (47%), Positives = 26/34 (76%), Gaps = 1/34 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDL-DTGKIVALKKIK 164
+E + +IG+G Y VF+ARDL + G+ VALK+++
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR 42
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 28/201 (13%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
++ + + + +QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA
Sbjct: 94 IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153
Query: 212 NTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
+R+ L +++ TL Y PELL + VD+WS G V +L G+ ++
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
Q + +K + + +K + + + L+ +L
Sbjct: 214 QEYSDWKEKKTYLNP--------------------------WKKIDSAPLALLHKILVEN 247
Query: 331 PYKRATASAALASEYFSTKPY 351
P R T ++ KP
Sbjct: 248 PSARITIPDIKKDRWY-NKPL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (127), Expect = 3e-08
Identities = 12/64 (18%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKG 189
+ ++ ++ +G+G Y V A + T + VA+K + M + + E+ +++ +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62
Query: 190 SNLL 193
N++
Sbjct: 63 ENVV 66
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 33/198 (16%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209
R+L ++ Y+ +L + L +CHS+ V+HRDIK NLL+ + G LK+ADFG +
Sbjct: 95 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
+ + R + TL Y PPE++ G + VDLWS+G + E L+GKP + T
Sbjct: 155 HAPSSRRT---TLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
Query: 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
E +I ++ + PD + A +LI LL
Sbjct: 211 ETYKRISRVEFTFPD-----------------------------FVTEGARDLISRLLKH 241
Query: 330 EPYKRATASAALASEYFS 347
P +R L + +
Sbjct: 242 NPSQRPMLREVLEHPWIT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (123), Expect = 9e-08
Identities = 11/35 (31%), Positives = 21/35 (60%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ FE +G+G + +V+ AR+ + I+ALK +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 40
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 66/234 (28%), Positives = 122/234 (52%), Gaps = 17/234 (7%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+++ + Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MT 176
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
VVT +YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G
Sbjct: 177 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDS-------------SLRETFKDLPTTAVNLIETLL 327
+P ++ KK + + + Y + E K + A +L+ +L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 328 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID-AKHREDARRKKV 380
++P KR + AL Y + ++ + P K++D +H + ++ +
Sbjct: 296 VIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (128), Expect = 3e-08
Identities = 11/33 (33%), Positives = 17/33 (51%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++ L+ IG G V A D + VA+KK+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS 51
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (354), Expect = 1e-37
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPL 219
I+ YM ++L L++CHS G++HRD+K N+++++E L+L D+GLA F + G
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 186
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKL 278
RV + +++ PELL+ Y S+D+WS+GC+ A ++ K P G +QL +I K+
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 279 CGSP-PDDYWKKSKLPHATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVE 330
G+ DY K + F S R E + A++ ++ LL +
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 331 PYKRATASAALASEYFST 348
R TA A+ YF T
Sbjct: 307 HQSRLTAREAMEHPYFYT 324
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 54.1 bits (129), Expect = 2e-08
Identities = 13/58 (22%), Positives = 26/58 (44%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDI 187
D ++ + K+G+G YS VF A ++ + V +K +K + + +I
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNI 92
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 32/218 (14%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209
D+ T + +I + L LE HS V+HRDIK N+L+ +G +KL DFG
Sbjct: 105 TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
+ ++ V T ++ PE++ YGP VD+WS+G + E++ G+P +
Sbjct: 165 QITP-EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
L+ I G+P +K L + + L +
Sbjct: 223 RALYLIAT-NGTPELQNPEK-------------------------LSAIFRDFLNRCLDM 256
Query: 330 EPYKRATASAALASEYFSTKPYACDLSSL-PIYPPSKE 366
+ KR +A L ++ A LSSL P+ +KE
Sbjct: 257 DVEKRGSAKELLQHQFLKI---AKPLSSLTPLIAAAKE 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (131), Expect = 1e-08
Identities = 13/33 (39%), Positives = 23/33 (69%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + EKIGQG +V+ A D+ TG+ VA++++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 138 bits (349), Expect = 2e-37
Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 32/200 (16%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
L ++ K+ + M LL + H ++HRD+K N+L++++ +KL DFG +
Sbjct: 101 LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGR 266
+ G + L T Y PE++ + + YG VD+WS G + LL G P R
Sbjct: 161 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218
Query: 267 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 326
++ L I W D T +L+
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEW-------------------------DDYSDTVKDLVSRF 253
Query: 327 LSVEPYKRATASAALASEYF 346
L V+P KR TA ALA +F
Sbjct: 254 LVVQPQKRYTAEEALAHPFF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 55.1 bits (132), Expect = 7e-09
Identities = 16/76 (21%), Positives = 29/76 (38%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKG 189
+ +E E +G+G S V R T K A+K I E R +++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 190 SNLLVNNEGVLKLADF 205
+ + +++L D
Sbjct: 63 LRKVSGHPNIIQLKDT 78
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (354), Expect = 2e-37
Identities = 50/246 (20%), Positives = 81/246 (32%), Gaps = 30/246 (12%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANF 210
D ++ + YM Q+ GL H H +H D+K N++ + LKL DFGL
Sbjct: 116 DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
+ + T + PE+ G G D+WSVG + LL G G + E
Sbjct: 176 LDPKQS--VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
L + + D + + + I LL +
Sbjct: 233 TLRNVKSCDWNMDDSAF-------------------------SGISEDGKDFIRKLLLAD 267
Query: 331 PYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETR 390
P R T AL + + S +P +K D+ + + +
Sbjct: 268 PNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNY 327
Query: 391 KTTRKS 396
+ RK
Sbjct: 328 SSLRKH 333
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 31/199 (15%)
Query: 153 DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212
+ + + +I+ Q L L + H ++HRD+K N+L +G +KLADFG++ N
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-N 160
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTE 268
T Q S + T ++ PE+++ T Y D+WS+G E+ +P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
+ L KI K P + + + ++ L
Sbjct: 221 MRVLLKIAK-SEPPTLAQPSR-------------------------WSSNFKDFLKKCLE 254
Query: 329 VEPYKRATASAALASEYFS 347
R T S L + +
Sbjct: 255 KNVDARWTTSQLLQHPFVT 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 1e-35
Identities = 49/221 (22%), Positives = 82/221 (37%), Gaps = 36/221 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+I + L GL + HS ++HRD+K N+L++ G++KL DFG A+ P
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPAN 169
Query: 221 SRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
S V T ++ PE++L + Y VD+WS+G EL KP L + L+ I +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ- 228
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
P N +++ L P R T+
Sbjct: 229 -NESPALQS-------------------------GHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 339 AALASEYFSTKPYACDLSSLP--IYPPSKEIDAKHREDARR 377
L + + + L +E+D ++
Sbjct: 263 VLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.6 bits (131), Expect = 1e-08
Identities = 13/33 (39%), Positives = 23/33 (69%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
F L +IG G++ +V+ ARD+ ++VA+KK+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 49
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 44/211 (20%), Positives = 79/211 (37%), Gaps = 20/211 (9%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANF 210
L + + + ++ GL + + ++HRD+K SN+LVN+ G +KL DFG++
Sbjct: 95 LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
S V T Y PE L G T Y D+WS+G E+ +G+ + E
Sbjct: 155 LIDSM---ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 271 -QLHKIFKLCGSPPDDYWK-----KSKLPHATLFKPQQPYDSSLRETFKDLPTT------ 318
+L ++ G + + + + +P L + P
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
Query: 319 ---AVNLIETLLSVEPYKRATASAALASEYF 346
+ + L P +RA + +
Sbjct: 271 SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.5 bits (141), Expect = 7e-10
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 11/63 (17%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMN-----------QLLHGLE 175
L+ D FEK+ ++G G VF+ +G ++A K I + Q+LH
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 176 HCH 178
+
Sbjct: 63 SPY 65
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (340), Expect = 1e-35
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 35/221 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQP 218
++ YM Q GL+H H ++H DIK N++ +K+ DFGLA N
Sbjct: 127 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 184
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
+ T + PE++ G D+W++G + LL G G ++E L + +
Sbjct: 185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 243
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+D + + A + I+ LL EP KR T
Sbjct: 244 DWEFDEDAFSS-------------------------VSPEAKDFIKNLLQKEPRKRLTVH 278
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 379
AL + D S+L PS + ++ +
Sbjct: 279 DALEHPWLKG-----DHSNLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-34
Identities = 44/242 (18%), Positives = 81/242 (33%), Gaps = 33/242 (13%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQP 218
++I Y++Q+ L+ HS + H DI+ N++ +K+ +FG A G
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
Y PE+ + D+WS+G + LL G T + + I
Sbjct: 160 FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+ ++ + K++ A++ ++ LL E R TAS
Sbjct: 219 EYTFDEEAF-------------------------KEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 339 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHG 398
AL + K + + ++D R+ R G
Sbjct: 254 EALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG---GAIRSQKG 310
Query: 399 MS 400
+S
Sbjct: 311 VS 312
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 31/192 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ Y +++ LE+ H +G++HRD+K N+L+N + +++ DFG A + +Q
Sbjct: 108 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
Query: 221 SRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ V T Y PELL + S DLW++GC+ +L+ G P + E KI KL
Sbjct: 168 NSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
P+ ++ K A +L+E LL ++ KR
Sbjct: 227 YDFPEKFFPK-----------------------------ARDLVEKLLVLDATKRLGCEE 257
Query: 340 ALASEYFSTKPY 351
P+
Sbjct: 258 MEGYGPLKAHPF 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (131), Expect = 1e-08
Identities = 12/65 (18%), Positives = 30/65 (46%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDI 187
R + F+ + +G+G++S+V AR+L T + A+K ++ + + + + +
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 188 KGSNL 192
Sbjct: 66 DHPFF 70
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-33
Identities = 35/187 (18%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
+ K+ Q G+++ H++ ++HRD+K +N+ ++ + +K+ DFGLA +
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 220 TSRVV-TLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
++ ++ + PE++ Y D+++ G V EL+ G+ +Q+ +
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
PD L + + P L+ L + +R
Sbjct: 223 GRGYLSPD-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPL 259
Query: 337 ASAALAS 343
LAS
Sbjct: 260 FPQILAS 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (87), Expect = 0.003
Identities = 7/35 (20%), Positives = 17/35 (48%), Gaps = 3/35 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++IG G++ +V++ + VA+K +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLN 39
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 5e-32
Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 36/216 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRG-----VLHRDIKG 189
+E G +SV + + + + + M QL L+ CH R VLHRD+K
Sbjct: 84 MEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 142
Query: 190 SNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 249
+N+ ++ + +KL DFGLA N + V T +Y PE + Y D+WS+
Sbjct: 143 ANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSL 200
Query: 250 GCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 309
GC+ EL P ++ E KI + K ++P+
Sbjct: 201 GCLLYELCALMPPFTAFSQKELAGKIRE---------GKFRRIPY--------------- 236
Query: 310 ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 345
+I +L+++ Y R + L +
Sbjct: 237 ----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.1 bits (140), Expect = 6e-10
Identities = 13/37 (35%), Positives = 20/37 (54%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
RA+ +E L IG G+Y + R GKI+ K++
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD 38
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR 216
++ ++ Q+L+G+ + HS + H D+K N+++ + V +K+ DFGLA+ + G+
Sbjct: 113 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 276
+ T + PE++ G D+WS+G + LL G G T+ E L +
Sbjct: 173 --FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
+ D+Y+ + A + I LL +P KR T
Sbjct: 230 AVNYEFEDEYF-------------------------SNTSALAKDFIRRLLVKDPKKRMT 264
Query: 337 ASAALASEYFSTKPYACDLSSLPIYPP 363
+L + K LSS +P
Sbjct: 265 IQDSLQHPWIKPKDTQQALSSAWSHPQ 291
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (132), Expect = 7e-09
Identities = 17/77 (22%), Positives = 33/77 (42%), Gaps = 4/77 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKG 189
D ++ E++G G ++ V + R+ TG A K IK + SR + R++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSI 66
Query: 190 SNLLVNNEGVLKLADFG 206
+ + V+ L +
Sbjct: 67 LKEI-QHPNVITLHEVY 82
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 3e-31
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 31/215 (14%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ 217
+ + Q+L +++ H G++HRD+K NLL + + + ++DFGL+ + G
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV- 165
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
L++ T Y PE+L Y +VD WS+G + LL G P + + +I K
Sbjct: 166 -LSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
YW D+ +A + I L+ +P KR T
Sbjct: 224 AEYEFDSPYW-------------------------DDISDSAKDFIRHLMEKDPEKRFTC 258
Query: 338 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR 372
AL + + + K+ AK +
Sbjct: 259 EQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSK 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 52/250 (20%), Positives = 92/250 (36%), Gaps = 36/250 (14%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQ 217
++ M + +++ HS + HRD+K NLL +LKL DFG A + + +
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ T +Y PE+L Y S D+WS+G + LL G P + +
Sbjct: 171 T--TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
++ P S + E K LI LL EP +R T
Sbjct: 228 RIRMGQ--------------YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTI 266
Query: 338 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 397
+ + + + + P++ + K R + ++++ T R +
Sbjct: 267 TEFMNHPWIMQ---STKVPQTPLHTSRVLKEDKERWEDVKEEM------TSALATMRVDY 317
Query: 398 GMSKLAPVED 407
K+ +ED
Sbjct: 318 EQIKIKKIED 327
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 38/198 (19%), Positives = 72/198 (36%), Gaps = 34/198 (17%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNE-GVLKLADFGLA 208
L K++ +K ++ + Q+L GL+ H+R ++HRD+K N+ + G +K+ D GLA
Sbjct: 103 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
Query: 209 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 268
+ + T + PE+ Y SVD+++ G E+ +
Sbjct: 163 TLKRASF---AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN 217
Query: 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 328
Q+++ G P + K +IE +
Sbjct: 218 AAQIYRRVT-SGVKPASFD-------------------------KVAIPEVKEIIEGCIR 251
Query: 329 VEPYKRATASAALASEYF 346
+R + L +F
Sbjct: 252 QNKDERYSIKDLLNHAFF 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (111), Expect = 3e-06
Identities = 10/34 (29%), Positives = 22/34 (64%), Gaps = 1/34 (2%)
Query: 132 FEKLE-KIGQGTYSSVFRARDLDTGKIVALKKIK 164
F K + +IG+G++ +V++ D +T VA +++
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 43
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (300), Expect = 4e-30
Identities = 50/236 (21%), Positives = 96/236 (40%), Gaps = 39/236 (16%)
Query: 150 RDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 209
L + + ++ Y +++ GLEH H+R V++RD+K +N+L++ G ++++D GLA
Sbjct: 96 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 155
Query: 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 269
+ ++ + V T Y PE+L Y S D +S+GC+ +LL G +
Sbjct: 156 DFS---KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 270 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 329
++ H+I ++ + + +L+E LL
Sbjct: 213 DK-HEIDRMTLTMAVELP-------------------------DSFSPELRSLLEGLLQR 246
Query: 330 EPYKRATASAALASE-----YFST----KPYACDLSSLPIYPPSKEIDAKHREDAR 376
+ +R A E +F + + P+ PP E++A D
Sbjct: 247 DVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP-PLIPPRGEVNAADAFDIG 301
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-29
Identities = 43/196 (21%), Positives = 73/196 (37%), Gaps = 39/196 (19%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF 210
+ + + + + Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG
Sbjct: 101 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 211 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 270
T T Y PPE + +G S +WS+G + +++ G + E+
Sbjct: 161 LKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217
Query: 271 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 330
+ F+ + + + +LI L++
Sbjct: 218 RGQVFFR-----------------------------------QRVSSECQHLIRWCLALR 242
Query: 331 PYKRATASAALASEYF 346
P R T +
Sbjct: 243 PSDRPTFEEIQNHPWM 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 40/226 (17%)
Query: 145 SVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 204
S+ +TGK + L ++ Q+ G+ + +HRD++ +N+LV V K+AD
Sbjct: 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 156
Query: 205 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPIL 263
FGLA + + PE L + D+WS G + EL G+
Sbjct: 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 215
Query: 264 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323
G E L ++ + P + P + +L+
Sbjct: 216 PGMVNREVLDQVERGYRMPCPP----------------------------ECPESLHDLM 247
Query: 324 ETLLSVEPYKRATASAALA--SEYFSTKPYACDLSSLPIYPPSKEI 367
EP +R T A +YF+ S+ P Y P + +
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFT--------STEPQYQPGENL 285
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-29
Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 31/190 (16%)
Query: 152 LDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211
+ + L + Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ +
Sbjct: 94 IQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153
Query: 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 271
G + + T Y PE+LLG Y SVD WS G + E+LIG+ G+ E E
Sbjct: 154 MLGDAKT-NTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
Query: 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 331
H I P L A +L+ L EP
Sbjct: 212 FHSIRMDNPFYPR-----------------------------WLEKEAKDLLVKLFVREP 242
Query: 332 YKRATASAAL 341
KR +
Sbjct: 243 EKRLGVRGDI 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (125), Expect = 6e-08
Identities = 10/35 (28%), Positives = 19/35 (54%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ F + +G+G++ VF A T + A+K +K
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK 36
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (282), Expect = 8e-28
Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 36/240 (15%)
Query: 160 LKKIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGV------LKLADFGLANFSN 212
L +K QLL GL++ H G++H DIK N+L+ +K+AD G A + +
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 213 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT----- 267
+ + +R YR PE+LLGA +G D+WS C+ EL+ G + +
Sbjct: 184 EHYTNSIQTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
Query: 268 -EVEQLHKIFKLCGSPPDDYWKKSK----------LPHATLFKPQQPYDSSLRETFK--- 313
+ + + +I +L G P + K L P + L E +K
Sbjct: 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298
Query: 314 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 373
D + + +L ++P KRA A + + L I P +E+ +
Sbjct: 299 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD-----TLGMEEIRVPDRELYGSGSD 353
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 53.1 bits (126), Expect = 5e-08
Identities = 10/33 (30%), Positives = 21/33 (63%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + K+G G +S+V+ A+D+ VA+K ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR 47
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 8e-28
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
++ Y+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+ +
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 223 VVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 281
T+ Y P+++ G + + +VD WS+G + ELL G E +I +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250
Query: 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----AT 336
Y +++ A +LI+ LL +P KR
Sbjct: 251 SEPPYP-------------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRD 285
Query: 337 ASAALASEYFSTKPYACDLSSLPIYPPSK 365
A +F + DL++ + P K
Sbjct: 286 ADEIKEHLFFQKINWD-DLAAKKVPAPFK 313
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 2e-07
Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKI-KCYMNQLLHGLEHCHSRGVLHR 185
+ FE L+ +G G Y VF R + DTGK+ A+K + K + Q EH + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 186 DIKGSNLLVN 195
I+ S LV
Sbjct: 84 HIRQSPFLVT 93
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 9e-28
Identities = 33/191 (17%), Positives = 62/191 (32%), Gaps = 33/191 (17%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLAN 209
G+ ++K + Q+L ++ H + +++RDIK N L+ ++ + DFG+
Sbjct: 95 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154
Query: 210 F------SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 263
F + + T Y LG + DL ++G VF L G
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPW 213
Query: 264 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 323
QG K ++ ++ + LRE P +
Sbjct: 214 QGLKAATNKQKYERIG---------------------EKKQSTPLRELCAGFPEEFYKYM 252
Query: 324 ETLLSVEPYKR 334
++
Sbjct: 253 HYARNLAFDAT 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.3 bits (122), Expect = 1e-07
Identities = 8/33 (24%), Positives = 18/33 (54%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
++ +IG+G++ +F +L + VA+K
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP 39
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (274), Expect = 5e-27
Identities = 42/219 (19%), Positives = 77/219 (35%), Gaps = 40/219 (18%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222
K Y ++ LE+ HS+ +++RD+K N+L++ G +K+ DFG A + +
Sbjct: 106 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTL 161
Query: 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 282
T Y PE++ Y S+D WS G + E+L G ++ KI
Sbjct: 162 CGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 220
Query: 283 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATA 337
P + + +L+ L++ + +R
Sbjct: 221 PPFFNED-----------------------------VKDLLSRLITRDLSQRLGNLQNGT 251
Query: 338 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAR 376
+F + L S I P + + + D
Sbjct: 252 EDVKNHPWFKEVVWE-KLLSRNIETPYEPPIQQGQGDTS 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.3 bits (130), Expect = 1e-08
Identities = 13/62 (20%), Positives = 28/62 (45%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 191
F+ L +G G++ V R G+ A+K +K + L +EH + ++ +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 192 LL 193
++
Sbjct: 66 II 67
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
++ + Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL + +
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMK 163
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
+ T Y PE+L DYG +VD W +G V E++ G+ + I
Sbjct: 164 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--- 219
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----A 335
+ + P + L A +L+ LL +P +R +
Sbjct: 220 -----------------EEIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPS 253
Query: 336 TASAALASEYFSTKPYACDLSSLPIYPPSK-----EIDAKHRED 374
A + +F + + D+ + PP K E+D ++ +D
Sbjct: 254 DAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 2e-26
Identities = 40/208 (19%), Positives = 76/208 (36%), Gaps = 40/208 (19%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ Y Q++ E+ HS +++RD+K NLL++ +G +++ DFG A +
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTW 196
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
+ T PE++L Y +VD W++G + E+ G P ++ KI
Sbjct: 197 TLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----A 335
P + +L+ LL V+ KR
Sbjct: 256 RFPSHFSSD-----------------------------LKDLLRNLLQVDLTKRFGNLKN 286
Query: 336 TASAALASEYFSTKPYACDLSSLPIYPP 363
+ ++F+T + + + P
Sbjct: 287 GVNDIKNHKWFATTDWI-AIYQRKVEAP 313
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-26
Identities = 37/198 (18%), Positives = 74/198 (37%), Gaps = 30/198 (15%)
Query: 143 YSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 202
Y + R + + ++ + + C+ Q+ G+E + +HRD+ N+LV + V+K+
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205
Query: 203 ADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 260
DFGLA + + + + + + PE L Y D+WS G + E+ +G
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 264
Query: 261 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 320
G +K+ + FK QP
Sbjct: 265 NPYPGIPVDANFYKLIQ------------------NGFKMDQP---------FYATEEIY 297
Query: 321 NLIETLLSVEPYKRATAS 338
++++ + + KR +
Sbjct: 298 IIMQSCWAFDSRKRPSFP 315
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 2e-04
Identities = 10/45 (22%), Positives = 17/45 (37%), Gaps = 5/45 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKKIKCYMNQ 169
+ E + +G G + V A K VA+K +K +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 106 bits (265), Expect = 4e-26
Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 28/186 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQP 218
K+ + L H G++HRD+K +N++++ +K+ DFG+A +
Sbjct: 111 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 278
+ + T Y PE G + D++S+GCV E+L G+P G + V ++ +
Sbjct: 171 TAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
PP + L ++ L+ P R +
Sbjct: 230 DPIPPSARH-------------------------EGLSADLDAVVLKALAKNPENRYQTA 264
Query: 339 AALASE 344
A + ++
Sbjct: 265 AEMRAD 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 53.6 bits (128), Expect = 2e-08
Identities = 14/36 (38%), Positives = 21/36 (58%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+D +E E +G G S V ARDL + VA+K ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR 41
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (264), Expect = 6e-26
Identities = 37/180 (20%), Positives = 66/180 (36%), Gaps = 31/180 (17%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 219
+ C Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N + + +
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 199
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKL 278
+ + + + PPE + Y D+W+ G V E+ G G E ++ +
Sbjct: 200 GNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-- 256
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
D ++ ++ P NL+ S P R +
Sbjct: 257 --------------------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.6 bits (107), Expect = 1e-05
Identities = 12/40 (30%), Positives = 21/40 (52%), Gaps = 5/40 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKIK 164
+ E + IG+G + VF+AR + +VA+K +K
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK 52
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 43/185 (23%), Positives = 65/185 (35%), Gaps = 31/185 (16%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQ 217
L + Y Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL N H
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIF 276
R V + PE L T + + D W G E+ G+ G + LHKI
Sbjct: 170 MQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
K P +D P N++ + +P R T
Sbjct: 229 KEGERLPRP---------------------------EDCPQDIYNVMVQCWAHKPEDRPT 261
Query: 337 ASAAL 341
A
Sbjct: 262 FVALR 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 11/36 (30%), Positives = 16/36 (44%), Gaps = 3/36 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDT---GKIVALKKIK 164
LEK+G G++ V R VA+K +K
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK 45
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (257), Expect = 6e-25
Identities = 34/193 (17%), Positives = 65/193 (33%), Gaps = 31/193 (16%)
Query: 155 GKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFS 211
+ +LK + +Q++ +E+ HS+ +HRD+K N L+ ++ + DFGLA
Sbjct: 97 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 212 NTG------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 265
+ + T Y LG + DL S+G V +G QG
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQG 215
Query: 266 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 325
+ K ++ ++ + + K P+ +
Sbjct: 216 LKAATKRQKYERIS---------------------EKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 326 LLSVEPYKRATAS 338
S+ + S
Sbjct: 255 CRSLRFDDKPDYS 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.8 bits (123), Expect = 9e-08
Identities = 9/36 (25%), Positives = 18/36 (50%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + KIG G++ ++ D+ G+ VA+K
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC 41
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 36/189 (19%), Positives = 68/189 (35%), Gaps = 32/189 (16%)
Query: 162 KIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221
K+ Q+ G+ R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCG 280
+ + PE + T + D+WS G + E++ G+ G T E + + +
Sbjct: 170 AKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--- 225
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
++ +P + P L+ P R T
Sbjct: 226 ----------------GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYL 260
Query: 341 LA--SEYFS 347
+ ++F+
Sbjct: 261 RSVLEDFFT 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 1e-05
Identities = 8/35 (22%), Positives = 18/35 (51%), Gaps = 1/35 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ + +E++G G + V+ + VA+K +K
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLK 46
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 36/182 (19%), Positives = 63/182 (34%), Gaps = 30/182 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ + + G+ + V+HRD+ N LV V+K++DFG+ F T
Sbjct: 101 ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLC 279
+ + PE+ + Y D+WS G + E+ GK + R+ E + I
Sbjct: 161 GTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---- 215
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+T F+ +P + T ++ P R S
Sbjct: 216 ---------------STGFRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSR 251
Query: 340 AL 341
L
Sbjct: 252 LL 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 1e-05
Identities = 9/35 (25%), Positives = 16/35 (45%), Gaps = 1/35 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+++IG G + V L+ VA+K I+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR 38
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 41/214 (19%), Positives = 71/214 (33%), Gaps = 17/214 (7%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIV--ALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 192
+ G+ + ++ AL + + + + HRD+K N+
Sbjct: 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139
Query: 193 LVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGA-----TDYGPSV 244
LV G +AD GLA ++ RV T Y PE+L + +
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199
Query: 245 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304
D++++G VF E+ I G E QL + P + +K +P P
Sbjct: 200 DIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ--KLRPNIPN 256
Query: 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
E + + ++ R TA
Sbjct: 257 RWQSCEALRVM----AKIMRECWYANGAARLTAL 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (96), Expect = 2e-04
Identities = 10/30 (33%), Positives = 16/30 (53%), Gaps = 2/30 (6%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
E IG+G + V+R + G+ VA+K
Sbjct: 8 QESIGKGRFGEVWRGK--WRGEEVAVKIFS 35
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 4e-24
Identities = 31/208 (14%), Positives = 72/208 (34%), Gaps = 37/208 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194
E + +G+ R+R ++ + + + +E+ +HRD+ N+LV
Sbjct: 80 TEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 136
Query: 195 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+ + V K++DFGL +++ + + + + PE L + D+WS G +
Sbjct: 137 SEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLW 191
Query: 255 ELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 313
E+ G+ + + ++ K +K P
Sbjct: 192 EIYSFGRVPYPRIPLKDVVPRVEK-------------------GYKMDAP---------D 223
Query: 314 DLPTTAVNLIETLLSVEPYKRATASAAL 341
P +++ ++ R +
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 1e-23
Identities = 35/183 (19%), Positives = 70/183 (38%), Gaps = 30/183 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+++ + +E+ S+ LHRD+ N LVN++GV+K++DFGL+ +
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLC 279
+ + PPE+L+ + + D+W+ G + E+ +GK + T E I
Sbjct: 160 GSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---- 214
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
A + +P ++ + + +R T
Sbjct: 215 ---------------AQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKI 250
Query: 340 ALA 342
L+
Sbjct: 251 LLS 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (104), Expect = 2e-05
Identities = 9/33 (27%), Positives = 15/33 (45%), Gaps = 1/33 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
L+++G G + V + VA+K IK
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK 37
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.4 bits (247), Expect = 1e-23
Identities = 33/186 (17%), Positives = 66/186 (35%), Gaps = 34/186 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
++ + + G+++ +HRD+ N+LVN+ V K++DFGL+ F P
Sbjct: 128 IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 221 SRVV----TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 275
+ + + + PE + + + D+WS G V E++ G+ T + ++ I
Sbjct: 188 TSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246
Query: 276 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 335
+ PP D P+ L+ + R
Sbjct: 247 EQDYRLPPPM----------------------------DCPSALHQLMLDCWQKDRNHRP 278
Query: 336 TASAAL 341
+
Sbjct: 279 KFGQIV 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.0 bits (98), Expect = 1e-04
Identities = 10/41 (24%), Positives = 16/41 (39%), Gaps = 3/41 (7%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKIK 164
+ + + IG G + V GK VA+K +K
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 37/184 (20%), Positives = 70/184 (38%), Gaps = 30/184 (16%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219
L + Y QL L + S+ +HRDI N+LV++ +KL DFGL+ +
Sbjct: 107 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL 278
+ + + + PE + + + D+W G E+L+ G QG + + +I
Sbjct: 167 SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN- 224
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
++ +P + P T +L+ + +P +R +
Sbjct: 225 --------GERLPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFT 257
Query: 339 AALA 342
A
Sbjct: 258 ELKA 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 2e-04
Identities = 9/38 (23%), Positives = 15/38 (39%), Gaps = 3/38 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKIK 164
+ E IG+G + V + + VA+K K
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 44
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 3e-22
Identities = 32/194 (16%), Positives = 68/194 (35%), Gaps = 35/194 (18%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQP 218
K I ++Q+ G+++ +HRD+ N+L+ + K++DFGL+ ++ + +
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 277
T + + PE + + D+WS G + E G+ +G E + K
Sbjct: 167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
++ P P +L+ + + R
Sbjct: 226 ---------GERMGCP-------------------AGCPREMYDLMNLCWTYDVENRPGF 257
Query: 338 S---AALASEYFST 348
+ L + Y+
Sbjct: 258 AAVELRLRNYYYDV 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 9e-04
Identities = 8/30 (26%), Positives = 16/30 (53%), Gaps = 2/30 (6%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKIK 164
++G G + +V + + K VA+K +K
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK 43
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 8e-22
Identities = 37/197 (18%), Positives = 78/197 (39%), Gaps = 32/197 (16%)
Query: 148 RARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 207
A T ++ +++ + + G+++ + +HRD+ N+LV V K+ADFGL
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 208 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGR 266
+ ++ T + + + E L + Y + D+WS G + E++ +G G
Sbjct: 174 SRGQEVYVKK--TMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230
Query: 267 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 326
T E K+ + ++ ++P + +L+
Sbjct: 231 TCAELYEKLPQ-------------------GYRLEKP---------LNCDDEVYDLMRQC 262
Query: 327 LSVEPYKRATASAALAS 343
+PY+R + + L S
Sbjct: 263 WREKPYERPSFAQILVS 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 6e-05
Identities = 11/42 (26%), Positives = 22/42 (52%), Gaps = 2/42 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKIKCYMNQ 169
+ + + IG+G + V +AR G A+K++K Y ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 51
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.9 bits (230), Expect = 1e-21
Identities = 26/181 (14%), Positives = 55/181 (30%), Gaps = 28/181 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 115 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 280
+ + PE L + D+W+ G + E+ ++ Q++++ +
Sbjct: 175 GAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 233
Query: 281 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 340
+ P L+ P R + +
Sbjct: 234 RMERP---------------------------EGCPEKVYELMRACWQWNPSDRPSFAEI 266
Query: 341 L 341
Sbjct: 267 H 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 50.1 bits (119), Expect = 3e-07
Identities = 9/35 (25%), Positives = 13/35 (37%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKIK 164
K+G G Y V+ VA+K +K
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 51
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 2e-21
Identities = 32/194 (16%), Positives = 69/194 (35%), Gaps = 35/194 (18%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQ 217
+ + ++Q+ G+++ + +HRD+ N+L+ N K++DFGL+ ++ +
Sbjct: 108 VSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIF 276
++ L + PE + + D+WS G E L G+ + E + I
Sbjct: 168 ARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226
Query: 277 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 336
+ K+ + P + P L+ + R
Sbjct: 227 Q---------GKRMECP-------------------PECPPELYALMSDCWIYKWEDRPD 258
Query: 337 AS---AALASEYFS 347
+ + Y+S
Sbjct: 259 FLTVEQRMRACYYS 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 2e-21
Identities = 31/184 (16%), Positives = 57/184 (30%), Gaps = 31/184 (16%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
+ + + Q+ G+ + R ++HRD+ N+LV +K+ DFGLA ++
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 221 SRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKL 278
+ + E +L Y D+WS G EL+ G G E + K
Sbjct: 171 EGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK- 228
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
+ QP ++ ++ R
Sbjct: 229 ------------------GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFR 261
Query: 339 AALA 342
+
Sbjct: 262 ELII 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (116), Expect = 9e-07
Identities = 10/42 (23%), Positives = 25/42 (59%), Gaps = 4/42 (9%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKIK 164
L+ F+K++ +G G + +V++ + G+ VA+K+++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 47
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 3e-21
Identities = 38/207 (18%), Positives = 65/207 (31%), Gaps = 30/207 (14%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 196
+ + + A + + L+ + CY Q+ G+E SR +HRD+ N+L++
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169
Query: 197 EGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAE 255
+ V+K+ DFGLA L + PE + Y D+WS G + E
Sbjct: 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWE 228
Query: 256 LLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 314
+ G E+ + K
Sbjct: 229 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---------------------------DY 261
Query: 315 LPTTAVNLIETLLSVEPYKRATASAAL 341
+ EP +R T S +
Sbjct: 262 TTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 3e-05
Identities = 10/40 (25%), Positives = 18/40 (45%), Gaps = 5/40 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKIK 164
D + + +G+G + V A T + VA+K +K
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 52
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 4e-21
Identities = 38/208 (18%), Positives = 68/208 (32%), Gaps = 30/208 (14%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195
K S A D + L+ + + Q+ G+ S+ +HRD+ N+L+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179
Query: 196 NEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFA 254
+ + K+ DFGLA + + + PE + Y D+WS G
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLW 238
Query: 255 ELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 313
EL +G G + +K+ K +
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------------------------E 271
Query: 314 DLPTTAVNLIETLLSVEPYKRATASAAL 341
P ++++T +P KR T +
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 5e-05
Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 13/81 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKIKCYMNQLLHGLEHCHSRGVLH 184
+ + +G G + V A D VA+K +K + R L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--------TEREALM 74
Query: 185 RDIKGSNLLVNNEGVLKLADF 205
++K + L N+ ++ L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGA 95
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 29/185 (15%), Positives = 63/185 (34%), Gaps = 30/185 (16%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQ 217
+ ++ + + G+++ + +HRD+ N+LVN+ V K++DFGL+ +
Sbjct: 109 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 277
+ + + + PE + + D+WS G V E++ ++ K
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 227
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
P D P+ L+ E +R
Sbjct: 228 DGFRLPTP---------------------------MDCPSAIYQLMMQCWQQERARRPKF 260
Query: 338 SAALA 342
+ ++
Sbjct: 261 ADIVS 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 5e-04
Identities = 8/47 (17%), Positives = 18/47 (38%), Gaps = 4/47 (8%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKIKCYMNQ 169
+ + + IG G + V++ + VA+K +K +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 37/182 (20%), Positives = 63/182 (34%), Gaps = 29/182 (15%)
Query: 161 KKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220
K + Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + T
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 221 -SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 279
+ + + + PE L Y D+WS G + E+ VE+L K+ K
Sbjct: 195 TNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 339
+ ++ P +R T
Sbjct: 254 HRMDKP---------------------------SNCTNELYMMMRDCWHAVPSQRPTFKQ 286
Query: 340 AL 341
+
Sbjct: 287 LV 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 4e-04
Identities = 10/42 (23%), Positives = 17/42 (40%), Gaps = 7/42 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGK-------IVALKKIK 164
D + +G+G + V A + K VA+K +K
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 54
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 31/186 (16%), Positives = 65/186 (34%), Gaps = 31/186 (16%)
Query: 160 LKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQP 218
L K+ ++ G+ + ++ +HRD+ N +V + +K+ DFG+ T + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFK 277
++ + + PE L + D+WS G V E+ + QG + + L +
Sbjct: 192 GGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249
Query: 278 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 337
+ L + + P L+ P R +
Sbjct: 250 ---------------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 338 SAALAS 343
++S
Sbjct: 283 LEIISS 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 7e-05
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 6/60 (10%)
Query: 110 PAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKIK 164
P + SA W + + ++GQG++ V+ + VA+K +
Sbjct: 1 PEYFSAADVYVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 6e-20
Identities = 29/184 (15%), Positives = 62/184 (33%), Gaps = 33/184 (17%)
Query: 163 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPL 219
+ + Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL 278
T + + + E L + D+WS G + EL+ G P + + +
Sbjct: 192 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ- 249
Query: 279 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 338
++ P + P ++ + R + S
Sbjct: 250 --------GRRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFS 282
Query: 339 AALA 342
++
Sbjct: 283 ELVS 286
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 0.001
Identities = 10/57 (17%), Positives = 19/57 (33%), Gaps = 14/57 (24%)
Query: 136 EKIGQGTYSSVFRARDLD---TGKIVALKKIKCYMNQ-----------LLHGLEHCH 178
E IG+G + V+ LD A+K + + ++ H +
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.0 bits (168), Expect = 5e-14
Identities = 18/118 (15%), Positives = 42/118 (35%), Gaps = 12/118 (10%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195
+ + + D V ++ ++ +L + + RG++H D+ N+LV+
Sbjct: 78 KVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS 137
Query: 196 NEGVLKLADFGLANFSNTGHRQPLTSR---VVTLWYRPPELLLGATDYGPSVDLWSVG 250
EG+ + DF + + + R + ++ Y D+ S
Sbjct: 138 EEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSAI 186
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 39.0 bits (90), Expect = 7e-04
Identities = 7/29 (24%), Positives = 12/29 (41%), Gaps = 1/29 (3%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKIK 164
+ +G+G S+VF +K K
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHK 33
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 634 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 94.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.56 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 86.42 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 83.59 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=379.42 Aligned_cols=225 Identities=43% Similarity=0.737 Sum_probs=192.6
Q ss_pred eEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------------
Q 006714 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------------- 162 (634)
Q Consensus 133 ~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------------- 162 (634)
|.+++||+|+||+||+|+++.+++.||||+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 468999999999999999999999999995
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTH 159 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccccc
Confidence 56799999999999999999999999999999999999999999998665432 22345
Q ss_pred ccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC-CcccCCC
Q 006714 222 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKP 300 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~-~~~~~~~ 300 (634)
.++|+.|+|||++.....|+.++|||||||++|||++|.+||.+.++.+++..|++.++.++.+.|...... ....+..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 678999999999987677899999999999999999999999999999999999999999988877653222 1111111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 360 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~p~ 360 (634)
.....+...+..+++++++||.+||++||++|||+.|+|+||||++.|.|+++..+|.
T Consensus 240 --~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 240 --FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp --CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred --CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 1123455667788999999999999999999999999999999999998887776664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=364.38 Aligned_cols=223 Identities=42% Similarity=0.729 Sum_probs=188.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
+|+|++++.||+|+||+||+|+++.+++.||||+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 3799999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~ 159 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 159 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-ccc
Confidence 57899999999999999999999999999999999999999999998765432 334
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...++|+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+++..+....+.+.+..|............
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 55688999999999887666789999999999999999999999999999999999999999888777653222111111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
............+..+++++++||.+||.+||.+|||+.|||+||||++...|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 11112233455567889999999999999999999999999999999876443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=365.81 Aligned_cols=215 Identities=43% Similarity=0.754 Sum_probs=183.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCC-CcEEehHH----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKK---------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~t-g~~vAlK~---------------------------------------------- 162 (634)
++|+++++||+|+||+||+|++..+ ++.||||+
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999766 67899996
Q ss_pred -------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEecccccccc
Q 006714 163 -------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 211 (634)
Q Consensus 163 -------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~ 211 (634)
++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 5679999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccC
Q 006714 212 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 291 (634)
Q Consensus 212 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~ 291 (634)
... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|+..++.+....|....
T Consensus 167 ~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 167 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred ccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 432 23456788999999999987 679999999999999999999999999999999999999999999888776543
Q ss_pred CCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 292 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 292 l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
......+... ....+......+++.+++||.+||.+||.+|||+.|||+||||++.
T Consensus 244 ~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 244 ALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 3222222111 1223444556789999999999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=361.60 Aligned_cols=187 Identities=34% Similarity=0.548 Sum_probs=166.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||+|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---cc
Confidence 5679999999999999999999999999999999999999999999766543 23
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..+.......|
T Consensus 162 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p---------------- 224 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP---------------- 224 (263)
T ss_dssp EETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----------------
T ss_pred cccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------------
Confidence 55689999999999987 6789999999999999999999999999988888887755321111
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 225 -------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 225 -------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 347889999999999999999999999999999964
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=366.19 Aligned_cols=226 Identities=44% Similarity=0.749 Sum_probs=184.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+|+.||||+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4799999999999999999999999999999995
Q ss_pred ------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccC
Q 006714 163 ------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 212 (634)
Q Consensus 163 ------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~ 212 (634)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 56799999999999999999999999999999999999999999997654
Q ss_pred CCC---CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 213 TGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 213 ~~~---~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
... .......++|+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+...++.++.+.+..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 12334457899999999998767899999999999999999999999999999999999999999988776654
Q ss_pred cCCCCc-ccCCCCCCCCchhhhhc--CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCC
Q 006714 290 SKLPHA-TLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 354 (634)
Q Consensus 290 ~~l~~~-~~~~~~~~~~~~l~~~~--~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~ 354 (634)
...... ..+.........+.+.+ ...++.+++||.+||++||++|||+.|||+||||++.|.|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 322111 11111111122222222 134678899999999999999999999999999998776553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=363.65 Aligned_cols=194 Identities=27% Similarity=0.414 Sum_probs=163.0
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4789999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-CCCcc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLT 220 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~ 220 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 57799999999999999999999999999999999999999999998764322 23345
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..+||+.|+|||++.+...++.++|||||||+||||++|++||....+...............
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~----------------- 226 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----------------- 226 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-----------------
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------------
Confidence 678999999999998755557889999999999999999999987665443333322211111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
..+..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 227 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 112457899999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-43 Score=359.92 Aligned_cols=218 Identities=39% Similarity=0.733 Sum_probs=179.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
+|+|+++++||+|+||+||+|+++ +++.||||+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 379999999999999999999985 789999997
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||++....... ....
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 158 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT 158 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccc
Confidence 57899999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
...+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.+++..++.++...|.............
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 45679999999999876778999999999999999999999999999999999999999999887776432211111111
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
...........+..+++.+.+||.+||++||++|||+.|||+||||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 111122344555778999999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-42 Score=368.09 Aligned_cols=203 Identities=28% Similarity=0.414 Sum_probs=175.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4689999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC--CCceEEeccccccccCCCCCCCc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||++...... ...
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~ 182 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSV 182 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SCE
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--ccc
Confidence 5679999999999999999999999999999954 578999999999876543 233
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++...
T Consensus 183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 248 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------------- 248 (350)
T ss_dssp EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG-------------
T ss_pred ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-------------
Confidence 55788999999999987 6789999999999999999999999999999999988877544443222
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCCCCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 359 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~~~~~~p 359 (634)
+..+++++++||.+||++||.+|||+.|||+||||+....+.....+|
T Consensus 249 ------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 249 ------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp ------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred ------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 246789999999999999999999999999999999876655444333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=361.21 Aligned_cols=191 Identities=30% Similarity=0.516 Sum_probs=167.2
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|+++.+|+.||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 589999999999999999999999999999996
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccccc
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~g 178 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVG 178 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCS
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cccccccc
Confidence 56799999999999999999999999999999999999999999998765432 23356689
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 304 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~ 304 (634)
|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+..... +...
T Consensus 179 t~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~------------------- 237 (293)
T d1yhwa1 179 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQ------------------- 237 (293)
T ss_dssp CGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCS-------------------
T ss_pred CCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCC-------------------
Confidence 999999999987 6789999999999999999999999999888887777655321 1100
Q ss_pred CchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 305 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 305 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
....+++++++||.+||..||.+|||+.|+|+||||+.
T Consensus 238 ------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 238 ------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 11357899999999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=364.85 Aligned_cols=221 Identities=36% Similarity=0.650 Sum_probs=180.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3689999999999999999999999999999996
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-- 174 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 174 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--
Confidence 5679999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.+..++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.++|.........
T Consensus 175 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred --cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 355678999999999987677899999999999999999999999999999999999999999998877654322111
Q ss_pred cCC--CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCCC
Q 006714 297 LFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 353 (634)
Q Consensus 297 ~~~--~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~~ 353 (634)
... ........+...+..+++.+++||.+||.+||.+|||+.|||+||||+....+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 000 001112234455577899999999999999999999999999999999765433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=365.84 Aligned_cols=217 Identities=39% Similarity=0.641 Sum_probs=183.8
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
+|.++++||+|+||+||+|+++.+++.||||+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 69999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~ 218 (634)
++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++...... ..
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--~~ 178 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EP 178 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT--SC
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC--cc
Confidence 467999999999999999999999999999998775 8999999999876543 23
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+...|+.++|||||||++|||++|.+||...+..+++..|++.++.++.+.|...........
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 35568899999999988767899999999999999999999999999999999999999999999888876433222222
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..............+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222222222233345789999999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=363.50 Aligned_cols=194 Identities=29% Similarity=0.492 Sum_probs=170.7
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
+.+++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 356799999999999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 56799999999999999999999999999999999999999999998654322 3
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+......+|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p-------------- 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-------------- 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC--------------
Confidence 3456789999999999987 6789999999999999999999999999998888887765322211
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++++++||.+||++||.+|+ +++||++||||+...|
T Consensus 226 ---------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 226 ---------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 35789999999999999999999 4999999999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-42 Score=366.66 Aligned_cols=191 Identities=25% Similarity=0.441 Sum_probs=169.9
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH--------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-------------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~-------------------------------------------- 162 (634)
...++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 345899999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++.....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 5679999999999999999999999999999999999999999999876532
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
....+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+....+..|......++
T Consensus 195 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 258 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP-------------- 258 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred -cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--------------
Confidence 345689999999999987 6789999999999999999999999999998888888866432221
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+|+ |+++||+||||+...|
T Consensus 259 ---------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 259 ---------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ---------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ---------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 35789999999999999999995 9999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=358.93 Aligned_cols=193 Identities=31% Similarity=0.510 Sum_probs=165.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999995
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-CCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQP 218 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~ 218 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...... ...
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 56799999999999999999999999999999999999999999998765332 233
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++.+|.......|
T Consensus 167 ~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 230 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--------------- 230 (288)
T ss_dssp ---CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---------------
T ss_pred cccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC---------------
Confidence 455689999999999987 6789999999999999999999999999998888888865321111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHH------HHhccccCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA------ALASEYFSTKPY 351 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e------lL~hpwf~~~~~ 351 (634)
..+++++++||.+||+.||.+|||++| +++||||+...|
T Consensus 231 --------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 231 --------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp --------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred --------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 357889999999999999999999987 588999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=350.58 Aligned_cols=220 Identities=44% Similarity=0.755 Sum_probs=182.8
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
+++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 3689999999999999999999999999999996
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcc
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.++.|++.||+|||+++|+||||||+||||+.++.+||+|||.+....... ....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~ 159 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS 159 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCCC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccce
Confidence 56799999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCC-CCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~p-f~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+++.|+|||++.....++.++|||||||++|||++|+.| |.+.+..+++..+....+.++...|............
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 456688999999998766689999999999999999998866 6777888889999999998887776543221111112
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
...............+++.+.+||.+||++||.+||||+|||+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 22222334445556789999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-42 Score=357.46 Aligned_cols=189 Identities=24% Similarity=0.411 Sum_probs=168.3
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4689999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----c
Confidence 4568999999999999999999999999999999999999999999876532 3
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.++.......|
T Consensus 159 ~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---------------- 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP---------------- 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred ccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----------------
Confidence 45789999999999976 6789999999999999999999999999999888888866322211
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
..+++++.+||.+||..||.+|+ |+++||+||||+...|
T Consensus 222 -------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 222 -------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp -------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 35788999999999999999996 9999999999988644
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=352.04 Aligned_cols=188 Identities=30% Similarity=0.461 Sum_probs=154.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 5799999999999999999999999999999995
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCC-----ceeccCCCCCceecCCCceEEecccccc
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~g-----IvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 4678999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhc
Q 006714 210 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 210 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
...... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+......+
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~------- 233 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR------- 233 (269)
T ss_dssp HC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------
T ss_pred ecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 765432 23355788999999999976 678999999999999999999999999998888877775521110
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcccc
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 346 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf 346 (634)
....+++++.+||.+||+.||.+|||+.|||+|||+
T Consensus 234 ---------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 ---------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 113578899999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=364.36 Aligned_cols=219 Identities=25% Similarity=0.350 Sum_probs=159.0
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..|+|+++++||+|+||+||+|+++.+++.||+|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4567899999999999999999999999999999996
Q ss_pred ------------------------HHHHHHHHHHHHHHHHH-CCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs-~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|......
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 56799999999999997 59999999999999999999999999999865432
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHH-HHHHHHhcCCCCchhhh----ccCC
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWK----KSKL 292 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~-l~~i~~~~g~pp~~~~~----~~~l 292 (634)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+. +..+....+.+...... ....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2345689999999999987 6799999999999999999999999987654332 22222222222111000 0000
Q ss_pred C-CcccCCCCCCCCchhhhh---------cCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 293 P-HATLFKPQQPYDSSLRET---------FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 293 ~-~~~~~~~~~~~~~~l~~~---------~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
. ......+.......+... ...++.++++||.+||.+||.+|||++|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 000000000000000000 0236789999999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-42 Score=357.46 Aligned_cols=192 Identities=29% Similarity=0.481 Sum_probs=156.3
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++++.||+|+||+||+|+++.+++.||||+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 679999999999999999999999999999996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec---CCCceEEeccccccccCCCCCCCc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..|+.||+.||.|||+++|+||||||+|||+. .++.+||+|||++....... ..
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~ 166 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VL 166 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--ee
Confidence 567999999999999999999999999999994 57899999999998665432 23
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
...+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+....+......++..
T Consensus 167 ~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------- 231 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------------- 231 (307)
T ss_dssp ------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT--------------
T ss_pred eeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc--------------
Confidence 55689999999999987 678999999999999999999999999999888888886643333221
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 232 -----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 232 -----------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 124688999999999999999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.5e-42 Score=364.53 Aligned_cols=195 Identities=28% Similarity=0.457 Sum_probs=164.0
Q ss_pred cCCCeeEEEEecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
.+++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46899999999999999999999999999999995
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 4679999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
.....+||+.|+|||++.....|+.++|||||||+||||++|++||.+....+... +.......+..
T Consensus 161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~---------- 227 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVE---------- 227 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCC----------
T ss_pred --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCC----------
Confidence 23456899999999999765678999999999999999999999998755433222 22211111110
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcC-----HHHHHhccccCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 351 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-----a~elL~hpwf~~~~~ 351 (634)
....+++++.+||.+||..||.+||| ++|||+||||+...|
T Consensus 228 ---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 228 ---------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ---------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 11357899999999999999999999 799999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-42 Score=363.19 Aligned_cols=193 Identities=28% Similarity=0.471 Sum_probs=171.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3689999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec--CCCceEEeccccccccCCCCCCCc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~--~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++...... ...
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~ 185 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIV 185 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--Cce
Confidence 567999999999999999999999999999997 5689999999999877643 233
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
....+|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++..|......++...
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 251 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA------------- 251 (352)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST-------------
T ss_pred eeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-------------
Confidence 55678999999999976 6789999999999999999999999999999999988877554444322
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
+..+++++.+||.+||++||.+|||+.|||+||||+..
T Consensus 252 ------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 ------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 24688999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=351.83 Aligned_cols=194 Identities=27% Similarity=0.414 Sum_probs=168.6
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|+++.+|+.||||+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 679999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC----ceEEeccccccccCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 213 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 213 (634)
++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 567999999999999999999999999999998776 499999999987654
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.. ......+|+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+..+......++..
T Consensus 170 ~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 238 (293)
T d1jksa_ 170 GN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-------- 238 (293)
T ss_dssp SC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH--------
T ss_pred Cc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch--------
Confidence 32 2345678999999999986 678999999999999999999999999999999888886654333322
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
.+..+++.+.+||.+||+.||.+|||++|+|+||||+...+
T Consensus 239 -----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 239 -----------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred -----------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 23568899999999999999999999999999999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=355.21 Aligned_cols=192 Identities=25% Similarity=0.382 Sum_probs=164.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+.|++++.||+|+||+||+|+++.+++.||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 579999999999999999999999999999996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~ 170 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF 170 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccc
Confidence 56799999999999999999999999999999999999999999987543211 122356
Q ss_pred cccccCCCcccccC----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 223 VVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 223 ~gt~~Y~APE~l~~----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
+||+.|+|||++.. ...|+.++|||||||+||||++|++||.+.+..+.+..+........
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 235 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--------------- 235 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC---------------
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 78999999999852 35588999999999999999999999999888888877765321100
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 348 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~ 348 (634)
.....+++++.+||.+||+.||.+|||+.|||+||||+.
T Consensus 236 -----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 -----------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -----------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -----------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011357899999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-41 Score=354.92 Aligned_cols=187 Identities=30% Similarity=0.495 Sum_probs=164.1
Q ss_pred CeeEEEEecccCceeEEEEEECCCCcEEehHH------------------------------------------------
Q 006714 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------ 162 (634)
Q Consensus 131 ~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------ 162 (634)
.|+++++||+|+||+||+|++..+++.||||+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCccc
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 221 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 221 (634)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCc
Confidence 567999999999999999999999999999999999999999999986543 245
Q ss_pred ccccccCCCcccccC--CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCC
Q 006714 222 RVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 299 (634)
Q Consensus 222 ~~gt~~Y~APE~l~~--~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~ 299 (634)
.+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.+..+.+..+......+..
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------------- 235 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------------- 235 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---------------
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC---------------
Confidence 679999999999864 245899999999999999999999999998888888777653211110
Q ss_pred CCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 300 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 300 ~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
...+++++.+||.+||+.||.+|||++|||+||||...
T Consensus 236 ------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 13578899999999999999999999999999999764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=355.69 Aligned_cols=218 Identities=39% Similarity=0.640 Sum_probs=181.1
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 789999999999999999999999999999995
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---- 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---- 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG----
T ss_pred EEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc----
Confidence 577999999999999999999999999999999999999999999976542
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|....+.++.+.+..........
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 23456789999999998876678999999999999999999999999999999999999999888876654432211110
Q ss_pred --CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 298 --FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 298 --~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
..........+...+..+++++++||.+||.+||.+|||+.|||+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 011111223445556788999999999999999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-41 Score=353.72 Aligned_cols=223 Identities=36% Similarity=0.597 Sum_probs=181.4
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 579999999999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC--CC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQ 217 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~ 217 (634)
++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ..
T Consensus 88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence 56799999999999999999999999999999999999999999997654322 12
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc--
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-- 295 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~-- 295 (634)
.....++|+.|+|||++.....|+.++||||+||++|+|++|++||.+.+..++...+...+..+.............
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhc
Confidence 335567899999999987667789999999999999999999999999999999999888888777654432211111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
............+...+..+++++++||.+||++||.+|||+.|||+||||+....+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 011111222233456677889999999999999999999999999999999976443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=342.14 Aligned_cols=186 Identities=24% Similarity=0.396 Sum_probs=155.8
Q ss_pred Ce-eEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 131 AF-EKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 131 ~Y-~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
+| ++.++||+|+||+||+|++..+++.||+|+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45 677899999999999999999999999985
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCC--ceeccCCCCCceec-CCCceEEeccccccccCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~g--IvHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~ 214 (634)
++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++......
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 4679999999999999998 99999999999996 5789999999999865432
Q ss_pred CCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.....+||+.|+|||++.+ .|+.++|||||||+||||++|++||.+......+.+.+.. +..+..
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~--------- 233 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS--------- 233 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG---------
T ss_pred ---ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcc---------
Confidence 2356789999999999865 5899999999999999999999999876655544443322 111111
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
....+++++.+||.+||..||++|||+.|+|+||||+
T Consensus 234 ----------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 ----------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1135678899999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-40 Score=342.56 Aligned_cols=193 Identities=31% Similarity=0.445 Sum_probs=168.7
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 689999999999999999999999999999985
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 567999999999999999999999999999999999999999999987765
Q ss_pred CCCCCcccccccccCCCcccccC-----CCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhh
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 288 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~-----~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~ 288 (634)
.. .....+||+.|+|||++.+ ...++.++|||||||+||+|++|++||.+.+..+.+..+......++..
T Consensus 163 ~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 237 (277)
T d1phka_ 163 GE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP--- 237 (277)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred CC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence 32 2355688999999999852 3457889999999999999999999999999888888887643222211
Q ss_pred ccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 289 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 289 ~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+..+++++++||.+||+.||.+|||+.|||+||||+..
T Consensus 238 ----------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 ----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ----------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 124688999999999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=350.77 Aligned_cols=192 Identities=31% Similarity=0.477 Sum_probs=168.2
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.|+|++++.||+|+||+||+|+++.+++.||||+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 3789999999999999999999999999999996
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~ 159 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AK 159 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-cc
Confidence 56799999999999999999999999999999999999999999998654332 33
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++..+.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------- 222 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---------------- 222 (320)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred ccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 455688999999999987 678999999999999999999999999999888888875421111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH-HHHhccccCCCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 351 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~-elL~hpwf~~~~~ 351 (634)
...+++++.+||.+||..||.+|||+. ++++||||+...|
T Consensus 223 -------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 223 -------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp -------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 135789999999999999999999995 8999999987543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=343.04 Aligned_cols=182 Identities=26% Similarity=0.418 Sum_probs=156.0
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++.+.||+|+||+||+|+++.+++.||||+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 589999999999999999999999999999995
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC-CceEEeccccccccCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~-g~vkL~DFGla~~~~~ 213 (634)
++.|+.||+.||+|||+++|+||||||+||||+.+ +.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 56799999999999999999999999999999854 7899999999986543
Q ss_pred CCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 214 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 214 ~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
. ..+..+||+.|+|||++.+...++.++|||||||+||||++|++||.+.+ .+......
T Consensus 164 ~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~------------ 222 (273)
T d1xwsa_ 164 T---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF------------ 222 (273)
T ss_dssp S---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC------------
T ss_pred c---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC------------
Confidence 2 33567899999999999765556788999999999999999999997632 22221100
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
....+++++.+||.+||.+||.+|||++|+|+||||++.
T Consensus 223 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 223 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 013578999999999999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=346.76 Aligned_cols=221 Identities=30% Similarity=0.562 Sum_probs=172.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|+++.+++.||||+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 4789999999999999999999999999999996
Q ss_pred -----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCC-ceEEeccccccccCCCCCCCcccccc
Q 006714 163 -----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVV 224 (634)
Q Consensus 163 -----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~g 224 (634)
++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++....... .....++
T Consensus 114 ~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~ 191 (328)
T d3bqca1 114 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVA 191 (328)
T ss_dssp CCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCS
T ss_pred cCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC--ccccccc
Confidence 678999999999999999999999999999998655 69999999998765432 2355678
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC-CChHHHHHHHHHhcCCCCchhhhc-cCCCCcccCC---
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFK--- 299 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~e~l~~i~~~~g~pp~~~~~~-~~l~~~~~~~--- 299 (634)
|+.|+|||++.+...|+.++|||||||++|+|++|..||.. .+..++...+...++.+....|.. ........+.
T Consensus 192 t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 271 (328)
T d3bqca1 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271 (328)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTC
T ss_pred CccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhc
Confidence 99999999998767789999999999999999999999865 455667777777776543332221 1111111110
Q ss_pred ---CCCCCCc-hhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCC
Q 006714 300 ---PQQPYDS-SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 351 (634)
Q Consensus 300 ---~~~~~~~-~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~ 351 (634)
....... ........+++++++||.+||.+||.+|||++|||+||||++..+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred ccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0000000 011122457889999999999999999999999999999987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=348.14 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=170.7
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 3789999999999999999999999999999996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCC--CceEEeccccccccCCCCCCCcc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLT 220 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~--g~vkL~DFGla~~~~~~~~~~~~ 220 (634)
++.|+.||+.||+|||++||+||||||+||||+.+ ..+||+|||++...... ....
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~ 161 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--Cccc
Confidence 56799999999999999999999999999999754 47999999999876543 2234
Q ss_pred cccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCC
Q 006714 221 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 300 (634)
Q Consensus 221 ~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~ 300 (634)
..++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......++...|
T Consensus 162 ~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------- 227 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------- 227 (321)
T ss_dssp EEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-------------
T ss_pred ccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc-------------
Confidence 5678999999999876 67899999999999999999999999999999999999876555554333
Q ss_pred CCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 301 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 301 ~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
..+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 228 ------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 ------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 5688999999999999999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-41 Score=354.56 Aligned_cols=220 Identities=33% Similarity=0.562 Sum_probs=169.9
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|+++++||+|+||+||+|+++.+|+.||||+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 589999999999999999999999999999996
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~ 174 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FM 174 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc--cc
Confidence 5779999999999999999999999999999999999999999998766543 23
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...++.+++...+.+..++|...........
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence 355678999999999987 6789999999999999999999999999999999999999999988887754221100000
Q ss_pred CCCCCC-Cch------------hhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCCCC
Q 006714 299 KPQQPY-DSS------------LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 352 (634)
Q Consensus 299 ~~~~~~-~~~------------l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~~~ 352 (634)
...... ... .......+++++++||.+||.+||++||||+|||+||||+....+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320 (355)
T ss_dssp HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence 000000 000 001112346789999999999999999999999999999976443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=347.65 Aligned_cols=197 Identities=25% Similarity=0.387 Sum_probs=158.5
Q ss_pred CCCeeEEE-EecccCceeEEEEEECCCCcEEehHH---------------------------------------------
Q 006714 129 ADAFEKLE-KIGQGTYSSVFRARDLDTGKIVALKK--------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~-~LG~G~fg~Vy~a~d~~tg~~vAlK~--------------------------------------------- 162 (634)
.++|+|+. .||+|+||+||+|+++.+++.||||+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 47899986 59999999999999999999999996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCC
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~ 216 (634)
++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~- 168 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 168 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC-
Confidence 5779999999999999999999999999999975 4579999999998765432
Q ss_pred CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 217 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....+.........
T Consensus 169 -~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~------------ 234 (335)
T d2ozaa1 169 -SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------ 234 (335)
T ss_dssp -CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS------------
T ss_pred -ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC------------
Confidence 2356689999999999876 67899999999999999999999999887655554444332111100
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCC
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 349 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~ 349 (634)
.+. ...+..+++++.+||.+||+.||.+|||+.|||+||||...
T Consensus 235 ------~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 235 ------EFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ------SCC---TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ------CCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000 01123578999999999999999999999999999999753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-39 Score=340.98 Aligned_cols=228 Identities=29% Similarity=0.510 Sum_probs=177.4
Q ss_pred ccccccchhhccccchhhhhhhhhhccCcccccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------
Q 006714 96 LHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------- 162 (634)
Q Consensus 96 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------- 162 (634)
+|++..||.+.++ +|+++++||+|+||+||+|+++.+|+.||||+
T Consensus 1 ~~p~~~g~~~~~~----------------------rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~ 58 (362)
T d1q8ya_ 1 YHPAFKGEPYKDA----------------------RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED 58 (362)
T ss_dssp CCCCCTTCEETTT----------------------TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHH
T ss_pred CCCCCCCCCccCC----------------------cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHH
Confidence 4677777776643 79999999999999999999999999999985
Q ss_pred --------------------------------------------------------------------HHHHHHHHHHHH
Q 006714 163 --------------------------------------------------------------------IKCYMNQLLHGL 174 (634)
Q Consensus 163 --------------------------------------------------------------------i~~i~~Qll~aL 174 (634)
++.++.||+.||
T Consensus 59 Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al 138 (362)
T d1q8ya_ 59 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138 (362)
T ss_dssp HHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHH
Confidence 567999999999
Q ss_pred HHHHH-CCceeccCCCCCceecCCC------ceEEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccc
Q 006714 175 EHCHS-RGVLHRDIKGSNLLVNNEG------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 247 (634)
Q Consensus 175 ~yLHs-~gIvHrDLKp~NILl~~~g------~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIW 247 (634)
.|||+ +||+||||||+||||+.++ .++|+|||.+...... ....++|+.|+|||++.. ..|+.++|||
T Consensus 139 ~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 213 (362)
T d1q8ya_ 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGCGADIW 213 (362)
T ss_dssp HHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCTHHHHH
T ss_pred HHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccc-cCCCcccccc
Confidence 99998 8999999999999997654 3899999999765432 245678999999999886 6789999999
Q ss_pred cchhhHHHHhhCCCCCCCC------ChHHHHHHHHHhcCCCCchhhhccCCCCccc-------CCCCC---CCCchhhhh
Q 006714 248 SVGCVFAELLIGKPILQGR------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATL-------FKPQQ---PYDSSLRET 311 (634)
Q Consensus 248 SLG~iLyeLltG~~pf~~~------~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~-------~~~~~---~~~~~l~~~ 311 (634)
||||++++|++|++||... ...+.+..++..++.++.+.+.......... ..... +........
T Consensus 214 SlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (362)
T d1q8ya_ 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 293 (362)
T ss_dssp HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT
T ss_pred chHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccc
Confidence 9999999999999999754 3456778888889998877665432211000 00000 011111111
Q ss_pred c---CCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccCCCC
Q 006714 312 F---KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 350 (634)
Q Consensus 312 ~---~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~~~~ 350 (634)
+ ...++++++||.+||.+||.+|||++|||+||||++..
T Consensus 294 ~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred cccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 1 23467899999999999999999999999999999653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=337.58 Aligned_cols=198 Identities=29% Similarity=0.477 Sum_probs=163.0
Q ss_pred CCCeeEEEEecccCceeEEEEEEC---CCCcEEehHH-------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~---~tg~~vAlK~------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++. .+|+.||||+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999974 4789999995
Q ss_pred ----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCC
Q 006714 163 ----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 214 (634)
Q Consensus 163 ----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 214 (634)
++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 4678999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccccCCCcccccCCC-CCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 215 HRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 215 ~~~~~~~~~gt~~Y~APE~l~~~~-~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.........+++.|++||.+.+.. .++.++|||||||+||+|++|..||.+....+....+.........
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--------- 253 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------- 253 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC---------
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC---------
Confidence 444445678899999999997533 5788999999999999999999999887655555554432211110
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCc-----CHHHHHhccccCCCCC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 351 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp-----Ta~elL~hpwf~~~~~ 351 (634)
.....+++++.+||.+||.+||.+|| |++|+|+||||+...|
T Consensus 254 ----------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 254 ----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 01135789999999999999999999 5899999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-38 Score=326.95 Aligned_cols=193 Identities=26% Similarity=0.406 Sum_probs=156.6
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|++++.||+|+||+||+|+++.+++.||||+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4789999999999999999999999999999996
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 56799999999999999999999999999999999999999999987553322
Q ss_pred --CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 216 --RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 216 --~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+++.....++.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 235 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc---------
Confidence 223455688999999999976 67899999999999999999999999999988888877664333221
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhccccC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 347 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hpwf~ 347 (634)
.....+|+++.+||.+||+.||.+||+..+.|.|+|++
T Consensus 236 ----------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 12256899999999999999999999555555677753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=326.59 Aligned_cols=193 Identities=21% Similarity=0.356 Sum_probs=162.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|+++++||+|+||+||+|++. +++.||||+
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~E 87 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEE
Confidence 456689999999999999999999975 577899996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++..........
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 457999999999999999999999999999999999999999999987765444444
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+|+.|+|||++.. ..|+.++|||||||+||||++ |.+||...+..+.+..+......+
T Consensus 168 ~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---------------- 230 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---------------- 230 (272)
T ss_dssp TTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred cccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence 55678999999999875 568999999999999999999 567777777777776664421111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh--ccccCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFST 348 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~--hpwf~~ 348 (634)
....+++++.+||.+||+.||++|||+.+|++ ++||+.
T Consensus 231 ------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 ------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01357889999999999999999999999998 888863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=323.92 Aligned_cols=192 Identities=21% Similarity=0.352 Sum_probs=154.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++.++||+|+||+||+|+.. ..||||+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEE
Confidence 456689999999999999999999853 3599986
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC-C
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-R 216 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~ 216 (634)
+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||++....... .
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 46789999999999999999999999999999999999999999997664322 2
Q ss_pred CCcccccccccCCCcccccCC--CCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 217 QPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 217 ~~~~~~~gt~~Y~APE~l~~~--~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
.......||+.|+|||++.+. ..|+.++|||||||+||||++|+.||.+.+....+..+......+|.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD---------- 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc----------
Confidence 233556789999999998642 35889999999999999999999999988777666665544322221
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+......+++++.+||.+||..||.+|||+.||+++
T Consensus 231 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 -------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112234678999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-38 Score=327.04 Aligned_cols=188 Identities=18% Similarity=0.266 Sum_probs=155.8
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++.++||+|+||+||+|++..+++.||||+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 4666899999999999999999999999999999996
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 45689999999999999999999999999999999999999999998776544433
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCC-CCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~p-f~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.+ ..|+.++|||||||++|||+++..| |.+.+..+....+ .....++
T Consensus 173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~-------------- 236 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRME-------------- 236 (287)
T ss_dssp ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCC--------------
T ss_pred eccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCC--------------
Confidence 444567899999999876 6789999999999999999996554 5555554444433 2211111
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++++.+||.+||+.||.+|||+.||++
T Consensus 237 -------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 -------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11357889999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-38 Score=318.16 Aligned_cols=185 Identities=22% Similarity=0.319 Sum_probs=146.4
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++. +++.||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 468999999999999999999986 567899996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.............
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 456999999999999999999999999999999999999999999987655443334456
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||...+..+.+..+......+.
T Consensus 163 ~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------------ 223 (263)
T d1sm2a_ 163 KFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------------ 223 (263)
T ss_dssp --CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC------------------
T ss_pred ecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Confidence 78999999999986 678999999999999999998 6788888887777777654321110
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++++.+||.+||+.||.+|||++|||+|
T Consensus 224 ----------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 ----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 13467889999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-38 Score=323.19 Aligned_cols=190 Identities=24% Similarity=0.339 Sum_probs=149.9
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECC-----CCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~-----tg~~vAlK~-------------------------------------- 162 (634)
++..++|+++++||+|+||+||+|++.. +++.||||+
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3445799999999999999999999754 446899985
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceec
Q 006714 163 -----------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 195 (634)
Q Consensus 163 -----------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~ 195 (634)
+..|+.||+.||.|||+++|+||||||+||||+
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 235788999999999999999999999999999
Q ss_pred CCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHH
Q 006714 196 NEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLH 273 (634)
Q Consensus 196 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~ 273 (634)
.++.+||+|||+++....... .......||+.|+|||++.+ ..|+.++|||||||++|||+++ .+||.+....+.+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986543322 23345678999999999986 6789999999999999999986 57888776555555
Q ss_pred HHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 274 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 274 ~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.++.....++ ....+++++.+||.+||+.||.+|||+.|||+|
T Consensus 248 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5444321111 113578899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-38 Score=327.56 Aligned_cols=190 Identities=21% Similarity=0.296 Sum_probs=157.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCc-----EEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~-----~vAlK~-------------------------------------- 162 (634)
++..++|++.++||+|+||+||+|++..+++ .||+|+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4556899999999999999999999876554 588875
Q ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCC
Q 006714 163 -----------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKG 189 (634)
Q Consensus 163 -----------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp 189 (634)
+..|+.||+.||.|||+++||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 123788999999999999999999999
Q ss_pred CCceecCCCceEEeccccccccCCCCCC-CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCC
Q 006714 190 SNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT 267 (634)
Q Consensus 190 ~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~ 267 (634)
+|||++.++.+||+|||+++........ ......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999865433222 2234567999999999876 678999999999999999997 899999877
Q ss_pred hHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 268 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 268 ~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..+.+.+++.....++ ....+++++.+||.+||+.||++|||++||++|
T Consensus 272 ~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7666666655322221 013578899999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=320.39 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=156.4
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|++.+.||+|+||+||+|++..+ +.||||+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~E 91 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEE
Confidence 45668999999999999999999998755 5699996
Q ss_pred -----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCc
Q 006714 163 -----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 219 (634)
Q Consensus 163 -----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 219 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++..........
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 467999999999999999999999999999999999999999999987654443444
Q ss_pred ccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccC
Q 006714 220 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 298 (634)
Q Consensus 220 ~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~ 298 (634)
....+|+.|+|||++.. ..++.++|||||||+||||++ |.++|......+.+..+......+
T Consensus 172 ~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---------------- 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------------- 234 (285)
T ss_dssp ----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred ccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence 45678999999999976 678999999999999999999 567777777777777765432111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh--ccccCCC
Q 006714 299 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFSTK 349 (634)
Q Consensus 299 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~--hpwf~~~ 349 (634)
....+++++.+||.+||+.||++|||+++|++ ++||+..
T Consensus 235 ------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 ------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11357889999999999999999999999998 8999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=316.12 Aligned_cols=185 Identities=22% Similarity=0.315 Sum_probs=159.9
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|+++ +++.||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 468999999999999999999984 778899996
Q ss_pred --------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCCcccc
Q 006714 163 --------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 222 (634)
Q Consensus 163 --------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 222 (634)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..............
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 467999999999999999999999999999999999999999999987655444444556
Q ss_pred cccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCC
Q 006714 223 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 301 (634)
Q Consensus 223 ~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~ 301 (634)
.+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+......+.
T Consensus 162 ~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 222 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------------ 222 (258)
T ss_dssp CCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC------------------
T ss_pred CCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence 78999999999986 678999999999999999998 8999999998888877755321111
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 302 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 302 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++++.+||.+||+.||.+|||+++||+|
T Consensus 223 ----------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 223 ----------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 13467889999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=317.92 Aligned_cols=189 Identities=23% Similarity=0.363 Sum_probs=147.2
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC---cEEehHH----------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKK---------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg---~~vAlK~---------------------------------------- 162 (634)
++..++|++.+.||+|+||+||+|++..++ ..||||.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 82 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 82 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeE
Confidence 345579999999999999999999987554 4588875
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 46789999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCC
Q 006714 216 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 294 (634)
Q Consensus 216 ~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~ 294 (634)
........+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..+......+
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~------------ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------ 229 (273)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------------
T ss_pred ceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 334455677999999999976 678999999999999999997 899999988888777765421110
Q ss_pred cccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 295 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 295 ~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
..+.+++.+.+||.+||+.||.+|||+.||++|
T Consensus 230 ----------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 ----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 114678999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-37 Score=317.67 Aligned_cols=188 Identities=22% Similarity=0.348 Sum_probs=146.1
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCc---EEehHH-----------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~---~vAlK~----------------------------------------- 162 (634)
+..++|++.++||+|+||+||+|+++.+++ .||||.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 445789999999999999999999987765 588875
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 45799999999999999999999999999999999999999999998665332
Q ss_pred CC----CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 216 RQ----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 216 ~~----~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
.. ......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..+......+.
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 254 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP------- 254 (299)
T ss_dssp -------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------
T ss_pred CcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 21 1122356889999999876 678999999999999999998 8999999988887777754321111
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
...+++.+.+||.+||+.||.+|||+.||+++
T Consensus 255 ---------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 ---------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 13578899999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=321.35 Aligned_cols=187 Identities=21% Similarity=0.330 Sum_probs=151.5
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCc----EEehHH------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKK------------------------------------------ 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~----~vAlK~------------------------------------------ 162 (634)
.++|+++++||+|+||+||+|++..+++ .||+|.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 87 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 87 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeE
Confidence 4689999999999999999999988876 477764
Q ss_pred -------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC
Q 006714 163 -------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 217 (634)
Q Consensus 163 -------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 217 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 4679999999999999999999999999999999999999999999876543322
Q ss_pred -CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 218 -PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 218 -~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+....+.... .++
T Consensus 168 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~------------ 233 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP------------ 233 (317)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC------------
T ss_pred ccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC------------
Confidence 2334467999999999986 578999999999999999998 899999887766665554321 111
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhcc
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 344 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~hp 344 (634)
....+++.+.+||.+||..||.+|||+.|||.|-
T Consensus 234 ---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 234 ---------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ---------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 0135788999999999999999999999999883
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-37 Score=315.64 Aligned_cols=197 Identities=21% Similarity=0.310 Sum_probs=154.8
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
++|++++.||+|+||+||+|++..+++.||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 579999999999999999999999999999996
Q ss_pred ------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC---CCceEEeccccccccCCCCC-----
Q 006714 163 ------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR----- 216 (634)
Q Consensus 163 ------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~~----- 216 (634)
+..++.||+.||+|||++||+||||||+|||++. +..++|+|||+++.......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 166 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccccee
Confidence 5679999999999999999999999999998753 45799999999987653321
Q ss_pred -CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCc
Q 006714 217 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 295 (634)
Q Consensus 217 -~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~ 295 (634)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........+........
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------------ 233 (299)
T d1ckia_ 167 YRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM------------ 233 (299)
T ss_dssp CCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH------------
T ss_pred ccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC------------
Confidence 12345678999999999987 6689999999999999999999999987665444433322110000
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHH---HHHhccccCC
Q 006714 296 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFST 348 (634)
Q Consensus 296 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~---elL~hpwf~~ 348 (634)
..........+|+++.+||..||..||.+||++. ++|+|+|.+.
T Consensus 234 ---------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 ---------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0012233467899999999999999999999986 5578887643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=309.91 Aligned_cols=188 Identities=20% Similarity=0.319 Sum_probs=145.5
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCC----cEEehHH---------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKK--------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg----~~vAlK~--------------------------------------- 162 (634)
++..+.|++.+.||+|+||+||+|.+..++ ..||||+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 345578999999999999999999987654 4699985
Q ss_pred -----------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 -----------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 -----------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 457999999999999999999999999999999999999999999987644
Q ss_pred CCC--CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhcCCCCchhhhcc
Q 006714 214 GHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 290 (634)
Q Consensus 214 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~ 290 (634)
... .......+|+.|+|||++.+ ..|+.++|||||||+||||+++ .+||...+..+.+..+..... ++
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~------- 233 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP------- 233 (283)
T ss_dssp -----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC-------
T ss_pred CCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CC-------
Confidence 322 12233467899999999976 6789999999999999999985 566666666666655543211 11
Q ss_pred CCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 291 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 291 ~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....++..+.+||.+||+.||.+|||+.||++
T Consensus 234 --------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 --------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01357889999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=313.41 Aligned_cols=192 Identities=20% Similarity=0.249 Sum_probs=157.7
Q ss_pred ccCCCeeEEEE-ecccCceeEEEEEECCC--CcEEehHH-----------------------------------------
Q 006714 127 LRADAFEKLEK-IGQGTYSSVFRARDLDT--GKIVALKK----------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~-LG~G~fg~Vy~a~d~~t--g~~vAlK~----------------------------------------- 162 (634)
+..++|.+.+. ||+|+||+||+|.++.+ +..||||+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 84 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 84 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEE
Confidence 34578999984 99999999999987543 45799985
Q ss_pred --------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC
Q 006714 163 --------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 216 (634)
Q Consensus 163 --------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 216 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 467999999999999999999999999999999999999999999987654322
Q ss_pred --CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCC
Q 006714 217 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 293 (634)
Q Consensus 217 --~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~ 293 (634)
.......+|+.|+|||++.. ..|+.++|||||||++|||++ |.+||.+.+..+.+..+..... ++
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-~~---------- 232 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-ME---------- 232 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-CC----------
T ss_pred ccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC----------
Confidence 22234567899999999876 578999999999999999998 9999999888777776644211 10
Q ss_pred CcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHH---HhccccC
Q 006714 294 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYFS 347 (634)
Q Consensus 294 ~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~el---L~hpwf~ 347 (634)
..+.+++++.+||.+||..||++|||+.+| |+|+|++
T Consensus 233 -----------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 -----------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 114578999999999999999999999888 6788874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=308.67 Aligned_cols=182 Identities=21% Similarity=0.291 Sum_probs=148.4
Q ss_pred EEecccCceeEEEEEEC--CCCcEEehHH---------------------------------------------------
Q 006714 136 EKIGQGTYSSVFRARDL--DTGKIVALKK--------------------------------------------------- 162 (634)
Q Consensus 136 ~~LG~G~fg~Vy~a~d~--~tg~~vAlK~--------------------------------------------------- 162 (634)
++||+|+||+||+|.+. .+++.||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 46999999999999864 4567899985
Q ss_pred ----------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCC--Ccccccc
Q 006714 163 ----------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVV 224 (634)
Q Consensus 163 ----------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~~g 224 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........ ......+
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 172 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCC
Confidence 4679999999999999999999999999999999999999999999866533221 2234567
Q ss_pred cccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCC
Q 006714 225 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 303 (634)
Q Consensus 225 t~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~ 303 (634)
|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+.... .++
T Consensus 173 t~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~-------------------- 230 (277)
T d1xbba_ 173 PVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMG-------------------- 230 (277)
T ss_dssp CGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC--------------------
T ss_pred CceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CCC--------------------
Confidence 899999999976 568999999999999999997 899999988877766664321 110
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHH---Hhcccc
Q 006714 304 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYF 346 (634)
Q Consensus 304 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~el---L~hpwf 346 (634)
....+++++.+||.+||+.||.+|||+.+| |+|+|+
T Consensus 231 -------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 013578899999999999999999999998 466665
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-36 Score=311.72 Aligned_cols=187 Identities=24% Similarity=0.346 Sum_probs=154.5
Q ss_pred ccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH---------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK--------------------------------------- 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~--------------------------------------- 162 (634)
+..++|++++.||+|+||+||+|+++ .+++.||||+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34578999999999999999999975 3567899985
Q ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCC
Q 006714 163 ----------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGS 190 (634)
Q Consensus 163 ----------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~ 190 (634)
+..|+.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 3457899999999999999999999999
Q ss_pred CceecCCCceEEeccccccccCCCC-CCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCC-CCCCCCCh
Q 006714 191 NLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTE 268 (634)
Q Consensus 191 NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~-~pf~~~~~ 268 (634)
||||+.++.+||+|||++....... ........+|+.|+|||++.+ ..|+.++|||||||+||||+++. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999997554322 223345677899999999986 67999999999999999999984 78999988
Q ss_pred HHHHHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 269 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 269 ~e~l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+.+..+.+... + .....+++++.+||.+||+.||.+|||+.||++
T Consensus 249 ~e~~~~v~~~~~--~--------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNI--L--------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCC--C--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCC--C--------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888877654211 1 011467889999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=305.50 Aligned_cols=189 Identities=23% Similarity=0.317 Sum_probs=151.6
Q ss_pred ccccCCCeeEEEEecccCceeEEEEEECCCC-------cEEehHH-----------------------------------
Q 006714 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTG-------KIVALKK----------------------------------- 162 (634)
Q Consensus 125 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg-------~~vAlK~----------------------------------- 162 (634)
+++..++|++.+.||+|+||.||+|++..++ ..||||+
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 3456689999999999999999999976554 3799986
Q ss_pred -------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCce
Q 006714 163 -------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 193 (634)
Q Consensus 163 -------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NIL 193 (634)
+..++.||+.||+|||+++||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 3578999999999999999999999999999
Q ss_pred ecCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHH
Q 006714 194 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 271 (634)
Q Consensus 194 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~ 271 (634)
++.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 99999999999999986643322 22344577999999999976 679999999999999999998 7999998887766
Q ss_pred HHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 272 l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+..+... ..++ ....+++++.+||.+||+.||.+|||+.|||+
T Consensus 247 ~~~i~~~-~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEG-HRMD---------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTT-CCCC---------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcC-CCCC---------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6555331 1111 01357889999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-36 Score=310.33 Aligned_cols=188 Identities=18% Similarity=0.278 Sum_probs=157.3
Q ss_pred cccCCCeeEEEEecccCceeEEEEEEC-----CCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~-----~tg~~vAlK~-------------------------------------- 162 (634)
++..++|++.++||+|+||+||+|.+. .++..||||+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 556689999999999999999999874 2357899985
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEe
Q 006714 163 ---------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 203 (634)
Q Consensus 163 ---------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~ 203 (634)
+..|+.||+.||.|||+++|+||||||+||||+.++.+||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 24589999999999999999999999999999999999999
Q ss_pred ccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhcCC
Q 006714 204 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGS 281 (634)
Q Consensus 204 DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~g~ 281 (634)
|||+++....... .......+|+.|+|||.+.+ ..++.++|||||||+||||++| .+||.+.+..+.+..+.+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999976543222 22234467999999999986 6788999999999999999998 5889998888888877542211
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 282 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 282 pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+ ....+++.+.+||.+||+.||.+|||+.+||+
T Consensus 255 ~----------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 D----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 11357889999999999999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-36 Score=305.20 Aligned_cols=187 Identities=27% Similarity=0.375 Sum_probs=149.7
Q ss_pred cCCCeeEEEEecccCceeEEEEEECC-CC--cEEehHH------------------------------------------
Q 006714 128 RADAFEKLEKIGQGTYSSVFRARDLD-TG--KIVALKK------------------------------------------ 162 (634)
Q Consensus 128 ~~~~Y~i~~~LG~G~fg~Vy~a~d~~-tg--~~vAlK~------------------------------------------ 162 (634)
..++|++++.||+|+||+||+|++.. ++ ..||||+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~ 85 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM 85 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecch
Confidence 34689999999999999999998643 33 3688875
Q ss_pred ---------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCC
Q 006714 163 ---------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 215 (634)
Q Consensus 163 ---------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 215 (634)
+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 45789999999999999999999999999999999999999999998765432
Q ss_pred CC--CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCC
Q 006714 216 RQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 292 (634)
Q Consensus 216 ~~--~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l 292 (634)
.. ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 235 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--------- 235 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------
T ss_pred CcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence 21 2233456889999999986 678999999999999999998 8999999999998888765422221
Q ss_pred CCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 293 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 293 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
....+++.+.+||.+||..||.+|||+.+|++
T Consensus 236 ------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 ------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11467889999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.6e-35 Score=302.39 Aligned_cols=189 Identities=21% Similarity=0.292 Sum_probs=154.1
Q ss_pred CCCeeEEEEecccCceeEEEEEECCCCcEEehHH----------------------------------------------
Q 006714 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK---------------------------------------------- 162 (634)
Q Consensus 129 ~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~---------------------------------------------- 162 (634)
.++|+++++||+|+||+||+|++..+++.||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 3689999999999999999999999999999996
Q ss_pred -------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecC-----CCceEEeccccccccCCCCC--
Q 006714 163 -------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANFSNTGHR-- 216 (634)
Q Consensus 163 -------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~-----~g~vkL~DFGla~~~~~~~~-- 216 (634)
+..++.||+.||+|||++||+||||||+||||+. ++.+||+|||+++.......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence 4579999999999999999999999999999964 56899999999986543211
Q ss_pred ----CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCCCC---hHHHHHHHHHhcCCCCchhhhc
Q 006714 217 ----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKK 289 (634)
Q Consensus 217 ----~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~~~---~~e~l~~i~~~~g~pp~~~~~~ 289 (634)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+......+
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~------- 235 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST------- 235 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-------
T ss_pred ceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-------
Confidence 12345679999999999987 678999999999999999999999998643 333333333221111
Q ss_pred cCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 290 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 290 ~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
...+.++.+|+++.+||..|+..+|.+||+.+.+.+
T Consensus 236 -----------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 -----------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123445678999999999999999999999877654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-35 Score=297.33 Aligned_cols=183 Identities=19% Similarity=0.331 Sum_probs=149.1
Q ss_pred cccCCCeeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------- 162 (634)
++..++|+++++||+|+||+||+|++ ++..||||+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 46678999999999999999999998 477899997
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 4579999999999999999999999999999999999999999999865432
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHHHHHHHhcCCCCchhhhccCCCCccc
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 297 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~~ 297 (634)
.....+++.|+|||++.+ ..++.++|||||||++|||++ |++||...+..+.+..+.+.. .+
T Consensus 157 ~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-~~--------------- 219 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KM--------------- 219 (262)
T ss_dssp -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CC---------------
T ss_pred CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC---------------
Confidence 233456889999999986 578999999999999999998 799998887777766663311 00
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 298 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 298 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
+....+++++.+||.+||..||.+|||+.+|+++
T Consensus 220 ------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 ------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0113578899999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=301.66 Aligned_cols=189 Identities=22% Similarity=0.340 Sum_probs=157.7
Q ss_pred cccCCCeeEEEEecccCceeEEEEEE-----CCCCcEEehHH--------------------------------------
Q 006714 126 PLRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKK-------------------------------------- 162 (634)
Q Consensus 126 ~~~~~~Y~i~~~LG~G~fg~Vy~a~d-----~~tg~~vAlK~-------------------------------------- 162 (634)
++..++|++.++||+|+||.||+|++ ..+++.||||+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 45668999999999999999999986 35677899986
Q ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCcee
Q 006714 163 ------------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 194 (634)
Q Consensus 163 ------------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl 194 (634)
+..|+.||+.||.|||+++|+||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 34589999999999999999999999999999
Q ss_pred cCCCceEEeccccccccCCCCC-CCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhh-CCCCCCCCChHHHH
Q 006714 195 NNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 272 (634)
Q Consensus 195 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLlt-G~~pf~~~~~~e~l 272 (634)
+.++.++|+|||+++....... ......++|+.|+|||++.+ ..++.++|||||||++|||++ |.+||......+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 22344678999999999976 678999999999999999998 77888887777777
Q ss_pred HHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 273 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 273 ~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
.+++.....+.. ...+++.+.+||.+||+.||.+|||+.+||+
T Consensus 258 ~~~i~~~~~~~~---------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRMLS---------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCCC---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCC---------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 766654222210 1356889999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=301.22 Aligned_cols=186 Identities=23% Similarity=0.324 Sum_probs=153.0
Q ss_pred ccCCCeeEEEEecccCceeEEEEEECCCCcE--EehHH------------------------------------------
Q 006714 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKK------------------------------------------ 162 (634)
Q Consensus 127 ~~~~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~--vAlK~------------------------------------------ 162 (634)
+..++|++.++||+|+||+||+|+++.++.. ||||+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4558999999999999999999999888875 56654
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCce
Q 006714 163 ------------------------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 200 (634)
Q Consensus 163 ------------------------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~v 200 (634)
+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 24578999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhC-CCCCCCCChHHHHHHHHHhc
Q 006714 201 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLC 279 (634)
Q Consensus 201 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG-~~pf~~~~~~e~l~~i~~~~ 279 (634)
||+|||++........ .....+|..|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999976543221 234467999999999976 6789999999999999999996 57888888887776664321
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 280 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 280 g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
.++ ....+++++.+||.+||+.||++|||+.|||++
T Consensus 244 -~~~---------------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 -RLE---------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -CCC---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 113578899999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.6e-33 Score=289.36 Aligned_cols=182 Identities=19% Similarity=0.233 Sum_probs=141.6
Q ss_pred eEEEEecccCceeEEEEEECCCC---cEEehHH-----------------------------------------------
Q 006714 133 EKLEKIGQGTYSSVFRARDLDTG---KIVALKK----------------------------------------------- 162 (634)
Q Consensus 133 ~i~~~LG~G~fg~Vy~a~d~~tg---~~vAlK~----------------------------------------------- 162 (634)
.+-++||+|+||+||+|++..++ ..||||+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 34678999999999999987654 3589885
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCC---C
Q 006714 163 ----------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---Q 217 (634)
Q Consensus 163 ----------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---~ 217 (634)
+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 457999999999999999999999999999999999999999999986543322 2
Q ss_pred CcccccccccCCCcccccCCCCCCCccccccchhhHHHHhhCCCCCCC-CChHHHHHHHHHhcCCCCchhhhccCCCCcc
Q 006714 218 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 296 (634)
Q Consensus 218 ~~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~iLyeLltG~~pf~~-~~~~e~l~~i~~~~g~pp~~~~~~~~l~~~~ 296 (634)
......+|+.|+|||++.. ..++.++|||||||+||||++|..||.. .+..+....+.... .++
T Consensus 190 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~------------- 254 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLL------------- 254 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-CCC-------------
T ss_pred ecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC-------------
Confidence 2233567999999999876 6789999999999999999997666554 33333344433211 110
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHhc
Q 006714 297 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 343 (634)
Q Consensus 297 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~h 343 (634)
....+++.+.+||.+||..||.+|||+.||++|
T Consensus 255 --------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 --------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 013567899999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=285.95 Aligned_cols=190 Identities=26% Similarity=0.325 Sum_probs=140.5
Q ss_pred CCeeEEEEecccCceeEEEEEECCCCcEEehHH-----------------------------------------------
Q 006714 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK----------------------------------------------- 162 (634)
Q Consensus 130 ~~Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~----------------------------------------------- 162 (634)
.+|.+.+.||+|+||+||+|++ +|+.||||+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5799999999999999999986 689999996
Q ss_pred ---------------------HHHHHHHHHHHHHHHHH--------CCceeccCCCCCceecCCCceEEeccccccccCC
Q 006714 163 ---------------------IKCYMNQLLHGLEHCHS--------RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 213 (634)
Q Consensus 163 ---------------------i~~i~~Qll~aL~yLHs--------~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 213 (634)
+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 35689999999999997 5999999999999999999999999999986543
Q ss_pred CCC---CCcccccccccCCCcccccCCC-----CCCCccccccchhhHHHHhhCCCCCCCCCh--------------HHH
Q 006714 214 GHR---QPLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE--------------VEQ 271 (634)
Q Consensus 214 ~~~---~~~~~~~gt~~Y~APE~l~~~~-----~~s~~sDIWSLG~iLyeLltG~~pf~~~~~--------------~e~ 271 (634)
... ......+||+.|+|||++.+.. .++.++|||||||+||||++|.+||..... .+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 221 1234567899999999986532 256789999999999999999887743221 111
Q ss_pred HHHHHHhcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcCCCcHHHHHHHHHhhccCcCCCcCHHHHHh
Q 006714 272 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 342 (634)
Q Consensus 272 l~~i~~~~g~pp~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~elL~ 342 (634)
+.......+ +++..+ . ..........+.+||.+||..||.+|||+.||++
T Consensus 241 ~~~~~~~~~-----------------~~p~~~--~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 241 MRKVVCEQK-----------------LRPNIP--N--RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHTTSC-----------------CCCCCC--G--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHhccc-----------------cCCCCC--c--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111111000 000000 0 0001123456889999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.69 E-value=3.1e-18 Score=164.04 Aligned_cols=114 Identities=19% Similarity=0.163 Sum_probs=83.9
Q ss_pred eeEEEEecccCceeEEEEEECCCCcEEehHH-------------------------------------------------
Q 006714 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK------------------------------------------------- 162 (634)
Q Consensus 132 Y~i~~~LG~G~fg~Vy~a~d~~tg~~vAlK~------------------------------------------------- 162 (634)
|.+.++||+|+||+||+|++. +|+.||||+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999985 689999993
Q ss_pred ------------------------HHHHHHHHHHHHHHHHHCCceeccCCCCCceecCCCceEEeccccccccCCCCCCC
Q 006714 163 ------------------------IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 218 (634)
Q Consensus 163 ------------------------i~~i~~Qll~aL~yLHs~gIvHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 218 (634)
+..++.||+.+|.|||++||+||||||+|||++++ .++|+|||++..........
T Consensus 81 ~~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~ 159 (191)
T d1zara2 81 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE 159 (191)
T ss_dssp EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH
T ss_pred EecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHH
Confidence 45689999999999999999999999999999865 58999999987654221110
Q ss_pred cccccccccCCCcccccCCCCCCCccccccchhh
Q 006714 219 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 252 (634)
Q Consensus 219 ~~~~~gt~~Y~APE~l~~~~~~s~~sDIWSLG~i 252 (634)
......+ .-.+.+. ..|+..+|+||+.--
T Consensus 160 ~l~rd~~---~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 160 ILERDVR---NIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp HHHHHHH---HHHHHHH--HHHCCCCCHHHHHHH
T ss_pred HHHHHHH---HHHHHHc--CCCCCcccHHHHHHH
Confidence 0000000 0012221 457889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=94.02 E-value=0.026 Score=53.39 Aligned_cols=28 Identities=29% Similarity=0.463 Sum_probs=24.0
Q ss_pred ceeccCCCCCceecCCCceEEecccccc
Q 006714 182 VLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 182 IvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 6899999999999877666799998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.56 E-value=0.023 Score=58.12 Aligned_cols=28 Identities=18% Similarity=0.315 Sum_probs=24.0
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++|+|+++.|||++++ .++|+||.++.
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence 48999999999999876 48999998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.24 E-value=0.039 Score=53.94 Aligned_cols=29 Identities=31% Similarity=0.472 Sum_probs=25.9
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
|+||+|+.++|||++.+..+-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999988777899998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=86.42 E-value=0.099 Score=48.80 Aligned_cols=29 Identities=28% Similarity=0.257 Sum_probs=24.6
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999887667799998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=83.59 E-value=0.28 Score=48.04 Aligned_cols=27 Identities=30% Similarity=0.356 Sum_probs=22.1
Q ss_pred CceeccCCCCCceecCCCceEEecccccc
Q 006714 181 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 209 (634)
Q Consensus 181 gIvHrDLKp~NILl~~~g~vkL~DFGla~ 209 (634)
++||+|+++.|||+++ + ..|+||+.+.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 6899999999999964 3 4588998664
|